<?xml version="1.0"?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">9809671</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">21092</journal-id>
      <journal-id journal-id-type="nlm-ta">Nat Neurosci</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Neurosci</journal-id>
      <journal-title-group>
        <journal-title>Nature neuroscience</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1097-6256</issn>
      <issn pub-type="epub">1546-1726</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33558695</article-id>
      <article-id pub-id-type="pmc">8095368</article-id>
      <article-id pub-id-type="doi">10.1038/s41593-020-00787-0</article-id>
      <article-id pub-id-type="manuscript">NIHMS1656366</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Maynard</surname>
            <given-names>Kristen R.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Collado-Torres</surname>
            <given-names>Leonardo</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weber</surname>
            <given-names>Lukas M.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Uytingco</surname>
            <given-names>Cedric</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barry</surname>
            <given-names>Brianna K.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Stephen R.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Catallini</surname>
            <given-names>Joseph L.</given-names>
            <suffix>II</suffix>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tran</surname>
            <given-names>Matthew N.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Besich</surname>
            <given-names>Zachary</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tippani</surname>
            <given-names>Madhavi</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chew</surname>
            <given-names>Jennifer</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>Yifeng</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kleinman</surname>
            <given-names>Joel E.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hyde</surname>
            <given-names>Thomas M.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>Nikhil</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hicks</surname>
            <given-names>Stephanie C.</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martinowich</surname>
            <given-names>Keri</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref rid="CR1" ref-type="corresp">+</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jaffe</surname>
            <given-names>Andrew E.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A5">5</xref>
          <xref ref-type="aff" rid="A6">6</xref>
          <xref ref-type="aff" rid="A7">7</xref>
          <xref ref-type="aff" rid="A9">9</xref>
          <xref rid="CR1" ref-type="corresp">+</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1.</label>Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, 21205, USA</aff>
      <aff id="A2"><label>2.</label>Center for Computational Biology, Johns Hopkins University, Baltimore, MD, 21205, USA</aff>
      <aff id="A3"><label>3.</label>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA</aff>
      <aff id="A4"><label>4.</label>10x Genomics, Pleasanton, CA, 94588, USA.</aff>
      <aff id="A5"><label>5.</label>Department of Neuroscience, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA</aff>
      <aff id="A6"><label>6.</label>Department of Genetic Medicine, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA</aff>
      <aff id="A7"><label>7.</label>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA</aff>
      <aff id="A8"><label>8.</label>Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA</aff>
      <aff id="A9"><label>9.</label>Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21205, USA</aff>
      <author-notes>
        <corresp id="CR1"><label>+</label>Corresponding authors</corresp>
        <fn fn-type="con" id="FN1">
          <p id="P1">Author contribution
<list list-type="bullet" id="L1"><list-item><p id="P2">K.R.M. - Conceptualization, Methodology, Validation, Investigation, Writing, Visualization</p></list-item><list-item><p id="P3">L.C-T. - Methodology, Software, Formal analysis, Data Curation, Writing, Visualization</p></list-item><list-item><p id="P4">L.M.W. - Methodology, Software, Formal analysis, Writing, Visualization</p></list-item><list-item><p id="P5">C.U. - Methodology, Investigation, Resources</p></list-item><list-item><p id="P6">B.K.B. - Formal analysis, Data Curation, Visualization</p></list-item><list-item><p id="P7">S.R.W. - Software, Data Curation</p></list-item><list-item><p id="P8">J.L.C. - Software, Formal analysis, Visualization</p></list-item><list-item><p id="P9">M.N.T. - Investigation, Formal analysis</p></list-item><list-item><p id="P10">Z.B. - Software</p></list-item><list-item><p id="P11">M.T. - Formal analysis, Visualization</p></list-item><list-item><p id="P12">J.C. - Investigation</p></list-item><list-item><p id="P13">Y.Y. - Investigation</p></list-item><list-item><p id="P14">J.E.K. - Resources</p></list-item><list-item><p id="P15">T.M.H. - Methodology, Resources</p></list-item><list-item><p id="P16">N.R. - Resources, Supervision, Funding acquisition</p></list-item><list-item><p id="P17">S.C.H. - Methodology, Software, Formal analysis, Writing, Visualization, Supervision</p></list-item><list-item><p id="P18">K.M. - Conceptualization, Methodology, Writing, Supervision, Project administration, Funding acquisition</p></list-item><list-item><p id="P19">A.E.J.- Conceptualization, Methodology, Software, Formal analysis, Writing, Visualization, Supervision, Project administration, Funding acquisition</p></list-item></list>
</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>28</day>
        <month>4</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>2</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>08</day>
        <month>8</month>
        <year>2021</year>
      </pub-date>
      <volume>24</volume>
      <issue>3</issue>
      <fpage>425</fpage>
      <lpage>436</lpage>
      <!--elocation-id from pubmed: 10.1038/s41593-020-00787-0-->
      <permissions>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://www.nature.com/authors/editorial_policies/license.html#terms</ali:license_ref>
          <license-p>Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:<uri xlink:href="http://www.nature.com/authors/editorial_policies/license.html#terms">http://www.nature.com/authors/editorial_policies/license.html#terms</uri></license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <p id="P20">We used the 10x Genomics Visium platform to define the spatial topography of gene expression in the six-layered human dorsolateral prefrontal cortex (DLPFC). We identified extensive layer-enriched expression signatures, and refined associations to previous laminar markers. We overlaid our laminar expression signatures onto large-scale single nuclei RNA sequencing data, enhancing spatial annotation of expression-driven clusters. By integrating neuropsychiatric disorder gene sets, we showed differential layer-enriched expression of genes associated with schizophrenia and autism spectrum disorder, highlighting the clinical relevance of spatially-defined expression. We then developed a data-driven framework to define unsupervised clusters in spatial transcriptomics data, which can be applied to other tissues or brain regions where morphological architecture is not as well-defined as cortical laminae. We lastly created a web application for the scientific community to explore these raw and summarized data to augment ongoing neuroscience and spatial transcriptomics research (<ext-link ext-link-type="uri" xlink:href="http://research.libd.org/spatialLIBD">http://research.libd.org/spatialLIBD</ext-link>).</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec id="S1">
      <title>Introduction</title>
      <p id="P21">The spatial organization of the brain is fundamentally related to its function. This structure-function relationship is especially apparent in the context of the laminar organization of the human cerebral cortex where cells residing within different cortical layers show distinct gene expression patterns and exhibit differing patterns of morphology, physiology, and connectivity <sup><xref rid="R1" ref-type="bibr">1</xref>&#x2013;<xref rid="R4" ref-type="bibr">4</xref></sup>. To the extent that structure entrains function, understanding normal brain development as well as disorders of the central nervous system will require identifying the cell types that make up the brain, and ultimately linking functional correlates of individual cell classes with structural architecture.</p>
      <p id="P22">Major advances in single-cell (scRNA-seq) and single-nuclei (snRNA-seq) sequencing technologies have dramatically increased identification of molecularly-defined cell types in the human brain and implicated unique cell classes in risk for specific brain disorders <sup><xref rid="R5" ref-type="bibr">5</xref>&#x2013;<xref rid="R11" ref-type="bibr">11</xref></sup>. While scRNA-seq approaches are common in rodent brain tissue, the relatively large size and fragility of human neurons, coupled with the fact that most available postmortem human brain tissue is frozen, has resulted in nearly all available data in the human brain being generated on isolated nuclei with snRNA-seq approaches <sup><xref rid="R12" ref-type="bibr">12</xref></sup>. While nuclear profiles are generally representative of whole cell profiles <sup><xref rid="R13" ref-type="bibr">13</xref></sup>, isolated nuclei lack the cytoplasmic compartment as well as axons and proximal dendrites, which limits our understanding of gene expression in the cytosol and neuropil <sup><xref rid="R12" ref-type="bibr">12</xref></sup>. This is problematic for studies of brain disorders as converging evidence suggests that impairments in the formation or maintenance of synapses in critical cortical microcircuits are involved in many neuropsychiatric and neurodevelopmental disorders, including schizophrenia disorder (SCZD) and autism spectrum disorder (ASD) <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup>. Indeed, studies in the postmortem brains of individuals with these disorders have implicated not only specific cell types <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R12" ref-type="bibr">12</xref>,<xref rid="R16" ref-type="bibr">16</xref></sup>, but also revealed differences in neuronal and synaptic structure that are spatially localized to specific cortical layers <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup>. Furthermore, genes associated with increased risk for SCZD that were identified by genome-wide association studies (GWAS) are preferentially enriched for synaptic neuropil transcripts <sup><xref rid="R12" ref-type="bibr">12</xref></sup>, suggesting that the extra-nuclear information missed by snRNA-seq approaches may be especially relevant for understanding genetic risk for brain disorders. While molecular profiles derived from sc/sn-RNAseq data can be used to predict anatomical location based on canonical marker genes described in the literature or from curated datasets, precisely assigning gene expression to the spatial coordinates of individual cell populations within intact brain cytoarchitecture of postmortem human brain tissue would significantly advance our understanding of studies of human brain development and disease.</p>
      <p id="P23">Because it is considered a gold standard for quantifying gene expression with high spatial resolution, we recently established and optimized methods for using multiplex single-molecule fluorescent in situ hybridization (smFISH) in postmortem human brain tissue <sup><xref rid="R17" ref-type="bibr">17</xref></sup>. However, multiplexing with these technologies is limited, and even for methodologies that can accommodate hundreds to thousands of transcripts simultaneously, molecular crowding within cells leads to fluorescence overlap, which introduces significant microscopy-related issues and computational challenges <sup><xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup>. The relatively large size of the human brain and lipofuscin-derived autofluorescence pose additional challenges for microscopy-based spatial transcriptomic methods in postmortem human tissue. While methods such as laser capture microdissection (LCM)-seq do allow for transcriptome-wide profiling from cytosol in a spatially-defined area <sup><xref rid="R20" ref-type="bibr">20</xref>&#x2013;<xref rid="R22" ref-type="bibr">22</xref></sup>, the tissue is removed from the surrounding spatial context and processed separately, hindering the ability to analyze gradients of gene expression and examine spatial relationships within intact sections.</p>
      <p id="P24">Emerging technologies for genome-wide spatial transcriptomics offer significant potential for providing detailed molecular maps that overcome limitations associated with sn/scRNA-seq and microscopy-based spatial transcriptomic methods. Importantly, these technologies use an on-slide cDNA synthesis approach that captures gene expression in the architecture of intact tissue, meaning that information from cytosol and neuronal processes is retained <sup><xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R24" ref-type="bibr">24</xref></sup>. To further our understanding of gene expression within the context of the spatial organization of the human cortex, we used the recently-released, 10x Genomics Visium platform, a novel barcoding-based transcriptome-wide spatial transcriptomics technology, to generate spatial maps of gene expression in the six-layered dorsolateral prefrontal cortex (DLPFC) of the adult human brain. The Visium platform expands the spatial resolution 5-fold beyond the first-generation &#x2018;Spatial Transcriptomics&#x2019; approach <sup><xref rid="R23" ref-type="bibr">23</xref></sup> upon which it is based. While the original approach was successfully used to generate gene expression atlases and identify perturbations in transcriptional pathways for several normal and pathological human tissues, including the developing heart <sup><xref rid="R25" ref-type="bibr">25</xref></sup>, invasive ductal cancer <sup><xref rid="R23" ref-type="bibr">23</xref></sup>, pancreatic ductal adenocarcinoma <sup><xref rid="R26" ref-type="bibr">26</xref></sup>, prostate cancer <sup><xref rid="R27" ref-type="bibr">27</xref></sup>, postmortem spinal cord <sup><xref rid="R28" ref-type="bibr">28</xref></sup> and cerebellum <sup><xref rid="R29" ref-type="bibr">29</xref></sup> of patients with amyotrophic lateral sclerosis (ALS), it lacked the necessary spatial resolution to resolve both individual cells and laminar structures in the human cortex.</p>
      <p id="P25">Since some differences in pathology and gene expression associated with neuropsychiatric disorders are localized to specific cortical layers <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup>, the ability to localize spatial gene expression in the human brain at cellular resolution will be critical to gain further insight into disease mechanisms. Towards this end, we sought to define the laminar topography of gene expression in the human DLPFC, a brain area that has been implicated in a number of neuropsychiatric disorders. We overlaid data from recent large-scale snRNA-seq studies in the human brain with our spatial data to first confirm our layer-enriched expression signatures, and to then increase precision in manual annotation of gene expression-driven clusters to cortical laminae. To exemplify the potential of this type of data for clinical translation, we integrated our dataset with various neuropsychiatric disorder gene sets to demonstrate preferential layer-enriched expression of ASD risk genes and layer-enriched association of risk for several neuropsychiatric disorders. Finally, we compared the manually-annotated laminar clusters to entirely data-driven spatial clusters in the same human cortical tissue, using an approach that can also be applied to other human tissues and brain regions that do not have as clear morphological patterning as the cerebral cortex. We provide these data and analysis tools as a significant scientific resource for the neuroscience community to augment current molecular profiling and spatial transcriptomics efforts in the human brain.</p>
    </sec>
    <sec id="S2">
      <title>Results</title>
      <p id="P26">We profiled spatial gene expression in human postmortem DLPFC tissue sections from two pairs of &#x2018;spatial replicates&#x2019; from three independent neurotypical adult donors. Each pair consisted of two, directly adjacent 10&#x3BC;m serial tissue sections with the second pair located 300&#x3BC;m posterior from the first, resulting in a total of 12 samples run on the Visium platform (<xref rid="F1" ref-type="fig">Figure 1 A</xref>&#x2013;<xref rid="F1" ref-type="fig">B</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S1</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1</xref>) <xref rid="S14" ref-type="sec">Method Details: Tissue processing and Visium data generation</xref>). We sequenced each sample to a median depth of 291.1M reads (IQR: 269.3M-327.7M), which corresponded to a mean 3,462 unique molecular indices (UMIs) and a mean 1,734 genes per spot. We note these rates are analogous to snRNA-seq and scRNA-seq data using the 10x Genomics Chromium platform, where a &#x2018;cell&#x2019; barcode on the Chromium platform corresponds to a &#x2018;spatial&#x2019; barcode on the Visium platform. However, unlike snRNA-seq data from postmortem human brain, which contains high numbers of intronic reads that map to immature transcripts, we found strong enrichment of mature mRNAs with high mean rates of exonic alignments (mean: 83.3%, IQR: 82.5-84.3%, <xref rid="S15" ref-type="sec">Method Details: Visium raw data processing</xref>). Independent processing and cell segmentation of high-resolution histology images acquired before on-slide cDNA synthesis indicated an average of 3.3 cells per spot (IQR: 1-4), with a mean 15.0% (IQR: 12.8-17.9%) spots per sample containing a single cell body and 9.7% (IQR: 5.4-12.3%) &#x2018;neuropil&#x2019; spots that lacked any cell bodies (<xref rid="S16" ref-type="sec">Method Details: Histology image processing and segmentation</xref>). Tissue sections were acquired in the plane perpendicular to the pial surface that extended to the gray-white matter junction (<xref rid="F1" ref-type="fig">Figure 1 C</xref>). The orientation of each sample was confirmed by delineating the border between layer 6 (L6) and the adjacent white matter (WM) and identifying layer (L5) using marker genes for gray matter/neurons (<italic>SNAP25</italic>), WM/oligodendrocytes (<italic>MOBP</italic>), and L5 (<italic>PCP4</italic>) in each tissue section (<xref rid="F1" ref-type="fig">Figure 1 D</xref>&#x2013;<xref rid="F1" ref-type="fig">F</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 2</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 3</xref>, and <xref rid="F8" ref-type="fig">Extended Data 1</xref>). A summary of the data generated and analyses performed is located in <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 4</xref>.</p>
      <sec id="S3">
        <title>Gene expression in the DLPFC across cortical laminae</title>
        <p id="P27">We first generated aggregated layer-enriched expression profiles for each spatial replicate using a &#x2018;supervised&#x2019; approach to assign individual spots to each of the six neocortical layers or the WM (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 5</xref>, <xref rid="S17" ref-type="sec">Method Details: Spot-level data processing</xref>). Then, we performed &#x2018;pseudo-bulking&#x2019; by summing the UMI counts for each gene within each layer across each spatial replicate to generate layer-enriched expression profiles (<xref rid="F2" ref-type="fig">Figure 2A</xref>, <xref rid="S18" ref-type="sec">Method Details: Layer-level data processing</xref>). The pseudo-bulking approach, summarizing 47,681 spots to 76 layer-aggregated profiles across the 12 samples, removed sparsity and greatly increased UMI coverage of genes (<xref rid="F2" ref-type="fig">Figure 2A</xref>). Unsupervised clustering of these layer-enriched expression profiles revealed the top component of variation in the data related to laminar differences, particularly between the white and gray matter (<xref rid="F2" ref-type="fig">Figure 2B</xref>), with high concordance between the pairs of spatial replicates (<xref rid="F9" ref-type="fig">Extended Data 2</xref>). Segmentation of histological images confirmed sparser cell densities in layer 1 (L1), a molecular layer enriched in synaptic processes, with 33.4% and 21.7% of spots containing 0 and 1 cell body, respectively. We observed increased cell densities in the oligodendrocyte-enriched WM, with 3.9% and 5.9% of spots containing 0 and 1 cell body, respectively (<xref rid="SD4" ref-type="supplementary-material">Table S2</xref>). We hypothesized that these &#x2018;neuropil spots&#x2019; with 0 cell bodies may be enriched with neuronal processes (i.e. axons and dendrites; <xref rid="SD4" ref-type="supplementary-material">Table S3</xref>), and as predicted we identified significant enrichment of genes that are preferentially expressed in the transcriptome of synaptic terminals <sup><xref rid="R30" ref-type="bibr">30</xref></sup> (&#x3C1;=0.38, <italic>p</italic>=1.9e-30, <xref rid="F10" ref-type="fig">Extended Data 3</xref>) (<xref rid="S19" ref-type="sec">Method Details: Neuropil enrichment analyses</xref>). Together, these analyses demonstrate the power of concurrently acquiring histology and gene expression data and highlight the ability of the Visium platform to achieve high resolution spatial expression profiling within the human DLPFC.</p>
        <p id="P28">We used three strategies to perform differential expression (DE) analyses using the layer-enriched expression profiles generated above with linear mixed-effects modeling (<xref rid="F11" ref-type="fig">Extended Data 4</xref>, <xref rid="S20" ref-type="sec">Method Details: Layer-level gene modeling</xref>). The first strategy involved testing for differences in mean expression across the six layers plus WM (we also tested for differences in mean expression with only six layers, excluding WM), termed the &#x2018;ANOVA&#x2019; model (<xref rid="F2" ref-type="fig">Figure 2 C</xref>), which estimates an F-statistic for each gene. This strategy revealed extensive differential expression across the laminar organization of the DLPFC, with 10,633 (47.6%) DE genes (DEGs) across the six gray matter layers plus WM (at FDR &lt; 0.05) and 8,581 (38.4%) DEGs across the six gray matter layers excluding WM (FDR &lt; 0.05). As expected, these results suggested extensive differences in gene expression between the layers of the DLPFC beyond broad white versus gray matter comparisons. The second strategy identified layer-enriched genes by testing for differences in expression between one layer versus all other layers, termed the &#x2018;enrichment&#x2019; model (<xref rid="F2" ref-type="fig">Figure 2 D</xref>), which resulted in a <italic>t</italic>-statistic (termed &#x2018;layer-enriched statistics&#x2019; hereafter) and <italic>p</italic>-value (and corresponding FDR adjusted <italic>q</italic>-value) for each expressed gene and layer (<xref rid="S20" ref-type="sec">Method Details: Layer-level gene modeling</xref>). The largest expression differences were between WM and the neocortical layers, with 9,124 DEGs (FDR &lt; 0.05), and the smallest differences were between L3 and all other layers with 183 DEGs genes (<xref rid="SD4" ref-type="supplementary-material">Table S4</xref>). In the third strategy, we tested for genes differentially expressed between each pair of layers (21 pairs), termed the &#x2018;pairwise&#x2019; model (<xref rid="F2" ref-type="fig">Figure 2 E</xref>, <xref rid="S20" ref-type="sec">Method Details: Layer-level gene modeling</xref>), which produced significant DEGs ranging from 8,500 for WM versus L3 to 292 for L4 versus L5 (<xref rid="SD4" ref-type="supplementary-material">Table S4</xref>). Together, these analyses highlight the extensive gene expression differences between the different layers of the human adult DLPFC.</p>
      </sec>
      <sec id="S4">
        <title>Identifying novel layer-enriched genes in human cortex</title>
        <p id="P29">Several resources have compiled genes that exhibit laminar-specific expression across both rodent <sup><xref rid="R31" ref-type="bibr">31</xref></sup> and human cortex <sup><xref rid="R32" ref-type="bibr">32</xref></sup>. While both overlapping and unique marker genes have been identified, these studies used different technologies, examined different developmental stages, and queried different regions of cortex. Therefore, we systematically assessed the robustness of these previously identified marker genes in our human adult DLPFC layer-enriched gene expression dataset. First, we tested for enrichment of previously published layer-enriched genes - as a set - among our layer-enriched DEGs, and found strong enrichment (<italic>p</italic>=1.22e-41). Since many of these marker genes were previously annotated to multiple layers (i.e. <italic>CCK</italic> and <italic>ENC1</italic>, <xref rid="F3" ref-type="fig">Figure 3</xref>), rather than a single layer as queried in our DE analyses, we fit the &#x2018;optimal&#x2019; statistical model for each gene using our layer-enriched expression profiles (<xref rid="S21" ref-type="sec">Method Details: Known marker genes optimal modeling</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S5</xref>). For example, <italic>CCK</italic> was annotated to L2, L3, and L6, which were together tested against combining L1, L3, L4, and WM in this optimal model. Only a subset of previously-associated layer-enriched genes showed high ranks and significant differential expression in our human DLPFC data (<xref rid="F12" ref-type="fig">Extended Data 5</xref>), which were largely driven by markers identified by Zeng <italic>et al.</italic>
<sup><xref rid="R32" ref-type="bibr">32</xref></sup>.</p>
        <p id="P30">We further confirmed laminar enrichment of a number of canonical marker genes, including <italic>CCK, ENC1, CUX2, RORB</italic>, and <italic>NTNG2</italic>, and validated these findings against publicly available singleplex <italic>in situ</italic> hybridization data from the Allen Brain Institute&#x2019;s Human Brain Atlas <sup><xref rid="R33" ref-type="bibr">33</xref></sup> (<xref rid="F3" ref-type="fig">Figure 3</xref> and <xref rid="F13" ref-type="fig">Extended Data 6</xref>). Interestingly, while many of these genes (<italic>FABP7, ADCYAP1, PVALB</italic>) showed layer-enriched expression in our data, they were not classified by the Allen Brain Institute resources as being layer markers, demonstrating the utility of quantitative transcriptome-scale spatial approaches. Although we confirmed several canonical layer-enriched/specific genes, we found that only 59.5% of previously identified marker genes were significant DEGs (FDR &lt; 0.05) in human DLPFC (<xref rid="SD4" ref-type="supplementary-material">Table S5</xref>). Indeed, we identified several genes previously underappreciated as laminar markers in human DLPFC, including <italic>AQP4</italic> (L1), <italic>HPCAL1</italic> (L2), <italic>FREM3</italic> (L3), <italic>TRABD2A</italic> (L5) and <italic>KRT17</italic> (L6) (<xref rid="F4" ref-type="fig">Figure 4</xref> and <xref rid="F14" ref-type="fig">Extended Data 7</xref>). We validated these novel layer-enriched DEGs using multiplex single molecule fluorescent <italic>in situ</italic> hybridization (<xref rid="F4" ref-type="fig">Figure 4</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 6</xref>, <xref rid="S22" ref-type="sec">Methods Details: RNAscope smFISH</xref>). Novel layer-enriched DEGs were also validated by multiplexing with previously identified layer markers in the literature, many of which were also replicated in our Visium data (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 7</xref>).</p>
      </sec>
      <sec id="S5">
        <title>Spatial registration of single nuclei RNA sequencing (snRNA-seq)</title>
        <p id="P31">Adding spatial resolution to snRNA-seq datasets generated from human brain tissue has the potential to provide further insights about the function of molecularly-defined cell types. Specifically, layer-enriched expression profiles and differential expression statistics derived from the &#x2018;enrichment model&#x2019; in our Visium data can be used to spatially &#x201C;register&#x201D; snRNA-seq datasets and add layer-enriched information to data-driven expression clusters that do not contain inherent anatomical information (<xref rid="F5" ref-type="fig">Figure 5 A</xref>, <xref rid="S23" ref-type="sec">Methods Details: snRNA-seq spatial registration</xref>). We first used snRNA-seq data from Hodge <italic>et al.</italic>
<sup><xref rid="R5" ref-type="bibr">5</xref></sup> to confirm our layer-enriched expression profiles and validate this spatial registration strategy. While the snRNA-seq data in that study was obtained predominantly from NeuN+ sorted neuronal nuclei that were isolated from manually-dissected layers of the human postmortem middle temporal gyrus cortex, our layer-enriched DEGs from spatially-barcoded bulk tissue sections were in agreement with the laminar assignments from which these nuclei were derived (<xref rid="F5" ref-type="fig">Figure 5 B</xref>). We further validated this strategy on bulk RNA-seq data that was generated from manually-dissected laminar serial sections of the human prefrontal cortex from four donors <sup><xref rid="R22" ref-type="bibr">22</xref></sup>. This data however lacked corresponding histology data to definitively annotate specific cortical layers, and assignment of sections to layers likely underestimated the amount of WM present (~5 sections/sample instead of just one predicted section), and missed L1 in one of their four subjects (H1) (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 8</xref>).</p>
        <p id="P32">We then used our layer-enriched statistics to perform spatial registration across three independent snRNA-seq datasets from human cortex. First, we generated our own snRNA-seq data from DLPFC using 5,231 nuclei from two donors, and performed data driven clustering to generate 30 preliminary cell clusters across 7 broad cell types (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 9</xref>, <xref rid="S24" ref-type="sec">Method Details: DLPFC snRNA-seq data generation</xref>). Integration of our layer-enriched statistics refined excitatory and inhibitory neuronal subclasses into upper and deep layer subgroups beyond expected enrichments of glial cells in the WM (<xref rid="F15" ref-type="fig">Extended Data 8 A</xref>). We further assessed the robustness of this approach by re-analyzing processed snRNA-seq from 48 donors across 70,634 nuclei obtained from the human prefrontal cortex (BA10) across 44 broad clusters in a study of Alzheimer&#x2019;s disease <sup><xref rid="R10" ref-type="bibr">10</xref></sup>. Glial cell subpopulations showed expected enrichments, with preferential expression of oligodendrocyte subtypes in the WM, astrocyte subtypes in L1, and microglia, oligodendrocyte precursor (OPC), pericytes, and endothelial subtypes in both L1 and WM (<xref rid="F5" ref-type="fig">Figure 5 C</xref>). Neuronal cell subtypes showed greater laminar diversity, with multiple excitatory and inhibitory neuronal cell types associating with L2/L3, L4, L5, and L6 preferential expression, with generally more layer-enriched expression within excitatory cells (<xref rid="F5" ref-type="fig">Figure 5 C</xref>). Interestingly, our analysis showed that the excitatory neuronal subclasses (Ex2, Ex4, Ex6) identified by Mathys <italic>et al.</italic> that were most associated with clinical traits of Alzheimer&#x2019;s disease were preferentially localized to the upper layers (L2/L3) of DLPFC in our data. This finding contrasts the inferences that were drawn by Mathys <italic>et al.</italic>, which made layer assignments based on data obtained from the serial sections in He <italic>et al.</italic> described above <sup><xref rid="R22" ref-type="bibr">22</xref></sup>. Specifically, they concluded that excitatory neuronal subclass Ex4 and Ex6 were preferentially expressed in the deeper layers while excitatory neuronal subclass Ex2 showed no laminar enrichment.</p>
        <p id="P33">We lastly applied our spatial registration analysis to a study of autism spectrum disorder (ASD) <sup><xref rid="R6" ref-type="bibr">6</xref></sup> including snRNA-seq data from 104,559 nuclei isolated from the human prefrontal cortex and anterior cingulate cortex that were obtained from 41 samples across 31 donors, which were annotated to 17 clusters in a study of ASD <sup><xref rid="R6" ref-type="bibr">6</xref></sup> (<xref rid="F15" ref-type="fig">Extended Data 8 B</xref>). As expected, we confirmed expected spatial contexts; for example, the highest enrichment of oligodendrocytes was again found in our histologically-defined WM. Our spatial registration framework was also able to refine the laminar predictions of cell-types in these previous studies. For example, integration of layer-enriched genes defined by Visium with snRNA-seq data from Velmeshev <italic>et al.</italic> indicated that astrocyte populations were most enriched in L1, while excitatory neurons annotated to L4 were more likely to be found in L5. These analyses demonstrate how this &#x2018;spatial registration&#x2019; framework can be readily applied to any existing snRNA-seq or scRNA-seq datasets from dissociated cells to add back anatomical information.</p>
      </sec>
      <sec id="S6">
        <title>Clinical relevance of layer-enriched gene expression profiling</title>
        <p id="P34">Given that several studies have identified associations between different brain disorders and molecularly-defined cell types, we assessed the clinical relevance of spatial gene expression using several different brain disorder-associated gene sets. We assessed the laminar enrichment of (1) gene sets derived from genes linked to different disorders via DNA profiling, (2) genes differentially expressed in postmortem brains of patients with a variety of brain disorders and neurotypical controls, and (3) genes associated with genetic risk via transcriptome-wide association studies (TWAS). We first used broad gene sets for different brain disorders compiled by Birnbaum <italic>et al.</italic>
<sup><xref rid="R34" ref-type="bibr">34</xref></sup>, which showed laminar enrichments specifically for ASD (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 10</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S6</xref>, <xref rid="S25" ref-type="sec">Method Details: Clinical gene set enrichment analyses</xref>). We used the latest SFARI Gene database <sup><xref rid="R35" ref-type="bibr">35</xref></sup> to refine these associations, and demonstrate enrichments of L2 (OR=2.74, <italic>p</italic>=6.0e-21), L5 (OR=2.1, <italic>p</italic>=8.7e-7) and L6 (OR=2.7, <italic>p</italic>=1.8e-7) with ASD risk genes (<xref rid="F6" ref-type="fig">Figure 6 A</xref>). We confirmed the L2 (OR=3.6, <italic>p</italic>=3.9e-6) and L5 (OR=4.0, <italic>p</italic>=6.7e-5) associations in a recent exome sequencing study by Satterstrom <italic>et al.</italic>
<sup><xref rid="R36" ref-type="bibr">36</xref></sup>, which identified 102 genes with ASD-associated variants. Interestingly, stratifying these genes by their clinical symptoms refined the laminar enrichments, as the 53 genes associated with ASD-dominant traits were more enriched for L5 (OR=4.9, <italic>p</italic>=5.3e-4, 8 genes: <italic>TBR1, SATB1, ANK2, RORB, MKX, CELF4, PPP5C, AP2S1</italic>), whereas the 49 genes associated with neurodevelopmental delay were more enriched for L2 (OR=4.5, <italic>p</italic>=7.8e-5, 12 genes: <italic>CACNA1E, MYT1L, SCN2A, TBL1XR1, NR3C2, SYNGAP1, GRIN2B, IRF2BPL, GABRB3, RAI1, TCF4, ADNP</italic>), suggesting that different functional subclasses of neurons might be contributing to each clinical subgroup. These layer-enriched expression associations for risk genes were largely independent of the enrichments seen comparing genes more highly expressed (WM: <italic>p</italic>=1.9e-29 and L1: <italic>p</italic>=4.5e-61) or more lowly expressed (L3: <italic>p</italic>=2.9e-5, L4: <italic>p</italic>=1.7e-42, L5: <italic>p</italic>=3.2e-36, and L6: <italic>p</italic>=1.9e-7) in brains of ASD patients compared to neurotypical controls (<xref rid="SD4" ref-type="supplementary-material">Table S6</xref>).</p>
        <p id="P35">We further assessed laminar enrichment of genes proximal to common genetic variation associated with SCZD, ASD, bipolar disorder (BPD), and major depressive disorder (MDD) <sup><xref rid="R37" ref-type="bibr">37</xref></sup>. These analyses identified significant overlap between L2-enriched and L5-enriched genes and risk for SCZD (at Bonferroni &lt; 0.05), with additional overlap between L2-enriched genes and risk for bipolar disorder (at FDR &lt; 0.05, <xref rid="SD4" ref-type="supplementary-material">Table S7</xref>). As above with ASD, there were markedly different laminar enrichments for genes associated with SCZD illness state. Enrichment analyses of DEGs identified in two large SCZD postmortem brain datasets <sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R38" ref-type="bibr">38</xref></sup>, while highly convergent across studies, showed extensive enrichment across all layers, with increased expression of L1, L2, and L3 genes and decreased expression of WM, L4, L5 and L6 genes in patients compared to controls (<xref rid="F6" ref-type="fig">Figure 6 B</xref>). As secondary analyses, we performed heritability partitioning analysis <sup><xref rid="R39" ref-type="bibr">39</xref></sup> for layer-enriched gene sets, which again identified significant heritability enrichment exclusively for L2 enriched-genes, specifically for SCZD, BPD, and educational attainment (<xref rid="SD4" ref-type="supplementary-material">Table S8</xref>, <xref rid="S25" ref-type="sec">Method Details: Clinical gene set enrichment analyses</xref>). We additionally assessed TWAS statistics constructed for SCZD and BPD from single nucleotide polymorphism (SNP) weights computed from DLPFC <sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup>. While we did not observe strong enrichments of TWAS signal for any layer-enriched gene expression, SCZD risk genes in L2 and L5 suggested decreased expression in illness (<xref rid="F6" ref-type="fig">Figure 6 B</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S6</xref>). Together, these analyses highlight the potential utility of these data in gleaning clinical insights by incorporating layer-enriched gene expression of the adult DLPFC into the interpretation of risk genes.</p>
      </sec>
      <sec id="S7">
        <title>Data-driven layer-enriched clustering in the DLPFC</title>
        <p id="P36">Lastly, we explored the use of three alternative &#x2018;data-driven&#x2019; approaches to classify Visium spots into laminar and non-laminar patterns, in contrast to the &#x2018;supervised&#x2019; approach of identifying layer-enriched DEGs from manually-annotation of layers based on cytoarchitecture (<xref rid="F7" ref-type="fig">Figure 7 A</xref>, <xref rid="F7" ref-type="fig">B</xref>; <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 11</xref>), which may not be feasible in other brain regions or human tissues that lack clear or established morphological boundaries. Towards this goal, we explored the use of two gene sets: (1) genes exhibiting spatially variable expression patterns (SVGs) within each of the 12 samples (<xref rid="SD4" ref-type="supplementary-material">Table S9</xref>), and (2) highly variable genes (HVGs; <xref rid="S26" ref-type="sec">Method Details: Data-driven layer-enriched clustering analysis</xref>). While no laminar information was used to identify SVGs and HVGs, interestingly these gene sets could identify both laminar and non-laminar spatial patterns (<xref rid="F7" ref-type="fig">Figure 7 C</xref>, <xref rid="F7" ref-type="fig">D</xref>). For example, we identified several SVGs that were non-laminar, including <italic>HBB, IGKC</italic>, and <italic>NPY</italic>, which likely relate to blood cells, immune cells, and inhibitory interneuron classes (<xref rid="F7" ref-type="fig">Figure 7 D</xref>). In a completely data-driven and &#x2018;unsupervised&#x2019; approach, we then used several implementations of unsupervised clustering methods with spot-level Visium data using these gene sets, with the possibility of further incorporating spatial coordinates of the spots, since we reasoned that adjacent spots should tend to show more similar expression levels (<xref rid="F7" ref-type="fig">Figure 7 E</xref>, <xref rid="F16" ref-type="fig">Extended Data 9</xref>, <xref rid="F17" ref-type="fig">Extended Data 10</xref>; <xref rid="S26" ref-type="sec">Method Details: Data-driven layer-enriched clustering analysis</xref>). We compared these results to a &#x2018;semi-supervised&#x2019; approach (unsupervised clustering guided by the layer-enriched genes identified using the DE &#x201C;enrichment&#x201D; models; <xref rid="F11" ref-type="fig">Extended Data 4</xref>) and an approach using known rodent and human layer marker genes from Zeng <italic>et al.</italic>
<sup><xref rid="R32" ref-type="bibr">32</xref></sup> (<xref rid="F7" ref-type="fig">Figure 7 E</xref>, and <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>).</p>
        <p id="P37">Using the manually-annotated layers as a &#x2018;gold standard&#x2019; (<xref rid="F7" ref-type="fig">Figure 7 A</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 11</xref>), we evaluated the performance of the three approaches (&#x2018;unsupervised&#x2019;, &#x2018;semi-supervised&#x2019; and &#x2018;markers&#x2019;) using the adjusted Rand index (ARI) as the performance metric. Specifically, the ARI measures the similarity between the predicted cluster labels from our three approaches and the &#x2018;gold standard&#x2019; cluster labels, with higher values corresponding to better performance (<xref rid="F7" ref-type="fig">Figure 7 F</xref>). First, we found consistent, but moderate, performance improvements by incorporating <italic>x, y</italic> spatial coordinates of the spots into the clustering methods across all three approaches (<xref rid="F7" ref-type="fig">Figure 7 F</xref>). Within the &#x2018;unsupervised&#x2019; approach, we found that using the HVGs resulted in the highest ARI, but with the SVGs also comparable in performance (<xref rid="F7" ref-type="fig">Figure 7 F</xref>). However, the &#x2018;semi-supervised&#x2019; approach resulted in the highest ARI out of all three approaches. This likely stems from the circularity of performing data-driven clustering guided by our layer-enriched DEGs on the same data, but this could be powerful in future spatial transcriptomics studies in the human cortex.</p>
      </sec>
    </sec>
    <sec id="S8">
      <title>Discussion</title>
      <p id="P38">Based on examination of its histological organization and cytoarchitecture, the neocortex can be divided into six layers, which can be differentiated based on cell type composition and density, as well as morphology and connectivity of resident cell types <sup><xref rid="R1" ref-type="bibr">1</xref>&#x2013;<xref rid="R4" ref-type="bibr">4</xref></sup>. Studies of postmortem brains from individuals with neuropsychiatric disorders have identified disease-associated changes in gene expression and synaptic structure that can be localized to individual layers <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R14" ref-type="bibr">14</xref></sup>. Our study, which is the first to our knowledge, to implement Visium technology in human brain tissue provides a number of important functional insights about the spatial and molecular definitions of cell populations across cortical laminae by analyzing gene expression within the intact spatial organization of the human DLPFC.</p>
      <p id="P39">First, we demonstrated the potential clinical translation of quantifying layer-enriched expression profiles in human DLPFCs. By integrating our data with clinical gene sets and genes differentially expressed in the brains of individuals with various neuropsychiatric disorders, we demonstrated preferential layer-enriched expression of genes implicated in ASD and SCZD. For example, genes that harbor <italic>de novo</italic> mutations associated with ASD <sup><xref rid="R36" ref-type="bibr">36</xref></sup> were preferentially expressed in L2 and L5 subsets of these genes that were associated with specific clinical characteristics could be further partitioned into specific laminae. Specifically, genes predominantly associated with neurodevelopmental delay (NDD) were preferentially expressed in L2 and genes predominantly associated with ASD were preferentially expressed in L5. These specific laminar associations with penetrant <italic>de novo</italic> variants were in contrast to broad laminar enrichments of genes differentially expressed in the brains of patients with ASD <sup><xref rid="R16" ref-type="bibr">16</xref></sup> and lack of laminar enrichment of genes implicated by common genetic variation <sup><xref rid="R40" ref-type="bibr">40</xref></sup>. Interestingly these same two layers - L2 and L5 - showed preferential enrichment of genes implicated in common variation for SCZD <sup><xref rid="R41" ref-type="bibr">41</xref></sup>, and to a lesser extent, BPD <sup><xref rid="R42" ref-type="bibr">42</xref></sup>. These results were in contrast to differential expression analyses from postmortem studies of brain tissue from patients with SCZD compared to neurotypical controls <sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R38" ref-type="bibr">38</xref></sup>, which showed increased expression of upper layer genes and decreased expression of deep layer and WM genes. Further, we show that SCZD heritability is enriched in L2, a finding that implicates intracortical information processing as a potential mechanism for genetic risk.</p>
      <p id="P40">Second, we overlaid recent large-scale snRNA-seq data from several cohorts to both confirm our layer-enriched expression signatures and further annotate gene expression-driven clusters to individual cortical layers. The shift from homogenate sequencing studies of brain tissue <sup><xref rid="R38" ref-type="bibr">38</xref>,<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R44" ref-type="bibr">44</xref></sup> to large-scale snRNA-seq has already begun, with increasing sample sizes and numbers of nuclei <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup>. Our &#x201C;spatial registration&#x201D; strategy, which uses individual gene-level statistics from both layer-specific versus cell type-specific expression profiles from hundreds or thousands of genes is likely more powerful than table-based enrichment analyses using small subsets of previously-defined marker genes. Spatial registration of multiple independent datasets with our Visium data showed that layer-enriched patterns of expression can be extracted from snRNA-seq data, as subtypes of excitatory neuronal cells, and to a lesser extent, inhibitory neuronal cells, could be classified by their preferential laminar enrichment. While this strategy does not aid in constructing cell clusters in snRNA-seq data, it is a powerful tool to better annotate and interpret data-driven clusters, and add spatial context to cell type-specific gene expression in the brain.</p>
      <p id="P41">Third, in contrast to manually annotating laminar clusters based on cytoarchitecture, which is very labor-intensive, we evaluated the performance of alternative, data-driven approaches to cluster spots based on spatially variable genes. Using these data-driven approaches, we identified variable spatial expression related to relatively rare inhibitory neuron subpopulations, brain vasculature, and immune function: 1) <italic>NPY</italic>, which encodes a neuropeptide highly expressed in a subpopulation of inhibitory interneurons, 2) <italic>HBB</italic>, which encodes a subunit of hemoglobin found in red blood cells, and 3) <italic>IGKC</italic>, which encodes the constant region of immunoglobulin light chains found in antibodies (<xref rid="F7" ref-type="fig">Figure 7 D</xref>). The layer-enriched genes identified here can be used to aid data-driven clustering in human cortex, and indeed, performed better than previously-defined markers (<xref rid="F7" ref-type="fig">Figure 7 E</xref>, <xref rid="F7" ref-type="fig">F</xref>). Since these data-driven approaches can identify previously unknown cellular organizations their application will be critical for analyzing other human tissues and brain structures where morphological patterning is not as well-defined or as well-characterized compared to the cerebral cortex.</p>
      <p id="P42">While LCM and other microdissection techniques have been used to generate laminar-specific gene expression profiles in human cortex <sup><xref rid="R20" ref-type="bibr">20</xref>&#x2013;<xref rid="R22" ref-type="bibr">22</xref></sup>, morphological boundaries cannot be definitively defined, which hinders the ability to examine spatial relationships between cell populations or to define gradients of gene expression across structures. For example, several layer-enriched genes identified by Visium show striking gradients of gene expression, such as <italic>HPCAL1</italic> which is highly expressed in L2 but steadily decreases in expression through L4, L5, and L6. Conversely, <italic>KRT17</italic> is enriched in L6 and progressively decreases in expression through L5, L4, L3, and L2. While the current resolution of a spatially-barcoded spot in the Visium platform is 55&#x3BC;m, we found that 15.0% of spots contained a single cell body, highlighting an additional available level of interrogation for downstream analysis. Ongoing advances will likely lead to improved spatial resolution, as custom platforms now reach subcellular resolutions of 10&#x3BC;m and 2&#x3BC;m <sup><xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R45" ref-type="bibr">45</xref></sup>. Although each Visium spot may contain a mixture of cell types, incorporating cell body segmentations from histological data can aid in refining interpretations and identifying spots with cell types of interest. Advances in Visium technology that allow for immunofluorescence (IF) protein detection can also be used to integrate morphological features of different cell types with gene expression data. Finally, Visium afforded several experimental advantages compared to fluorescence microscopy-based spatial transcriptomics approaches <sup><xref rid="R46" ref-type="bibr">46</xref>,<xref rid="R47" ref-type="bibr">47</xref></sup> including, 1) coverage across a large area of brain tissue, 2) unbiased, transcriptome-wide analysis of gene expression (i.e. no requirement to select gene targets of interest), and 3) no confounds from lipofuscin autofluorescence. These advantages provide flexibility to analyze spatial gene expression from numerous angles (i.e. supervised clustering, unsupervised clustering, neuropil only) within a single experiment, which would be nearly impossible to accomplish with more labor intensive approaches. However, it should be noted that the substantial gyrations inherent to the human cortex make consistency of dissections across individual donors difficult, which will remain a challenge for larger scale experiments aiming to generate equivalent clusters across tissue sections or perform clustering in a 3D coordinate system. The generation of additional human brain datasets and more finely-annotated human brain atlases that include microcircuitry (i.e. cortical layers as opposed to cortical regions) will be critical for developing new methods to register snRNA-seq, spatial transcriptomics, and accompanying histological data to a common coordinate framework.</p>
      <p id="P43">While the laminar structure of the neocortex is largely preserved across mammalian species, several recent studies have underscored key similarities and differences in laminar gene expression between humans, primates, and rodents <sup><xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R22" ref-type="bibr">22</xref>,<xref rid="R32" ref-type="bibr">32</xref></sup>. Given the functional importance associated with laminar origin, recent snRNA-seq studies in postmortem human cortex have attempted to annotate molecularly-defined cell type clusters to the layer from which they originated <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R10" ref-type="bibr">10</xref></sup>. However, these laminar annotations are largely derived from curated gene sets that come from rodents and non-human primates. While we validated laminar-enrichment of some canonical layer-specific genes that were previously identified in the rodent and human cortex (<xref rid="F3" ref-type="fig">Figure 3</xref> and <xref rid="SD1" ref-type="supplementary-material">Figure S9</xref>), some classical markers, such as <italic>BCL11B</italic> (L5), showed weak laminar patterning in adult DLPFC. Likewise, many genes showed no laminar patterning (<xref rid="F12" ref-type="fig">Extended Data 5</xref>). These findings may represent true differences between brain regions, species, and developmental time points, and reinforce previous studies that urge caution in translating rodent and primate studies of molecularly and spatially-defined cell types into the human brain. Indeed, our unbiased genome-wide approach identified a number of previously underappreciated layer-enriched genes in human DLPFC, including <italic>HPCAL1</italic> (L2) , <italic>KRT17</italic> (L6), and <italic>TRABD2A</italic> (L5), that may represent markers with higher fidelity for laminar annotation of snRNA-seq clusters in human brain (<xref rid="F4" ref-type="fig">Figure 4</xref>). We also confirmed laminar enrichment of several genes identified as cell type markers in specific cortical layers by Hodge <italic>et al.</italic> (<italic>LAMP5, AQP4, FREM3</italic>), suggesting conservation between laminar markers in middle temporal gyrus and DLPFC <sup><xref rid="R5" ref-type="bibr">5</xref></sup>.</p>
      <p id="P44">In contrast to the snRNA-seq approaches that encompass the vast majority of gene expression profiling studies in frozen postmortem human brain tissue, Visium is not limited to analysis of nuclear information. Indeed, on-slide cDNA synthesis methods capture information from both cytosol and neuronal processes, including dendrites and axons (neuropil). Using cell segmentation of high-resolution histology images acquired before on-slide cDNA synthesis we determined that each spot contained an average of 3.3 cells with 9.7% of spots containing no cell bodies. Confirming our hypothesis that spots containing no cell bodies would be enriched for transcripts highly expressed in neuronal processes and synapses, we identified significant enrichment of genes preferentially expressed in synaptic terminals. We further found enriched mitochondrial gene expression in sparser layers like L1 (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 12</xref>), which likely relates to our finding that L1 was most enriched for &#x2018;neuropil spots&#x2019;, and a higher energetic supply to axons and dendrites would be expected <sup><xref rid="R48" ref-type="bibr">48</xref>,<xref rid="R49" ref-type="bibr">49</xref></sup>. Moreover, converging evidence suggests that impairments in the formation or maintenance of synapses in key circuits underlies risk for neuropsychiatric and neurodevelopmental disorders, including SCZD and ASD <sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R15" ref-type="bibr">15</xref></sup>. Supporting this notion, genes associated with increased risk for SCZD that were identified by GWAS were found to be preferentially enriched for synaptic neuropil transcripts <sup><xref rid="R12" ref-type="bibr">12</xref></sup>. Better understanding regulation of synaptically localized transcripts is important because the synaptic proteins they encode control neuronal homeostasis and drive synaptic plasticity <sup><xref rid="R50" ref-type="bibr">50</xref></sup>, and directly studying neuropil-enriched transcripts in human brain may provide novel insights about expression of locally translated synaptic genes.</p>
      <p id="P45">Beyond these specific insights, we created several resources for the broader scientific community to continue to interrogate these large datasets for their own biological questions and to extend current neuroscience and spatial transcriptomics research. All raw and processed data and code presented here are freely available through our web application <italic>&#x201C;spatialLIBD&#x201D;</italic> (<ext-link ext-link-type="uri" xlink:href="http://spatial.libd.org/spatialLIBD">http://spatial.libd.org/spatialLIBD</ext-link>). Using this application, researchers can visualize the spot-level Visium data, manually annotate spots to layers, visualize the layer-level results, assess the enrichment of gene sets among layer-enriched genes, and perform spatial registration. These, and additional features, are described in detail at <ext-link ext-link-type="uri" xlink:href="http://research.libd.org/spatialLIBD/">http://research.libd.org/spatialLIBD/</ext-link>.</p>
    </sec>
    <sec id="S9">
      <title>Methods</title>
      <sec id="S10">
        <title>CONTACT FOR REAGENT AND RESOURCE SHARING</title>
        <p id="P46">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact: Andrew E Jaffe (<email>andrew.jaffe@libd.org</email>).</p>
      </sec>
      <sec id="S11">
        <title>EXPERIMENTAL MODEL AND SUBJECT DETAILS</title>
        <sec id="S12">
          <title>Post-mortem human tissue samples</title>
          <p id="P47">Post-mortem human brain tissue from three donors of European ancestry (<xref rid="SD4" ref-type="supplementary-material">Table S1</xref>) was obtained by autopsy primarily from the Offices of the Chief Medical Examiner of the District of Columbia, and of the Commonwealth of Virginia, Northern District, all with informed consent from the legal next of kin (protocol 90-M-0142 approved by the NIMH/NIH Institutional Review Board). Clinical characterization, diagnoses, and macro- and microscopic neuropathological examinations were performed on all samples using a standardized paradigm, and subjects with evidence of macro- or microscopic neuropathology were excluded. Details of tissue acquisition, handling, processing, dissection, clinical characterization, diagnoses, neuropathological examinations, RNA extraction and quality control measures have been described previously <sup><xref rid="R51" ref-type="bibr">51</xref></sup>. Briefly, dorsolateral prefrontal cortex (DLPFC) was microdissected and embedded in OCT in a 10mm x 10mm cryomold. Each sample was dissected in a plane perpendicular to the pial surface in area 46 of the cortex to capture from the pial surface to the gray-white matter junction and spanned L1-6 and the WM.</p>
        </sec>
      </sec>
      <sec id="S13">
        <title>METHOD DETAILS</title>
        <sec id="S14">
          <title>Tissue processing and Visium data generation</title>
          <p id="P48">Frozen samples were embedded in OCT (TissueTek Sakura) and cryosectioned at &#x2212;10C (Thermo Cryostar). Sections were placed on chilled Visium Tissue Optimization Slides (3000394, 10X Genomics) and Visium Spatial Gene Expression Slides (2000233, 10X Genomics), and adhered by warming the back of the slide. Tissue sections were then fixed in chilled methanol and stained according to the Visium Spatial Gene Expression User Guide (CG000239 Rev A, 10X Genomics) or Visium Spatial Tissue Optimization User Guide (CG000238 Rev A, 10X Genomics). For gene expression samples, tissue was permeabilized for 18 minutes (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 1</xref>), which was selected as the optimal time based on tissue optimization time course experiments. Brightfield histology images were taken using a 10X objective (Plan APO) on a Nikon Eclipse Ti2-E (27755 x 50783 pixels for TO, 13332 x 13332 pixels for GEX). Raw images were stitched together using NIS-Elements AR 5.11.00 (Nikon) and exported as .tiff files with low and high resolution settings. For tissue optimization experiments, fluorescent images were taken with a TRITC filter (ex/em brand) using a 10X objective and 400 ms exposure time.</p>
          <p id="P49">Libraries were prepared according to the Visium Spatial Gene Expression User Guide (CG000239, <ext-link ext-link-type="uri" xlink:href="https://assets.ctfassets.net/an68im79xiti/3pyXucRaiKWcscXy3cmRHL/a1ba41c77cbf60366202805ead8f64d7/CG000239_VisiumSpatialGeneExpression_UserGuide_Rev_A.pdf">https://assets.ctfassets.net/an68im79xiti/3pyXucRaiKWcscXy3cmRHL/a1ba41c77cbf60366202805ead8f64d7/CG000239_VisiumSpatialGeneExpression_UserGuide_Rev_A.pdf</ext-link>). Libraries were loaded at 300 pM and sequenced on a NovaSeq 6000 System (Illumina) using a NovaSeq S4 Reagent Kit (200 cycles, 20027466, Illumina), at a sequencing depth of approximately 250-400M read-pairs per sample. Sequencing was performed using the following read protocol: read 1, 28 cycles; i7 index read, 10 cycles; i5 index read, 10 cycles; read 2, 91 cycles.</p>
        </sec>
        <sec id="S15">
          <title>Visium raw data processing</title>
          <p id="P50">Raw FASTQ files and histology images were processed by sample with the Space Ranger software version 1.0.0, which uses STAR v.2.5.1b <sup><xref rid="R52" ref-type="bibr">52</xref></sup> for genome alignment, against the Cell Ranger hg38 reference genome &#x201C;refdata-cellranger-GRCh38-3.0.0&#x201D;, available at: <ext-link ext-link-type="uri" xlink:href="http://cf.10xgenomics.com/supp/cell-exp/refdata-cellranger-GRCh38-3.0.0.tar.gz">http://cf.10xgenomics.com/supp/cell-exp/refdata-cellranger-GRCh38-3.0.0.tar.gz</ext-link>. Quality control metrics returned by this software are available in <xref rid="SD4" ref-type="supplementary-material">Table S1</xref>.</p>
        </sec>
        <sec id="S16">
          <title>Histology image processing and segmentation</title>
          <p id="P51">Histology images were processed and nuclei were segmented using the &#x201C;Color-Based Segmentation using K-Means Clustering&#x201D; in MATLAB vR2019a. The MATLAB function rgb2lab is used to convert the image from RGB color space to CIELAB color space also called L*a*b color space (L - Luminosity layer measures lightness from black to white, a - chromaticity-layer measures color along red-green axis, b - chromaticity-layer measures color along blue-yellow axis). The CIELAB color space quantifies the visual differences caused by the different colors in the image. The a*b color space is extracted from the L*a*b converted image and is given to the K-means clustering function imsegkmeans along with the number of colors the user visually identifies in the image. The imsegkmeans outputs a binary mask for each color it identifies. Since the nuclei in the histology images have a bright color that can be easily differentiated from the background, a binary mask generated for the nuclei color is used as the nuclei segmentation.</p>
          <p id="P52">The segmented binary mask was used to estimate the number of nuclei in each spot. For each histology image, there is a JSON file describing some properties of the image, including the spot diameter in pixels at the full-resolution image. Additionally, for each image there is a text file in tabular format that includes one row for each spot with an identification barcode, a row, a column and pixel coordinates for the center of the spot on the full-resolution image. Using this information, the following protocol was implemented. For each spot, all pixels of the binary mask were set to zero except those within the spot radius of the center of that spot. The resulting binary mask was then labeled with a unique integer for each unique contiguous cluster of pixels. The maximum of this labeled mask was stored as an estimate of the number of nuclei within that spot.</p>
        </sec>
        <sec id="S17">
          <title>Spot-level data processing</title>
          <p id="P53">The raw Visium files for each sample (<xref rid="S15" ref-type="sec">Method Details: Visium raw data processing</xref>) were read into R into a custom structure using the <italic>SummarizedExperiment</italic> R package <sup><xref rid="R53" ref-type="bibr">53</xref></sup> to keep them paired with the low resolution histology images for visualization purposes. They were then combined into a single <italic>SingleCellExperiment</italic>
<sup><xref rid="R54" ref-type="bibr">54</xref></sup> v1.8.0 object (sce) to allow us to perform analyses using the gene expression data from all samples. We added information, including the number of estimated cell counts (<xref rid="S16" ref-type="sec">Method Details: Histology image processing and segmentation</xref>), the sum of UMIs per spot, number of expressed genes per spot, and graph-based clustering results (computed by sample) provided by 10x Genomics Space Ranger software to the sce object. We evaluated the per-spot quality metrics using the function perCellQCMetrics from the <italic>scran</italic> v1.14.3 R Bioconductor package <sup><xref rid="R55" ref-type="bibr">55</xref></sup> and did not drop any spots given the spatial pattern they presented. We used the <italic>scran</italic>
<sup><xref rid="R55" ref-type="bibr">55</xref></sup> functions quickCluster, blocking by the six pairs of spatially adjacent replicates, computeSumFactors, and <italic>scater</italic>&#x2019;s <sup><xref rid="R56" ref-type="bibr">56</xref></sup> logNormCounts to compute the log-normalized gene expression counts at the spot-level. By modeling the gene mean expression and variance with the modelGeneVar <italic>scran</italic>
<sup><xref rid="R55" ref-type="bibr">55</xref></sup> function, blocking again by the six pairs of spatially adjacent replicates, followed by getTopHVGs we identified the top 10% highly variable genes (HVGs): 1,942 genes. Using this subset of HVGs, we computed principal components (PCs) with <italic>scater</italic>&#x2019;s v1.14.3 <sup><xref rid="R56" ref-type="bibr">56</xref></sup> runPCA to produce 50 components. Using these 50 top PCs, we computed tSNE <sup><xref rid="R57" ref-type="bibr">57</xref></sup> and UMAP <sup><xref rid="R58" ref-type="bibr">58</xref></sup> dimension reduction methods using runTSNE (perplexity 5, 20, 50, 80) and runUMAP (15 neighbors) from <italic>scater</italic>
<sup><xref rid="R56" ref-type="bibr">56</xref></sup>. With the top 50 PCs, we performed graph-based clustering across all samples using 50 nearest neighbors using buildSNNGraph from <italic>scran</italic>
<sup><xref rid="R55" ref-type="bibr">55</xref></sup> and the Walktrap method from implemented by <italic>igraph</italic>
<sup><xref rid="R59" ref-type="bibr">59</xref></sup> v1.2.4.1 resulting in 28 clusters (snn_k50_k4 through snn_k50_k28). We further cut the graph to produce clusters from 4 to the 28 in increments of 1. We used <italic>spatialLIBD</italic>
<sup><xref rid="R60" ref-type="bibr">60</xref></sup> v0.99.0 to assign the graph-based clusters from 10x Genomic to the closest anatomical layers for each sample (Maynard and Martinowich).</p>
          <p id="P54">All this information was combined and displayed through a <italic>shiny</italic>
<sup><xref rid="R61" ref-type="bibr">61</xref></sup> v1.4.0 web application at <ext-link ext-link-type="uri" xlink:href="http://spatial.libd.org/spatialLIBD">http://spatial.libd.org/spatialLIBD</ext-link> in such a way that we, and now the scientific community, can visualize the expression of a given gene, or a given set of clustering results, across all samples or each sample individually. For any chosen sample, <italic>spatialLIBD</italic> allows users to view gene expression and selected cluster results both in the context of spatial histology and given dimension reduction results (PCA, tSNE, UMAP) using <italic>plotly</italic>
<sup><xref rid="R62" ref-type="bibr">62</xref></sup>. Using this web application to visualize cytoarchitecture <sup><xref rid="R63" ref-type="bibr">63</xref>,<xref rid="R64" ref-type="bibr">64</xref></sup> combined with a dimensionality reduction method, specifically <italic>t</italic>-Distributed Stochastic Neighbor Embedding (<italic>t</italic>-SNE) <sup><xref rid="R57" ref-type="bibr">57</xref></sup> as well as the expression patterns of MBP and <italic>PCP4</italic>, known WM and L5 marker genes, a single experimenter manually assigned each spot to a cortical layer for each sample for all but 352 out of the 47,681 spots across all samples. These 352 spots were located on small fragments of damaged tissue disconnected from the main tissue section. We added these supervised layer annotations to our sce object and the final version is available for download through the fetch_data function in <italic>spatialLIBD</italic>
<sup><xref rid="R60" ref-type="bibr">60</xref></sup>.</p>
        </sec>
        <sec id="S18">
          <title>Layer-level data processing</title>
          <p id="P55">For the subject with brain ID Br5595, which lacked L1 and clear cytoarchitecture for L2 and L3, we re-labelled all &#x201C;L2/L3&#x201D; ambiguous spots as L3 and dropped the 352 un-assigned spots. We then pseudo-bulked <sup><xref rid="R65" ref-type="bibr">65</xref>&#x2013;<xref rid="R67" ref-type="bibr">67</xref></sup> the spots into layer-level data by summing the raw gene expression counts across all spots in a given sample and in a given layer, and repeated this procedure for each gene, sample and layer combination (<xref rid="F2" ref-type="fig">Figure 2 A</xref>). This resulted in 47,329 genes quantified across 76 layer-sample combinations (7 * 12 = 84, because not all layers were clearly observed in each sample as Br5595 had no distinct L1 or L2 across all four spatial replicates, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 5</xref>). This resulted in another <italic>SingleCellExperiment</italic>
<sup><xref rid="R54" ref-type="bibr">54</xref></sup> object called sce_layer. We used librarySizeFactors and logNormCounts from <italic>scater</italic>
<sup><xref rid="R56" ref-type="bibr">56</xref></sup> to compute layer-level log normalized gene expression values. We dropped all mitochondrial genes and retained genes that were expressed in at least 5% (4 / 76 layer-sample combinations) and had an average counts greater than 0.5 as computed by calculateAverage from <italic>scater</italic>
<sup><xref rid="R56" ref-type="bibr">56</xref></sup>, resulting in a final set of 22,331 genes. We identified 1,280 top HVGs at the layer-level and computed 20 PCs (<xref rid="F2" ref-type="fig">Figure 2 B</xref>) which we then used in the tSNE (perplexity = 5, 15 and 20) and UMAP (15 neighbors) computations similar to <xref rid="S17" ref-type="sec">Method Details: Spot-level data processing</xref>. We then clustered the layer-level data using several graph-based approaches as well as using k-means. This is the sce_layer data that is available for download through the fetch_data function in <italic>spatialLIBD</italic>
<sup><xref rid="R60" ref-type="bibr">60</xref></sup>.</p>
        </sec>
        <sec id="S19">
          <title>Neuropil enrichment analyses</title>
          <p id="P56">We performed differential expression analysis at the spot-level in our Visium data, comparing the 4,855 spots with 0 cell bodies to the other 42,474 spots containing at least 1 cell body, adjusting for fixed effects of layer and spatial replicate. We downloaded differential expression statistics from RNA-seq of vGLUT1+ enriched synaptosomes in mouse brain from Hafner <italic>et al.</italic>
<sup><xref rid="R30" ref-type="bibr">30</xref></sup>, and lined up these data at the gene-level using homologous entrez IDs between mouse and human (via <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org/downloads/reports/HMD_HumanPhenotype.rpt">http://www.informatics.jax.org/downloads/reports/HMD_HumanPhenotype.rpt</ext-link>). We compared the effects of spots containing 0 cells in our data to vGLUT1+ enriched cells from Hafner et al, both across the full homologous transcript and then within genes significant in the Hafner dataset at FDR &lt; 0.05.</p>
        </sec>
        <sec id="S20">
          <title>Layer-level gene modeling</title>
          <p id="P57">Using the layer-level data we fit three types of models (<xref rid="F2" ref-type="fig">Figure 2 C</xref>, <xref rid="F11" ref-type="fig">Extended Data 4</xref>):
<list list-type="order" id="L2"><list-item><p id="P58"><italic>ANOVA</italic>: For this model we tested for each gene whether the log normalized gene expression counts are variable between the layers by computing F-statistics. We used lmFit and eBayes from <italic>limma</italic>
<sup><xref rid="R68" ref-type="bibr">68</xref></sup> v3.42.0 after blocking by the six pairs of spatially adjacent replicates and taking this correlation into account as computed by duplicateCorrelation.</p></list-item><list-item><p id="P59"><italic>Enrichment</italic>: Using the same functions and taking into account the same correlation structure, we computed t-statistics comparing one layer against the other six using the layer-level data. This resulted in seven sets of t-statistics (one per layer) with double-sided <italic>P</italic>-values. We focused on genes with positive t-statistics (expressed higher in one layer against the others) as these are enriched genes instead of depleted genes.</p></list-item><list-item><p id="P60"><italic>Pairwise</italic>: Using the same functions and taking into account the same correlation structure in addition to using contrasts.fit from <italic>limma</italic>
<sup><xref rid="R68" ref-type="bibr">68</xref></sup>, we computed t-statistics for each pair of layers resulting in t-statistics with double-sided <italic>P</italic>-values.</p></list-item></list>
</p>
          <p id="P61">The modeling results are available for download through the fetch_data function in <italic>spatialLIBD</italic>
<sup><xref rid="R60" ref-type="bibr">60</xref></sup> as the modeling_results object as well as in <xref rid="SD4" ref-type="supplementary-material">Table S4</xref>.</p>
        </sec>
        <sec id="S21">
          <title>Known marker genes optimal modeling</title>
          <p id="P62">Using two lists of known layer marker genes derived from previous mouse or human studies <sup><xref rid="R32" ref-type="bibr">32</xref><xref rid="R31" ref-type="bibr">31</xref></sup>, we identified 29 different unique optimal models for these genes. For example, L1 + L2 versus the other layers. Using the same modeling framework (<xref rid="S20" ref-type="sec">Method Details: Layer-level gene modeling</xref>) we computed t-statistics for all genes at the layer-level data for each of these 29 unique models. For each of the 29 unique models, we then retained information about the statistics for the known marker genes matching the model as well as the top ranked (with a positive t-statistic gene, <xref rid="SD4" ref-type="supplementary-material">Table S5</xref>).</p>
        </sec>
        <sec id="S22">
          <title>RNAscope single molecule fluorescent in situ hybridization (smFISH)</title>
          <p id="P63">Fresh frozen DLPFC from the same three neurotypical control samples used for Visium were sectioned at 10&#x3BC;m and stored at &#x2212;80&#xB0;C. <italic>In situ</italic> hybridization assays were performed with RNAscope technology utilizing the RNAscope Fluorescent Multiplex Kit V2 and 4-plex Ancillary Kit (Cat # 323100, 323120 ACD, Hayward, California) according to the manufacturer&#x2019;s instructions. Briefly, tissue sections (2 to 4 per individual) were fixed with a 10% neutral buffered formalin solution (Cat # HT501128 Sigma-Aldrich, St. Louis, Missouri) for 30 minutes at room temperature (RT), series dehydrated in ethanol, pretreated with hydrogen peroxide for 10 minutes at RT, and treated with protease IV for 30 minutes. Sections were incubated with 4 different probe combinations: A) L1 and L5: <italic>AQP4, RELN, TRABD2A, BCL11B</italic> (Cat 482441-C4, 413051-C2, 532881, 425561-C3, ACD, Hayward, California); B) L3 and L6: <italic>CARTPT, FREM3, NR4A2</italic>, (506591, 829021-C4, 582621-C3); C) L2/3 and WM: <italic>LAMP5, HPCAL1, NDRG1, MBP</italic> (487691-C2, 846051-C3, 481471, 411051-C4); D) Visium-identified genes: <italic>AQP4, TRABD2A, KRT17 (</italic>463661-C2), <italic>HPCAL1</italic>. Following probe labeling, sections were stored overnight in 4x SSC (saline-sodium citrate) buffer. After amplification steps (AMP1-3), probes were fluorescently labeled with Opal Dyes (Perkin Elmer, Waltham, MA; 1:500) and stained with DAPI (4&#x2032;,6-diamidino-2-phenylindole) to label the nucleus. Lambda stacks were acquired in z-series using a Zeiss LSM780 confocal microscope equipped with 20x x 1.4 NA and 63x x 1.4NA objectives, a GaAsP spectral detector, and 405, 488, 555, and 647 lasers. All lambda stacks were acquired with the same imaging settings and laser power intensities. For each subject, a cortical strip was tile imaged at 20x to capture L1 to WM. Following image acquisition, lambda stacks in <italic>z</italic>-series were linearly unmixed using Zen Black (weighted; no autoscale) using reference emission spectral profiles previously created in Zen for <italic>dotdotdot</italic> (git has version 4e1350b) <sup><xref rid="R17" ref-type="bibr">17</xref></sup>, stitched, maximum intensity projected, and saved as Carl Zeiss Image &#x201C;<italic>.czi</italic>&#x201D; files.</p>
        </sec>
        <sec id="S23">
          <title>snRNA-seq spatial registration</title>
          <p id="P64">For each snRNA-seq dataset, we utilized publicly-available processed unique molecular index (UMI) count data for each gene and nucleus, and provided annotations of cell clusters/subtypes. Within each dataset, we performed &#x2018;pseudo-bulking&#x2019; <sup><xref rid="R65" ref-type="bibr">65</xref>&#x2013;<xref rid="R67" ref-type="bibr">67</xref></sup> of nuclei-level UMIs into cell type-specific log-transformed normalized counts for each unique subject. We then computed cell type &#x2018;enrichment&#x2019; statistics for each gene and dataset-provided cell type within their pseudo-bulk profiles by performing linear mixed effects modeling comparing each cell type to all other cell types, treating donor as a random intercept <sup><xref rid="R69" ref-type="bibr">69</xref></sup>, and adjusting for study-specific covariates described below. This strategy was analogous to the layer &#x2018;enrichment&#x2019; statistics described for our Visium data (<xref rid="S20" ref-type="sec">Method Details: Layer-level gene modeling</xref>). We then computed Pearson correlation coefficients between our layer-enriched &#x2018;enrichment&#x2019; statistics and snRNA-seq cell type-specific &#x201C;enrichment&#x201D; statistics among the 700 most layer-enriched genes (combining the 100 most significant genes for each of the six layers and WM in the Visium data) expressed in each snRNA-seq dataset. In addition to our DLPFC snRNA-seq dataset (<xref rid="S24" ref-type="sec">Method Details: DLPFC snRNA-seq data generation</xref>), we utilized these publicly-available datasets:
<list list-type="order" id="L3"><list-item><p id="P65">Hodge <italic>et al.</italic>
<sup><xref rid="R5" ref-type="bibr">5</xref></sup>: Processed data was obtained from <ext-link ext-link-type="uri" xlink:href="https://portal.brain-map.org/atlases-and-data/rnaseq">https://portal.brain-map.org/atlases-and-data/rnaseq</ext-link>. We retained total gene counts (exons plus introns) from 49,494 nuclei corresponding to postmortem human brain tissue across both neurons and non-neurons across 50,281 genes across 6 layers and 2 cell types. These data were reduced to 52 pseudo-bulk profiles, for all unique donor-layer-type combinations. We calculated &#x2018;enrichment&#x2019; statistics for each of the six layers in their dataset, adjusting for the fixed effect of cell type (neuronal or glial) with a random intercept of donor.</p></list-item><list-item><p id="P66">Velmeshev <italic>et al.</italic>
<sup><xref rid="R6" ref-type="bibr">6</xref></sup>: Processed data was obtained from <ext-link ext-link-type="uri" xlink:href="https://cells.ucsc.edu/">https://cells.ucsc.edu/</ext-link> (under the &#x201C;Autism&#x201D; study data download). We used the post-QC UMI counts from all 104,559 nuclei across 65,217 genes across 41 unique donor-region pairs (for 31 unique donors and 2 brain regions) and 17 cell types. These data were reduced to 691 pseudo-bulked profiles, for all unique donor-region-type combinations. We calculated &#x2018;enrichment&#x2019; statistics for each of the 17 cell types in this dataset, adjusting for the fixed effect of brain region, age, sex, and ASD diagnosis, with a random intercept of donor.</p></list-item><list-item><p id="P67">Mathys <italic>et al.</italic>
<sup><xref rid="R10" ref-type="bibr">10</xref></sup>: Processed data were obtained from Synapse at accession: syn18485175. We used the post-QC UMI counts from all 70,634 nuclei across 17,926 genes across 48 unique donors and 44 cell subtypes (across 8 broad cell classes). These data were reduced to 1877 pseudo-bulked profiles, for all unique donor-subtype combinations. We calculated &#x2018;enrichment&#x2019; statistics for each of the 44 cell subtypes in this dataset, adjusting for the fixed effect of age, sex, race, and Alzheimer&#x2019;s disease diagnosis, with a random intercept of donor.</p></list-item><list-item><p id="P68">We also downloaded and reprocessed RNA-seq data from He <italic>et al.</italic>
<sup><xref rid="R22" ref-type="bibr">22</xref></sup> from SRA accession SRP199498 using our previously-described RNA-seq processing pipeline <sup><xref rid="R38" ref-type="bibr">38</xref></sup>. These data consisted of homogenate RNA-seq data from 18 serial sections across 4 unique donors.</p></list-item></list>
</p>
        </sec>
        <sec id="S24">
          <title>DLPFC snRNA-seq data generation</title>
          <p id="P69">We performed single-nucleus RNA-seq (snRNA-seq) on DLPFC tissue from two neurotypical donors using 10x Genomics Chromium Single Cell Gene Expression V3 technology. Nuclei were isolated using a &#x201C;Frankenstein&#x201D; nuclei isolation protocol developed by Martelotto <italic>et al.</italic> for frozen tissues <sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R70" ref-type="bibr">70</xref>&#x2013;<xref rid="R73" ref-type="bibr">73</xref></sup>. Briefly, ~40mg of frozen DLPFC tissue was homogenized in chilled Nuclei EZ Lysis Buffer (MilliporeSigma) using a glass dounce with ~15 strokes per pestle. Homogenate was filtered using a 70&#x3BC;m-strainer mesh and centrifuged at 500 x g for 5 minutes at 4&#xB0;C in a benchtop centrifuge. Nuclei were resuspended in the EZ lysis buffer, centrifuged again, and equilibrated to nuclei wash/resuspension buffer (1x PBS, 1% BSA, 0.2U/&#x3BC;L RNase Inhibitor). Nuclei were washed and centrifuged in this nuclei wash/resuspension buffer three times, before labeling with DAPI (10&#x3BC;g/mL). The sample was then filtered through a 35&#x3BC;m-cell strainer and sorted on a BD FACS Aria II Flow Cytometer (Becton Dickinson) at the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center (SKCCC) Flow Cytometry Core into 10X Genomics reverse transcription reagents. Gating criteria hierarchically selected for whole, singlet nuclei (by forward/side scatter), then for G<sub>0</sub>/G<sub>1</sub> nuclei (by DAPI fluorescence). A &#x201C;null&#x201D; sort into wash buffer was additionally performed from the same preparation for quantification of nuclei concentration and to ensure nuclei input was free of debris. Approximately 8,500 single nuclei were sorted directly into 25.1&#x3BC;L of reverse transcription reagents from the 10x Genomics Single Cell 3&#x2019; Reagents kit (without enzyme). Libraries were prepared according to manufacturer&#x2019;s instructions (10x Genomics) and sequenced on the Next-seq (Illumina) at the Johns Hopkins University Transcriptomics and Deep Sequencing Core.</p>
          <p id="P70">We processed the sequencing data with the 10x Genomics&#x2019; Cell Ranger pipeline v3.0.2, aligning to the human reference genome GRCh38, with a reconfigured GTF such that intronic alignments were additionally counted given the nuclear context, to generate UMI/feature-barcode matrices (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/advanced/references">https://support.10xgenomics.com/single-cell-gene-expression/software/pipelines/latest/advanced/references</ext-link>). We started with raw feature-barcode matrices for analysis with the Bioconductor suite of R packages for single-cell RNA-seq analysis <sup><xref rid="R74" ref-type="bibr">74</xref></sup>. For quality control and cell calling, we first used a Monte Carlo simulation-based approach to assess and rule out empty droplets or those with random ambient transcriptional noise, such as from debris <sup><xref rid="R75" ref-type="bibr">75</xref>,<xref rid="R76" ref-type="bibr">76</xref></sup>. This was then followed by mitochondrial rate adaptive thresholding, which, though expected to be near-zero in this nuclear context, we allowed for a 3x median absolute deviation (MAD) threshold. This allowed for flexibility in output/purity of FACS workflows. This QC pipeline yielded 5,399 high-quality nuclei from the DLPFC from two donors, which were then rescaled across all nuclear libraries, then log-transformed for determination of highly-variable genes, again with <italic>scran</italic>&#x2019;s modelGeneVar, this time taking all genes (9,313) with a greater variance than the fitted trend. Principal components analysis (PCA) was then performed on these selected genes to reduce the high dimensionality of nuclear transcriptomic data. The optimal PC space was defined with iterative graph-based clustering to determine the <italic>d</italic> PCs where resulting <italic>n</italic> clusters stabilize, with the constraint that <italic>n</italic> clusters &lt;/= (<italic>d</italic> + 1) PCs <sup><xref rid="R55" ref-type="bibr">55</xref></sup>, resulting in a chosen <italic>d</italic>=81 PCs. In this PCA-reduced space, graph-based clustering was performed (specifically, k-nearest neighbors with k=20 neighbors and the Walktrap method from R package <italic>igraph</italic>
<sup><xref rid="R59" ref-type="bibr">59</xref></sup> for community detection) to identify 31 preliminary clusters. We then took all feature counts for these assignments and pseudo-bulked counts across 31 preliminary nuclear clusters, rescaling for combined library size and log-transforming normalized counts, then performed hierarchical clustering to identify preliminary cluster relationships and merging with the cutreeDynamic function of R package <italic>dynamicTreeCut</italic>
<sup><xref rid="R77" ref-type="bibr">77</xref></sup>. These broader clusters were finally annotated with well-established cell type markers for nuclear type identity <sup><xref rid="R10" ref-type="bibr">10</xref></sup>. We also used Bioconductor package <italic>scater</italic>&#x2019;s <sup><xref rid="R56" ref-type="bibr">56</xref></sup> implementation of non-linear dimensionality reduction techniques, <italic>t</italic>-SNE and UMAP, with default parameters and within the aforementioned optimal PC space, simply for visualization of the high-dimensional structure in the data, which complemented the clustering results (<xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 9</xref>).</p>
        </sec>
        <sec id="S25">
          <title>Clinical gene set enrichment analyses</title>
          <p id="P71">We assessed the laminar enrichment of a series of predefined clinical gene sets for various neuropsychiatric and neurodevelopmental disorders. These gene sets consisted of data from:
<list list-type="order" id="L4"><list-item><p id="P72">Birnbaum <italic>et al.</italic>
<sup><xref rid="R34" ref-type="bibr">34</xref></sup>: 10 gene sets across SCZ, ASD, neurodevelopmental disorders, intellectual disability, bipolar disorder, and neurodegenerative disorders.</p></list-item><list-item><p id="P73">SFARI <sup><xref rid="R35" ref-type="bibr">35</xref></sup>: 3 gene sets consisting of all human genes, high confidence genes, and syndromic genes.</p></list-item><list-item><p id="P74">Satterstrom <italic>et al.</italic>
<sup><xref rid="R36" ref-type="bibr">36</xref></sup>: 6 gene sets based on exome sequencing studies.</p></list-item><list-item><p id="P75">psychENCODE <sup><xref rid="R16" ref-type="bibr">16</xref></sup>: 6 gene sets based on DE analyses of patients with ASD, SCZD, and bipolar disorder (BPD), stratified by directionality in cases, and 8 gene sets based on TWAS <sup><xref rid="R78" ref-type="bibr">78</xref></sup> (ASD, SCZD, BPD, SCZD-BPD, stratified by directionality), each at FDR &lt; 0.05.</p></list-item><list-item><p id="P76">BrainSeq <sup><xref rid="R38" ref-type="bibr">38</xref></sup>: 2 gene sets based on DE analyses of patients with SCZD versus controls (at FDR &lt; 0.05), stratified by directionality.</p></list-item><list-item><p id="P77">Down syndrome <sup><xref rid="R79" ref-type="bibr">79</xref></sup>: 2 gene sets based on DE analyses of patients with Down syndrome versus controls (at FDR &lt; 0.05), stratified by directionality.</p></list-item></list>
</p>
          <p id="P78">We collected all reported genes in each gene set, and retained the majority that were expressed in our Visium dataset - these gene set sizes are provided in <xref rid="SD4" ref-type="supplementary-material">Table S6</xref>. Enrichment for each gene set for each layer was based on a gene being significantly more highly expressed in one layer versus all other layers (at FDR &lt; 0.1, as this cutoff for defining genes with increased expression was approximately as conservative as using an FDR &lt; 0.05 cutoff with either direction). This calculation was performed using Fisher&#x2019;s exact test, which returned an odds ratio and <italic>p</italic>-value for each gene set and layer (<xref rid="SD4" ref-type="supplementary-material">Table S6</xref>). Pooling all <italic>p</italic>-values resulted in FDR control of 5% for marginal <italic>p</italic>-values &lt; 0.01.</p>
          <p id="P79">We additionally performed MAGMA <sup><xref rid="R37" ref-type="bibr">37</xref></sup> v1.07b using the subset of 24,347 Ensembl gene IDs expressed in our pseudo-bulked Visium data that were present in the provided GR37/hg19 annotation across multiple GWASs for SCZD <sup><xref rid="R41" ref-type="bibr">41</xref></sup>, BPD <sup><xref rid="R42" ref-type="bibr">42</xref></sup>, MDD <sup><xref rid="R80" ref-type="bibr">80</xref></sup> and ASD <sup><xref rid="R40" ref-type="bibr">40</xref></sup>. We used window sizes of +35kb and &#x2212;10kb around each gene to aggregate SNPs to genes using the 1000 Genomes EUR reference profile using SNP-wise stats. We then performed gene set testing using MAGMA for seven gene sets (related to the six layers and WM) for genes with positive (+) enrichment statistics at FDR &lt; 0.1. Additionally, we performed linkage disequilibrium score regression (LDSC v1.0.1) and partitioned heritability analysis <sup><xref rid="R39" ref-type="bibr">39</xref>,<xref rid="R81" ref-type="bibr">81</xref></sup> using 30 GWAS traits collected by Rizzardi <italic>et al</italic>
<sup><xref rid="R82" ref-type="bibr">82</xref></sup>. Genomic regions were created from the same enriched and FDR &lt; 0.1 genes as above, here with +10kb and &#x2212;5kb windows, and lifted over to hg19 coordinates.</p>
        </sec>
        <sec id="S26">
          <title>Data-driven layer-enriched clustering analysis</title>
          <p id="P80">For the data-driven layer-enriched clustering, we first performed feature selection in two ways to identify laminar and non-laminar patterns in our data. The first method for feature selection used was <italic>SpatialDE</italic>
<sup><xref rid="R83" ref-type="bibr">83</xref></sup> to identify genes exhibiting spatially variable expression patterns (SVGs). <italic>SpatialDE</italic> was run in Python version 3.8.0. We ran <italic>SpatialDE</italic> individually on each of the 12 samples, which returned a set of statistically significant (false discovery rate &lt; 0.05) SVGs per sample. We included an additional filtering step to remove lowly-expressed genes (less than 1,000 total UMIs summed across spots per sample), as well as removing mitochondrial genes. This left between 521 and 2,217 genes per sample (<xref rid="SD4" ref-type="supplementary-material">Table S9</xref>). In total, there were 2,775 unique genes across samples; for comparison, we also ran clustering methods using this pooled list (<xref rid="SD4" ref-type="supplementary-material">Table S9</xref> and <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>). The second feature selection method used the <italic>scran</italic> R Bioconductor package <sup><xref rid="R55" ref-type="bibr">55</xref></sup> to identify (non-spatial) highly variable genes (HVGs) across all samples combined, which identified 1,942 HVGs. Due to slow runtime, it was not possible to run <italic>SpatialDE</italic> on pooled spots from all samples combined.</p>
          <p id="P81">In the &#x2018;unsupervised&#x2019; approach to define sub-groups of spots with similar expression profiles in a completely data-driven manner, we considered the possible combinations of (i) two types of methods for dimensionality reduction (top 50 principal components (PCs) with the <italic>BiocSingular</italic> v1.2.2 Bioconductor package <sup><xref rid="R84" ref-type="bibr">84</xref></sup>, and top 10 UMAP <sup><xref rid="R58" ref-type="bibr">58</xref></sup> components with the <italic>uwot</italic> v0.1.5 R package <sup><xref rid="R85" ref-type="bibr">85</xref></sup> calculated on the top 50 PCs), (ii) the gene sets defined after applying feature selection (<italic>SpatialDE</italic> genes for each sample, pooled <italic>SpatialDE</italic> gene lists across all 12 samples, and HVGs), and (iii) including (or not) the two spatial coordinates (<italic>x</italic> and <italic>y</italic> coordinates) of each spot as additional features for clustering. For the clustering algorithm, we constructed a shared nearest neighbor graph with the <italic>scran</italic> Bioconductor package and then applied the Walktrap method from the <italic>igraph</italic> R package <sup><xref rid="R59" ref-type="bibr">59</xref></sup> to obtain predicted cluster labels. We set all clustering implementations to return eight final clusters (i.e. one more than the six DLPFC layers plus white matter), which gave slightly improved clustering performance (compared to seven clusters) due to additional splitting of the white matter cluster and some outlier spots. <xref rid="SD4" ref-type="supplementary-material">Table S10</xref> contains an overview of all combinations that were tried.</p>
          <p id="P82">For comparison, we also implemented a &#x2018;semi-supervised&#x2019; approach, where we used the layer-enriched gene sets identified using the DE &#x201C;enrichment&#x201D; models described previously (<xref rid="F11" ref-type="fig">Extended Data 4</xref>), and a &#x2018;markers&#x2019; approach using known marker genes from Zeng <italic>et al.</italic>
<sup><xref rid="R32" ref-type="bibr">32</xref></sup> (<xref rid="SD4" ref-type="supplementary-material">Table S10</xref>).</p>
          <p id="P83">To evaluate the performance of the clustering approaches, we used the adjusted Rand index (ARI), which measures the similarity between the predicted cluster labels and &#x201C;gold standard&#x201D; cluster labels. The manually-annotated layers were used as the &#x201C;gold standard&#x201D; (<xref rid="F7" ref-type="fig">Figure 7</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 11</xref>). Higher ARI values correspond to better clustering performance, with a maximum value of 1 indicating perfect clustering agreement. To evaluate the improvement in ARI when including spatial coordinates within the clustering methods, we fit a linear model on the ARI scores, comparing these methods against methods without spatial coordinates across all methods and samples, and recorded the p-value.</p>
          <p id="P84"><ext-link ext-link-type="uri" xlink:href="https://github.com/LieberInstitute/HumanPilot/blob/master/Analysis/Layer_Guesses/pdf/SFileXX_clustering_compressed.pdf">https://github.com/LieberInstitute/HumanPilot/blob/master/Analysis/Layer_Guesses/pdf/SFileXX_clustering_compressed.pdf</ext-link> contains visualizations of clustering results for all samples and clustering methods (<xref rid="SD4" ref-type="supplementary-material">Table S10</xref>) (similar to <xref rid="F16" ref-type="fig">Extended Data 9</xref> and <xref rid="F17" ref-type="fig">Extended Data 10</xref>, which display results for sample 151673 only). A description of the clustering methods is provided in <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>.</p>
        </sec>
      </sec>
      <sec id="S27">
        <title>STATISTICS AND REPRODUCIBILITY</title>
        <p id="P85">No statistical methods were used to pre-determine sample sizes, but our sample sizes are greater than previous publications with the earlier Spatial Transcriptomics technology that preceded Visium <sup><xref rid="R23" ref-type="bibr">23</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup>. <xref rid="SD4" ref-type="supplementary-material">Table S1</xref> contains the demographic information (two males one female neurotypical controls with age at time of death from 30 to 46 years old) for the three donor brains we used to generate the six pairs of spatial replicates (two per donor) for a total of twelve images. All boxplots shown in main and <xref rid="SD1" ref-type="supplementary-material">supplementary figures</xref> displayed the median as the center, interquartile range (IQR, 25th and 75th percentiles) as the box ranges, and 1.5 times the IQR as the whiskers. All reported p-values were two-sized and all p-values were adjusted for multiple testing with Benjamini-Hochberg correction unless otherwise indicated. Distributions of the residuals of our many linear models were assumed to be normally distributed across all genes and models but this was not formally tested. All points were used in all analyses, e.g. outliers were not removed. We used the six pairs of spatial replicates as a blocking factor in our analyses. Data collection and analysis were not performed blind to the conditions of the experiments. See the <xref rid="SD3" ref-type="supplementary-material">Life Sciences Reporting Summary</xref> for further details.</p>
        <sec id="S28">
          <title>Quantification and statistical analyses</title>
          <p id="P86">The different subsections of the &#x201C;<xref rid="S13" ref-type="sec">Method Details</xref>&#x201D; further specify the statistical models and tests used as well as the versions of the specific software used. Overall, statistical tests were performed using R versions 3.6.1 and 3.6.2 with Bioconductor version 3.10 with detailed R session information provided in the code GitHub repositories listed under &#x201C;Code Availability.&#x201D; The threshold and method used for statistical significance is listed in the main text along the description of the results. Plots in R were created in either base R or with the <italic>ggplot2</italic> R package <sup><xref rid="R86" ref-type="bibr">86</xref></sup>.</p>
        </sec>
      </sec>
      <sec id="S29">
        <title>CODE AVAILABILITY</title>
        <p id="P87"> The code for this project is publicly available through GitHub and archived through Zenodo. Specifically, the code is available through GitHub at <ext-link ext-link-type="uri" xlink:href="https://github.com/LieberInstitute/HumanPilot">https://github.com/LieberInstitute/HumanPilot</ext-link>
<sup><xref rid="R87" ref-type="bibr">87</xref></sup> and <ext-link ext-link-type="uri" xlink:href="https://github.com/LieberInstitute/spatialLIBD">https://github.com/LieberInstitute/spatialLIBD</ext-link>
<sup><xref rid="R60" ref-type="bibr">60</xref></sup>, both of which are described in their README.md files.</p>
      </sec>
      <sec id="S30">
        <title>ADDITIONAL RESOURCES</title>
        <p id="P88">In order to visualize the spot-level Visium data we generated, we created a <italic>shiny</italic>
<sup><xref rid="R61" ref-type="bibr">61</xref></sup> interactive browser available at <ext-link ext-link-type="uri" xlink:href="http://spatial.libd.org/spatialLIBD">http://spatial.libd.org/spatialLIBD</ext-link> that is powered by the Bioconductor package <italic>spatialLIBD</italic>
<sup><xref rid="R60" ref-type="bibr">60</xref></sup>.</p>
      </sec>
    </sec>
    <sec sec-type="extended-data" id="S31">
      <title>Extended Data</title>
      <fig id="F8" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 1</label>
        <caption>
          <title><italic>PCP4</italic> expression, related to <xref rid="F1" ref-type="fig">Figure 1 F</xref>.</title>
          <p id="P89">Log-transformed normalized (logcounts) for <italic>PCP4</italic> gene expression across all 12 samples arranged in rows by subject.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0008"/>
      </fig>
      <fig id="F9" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 2</label>
        <caption>
          <title>Layer-level dendrogram, related to Results: Gene expression in the DLPFC across cortical laminae and <xref rid="F2" ref-type="fig">Figure 2</xref>.</title>
          <p id="P90">Dendrogram from the hierarchical clustering performed across all 76 layer-level combinations: 6 layers plus WM across 12 samples, with two layers visually absent in one sample as shown in <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 5</xref>, second row. The layer-level combinations are colored by the brain subject (BR5292, Br5595, Br8100), position (0 or 300) and adjacent spatial replicate number (A or B).</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0009"/>
      </fig>
      <fig id="F10" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 3</label>
        <caption>
          <title>Enrichment of genes expressed in synaptic terminals among neuropil spots, related to Results: Gene expression in the DLPFC across cortical laminae.</title>
          <p id="P91">We compared DEGs from VGLUT1+ labeled synaptosomes from mouse brain from Hafner <italic>et al</italic>
<sup><xref rid="R30" ref-type="bibr">30</xref></sup> on the x-axis versus the log2 fold change comparing spot-level expression between spots with 0 cells and spots with &gt;0 cells. Association shown between (<bold>A</bold>) all expressed homologous genes and (<bold>B</bold>) those genes that were significant in the Hafner <italic>et al.</italic> dataset at FDR &lt; 0.05.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0010"/>
      </fig>
      <fig id="F11" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 4</label>
        <caption>
          <title>Layer-level modeling strategies illustrated with <italic>MOBP</italic>, related to Results: <xref rid="F2" ref-type="fig">Figure 2</xref>.</title>
          <p id="P92">Overview of the different modeling strategies we performed with the layer-level pseudo-bulked expression data. (<bold>A</bold>) The <italic>ANOVA</italic> model, which evaluates whether the gene is variable in any of the layers (F-statistic); <italic>MOBP</italic> is the top 10th ranked of such genes. Colors represent each layer. (<bold>B</bold>) The <italic>enrichment</italic> model, which tests one layer against the rest (t-statistic); <italic>MOBP</italic> is the top 36th gene for white matter against other layers. Colors show the comparison being done. (<bold>C</bold>) The <italic>pairwise</italic> model where we test one layer against another (t-statistic); <italic>MOBP</italic> is the top ranked gene for WM &gt; L3. Data from layers not used is shown in gray. 76 pseudo-bulked layers were used for computing the statistics in <bold>A-C</bold>.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0011"/>
      </fig>
      <fig id="F12" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 5</label>
        <caption>
          <title>Known marker genes compared to the best gene, related to Results: Identifying novel layer-enriched genes in human cortex.</title>
          <p id="P93">Using the optimal models (<xref rid="S21" ref-type="sec">Method Details: Known marker genes optimal modeling</xref>) for each known marker gene we compared the marker genes against the best gene for that given model. Results are visualized using the &#x2212;log10 p-values for the marker gene (y-axis) against the best gene for that model (x-axis). Points are colored by the &#x2212;log10 rank percentile of that gene in such a way that the top ranked gene is &#x2212;log10(1 / 22,331) and colored in yellow.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0012"/>
      </fig>
      <fig id="F13" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 6</label>
        <caption>
          <title>Replication of Visium layer-enriched genes by Allen Brain Atlas in situ hybridization (ISH) data, Related to <xref rid="F3" ref-type="fig">Figure 3</xref>.</title>
          <p id="P94">(<bold>A-F</bold>) Left panels: Boxplots of log-transformed normalized expression (logcounts) for genes <italic>CUX2</italic> (<bold>A</bold>, L2&gt;L6, p=3.75e-19), <italic>ADCYAP1</italic> (<bold>B</bold>, L3&gt;rest, p=3.57e-08), <italic>RORB</italic> (<bold>C</bold>, L4&gt;rest, p=2.91e-07), <italic>PCP4</italic> (<bold>D</bold>, L5&gt;rest, p=1.81e-19), <italic>NTNG2</italic> (<bold>E</bold>, L6&gt;rest, p=5.22e-13), and <italic>MBP</italic> (<bold>F</bold>, WM&gt;rest, p=1.71e-20). Middle panels: Spotplots of log-transformed normalized expression (logcounts) for sample 151673 for <italic>CUX2</italic> (<bold>A</bold>), <italic>ADCYAP1</italic> (<bold>B</bold>), <italic>RORB</italic> (<bold>C</bold>), <italic>PCP4</italic> (<bold>D</bold>), <italic>NTNG2</italic> (<bold>E</bold>), and <italic>MBP</italic> (<bold>F</bold>). Right panels: in situ hybridization (ISH) images from DLPFC (<bold>A, C, D, E, F</bold>) or frontal cortex (<bold>B</bold>) of adult human brain from Allen Brain Institute&#x2019;s Human Brain Atlas: <ext-link ext-link-type="uri" xlink:href="http://human.brain-map.org/">http://human.brain-map.org/</ext-link>
<sup><xref rid="R33" ref-type="bibr">33</xref></sup>. Scale bar for Allen Brain Atlas ISH images=1.6mm. 76 pseudo-bulked layers were used for computing the statistics in <bold>A-F</bold>.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0013"/>
      </fig>
      <fig id="F14" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 7</label>
        <caption>
          <title>smFISH validation of L1- and L5-enriched genes, related to <xref rid="F4" ref-type="fig">Figure 4</xref>.</title>
          <p id="P95">(<bold>A-B</bold>) Left panels: Boxplots of log-transformed normalized expression (logcounts) for previously identified L1 and L5 marker genes <italic>RELN</italic> (<bold>A</bold>, L1&gt;rest, p=7.94e-15,) and <italic>BCL11B</italic> (<bold>B</bold>, L5&gt;L3, p=4.44e-02), respectively. Right panels: Spotplots of log-transformed normalized expression (logcounts) for sample 151673 for genes <italic>RELN</italic> (<bold>A</bold>) and <italic>BCL11B</italic> (<bold>B</bold>). Corresponding boxplots and spotplots for Visium-identified genes <italic>AQP4</italic> and <italic>TRABD2A</italic> in <xref rid="F4" ref-type="fig">Figure 4</xref>. (<bold>C</bold>) Multiplex single molecule fluorescent in situ hybridization (smFISH) in a cortical strip of DLPFC. Maximum intensity confocal projections depicting expression of DAPI (nuclei), <italic>RELN</italic> (L1), <italic>AQP4</italic> (L1), <italic>BCL11B</italic> (L5), <italic>TRABD2A</italic> (L5) and lipofuscin autofluorescence. Merged image without lipofuscin autofluorescence. Scale bar=500&#x3BC;m. 76 pseudo-bulked layers were used for computing the statistics in <bold>A-B</bold>.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0014"/>
      </fig>
      <fig id="F15" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 8</label>
        <caption>
          <title>Spatial registration of snRNA-seq data, related to <xref rid="F5" ref-type="fig">Figure 5</xref>.</title>
          <p id="P96">Heatmaps of Pearson correlation values evaluating the relationship between our Visium-derived layer-enriched statistics (y-axis) for 700 genes and (<bold>A</bold>) Data from DLPFC from two donors, with data-driven cluster numbers and broad cell classes on the x-axis. (<bold>B</bold>) Data from Velmeshev <italic>et al.</italic> with data-driven clusters provided in their processed data.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0015"/>
      </fig>
      <fig id="F16" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 9</label>
        <caption>
          <title>Unsupervised&#x2019; clustering results for sample 151673, related to <xref rid="F7" ref-type="fig">Figure 7</xref>.</title>
          <p id="P97">Visualization of clustering results for &#x2018;unsupervised&#x2019; methods (<xref rid="SD4" ref-type="supplementary-material">Table S10</xref>) for sample 151673. Each panel displays clustering results from one clustering method. Rows display methods either without (top row) or with (bottom row) spatial coordinates included as additional features for clustering. A complete description of the different combinations of methodologies implemented in the clustering methods is provided in <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0016"/>
      </fig>
      <fig id="F17" orientation="portrait" position="anchor">
        <label>Extended Data Fig. 10</label>
        <caption>
          <title>Semi-supervised&#x2019; and &#x2018;markers&#x2019; clustering results for sample 151673, related to <xref rid="F7" ref-type="fig">Figure 7</xref>.</title>
          <p id="P98">Visualization of clustering results for &#x2018;semi-supervised&#x2019; and known &#x2018;markers&#x2019; gene set-based methods (<xref rid="SD4" ref-type="supplementary-material">Table S10</xref>) for sample 151673. Each panel displays clustering results from one clustering method. Rows display methods either without (top row) or with (bottom row) spatial coordinates included as additional features for clustering. A complete description of the different combinations of methodologies implemented in the clustering methods is provided in <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>.</p>
        </caption>
        <graphic xlink:href="nihms-1656366-f0017"/>
      </fig>
    </sec>
    <sec sec-type="supplementary-material" id="SM1">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <label>1</label>
        <media xlink:href="NIHMS1656366-supplement-1.pdf" orientation="portrait" id="d40e2504" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <label>2</label>
        <media xlink:href="NIHMS1656366-supplement-2.pdf" orientation="portrait" id="d40e2508" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD3">
        <label>3</label>
        <media xlink:href="NIHMS1656366-supplement-3.pdf" orientation="portrait" id="d40e2512" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD4">
        <label>1656366_Supp_Tab1-10</label>
        <media xlink:href="NIHMS1656366-supplement-1656366_Supp_Tab1-10.xlsx" orientation="portrait" id="d40e2516" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S32">
      <title>Acknowledgements</title>
      <p id="P99">The authors would like to express their gratitude to our colleagues whose efforts have led to the donation of postmortem tissue to advance these studies, including at the Office of the Chief Medical Examiner of the State of Maryland, Baltimore Maryland and the Office of the Chief Medical Examiner of Kalamazoo County Michigan. We also would like to acknowledge the contributions of Llewellyn B. Bigelow, MD and Amy Deep-Soboslay for their diagnostic expertise, and Daniel R. Weinberger for providing constructive commentary and editing of the manuscript. Finally, we are indebted to the generosity of the families of the decedents, who donated the brain tissue used in these studies. We would also like to thank the Accelerating Medicines Partnership - Alzheimer&#x2019;s Disease (AMP-AD) Target Discovery and Preclinical Validation program and the ROSMAP study. We would like to thank William S. Ulrich for assistance with <ext-link ext-link-type="uri" xlink:href="http://spatial.libd.org/spatialDE">http://spatial.libd.org/spatialDE</ext-link> and the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health for hosting mirrors of our web application. We thank the Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center (SKCCC) Flow Cytometry Core and the Johns Hopkins University Transcriptomics and Deep Sequencing Core for supporting snRNA-seq experiments.</p>
      <sec id="S33">
        <title>Funding</title>
        <p id="P100">This project was supported by the Lieber Institute for Brain Development. K.R.M., L.C-T., K.M., and A.E.J. were partially supported by the National Institute of Mental Health (U01MH122849). S.C.H. and L.M.W. were supported by the National Cancer Institute (R01CA237170). S.C.H. was also supported by the CZF2019-002443 from the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation, the National Human Genome Research Institute (R00HG009007).</p>
      </sec>
    </ack>
    <fn-group>
      <fn id="FN2">
        <p id="P101">Accession codes</p>
        <p id="P102">The raw data is publicly available from the Globus endpoint &#x201C;jhpce#HumanPilot10x&#x201D; that is also listed at <ext-link ext-link-type="uri" xlink:href="http://research.libd.org/globus/">http://research.libd.org/globus/</ext-link>. See &#x201C;<xref ref-type="fn" rid="FN4">Data Availability</xref>&#x201D; for more information.</p>
      </fn>
      <fn fn-type="COI-statement" id="FN3">
        <p id="P103">Competing Interests Statement</p>
        <p id="P104">C.U., S.R.W., J.C., Y.Y., and N.R. are employees of 10x Genomics. All other authors have no conflicts of interest to declare.</p>
      </fn>
      <fn id="FN4">
        <p id="P105">Data Availability Statement</p>
        <p id="P106">Processed data is publicly available from the Bioconductor package <italic>spatialLIBD</italic>
<sup><xref rid="R60" ref-type="bibr">60</xref></sup>. The raw data is publicly available from the Globus endpoint as described under &#x201C;Accession codes&#x201D;. The raw data provided through Globus includes all the FASTQ files and raw image files.</p>
        <p id="P107">External data used in this project is detailed under &#x201C;<xref rid="S23" ref-type="sec">Methods: snRNA-seq spatial registration</xref>&#x201D; as well as &#x201C;<xref rid="S25" ref-type="sec">Methods: Clinical gene set enrichment analyses</xref>&#x201D;.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><name><surname>DeFelipe</surname><given-names>J</given-names></name> &amp; <name><surname>Fari&#xF1;as</surname><given-names>I</given-names></name>
<article-title>The pyramidal neuron of the cerebral cortex: morphological and chemical characteristics of the synaptic inputs</article-title>. <source>Prog. Neurobiol</source>
<volume>39</volume>, <fpage>563</fpage>&#x2013;<lpage>607</lpage> (<year>1992</year>).<pub-id pub-id-type="pmid">1410442</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>KD</given-names></name> &amp; <name><surname>Shepherd</surname><given-names>GMG</given-names></name>
<article-title>The neocortical circuit: themes and variations</article-title>. <source>Nat. Neurosci</source>
<volume>18</volume>, <fpage>170</fpage>&#x2013;<lpage>181</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25622573</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><name><surname>Narayanan</surname><given-names>RT</given-names></name>, <name><surname>Udvary</surname><given-names>D</given-names></name> &amp; <name><surname>Oberlaender</surname><given-names>M</given-names></name>
<article-title>Cell Type-Specific Structural Organization of the Six Layers in Rat Barrel Cortex</article-title>. <source>Front. Neuroanat</source>
<volume>11</volume>, <fpage>91</fpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29081739</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><name><surname>Radnikow</surname><given-names>G</given-names></name> &amp; <name><surname>Feldmeyer</surname><given-names>D</given-names></name>
<article-title>Layer- and Cell Type-Specific Modulation of Excitatory Neuronal Activity in the Neocortex</article-title>. <source>Front. Neuroanat</source>
<volume>12</volume>, <fpage>1</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29440997</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><name><surname>Hodge</surname><given-names>RD</given-names></name>
<etal/>
<article-title>Conserved cell types with divergent features in human versus mouse cortex</article-title>. <source>Nature</source>
<volume>573</volume>, <fpage>61</fpage>&#x2013;<lpage>68</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31435019</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><name><surname>Velmeshev</surname><given-names>D</given-names></name>
<etal/>
<article-title>Single-cell genomics identifies cell type-specific molecular changes in autism</article-title>. <source>Science</source>
<volume>364</volume>, <fpage>685</fpage>&#x2013;<lpage>689</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31097668</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><name><surname>Darmanis</surname><given-names>S</given-names></name>
<etal/>
<article-title>A survey of human brain transcriptome diversity at the single cell level</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>112</volume>, <fpage>7285</fpage>&#x2013;<lpage>7290</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26060301</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><name><surname>Lake</surname><given-names>BB</given-names></name>
<etal/>
<article-title>Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain</article-title>. <source>Science</source>
<volume>352</volume>, <fpage>1586</fpage>&#x2013;<lpage>1590</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27339989</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><name><surname>Lake</surname><given-names>BB</given-names></name>
<etal/>
<article-title>Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain</article-title>. <source>Nat. Biotechnol</source>
<volume>36</volume>, <fpage>70</fpage>&#x2013;<lpage>80</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29227469</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><name><surname>Mathys</surname><given-names>H</given-names></name>
<etal/>
<article-title>Single-cell transcriptomic analysis of Alzheimer&#x2019;s disease</article-title>. <source>Nature</source>
<volume>570</volume>, <fpage>332</fpage>&#x2013;<lpage>337</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31042697</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><name><surname>Nowakowski</surname><given-names>TJ</given-names></name>
<etal/>
<article-title>Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex</article-title>. <source>Science</source>
<volume>358</volume>, <fpage>1318</fpage>&#x2013;<lpage>1323</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29217575</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><name><surname>Skene</surname><given-names>NG</given-names></name>
<etal/>
<article-title>Genetic identification of brain cell types underlying schizophrenia</article-title>. <source>Nat. Genet</source>
<volume>50</volume>, <fpage>825</fpage>&#x2013;<lpage>833</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29785013</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><name><surname>Bakken</surname><given-names>TE</given-names></name>
<etal/>
<article-title>Single-nucleus and single-cell transcriptomes compared in matched cortical cell types</article-title>. <source>PLoS ONE</source>
<volume>13</volume>, <fpage>e0209648</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30586455</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><name><surname>Sweet</surname><given-names>RA</given-names></name>, <name><surname>Fish</surname><given-names>KN</given-names></name> &amp; <name><surname>Lewis</surname><given-names>DA</given-names></name>
<article-title>Mapping Synaptic Pathology within Cerebral Cortical Circuits in Subjects with Schizophrenia</article-title>. <source>Front. Hum. Neurosci</source>
<volume>4</volume>, <fpage>44</fpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20631852</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><name><surname>Moyer</surname><given-names>CE</given-names></name>, <name><surname>Shelton</surname><given-names>MA</given-names></name> &amp; <name><surname>Sweet</surname><given-names>RA</given-names></name>
<article-title>Dendritic spine alterations in schizophrenia</article-title>. <source>Neurosci. Lett</source>
<volume>601</volume>, <fpage>46</fpage>&#x2013;<lpage>53</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25478958</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><name><surname>Gandal</surname><given-names>MJ</given-names></name>
<etal/>
<article-title>Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder</article-title>. <source>Science</source>
<volume>362</volume>, (<year>2018</year>).</mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><name><surname>Maynard</surname><given-names>KR</given-names></name>
<etal/>
<article-title>dotdotdot: an automated approach to quantify multiplex single molecule fluorescent in situ hybridization (smFISH) images in complex tissues</article-title>. <source>Nucleic Acids Res</source>. (<year>2020</year>). doi:<pub-id pub-id-type="doi">10.1093/nar/gkaa312</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><name><surname>Burgess</surname><given-names>DJ</given-names></name>
<article-title>Spatial transcriptomics coming of age</article-title>. <source>Nat. Rev. Genet</source>
<volume>20</volume>, <fpage>317</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30980030</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><name><surname>Lein</surname><given-names>E</given-names></name>, <name><surname>Borm</surname><given-names>LE</given-names></name> &amp; <name><surname>Linnarsson</surname><given-names>S</given-names></name>
<article-title>The promise of spatial transcriptomics for neuroscience in the era of molecular cell typing</article-title>. <source>Science</source>
<volume>358</volume>, <fpage>64</fpage>&#x2013;<lpage>69</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28983044</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><name><surname>Jaffe</surname><given-names>AE</given-names></name>
<etal/>
<article-title>Profiling gene expression in the human dentate gyrus granule cell layer reveals insights into schizophrenia and its genetic risk</article-title>. <source>Nat. Neurosci</source>
<volume>23</volume>, <fpage>510</fpage>&#x2013;<lpage>519</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">32203495</pub-id></mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><name><surname>Dong</surname><given-names>X</given-names></name>
<etal/>
<article-title>Global, integrated analysis of methylomes and transcriptomes from laser capture microdissected bronchial and alveolar cells in human lung</article-title>. <source>Epigenetics</source>
<volume>13</volume>, <fpage>264</fpage>&#x2013;<lpage>274</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29465290</pub-id></mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><name><surname>He</surname><given-names>Z</given-names></name>
<etal/>
<article-title>Comprehensive transcriptome analysis of neocortical layers in humans, chimpanzees and macaques</article-title>. <source>Nat. Neurosci</source>
<volume>20</volume>, <fpage>886</fpage>&#x2013;<lpage>895</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28414332</pub-id></mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><name><surname>St&#xE5;hl</surname><given-names>PL</given-names></name>
<etal/>
<article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>. <source>Science</source>
<volume>353</volume>, <fpage>78</fpage>&#x2013;<lpage>82</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27365449</pub-id></mixed-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><name><surname>Rodriques</surname><given-names>SG</given-names></name>
<etal/>
<article-title>Slide-seq: A scalable technology for measuring genome-wide expression at high spatial resolution</article-title>. <source>Science</source>
<volume>363</volume>, <fpage>1463</fpage>&#x2013;<lpage>1467</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30923225</pub-id></mixed-citation>
      </ref>
      <ref id="R25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><name><surname>Asp</surname><given-names>M</given-names></name>
<etal/>
<article-title>An Organ-Wide Gene Expression Atlas of the Developing Human Heart</article-title>. <source>SSRN Journal</source> (<year>2018</year>). doi:<pub-id pub-id-type="doi">10.2139/ssrn.3219263</pub-id></mixed-citation>
      </ref>
      <ref id="R26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><name><surname>Moncada</surname><given-names>R</given-names></name>
<etal/>
<article-title>Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas</article-title>. <source>Nat. Biotechnol</source>
<volume>38</volume>, <fpage>333</fpage>&#x2013;<lpage>342</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">31932730</pub-id></mixed-citation>
      </ref>
      <ref id="R27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><name><surname>Berglund</surname><given-names>E</given-names></name>
<etal/>
<article-title>Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity</article-title>. <source>Nat. Commun</source>
<volume>9</volume>, <fpage>2419</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29925878</pub-id></mixed-citation>
      </ref>
      <ref id="R28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><name><surname>Maniatis</surname><given-names>S</given-names></name>
<etal/>
<article-title>Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis</article-title>. <source>Science</source>
<volume>364</volume>, <fpage>89</fpage>&#x2013;<lpage>93</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30948552</pub-id></mixed-citation>
      </ref>
      <ref id="R29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><name><surname>Gregory</surname><given-names>JM</given-names></name>
<etal/>
<article-title>Spatial transcriptomics identifies spatially dysregulated expression of GRM3 and USP47 in amyotrophic lateral sclerosis</article-title>. <source>Neuropathol. Appl. Neurobiol</source> (<year>2020</year>). doi:<pub-id pub-id-type="doi">10.1111/nan.12597</pub-id></mixed-citation>
      </ref>
      <ref id="R30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><name><surname>Hafner</surname><given-names>A-S</given-names></name>, <name><surname>Donlin-Asp</surname><given-names>PG</given-names></name>, <name><surname>Leitch</surname><given-names>B</given-names></name>, <name><surname>Herzog</surname><given-names>E</given-names></name> &amp; <name><surname>Schuman</surname><given-names>EM</given-names></name>
<article-title>Local protein synthesis is a ubiquitous feature of neuronal pre- and postsynaptic compartments</article-title>. <source>Science</source>
<volume>364</volume>, (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="R31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><name><surname>Molyneaux</surname><given-names>BJ</given-names></name>, <name><surname>Arlotta</surname><given-names>P</given-names></name>, <name><surname>Menezes</surname><given-names>JRL</given-names></name> &amp; <name><surname>Macklis</surname><given-names>JD</given-names></name>
<article-title>Neuronal subtype specification in the cerebral cortex</article-title>. <source>Nat. Rev. Neurosci</source>
<volume>8</volume>, <fpage>427</fpage>&#x2013;<lpage>437</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">17514196</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><name><surname>Zeng</surname><given-names>H</given-names></name>
<etal/>
<article-title>Large-scale cellular-resolution gene profiling in human neocortex reveals species-specific molecular signatures</article-title>. <source>Cell</source>
<volume>149</volume>, <fpage>483</fpage>&#x2013;<lpage>496</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22500809</pub-id></mixed-citation>
      </ref>
      <ref id="R33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><name><surname>Hawrylycz</surname><given-names>MJ</given-names></name>
<etal/>
<article-title>An anatomically comprehensive atlas of the adult human brain transcriptome</article-title>. <source>Nature</source>
<volume>489</volume>, <fpage>391</fpage>&#x2013;<lpage>399</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22996553</pub-id></mixed-citation>
      </ref>
      <ref id="R34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><name><surname>Birnbaum</surname><given-names>R</given-names></name>, <name><surname>Jaffe</surname><given-names>AE</given-names></name>, <name><surname>Hyde</surname><given-names>TM</given-names></name>, <name><surname>Kleinman</surname><given-names>JE</given-names></name> &amp; <name><surname>Weinberger</surname><given-names>DR</given-names></name>
<article-title>Prenatal expression patterns of genes associated with neuropsychiatric disorders</article-title>. <source>Am. J. Psychiatry</source>
<volume>171</volume>, <fpage>758</fpage>&#x2013;<lpage>767</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24874100</pub-id></mixed-citation>
      </ref>
      <ref id="R35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><name><surname>Abrahams</surname><given-names>BS</given-names></name>
<etal/>
<article-title>SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs)</article-title>. <source>Mol. Autism</source>
<volume>4</volume>, <fpage>36</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">24090431</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><name><surname>Satterstrom</surname><given-names>FK</given-names></name>
<etal/>
<article-title>Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism</article-title>. <source>Cell</source>
<volume>180</volume>, <fpage>568</fpage>&#x2013;<lpage>584.e23</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">31981491</pub-id></mixed-citation>
      </ref>
      <ref id="R37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><name><surname>de Leeuw</surname><given-names>CA</given-names></name>, <name><surname>Mooij</surname><given-names>JM</given-names></name>, <name><surname>Heskes</surname><given-names>T</given-names></name> &amp; <name><surname>Posthuma</surname><given-names>D</given-names></name>
<article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title>. <source>PLoS Comput. Biol</source>
<volume>11</volume>, <fpage>e1004219</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25885710</pub-id></mixed-citation>
      </ref>
      <ref id="R38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><name><surname>Collado-Torres</surname><given-names>L</given-names></name>
<etal/>
<article-title>Regional Heterogeneity in Gene Expression, Regulation, and Coherence in the Frontal Cortex and Hippocampus across Development and Schizophrenia</article-title>. <source>Neuron</source>
<volume>103</volume>, <fpage>203</fpage>&#x2013;<lpage>216.e8</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31174959</pub-id></mixed-citation>
      </ref>
      <ref id="R39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><name><surname>Finucane</surname><given-names>HK</given-names></name>
<etal/>
<article-title>Partitioning heritability by functional annotation using genome-wide association summary statistics</article-title>. <source>Nat. Genet</source>
<volume>47</volume>, <fpage>1228</fpage>&#x2013;<lpage>1235</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">26414678</pub-id></mixed-citation>
      </ref>
      <ref id="R40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><name><surname>Grove</surname><given-names>J</given-names></name>
<etal/>
<article-title>Identification of common genetic risk variants for autism spectrum disorder</article-title>. <source>Nat. Genet</source>
<volume>51</volume>, <fpage>431</fpage>&#x2013;<lpage>444</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30804558</pub-id></mixed-citation>
      </ref>
      <ref id="R41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><name><surname>Pardi&#xF1;as</surname><given-names>AF</given-names></name>
<etal/>
<article-title>Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection</article-title>. <source>Nat. Genet</source>
<volume>50</volume>, <fpage>381</fpage>&#x2013;<lpage>389</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29483656</pub-id></mixed-citation>
      </ref>
      <ref id="R42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><name><surname>Stahl</surname><given-names>EA</given-names></name>
<etal/>
<article-title>Genome-wide association study identifies 30 loci associated with bipolar disorder</article-title>. <source>Nat. Genet</source>
<volume>51</volume>, <fpage>793</fpage>&#x2013;<lpage>803</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31043756</pub-id></mixed-citation>
      </ref>
      <ref id="R43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><name><surname>Jaffe</surname><given-names>AE</given-names></name>
<etal/>
<article-title>Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis</article-title>. <source>Nat. Neurosci</source>
<volume>21</volume>, <fpage>1117</fpage>&#x2013;<lpage>1125</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30050107</pub-id></mixed-citation>
      </ref>
      <ref id="R44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><name><surname>Fromer</surname><given-names>M</given-names></name>
<etal/>
<article-title>Gene expression elucidates functional impact of polygenic risk for schizophrenia</article-title>. <source>Nat. Neurosci</source>
<volume>19</volume>, <fpage>1442</fpage>&#x2013;<lpage>1453</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27668389</pub-id></mixed-citation>
      </ref>
      <ref id="R45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><name><surname>Vickovic</surname><given-names>S</given-names></name>
<etal/>
<article-title>High-definition spatial transcriptomics for in situ tissue profiling</article-title>. <source>Nat. Methods</source>
<volume>16</volume>, <fpage>987</fpage>&#x2013;<lpage>990</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">31501547</pub-id></mixed-citation>
      </ref>
      <ref id="R46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>KH</given-names></name>, <name><surname>Boettiger</surname><given-names>AN</given-names></name>, <name><surname>Moffitt</surname><given-names>JR</given-names></name>, <name><surname>Wang</surname><given-names>S</given-names></name> &amp; <name><surname>Zhuang</surname><given-names>X</given-names></name>
<article-title>RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells</article-title>. <source>Science</source>
<volume>348</volume>, <fpage>aaa6090</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25858977</pub-id></mixed-citation>
      </ref>
      <ref id="R47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><name><surname>Codeluppi</surname><given-names>S</given-names></name>
<etal/>
<article-title>Spatial organization of the somatosensory cortex revealed by osmFISH</article-title>. <source>Nat. Methods</source>
<volume>15</volume>, <fpage>932</fpage>&#x2013;<lpage>935</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">30377364</pub-id></mixed-citation>
      </ref>
      <ref id="R48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><name><surname>Overly</surname><given-names>CC</given-names></name>, <name><surname>Rieff</surname><given-names>HI</given-names></name> &amp; <name><surname>Hollenbeck</surname><given-names>PJ</given-names></name>
<article-title>Organelle motility and metabolism in axons vs dendrites of cultured hippocampal neurons</article-title>. <source>J. Cell Sci</source>
<volume>109</volume> ( <issue>Pt 5</issue>), <fpage>971</fpage>&#x2013;<lpage>980</lpage> (<year>1996</year>).<pub-id pub-id-type="pmid">8743944</pub-id></mixed-citation>
      </ref>
      <ref id="R49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><name><surname>Harris</surname><given-names>JJ</given-names></name>, <name><surname>Jolivet</surname><given-names>R</given-names></name> &amp; <name><surname>Attwell</surname><given-names>D</given-names></name>
<article-title>Synaptic energy use and supply</article-title>. <source>Neuron</source>
<volume>75</volume>, <fpage>762</fpage>&#x2013;<lpage>777</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22958818</pub-id></mixed-citation>
      </ref>
      <ref id="R50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><name><surname>Biever</surname><given-names>A</given-names></name>, <name><surname>Donlin-Asp</surname><given-names>PG</given-names></name> &amp; <name><surname>Schuman</surname><given-names>EM</given-names></name>
<article-title>Local translation in neuronal processes</article-title>. <source>Curr. Opin. Neurobiol</source>
<volume>57</volume>, <fpage>141</fpage>&#x2013;<lpage>148</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30861464</pub-id></mixed-citation>
      </ref>
    </ref-list>
    <ref-list>
      <title>Methods-only References</title>
      <ref id="R51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><name><surname>Lipska</surname><given-names>BK</given-names></name>
<etal/>
<article-title>Critical factors in gene expression in postmortem human brain: Focus on studies in schizophrenia</article-title>. <source>Biol. Psychiatry</source>
<volume>60</volume>, <fpage>650</fpage>&#x2013;<lpage>658</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16997002</pub-id></mixed-citation>
      </ref>
      <ref id="R52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><name><surname>Dobin</surname><given-names>A</given-names></name>
<etal/>
<article-title>STAR: ultrafast universal RNA-seq aligner</article-title>. <source>Bioinformatics</source>
<volume>29</volume>, <fpage>15</fpage>&#x2013;<lpage>21</lpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23104886</pub-id></mixed-citation>
      </ref>
      <ref id="R53">
        <label>53.</label>
        <mixed-citation publication-type="journal"><name><surname>Martin Morgan</surname><given-names>VO</given-names></name>
<article-title>SummarizedExperiment</article-title>. <source>Bioconductor</source> (<year>2017</year>). doi:<pub-id pub-id-type="doi">10.18129/b9.bioc.summarizedexperiment</pub-id></mixed-citation>
      </ref>
      <ref id="R54">
        <label>54.</label>
        <mixed-citation publication-type="journal"><name><surname>Lun</surname><given-names>Aaron</given-names></name> [<name><surname>Aut</surname><given-names>C</given-names></name>, <name><surname>Davide</surname><given-names>Risso</given-names></name>. <article-title>SingleCellExperiment</article-title>. <source>Bioconductor</source> (<year>2017</year>). doi:<pub-id pub-id-type="doi">10.18129/b9.bioc.singlecellexperiment</pub-id></mixed-citation>
      </ref>
      <ref id="R55">
        <label>55.</label>
        <mixed-citation publication-type="journal"><name><surname>Lun</surname><given-names>ATL</given-names></name>, <name><surname>McCarthy</surname><given-names>DJ</given-names></name> &amp; <name><surname>Marioni</surname><given-names>JC</given-names></name>
<article-title>A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. [version 2; peer review: 3 approved, 2 approved with reservations]</article-title>. <source>F1000Res</source>. <volume>5</volume>, <fpage>2122</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27909575</pub-id></mixed-citation>
      </ref>
      <ref id="R56">
        <label>56.</label>
        <mixed-citation publication-type="journal"><name><surname>McCarthy</surname><given-names>DJ</given-names></name>, <name><surname>Campbell</surname><given-names>KR</given-names></name>, <name><surname>Lun</surname><given-names>ATL</given-names></name> &amp; <name><surname>Wills</surname><given-names>QF</given-names></name>
<article-title>Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R</article-title>. <source>Bioinformatics</source>
<volume>33</volume>, <fpage>1179</fpage>&#x2013;<lpage>1186</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28088763</pub-id></mixed-citation>
      </ref>
      <ref id="R57">
        <label>57.</label>
        <mixed-citation publication-type="journal"><name><surname>van der Maaten</surname><given-names>L</given-names></name> &amp; <name><surname>Hinton</surname><given-names>G</given-names></name>
<article-title>Visualizing Data using t-SNE</article-title>. <source>Journal of Machine Learning Research</source>
<volume>9</volume>, <fpage>2579</fpage>&#x2013;<lpage>2605</lpage> (<year>2008</year>).</mixed-citation>
      </ref>
      <ref id="R58">
        <label>58.</label>
        <mixed-citation publication-type="journal"><name><surname>McInnes</surname><given-names>L</given-names></name>, <name><surname>Healy</surname><given-names>J</given-names></name>, <name><surname>Saul</surname><given-names>N</given-names></name> &amp; <name><surname>Gro&#xDF;berger</surname><given-names>L</given-names></name>
<article-title>UMAP: uniform manifold approximation and projection</article-title>. <source>JOSS</source>
<volume>3</volume>, <fpage>861</fpage> (<year>2018</year>).</mixed-citation>
      </ref>
      <ref id="R59">
        <label>59.</label>
        <mixed-citation publication-type="journal"><name><surname>Csardi</surname><given-names>G</given-names></name> &amp; <name><surname>Nepusz</surname><given-names>T</given-names></name>
<article-title>The igraph software package for complex network research</article-title>. <source>InterJournal <bold>Complex Systems</bold></source>, <volume>1695</volume> (<year>2006</year>).</mixed-citation>
      </ref>
      <ref id="R60">
        <label>60.</label>
        <mixed-citation publication-type="journal"><name><surname>Collado-Torres</surname><given-names>L</given-names></name>
<article-title>LieberInstitute/spatialLIBD: spatialLIBD: initial Bioconductor submission</article-title>. <source>Zenodo</source> (<year>2020</year>). doi:<pub-id pub-id-type="doi">10.5281/zenodo.3689719</pub-id></mixed-citation>
      </ref>
      <ref id="R61">
        <label>61.</label>
        <mixed-citation publication-type="journal"><name><surname>Chang</surname><given-names>W</given-names></name>, <name><surname>Cheng</surname><given-names>J</given-names></name>, <name><surname>Allaire</surname><given-names>JJ</given-names></name>, <name><surname>Xie</surname><given-names>Y</given-names></name> &amp; <name><surname>McPherson</surname><given-names>J</given-names></name>
<source>shiny: Web Application Framework for R</source>. (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="R62">
        <label>62.</label>
        <mixed-citation publication-type="journal"><name><surname>Sievert</surname><given-names>C</given-names></name>
<source>plotly for R</source>. (<year>2018</year>).</mixed-citation>
      </ref>
      <ref id="R63">
        <label>63.</label>
        <mixed-citation publication-type="journal"><name><surname>Rajkowska</surname><given-names>G</given-names></name> &amp; <name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name>
<article-title>Cytoarchitectonic definition of prefrontal areas in the normal human cortex: I. Remapping of areas 9 and 46 using quantitative criteria</article-title>. <source>Cereb. Cortex</source>
<volume>5</volume>, <fpage>307</fpage>&#x2013;<lpage>322</lpage> (<year>1995</year>).<pub-id pub-id-type="pmid">7580124</pub-id></mixed-citation>
      </ref>
      <ref id="R64">
        <label>64.</label>
        <mixed-citation publication-type="journal"><name><surname>Rajkowska</surname><given-names>G</given-names></name> &amp; <name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name>
<article-title>Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System</article-title>. <source>Cereb. Cortex</source>
<volume>5</volume>, <fpage>323</fpage>&#x2013;<lpage>337</lpage> (<year>1995</year>).<pub-id pub-id-type="pmid">7580125</pub-id></mixed-citation>
      </ref>
      <ref id="R65">
        <label>65.</label>
        <mixed-citation publication-type="journal"><name><surname>Lun</surname><given-names>ATL</given-names></name> &amp; <name><surname>Marioni</surname><given-names>JC</given-names></name>
<article-title>Overcoming confounding plate effects in differential expression analyses of single-cell RNA-seq data</article-title>. <source>Biostatistics</source>
<volume>18</volume>, <fpage>451</fpage>&#x2013;<lpage>464</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28334062</pub-id></mixed-citation>
      </ref>
      <ref id="R66">
        <label>66.</label>
        <mixed-citation publication-type="journal"><name><surname>Kang</surname><given-names>HM</given-names></name>
<etal/>
<article-title>Multiplexed droplet single-cell RNA-sequencing using natural genetic variation</article-title>. <source>Nat. Biotechnol</source>
<volume>36</volume>, <fpage>89</fpage>&#x2013;<lpage>94</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29227470</pub-id></mixed-citation>
      </ref>
      <ref id="R67">
        <label>67.</label>
        <mixed-citation publication-type="journal"><name><surname>Crowell</surname><given-names>HL</given-names></name>
<etal/>
<article-title>muscat detects subpopulation-specific state transitions from multi-sample multi-condition single-cell transcriptomics data</article-title>. <source>Nat. Commun</source>
<volume>11</volume>, <fpage>6077</fpage> (<year>2020</year>).<pub-id pub-id-type="pmid">33257685</pub-id></mixed-citation>
      </ref>
      <ref id="R68">
        <label>68.</label>
        <mixed-citation publication-type="journal"><name><surname>Ritchie</surname><given-names>ME</given-names></name>
<etal/>
<article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies</article-title>. <source>Nucleic Acids Res</source>. <volume>43</volume>, <fpage>e47</fpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25605792</pub-id></mixed-citation>
      </ref>
      <ref id="R69">
        <label>69.</label>
        <mixed-citation publication-type="journal"><name><surname>Law</surname><given-names>CW</given-names></name>, <name><surname>Chen</surname><given-names>Y</given-names></name>, <name><surname>Shi</surname><given-names>W</given-names></name> &amp; <name><surname>Smyth</surname><given-names>GK</given-names></name>
<article-title>voom: Precision weights unlock linear model analysis tools for RNA-seq read counts</article-title>. <source>Genome Biol</source>. <volume>15</volume>, <fpage>R29</fpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24485249</pub-id></mixed-citation>
      </ref>
      <ref id="R70">
        <label>70.</label>
        <mixed-citation publication-type="journal"><name><surname>Habib</surname><given-names>N</given-names></name>
<etal/>
<article-title>Massively parallel single-nucleus RNA-seq with DroNc-seq</article-title>. <source>Nat. Methods</source>
<volume>14</volume>, <fpage>955</fpage>&#x2013;<lpage>958</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">28846088</pub-id></mixed-citation>
      </ref>
      <ref id="R71">
        <label>71.</label>
        <mixed-citation publication-type="journal"><name><surname>Lacar</surname><given-names>B</given-names></name>
<etal/>
<article-title>Nuclear RNA-seq of single neurons reveals molecular signatures of activation</article-title>. <source>Nat. Commun</source>
<volume>7</volume>, <fpage>11022</fpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27090946</pub-id></mixed-citation>
      </ref>
      <ref id="R72">
        <label>72.</label>
        <mixed-citation publication-type="journal"><name><surname>Habib</surname><given-names>N</given-names></name>
<etal/>
<article-title>Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons</article-title>. <source>Science</source>
<volume>353</volume>, <fpage>925</fpage>&#x2013;<lpage>928</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">27471252</pub-id></mixed-citation>
      </ref>
      <ref id="R73">
        <label>73.</label>
        <mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>P</given-names></name>
<etal/>
<article-title>Dissecting Cell-Type Composition and Activity-Dependent Transcriptional State in Mammalian Brains by Massively Parallel Single-Nucleus RNA-Seq</article-title>. <source>Mol. Cell</source>
<volume>68</volume>, <fpage>1006</fpage>&#x2013;<lpage>1015.e7</lpage> (<year>2017</year>).<pub-id pub-id-type="pmid">29220646</pub-id></mixed-citation>
      </ref>
      <ref id="R74">
        <label>74.</label>
        <mixed-citation publication-type="journal"><name><surname>Amezquita</surname><given-names>RA</given-names></name>
<etal/>
<article-title>Orchestrating single-cell analysis with Bioconductor</article-title>. <source>Nat. Methods</source>
<volume>17</volume>, <fpage>137</fpage>&#x2013;<lpage>145</lpage> (<year>2020</year>).<pub-id pub-id-type="pmid">31792435</pub-id></mixed-citation>
      </ref>
      <ref id="R75">
        <label>75.</label>
        <mixed-citation publication-type="journal"><name><surname>Lun</surname><given-names>ATL</given-names></name>
<etal/>
<article-title>EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data</article-title>. <source>Genome Biol</source>. <volume>20</volume>, <fpage>63</fpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30902100</pub-id></mixed-citation>
      </ref>
      <ref id="R76">
        <label>76.</label>
        <mixed-citation publication-type="journal"><name><surname>Griffiths</surname><given-names>JA</given-names></name>, <name><surname>Richard</surname><given-names>AC</given-names></name>, <name><surname>Bach</surname><given-names>K</given-names></name>, <name><surname>Lun</surname><given-names>ATL</given-names></name> &amp; <name><surname>Marioni</surname><given-names>JC</given-names></name>
<article-title>Detection and removal of barcode swapping in single-cell RNA-seq data</article-title>. <source>Nat. Commun</source>
<volume>9</volume>, <fpage>2667</fpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29991676</pub-id></mixed-citation>
      </ref>
      <ref id="R77">
        <label>77.</label>
        <mixed-citation publication-type="journal"><name><surname>Langfelder</surname><given-names>P</given-names></name>, <name><surname>Zhang</surname><given-names>B</given-names></name> &amp; <article-title>with contributions from Steve Horvath</article-title>. <source>dynamicTreeCut: Methods for Detection of Clusters in Hierarchical Clustering Dendrograms</source>. (<year>2016</year>).</mixed-citation>
      </ref>
      <ref id="R78">
        <label>78.</label>
        <mixed-citation publication-type="journal"><name><surname>Gusev</surname><given-names>A</given-names></name>
<etal/>
<article-title>Integrative approaches for large-scale transcriptome-wide association studies</article-title>. <source>Nat. Genet</source>
<volume>48</volume>, <fpage>245</fpage>&#x2013;<lpage>252</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26854917</pub-id></mixed-citation>
      </ref>
      <ref id="R79">
        <label>79.</label>
        <mixed-citation publication-type="journal"><name><surname>Olmos-Serrano</surname><given-names>JL</given-names></name>
<etal/>
<article-title>Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination</article-title>. <source>Neuron</source>
<volume>89</volume>, <fpage>1208</fpage>&#x2013;<lpage>1222</lpage> (<year>2016</year>).<pub-id pub-id-type="pmid">26924435</pub-id></mixed-citation>
      </ref>
      <ref id="R80">
        <label>80.</label>
        <mixed-citation publication-type="journal"><name><surname>Wray</surname><given-names>NR</given-names></name>
<etal/>
<article-title>Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression</article-title>. <source>Nat. Genet</source>
<volume>50</volume>, <fpage>668</fpage>&#x2013;<lpage>681</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29700475</pub-id></mixed-citation>
      </ref>
      <ref id="R81">
        <label>81.</label>
        <mixed-citation publication-type="journal"><name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name>
<etal/>
<article-title>LD Score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title>. <source>Nat. Genet</source>
<volume>47</volume>, <fpage>291</fpage>&#x2013;<lpage>295</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25642630</pub-id></mixed-citation>
      </ref>
      <ref id="R82">
        <label>82.</label>
        <mixed-citation publication-type="journal"><name><surname>Rizzardi</surname><given-names>LF</given-names></name>
<etal/>
<article-title>Neuronal brain-region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability</article-title>. <source>Nat. Neurosci</source>
<volume>22</volume>, <fpage>307</fpage>&#x2013;<lpage>316</lpage> (<year>2019</year>).<pub-id pub-id-type="pmid">30643296</pub-id></mixed-citation>
      </ref>
      <ref id="R83">
        <label>83.</label>
        <mixed-citation publication-type="journal"><name><surname>Svensson</surname><given-names>V</given-names></name>, <name><surname>Teichmann</surname><given-names>SA</given-names></name> &amp; <name><surname>Stegle</surname><given-names>O</given-names></name>
<article-title>SpatialDE: identification of spatially variable genes</article-title>. <source>Nat. Methods</source>
<volume>15</volume>, <fpage>343</fpage>&#x2013;<lpage>346</lpage> (<year>2018</year>).<pub-id pub-id-type="pmid">29553579</pub-id></mixed-citation>
      </ref>
      <ref id="R84">
        <label>84.</label>
        <mixed-citation publication-type="journal"><name><surname>Lun</surname><given-names>A</given-names></name>
<article-title>BiocSingular</article-title>. <source>Bioconductor</source> (<year>2019</year>). doi:<pub-id pub-id-type="doi">10.18129/b9.bioc.biocsingular</pub-id></mixed-citation>
      </ref>
      <ref id="R85">
        <label>85.</label>
        <mixed-citation publication-type="journal"><name><surname>Melville</surname><given-names>J</given-names></name>
<source>uwot: R package</source>. (<year>2019</year>).</mixed-citation>
      </ref>
      <ref id="R86">
        <label>86.</label>
        <mixed-citation publication-type="book"><name><surname>Wickham</surname><given-names>H</given-names></name>
<source>ggplot2 - Elegant Graphics for Data Analysis</source>. (<publisher-name>Springer International Publishing</publisher-name>, <year>2016</year>). doi:<pub-id pub-id-type="doi">10.1007/978-3-319-24277-4</pub-id></mixed-citation>
      </ref>
      <ref id="R87">
        <label>87.</label>
        <mixed-citation publication-type="journal"><name><surname>Collado-Torres</surname><given-names>L</given-names></name>, <name><surname>Weber</surname><given-names>L</given-names></name> &amp; <name><surname>Hicks</surname><given-names>S</given-names></name>
<article-title>LieberInstitute/HumanPilot: Archive the HumanPilot code for the preprint version of our project</article-title>. <source>Zenodo</source> (<year>2020</year>). doi:<pub-id pub-id-type="doi">10.5281/zenodo.3691916</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1:</label>
      <caption>
        <title>Spatial transcriptomics in DLPFC using Visium.</title>
        <p id="P108">(<bold>A</bold>) Tissue blocks of DLPFC were acquired in the anatomical plane perpendicular to the pial surface and extended to the gray-white matter junction. Each block spanned the 6 cortical layers and WM. (<bold>B</bold>) Schematic of experimental design including two pairs of &#x2018;spatial replicates&#x2019; from three independent neurotypical adult donors. Each pair consisted of two, directly adjacent 10&#x3BC;m serial tissue sections with the second pair located 300&#x3BC;m posterior from the first, resulting in a total of 12 samples run on the Visium platform. (<bold>C</bold>) DLPFC tissue block and corresponding histology from sample 151673. (<bold>D-F</bold>) Spotplots depicting log-transformed normalized expression (logcounts) for sample 151673 for genes <italic>SNAP25</italic> (<bold>D</bold>), <italic>MOBP</italic> (<bold>E</bold>), and <italic>PCP4</italic> (<bold>F</bold>). Expression of these genes confirmed the spatial orientation of each sample by delineating the border between gray matter/neurons (<italic>SNAP25</italic>) and white matter/oligodendrocytes (<italic>MOBP</italic>) and defining L5 (<italic>PCP4</italic>). Spotplots of <italic>SNAP25, MOBP</italic>, and <italic>PCP4</italic> for all 12 samples can be found in <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 2</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 3</xref>, and <xref rid="F8" ref-type="fig">Extended Data 1</xref>. See also <xref rid="SD4" ref-type="supplementary-material">Table S1</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1656366-f0001"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2:</label>
      <caption>
        <title>Layer-enriched gene expression in the DLPFC.</title>
        <p id="P109">(<bold>A</bold>) Visual description of the &#x2018;pseudo-bulking&#x2019; statistical procedure, which collapses the spatial transcriptomics data from spot-level (~4000 spots) to layer-level (6 layers + WM) data within each tissue section. (<bold>B</bold>) Principal component analysis (PCA) of layer-level (&#x2018;pseudo-bulked&#x2019;) expression profiles across all sections and subjects. The first principal component separates the white and gray matter, and the second principal component associates with laminae. Visual depictions of the three statistical models employed to assess laminar enrichment, using <italic>MOBP</italic> as an example, including (<bold>C</bold>) &#x201C;ANOVA&#x201D; model, which tests whether the means of the seven layers are different, (<bold>D</bold>) &#x2018;enrichment&#x2019; model, which tests whether each layer differs from all other layers - shown is WM (orange) vs other 6 layers (light blue), and (<bold>E</bold>) &#x2018;pairwise&#x2019; model, which tests each layer versus each other layer - shown in WM (orange) versus L3 (light blue), which other layers in gray. 76 pseudo-bulked layers were used for computing the statistics in <bold>C-E</bold>. See also <xref rid="SD4" ref-type="supplementary-material">Supplementary Figure 5</xref>, <xref rid="F9" ref-type="fig">Extended Data 2</xref>, <xref rid="F11" ref-type="fig">Extended Data 4</xref>, and <xref rid="SD4" ref-type="supplementary-material">Table S4</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1656366-f0002"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3:</label>
      <caption>
        <title>Visium replicates layer-enrichment of previously identified layer marker genes.</title>
        <p id="P110"><bold>(A-D)</bold> Left panels: Boxplots of log-transformed normalized expression (logcounts) for genes <italic>FABP7</italic> (<bold>A,</bold> L1&gt;rest, <italic>p</italic>=5.01e-19), <italic>PVALB</italic> (<bold>B,</bold> L4&gt;rest, <italic>p</italic>=1.74e-09), <italic>CCK</italic> (<bold>C,</bold> L6&gt;WM, <italic>p</italic>=4.48e-19), and <italic>ENC1</italic> (<bold>D,</bold> L2&gt;WM, <italic>p</italic>=4.61e-25). Middle panels: Spotplots of log-transformed normalized expression (logcounts) for sample 151673 for genes <italic>FABP7</italic> (<bold>A</bold>), <italic>PVALB</italic> (<bold>B</bold>), <italic>CCK</italic> (<bold>C</bold>), and <italic>ENC1</italic> (<bold>D</bold>). Right panels: <italic>in situ</italic> hybridization (ISH) images from temporal cortex (<bold>A, D</bold>), DLPFC (<bold>B</bold>), or visual cortex (<bold>C</bold>) of adult human brain from Allen Human Brain Atlas: <ext-link ext-link-type="uri" xlink:href="http://human.brain-map.org/">http://human.brain-map.org/</ext-link>
<sup><xref rid="R33" ref-type="bibr">33</xref></sup>. Box and spot plots can be reproduced using our web application at: <ext-link ext-link-type="uri" xlink:href="http://spatial.libd.org/spatialLIBD">http://spatial.libd.org/spatialLIBD</ext-link>. Scale bar for Allen Brain Atlas ISH images=1.6mm. 76 pseudo-bulked layers were used for computing the statistics in <bold>A-D</bold>. See also <xref rid="F13" ref-type="fig">Extended Data 6</xref> and <xref rid="SD4" ref-type="supplementary-material">Table S5</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1656366-f0003"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4:</label>
      <caption>
        <title>Discovery and smFISH validation of novel layer-enriched genes.</title>
        <p id="P111"><bold>(A-D)</bold> Left panels: Boxplots of log-transformed normalized expression (logcounts) for genes <italic>AQP4</italic> (<bold>A,</bold> L1&gt;rest, <italic>p</italic>=1.47e-10), <italic>TRABD2A</italic> (<bold>B,</bold> L5&gt;rest, <italic>p</italic>=4.33e-12), <italic>HPCAL1</italic> (<bold>C</bold>, L2&gt;rest, <italic>p</italic>=9.73e-11), and <italic>KRT17</italic> (<bold>D</bold>, L6&gt;rest, <italic>p</italic>=5.05e-12). Middle panels: Spotplots of log-transformed normalized expression (logcounts) for sample 151673 for genes <italic>AQP4</italic> (<bold>A</bold>), <italic>TRABD2A</italic> (<bold>B</bold>), <italic>HPCAL1</italic> (<bold>C</bold>) <italic>and KRT17</italic>(<bold>D</bold>). (<bold>E</bold>) Multiplex single molecule fluorescent in situ hybridization (smFISH) in a cortical strip of DLPFC. Maximum intensity confocal projections depicting expression of DAPI (nuclei), <italic>AQP4, HPCAL1, TRABD2A, KRT17</italic>, and lipofuscin autofluorescence. Merged image without lipofuscin autofluorescence. Scale bar=200&#x3BC;m. 76 pseudo-bulked layers were used for computing the statistics in <bold>A-D</bold>. See also <xref rid="F14" ref-type="fig">Extended Data 7</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 6</xref>, and <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 7</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1656366-f0004"/>
    </fig>
    <fig id="F5" orientation="portrait" position="float">
      <label>Figure 5:</label>
      <caption>
        <title>Spatial registration of snRNA-seq data.</title>
        <p id="P112">(<bold>A</bold>) Overview of the spatial registration approach. Heatmap of Pearson correlation values evaluating the relationship between our derived layer-enriched statistics (y-axis) for 700 genes and (<bold>B</bold>) layer-enriched statistics from snRNA-seq data in human medial temporal cortex produced by Hodge et al. <sup><xref rid="R5" ref-type="bibr">5</xref></sup> (these data only profiled layers 1-6 in the gray matter, x-axis) and (<bold>C</bold>) cell type-specific statistics for cellular subtypes that were annotated by Mathys <italic>et al.</italic> from snRNA-seq data in human prefrontal cortex <sup><xref rid="R10" ref-type="bibr">10</xref></sup>(x-axis). Oli = oligodendrocyte, Ast = astrocyte, Mic = microglia, Opc = oligodendrocyte precursor cell, Per = pericyte, End = endothelial, Ex = excitatory neurons, In = inhibitory neurons. See also <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 8</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 9</xref>, and <xref rid="F15" ref-type="fig">Extended Data 8</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1656366-f0005"/>
    </fig>
    <fig id="F6" orientation="portrait" position="float">
      <label>Figure 6</label>
      <caption>
        <title>Layer-enrichment of neurodevelopmental and neuropsychiatric gene sets.</title>
        <p id="P113">We performed enrichment analyses using Fisher&#x2019;s exact tests for our layer-enriched statistics versus a series of predefined gene sets related. (<bold>A</bold>) Autism spectrum disorder (ASD) laminar enrichments for SFARI <sup><xref rid="R35" ref-type="bibr">35</xref></sup> and Satterstrom <italic>et al</italic>
<sup><xref rid="R36" ref-type="bibr">36</xref></sup> for 102 overall ASD genes (ASC102), which were further stratified into 53 predominantly ASD (ASD53) and 49 predominantly developmental delay (DDID49) genes, as well as genes differentially expressed (DE) in the brains of individuals with ASD versus neurotypical controls as reported in the Gandal et al psychENCODE (PE) study <sup><xref rid="R16" ref-type="bibr">16</xref></sup>.(<bold>B</bold>) Schizophrenia disorder (SCZD) genes, including those from differential expression (DE) and transcriptome-wide association study (TWAS) analyses of RNA-seq data from brains of individuals with SCZD compared to neurotypical controls in the BrainSeq (BS) <sup><xref rid="R38" ref-type="bibr">38</xref></sup> and PE <sup><xref rid="R16" ref-type="bibr">16</xref></sup> studies. &#x2018;Up&#x2019; and &#x2018;Down&#x2019; labels indicate whether genes are more highly or lowly expressed, respectively, in individuals with ASD or SCZD compared to neurotypical controls. Color scales indicate &#x2212;log10(<italic>p</italic>-values), which were thresholded at <italic>p</italic>=10<sup>&#x2212;12</sup>, and numbers within significant heatmap cells indicate odds ratios (ORs) for the enrichments. See also <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 10</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S6</xref>, <xref rid="SD4" ref-type="supplementary-material">Table S7</xref>, and <xref rid="SD4" ref-type="supplementary-material">Table S8</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1656366-f0006"/>
    </fig>
    <fig id="F7" orientation="portrait" position="float">
      <label>Figure 7:</label>
      <caption>
        <title>Data-driven layer-enriched clustering in the DLPFC.</title>
        <p id="P114">(<bold>A</bold>) Supervised annotation of DLPFC layers based on cytoarchitecture and selected gene markers (as shown in <xref rid="F2" ref-type="fig">Figure 2A</xref>), used as &#x2018;ground truth&#x2019; to evaluate the data-driven clustering results, for sample 151673. <bold>(B)</bold> Schematic illustrating the data-driven clustering pipeline, consisting of: (i) identifying genes (HVGs or SVGs) in an unbiased manner, (ii) clustering on these genes, and (iii) evaluation of clustering performance by comparing with ground truth. <bold>(C)</bold> Comparison of gene-wise test statistics for SVGs identified using <italic>SpatialDE</italic> (log-likelihood ratio, LLR) and genes from the DE &#x2018;enrichment&#x2019; models (<xref rid="F11" ref-type="fig">Extended Data 4</xref>) (F-statistics; WM included) for sample 151673. Colors indicate selected genes with laminar (yellow shades) and non-laminar (red shades) expression patterns. <bold>(D)</bold> Expression patterns for selected laminar (top row) and non-laminar (bottom row) genes identified using <italic>SpatialDE</italic> (corresponding to highlighted genes in (C)) in sample 151673. <bold>(E)</bold> Visualization of clustering results for the best-performing implementations of: (i) &#x2018;unsupervised&#x2019; clustering (method &#x2018;HVG_PCA_spatial&#x2019;, which uses highly variable genes (HVGs) from <italic>scran</italic>, 50 principal components (PCs) for dimension reduction, and includes spatial coordinates as features for clustering); (ii) &#x2018;semi-supervised&#x2019; clustering guided by layer-enriched genes identified using the DE enrichment models; and (iii) clustering guided by known markers from Zeng <italic>et al.</italic>
<sup><xref rid="R32" ref-type="bibr">32</xref></sup> (<xref rid="S26" ref-type="sec">Method Details: Data-driven layer-enriched clustering analysis</xref> and <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>). <bold>(F)</bold> Evaluation of clustering performance for all methods across all 12 samples, using manually annotated ground truth layers (as in (A)) and adjusted Rand index (ARI). Points represent each method and sample, with results stratified by clustering methodology (<xref rid="S26" ref-type="sec">Method Details: Data-driven layer-enriched clustering analysis</xref> and <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>). <italic>P</italic>-values represent statistical significance of the difference in ARI scores when including the two spatial coordinates as features within the clustering, using a linear model fit for each method (overall model across all methods: <italic>p</italic>=5.8e-6). See also <xref rid="SD1" ref-type="supplementary-material">Supplementary Figure 11</xref>, <xref rid="F16" ref-type="fig">Extended Data 9</xref>, <xref rid="F17" ref-type="fig">Extended Data 10</xref>,<xref rid="SD4" ref-type="supplementary-material">Table S9</xref>, and <xref rid="SD4" ref-type="supplementary-material">Table S10</xref>.</p>
      </caption>
      <graphic xlink:href="nihms-1656366-f0007"/>
    </fig>
  </floats-group>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0410462</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">6011</journal-id>
      <journal-id journal-id-type="nlm-ta">Nature</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nature</journal-id>
      <journal-title-group>
        <journal-title>Nature</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0028-0836</issn>
      <issn pub-type="epub">1476-4687</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34381231</article-id>
      <article-id pub-id-type="pmc">8475179</article-id>
      <article-id pub-id-type="doi">10.1038/s41586-021-03634-9</article-id>
      <article-id pub-id-type="manuscript">NIHMS1740401</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Exploring tissue architecture using spatial transcriptomics</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>Anjali</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barkley</surname>
            <given-names>Dalia</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="author-notes" rid="FN1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fran&#xE7;a</surname>
            <given-names>Gustavo S.</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yanai</surname>
            <given-names>Itai</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Institute for Computational Medicine, NYU Langone Health, New York, NY 10016, USA</aff>
      <aff id="A2"><label>2</label>Department of Biochemistry and Molecular Pharmacology, NYU Langone Health, New York, NY 10016, USA.</aff>
      <author-notes>
        <corresp id="CR1"><email>itai.yanai@nyulangone.org</email>.</corresp>
        <fn fn-type="equal" id="FN1">
          <label>*</label>
          <p id="P1">Equal first authors</p>
        </fn>
        <fn fn-type="con" id="FN2">
          <p id="P2"><bold>Author contributions:</bold> AR, DB, and IY collectively wrote the review. All authors conceptualized the figures, which GSF then created. All authors edited and revised the manuscript.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>22</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>8</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>8</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <volume>596</volume>
      <issue>7871</issue>
      <fpage>211</fpage>
      <lpage>220</lpage>
      <!--elocation-id from pubmed: 10.1038/s41586-021-03634-9-->
      <abstract id="ABS1">
        <p id="P3">Deciphering the principles and mechanisms by which gene activity orchestrates complex cellular arrangements in multicellular organisms has far-reaching implications for research in the life sciences. Recent technological advancements in next-generation sequencing-based and imaging-based approaches have established the potential of spatial transcriptomics to measure expression levels of all or most genes systematically throughout tissue space, and have been adopted to generate biological insight in neuroscience, development, plant biology, and a range of diseases including cancer. Similar to datasets made possible by genomic sequencing and population health surveys, the large-scale atlases generated by this technology lend themselves to exploratory data analysis for hypothesis generation. Here, we review spatial transcriptomic technologies and describe the repertoire of operations available for paths of analysis of the resulting data. Spatial transcriptomics can also be deployed for hypothesis testing using experimental designs comparing timepoints or conditions - including genetic or environmental perturbations. Finally, spatial transcriptomic data is naturally amenable to integration with other data modalities providing an expandable framework for insight into tissue organization.</p>
      </abstract>
    </article-meta>
  </front>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">JCI Insight</journal-id>
      <journal-id journal-id-type="iso-abbrev">JCI Insight</journal-id>
      <journal-id journal-id-type="publisher-id">JCI Insight</journal-id>
      <journal-title-group>
        <journal-title>JCI Insight</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2379-3708</issn>
      <publisher>
        <publisher-name>American Society for Clinical Investigation</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34003797</article-id>
      <article-id pub-id-type="pmc">8262485</article-id>
      <article-id pub-id-type="publisher-id">147703</article-id>
      <article-id pub-id-type="doi">10.1172/jci.insight.147703</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Resource and Technical Advance</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Integration of spatial and single-cell transcriptomics localizes epithelial cell&#x2013;immune cross-talk in kidney injury</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-2063-9744</contrib-id>
          <name>
            <surname>Ferreira</surname>
            <given-names>Ricardo Melo</given-names>
          </name>
          <email>rimelof@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sabo</surname>
            <given-names>Angela R.</given-names>
          </name>
          <email>saboa@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Winfree</surname>
            <given-names>Seth</given-names>
          </name>
          <email>winfrees@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-4978-4593</contrib-id>
          <name>
            <surname>Collins</surname>
            <given-names>Kimberly S.</given-names>
          </name>
          <email>ksburges@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Janosevic</surname>
            <given-names>Danielle</given-names>
          </name>
          <email>djanosev@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-2977-7185</contrib-id>
          <name>
            <surname>Gulbronson</surname>
            <given-names>Connor J.</given-names>
          </name>
          <email>cgulbron@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>Ying-Hua</given-names>
          </name>
          <email>yicheng@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Casbon</surname>
            <given-names>Lauren</given-names>
          </name>
          <email>casbonl@purdue.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barwinska</surname>
            <given-names>Daria</given-names>
          </name>
          <email>dbarwins@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ferkowicz</surname>
            <given-names>Michael J.</given-names>
          </name>
          <email>mferkow@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-4143-2024</contrib-id>
          <name>
            <surname>Xuei</surname>
            <given-names>Xiaoling</given-names>
          </name>
          <email>xxuei@iu.edu</email>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0001-9553-0925</contrib-id>
          <name>
            <surname>Zhang</surname>
            <given-names>Chi</given-names>
          </name>
          <email>czhang87@iu.edu</email>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dunn</surname>
            <given-names>Kenneth W.</given-names>
          </name>
          <email>kwdunn@iupui.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0001-7244-9657</contrib-id>
          <name>
            <surname>Kelly</surname>
            <given-names>Katherine J.</given-names>
          </name>
          <email>kajkelly@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-4117-1434</contrib-id>
          <name>
            <surname>Sutton</surname>
            <given-names>Timothy A.</given-names>
          </name>
          <email>tsutton2@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0002-0446-6575</contrib-id>
          <name>
            <surname>Hato</surname>
            <given-names>Takashi</given-names>
          </name>
          <email>thato@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dagher</surname>
            <given-names>Pierre C.</given-names>
          </name>
          <email>pdaghe2@iupui.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-4645-3614</contrib-id>
          <name>
            <surname>El-Achkar</surname>
            <given-names>Tarek M.</given-names>
          </name>
          <email>telachka@iu.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid" authenticated="true">http://orcid.org/0000-0003-3066-2876</contrib-id>
          <name>
            <surname>Eadon</surname>
            <given-names>Michael T.</given-names>
          </name>
          <email>meadon@iupui.edu</email>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Medicine and</aff>
      <aff id="A2"><label>2</label>Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.</aff>
      <author-notes>
        <corresp>Address correspondence to: Michael Eadon or Tarek El-Achkar, 950 West Walnut Street R2, 202, Indianapolis, Indiana 46202, USA. Phone: 317.274.2502; Email: <email>meadon@iupui.edu</email> (ME); Email: <email>telachka@iu.edu</email> (TEA).</corresp>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic" iso-8601-date="2021-06-22T12:00:00-0400">
        <day>22</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date date-type="collection" publication-format="electronic" iso-8601-date="2021-06-22T12:00:00-0400">
        <day>22</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>22</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. -->
      <volume>6</volume>
      <issue>12</issue>
      <elocation-id>e147703</elocation-id>
      <permissions>
        <copyright-statement>&#xA9; 2021 Ferreira et al.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Ferreira et al.</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit <ext-link xlink:href="https://creativecommons.org/licenses/by/4.0/" ext-link-type="uri">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://insight.jci.org/articles/view/147703">This article is available online at https://insight.jci.org/articles/view/147703</self-uri>
      <abstract>
        <p>Single-cell sequencing studies have characterized the transcriptomic signature of cell types within the kidney. However, the spatial distribution of acute kidney injury (AKI) is regional and affects cells heterogeneously. We first optimized coordination of spatial transcriptomics and single-nuclear sequencing data sets, mapping 30 dominant cell types to a human nephrectomy. The predicted cell-type spots corresponded with the underlying histopathology. To study the implications of AKI on transcript expression, we then characterized the spatial transcriptomic signature of 2 murine AKI models: ischemia/reperfusion injury (IRI) and cecal ligation puncture (CLP). Localized regions of reduced overall expression were associated with injury pathways. Using single-cell sequencing, we deconvoluted the signature of each spatial transcriptomic spot, identifying patterns of colocalization between immune and epithelial cells. Neutrophils infiltrated the renal medulla in the ischemia model. <italic>Atf3</italic> was identified as a chemotactic factor in S3 proximal tubules. In the CLP model, infiltrating macrophages dominated the outer cortical signature, and <italic>Mdk</italic> was identified as a corresponding chemotactic factor. The regional distribution of these immune cells was validated with multiplexed CO-Detection by indEXing (CODEX) immunofluorescence. Spatial transcriptomic sequencing complemented single-cell sequencing by uncovering mechanisms driving immune cell infiltration and detection of relevant cell subpopulations.</p>
      </abstract>
      <kwd-group kwd-group-type="specialties">
        <kwd>Nephrology</kwd>
      </kwd-group>
      <kwd-group kwd-group-type="keywords">
        <kwd>Expression profiling</kwd>
        <kwd>Mouse models</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution>
              <institution-id>https://doi.org/10.13039/100000062</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>K08DK107864</award-id>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Acute kidney injury (AKI) is a devastating disease with a negative effect on morbidity and mortality. Developing therapeutic targets to treat AKI requires a better grasp of its molecular pathogenesis. Despite important advances in understanding this disease, the pathogenesis of AKI at the cellular and molecular levels remains incompletely understood. This is partially due to the diverse renal milieu of heterogeneous cell types (epithelial, endothelial, fibroblast, vascular smooth muscle, resident immune, and infiltrating immune cells) that interact with each other within a cosmos of unique microenvironments. Furthermore, AKI differentially affects the kidney&#x2019;s diverse array of cells (<xref rid="B1" ref-type="bibr">1</xref>). Recently, single-cell and single-nuclear sequencing have proved major breakthroughs in the creation of a molecular atlas of the kidney (<xref rid="B2" ref-type="bibr">2</xref>&#x2013;<xref rid="B5" ref-type="bibr">5</xref>) by defining the transcriptomic signatures of specific cells within the kidney. However, spatial anchoring is essential to understanding the relationship between cells and structures within specific renal microenvironments.</p>
      <p>Single-cell and single-nuclear sequencing afford indirect spatial localization. In contrast, spatial transcriptomic platforms enable measurement of whole-transcriptome mRNA expression of thousands of genes superimposed upon histological information from the same tissue section. Gene expression profiles are mapped back to their original location, enabling a direct link between histology and gene expression (<xref rid="B6" ref-type="bibr">6</xref>). Integration of the single-cell sequencing with spatial transcriptomics improves power and enables in situ visualization of signatures with mapping of a greater number of cell types than spatial transcriptomics alone (<xref rid="B7" ref-type="bibr">7</xref>). Together, the 2 orthogonal data sets allow determination of where immune cells reside in proximity to other cells in disease states and how regional injury influences the signature of epithelial cells.</p>
      <p>In the present study, we utilized single-nuclear and single-cell sequencing data sets to map cell types back to spatial transcriptomic anchoring landmarks (spots) overlaid upon the human and murine kidney. We first optimized the methodology in the human kidney. We then examined differentially expressed genes (DEGs) and pathways in murine ischemia/reperfusion injury (IRI) and cecal ligation puncture (CLP) models of AKI. We used the transcriptomic signatures derived from the 10&#xD7; Genomics Visium spatial gene expression platform to colocalize immune cells with epithelial cells, defining the distribution of immune cell transcript expression in these models. Key chemotactic factors expressed in epithelial cells were identified that contributed to immune cell infiltration and cross-talk in each injury model. Immune cell&#x2013;type distributions were validated with spatially resolved multiplexed CO-Detection by indEXing (CODEX) immunofluorescence. Together, the complementary single-cell and spatial transcriptomic data sets are synergistic, enabling the development of a transcriptomic atlas of the kidney in health and disease, with direct correlation to histopathology. These tools will enhance the diagnostic capability of renal pathologists interpreting manifestations of AKI in kidney tissue.</p>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Unsupervised mapping and cell-type identification within the spatial transcriptomic map of the human kidney.</title>
        <p>We sought to map transcriptomic signatures directly upon a histological section from a human reference nephrectomy stained with H&amp;E. The tissue was obtained from a 59-year-old woman with minimal glomerular obsolescence and interstitial fibrosis (each affecting less than 10% of the glomeruli or renal parenchyma, respectively). No arteriolar hyalinosis was observed. An OCT compound&#x2013;embedded tissue section underwent H&amp;E staining and microscopy followed by permeabilization, RNA isolation, and sequencing with spatially localized barcodes to map back the transcriptomic signature directly upon the histological image.</p>
        <p>The result of the spatial transcriptomic mapping was a set of &#x201C;spots&#x201D; (55 &#x3BC;m in diameter), each with its own expression signature. These spots were overlaid upon the histological image of the kidney based on the localization barcodes (<xref ref-type="fig" rid="F1">Figure 1, A and B</xref>) and clustered in an unsupervised fashion according to the gene expression of each spot. The identity of these clusters was established and named according to known kidney regions and cell types using differentially expressed marker genes and the underlying histology. Nine unsupervised clusters were generated by Space Ranger (<xref ref-type="fig" rid="F1">Figure 1B</xref>), with expression signatures aligning with known marker genes of glomeruli and various tubular subsegments. These clusters were overlaid upon histological features, including glomeruli, tubules, vascular structures, and medullary rays, which were readily observed. On average, 10,270 counts were measured and 3205 genes were detected per spot. The average number of unique genes detected was 17,506 per cluster, with at least 16,000 detected in every cluster.</p>
        <p>Spots assigned to a given cluster consistently localized over the expected underlying histology. An example of cluster mapping and identification is provided in <xref ref-type="fig" rid="F1">Figure 1, C&#x2013;I</xref>. A subset of marker genes is provided in <xref ref-type="fig" rid="F1">Figure 1J</xref> and the full set is in <xref ref-type="supplementary-material" rid="sd">Supplemental Table 1</xref>; supplemental material available online with this article; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/jci.insight.147703DS1">https://doi.org/10.1172/jci.insight.147703DS1</ext-link> A close-up of the H&amp;E section is provided without (<xref ref-type="fig" rid="F1">Figure 1C</xref>) and with (<xref ref-type="fig" rid="F1">Figure 1, D and E</xref>) unsupervised clusters overlaid. Glomeruli, small vessels, tubules, and a portion of the medullary rays can be visualized. Transcriptomic spots associated with glomerular genes (red) clearly overlie histologically identified glomeruli. The interstitial cluster, which includes expression of fibroblast, vascular smooth muscle cell (VSMC), and endothelial cell marker genes, is seen located over vessels (pink). Although tubular morphology in OCT-embedded sections is imperfect, distinctions can still be observed. The spatial transcriptomic&#x2013;defined proximal tubule (PT) clusters overlie eosinophilic tubules without visible lumens. This histological pattern corresponded with megalin (<italic>LRP2</italic>) expression (<xref ref-type="fig" rid="F1">Figure 1F</xref>). Spots assigned to thick ascending limb (TAL) clusters were congregated over medullary rays and correlated with expression of the loop diuretic sensitive sodium-potassium 2-chloride transporter (<italic>SLC12A1</italic>, <xref ref-type="fig" rid="F1">Figure 1G</xref>). Distal convoluted tubules (DCTs) and connecting tubules (CNTs) were characterized by eosinophilic tubules with open lumens. DCTs had high corresponding expression of the thiazide-sensitive sodium-chloride transporter (<italic>SLC12A3</italic>, <xref ref-type="fig" rid="F1">Figure 1H</xref>). Collecting ducts (CDs) were identified histologically with their characteristic nuclei in cuboidal cells and reduced eosinophilia. These tubules were overlaid by spots with high aquaporin-2 (<italic>AQP2</italic>) expression (<xref ref-type="fig" rid="F1">Figure 1I</xref>).</p>
        <p>Since each spatial transcriptomic spot was 55 &#x3BC;m in diameter, roughly the size of a tubular cross-section, the spots can overlie multiple cell types. Two PT and 2 TAL clusters were obtained in the unsupervised mapping. One PT and 1 TAL cluster each had stronger enrichment of known marker genes and were labeled &#x201C;pure.&#x201D; The clusters with less enrichment of marker genes or signatures with elements of 2 or more cell types were labeled &#x201C;mixed.&#x201D; The mixed TAL signature was seen on the periphery of the medullary rays, and the pure cluster was more centrally located (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
        <p>As stated, spots were classified into clusters based on the known gene expression markers of renal cell types (<xref ref-type="fig" rid="F1">Figure 1J</xref> and <xref ref-type="supplementary-material" rid="sd">Supplemental Table 1</xref>). The spots classified based on their gene expression signature mapped to expected histological/renal structures consistently. We assessed the consistence of the assigned transcriptomic cluster to the underlying histology in 5 randomly selected fields (<xref ref-type="fig" rid="F1">Figure 1K</xref>). The overall correlation between assigned clusters and histological structures was 97.6%. All clusters mapped to a corresponding histological structure at greater than 95% accuracy except the CD (90.7%), which had the fewest overall spots in the specimen. The most frequent reason for discordance was the lack of significant tissue underlying a spot (e.g., a spot at the edge or within a large vessel).</p>
      </sec>
      <sec>
        <title>Mapping of single-nuclear sequencing clusters to human kidney tissue.</title>
        <p>A uniform manifold approximation and projection (UMAP) of the unsupervised clusters obtained through Space Ranger is provided in <xref ref-type="fig" rid="F2">Figure 2A</xref>. To improve the specificity of spot mapping and identify less frequent cell types that may contribute to the signature of a spot, we reclustered a publicly available single-nuclear RNA sequencing (snRNA-Seq) data set from human kidney samples (<xref ref-type="fig" rid="F2">Figure 2B</xref> and ref. <xref rid="B2" ref-type="bibr">2</xref>). The full list of DEG markers of each single-cell RNA sequencing (scRNA-Seq) cluster is in <xref ref-type="supplementary-material" rid="sd">Supplemental Table 2</xref>. Thirty cell-type clusters were identified. In a process similar to single-cell cluster integration (<xref rid="B8" ref-type="bibr">8</xref>), transfer scores were assigned to spatial transcriptomic spots for each of the 30 snRNA-Seq clusters based on anchoring of common neighbors. Each spot was then labeled according to the snRNA-Seq cluster with the highest transfer score (<xref ref-type="fig" rid="F2">Figure 2C</xref>). The percentage of spots overlapping between the unsupervised spatial transcriptomic clusters and those relabeled according to the snRNA-Seq transfer scores was assessed. A strong correlation was found between the unsupervised spatial transcriptomic classified spots and the spots redefined with the expected snRNA-Seq transfer labels.</p>
        <p>Several cell types that were not represented in the unsupervised spatial transcriptomic clusters had spots assigned to them after snRNA-Seq relabeling. Since each spot covered multiple cells, the cell type was assigned to the most dominant cell type in that 55 &#x3BC;m spot. For example, multiple cell types contribute to the expression signature of the interstitium (<xref rid="B9" ref-type="bibr">9</xref>). The inclusion of snRNA-Seq data resolved the spots localizing in the interstitium to a more specific set of cell types (<xref ref-type="fig" rid="F2">Figure 2, D&#x2013;M</xref>). This data set allowed discrimination of spots assigned to fibroblasts, VSMCs, and some endothelium subtypes. Feature plots of known markers for the interstitium are shown in <xref ref-type="fig" rid="F2">Figure 2, F&#x2013;M</xref>.</p>
      </sec>
      <sec>
        <title>Cell-type deconvolution.</title>
        <p>Since each spot may overlie multiple cell types, we sought to determine the contribution of each snRNA-Seq cluster to the expression signature of each spot in a neural network analysis (<xref ref-type="fig" rid="F3">Figure 3</xref>). As expected, the podocyte, mesangial cell, and endothelial cell clusters contributed the greatest proportion of signature to spots overlying glomeruli. A portion of medulla was included in the right lower portion of the nephrectomy sample. We quantitated the proportion of signature arising from each snRNA-Seq cluster in the medulla as compared with the remaining sample. Expression of genes defining the descending thin limb, ascending thin limb, and thick ascending loop of Henle were enriched in the medulla. As expected, no expression of podocyte signature and minimal contribution from S1 and S2 PTs were observed in the medulla. Two cortical CD clusters had been identified in the original snRNA-Seq data set (C16 and C18); however, in the spatial transcriptomic data set, the signature of C18 was found in both the cortex and medulla, while C16 mapped exclusively to the cortex.</p>
      </sec>
      <sec>
        <title>Spatial transcriptomic cell-type localization in the murine kidney.</title>
        <p>AKI does not affect all regions of the kidney uniformly. The etiology of injury may differentially affect the spatial distribution of gene expression, especially in the early course of disease. Therefore, we applied spatial transcriptomics on 2 common murine models of AKI (IRI and CLP), and the mice were euthanized at 6 hours. The unsupervised spatial transcriptomic cluster mapping is shown in <xref ref-type="fig" rid="F4">Figure 4</xref> for the sham, IRI, and CLP models. In matched cross-sections of the 3 models, minimal histopathological injury was observed with H&amp;E staining at the 6-hour time point (<xref ref-type="fig" rid="F4">Figure 4A</xref>). At low-power magnification, the IRI tissue area was larger (25.5 mm<sup>2</sup>) than the sham (16.9 mm<sup>2</sup>) and CLP (15.9 mm<sup>2</sup>) sections. <xref ref-type="fig" rid="F4">Figure 4B</xref> overlays each section with the clusters obtained from Space Ranger. Two clusters were only present in the IRI model: the interstitium and urothelium clusters, the latter possibly because of the size of the papilla in the section. The 3 models were merged and normalized to allow comparisons between models (<xref ref-type="fig" rid="F4">Figure 4C</xref>). A full set of DEGs between unsupervised spatial transcriptomic clusters is in <xref ref-type="supplementary-material" rid="sd">Supplemental Table 3</xref>. Murine cells and tubules are smaller than their human counterparts, so each 55 &#x3BC;m spot is labeled by its dominant contributor. Fewer unsupervised clusters were identified in the mouse than the human. For example, the DCT, CNT, and CD of the distal nephron all clustered together. Similarly, the PT S3 segment cluster localized to the outer stripe and contained gene expression from the neighboring TAL. A subset of marker genes used to identify the clusters is depicted in <xref ref-type="fig" rid="F4">Figure 4D</xref>. A specific comparison of the PT cluster DEGs is in <xref ref-type="supplementary-material" rid="sd">Supplemental Figure 1</xref>.</p>
      </sec>
      <sec>
        <title>Regional expression differences and pathway enrichment in injury models.</title>
        <p>The expression of 2 common markers of injury, kidney injury molecule-1 (<italic>Havcr1</italic>) and neutrophil gelatinase-associated lipocalin (<italic>Lcn2</italic>), were plotted in each model (<xref ref-type="supplementary-material" rid="sd">Supplemental Figure 2</xref>). The distribution of <italic>Havcr1</italic> expression was localized to the outer stripe in the IRI model and not upregulated in the CLP model. <italic>Lcn2</italic> expression was diffusely upregulated in both models.</p>
        <p>In the cortex of both models, we observed regional differences in the overall expression level of each spot as measured in total read counts across all genes (<xref ref-type="fig" rid="F5">Figure 5A</xref>). We selected circumscribed regions of the IRI and CLP models that had areas of reduced expression when compared with the sham, despite minimal histopathological evidence of injury. These regions of &#x201C;low&#x201D; expression in IRI and CLP were compared with size-matched regions with relatively &#x201C;preserved&#x201D; expression. The low-expression regions were also compared with identically sized regions in the sham.</p>
        <p>The DEGs, across all spots regardless of cluster identity, were uncovered in the IRI low-expression region and the equivalent sham region (<xref ref-type="fig" rid="F5">Figure 5B</xref>). Despite the overall reduction in total read counts in IRI, a number of genes were significantly upregulated in the low-expression region. The enriched pathways based on the DEGs are presented in <xref ref-type="fig" rid="F5">Figure 5C</xref> with a subset of pathways annotated. Several enriched pathways were identified related to metabolism of amino acids and fatty acids, possibly related to a metabolic shift associated with hypoxia (<xref rid="B10" ref-type="bibr">10</xref>&#x2013;<xref rid="B14" ref-type="bibr">14</xref>). Other pathways suggest prominent injury response mechanisms, such as apoptosis, oxidative stress, and the p38 MAPK cascade (<xref rid="B15" ref-type="bibr">15</xref>&#x2013;<xref rid="B17" ref-type="bibr">17</xref>). IL-17 signaling and enrichment of neutrophil migration indicate a potential inflammatory response of neutrophils in the IRI model (<xref rid="B18" ref-type="bibr">18</xref>&#x2013;<xref rid="B20" ref-type="bibr">20</xref>). The full pathway list is in <xref ref-type="supplementary-material" rid="sd">Supplemental Table 4</xref> and DEGs are in <xref ref-type="supplementary-material" rid="sd">Supplemental Table 5</xref>.</p>
        <p>In a separate comparison, the IRI low- and preserved-expression regions were compared (<xref ref-type="supplementary-material" rid="sd">Supplemental Tables 4 and 5</xref>). Similar DEGs and pathways were identified, albeit at lower levels of significance. The IRI preserved-expression region fell along the spectrum of expression changes between the IRI low-expression region and the sham region. We assessed the total nuclei count and spot distribution in each of these selected regions (<xref ref-type="fig" rid="F5">Figure 5D</xref>). The sham region had approximately twice the nuclei of the IRI normal region and 4-fold more nuclei than the IRI low region. This finding is consistent with the overall changes in total regional expression. We speculate that this relative loss of nuclei in the IRI regions was due to interstitial edema because widespread apoptosis is not expected 6 hours after IRI. Furthermore, the change in the distribution of spot identity is also supportive, wherein the IRI model had an increased number of spots assigned to the interstitial cluster compared with the sham region, which had no spots mapping to the interstitial cluster. A reduced number of epithelial cells in the spots of the injured tissue may account for this shift in distribution. Indeed, fewer spots were found to map to tubular clusters (DCT/CNT/CD and PT [S1/S2]) in the IRI model.</p>
        <p>An equivalent analysis was performed for the CLP model (<xref ref-type="supplementary-material" rid="sd">Supplemental Tables 4 and 5</xref>). The DEGs and enriched pathways between the CLP low and sham regions were consistent with known changes in the CLP model, including p53 signaling, cell cycle arrest, apoptosis, TNF signaling, and macrophage differentiation (<xref ref-type="fig" rid="F5">Figure 5, E and F</xref>). The preserved CLP region had muted expression differences and pathway enrichment, again falling along the differential expression spectrum between the CLP low and sham comparison. In contrast to the IRI model, differences in the nuclei count and the spot cluster identity distribution were not found (<xref ref-type="fig" rid="F5">Figure 5G</xref>). Together, the expression patterns, nuclei count, and similarity in spot identity distribution between regions in the CLP model suggest a very different injury pattern than IRI. As compared with IRI, CLP injury may lead to less space occupying interstitial edema.</p>
      </sec>
      <sec>
        <title>Mapping of single-cell sequencing clusters to murine kidney tissue.</title>
        <p>To improve resolution and cell-type specificity, murine scRNA-Seq data sets were clustered to build a common reference murine kidney cell atlas across models. To define cell types relevant to each model, kidneys from a sham and IRI mouse were disaggregated for scRNA-Seq. To obtain signatures of cell types relevant to the CLP model, publicly available scRNA-Seq data from an endotoxin LPS model (mouse euthanized 4 hours after endotoxin) and a corresponding sham animal were utilized (<xref rid="B21" ref-type="bibr">21</xref>). Although the models for the scRNA-Seq and spatial transcriptomic data sets were not identical, the scRNA-Seq data serve a broader purpose by allowing the identification of cell-type signatures within the spatial transcriptomic samples. Expected epithelial, infiltrating immune, and other cell types were identified based on their expression signature (<xref ref-type="fig" rid="F6">Figure 6A</xref> and <xref ref-type="supplementary-material" rid="sd">Supplemental Table 6</xref>). The common scRNA-Seq clusters from the composite UMAP of all 4 animals (IRI and sham, LPS and sham) were then mapped upon the histological section of each model (<xref ref-type="fig" rid="F6">Figure 6, B&#x2013;E</xref>). Beyond the traditional epithelial cell types, we identified 2 clusters of injured PT cells highly expressing either <italic>Havcr1</italic> or fibrinogen (<italic>Fga, Fgb, Fgg</italic>; ref. <xref rid="B22" ref-type="bibr">22</xref>). The cluster expressing <italic>Havcr1</italic>, PT (S3-OS), expressed markers of the S3 PT, suggesting injury to the outer stripe region of the medulla. The PT fibrinogen cluster also had some expression of <italic>Havcr1</italic>, but was rich in <italic>Fga</italic>, <italic>Fgb</italic>, and <italic>Fgg</italic> and markers of the more cortical S1 and S2 PT markers. Both a cortical PT S3 cluster (PT-S3-C) and a medullary PT S3 cluster (PT-S3-OS) were identified in the scRNA-Seq data set (<xref rid="B21" ref-type="bibr">21</xref>). The DEGs between these 2 clusters were compared (<xref ref-type="supplementary-material" rid="sd">Supplemental Figure 1</xref>). Although a similar number of spatial transcriptomic spots mapped to each cluster, the density of PT-S3-OS was much greater in the outer stripe than the PT-S3-C in the cortex. The PT-S3-C appeared to reside near medullary rays, although the contribution of PT S2 to the PT-S3-C cluster cannot be excluded.</p>
        <p>We examined differential expression between the IRI and CLP models in a subset of epithelial cell clusters in the spatial transcriptomic data set (<xref ref-type="supplementary-material" rid="sd">Supplemental Figure 3</xref>) and between the IRI and LPS scRNA-Seq data sets (<xref ref-type="supplementary-material" rid="sd">Supplemental Figure 4</xref>). A high degree of overlap was found in each technology&#x2019;s epithelial cell DEGs but not immune cell DEGs because of the paucity of spatial transcriptomic immune cell spots.</p>
        <p>Among the immune cell clusters mapped using the scRNA-Seq data set, we identified neutrophils, NK cells, B and T lymphocytes, plasmacytoid DCs (high in <italic>Siglech</italic>), and 2 infiltrating macrophage clusters, <italic>Ear2</italic><sup>+</sup> (Ly6c<sup>lo</sup>) and <italic>Chil3</italic><sup>+</sup> (Ly6c<sup>hi</sup>; ref. <xref rid="B23" ref-type="bibr">23</xref>). A single cluster was found to contain resident macrophages and classical DCs (high in <italic>H2-Aa</italic>, <italic>H2-Ab1</italic>), which could not be subclustered because of cell sample size. The resultant composite cluster set was used to transfer the scRNA-Seq cluster labels to the spatial transcriptomic spots.</p>
        <p>The number of spots assigned to each cell type is provided in <xref ref-type="fig" rid="F6">Figure 6F</xref>. Although the single-cell data set yielded an abundant immune cell population, very few spatial transcriptomic spots were assigned to those cell types. This apparent discord may be related to the dominant transcriptomic signature originating from the more abundant epithelial cells. To understand the immune cell distribution, we first applied a SPOTlight neural network analysis to each model (<xref ref-type="supplementary-material" rid="sd">Supplemental Figure 5</xref>). The resulting cell distribution qualitatively agreed with the results of <xref ref-type="fig" rid="F7">Figure 7</xref>. However, immune cell populations were not sufficiently represented in the neural network analysis. Thus, a transfer score system was adapted to understand the rank and relative contribution of each scRNA-Seq cell type to the signature of a given spatial transcriptomic spot (<xref ref-type="supplementary-material" rid="sd">Supplemental Table 7</xref>). After suppression of the epithelial and endothelial scRNA-Seq clusters, the immune cell and fibroblast scRNA-Seq cluster labels were remapped over the histological images (<xref ref-type="fig" rid="F7">Figures 7, 8, and 9</xref>).</p>
      </sec>
      <sec>
        <title>Colocalization of immune and epithelial cell transcriptomic signatures in spots of the IRI model.</title>
        <p><xref ref-type="fig" rid="F7">Figure 7, A and B</xref> presents the spatial distribution of immune cell and fibroblast clusters mapped onto the sham and IRI models, respectively. A transfer score was quantitated for each scRNA-Seq cluster signature for every spatial transcriptomic spot. Only the immune cell with the highest ranked transfer score is displayed. Fibroblasts were included in the analysis as a control, i.e., the immune cell transfer score had to at least exceed that of a fibroblast to be mapped to the histological section. These new immune cell spot identities were then compared with the original epithelial cell type spot identities mapped in <xref ref-type="fig" rid="F6">Figure 6</xref>.</p>
        <p>To evaluate the colocalization of immune and epithelial cells, an odds ratio of colocalization was calculated across all spatial transcriptomic spots (<xref ref-type="fig" rid="F8">Figure 8C</xref> and <xref ref-type="supplementary-material" rid="sd">Supplemental Table 8</xref>) as compared with the sham mouse. The strongest association was found between the PT S3 spots of the outer stripe (PT [S3-OS]) with the neutrophil and infiltrating macrophage signature. The remaining significant cluster pairs possessed lower odds ratios or were indicative of resident macrophage colocalization. We elected to explore the relationship between the PT (S3-OS) and neutrophil migration.</p>
        <p>The neutrophil scRNA-Seq cluster mapped specifically to spatial transcriptomic spots of the outer stripe of the medulla in the IRI model (<xref ref-type="fig" rid="F7">Figure 7D</xref>). Such coclustering was not apparent in the sham and CLP models. In the IRI model, we then queried DEGs between the PT (S3-OS) spots that colocalized with neutrophils and the PT (S3-OS) spots that colocalized with any other immune cell type (<xref ref-type="fig" rid="F7">Figure 7E</xref> and <xref ref-type="supplementary-material" rid="sd">Supplemental Table 9</xref>). Among the DEGs was <italic>Atf3</italic> (activating transcription factor 3), a regulator of neutrophil migration (<xref rid="B24" ref-type="bibr">24</xref>). The expression of <italic>Atf3</italic> specifically colocalized to the outer stripe of the medulla (<xref ref-type="fig" rid="F7">Figure 7F</xref>). <italic>Atf3</italic> protein expression similarly localized to the outer stripe (<xref ref-type="fig" rid="F7">Figure 7G</xref> and <xref ref-type="supplementary-material" rid="sd">Supplemental Figure 6</xref>). The expression of <italic>Atf3</italic> was higher in the PT (S3-OS) that colocalized with neutrophils versus the PT (S3-OS) that did not colocalize; expression of <italic>Atf3</italic> was also higher in the PT (S3-OS) than all other epithelial cell types (<xref ref-type="fig" rid="F7">Figure 7H</xref>).</p>
        <p>Given that a subpopulation of PT S3 expressing <italic>Atf3</italic> was detected, the expression of <italic>Atf3</italic> was assessed in the single-cell data (<xref ref-type="fig" rid="F8">Figure 8A</xref>). The presence of a small, tightly grouped set of cells with high expression of <italic>Atf3</italic> suggested the possibility of a meaningful subpopulation. We then reclustered the cortical and outer-stripe clusters of PT S3 to better identify the subpopulation equivalent to the one detected in spatial transcriptomics. <xref ref-type="fig" rid="F8">Figure 8B</xref> shows the UMAP of the subclusters; <xref ref-type="fig" rid="F8">Figure 8C</xref> shows the expression of <italic>Atf3</italic> in those cells. Finally, <xref ref-type="fig" rid="F8">Figure 8D</xref> shows we were able to identify a subpopulation of cells originating from the outer stripe that highly expressed <italic>Atf3</italic>. Thus, the spatial transcriptomic data facilitated the discovery of a potentially new cell type within the scRNA-Seq data set: a PT S3 cell that is signaling neutrophils.</p>
        <p>As a control, we identified <italic>S100a6</italic> as a significantly downregulated gene in the PT (S3-OS) cluster that colocalized with neutrophils (<xref ref-type="supplementary-material" rid="sd">Supplemental Figure 7</xref>). This gene was not highly expressed in the outer stripe by spatial transcriptomics. In the scRNA-Seq data set, <italic>S100a6</italic> was expressed across most immune cell types, including neutrophils.</p>
      </sec>
      <sec>
        <title>Colocalization of immune and epithelial cell transcriptomic signatures in spots of the CLP model.</title>
        <p>In a corresponding analysis, we then investigated the transfer of the scRNA-Seq immune cell clusters over the CLP section (<xref ref-type="fig" rid="F9">Figure 9A</xref>). The odds ratio of colocalization (<xref ref-type="fig" rid="F9">Figure 9B</xref> and <xref ref-type="supplementary-material" rid="sd">Supplemental Table 8</xref>) indicates macrophage signature colocalization throughout the cortical segments of PTs. Chil3<sup>+</sup> and Ear2<sup>+</sup> infiltrating macrophage clusters were merged to increase detection power. The spots containing a highest-ranking macrophage transfer score (i.e., strongest macrophage expression signature components) are highlighted in the 3 models (<xref ref-type="fig" rid="F9">Figure 9C</xref>) and suggest that macrophage infiltration was most pronounced in the cortex of the CLP mouse as compared with the sham or IRI model. DEGs were assessed between PT spots in the CLP model that colocalized with infiltrating macrophage clusters versus PT spots that colocalized with any other immune cell or fibroblasts (<xref ref-type="fig" rid="F9">Figure 9D</xref> and <xref ref-type="supplementary-material" rid="sd">Supplemental Table 9</xref>). Among the top DEGs associated with macrophage colocalization was Midkine (<italic>Mdk</italic>), a gene encoding a growth factor associated with macrophage recruitment (<xref rid="B25" ref-type="bibr">25</xref>), which was more highly expressed in the outer cortex of the CLP section (<xref ref-type="fig" rid="F9">Figure 9E</xref>). The expression of <italic>Mdk</italic> was higher in cortical PT spots that colocalized with infiltrating macrophages compared with cortical PT spots that did not colocalize with macrophages and compared with all other epithelial cell types (<xref ref-type="fig" rid="F9">Figure 9F</xref>). In contrast to <italic>Atf3</italic>, the expression of <italic>Mdk</italic> in the scRNA-Seq data set (<xref ref-type="fig" rid="F9">Figure 9G</xref>) did not indicate a clear subpopulation of <italic>Mdk</italic>-expressing PT cells, but was instead diffusely expressed across the PT. In addition to the colocalization of the macrophage signature with the PT signature, a smaller but still significant association was observed between the NK cell signature and the proximal tubular signature in the CLP model.</p>
      </sec>
      <sec>
        <title>Visualization of immune cells by multiplexed immunofluorescence imaging of the murine injury models.</title>
        <p>To validate the localization of immune cells in each model, we performed CODEX multiplexed immunofluorescence imaging on sections from the same animals (<xref rid="B26" ref-type="bibr">26</xref>). <xref ref-type="fig" rid="F10">Figure 10</xref> shows the immune cell distribution in the sham, IRI, and CLP models. <xref ref-type="supplementary-material" rid="sd">Supplemental Figure 8</xref> presents the gating strategy employed in CODEX interrogation. In comparison with the sham model, neutrophils (Ly6G<sup>+</sup> and CD11b<sup>hi</sup>) were found to predominantly infiltrate the outer stripe of the IRI section (<xref ref-type="fig" rid="F10">Figure 10D</xref>). The percentage of neutrophils and infiltrating macrophages in each approximate region of the kidney (papilla, inner medulla, outer stripe of the medulla, and cortex) was quantitated (<xref ref-type="fig" rid="F10">Figure 10, D&#x2013;F</xref>). In the IRI model, 52.2% of all infiltrating neutrophils localized to the outer stripe. This finding is consistent with the localization of neutrophil cluster spatial transcriptomic spots to the outer stripe (<xref ref-type="supplementary-material" rid="sd">Supplemental Table 10</xref>).</p>
        <p>In the CLP model, 80.2% of infiltrating macrophages (Ly6G<sup>&#x2013;</sup> and CD11b<sup>hi</sup>) localized to the outer cortex (<xref ref-type="fig" rid="F10">Figure 10F</xref>). The infiltrating macrophage signature dominated and colocalized with PT epithelial spots in the spatial transcriptomic analysis (<xref ref-type="fig" rid="F9">Figure 9C</xref>), and the distribution of these macrophages localized to the outer cortex of the kidney by immunofluorescence. However, no increase in macrophage quantity was observed in the CLP model as compared with the sham model. We speculate that the activated macrophages in the CLP model contributed to the transcriptomic signature to a greater extent than the macrophages in the sham model.</p>
        <p>A second finding in the CLP model was the infiltration of NK cells in the cortex and outer stripe of the kidney. Cells consistent with NK cells (CD45<sup>+</sup>, CD11b<sup>&#x2013;</sup>, B220<sup>&#x2013;</sup>, CD3<sup>&#x2013;</sup>, CD4<sup>&#x2013;</sup>, CD8<sup>&#x2013;</sup>) localized to these regions in the CODEX assay. Further, the NK cell infiltration aligned with spatial transcriptomic colocalization of NK cells with PT S2 and PT S3 expression signatures in the CLP model (<xref ref-type="fig" rid="F9">Figure 9B</xref>). In summary, the spatial transcriptomic signatures uncovered in the IRI and CLP models were supported by the immunofluorescence data.</p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p>In this work, we localized the transcriptomic signature of various immune cells to spatial transcriptomic spots of known renal epithelial cells in 2 models of AKI. Signatures from immune and epithelial cells were colocalized to identify possible chemotactic molecules of neutrophils and infiltrating macrophages in the IRI and CLP models, respectively. The spatial transcriptomic analysis enhanced our understanding of the single-cell data by detecting a subpopulation of injured PT cells with <italic>Atf3</italic> expression, which may be responsible for neutrophil chemotaxis. To accomplish this, we first optimized a workflow for the interrogation of human and murine kidney tissue with spatial transcriptomics. The technology facilitated the identification of key renal cell types and regions, including most epithelial, endothelial, and stromal cell types. The specificity of cell-type mapping was improved by concomitant snRNA-Seq or scRNA-Seq cluster analysis. The technique appeared robust, revealing strong concordance (&gt;97%) between the transcriptomic signature of a given spot and its underlying histopathology. Supporting data were provided that AKI did not affect all regions of the kidney uniformly. The early effects of acute tubular necrosis in the IRI model led to regional changes in the transcriptomic signature at the 6-hour time point.</p>
      <p>Single-cell sequencing has rapidly enhanced our knowledge of the kidney&#x2019;s expression signature and its cell types (<xref rid="B27" ref-type="bibr">27</xref>), thereby helping to uncover the pathophysiology of a variety of conditions, including early diabetic nephropathy (<xref rid="B28" ref-type="bibr">28</xref>), the composition of a Wilm&#x2019;s tumor (<xref rid="B29" ref-type="bibr">29</xref>), and allograft rejection (<xref rid="B5" ref-type="bibr">5</xref>). Similar studies in the mouse have facilitated query of murine disease state models (<xref rid="B30" ref-type="bibr">30</xref>) and the response to water deprivation (<xref rid="B31" ref-type="bibr">31</xref>). In addition, scRNA-Seq and snRNA-Seq are foundational technologies for the generation of a kidney cell atlas and detection of novel cell types in humans (<xref rid="B2" ref-type="bibr">2</xref>) and mice (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). scRNA-Seq has also aided in our understanding of kidney organ development: studies performed in organoids have shown expression of disease markers in early glomerular cells (<xref rid="B34" ref-type="bibr">34</xref>) and revealed that organoid expression patterns maintain strong agreement with fetal kidney expression, including lineage differences and growth signatures (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Single-cell analysis has also aided in understanding the development of fetal kidney (<xref rid="B37" ref-type="bibr">37</xref>&#x2013;<xref rid="B40" ref-type="bibr">40</xref>) and myofibroblast origin (<xref rid="B41" ref-type="bibr">41</xref>).</p>
      <p>In our study, we used the snRNA-Seq and scRNA-Seq data sets to effectively expand the breadth of cell types mapped to kidney tissue by spatial transcriptomics. For example, the snRNA-Seq clustering in the human kidney allowed us to differentiate interstitium spots into dominant signatures of endothelial cells, fibroblasts, and VSMCs. In the mouse, we were able to detect multiple clusters not present in the unsupervised spatial transcriptomic data set, particularly immune cells. Because there are often up to 10,000 single nuclei or cells in a given sample, the scRNA-Seq and snRNA-Seq technologies have improved sample size to detect less-represented cell types. Furthermore, the scRNA-Seq data is cell specific, rather than representative of a 55 &#x3BC;m spot with multiple underlying cells.</p>
      <p>Multiple spatial transcriptomic platforms exist (<xref rid="B42" ref-type="bibr">42</xref>), including Slide-seq and the 10&#xD7; Genomics Visium platform (<xref rid="B6" ref-type="bibr">6</xref>). Spatial transcriptomics have been used to establish atlases in other organs, such as the mouse brain (<xref rid="B6" ref-type="bibr">6</xref>) and human heart (<xref rid="B43" ref-type="bibr">43</xref>). In the context of disease, the spatial heterogeneity of prostate cancer (<xref rid="B44" ref-type="bibr">44</xref>) and melanoma in lymph nodes (<xref rid="B45" ref-type="bibr">45</xref>) has been described, along with the progression of amyotrophic lateral sclerosis in mice (<xref rid="B46" ref-type="bibr">46</xref>). The advantages of the 10&#xD7; Genomics Visium platform used here include direct visualization of the underlying histology along with a higher sensitivity for gene detection. Other in situ mRNA capturing technologies maintain a higher resolution but lower sensitivity for gene expression detection. These alternatives often require the histology image from a sequential slice (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>) or capture smaller tissue areas (<xref rid="B49" ref-type="bibr">49</xref>). Other approaches to determining the spatial distribution of mRNA, such as in situ sequencing (<xref rid="B50" ref-type="bibr">50</xref>) or sequential in situ hybridization (<xref rid="B51" ref-type="bibr">51</xref>), are expensive but important ways to visualize the transcriptomic signature with spatial resolution.</p>
      <p>The main limitation of the 10&#xD7; Genomics Visium spatial gene expression platform is its resolution with a spot size of 55 &#x3BC;m, which will overlay multiple cells. For instance, Slide-seq has improved cellular resolution, but has not been optimized for direct visualization on the same histopathology H&amp;E-stained specimen (<xref rid="B42" ref-type="bibr">42</xref>). In this work, we chose to examine the 10&#xD7; Genomics Visium platform because it had the ability to create an atlas of the kidney with direct mapping of expression onto the renal structures a pathologist would assess, thereby being more readily translatable. We overcame the limitation in resolution by deconvoluting each spot with neural network analyses and a transfer score system that ranks the contribution of each scRNA-Seq cluster cell type to each transcriptomic spot signature. The limitations of this technology are further counterbalanced by its deep signature (approximately 3,000 genes detected and 10,000 reads per spot with over 16,000 genes per cluster) and the ability to directly visualize the signature over a histological image. Thus, this technique affords more than simply identifying the proximity of localized scRNA-Seq cells; it can actually identify distinct molecular signatures (as in the case of IRI) and correlate these with histology. We leveraged the advantages of the 10&#xD7; Genomics Visium platform to assess regional distribution of kidney injury expression changes in both murine models. An additional limitation is that each capture area has about 5,000 spots; therefore, even if the sample covers the capture area completely, the number of spots may not be enough to cluster and differentiate all cell types. As stated above, we were able to effectively use scRNA-Seq to expand the breadth of cell types mapped.</p>
      <p>In this work, we also employed techniques to deconvolute and colocalize transcriptomic signatures of multiple cell types within a single spot (<xref rid="B52" ref-type="bibr">52</xref>). A second approach was employed to detect immune cell localization and uncover potential chemotactic signals. This second form of deconvolution has been used to classify secondary contributors to a spot&#x2019;s expression signature, in a similar way to what has been done in the heart (<xref rid="B53" ref-type="bibr">53</xref>). The immune cell population of the kidney has been extensively studied using scRNA-Seq in healthy subjects and in the context of diabetic nephropathy and lupus nephritis (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B54" ref-type="bibr">54</xref>, <xref rid="B55" ref-type="bibr">55</xref>). In our study, we united scRNA-Seq with spatial transcriptomics to study the immune cell distribution in known murine models of AKI. Much is known of the role of immune cells in these common models of AKI. It has been shown in IRI models that infiltration of neutrophils occurs in the outer stripe of the medulla (<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>). Further, macrophage colocalization in the S1 segment of PTs has been found protective in sepsis models (<xref rid="B58" ref-type="bibr">58</xref>, <xref rid="B59" ref-type="bibr">59</xref>). Thus, the localization of these immune cells in the AKI models is not the novelty; instead, it is the capture of gene signatures underlying this colocalization. We used 10&#xD7; Genomics Visium to predict the spatial distribution of immune cell types in the kidney and identify potential chemotactic factors associated with particular epithelial cells. The regional distribution of these cells was validated with CODEX multiplexed immunofluorescence. By design, this work is descriptive. Future investigations are needed to understand the cause-and-effect relationship of these immune cell signals in the kidney.</p>
      <sec>
        <title>Conclusions and future directions.</title>
        <p>In summary, we present the spatially mapped transcriptomic signature of AKI in murine models and show how this methodology can be applied to human kidney tissue. In the future, this technology may assist renal pathologists in their interpretation of kidney biopsy specimens. The ability to link upregulation of a particular injury gene to a particular nephron structure is vitally important. This might allow improved classification of human AKI. Future endeavors will seek to quantitatively define the contribution of each cell-type signature to each spot and to apply this methodology to diseased human kidney tissue.</p>
      </sec>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Human tissue, data source, and snRNA sequencing.</title>
        <p>Publicly available snDrop-Seq RNA-Seq data were acquired for 6 Kidney Precision Medicine Project (KPMP; <ext-link ext-link-type="uri" xlink:href="https://www.kpmp.org/">https://www.kpmp.org/</ext-link>) samples and 9 additional samples from the Washington University Kidney Translational Research Center (Gene Expression Omnibus [GEO], GSE121862). Sequencing data of nuclei for the samples were subjected to quality control metrics as previously described (<xref rid="B2" ref-type="bibr">2</xref>). Using Seurat 3.1 and PAGODA2 (<ext-link ext-link-type="uri" xlink:href="https://github.com/kharchenkolab/pagoda2/commit/master">https://github.com/kharchenkolab/pagoda2/commit/master</ext-link>; commit ID, e4bff4a), nuclei were reclustered and displayed as a UMAP. A single human reference nephrectomy (female aged 59 without histological evidence of kidney disease) was acquired from the Biopsy Biobank Cohort of Indiana (<xref rid="B60" ref-type="bibr">60</xref>).</p>
      </sec>
      <sec>
        <title>Murine models.</title>
        <p>From age-matched 8- to 10-week-old 129/SvEv mice (Taconic Biosciences), tissues were acquired from a sham mouse in which the abdomen was opened and sutured back and from mice that underwent IRI or CLP. In the IRI model (<xref rid="B61" ref-type="bibr">61</xref>), both renal pedicles were exposed and clamped for 22 minutes or 30 minutes through a midline incision and then released. Spatial transcriptomics, histopathology, CODEX, and immunofluorescence data were acquired from the 22-minute IRI model. scRNA-Seq data were acquired from the 30-minute IRI model. In the CLP model (<xref rid="B59" ref-type="bibr">59</xref>), the cecum was ligated and punctured with a 25-gauge needle. Kidneys were excised upon mouse euthanization 6 hours after each procedure and frozen in OCT compound. The presence or absence of AKI was assessed on the H&amp;E histology image and in a consecutive periodic acid&#x2013;Schiff-stained section. As expected, blood urea nitrogen and creatinine measurements were not elevated in either the IRI and CLP models at the 6-hour time point.</p>
      </sec>
      <sec>
        <title>Slide preparation and imaging.</title>
        <p>Slide preparation (CG000240_Demonstrated_Protocol_VisiumSpatialProtocols_TissuePreparationGuide_Rev_A, 10&#xD7; Genomics) and imaging were conducted according to Visium spatial gene expression protocols (CG000241_VisiumImagingGuidelinesTN_Rev_A, 10&#xD7; Genomics). Frozen transverse 10 &#x3BC;m sections from the human nephrectomy or each murine model were placed within the etched frames of the capture areas on the active surface of the Visium spatial slide. Tissue sections were fixed in methanol and stained with H&amp;E. Bright-field images of stained sections in the fiducial frames were collected as mosaics of 10&#xD7; fields using a Keyence BZ-X810 microscope equipped with a Nikon 10&#xD7; CFI Plan Fluor objective.</p>
      </sec>
      <sec>
        <title>mRNA extraction and sequencing.</title>
        <p>mRNA extraction, library preparation, and sequencing were conducted according to the Visium spatial protocols. Stained tissue sections were permeabilized for 12 minutes and mRNA was released to bind oligonucleotides on the capture areas followed by reverse transcription, second strand synthesis, denaturation, cDNA amplification, and SPRIselect cDNA cleanup (CG000239_VisiumSpatialGeneExpression_UserGuide_RevD, 10&#xD7; Genomics), and then the cDNA libraries were prepared and sequenced on an Illumina NovaSeq 6000 with 28 bp + 120 bp paired-end sequencing mode.</p>
      </sec>
      <sec>
        <title>Murine single-cell isolation, library preparation, and sequencing.</title>
        <p>Sham and IRI murine kidneys were transported on ice, minced, and dissociated using the Multi-Tissue Dissociation Kit 2 and a dissociator tube rotator (GentleMACS, Miltenyi Biotec). Samples were prepared according to protocol with modifications: 10 mL of RPMI 1640 (Corning) and 10% BSA (Sigma-Aldrich) were added to the mixture, then filtered, centrifuged at 300<italic>g</italic> for 5 minutes, and the cell pellet was resuspended in 1 mL of lysis buffer (Sigma-Aldrich). Annexin V dead cell removal was performed using magnetic bead separation after washing. The pellet was resuspended in RPMI 1640 and BSA 0.04%. A final concentration of 1 million cells/mL with over 80% viability was achieved. In a single-cell master mix with lysis buffer and reverse transcription reagents, the sample was processed according to the Chromium Single Cell 3&#x2032; Reagent Kits V3 protocol (CG000183_ChromiumSingleCell3_v3_UG_Rev-A, 10&#xD7; Genomics). cDNA was synthesized and libraries were prepared. Sequencing was performed on the Illumina NovaSeq6000 with 28 bp + 91 bp paired-end mode.</p>
        <p>scRNA-Seq was not performed for CLP mice. Instead, publicly available kidney scRNA-Seq data were downloaded from GEO (GSE154107) for mice exposed to LPS (5 mg/kg) or vehicle and euthanized at 4 hours as previously described (<xref rid="B21" ref-type="bibr">21</xref>).</p>
      </sec>
      <sec>
        <title>Murine single-cell data processing.</title>
        <p>Data from 4 scRNA-Seq experiments (2 sham, 1 IRI, 1 LPS) were processed with Cell Ranger 2.1.0 and Seurat 3.1 in R (<xref rid="B62" ref-type="bibr">62</xref>). Raw base call files were demultiplexed from FASTQ files and aligned to the mm10 murine genome using STAR (<xref rid="B63" ref-type="bibr">63</xref>). Cells were removed based on a mitochondrial content higher than 50%, less than 200 unique genes, and the lower 10% and top 5% percentiles of unique genes distribution on each mouse. Each mouse data set was independently scaled and normalized and then merged to create a single-cell reference. After defining the clusters with a resolution of 0.65, the immune, interstitium, and endothelial clusters were reclustered with a higher resolution of 1.4.</p>
      </sec>
      <sec>
        <title>Spatial transcriptomics expression analysis.</title>
        <p>Mapping and counting were performed using Space Ranger 1.0.0 with the reference genome GRCh38 3.0.0 or mmu10 provided by 10&#xD7; Genomics. Space Ranger aligns the barcodes in each read with a 55 &#x3BC;m spot coordinate relative to the fiducial frame, associating read counts with the image. After generating counts, Space Ranger clusters spots using a graph-based clustering algorithm where a nearest-neighbor network is built in a principal components space and a Louvain modularity optimization algorithm selects the modules of highly connected spots. Finally, Space Ranger calculates differential expression between the clusters to identify DEGs using the sSeq method with a <italic>t</italic> test for spots with low counts and edgeR method with asymptotic &#x3B2; test for cells with high counts. The feature plots present expression levels that were normalized in Space Ranger. After mapping of the 3 mouse samples by Space Ranger, the data were processed in Seurat 3.1. The data were normalized by SCTransform and merged to build a unified UMAP. Glomerular spots in the sham model were manually annotated based on the composite reference UMAP. Dot plots show only above-average expression.</p>
        <p>Seurat was used to transfer cluster labels from snRNA-Seq and scRNA-Seq to spatial transcriptomic spots in humans and mice, respectively. The integrated murine scRNA-Seq clusters were transferred to each murine spatial transcriptomic sample. The transfer procedure generates a probability score for each spot and its association with a given scRNA-Seq or snRNA-Seq cluster. The spot is assigned to the cluster with the highest score and mapped back to the spatial transcriptomic sample image. For deconvolution analyses, either a SPOTlight neural network analysis was used (<xref rid="B52" ref-type="bibr">52</xref>) or the dominant nonimmune clusters were suppressed in the analyses and the immune cell types with the highest probability transfer score were mapped on each mouse.</p>
      </sec>
      <sec>
        <title>Correlation with histology.</title>
        <p>In human nephrectomy, 5 fields were selected at random, each composed of 237 to 245 spots, representing 40% of all spots mapped to the nephrectomy tissue. The histology underlying each spot was assessed and the percentage of concordance was determined. Spots were only counted if completely in frame. A spot was considered in alignment if any portion overlapped histology consistent with cluster identity.</p>
      </sec>
      <sec>
        <title>Multiplexed CODEX immunofluorescence.</title>
        <p>Murine tissue sections of 10 &#x3BC;m were acquired from the same OCT block as the spatial transcriptomic sections and were collected on coverslips coated in poly-L-lysine. Sections were prepared following the protocol provided by the manufacturer, Akoya Biosciences, which is also described in detail by Goltsev et al. (<xref rid="B26" ref-type="bibr">26</xref>). Tissue retrieval was conducted with a 3-step hydration process. After hydration, tissues were fixed for staining. An antibody cocktail was made using the antibodies listed below and dispensed among the 3 tissues. After staining, another fixation step was performed to ensure adherence of the tissue to the slide in preparation for washing cycles during imaging. Sections were imaged at 20&#xD7; resolution using the fully automated CODEX system (Akoya Biosciences) and a Keyence BZ-X810 slide scanning microscope. Samples were processed, analyzed, and visualized in CODEX-MAV software, a plugin for FIJI/ImageJ (NIH). The following antibodies and their barcodes were used for staining (all from Akoya with parenthetical catalog number): CD3-BX021 (17A2) &#x2014; Cy5-RX021, CD4-BX026 (RM4-5) Atto 550-RX026, CD8a-BX029 (53-6.7) &#x2014; Atto 550-RX029, CD11b-BX025 (M1/70) &#x2014; Alexa Fluor 488-RX025, CD31-BX002 (MEC13.3) &#x2014; Atto 550-RX002, CD45-BX007 (30-F11) &#x2014; Alexa Fluor 488-RX007, CD45R/B220-BX010 (Ra3-6B2) &#x2014; Alexa Fluor 488-RX010, CD169-BX015 (3D6.112) &#x2014; Cy5-RX015, Ki67-BX047 (B56) &#x2014; Atto 550-RX047, Ly6G-BX024 (1A8)- Cy5-RX024, MHC II&#x2013;BX014 (M5/114.15.2) &#x2014; Atto 550-RX014. Signal specificity was validated by ensuring the disappearance of the signal in between the imaging cycles. Gating strategy was performed similar to commonly used approaches for profiling immune cells using flow cytometry (<xref rid="B61" ref-type="bibr">61</xref>). The total number of cells was reported, as well as percentages of total CD45<sup>+</sup> leukocytes.</p>
      </sec>
      <sec>
        <title>Immunofluorescence.</title>
        <p>Tissue from the WT sham and 22-minute IRI samples (<italic>n =</italic> 3 per group) were harvested and stored in 4% paraformaldehyde before transfer to 0.25% paraformaldehyde. Tissues were cut at 50 &#x3BC;m thickness on a vibratome. An ATF3 primary antibody (Thermo Fisher Scientific, BS-0519R) was incubated overnight at a 1:100 concentration and washed with PBS. A donkey anti-rabbit Alexa Fluor 555 secondary antibody (1:200 dilution, Thermo Fisher Scientific, A32794) and FITC-phalloidin (Oregon Green 488, Thermo Fisher Scientific, O7466) with DAPI (1:200 dilution, Thermo Fisher Scientific, 62248) were subsequently incubated overnight. On the following day, tissues were washed with PBS and fixed with 4% PFA for 10 minutes. Samples were mounted on glass slides with coverslips on regular mounting media and sealed with nail polish (Electron Microscopy, 72180). Large scale tile scanning and imaging were performed on the Leica SP8 microscope and images were digitally stitched using Leica LAS X software. Four random fields (400 &#xD7; 400 pixels) of the medullary outer stripe were assessed in each sample and scored according to immunofluorescence intensity of ATF3; and significance was calculated by a 2-tailed Student&#x2019;s <italic>t</italic> test.</p>
      </sec>
      <sec>
        <title>Data and materials availability.</title>
        <p>Spatial transcriptomic data are archived in GEO (GSE171406). Single-cell sequencing data are archived in GEO (GSE154107 and GSE171639).</p>
      </sec>
      <sec>
        <title>Statistics.</title>
        <p>The DEGs in each comparison were found with the Seurat function FindMarkers (Wilcoxon&#x2019;s rank sum test). Pathway enrichment for those genes was performed with the R packages ReactomePA (<xref rid="B64" ref-type="bibr">64</xref>) and ClusterProfiler (<xref rid="B65" ref-type="bibr">65</xref>). An odds ratio was calculated to determine the likelihood of sets of scRNA-Seq clusters colocalizing in the same spatial transcriptomic spot. Fisher&#x2019;s exact tests were performed to test whether the odds ratio was greater than 1 and to verify the significance of spot distributions on regions of low expression. <italic>P</italic> values less than 0.05 were considered significant.</p>
      </sec>
      <sec>
        <title>Study approval.</title>
        <p>This study was approved by the IRB of Indiana University (1906572234). The need for informed consent was waived given the retrospective, deidentified nature of the human subject analysis. Animal experiments and protocols were approved by the Indiana University Animal Care and Use Committee.</p>
      </sec>
    </sec>
    <sec>
      <title>Author contributions</title>
      <p>RMF, MTE, TME, PCD, KSC, ARS, SW, LC, DJ, MJF, DB, and TH were responsible for the conception, analysis, and interpretation of data. YHC, MTE, ARS, SW, CG, XX, DJ, and KWD conducted the experiments. MTE, RMF, ARS, TME, PCD, and CZ drafted and revised the manuscript. KJK, TH, TAS, and KWD provided intellectual content. All authors gave final approval of the version to be published.</p>
    </sec>
    <sec sec-type="supplementary-material" id="sd">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="SD1">
        <caption>
          <title>Supplemental data</title>
        </caption>
        <media mimetype="application" mime-subtype="pdf" xlink:href="jciinsight-6-147703-s070.pdf" orientation="portrait" id="d31e1057" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="SD2">
        <caption>
          <title>Supplemental Tables 1-10</title>
        </caption>
        <media mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="jciinsight-6-147703-s071.xlsx" orientation="portrait" id="d31e1061" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>The authors would like to thank Sanjay Jain and Blue Lake as well as the investigators of KPMP for their gracious support and advice. The 10&#xD7; Genomics 3&#x2032; scRNA sequencing and 10&#xD7; Genomics Visium Spatial 3&#x2032; transcriptome sequencing were performed in the Center for Medical Genomics at Indiana University School of Medicine. We would like to thank the Indiana Center for Biological Microscopy for imaging assistance. Support for this work was provided by the NIH/National Institute of Diabetes and Digestive and Kidney Diseases K08DK107864 (MTE); Indiana Grand Challenge Precision Health fund (RMF); R01DK099345 (TAS).</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><bold>Conflict of interest:</bold> The authors have declared that no conflict of interest exists.</p>
      </fn>
      <fn>
        <p><bold>Copyright:</bold> &#xA9; 2021, Ferreira et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.</p>
      </fn>
      <fn>
        <p><bold>Reference information:</bold><italic> JCI Insight</italic>. 2021;6(12):e147703.https://doi.org/10.1172/jci.insight.147703.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Renal-tubule epithelial cell nomenclature for single-cell RNA-sequencing studies</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2019</year>
          <volume>30</volume>
          <issue>8</issue>
          <fpage>1358</fpage>
          <lpage>1364</lpage>
          <!--<pub-id pub-id-type="pmcid">6683720</pub-id>-->
          <pub-id pub-id-type="pmid">31253652</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lake</surname>
              <given-names>BB</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys</article-title>
          <source>Nat Commun</source>
          <year>2019</year>
          <volume>10</volume>
          <issue>1</issue>
          <elocation-id>2832</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6597610</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/s41467-019-10861-2</pub-id>
          <pub-id pub-id-type="pmid">31249312</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>BJ</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Using single-cell technologies to map the human immune system &#x2014; implications for nephrology</article-title>
          <source>Nat Rev Nephrol</source>
          <year>2020</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>112</fpage>
          <lpage>128</lpage>
          <pub-id pub-id-type="doi">10.1038/s41581-019-0227-3</pub-id>
          <pub-id pub-id-type="pmid">31831877</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Advantages of single-nucleus over single-cell RNA sequencing of adult kidney: rare cell types and novel cell states revealed in fibrosis</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2019</year>
          <volume>30</volume>
          <issue>1</issue>
          <fpage>23</fpage>
          <lpage>32</lpage>
          <!--<pub-id pub-id-type="pmcid">6317600</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2018090912</pub-id>
          <pub-id pub-id-type="pmid">30510133</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2018</year>
          <volume>29</volume>
          <issue>8</issue>
          <fpage>2069</fpage>
          <lpage>2080</lpage>
          <!--<pub-id pub-id-type="pmcid">6065085</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2018020125</pub-id>
          <pub-id pub-id-type="pmid">29980650</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xE5;hl</surname>
              <given-names>PL</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>
          <source>Science</source>
          <year>2016</year>
          <volume>353</volume>
          <issue>6294</issue>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaf2403</pub-id>
          <pub-id pub-id-type="pmid">27365449</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Identification of spatially associated subpopulations by combining scRNAseq and sequential fluorescence in situ hybridization data</article-title>
          <source>Nat Biotechnol</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>1183</fpage>
          <lpage>1190</lpage>
          <!--<pub-id pub-id-type="pmcid">6488461</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/nbt.4260</pub-id>
          <pub-id pub-id-type="pmid">30371680</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Comprehensive integration of single-cell data</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <issue>7</issue>
          <fpage>1888</fpage>
          <lpage>1902</lpage>
          <!--<pub-id pub-id-type="pmcid">6687398</pub-id>-->
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barwinska</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Molecular characterization of the human kidney interstitium in health and disease</article-title>
          <source>Sci Adv</source>
          <year>2021</year>
          <volume>7</volume>
          <issue>7</issue>
          <elocation-id>eabd3359</elocation-id>
          <!--<pub-id pub-id-type="pmcid">7875540</pub-id>-->
          <pub-id pub-id-type="doi">10.1126/sciadv.abd3359</pub-id>
          <pub-id pub-id-type="pmid">33568476</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Devarajan</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Update on mechanisms of ischemic acute kidney injury</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2006</year>
          <volume>17</volume>
          <issue>6</issue>
          <fpage>1503</fpage>
          <lpage>1520</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2006010017</pub-id>
          <pub-id pub-id-type="pmid">16707563</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Proteo-metabolomics reveals compensation between ischemic and non-injured contralateral kidneys after reperfusion</article-title>
          <source>Sci Rep</source>
          <year>2018</year>
          <volume>8</volume>
          <issue>1</issue>
          <elocation-id>8539</elocation-id>
          <!--<pub-id pub-id-type="pmcid">5986744</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/s41598-018-26804-8</pub-id>
          <pub-id pub-id-type="pmid">29867102</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lan</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2016</year>
          <volume>27</volume>
          <issue>11</issue>
          <fpage>3356</fpage>
          <lpage>3367</lpage>
          <!--<pub-id pub-id-type="pmcid">5084876</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2015020177</pub-id>
          <pub-id pub-id-type="pmid">27000065</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szeto</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Pharmacologic approaches to improve mitochondrial function in AKI and CKD</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2017</year>
          <volume>28</volume>
          <issue>10</issue>
          <fpage>2856</fpage>
          <lpage>2865</lpage>
          <!--<pub-id pub-id-type="pmcid">5619975</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2017030247</pub-id>
          <pub-id pub-id-type="pmid">28778860</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>Q</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Changes in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusion</article-title>
          <source>PLoS One</source>
          <year>2014</year>
          <volume>9</volume>
          <issue>9</issue>
          <elocation-id>e106647</elocation-id>
          <!--<pub-id pub-id-type="pmcid">4156324</pub-id>-->
          <pub-id pub-id-type="doi">10.1371/journal.pone.0106647</pub-id>
          <pub-id pub-id-type="pmid">25191961</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moonen</surname>
              <given-names>L</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Epithelial cell cycle behaviour in the injured kidney</article-title>
          <source>Int J Mol Sci</source>
          <year>2018</year>
          <volume>19</volume>
          <issue>7</issue>
          <elocation-id>E2038</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6073451</pub-id>-->
          <pub-id pub-id-type="pmid">30011818</pub-id>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guan</surname>
              <given-names>HL</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The involvement of p38MAPK in the rat model of lower-extremity arterial ischemia-reperfusion injury</article-title>
          <source>Eur Rev Med Pharmacol Sci</source>
          <year>2018</year>
          <volume>22</volume>
          <issue>17</issue>
          <fpage>5659</fpage>
          <lpage>5664</lpage>
          <pub-id pub-id-type="pmid">30229843</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ashraf</surname>
              <given-names>MI</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury</article-title>
          <source>Cell Commun Signal</source>
          <year>2014</year>
          <volume>12</volume>
          <elocation-id>6</elocation-id>
          <!--<pub-id pub-id-type="pmcid">3896752</pub-id>-->
          <pub-id pub-id-type="pmid">24423080</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cortvrindt</surname>
              <given-names>C</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The role of interleukin-17A in the pathogenesis of kidney diseases</article-title>
          <source>Pathology</source>
          <year>2017</year>
          <volume>49</volume>
          <issue>3</issue>
          <fpage>247</fpage>
          <lpage>258</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pathol.2017.01.003</pub-id>
          <pub-id pub-id-type="pmid">28291548</pub-id>
        </element-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Awad</surname>
              <given-names>AS</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury</article-title>
          <source>Kidney Int</source>
          <year>2009</year>
          <volume>75</volume>
          <issue>7</issue>
          <fpage>689</fpage>
          <lpage>698</lpage>
          <!--<pub-id pub-id-type="pmcid">2656389</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/ki.2008.648</pub-id>
          <pub-id pub-id-type="pmid">19129795</pub-id>
        </element-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>L</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury</article-title>
          <source>J Clin Invest</source>
          <year>2010</year>
          <volume>120</volume>
          <issue>1</issue>
          <fpage>331</fpage>
          <lpage>342</lpage>
          <!--<pub-id pub-id-type="pmcid">2798679</pub-id>-->
          <pub-id pub-id-type="doi">10.1172/JCI38702</pub-id>
          <pub-id pub-id-type="pmid">20038794</pub-id>
        </element-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Janosevic</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline</article-title>
          <source>Elife</source>
          <year>2021</year>
          <volume>10</volume>
          <elocation-id>e62270</elocation-id>
          <!--<pub-id pub-id-type="pmcid">7810465</pub-id>-->
          <pub-id pub-id-type="pmid">33448928</pub-id>
        </element-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hoffmann</surname>
              <given-names>D</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Fibrinogen excretion in the urine and immunoreactivity in the kidney serves as a translational biomarker for acute kidney injury</article-title>
          <source>Am J Pathol</source>
          <year>2012</year>
          <volume>181</volume>
          <issue>3</issue>
          <fpage>818</fpage>
          <lpage>828</lpage>
          <!--<pub-id pub-id-type="pmcid">3432430</pub-id>-->
          <pub-id pub-id-type="doi">10.1016/j.ajpath.2012.06.004</pub-id>
          <pub-id pub-id-type="pmid">22819533</pub-id>
        </element-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmerman</surname>
              <given-names>KA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell RNA sequencing identifies candidate renal resident macrophage gene expression signatures across species</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2019</year>
          <volume>30</volume>
          <issue>5</issue>
          <fpage>767</fpage>
          <lpage>781</lpage>
          <!--<pub-id pub-id-type="pmcid">6493978</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2018090931</pub-id>
          <pub-id pub-id-type="pmid">30948627</pub-id>
        </element-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boespflug</surname>
              <given-names>ND</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>ATF3 is a novel regulator of mouse neutrophil migration</article-title>
          <source>Blood</source>
          <year>2014</year>
          <volume>123</volume>
          <issue>13</issue>
          <fpage>2084</fpage>
          <lpage>2093</lpage>
          <!--<pub-id pub-id-type="pmcid">3968391</pub-id>-->
          <pub-id pub-id-type="doi">10.1182/blood-2013-06-510909</pub-id>
          <pub-id pub-id-type="pmid">24470589</pub-id>
        </element-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horiba</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Neointima formation in a restenosis model is suppressed in midkine-deficient mice</article-title>
          <source>J Clin Invest</source>
          <year>2000</year>
          <volume>105</volume>
          <issue>4</issue>
          <fpage>489</fpage>
          <lpage>495</lpage>
          <!--<pub-id pub-id-type="pmcid">289157</pub-id>-->
          <pub-id pub-id-type="doi">10.1172/JCI7208</pub-id>
          <pub-id pub-id-type="pmid">10683378</pub-id>
        </element-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goltsev</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Deep profiling of mouse splenic architecture with CODEX multiplexed imaging</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <issue>4</issue>
          <fpage>968</fpage>
          <lpage>981</lpage>
          <!--<pub-id pub-id-type="pmcid">6086938</pub-id>-->
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.010</pub-id>
          <pub-id pub-id-type="pmid">30078711</pub-id>
        </element-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Greka</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The power of one: advances in single-cell genomics in the kidney</article-title>
          <source>Nat Rev Nephrol</source>
          <year>2020</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>73</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1038/s41581-019-0237-1</pub-id>
          <pub-id pub-id-type="pmid">31819231</pub-id>
        </element-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wilson</surname>
              <given-names>PC</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The single-cell transcriptomic landscape of early human diabetic nephropathy</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2019</year>
          <volume>116</volume>
          <issue>39</issue>
          <fpage>19619</fpage>
          <lpage>19625</lpage>
          <!--<pub-id pub-id-type="pmcid">6765272</pub-id>-->
          <pub-id pub-id-type="doi">10.1073/pnas.1908706116</pub-id>
          <pub-id pub-id-type="pmid">31506348</pub-id>
        </element-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>MD</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors</article-title>
          <source>Science</source>
          <year>2018</year>
          <volume>361</volume>
          <issue>6402</issue>
          <fpage>594</fpage>
          <lpage>599</lpage>
          <!--<pub-id pub-id-type="pmcid">6104812</pub-id>-->
          <pub-id pub-id-type="doi">10.1126/science.aat1699</pub-id>
          <pub-id pub-id-type="pmid">30093597</pub-id>
        </element-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>JJ</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell transcriptome profiling of the kidney glomerulus identifies key cell types and reactions to injury</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2020</year>
          <volume>31</volume>
          <issue>10</issue>
          <fpage>2341</fpage>
          <lpage>2354</lpage>
          <!--<pub-id pub-id-type="pmcid">7609001</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2020020220</pub-id>
          <pub-id pub-id-type="pmid">32651223</pub-id>
        </element-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dumas</surname>
              <given-names>SJ</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2020</year>
          <volume>31</volume>
          <issue>1</issue>
          <fpage>118</fpage>
          <lpage>138</lpage>
          <!--<pub-id pub-id-type="pmcid">6935008</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2019080832</pub-id>
          <pub-id pub-id-type="pmid">31818909</pub-id>
        </element-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>J</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease</article-title>
          <source>Science</source>
          <year>2018</year>
          <volume>360</volume>
          <issue>6390</issue>
          <fpage>758</fpage>
          <lpage>763</lpage>
          <!--<pub-id pub-id-type="pmcid">6188645</pub-id>-->
          <pub-id pub-id-type="doi">10.1126/science.aar2131</pub-id>
          <pub-id pub-id-type="pmid">29622724</pub-id>
        </element-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ransick</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell profiling reveals sex, lineage, and regional diversity in the mouse kidney</article-title>
          <source>Dev Cell</source>
          <year>2019</year>
          <volume>51</volume>
          <issue>3</issue>
          <fpage>399</fpage>
          <lpage>413</lpage>
          <!--<pub-id pub-id-type="pmcid">6948019</pub-id>-->
          <pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.005</pub-id>
          <pub-id pub-id-type="pmid">31689386</pub-id>
        </element-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harder</surname>
              <given-names>JL</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Organoid single cell profiling identifies a transcriptional signature of glomerular disease</article-title>
          <source>JCI Insight</source>
          <year>2019</year>
          <volume>4</volume>
          <issue>1</issue>
          <elocation-id>e122697</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6485369</pub-id>-->
          <pub-id pub-id-type="doi">10.1172/jci.insight.122697</pub-id>
          <pub-id pub-id-type="pmid">30626756</pub-id>
        </element-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Subramanian</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single cell census of human kidney organoids shows reproducibility and diminished off-target cells after transplantation</article-title>
          <source>Nat Commun</source>
          <year>2019</year>
          <volume>10</volume>
          <issue>1</issue>
          <elocation-id>5462</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6884507</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/s41467-019-13382-0</pub-id>
          <pub-id pub-id-type="pmid">31784515</pub-id>
        </element-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Combes</surname>
              <given-names>AN</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell analysis reveals congruence between kidney organoids and human fetal kidney</article-title>
          <source>Genome Med</source>
          <year>2019</year>
          <volume>11</volume>
          <issue>1</issue>
          <elocation-id>3</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6345028</pub-id>-->
          <pub-id pub-id-type="doi">10.1186/s13073-019-0615-0</pub-id>
          <pub-id pub-id-type="pmid">30674341</pub-id>
        </element-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menon</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell analysis of progenitor cell dynamics and lineage specification in the human fetal kidney</article-title>
          <source>Development</source>
          <year>2018</year>
          <volume>145</volume>
          <issue>16</issue>
          <elocation-id>dev164038</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6124540</pub-id>-->
          <pub-id pub-id-type="doi">10.1242/dev.164038</pub-id>
          <pub-id pub-id-type="pmid">30166318</pub-id>
        </element-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Combes</surname>
              <given-names>AN</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single cell analysis of the developing mouse kidney provides deeper insight into marker gene expression and ligand-receptor crosstalk</article-title>
          <source>Development</source>
          <year>2019</year>
          <volume>146</volume>
          <issue>12</issue>
          <elocation-id>dev178673</elocation-id>
          <pub-id pub-id-type="pmid">31118232</pub-id>
        </element-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hochane</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell transcriptomics reveals gene expression dynamics of human fetal kidney development</article-title>
          <source>PLoS Biol</source>
          <year>2019</year>
          <volume>17</volume>
          <issue>2</issue>
          <elocation-id>e3000152</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6400406</pub-id>-->
          <pub-id pub-id-type="doi">10.1371/journal.pbio.3000152</pub-id>
          <pub-id pub-id-type="pmid">30789893</pub-id>
        </element-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>AD</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter</article-title>
          <source>iScience</source>
          <year>2019</year>
          <volume>20</volume>
          <fpage>402</fpage>
          <lpage>414</lpage>
          <!--<pub-id pub-id-type="pmcid">6817668</pub-id>-->
          <pub-id pub-id-type="doi">10.1016/j.isci.2019.09.029</pub-id>
          <pub-id pub-id-type="pmid">31622881</pub-id>
        </element-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuppe</surname>
              <given-names>C</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Decoding myofibroblast origins in human kidney fibrosis</article-title>
          <source>Nature</source>
          <year>2021</year>
          <volume>589</volume>
          <issue>7841</issue>
          <fpage>281</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-020-2941-1</pub-id>
          <pub-id pub-id-type="pmid">33176333</pub-id>
        </element-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asp</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Spatially resolved transcriptomes-next generation tools for tissue exploration</article-title>
          <source>Bioessays</source>
          <year>2020</year>
          <volume>42</volume>
          <issue>10</issue>
          <elocation-id>e1900221</elocation-id>
          <pub-id pub-id-type="pmid">32363691</pub-id>
        </element-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asp</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>A spatiotemporal organ-wide gene expression and cell atlas of the developing human heart</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>179</volume>
          <issue>7</issue>
          <fpage>1647</fpage>
          <lpage>1660</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.11.025</pub-id>
          <pub-id pub-id-type="pmid">31835037</pub-id>
        </element-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berglund</surname>
              <given-names>E</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity</article-title>
          <source>Nat Commun</source>
          <year>2018</year>
          <volume>9</volume>
          <issue>1</issue>
          <elocation-id>2419</elocation-id>
          <!--<pub-id pub-id-type="pmcid">6010471</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/s41467-018-04724-5</pub-id>
          <pub-id pub-id-type="pmid">29925878</pub-id>
        </element-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thrane</surname>
              <given-names>K</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Spatially resolved transcriptomics enables dissection of genetic heterogeneity in stage III cutaneous malignant melanoma</article-title>
          <source>Cancer Res</source>
          <year>2018</year>
          <volume>78</volume>
          <issue>20</issue>
          <fpage>5970</fpage>
          <lpage>5979</lpage>
          <pub-id pub-id-type="pmid">30154148</pub-id>
        </element-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maniatis</surname>
              <given-names>S</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>364</volume>
          <issue>6435</issue>
          <fpage>89</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aav9776</pub-id>
          <pub-id pub-id-type="pmid">30948552</pub-id>
        </element-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriques</surname>
              <given-names>SG</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>363</volume>
          <issue>6434</issue>
          <fpage>1463</fpage>
          <lpage>1467</lpage>
          <!--<pub-id pub-id-type="pmcid">6927209</pub-id>-->
          <pub-id pub-id-type="doi">10.1126/science.aaw1219</pub-id>
          <pub-id pub-id-type="pmid">30923225</pub-id>
        </element-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vickovic</surname>
              <given-names>S</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>High-definition spatial transcriptomics for in situ tissue profiling</article-title>
          <source>Nat Methods</source>
          <year>2019</year>
          <volume>16</volume>
          <issue>10</issue>
          <fpage>987</fpage>
          <lpage>990</lpage>
          <!--<pub-id pub-id-type="pmcid">6765407</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/s41592-019-0548-y</pub-id>
          <pub-id pub-id-type="pmid">31501547</pub-id>
        </element-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue</article-title>
          <source>Cell</source>
          <year>2020</year>
          <volume>183</volume>
          <issue>6</issue>
          <fpage>1665</fpage>
          <lpage>1681</lpage>
          <!--<pub-id pub-id-type="pmcid">7736559</pub-id>-->
          <pub-id pub-id-type="doi">10.1016/j.cell.2020.10.026</pub-id>
          <pub-id pub-id-type="pmid">33188776</pub-id>
        </element-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JH</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Highly multiplexed subcellular RNA sequencing in situ</article-title>
          <source>Science</source>
          <year>2014</year>
          <volume>343</volume>
          <issue>6177</issue>
          <fpage>1360</fpage>
          <lpage>1363</lpage>
          <!--<pub-id pub-id-type="pmcid">4140943</pub-id>-->
          <pub-id pub-id-type="doi">10.1126/science.1250212</pub-id>
          <pub-id pub-id-type="pmid">24578530</pub-id>
        </element-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eng</surname>
              <given-names>CL</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>568</volume>
          <issue>7751</issue>
          <fpage>235</fpage>
          <lpage>239</lpage>
          <!--<pub-id pub-id-type="pmcid">6544023</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/s41586-019-1049-y</pub-id>
          <pub-id pub-id-type="pmid">30911168</pub-id>
        </element-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elosua-Bayes</surname>
              <given-names>M</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes</article-title>
          <comment>[published online February 5, 2021].</comment>
          <source>Nucleic Acids Res</source>
          <pub-id pub-id-type="doi">10.1093/nar/gkab043</pub-id>
          <!--<pub-id pub-id-type="pmcid">8136778</pub-id>-->
          <pub-id pub-id-type="pmid">33544846</pub-id>
        </element-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation publication-type="web" publication-format="online">
          <comment>Kuppe C, et al. Spatial multi-omic map of human myocardial infarction [preprint]. </comment>
          <pub-id pub-id-type="doi">10.1101/2020.12.08.411686</pub-id>
          <comment> Posted on bioRxiv December 10, 2020</comment>
        </mixed-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arazi</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The immune cell landscape in kidneys of patients with lupus nephritis</article-title>
          <source>Nat Immunol</source>
          <year>2019</year>
          <volume>20</volume>
          <issue>7</issue>
          <fpage>902</fpage>
          <lpage>914</lpage>
          <!--<pub-id pub-id-type="pmcid">6726437</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/s41590-019-0398-x</pub-id>
          <pub-id pub-id-type="pmid">31209404</pub-id>
        </element-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fu</surname>
              <given-names>J</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Single-cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2019</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>533</fpage>
          <lpage>545</lpage>
          <!--<pub-id pub-id-type="pmcid">6442341</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2018090896</pub-id>
          <pub-id pub-id-type="pmid">30846559</pub-id>
        </element-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>El-Achkar</surname>
              <given-names>TM</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression</article-title>
          <source>Am J Physiol Renal Physiol</source>
          <year>2008</year>
          <volume>295</volume>
          <issue>2</issue>
          <fpage>F534</fpage>
          <lpage>F544</lpage>
          <!--<pub-id pub-id-type="pmcid">5504389</pub-id>-->
          <pub-id pub-id-type="pmid">18495803</pub-id>
        </element-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Micanovic</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Tamm-horsfall protein regulates granulopoiesis and systemic neutrophil homeostasis</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2015</year>
          <volume>26</volume>
          <issue>9</issue>
          <fpage>2172</fpage>
          <lpage>2182</lpage>
          <!--<pub-id pub-id-type="pmcid">4552115</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2014070664</pub-id>
          <pub-id pub-id-type="pmid">25556169</pub-id>
        </element-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>The macrophage mediates the renoprotective effects of endotoxin preconditioning</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2015</year>
          <volume>26</volume>
          <issue>6</issue>
          <fpage>1347</fpage>
          <lpage>1362</lpage>
          <!--<pub-id pub-id-type="pmcid">4446880</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2014060561</pub-id>
          <pub-id pub-id-type="pmid">25398784</pub-id>
        </element-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Endotoxin preconditioning reprograms s1 tubules and macrophages to protect the kidney</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2018</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>104</fpage>
          <lpage>117</lpage>
          <!--<pub-id pub-id-type="pmcid">5748923</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2017060624</pub-id>
          <pub-id pub-id-type="pmid">29018138</pub-id>
        </element-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eadon</surname>
              <given-names>MT</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Kidney histopathology and prediction of kidney failure: a retrospective cohort study</article-title>
          <source>Am J Kidney Dis</source>
          <year>2020</year>
          <volume>76</volume>
          <issue>3</issue>
          <fpage>350</fpage>
          <lpage>360</lpage>
          <!--<pub-id pub-id-type="pmcid">7483298</pub-id>-->
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2019.12.014</pub-id>
          <pub-id pub-id-type="pmid">32336487</pub-id>
        </element-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Micanovic</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Tamm-Horsfall protein regulates mononuclear phagocytes in the kidney</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2018</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>841</fpage>
          <lpage>856</lpage>
          <!--<pub-id pub-id-type="pmcid">5827593</pub-id>-->
          <pub-id pub-id-type="doi">10.1681/ASN.2017040409</pub-id>
          <pub-id pub-id-type="pmid">29180395</pub-id>
        </element-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
          <source>Nat Biotechnol</source>
          <year>2018</year>
          <volume>36</volume>
          <issue>5</issue>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <!--<pub-id pub-id-type="pmcid">6700744</pub-id>-->
          <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
          <pub-id pub-id-type="pmid">29608179</pub-id>
        </element-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobin</surname>
              <given-names>A</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>
          <source>Bioinformatics</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>15</fpage>
          <lpage>21</lpage>
          <!--<pub-id pub-id-type="pmcid">3530905</pub-id>-->
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
          <pub-id pub-id-type="pmid">23104886</pub-id>
        </element-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>QY</given-names>
            </name>
          </person-group>
          <article-title>ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization</article-title>
          <source>Mol Biosyst</source>
          <year>2016</year>
          <volume>12</volume>
          <issue>2</issue>
          <fpage>477</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="pmid">26661513</pub-id>
        </element-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>G</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>
          <source>OMICS</source>
          <year>2012</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>284</fpage>
          <lpage>287</lpage>
          <!--<pub-id pub-id-type="pmcid">3339379</pub-id>-->
          <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
          <pub-id pub-id-type="pmid">22455463</pub-id>
        </element-citation>
      </ref>
    </ref-list>
    <notes notes-type="version-changes">
      <sec sec-type="version-changes">
        <label>Version 1</label>
        <title>05/18/2021</title>
        <p>In-Press Preview</p>
      </sec>
      <sec sec-type="version-changes">
        <label>Version 2</label>
        <title>06/22/2021</title>
        <p>Electronic publication</p>
      </sec>
    </notes>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Spatial transcriptomics in a human nephrectomy sample.</title>
        <p>(<bold>A</bold>) H&amp;E staining of the human reference nephrectomy. (<bold>B</bold>) The 9 unsupervised spatial transcriptomic (ST) clusters are overlaid upon the nephrectomy. Glomeruli can be seen scattered across the cortex in red. A medullary ray is seen in the right lower quadrant of the sample. Midsized vessels are often overlaid by pink interstitial cluster ST spots. Pure clusters are defined as those located mainly over the associated structure; mixed clusters often overlap with neighboring structures. (<bold>C</bold>) A high-magnification image showing histological structures in a reference nephrectomy. (<bold>D</bold>) Histological structures are highlighted in the nephrectomy. (<bold>E</bold>) Unsupervised clusters overlaid upon the nephrectomy. (<bold>F</bold>&#x2013;<bold>I</bold>) Expression levels of <italic>LRP2</italic>, <italic>SLC12A1</italic>, <italic>SLC12A3</italic>, and <italic>AQP2</italic> in the spots over the high magnification region with histological features highlighted. (<bold>J</bold>) Expression of markers used to classify unsupervised clusters. (<bold>K</bold>) In 5 random fields covering 40% of all spots, the histology underlying each spot was assessed and the percentage of concordance is provided. All clusters held greater than 90% concordance with their corresponding histology. <italic>n =</italic> 1 human nephrectomy. PT, proximal tubule; S1, S2, S3, segments of PT; TAL, thick ascending limb; DCT, distal convoluted tubule; CNT, connecting tubule; CD, collecting duct. Each spot is 55 &#x3BC;m in diameter.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g060"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>Transfer of single-nuclei RNA sequencing clusters to the human spatial transcriptomic sample.</title>
        <p>(<bold>A</bold>) UMAP projection of spatial transcriptomic (ST) data with 9 unsupervised clusters defined by Space Ranger. Spots assigned to the pure PT or thick ascending limb clusters were more frequently located over their corresponding histology; mixed clusters often overlapped neighboring structures. (<bold>B</bold>) A UMAP projection of the single-nucleus RNA-Seq data (GSE121862) depicts the 30 kidney cell clusters obtained from Pagoda. (<bold>C</bold>) The percentage of ST spots overlapping between unsupervised cluster spot identities and supervised cluster identities defined by single-nuclei expression signatures. Strong correlation is seen between expected clusters. Each row of the table adds to 100%. (<bold>D</bold>) A high-magnification image of the H&amp;E-stained human reference nephrectomy with unsupervised interstitium cluster spots overlaid. Histological structures are highlighted. (<bold>E</bold>) A high-magnification image of the H&amp;E-stained reference nephrectomy with mapped single-nucleus clusters associated with interstitium and histological structures highlighted. (<bold>F</bold>&#x2013;<bold>M</bold>) Feature plots depict the expression levels of interstitial cell-type markers, such as <italic>PDGFRA</italic>, <italic>COL1A1</italic>, <italic>FLT1</italic>, <italic>TAGLN</italic>, <italic>ACTA2</italic>, <italic>MYH11</italic>, <italic>FLNA</italic>, and <italic>AEBP1,</italic> in the high-magnification region. Histological features highlighted. PT, proximal tubule; S1, S2, S3, segments of PT; TAL, thick ascending limb; DCT, distal convoluted tubule; CNT, connecting tubule; CD, collecting duct; DTL, descending thin limb; Asc, ascending; PC, principal cells; IC, intercalated cells; End, endothelial; GC, glomerular capsule; AVR, ascending vasa recta; AEA, afferent and efferent arterioles; DVR, descending vasa recta; VSMC-P, vascular smooth cells and pericytes. Each spot is 55 &#x3BC;m in diameter.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g062"/>
    </fig>
    <fig id="F3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <title>Neural network analysis of human kidney.</title>
        <p>(<bold>A</bold>) Each pie chart represents the contribution of the cell types from the single-nuclei reference data set to the transcriptomic signature of each spot in the human nephrectomy. Only cell types contributing to at least 10% of the spot signature are displayed. (<bold>B</bold>) An inset depicts the medullary region highlighted in blue (manually annotated). The remaining nephrectomy was considered cortex. (<bold>C</bold>) Fraction of total signature of each cell type present in the cortex and medulla, normalized to the total number of spots in the cortex and medulla. Each bar is calculated as follows: the proportion of expression arising from each spot was summed for each cell type in both the cortex and medulla. Summed expression was first normalized for (divided by) the number of spots in the cortex and medulla and then expressed as a ratio of expression arising from the cortex or medulla for each cell type. PT, proximal tubule; S1, S2, S3, segments of PT; TAL, thick ascending limb; DCT, distal convoluted tubule; CNT, connecting tubule; CD, collecting duct; DTL, descending thin limb; Asc, ascending; PC, principal cells; IC, intercalated cells; End, endothelial; GC, glomerular capsule; AVR, ascending vasa recta; AEA afferent and efferent arterioles; DVR, descending vasa recta; VSMC-P, vascular smooth cells and pericytes. Each spot is 55 &#x3BC;m in diameter.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g063"/>
    </fig>
    <fig id="F4" orientation="portrait" position="float">
      <label>Figure 4</label>
      <caption>
        <title>Spatial transcriptomics in murine kidney injury models.</title>
        <p>(<bold>A</bold>) H&amp;E-stained sections of the 3 murine models: sham, ischemia/reperfusion injury (IRI), and cecal ligation puncture (CLP), respectively. (<bold>B</bold>) Spatial transcriptomic spots are overlaid upon each murine kidney derived from unbiased clustering. (<bold>C</bold>) A UMAP of the spatial clusters after the data was merged, split by tissue of origin (sham on left, IRI in middle, and CLP on right). (<bold>D</bold>) Expression of markers used to classify the spatial transcriptomic clusters. <italic>n =</italic> 1 murine sample per model. PT, proximal tubule; S1, S2, S3, segments of PT; Med, medullary; TAL, thick ascending limb; DCT, distal convoluted tubule; CNT, connecting tubule; CD, collecting; Glom, glomerulus. Each spot is 55 &#x3BC;m in diameter.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g064"/>
    </fig>
    <fig id="F5" orientation="portrait" position="float">
      <label>Figure 5</label>
      <caption>
        <title>Regional expression in murine kidney injury models.</title>
        <p>(<bold>A</bold>) Total expression in read counts was summed for each spatial transcriptomic (ST) spot and the total expression level was overlaid upon each of the 3 murine model sections: sham (left), ischemia/reperfusion injury (IRI, middle), and cecal ligation puncture (CLP, right). Regions of interest and comparator regions are highlighted. In the sham, areas are selected to serve as reference to IRI (1, outlined in purple) and to CLP (4, outlined in green). In the IRI section, region 2 corresponds to the relatively &#x201C;preserved&#x201D; overall expression region and region 3 corresponds to a region of low relative expression. In the CLP section, analogous regions of preserved expression (<xref rid="B5" ref-type="bibr">5</xref>) and low expression (<xref rid="B6" ref-type="bibr">6</xref>) were selected. The regions were defined with similar areas within each comparison. (<bold>B</bold>) Volcano plot comparing the low-expression region in the IRI to the equivalent region in the sham. Despite the overall reduced expression of the IRI region, many individual genes were upregulated in IRI (right). (<bold>C</bold>) Pathways enriched for the differentially expressed genes (DEGs) between the low-expression region in IRI when compared with the sham. (<bold>D</bold>) Bar plots showing the number of nuclei and number of spots of each cluster in the 3 purple comparison regions. The asterisks indicate the significance level (*<italic>P &lt;</italic> 0.1, **<italic>P &lt;</italic> 0.001 as calculated by Fisher&#x2019;s exact test. (<bold>E</bold>) Volcano plot comparing the low-expression region in the CLP to the equivalent region in the sham with upregulated genes in CLP on the right. (<bold>F</bold>) Pathways enriched for the DEGs between the low--expression region in CLP when compared with sham. (<bold>G</bold>) Bar plots showing the number of nuclei and number of spots of each cluster in the 3 green comparison regions. Each spot is 55 &#x3BC;m in diameter.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g065"/>
    </fig>
    <fig id="F6" orientation="portrait" position="float">
      <label>Figure 6</label>
      <caption>
        <title>Single-cell murine data and cluster transfer to spatial transcriptomic samples.</title>
        <p>(<bold>A</bold>) Expression levels of markers used to define clusters in the single-cell data. The single-cell RNA sequencing data set consists of 4 murine samples: an ischemia/reperfusion injury (IRI) mouse with corresponding sham and an LPS endotoxin&#x2013;administered mouse with its corresponding sham. (<bold>B</bold>) A UMAP displays the clusters obtained from the single-cell data. (<bold>C</bold>&#x2013;<bold>E</bold>) Mapping of the single-cell clusters over the 3 murine spatial transcriptomic sections: sham, IRI, and cecal ligation puncture, respectively. (<bold>F</bold>) Quantitation of the number of spots mapped to each of the single-cell clusters. Raw spot counts are provided without further calculation. PT, proximal tubule; S1, S2, S3, segments of PT; S3-C, cortical section of S3; S3-OS, outer stripe section of S3; TAL, thick ascending limb; DCT, distal convoluted tubule; CNT, connecting tubule; CD, collecting duct; PC, principal cells; IC, intercalated cells; VSM, vascular smooth muscle; pDC, plasmacytoid DCs; cDC, conventional DCs; Res. M&#x3A6;, resident macrophages; Inf. M&#x3A6;, infiltrating macrophages. Each spot is 55 &#x3BC;m in diameter.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g066"/>
    </fig>
    <fig id="F7" orientation="portrait" position="float">
      <label>Figure 7</label>
      <caption>
        <title>Colocalization of immune clusters in the ischemia/reperfusion injury model.</title>
        <p>(<bold>A</bold> and <bold>B</bold>) Selected single-cell immune clusters are overlaid upon the spatial transcriptomic sections for the sham and ischemia/reperfusion injury (IRI) models, respectively. Each spot was labeled with the immune cell with the highest corresponding transfer score. (<bold>C</bold>) The odds ratio of colocalization for each pair of immune and epithelial clusters in the IRI model when compared with the sham. Only significant comparisons are included in the dot plot as calculated by a Fisher&#x2019;s exact test. Neutrophils most frequently colocalized with the PT (S3-OS) epithelial cluster. (<bold>D</bold>) Neutrophil plot in IRI (left), sham (top-right), and cecal ligation puncture (CLP, bottom-right). (<bold>E</bold>) The differentially expressed genes (DEGs) between the PT (S3-OS) spots colocalizing with neutrophils (right) and the PT (S3-OS) spots colocalizing with other immune clusters in IRI (left). (<bold>F</bold>) The gene expression of <italic>Atf3</italic> localizes to the outer stripe in IRI. (<bold>G</bold>) Antibody immunofluorescence of ATF3 reveals medullary outer stripe protein expression in the IRI model (<italic>n =</italic> 3). (<bold>H</bold>) The expression distribution of <italic>Atf3</italic> in selected clusters (**<italic>P &lt;</italic> 10<sup>&#x2013;9</sup>, ***<italic>P &lt;</italic> 10<sup>&#x2013;15</sup>) as calculated by a Fisher&#x2019;s exact test. PT, proximal tubule; S1, S2, S3, segments of PT; S3-C, cortical section of S3; S3-OS, outer stripe section of S3; TAL, thick ascending limb; DCT, distal convoluted tubule; CNT, connecting tubule; CD, collecting duct; PC, principal cells; IC, intercalated cells; pDC, plasmacytoid DCs; cDC, conventional DCs; Res. M&#x3A6;, resident macrophages; Inf. M&#x3A6;, infiltrating macrophages. Each spot is 55 &#x3BC;m in diameter. Scale bar: 500 &#x3BC;m (<bold>G</bold>).</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g067"/>
    </fig>
    <fig id="F8" orientation="portrait" position="float">
      <label>Figure 8</label>
      <caption>
        <title>Identification of a proximal tubular single-cell subcluster expressing <italic>Atf3</italic>.</title>
        <p>(<bold>A</bold>) Feature plot of the single-cell data presenting the expression of <italic>Atf3</italic> with PT (S3-C) and PT (S3-OS) clusters highlighted. (<bold>B</bold>) A UMAP of the PT (S3-C) and PT (S3-OS) single-cell clusters, reclustered at increased resolution. (<bold>C</bold>) Feature plot of <italic>Atf3</italic> with its expression in the single-cell subclusters shows <italic>Atf3</italic> specifically in 1 outer stripe subcluster. (<bold>D</bold>) The expression of <italic>Atf3</italic> in all subclusters. PT, proximal tubule; S1, S2, S3, segments of PT; S3-C, cortical section of S3; S3-OS, outer stripe section of S3.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g068"/>
    </fig>
    <fig id="F9" orientation="portrait" position="float">
      <label>Figure 9</label>
      <caption>
        <title>Colocalization of immune clusters in the cecal ligation puncture model.</title>
        <p>(<bold>A</bold>) Selected single-cell immune clusters were transferred over the cecal ligation puncture (CLP) spatial transcriptomic section. (<bold>B</bold>) The odds ratio of colocalization for each pair of immune and epithelial clusters in CLP when compared with the sham. (<bold>C</bold>) Infiltrating macrophages localized to the outer cortex and inner medulla. Infiltrating macrophage localization is depicted in the CLP (left), sham (top-right), and ischemia/reperfusion injury (bottom-right). (<bold>D</bold>) The differentially expressed genes (DEGs) between the PT (S1/S2/S3-C) spots colocalizing with infiltrating macrophages (right) and the ones colocalizing with other immune clusters in CLP. (<bold>E</bold>) The gene expression of <italic>MdK</italic> in CLP. (<bold>F</bold>) The expression distribution of <italic>Mdk</italic> in selected clusters (***<italic>P &lt;</italic> 10<sup>&#x2013;15</sup>) as calculated by a Fisher&#x2019;s exact test. (<bold>G</bold>) The expression of <italic>Mdk</italic> in the single-cell data. PT, proximal tubule; S1, S2, S3, segments of PT; S3-C, cortical section of S3; S3-OS, outer stripe section of S3; TAL, thick ascending limb; DCT, distal convoluted tubule; CNT, connecting tubule; CD, collecting duct; PC, principal cells; IC, intercalated cells; pDC, plasmacytoid DCs; cDC, conventional DCs; Res. M&#x3A6;, resident macrophages; Inf. M&#x3A6;, infiltrating macrophages. Each spot is 55 &#x3BC;m in diameter.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g069"/>
    </fig>
    <fig id="F10" orientation="portrait" position="float">
      <label>Figure 10</label>
      <caption>
        <title>Multiplexed imaging of proteins in toto with CODEX validates the localization of immune cell clusters inferred by spatial transcriptomics.</title>
        <p>CODEX imaging for kidney sections from sham, ischemia/reperfusion injury (IRI), and cecal ligation puncture (CLP) are shown in <bold>A</bold>, <bold>B</bold>, and <bold>C</bold>, respectively. In the left column for all sections, spatial mapping of various immune cells (neutrophils, infiltrating and resident macrophages, B cells, CD4<sup>+</sup> and CD8<sup>+</sup> T cells, NK and IL cells, and DCs) are displayed using colored overlays, and CD31 staining is included for context. The definition of each cell type based on the presence and absence of markers is detailed in <xref ref-type="supplementary-material" rid="sd">Supplemental Figure 8</xref>. The second column shows only CD31 and neutrophils (Neut, red), and the third column displays infiltrating macrophages (Inf Mac, orange). (<bold>D</bold>&#x2013;<bold>F</bold>) show the distribution of neutrophils and infiltrating macrophages in specific regions of the kidney for sham, IRI, and CLP. The cortex, outer stripe of the medulla, inner medulla, and papilla regions were identified based on structural landmarks and annotated using region of interest (ROI) tool in ImageJ. The corresponding spatial transcriptomic signature for neutrophils and infiltrating macrophages is shown on the right side for each specimen.</p>
      </caption>
      <graphic xlink:href="jciinsight-6-147703-g061"/>
    </fig>
  </floats-group>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
      <journal-title-group>
        <journal-title>Nature Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2041-1723</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33469025</article-id>
      <article-id pub-id-type="pmc">7815907</article-id>
      <article-id pub-id-type="publisher-id">20343</article-id>
      <article-id pub-id-type="doi">10.1038/s41467-020-20343-5</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A spatially resolved brain region- and cell type-specific isoform atlas of the postnatal mouse brain</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7818-6867</contrib-id>
          <name>
            <surname>Joglekar</surname>
            <given-names>Anoushka</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Prjibelski</surname>
            <given-names>Andrey</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mahfouz</surname>
            <given-names>Ahmed</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
          <xref ref-type="aff" rid="Aff4">4</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Collier</surname>
            <given-names>Paul</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9344-6594</contrib-id>
          <name>
            <surname>Lin</surname>
            <given-names>Susan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schlusche</surname>
            <given-names>Anna Katharina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8357-5288</contrib-id>
          <name>
            <surname>Marrocco</surname>
            <given-names>Jordan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff8">8</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>Stephen R.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haase</surname>
            <given-names>Bettina</given-names>
          </name>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hayes</surname>
            <given-names>Ashley</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chew</surname>
            <given-names>Jennifer G.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Weisenfeld</surname>
            <given-names>Neil I.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>Man Ying</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stein</surname>
            <given-names>Alexander N.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff12">12</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hardwick</surname>
            <given-names>Simon A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff13">13</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hunt</surname>
            <given-names>Toby</given-names>
          </name>
          <xref ref-type="aff" rid="Aff14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Qi</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dieterich</surname>
            <given-names>Christoph</given-names>
          </name>
          <xref ref-type="aff" rid="Aff15">15</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bent</surname>
            <given-names>Zachary</given-names>
          </name>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fedrigo</surname>
            <given-names>Olivier</given-names>
          </name>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sloan</surname>
            <given-names>Steven A.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff16">16</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Risso</surname>
            <given-names>Davide</given-names>
          </name>
          <xref ref-type="aff" rid="Aff17">17</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jarvis</surname>
            <given-names>Erich D.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff10">10</xref>
          <xref ref-type="aff" rid="Aff18">18</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3897-7955</contrib-id>
          <name>
            <surname>Flicek</surname>
            <given-names>Paul</given-names>
          </name>
          <xref ref-type="aff" rid="Aff14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3752-8266</contrib-id>
          <name>
            <surname>Luo</surname>
            <given-names>Wenjie</given-names>
          </name>
          <xref ref-type="aff" rid="Aff11">11</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2246-0289</contrib-id>
          <name>
            <surname>Pitt</surname>
            <given-names>Geoffrey S.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Frankish</surname>
            <given-names>Adam</given-names>
          </name>
          <xref ref-type="aff" rid="Aff14">14</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Smit</surname>
            <given-names>August B.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff19">19</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6440-8089</contrib-id>
          <name>
            <surname>Ross</surname>
            <given-names>M. Elizabeth</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7058-3606</contrib-id>
          <name>
            <surname>Tilgner</surname>
            <given-names>Hagen U.</given-names>
          </name>
          <address>
            <email>hut2006@med.cornell.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Brain and Mind Research Institute and Center for Neurogenetics, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.15447.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2289 6897</institution-id><institution>Center for Algorithmic Biotechnology, Institute of Translational Biomedicine, </institution><institution>St. Petersburg State University, </institution></institution-wrap>St Petersburg, Russia </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution>Department of Human Genetics, </institution><institution>Leiden University Medical Center, </institution></institution-wrap>Leiden, 2333 ZC The Netherlands </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.10419.3d</institution-id><institution-id institution-id-type="ISNI">0000000089452978</institution-id><institution>Leiden Computational Biology Center, </institution><institution>Leiden University Medical Center, </institution></institution-wrap>Leiden, 2333 ZC The Netherlands </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.5292.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 4740</institution-id><institution>Delft Bioinformatics Lab, </institution><institution>Delft University of Technology, </institution></institution-wrap>Delft, 2628 XE The Netherlands </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Graduate Program in Neuroscience, </institution><institution>Weill Cornell Medical College, </institution></institution-wrap>1300 York Avenue, New York, NY 10065 USA </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Cardiovascular Research Institute, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.134907.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2166 1519</institution-id><institution>Harold and Margaret Milliken Hatch Laboratory of Neuroendocrinology, </institution><institution>The Rockefeller University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.498512.3</institution-id><institution>10x Genomics, </institution></institution-wrap>Pleasanton, CA USA </aff>
        <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.134907.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 2166 1519</institution-id><institution>The Vertebrate Genomes Lab, </institution><institution>The Rockefeller University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Brain and Mind Research Institute and Appel Alzheimer&#x2019;s Research Institute, </institution><institution>Weill Cornell Medicine, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000000419368729</institution-id><institution>School of General Studies, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff>
        <aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="GRID">grid.415306.5</institution-id><institution-id institution-id-type="ISNI">0000 0000 9983 6924</institution-id><institution>Genomics and Epigenetics Division, </institution><institution>Garvan Institute of Medical Research, </institution></institution-wrap>Sydney, NSW Australia </aff>
        <aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="GRID">grid.225360.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 9709 7726</institution-id><institution>European Molecular Biology Laboratory, </institution><institution>European Bioinformatics Institute, </institution></institution-wrap>Hinxton, UK </aff>
        <aff id="Aff15"><label>15</label>Section of Bioinformatics and Systems Cardiology, University Hospital, 96120 Heidelberg, Germany </aff>
        <aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 6502</institution-id><institution>Department of Human Genetics, </institution><institution>Emory University School of Medicine, </institution></institution-wrap>Atlanta, GA USA </aff>
        <aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="GRID">grid.5608.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3470</institution-id><institution>Department of Statistical Sciences, </institution><institution>University of Padova, </institution></institution-wrap>Padova, Italy </aff>
        <aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="GRID">grid.413575.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 1581</institution-id><institution>Howard Hughes Medical Institute, </institution></institution-wrap>Chevy Chase, MD USA </aff>
        <aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="GRID">grid.12380.38</institution-id><institution-id institution-id-type="ISNI">0000 0004 1754 9227</institution-id><institution>Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, </institution><institution>VU University, </institution></institution-wrap>Amsterdam, The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>1</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>1</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>463</elocation-id>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>9</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>11</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2021</copyright-statement>
        <license license-type="OpenAccess">
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Splicing varies across brain regions, but the single-cell resolution of regional variation is unclear. We present a single-cell investigation of differential isoform expression (DIE) between brain regions using single-cell long-read sequencing in mouse hippocampus and prefrontal cortex in 45 cell types at postnatal day 7 (<ext-link ext-link-type="uri" xlink:href="http://www.isoformAtlas.com">www.isoformAtlas.com</ext-link>). Isoform tests for DIE show better performance than exon tests. We detect hundreds of DIE events traceable to cell types, often corresponding to functionally distinct protein isoforms. Mostly, one cell type is responsible for brain-region specific DIE. However, for fewer genes, multiple cell types influence DIE. Thus, regional identity can, although rarely, override cell-type specificity. Cell types indigenous to one anatomic structure display distinctive DIE, e.g. the choroid plexus epithelium manifests distinct transcription-start-site usage. Spatial transcriptomics and long-read sequencing yield a spatially resolved splicing map. Our methods quantify isoform expression with cell-type and spatial resolution and it contributes to further our understanding of how the brain integrates molecular and cellular complexity.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Alternative RNA splicing varies across the brain. Its mapping at single cell resolution is unclear. Here, the authors provide a spatial and single-cell splicing atlas reporting brain region- and cell type-specific expression of different isoforms in the postnatal mouse brain.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Computational neuroscience</kwd>
        <kwd>RNA splicing</kwd>
        <kwd>Transcriptomics</kwd>
        <kwd>Development of the nervous system</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100002261</institution-id>
              <institution>Russian Foundation for Basic Research (RFBR)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>19-04-01074</award-id>
          <principal-award-recipient>
            <name>
              <surname>Prjibelski</surname>
              <given-names>Andrey</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000026</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute on Drug Abuse (NIDA)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>T32DA03980</award-id>
          <award-id>T32DA03980</award-id>
          <principal-award-recipient>
            <name>
              <surname>Lin</surname>
              <given-names>Susan</given-names>
            </name>
            <name>
              <surname>Pitt</surname>
              <given-names>Geoffrey S.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000923</institution-id>
              <institution>Silicon Valley Community Foundation (SVCF)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>CZF2019-002443</award-id>
          <principal-award-recipient>
            <name>
              <surname>Risso</surname>
              <given-names>Davide</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000054</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>2U24CA180996</award-id>
          <principal-award-recipient>
            <name>
              <surname>Risso</surname>
              <given-names>Davide</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100004440</institution-id>
              <institution>Wellcome Trust (Wellcome)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>WT108749/Z/15/Z</award-id>
          <principal-award-recipient>
            <name>
              <surname>Flicek</surname>
              <given-names>Paul</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000051</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | National Human Genome Research Institute (NHGRI)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>2U41HG007234</award-id>
          <principal-award-recipient>
            <name>
              <surname>Flicek</surname>
              <given-names>Paul</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute on Drug Abuse (NIDA)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000025</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Mental Health (NIMH)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01MH118934</award-id>
          <principal-award-recipient>
            <name>
              <surname>Pitt</surname>
              <given-names>Geoffrey S.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par3">Alternative splicing (AS) affects almost all spliced genes in mammals<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>, vastly expands the proteome<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> and increases functional diversity of cell types<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Alternative transcription start sites (TSS) and poly-adenylation (polyA) sites further expand the alternative isoform landscape, regulating development, differentiation, and disease<sup><xref ref-type="bibr" rid="CR5">5</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref></sup>. These RNA variables often depend on each other<sup><xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref></sup>, and how their combined status impacts individual molecules can only be assessed using long-read sequencing<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR14">14</xref>&#x2013;<xref ref-type="bibr" rid="CR17">17</xref></sup>, which sequences transcripts in single reads with no assembly required, thereby reducing alternative transcript assembly errors and enabling accurate isoform quantification.</p>
      <p id="Par4">Brain AS is especially diverse<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> and brain-region specific expression patterns of splicing factors<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> and other RNA-binding proteins<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> drive brain-region-specific splicing. Examples include diseases implicated by genes such as <italic>MAPT, Bin1</italic>, and neurexins<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. Brain-region-specific isoform expression can either originate from molecular regulation in one or multiple cell types, or can arise purely from gene-expression or cell-type abundance differences without splicing regulation. These distinct models are especially important during postnatal development. For instance, in hippocampus (HIPP) and prefrontal cortex (PFC), multiple cell types undergo differentiation, which is influenced by development-specific splicing<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR22">22</xref>&#x2013;<xref ref-type="bibr" rid="CR25">25</xref></sup> distinct from that of mature cell types. However, no cell-type-specific isoform investigation across brain regions exists to-date, owing to limitations in technology, throughput, and testing methods. HIPP and PFC are highly specialized regions of the telencephalon, and their circuitry is heavily implicated in movement control, cognition, learning, and memory formation. Disorders involving HIPP and PFC manifest in cognitive deficits, and understanding changes occurring at crucial developmental timepoints of these structures is important for case&#x2013;control studies. Here, we employ single-cell isoform RNA sequencing (ScISOrSeq)<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> with increased throughput in HIPP and PFC at mouse postnatal day 7 (P7) to test and define cell-type-specific contributions to brain-region-specific splicing. Furthermore, we devised a spatial isoform expression method, which provides a spatial exon expression map (see <ext-link ext-link-type="uri" xlink:href="http://www.isoformAtlas.com">www.isoformAtlas.com</ext-link>) in addition to the existing spatial gene-expression map of the Allen developing brain atlas.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>Short read clustering of P7 hippocampus and prefrontal cortex tissue assigns precursors to known adult cell-types</title>
        <p id="Par5">Our ScISOrSeq approach used barcoded single cells followed by both short and long-read analyses to reveal splice variants specific to cell types (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). We identified cell types first using single-cell 3&#x2032;-end sequencing. Short-read clustering across two hippocampal replicates revealed no need for integration anchors<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> to correct for batch effects (Fig. S<xref rid="MOESM1" ref-type="media">1a</xref>). Characteristic markers<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup> for 24 clusters in HIPP (Fig. S<xref rid="MOESM1" ref-type="media">1b</xref>) identified eight glial types, including two astrocyte, three oligodendrocyte, a radial glia like (RGLs), ciliated ependymal, and secretory choroid plexus epithelial (CPE) cell clusters. Furthermore, we observed six vascular and immune populations including vascular endothelial cells, microglia, and macrophages (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). RNA velocity analysis revealed neuronal lineages in various differentiation stages (Fig. S<xref rid="MOESM1" ref-type="media">1c, d</xref>): a neuronal intermediate progenitor cell (NIPC) population; three dentate gyrus granule neuroblast clusters (DG-GranuleNB); and three clusters each of excitatory (EN) and inhibitory neurons (IN). Alignment of our P7 data with published P30 hippocampal data<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> revealed subtype identities (CA3, CA1, Subiculum) for three excitatory neuron clusters and medial ganglionic eminence (MGE) and non-MGE-derived interneurons<sup><xref ref-type="bibr" rid="CR31">31</xref>&#x2013;<xref ref-type="bibr" rid="CR33">33</xref></sup> (<italic>PV</italic>&#x2009;+, <italic>Sst</italic>&#x2009;+, <italic>Lamp5</italic>&#x2009;+, <italic>Vip</italic>&#x2009;+) in one cluster (IN1), distinct from Cajal&#x2013;Retzius (IN3) cells (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>, Supplementary Fig. <xref rid="MOESM1" ref-type="media">1e&#x2013;g</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Short read clustering of P7 hippocampus and prefrontal cortex tissue recovers precursors to known adult cell-types.</title><p><bold>a</bold> Schematic of the ScISOrSeq workflow (created with BioRender.com). <bold>b</bold> UMAP of P7 hippocampus (HIPP) data. Cell-types identified by marker genes, RNA velocity analysis, and alignment to published data shown in S1. <bold>c</bold> UMAP of P7 prefrontal cortex (PFC) data. Cell-types identified by marker genes, RNA velocity analysis, and alignment to published data shown in S2. <bold>d</bold> In situ hybridization (ISH) images from Allen developing mouse brain atlas for marker genes and corresponding projections on UMAP plots from HIPP and PFC.</p></caption><graphic xlink:href="41467_2020_20343_Fig1_HTML" id="d32e927"/></fig></p>
        <p id="Par6">Similar analysis in PFC revealed seven glial clusters including astrocytes, oligodendrocytes, six populations of vascular and immune cells, and seven neuronal types<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup> with confirmation of intermediate states from RNA velocity (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>, Fig. S<xref rid="MOESM1" ref-type="media">2a&#x2013;d</xref>). Alignment with public P30 cortex data<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> further subdivided neuronal clusters into known cortical excitatory and interneuron classes (Fig. S<xref rid="MOESM1" ref-type="media">2e&#x2013;g</xref>). In contrast to HIPP, the MGE (<italic>PV</italic>&#x2009;+, <italic>Sst</italic>&#x2009;+) and non-MGE interneurons (<italic>Vip</italic>&#x2009;+<italic>, Lamp5</italic>&#x2009;+) in the PFC were better separated into two clusters (IN1, IN2), while Cajal&#x2013;Retzius cells again clustered separately (IN3). We identified excitatory neurons corresponding to different cortical layers which are not well-differentiated at P7. P4 ISH images (Image credit: Allen Institute) alongside gene expression projected onto the UMAP plots further validated our cell-type identification for both regions (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>).</p>
      </sec>
      <sec id="Sec4">
        <title>A gene-wise test to determine differential isoform expression (DIE)</title>
        <p id="Par7">We next conducted long-read sequencing on our single-cell full-length HIPP and PFC cDNA (Supplementary Table&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>), and deconvolved reads for each cell type using single-cell barcodes (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>) for two independent replicates (Fig. S<xref rid="MOESM1" ref-type="media">3</xref>, SS<xref rid="MOESM1" ref-type="media">3</xref>). Differential exon usage between two conditions has been successfully assessed using a 2&#x2009;&#xD7;&#x2009;2 contingency table per exon<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Using this method on our long-read data from HIPP and PFC yielded 31 genes (1.45%, <italic>n</italic>&#x2009;=&#x2009;2132) exhibiting differential exon usage after Benjamini&#x2013;Yekutieli (BY) correction<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> for dependent tests (Fig. S<xref rid="MOESM1" ref-type="media">5a</xref>). Given this harsh correction, we devised a more sensitive gene-level test that considers TSS and polyA-sites in addition to exon connectivity. In this test, we count isoforms per gene in both conditions, leading to a n&#x2009;x&#x2009;2 table. This yields fewer and independent tests, allowing for the Benjamini&#x2013;Hochberg (BH) correction<sup><xref ref-type="bibr" rid="CR36">36</xref></sup> and reducing false negatives. In each brain region, we define &#x201C;percent isoform&#x201D; (&#x3A0;) as an isoform&#x2019;s relative abundance among its gene&#x2019;s transcripts. Similarly to requiring a &#x394;<italic>&#x3A8;</italic>&#x2009;&#x2265;&#x2009;0.1 for short reads<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>, we require FDR&#x2009;&lt;&#x2009;=&#x2009;0.05 and &#x394;&#x3A0;&#x2009;&#x2265;&#x2009;0.1. This &#x394;&#x3A0;&#x2009;&#x2265;&#x2009;0.1 can be contributed collectively by at most two isoforms, provided their isoform &#x394;&#x3A0; point in the same direction, to consider a gene exhibiting differential isoform expression (DIE, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>A gene-wise test for differential isoform expression (DIE) is more sensitive than an exon-wise test at detecting splicing changes.</title><p><bold>a</bold> Schematic of the scisorseqR approach&#x2014;Barcode deconvolution, filtering, pairwise comparison, and reporting of significant results based on FDR and &#x394;&#x3A0; cutoffs (created with BioRender.com). <bold>b</bold> Volcano plot of bulk HIPP vs. bulk PFC differential abundance analysis, with the effect size (&#x394;&#x3A0;) on the <italic>X</italic>-axis. <italic>P</italic>-values derived from a <italic>&#x3C7;</italic><sup>2</sup> test and corrected for multiple testing using the Benjamini&#x2013;Hochberg correction are plotted on the <italic>Y</italic>-axis. Points are colored according to the levels of significance based on FDR and &#x394;&#x3A0; value. Genes considered significant (pink) when FDR&#x2009;&#x2264;&#x2009;0.05 and |&#x394;&#x3A0;|&#x2009;&#x2265;&#x2009;0.1. <bold>c</bold> Scatter plot showing the &#x394;<italic>&#x3A8;</italic> of all exons for genes that show significant DIE between HIPP and PFC. Gray points represent non-significant exons. Points are colored according to the cell-type in which an exon is considered significant by a BY corrected <italic>p</italic>-value and a &#x394;&#x3A0;&#x2009;&#x2265;&#x2009;0.1. Diagonal lines indicate cutoff of 0.1 &#x394;<italic>&#x3A8;</italic>. <bold>d</bold> Venn diagram showing the overlap of genes significant by DIE (BH correction) with genes significant by exon tests (BY correction). <bold>e</bold> Boxplot showing the maximum absolute value of &#x394;<italic>&#x3A8;</italic> per gene in three different categories: genes that are not significant by DIE tests (<italic>n</italic>&#x2009;=&#x2009;1395), genes that are significant by DIE tests and also exhibit differential TSS or polyA-site usage (<italic>n</italic>&#x2009;=&#x2009;38), and genes that are significant by DIE and do not exhibit differential TSS or polyA-site usage (<italic>n</italic>&#x2009;=&#x2009;128). <italic>P</italic>-values were calculated using a two-sided Wilcoxon rank sum test. Data are represented as boxplots where the middle line is the median, the lower and upper hinges correspond to the first and third quartiles, the upper whisker extends from the hinge to the largest value no further than 1.5&#xD7; IQR from the hinge (where IQR is the inter-quartile range) and the lower whisker extends from the hinge to the smallest value at most 1.5&#xD7; IQR of the hinge. Please see function geom_boxplot in R (ggplot2). <bold>f</bold> Percentage of novel transcripts by scisorseqR that were manually validated as being novel by Gencode team, and breakdown of predicted function. <bold>g</bold> Heatmap of significant DIE genes (<italic>n</italic>&#x2009;=&#x2009;395, BH correction) according to entire isoform between bulk HIPP and bulk PFC that also exhibit differential usage of transcription start site (TSS) and polyA-site (PolyA). Each row is a single gene. Gray represents genes that are non-significant by category (Iso/TSS/PolyA) whereas purple represents significant by category. <bold>h</bold> Isoform expression of Nsfl1c gene. Each horizontal line in the plot represents a single transcript colored according to the cell-type it is represented in. Therefore, blocks represent exons and whitespace represents intronic space (not drawn to scale). Orange exon represents alternative inclusion. <bold>i</bold> Isoform expression for the Nsmf gene. Each row represents an isoform colored by &#x3A0; and each column represents a cell-type in HIPP or PFC.</p></caption><graphic xlink:href="41467_2020_20343_Fig2_HTML" id="d32e1093"/></fig></p>
        <p id="Par8">In contrast to the 31 significant genes derived by the exon-based test, 395 genes (FDR&#x2009;&lt;=&#x2009;0.05, &#x394;&#x3A0;&#x2009;&#x2265;&#x2009;0.1; 9.06%; <italic>n</italic>&#x2009;=&#x2009;3958) exhibited DIE when comparing HIPP and PFC isoforms using the gene-level test (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). The multiple testing correction factor influenced the significant gene number. For example, the <italic>H13</italic> gene (Fig. S5b) had a <italic>p</italic>-value of 1.7&#x2009;&#xD7;&#x2009;10<sup>&#x2212;4</sup> (uncorrected) and 2.7&#x2009;&#xD7;&#x2009;10<sup>&#x2212;3</sup> (corrected) by isoform tests, with a Benjamini&#x2013;Hochberg correction factor of 15.6. The same gene&#x2019;s alternative exon had a <italic>p</italic>-value of 1.3&#x2009;&#xD7;&#x2009;10<sup>&#x2212;4</sup> (uncorrected) and 0.057 (corrected, non-significant) by exon tests with a Bejamini&#x2013;Yekutieli correction factor of 431.3. Thus, gene-wise isoform testing is more sensitive (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c, d</xref>). Concordantly, the maximum &#x394;<italic>&#x3A8;</italic> for genes with DIE is higher than genes without DIE (<italic>p</italic>&#x2009;&#x2264;&#x2009;0.015, Wilcoxon-rank-sum test) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2e</xref>).</p>
        <p id="Par9">Since our gene-level test considers exon connectivity, we can identify the exact isoforms contributing to DIE. Among the top two contributing isoforms for each of the 395 genes exhibiting regional DIE, we identified 76 high-confidence novel isoforms (Methods). Manual validation using GENCODE criteria confirmed all 76. Functionally, 40 (52.6%) are coding transcripts, 24 (31.6%) show nonsense mediated decay (NMD), 11 (14.5%) show intron retention, and one isoform is of a long noncoding gene (<italic>Meg3)</italic> (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2f</xref>). Such non-coding and NMD transcripts indicate region-specific regulation<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. To pinpoint the source of isoform differences in the 395 genes, we tested TSS and polyA-site abundance per gene across brain regions, which follow the same statistical framework as the isoform tests. 141 (of 395) genes exhibited differential TSS or polyA-site usage (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2g</xref>). By extension, the remaining 254 genes are explained by splice-site usage differences.</p>
        <p id="Par10">Many genes with DIE have &#x394;&#x3A0;&#x2009;&#x2264;&#x2009;0.5; however, we also identified drastic switches (&#x394;&#x3A0;&#x2009;&#x2265;&#x2009;0.5): <italic>Nsfl1c</italic> encodes the Nsfl1 cofactor p47, which regulates tubular ER formation, influences neuronal dendritic spine formation, and dendritic arborization<sup><xref ref-type="bibr" rid="CR37">37</xref>,<xref ref-type="bibr" rid="CR38">38</xref></sup>. A 6nt microexon is preferentially included in HIPP across neuronal and glial cell types but is absent in the same PFC cell types (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2h</xref>). The synaptic gene <italic>Nsmf</italic> is involved in the cAMP pathway<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup> and through nuclear translocation of its protein, in memory formation<sup><xref ref-type="bibr" rid="CR39">39</xref>,<xref ref-type="bibr" rid="CR40">40</xref></sup>. In our data, the major HIPP isoform is absent in PFC, while the second HIPP isoform represents the majority of that gene&#x2019;s PFC expression. The isoforms differ by a 69nt exon with a nuclear localization signal and one of two synaptic targeting elements. Hence, this exon may affect the synapse to nucleus signaling that the protein is involved in. A third <italic>Nsmf</italic> isoform with the 69nt exon but lacking a 6nt micro-exon is favored in PFC over HIPP but completely missing from neuronal cells, highlighting the regulatory role of micro-exons in neuronal function<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup> (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2i</xref>).</p>
      </sec>
      <sec id="Sec5">
        <title>Differential isoform expression across brain regions is governed predominantly by one specific cell type</title>
        <p id="Par11">Gene expression transcript similarities among clusters defined a cell-type hierarchy, first separated by neurons and non-neurons, and then by other cell types (Fig. S<xref rid="MOESM1" ref-type="media">6</xref>). Since inhibitory neuron types are transcriptionally more similar to each other than to excitatory types<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>, we grouped finer inhibitory neuron subtypes (IN1, IN2, IN3) into a composite inhibitory neuron (IN) category, and excitatory neuron subtypes into an excitatory neuron (EN) category. We hypothesized three alternative models that could underlie differential isoform expression between brain regions: 1) multiple or all cell types change splice variants (&#x2018;Both-Cell-Types-Model&#x2019;); 2) a single cell type changes splice variants (&#x2018;Single-Cell-Type-Model&#x2019;); or 3) changes in expression or cell-type abundance without any change in splice variants (&#x2018;No-Cell-Type-Model&#x2019;) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Three models of alternative splicing followed by differentially spliced genes across brain regions.</title><p><bold>a</bold> Schematic of three models that explain splicing changes between any two categories (e.g., HIPP neurons versus PFC neurons). <bold>b</bold> Upset plot of DIE genes in bulk, neuron, and non-neuron. <bold>c</bold> Five gene&#x2009;&#xD7;&#x2009;celltype heatmaps clustered by the ratio of &#x394;&#x3A0; of an individual cell-subtype to a parent cell-type i.e., value for Neuron&#x2009;=&#x2009;&#x394;&#x3A0;<sub>Neuron</sub>/&#x394;&#x3A0;<sub>Bulk</sub>. Each vertical line indicates the ratio of &#x394;&#x3A0; for a single gene. Gray lines indicate lack of sufficient depth or lack of expression. Clusters of genes are colored by whether both cell-types show similar relative &#x394;&#x3A0; to the parent (purple, Model I, Model III) or whether one cell-type explains most of the splicing changes (Model II). <bold>d</bold>
<italic>Hexa</italic> gene representing an example of Model II. Each horizontal line in the plot represents a single transcript colored according to the cell-type it is represented in. Therefore, blocks represent exons and whitespace represents intronic space (not drawn to scale). Orange exon represents alternative inclusion. <bold>e</bold> Barplots indicating percent of genes with |&#x394;&#x3A0;|&#x2009;&#x2265;&#x2009;0.1 for two concurrently assessed cell-types. Pink bar indicates expected levels assuming independence, while blue bars represent observed levels (<italic>n</italic>&#x2009;=&#x2009;2351,1320,785). Error bars indicate 95% confidence interval of proportion. <italic>P</italic>-values calculated using Fisher&#x2019;s two-sided exact test.</p></caption><graphic xlink:href="41467_2020_20343_Fig3_HTML" id="d32e1253"/></fig></p>
        <p id="Par12">We analyzed neuronal and non-neuronal reads separately and cross-referenced the results of the 395 genes with DIE. 26 genes (6.6%, FDR&#x2009;&lt;&#x2009;=&#x2009;0.05) had DIE in neurons and non-neurons under the Both-Cell-Types-Model, 151 (38.2%) in neurons only and 81 (20.5%) in non-neurons only under a Single-Cell-Type-Model, and 137 (34.7%) that were either too low in expression for testing (Methods) in both neuronal and non-neuronal cells or followed the No-Cell-Type-Model (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>). To distinguish these two explanations for the 137 genes, we considered genes with &#x394;&#x3A0;&#x2009;&#x2265;&#x2009;0.1 irrespective of <italic>p</italic>-values for the 395 genes. Specifically, we calculated the ratio of &#x394;&#x3A0; in a finer subtype to the &#x394;&#x3A0; in the composite cell type. After dividing all cells (composite) into neurons and non-neurons (finer level), 75% (&#xB1;2.3, SE<sub>p</sub>) of bulk DIE events were traced to only neurons or only non-neurons (Single-Cell-Type-Model, green) and 24.4% to both (Both-Cell-Types-Model, light purple, Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3ci</xref>). A single gene followed the No-Cell-Type-Model (0.3%, dark purple). Similarly, when dividing neurons into excitatory and inhibitory subtypes, we found 78.8% (&#xB1;2.97) for the Single-Cell-Type-Model, 19.58% for Both-Cell-Types-Model, and 1% for No-Cell-Type-Model (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3cii</xref>). When separating composite non-neuronal cells into glia and vascular&#x2009;+&#x2009;immune cells, and again when separating glia into astrocytes and oligodendrocytes, and then the vascular&#x2009;+&#x2009;immune cluster into vascular and immune cells, we observe similar trends. The Single-Cell-Type-Model was more prevalent than the Both-Cell-Types and No-Cell-Type Models (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref>). These observations were replicated in replicate 2, despite differences in cell-type proportions between replicates (Fig. S<xref rid="MOESM1" ref-type="media">7a&#x2013;c</xref>). In summary, the No-Cell-Type-Model is rare, representing 0.3&#x2013;3.28% for the different cell group divisions. Extending this observation to the 137 genes above (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>), one gene (0.3% of 395) likely represents the No-Cell-Type-Model whereas the other 136 can be attributed to low read depth.</p>
        <p id="Par13">An example of the dominant Single-Cell-Type-Model is Hexosaminidase A (<italic>Hexa</italic>), which is implicated in Tay-Sach&#x2019;s disease<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. In addition to a single annotated isoform, PFC excitatory neurons show significantly diminished inclusion of an internal exon (from 81% inclusion in HIPP to 22%), thus expressing a novel isoform. Other cell types show no difference between HIPP and PFC. Manual validation classified this novel isoform as NMD, indicating brain-region and cell-type-specific NMD (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3d</xref>).</p>
      </sec>
      <sec id="Sec6">
        <title>Brain regions can override cell-type specificity for a subset of genes, possibly through microenvironmental influence</title>
        <p id="Par14">Despite the prevalence of the Single-Cell-Type-Model, the Both-Cell-Types-Model is still common. To avoid circular reasoning, we considered all genes sufficiently expressed (Methods) in neurons and non-neurons in both brain regions. Concurrent regional DIE differences (&#x394;&#x3A0;&#x2009;&#x2265;&#x2009;0.1) in both neurons and non-neurons occur more often than expected by chance (<inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{{{\mathrm{observed}}}}{{{\mathrm{expected}}}} = \frac{{23.9\% }}{{15.6\% }} = 1.5,p \le 2.2e^{ - 16}$$\end{document}</tex-math><mml:math id="M2"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">observed</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">expected</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mn>23.9</mml:mn><mml:mi>%</mml:mi></mml:mrow><mml:mrow><mml:mn>15.6</mml:mn><mml:mi>%</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn><mml:mo>,</mml:mo><mml:mi>p</mml:mi><mml:mo>&#x2264;</mml:mo><mml:mn>2.2</mml:mn><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mn>16</mml:mn></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="41467_2020_20343_Article_IEq1.gif"/></alternatives></inline-formula>, Fisher&#x2019;s two-sided exact test). This trend is also conserved in excitatory and inhibitory neurons (<italic>p</italic>&#x2009;&#x2264;&#x2009;2.2<italic>e</italic><sup>&#x2212;16</sup>) as well as in glia and vascular&#x2009;+&#x2009;immune cells (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3e</xref>). Not only do we see concurrence in Rep1, but we find that the observation is conserved in all investigated levels across both replicates considered together (Fig. S<xref rid="MOESM1" ref-type="media">7d</xref>). Two non-mutually exclusive models may underlie this observation&#x2014;microenvironment and cell origin. Firstly, HIPP and PFC interneurons originate in the ganglionic eminences<sup><xref ref-type="bibr" rid="CR31">31</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>, while excitatory neurons do not. Thus, splicing similarities between HIPP EN and IN that are different from PFC EN and IN might be imposed by the regional microenvironment. Secondly, considering neurons and glia, their common descendance from radial glial stem cells may underlie cases of brain-region-specific regulation that overrides cell-type specificity.</p>
      </sec>
      <sec id="Sec7">
        <title>Cell types endogenous to one brain region have distinct splicing signatures</title>
        <p id="Par15">We traced the contribution of individual cell types to bulk DIE. Region-specific DIE was clearly traceable (<inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{{\Delta \pi _{{\mathrm{cell - type}}}}}{{\Delta \pi _{{\mathrm{Bulk}}}}} \ge 0.9$$\end{document}</tex-math><mml:math id="M4"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">&#x394;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x3C0;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">cell-type</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x394;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x3C0;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Bulk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>&#x2265;</mml:mo><mml:mn>0.9</mml:mn></mml:math><inline-graphic xlink:href="41467_2020_20343_Article_IEq2.gif"/></alternatives></inline-formula>) in 73.4% (<italic>n</italic>&#x2009;=&#x2009;395) of the cases, while 10.4% had <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{{\Delta \pi _{{\mathrm{cell - type}}}}}{{\Delta \pi _{{\mathrm{Bulk}}}}} \le 0.9$$\end{document}</tex-math><mml:math id="M6"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">&#x394;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x3C0;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">cell-type</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x394;</mml:mi><mml:msub><mml:mrow><mml:mi>&#x3C0;</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Bulk</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>&#x2264;</mml:mo><mml:mn>0.9</mml:mn></mml:math><inline-graphic xlink:href="41467_2020_20343_Article_IEq3.gif"/></alternatives></inline-formula> in all cell types (Fig. S<xref rid="MOESM1" ref-type="media">7e, f</xref>). The remaining 16.2% had low read counts in all cell types. Some genes truly have a regional component i.e., concurrent changes across multiple cell types (Fig. S<xref rid="MOESM1" ref-type="media">7f</xref>). The low depth and &#x394;&#x3A0; ratio could arise from cell types only present in HIPP but not PFC. Indeed, reads originating from granule NB, RGL, ependymal, and CPE clusters have a higher ratio in the 26.4% of genes for which DIE was not explained (gray) than in the genes where DIE was explained (yellow) (Fig. S<xref rid="MOESM1" ref-type="media">7g</xref>). For example, for the <italic>Fxyd1</italic> gene, CPE cells in HIPP had a different splicing signature from astrocytes in HIPP and PFC, leading to regional DIE (Fig. S<xref rid="MOESM1" ref-type="media">7h</xref>). These observations warrant further exploration of each cell type&#x2019;s splicing signatures.</p>
      </sec>
      <sec id="Sec8">
        <title>Choroid plexus epithelial cells (CPEs) generate distinct isoforms predominantly through alternative TSS</title>
        <p id="Par16">We performed DIE tests in pairwise comparisons of HIPP cell types. DIE was most frequent for neuron vs. non-neuron comparisons in HIPP (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a</xref>), and this was confirmed in PFC (Fig. S<xref rid="MOESM1" ref-type="media">8</xref>). High percentages were also seen in some comparisons between non-neuronal cell types. Interestingly, comparisons between non-neuronal cell types showed higher DIE than those observed within neurons (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4b</xref>). Importantly, non-neuronal comparisons involving CPEs clearly had the highest DIE fractions. CPEs are cerebrospinal fluid secreting ependymal cells in cerebral ventricles, and alternative splicing in CPEs relates to disease<sup><xref ref-type="bibr" rid="CR9">9</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup> (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4c</xref>). Surprisingly, TSS choice (compared to exons and polyA-sites) largely explained the isoform regulation of CPE cells (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4d</xref>). Furthermore, CPE-associated transcripts strongly favored an upstream TSS compared to the non-CPE transcripts (70/93 genes, Bernoulli <italic>p</italic>&#x2009;=&#x2009;3&#x2009;&#xD7;&#x2009;10<sup>&#x2212;7</sup>). This can allow for CPE-specific post-transcriptional modifications<sup><xref ref-type="bibr" rid="CR44">44</xref></sup>, translation initiation, and transcription factor control of gene expression (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4e</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Choroid plexus epithelial cells (CPEs) generate distinct isoforms predominantly through alternative TSS.</title><p><bold>a</bold> Triangular heatmap representing percentage of significant DIE in pairwise comparisons at two levels of granularity. At the broad level: pairwise comparisons of neurons, non-neurons, immune cells, and vascular cells. Zooming in, at the narrow level: neuronal and non-neuronal categories are broken up into their constitutive cell-subtypes. <bold>b</bold> Density plot of percentage of significant DIE in pairwise comparisons from 4A, broken down by two categories: within neurons and within non-neurons. <bold>c</bold> Density plot showing DIE within non-neurons (pink region, Fig. 4b) broken up further by comparisons that either include (purple) or exclude (orange) choroid plexus epithelial (CPE) cells. <bold>d</bold> Boxplots of percentage significant genes in non-neuronal comparisons including and excluding the CPE, broken down by part of the transcript (TSS/splice-site/PolyA) responsible for splicing changes. <italic>X</italic>-axis indicates the part of the transcript assessed. <italic>P</italic>-values were calculated using a two-sided Wilcoxon rank sum test (***<italic>p</italic>&#x2009;&lt;&#x2009;10<sup>&#x2212;15</sup>, **<italic>p</italic>&#x2009;&lt;&#x2009;0.001, *<italic>p</italic>&#x2009;&lt;&#x2009;0.05). Data are represented as boxplots where the middle line is the median, the lower and upper hinges correspond to the first and third quartiles, the upper whisker extends from the hinge to the largest value no further than 1.5&#x2009;&#xD7;&#x2009;IQR from the hinge (where IQR is the inter-quartile range) and the lower whisker extends from the hinge to the smallest value at most 1.5&#x2009;&#xD7;&#x2009;IQR of the hinge. Please see function geom_boxplot in R (ggplot2). <bold>e</bold> Barplot showing the percentage of genes (n-90) for which the CPE transcripts are either upstream or downstream of non-CPE transcripts. <bold>f</bold> Percent inclusion (&#x3A0;) of two <italic>Nnat</italic> isoforms across three cell-types: ependymal cells, excitatory neurons, and granule neuroblasts i. Violin plots of &#x3A0; values of each isoform per single cell ii. &#x3A0; values per isoform across all single cells.</p></caption><graphic xlink:href="41467_2020_20343_Fig4_HTML" id="d32e1550"/></fig></p>
      </sec>
      <sec id="Sec9">
        <title>Single-cell basis of DIE between cell types</title>
        <p id="Par17">When DIE is observed between two cell types, two competing hypotheses can explain this phenomenon<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Either all cells of each cell-type behave uniformly and reflect the differences in isoform expression between the two cell types, or individual cells of one or both cell types could show variability in isoform expression. Neuronatin (<italic>Nnat</italic>) is an important developmental gene expressing a neuron-specific isoform. In <italic>Nnat</italic>, DIE between ependymal cells and excitatory neurons is represented by the vast majority of individual cells. However, the case of DIE between excitatory neurons and granule neuroblasts is different: some granule neuroblasts behave like excitatory neurons, while others behave like non-neurons. This may be due to different sub-populations of granule neuroblasts (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4f</xref>).</p>
      </sec>
      <sec id="Sec10">
        <title>Clustering on long-read data recapitulates short-read cell-type assignments</title>
        <p id="Par18">We clustered hippocampal cells using their isoform expression similarities. Compared to 3&#x2032;seq clustering, glial, immune, and vascular clusters were similarly defined (Figs. S<xref rid="MOESM1" ref-type="media">9a, b</xref> and <xref rid="Fig4" ref-type="fig">4a</xref>). Jaccard similarity index analysis between short-read and long-read clusters showed high concordance for broad-level classification (Fig. S<xref rid="MOESM1" ref-type="media">9c</xref>). Additionally, isoforms of some genes are better resolved with long reads than with than 3&#x2032;-expression short reads, including for distinguishing neurons and non-neurons (e.g., <italic>Pkm, Clta, H3f3b)</italic>, or mature and immature neurons (e.g., <italic>Cdc42</italic>, <italic>Srsf3</italic>, <italic>Thra</italic>, Fig. S<xref rid="MOESM1" ref-type="media">9d</xref>). However, despite striking differences in isoform expression within neuronal subtypes, differences between isoform-derived clusters and short-read derived clusters remained. Long-read clustering successfully separated CA1 from CA3 neurons (i.e., short-read EN1 vs EN2) but did not separate all cells of the more immature IN2 cluster from mature granule neuroblasts i.e., GranuleNB-2 (Fig. S<xref rid="MOESM1" ref-type="media">9e, f</xref>). Such differences could be explained by cell subtype specificity in isoforms only, or reduced sequencing depth of isoforms.</p>
      </sec>
      <sec id="Sec11">
        <title>Relative isoform expression differences during development reflect dynamic changes in function</title>
        <p id="Par19">Using Slingshot<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> on a subset of hippocampal cells, we recovered the radial-glia-like (RGL) to excitatory-neuron developmental lineage. From RGLs to NIPCs only 5.1% of tested genes showed DIE (<italic>n</italic>&#x2009;=&#x2009;73; 95% CI&#x2009;=&#x2009;[4.03,6.34]). However, threefold more did so from NIPCs to GranuleNB (<italic>n</italic>&#x2009;=&#x2009;359, 95% CI&#x2009;=&#x2009;[15.81,19.10]) and then from GranuleNB to excitatory neurons (<italic>n</italic>&#x2009;=&#x2009;423, 95% CI&#x2009;=&#x2009;[14.72,17.54]) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>). Gene ontology (GO) analysis<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup> revealed isoform changes in the splicing machinery itself in earlier steps, i.e., from RGL to NIPCs (for <italic>Hnrnpa2b1, Snrnp70, Srsf2, Srsf5, Srsf6, Srsf7, Rbm3</italic>; Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5b</xref>). However, as granule neuroblasts matured to excitatory neurons, DIE was associated with synapse formation and axon elongation (<italic>Snap25, Snca, Syp, Dbn1, Cdc42, Nptn, Gap43</italic>) among others (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5c, d</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><title>Relative isoform expression differences during development reflect dynamic changes in function.</title><p><bold>a</bold> Splicing changes seen at every transition step of neuronal differentiation trajectory. Pie chart indicates the number of isoforms needed to be considered in order to reach the |&#x394;&#x3A0;|&#x2009;&#x2265;&#x2009;0.1 threshold for a gene to be considered significantly DIE. <bold>b</bold> Treemap of condensed gene ontology (GO) terms for the transition from RGL to NIPCs in the neuronal differentiation trajectory, with size of boxes corresponding to number of significant terms associated with the GO category. <bold>c</bold> Treemap of condensed GO terms for the transition from NIPCs to GranuleNB (GNB1, GNB2, GNB3). <bold>d</bold> Treemap of condensed GO terms for the transition from NIPCs to Excitatory Neurons (EN1, EN2, EN3). <bold>e</bold> Hippocampal cell-type specific isoform expression in <italic>Camk2b</italic> gene. Each horizontal line in the plot represents a single transcript colored according to the cell-type it is represented in. Orange exons represent alternative inclusion, red extension of exon 11 represents a 3nt addition. <bold>f</bold> &#x3A0; value of the S and VY isoforms for <italic>Fgf13</italic> gene across hippocampal neuronal cell types. <bold>g</bold> Basescope (in situ hybridization) images (<italic>N</italic>&#x2009;=&#x2009;1, repeated for 2 technical replicates). Data showing <italic>Fgf13</italic>-S and <italic>Fgf13</italic>-VY isoform expression (pink stain) in the hippocampus, with simultaneous staining for excitatory neurons (<italic>Neurod6</italic>&#x2014;green) and inhibitory neurons (<italic>Gad2</italic> - green). Scale bar, 1&#x2009;mm. Each plot features enlargements of the dentate gyrus for the S isoform, and CA1 region for the VY isoform with arrows indicating co-localization while circles indicate lack of co-localization. Scale bar, 200&#x2009;&#x3BC;m. <bold>h</bold> Representative images of subcellular localization of overexpressed GFP-tagged Fgf13-S isoform in nucleolus and GFP-tagged Fgf13-VY isoform in cytoplasm. (<italic>N</italic>&#x2009;=&#x2009;3, 20&#x2013;30 GFP&#x2009;+&#x2009;neurons examined per transfection). Scale bar, 30&#x2009;&#x3BC;m.</p></caption><graphic xlink:href="41467_2020_20343_Fig5_HTML" id="d32e1702"/></fig></p>
        <p id="Par20">Importantly, many exon inclusion levels are altered in the transition from dentate gyrus (DG) granuleNB to more mature EN in CA1 and CA3. The synaptic Calcium/Calmodulin-dependent protein kinase II Beta (<italic>Camk2b</italic>) has enzymatic and structural roles in neuronal plasticity<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Embryonic <italic>Camk2b</italic> exploits a 3nt addition to exon 11 and exon-12 exclusion, translating an Alanine instead of Valine<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. The embryonic form (red exon-11 extension, exon-12 exclusion, Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5e</xref>) dominates in more immature granuleNB2 compared to granuleNB1. However, this isoform persists infrequently in mature neuronal types (EN1, EN2, and IN1) indicating cell-type specificity during developmental regulation. Moreover, the additional 3 nucleotides (red in exon 11) co-occur with exon 12, which has not been reported. Also, the first alternative exon (exon 9) increases inclusion as cells differentiate. Furthermore, exon 9 coordination with exon 12 defines cell-subtype differences between EN and IN. All three splicing events occur in the actin binding domain of the CaMKII&#x3B2; structure and encode several confirmed phosphorylation sites<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. Thus, exon coordination among distinct cell types could indicate cell-type-specific morphological changes in the actin cytoskeleton, for instance in spine dynamics<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5e</xref>).</p>
        <p id="Par21">For the post-synaptic <italic>Dlgap4</italic> linked to neuropsychiatric disorders<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> non-neurons and immature neurons predominantly express one exon. However, during neuronal maturation, exon inclusion switches to both exons (Fig. S<xref rid="MOESM1" ref-type="media">10a, b</xref>). For <italic>Nptn</italic>, a gene involved in long-term potentiation, glia and immature neurons predominantly express a single 9nt micro-exon. Mature neurons employ an upstream acceptor, adding four amino acids encoding the cytoplasmic domain, likely relevant for protein&#x2013;protein interactions<sup><xref ref-type="bibr" rid="CR53">53</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup> (Fig S<xref rid="MOESM1" ref-type="media">10b</xref>).</p>
      </sec>
      <sec id="Sec12">
        <title>Hippocampus enriched developmental gene Fibroblast growth factor 13 (<italic>Fgf13)</italic> shows neuronal subtype-specific TSS</title>
        <p id="Par22"><italic>Fgf13</italic> exhibited high DIE (&#x394;&#x3A0;&#x2009;&gt;&#x2009;0.5) across multiple neuronal cell-type and subtype comparisons. <italic>Fgf13</italic> reaches peak expression, specifically in HIPP, at our investigated time point (P7)<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. <italic>Fgf13</italic> is a neuronal developmentally regulated gene and lethal when knocked-out<sup><xref ref-type="bibr" rid="CR56">56</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. A member of the fibroblast growth factor (FGF) superfamily, <italic>Fgf13</italic> is one of four FGF family members (<italic>Fgf11-14</italic>) labeled fibroblast growth factor homologous factors, which&#x2014;unlike most FGFs&#x2014;do not have signal sequences, are not secreted, and function intracellularly<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. Among its intracellular roles are regulation of voltage-gated sodium channels<sup><xref ref-type="bibr" rid="CR59">59</xref>&#x2013;<xref ref-type="bibr" rid="CR61">61</xref></sup>, rRNA transcription<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, and microtubule stabilization<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. Of the various <italic>Fgf13</italic> isoforms<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>, two isoforms with distinct TSS dominate during brain development<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR64">64</xref></sup>. We find that <italic>Fgf13</italic> is particularly alternatively spliced between excitatory and inhibitory neurons (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5f</xref>). The downstream-TSS isoform, Fgf13-S, is the major HIPP isoform across all excitatory types, and immature inhibitory types. Conversely, the upstream-TSS isoform, Fgf13-VY, is partially seen in DG neuroblasts and dominates in inhibitory interneuron classes. This was confirmed using Basescope analysis with probes designed for excitatory and inhibitory neuron marker genes, and separate probes for the S and VY isoforms. We find that the S isoform (pink) co-localizes with excitatory neurons (green, <italic>Neurod6</italic>) and not inhibitory neurons (green, <italic>Gad2</italic>), whereas the VY isoform (pink) co-localizes with the inhibitory neurons but not the excitatory neurons (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5g</xref>, Methods). The isoforms also differ in subcellular localization: reflecting its role in regulating ribosomal biogenesis<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>, Fgf13-S is primarily localized to the nucleolus, whereas Fgf13-VY is present throughout the cytoplasm, consistent with its known role in regulating voltage-gated sodium channels<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5h</xref>).</p>
      </sec>
      <sec id="Sec13">
        <title>Synaptic genes associated with vesicle transport show splicing differences in developing hippocampal neurons</title>
        <p id="Par23">Many synaptic genes have low expression in developing HIPP. However, sufficiently expressed (&gt;50 reads) genes&#x2019; isoforms distinguish neuronal subtypes. Two mutually exclusive exons define two isoforms (Snap25-a, Snap25-b) for Snap25, involved in endocytosis. Concordant with the literature<sup><xref ref-type="bibr" rid="CR65">65</xref>&#x2013;<xref ref-type="bibr" rid="CR67">67</xref></sup>, our CA3 excitatory neurons (EN3) have a higher proportion of Snap25-b transcripts than in CA1 and subiculum (EN1, EN2). However, our GranuleNBs have higher abundance of Snap25-a whereas mature excitatory neurons switch to Snap25-b. Interestingly, interneuron precursors and Cajal&#x2013;Retzius cells (IN1,IN3) rely more on Snap25b than their excitatory counterparts, and thereby seem to rely more heavily on larger primed vesicle pools<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> (Fig. S<xref rid="MOESM1" ref-type="media">11b</xref>). Alternatively, interneurons could switch from Snap25-a to Snap25-b before excitatory neuron development.</p>
        <p id="Par24">We also observe synaptic genes with key splicing differences between neurons and non-neurons. Clathrin light chain A and B (<italic>Clta</italic>, <italic>Cltb</italic>) work alongside <italic>Epsin1</italic> in vesicle-mediated endocytosis<sup><xref ref-type="bibr" rid="CR69">69</xref></sup>. For all three genes, exon inclusion distinguishes neurons from non-neurons and granuleNB from mature EN. For <italic>Clta</italic>, an additional exon distinguishes neuronal subtypes (Fig S<xref rid="MOESM1" ref-type="media">12a, b</xref>). The neuronal specific insertions in the clathrin light chain may influence the association with the slow axonal transport of clathrin<sup><xref ref-type="bibr" rid="CR70">70</xref></sup>.</p>
      </sec>
      <sec id="Sec14">
        <title>Slide isoform sequencing (sliso-Seq) to delineate spatial localization of splicing changes</title>
        <p id="Par25">To ground our observations in a spatial sense, we generated 10X Genomics Visium spatial transcriptomics data from a P8 sagittal section. Alignment with single-cell short-read HIPP data confirmed the spatial localization of excitatory neurons in the CA regions and subiculum (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6a</xref>), and alignment with the PFC data confirmed the excitatory precursors in distinct cortical layers (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6b</xref>). We then devised a long-read sequencing approach for spatial transcriptomics (Methods). To validate regional specificity of isoform expression using orthogonal techniques, we correlated &#x394;<italic>&#x3A8;</italic> values between composite HIPP and composite PFC single-cell data with &#x394;<italic>&#x3A8;</italic> values of hippocampus vs. cortex using long-read sequencing. Based on single-cell data, we focused on 40 exons with region-specific splicing patterns and without alternative acceptors/donors (Methods). Overall, we found strong concordance: for 85%, both single-cell and spatial HIPP vs. PFC splicing differences point in the same direction (Bernoulli probability&#x2009;&lt;&#x2009;=&#x2009;3.5e-06) (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6c</xref>). Additionally, we confirmed neurodevelopmental exon inclusion switches in <italic>Pkm</italic> and <italic>Clta</italic>, where the non-neuronal and developmental exons from the single-cell data were enriched in the DG and in the choroid plexus of the spatial data (Fig. S<xref rid="MOESM1" ref-type="media">12</xref>, Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6d</xref>). For <italic>Snap25</italic>, the neurodevelopmental switch from Snap25-a to Snap25-b in single-cell data (compare Fig. S<xref rid="MOESM1" ref-type="media">11b</xref>), occurs in a posterior-to-anterior gradient in spatially mapped exons (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6e</xref>). This supports the idea that the microenvironment can dictate brain-region-specific splicing for some genes. Also, the hypothesis that interneurons selectively switch isoforms before excitatory neurons seems unlikely.<fig id="Fig6"><label>Fig. 6</label><caption><title>Slide isoform sequencing (sl-ISO-Seq) confirms spatial localization of splicing changes.</title><p><bold>a</bold> Spatial localization of hippocampal single-cell excitatory neuron subtypes using gene-expression similarities to HIPP short reads. Color of spot indicates percentage of transcripts corresponding to indicated cell type. <bold>b</bold> Spatial localization of cortical excitatory neuron subtypes using gene-expression similarities to PFC short reads. Color of spot indicates percentage of transcripts corresponding to indicated cell type. <bold>c</bold> Scatter plot of the &#x394;<italic>&#x3A8;</italic> between HIPP and PFC from the single-cell data, and the &#x394;<italic>&#x3A8;</italic> between HIPP and cortex from 10X Visium spatial data (<italic>r</italic><sup>2</sup>&#x2009;=&#x2009;0.6). <bold>d</bold> Spatial distribution of alternatively spliced exons in <italic>Clta</italic> and <italic>Pkm</italic> genes in the hippocampal and choroid plexus regions. Color of spot indicates <italic>&#x3A8;</italic> values for each exon. <bold>e</bold> Spatial distribution of two mutually exclusive, alternatively spliced exons in <italic>Snap25</italic> gene across the whole slide. Color of spot indicates <italic>&#x3A8;</italic> values for each exon.</p></caption><graphic xlink:href="41467_2020_20343_Fig6_HTML" id="d32e1996"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec15" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par26">Temporal and anatomic differences in alternative splicing are implicated in developmental changes in molecular function<sup><xref ref-type="bibr" rid="CR71">71</xref></sup>. Building on the short-read investigation of cell-type-specific alternative splicing in the brain<sup><xref ref-type="bibr" rid="CR72">72</xref></sup>, our data enable the illumination of full-length isoform regulation across cell types. We endeavored to generate cell-type, brain-region, and age-specific maps of AS to understand functional consequences of differential isoform expression (DIE). Our analysis hinges on a single-per-gene isoform test that considers a gene&#x2019;s entire isoform repertoire and outperforms exon-based tests. Region-specific isoform testing revealed 395 genes with DIE between hippocampus and PFC, partially caused by isoforms novel to GENCODE. Manual validation by the GENCODE team using rigorous metrics lends credibility to this novel isoform detection. Thus, filtering these isoforms using bulk short reads, CAGE and polyA-site data provides a mechanism to automate genome annotation for isoforms.</p>
      <p id="Par27">We defined cell types underlying DIE between brain regions. In most cases and levels of granularity, we identified a finer cell type explanation of DIE, including the altered part of the transcripts. Despite inhibitory interneurons in HIPP and PFC migrating in from a common origin<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, we observe a signature of coordinated DIE in excitatory and inhibitory neurons for a gene subset. Such gene subsets with coordination across cell types were observed at all investigated levels. Microexons are linked to neuronal cell types for their regulatory function<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>, however, in the case of <italic>Nsfl1c</italic> we find that their expression is not limited to neurons but instead exhibits regional regulation by being expressed only in HIPP. Thus, brain region can override cell-type specificity for a subset of genes, which may explain region-specific sQTLs<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. The theoretical possibility that brain-region DIE in bulk arises purely from cell-type abundance or transcriptional activity differences is rarely observed. However, to which extent these observations persist in case&#x2013;control studies of disease, across adult brain regions, and across species requires further studies.</p>
      <p id="Par28">Our results indicate that understanding the cell-type basis of brain-region-specific DIE requires a thorough understanding of cell-type-specific DIE within each brain region. This further warrants a brain-wide map of isoform expression at a single-cell level. Within the brain, isoform diversity in non-neuronal cell types has attracted less attention than in their neuronal counterparts. However, we find that non-neuronal cell types exhibit high pairwise DIE. This may be partially due to the functional diversity of non-neuronal cells, or due to origins from different stem cell populations. Importantly, excitatory neurons and astrocytes which originate from the same stem cell population but are functionally distinct show high DIE (35.8%). However, the excitatory neuron population also shows high DIE with Cajal&#x2013;Retzius cells (18%) despite both originating from different stem cell populations but functioning as neurons. Among the non-neurons, choroid plexus epithelial cells show particularly large differences from other non-neuronal (but also neuronal) cell types. Surprisingly this observation is largely caused by CPE-specific choices of predominantly upstream TSSs. This raises the question whether other highly specialized cell types in other brain areas exhibit similar complex alternative transcriptome mechanisms.</p>
      <p id="Par29">We notice the sheer functional diversity that AS lends to the splicing machinery, synaptic plasticity, and vesicle-mediated endocytosis. This motivates further investigation linking a spliceosomal-gene isoform to the splicing of its target gene, as well as the isoform state of synaptic genes in neuronal subtypes. The evidence for isoforms adding to cellular diversity is further bolstered by long-read clustering, which yields coherent cell-types albeit with discrepancies, which could be partially due to the sparsity of the isoform matrix due to lower long-read throughput. Alternatively, cell states could be defined by an isoform expression program that does not correspond to 3&#x2032;seq-based cell-type definition, highlighting the need for factoring in isoform expression to re-define traditional transcriptional cell-types.</p>
      <p id="Par30">Finally, we have devised the method of slide-isoform sequencing (slISO-Seq), which employs spatial transcriptomics and long-read sequencing. This allows anchoring the above results in a spatial view of the brain and reveals important biology such as the brain-wide coordination of the <italic>Snap25</italic> isoform switch. Looking forward, the integration of long-read single-cell and spatial technologies allows for the possibility of constructing 3-dimensional maps of isoform expression at single-cell resolution.</p>
      <p id="Par31">In summary, these results present a detailed view of cell-type-specific full-length isoforms across brain regions, bringing us closer to a comprehensive isoform map of the brain. The software generated here is employable in a much larger setting and available as an R-package. It extends to case&#x2013;control studies, broad sample comparisons, and spatially anchored comparisons beyond mouse or brain.</p>
    </sec>
    <sec id="Sec16">
      <title>Methods</title>
      <sec id="Sec17">
        <title>Ethics statement</title>
        <p id="Par32">All experiments were conducted in accordance with relevant NIH guidelines and regulations, related to the Care and Use of Laboratory Animals tissue. Animal procedures were performed according to protocols approved by the Research Animal Resource Center at Weill Cornell College of Medicine.</p>
      </sec>
      <sec id="Sec18">
        <title>Animals and tissue isolation</title>
        <p id="Par33">C57BL/6NTac (<italic>n</italic>&#x2009;=&#x2009;6) female pups were quickly decapitated. For the single-cell experiments (P7; Rep1 <italic>n</italic>&#x2009;=&#x2009;1, Rep2 <italic>n</italic>&#x2009;=&#x2009;2), the brains were removed and placed on a stainless-steel brain matrix for mouse (coronal repeatable sections, 1&#x2009;mm spacing), and the prefrontal cortex and hippocampus were dissected<sup><xref ref-type="bibr" rid="CR73">73</xref></sup> in cold PBS solution (Fig. S<xref rid="MOESM1" ref-type="media">13a&#x2013;f</xref>). Brain tissues from both hemispheres were pooled in one sample. After dissection, tissues were snap frozen in dry ice until processing. For the 10X Visium spatial experiment (P8; <italic>n</italic>&#x2009;=&#x2009;1) brains were fresh-frozen and embedded in OCT. For the Basescope (P7; <italic>n</italic>&#x2009;=&#x2009;2) experiments, the brains were transcardially perfused, immersion fixated and cryo-protected (15% and 30% Sucrose in phosphate-buffered saline) each over night before being embedded in OCT. Mice were housed in an air-conditioned room at 65&#x2013;75&#x2009;&#xB0;F (~18&#x2013;23&#x2009;&#xB0;C) with 40&#x2013;60% humidity and a 12-h-light, 12-h-dark cycle. All animal experiments were approved by the institutional animal care and use committee (IACUC) of Weill Cornell Medicine</p>
      </sec>
      <sec id="Sec19">
        <title>Tissue disassociation</title>
        <p id="Par34">Following recommendations from 10x Genomics (Cat#CG00055 Rev C) dissected hippocampus and prefrontal cortex tissue was placed into 2.5&#x2009;ml Hibernate E/B27/GlutaMax medium (BrainBits cat#HEB) at Room Temp until all samples were dissected. HEB medium was removed and replaced with 2&#x2009;ml of 2&#x2009;mg/ml activated papain (BrainBits cat#PAP) then incubated for 25&#x2009;min at 37&#x2009;&#xB0;C with gentle mixing. After allowing tissue to settle, papain was removed and replaced with 2&#x2009;mL fresh HEB medium and tissue was gently triturated 15&#x2013;20 times using a wide-bore pipette tip and tissue left to settle. Supernatant was taken and filtered using a 30&#x2009;&#x3BC;m cell strainer (Miltenyi Biotec cat#130-041-407) into a collection tube. To the remaining tissue, another 2&#x2009;ml of fresh HEB medium was added and then triturated with a regular 1&#x2009;ml pipette tip an additional 10&#x2013;15 times until tissue was completely disassociated. Supernatant was taken and filtered through a 30&#x2009;um cell strainer and added to the collection tube. Supernatant was then centrifuged at 400rcf for 2&#x2009;min. The cell pellet was re-suspended in 1&#x2013;3&#x2009;ml of neuronal culture medium NbActiv1 (BrainBits cat#Nbactiv1) depending on cell pellet size, filtered through a 30&#x2009;&#x3BC;m cell strainer (Miltenyi Biotec cat#130-041-407), and was subsequently diluted to 1500 cells/&#x3BC;l in NbActiv1 for capture on the 10x Genomics Chromium controller.</p>
      </sec>
      <sec id="Sec20">
        <title>10x Genomics single-cell capture</title>
        <p id="Par35">The disassociated cells were captured on the 10x Genomics Chromium controller according to the Chromium Single Cell 3&#x2032; Reagent Kits V2 User Guide (10x Genomics CG00052 Rev F) with the following modification. PCR cycles were increased, from the recommended ten cycles for recovery of 8000 cells, to 16 cycles to target a yield of cDNA enabling simultaneous Illumina and PacBio library preparation.</p>
      </sec>
      <sec id="Sec21">
        <title>Illumina and Pacific Biosystems library preparation</title>
        <p id="Par36">Illumina library preparation was performed using 100&#x2009;ng of amplified cDNA following the Chromium Single Cell 3&#x2032; Reagent Kits V2 User Guide (10x Genomics CG00052 Rev F) reducing final indexing PCR cycles to ten cycles from the recommended 14 cycles to increase library complexity. Sequencing for Replicate 1 was performed on HiSeq4000 according to 10x Genomics run mode, for Replicate 2, sequencing was performed on a NovaSeq S1 flowcell also following 10x Genomics run mode and Bulk RNA-Seq was performed on the Illumina NextSeq 500 with a 150 PE run mode. PacBio library preparation was performed with 500&#x2009;ng of amplified cDNA using SMRTbell Express Template Prep Kit V2.0 (PacBio cat#PN: 100-938-900) to obtain Sequel II compatible library complex and was sequenced on a total 24 Sequel I SMRTcells with a run time of 10&#x2009;h and 20 Sequel II SMRTcells with a run time of 30&#x2009;h across samples and replicates.</p>
      </sec>
      <sec id="Sec22">
        <title>Modification of 10x Visium Illumina library preparation</title>
        <p id="Par37">Illumina compatible libraries were made from Visium-derived cDNA using a modified protocol derived from NEB Ultra II DNA FS kit (NEB #E6177). Visium-derived spatial cDNA was diluted to 100&#x2009;ng in 26&#x2009;&#x3BC;l and combined with 7&#x2009;&#x3BC;l NEBNext Ultra II FS Reaction Buffer and 2&#x2009;&#x3BC;l NEBNext Ultra II FS Enzyme Mix and incubated at 37&#x2009;&#xB0;C for 15&#x2009;min, 65&#x2009;&#xB0;C for 30&#x2009;min to obtain fragmented, end-repaired, and A-Tailed cDNA. Samples were then subjected to double-sided size selection by following the Beckman Coulter SpriSelect (Cat# B23318) protocol with an initial ratio of 0.6x SpriBeads. Supernatant was then taken and additional SpriBeads added for a final ratio of 0.8x eluting to 35&#x2009;&#x3BC;l EB Buffer. Adaptor ligation using 10x Genomics protocol was performed by combining 2.5&#x2009;&#x3BC;l 10x Adaptor Mix with 30&#x2009;&#x3BC;l NEBNext Ultra II Ligation Master Mix and 1&#x2009;&#x3BC;l of NEBNext Ligation Enhancer with the previously end-repaired cDNA and incubated at 20&#x2009;&#xB0;C for 15&#x2009;min. Single-sided SpriBead cleanup was performed using a 0.8x ratio and eluted in 15&#x2009;&#x3BC;l EB Buffer. Finally cDNA library was amplified by combining adaptor ligated cDNA with 5&#x2009;&#x3BC;l 10x Genomics i7 Barcoded primer and 5&#x2009;&#x3BC;l of 1:5 diluted 10x Genomics SI Primer and 25&#x2009;&#x3BC;l NEBNext Ultra II Q5 Master Mix and cycled with the following thermocyler profile: 98&#x2009;&#xB0;C 30&#x2009;s, 12 cycles of 98&#x2009;&#xB0;C 20&#x2009;s, 54&#x2009;&#xB0;C 30&#x2009;s, 72&#x2009;&#xB0;C 30&#x2009;s, then final extension of 65&#x2009;&#xB0;C for 5&#x2009;min, 10&#x2009;&#xB0;C hold. Amplified library was again subjected to a double-sided size selection using an initial ratio of 0.6x SpriBeads, supernatant was then taken and additional SpriBeads added for a final ratio of 0.8x eluting to 35&#x2009;&#x3BC;l EB Buffer. Illumina Libraries were then checked for quality and sequenced on an Illumina NextSeq500 instrument according to guidelines.</p>
      </sec>
      <sec id="Sec23">
        <title>Size selection of Visium cDNA using blue pippin for Oxford Nanopore</title>
        <p id="Par38">Visium-derived cDNA was size-selected using Sage Sciences Blue Pipin instrument to obtain cDNA fragments 800&#x2009;bp to 6000&#x2009;bp for efficient sequencing on Oxford Nanopore PromethIon Instrument. Samples were diluted to 1000&#x2009;ng in 30&#x2009;&#x3BC;l of TE buffer and combined with 10&#x2009;&#x3BC;l of Sage Loading Solution before loading into one lane of a 0.75% Agarose Blue Pippin Cassette (Cat# BLF7510). Samples were then separated according to protocol for a target range of 800&#x2013;6000&#x2009;bp, and target elution retrieved after 12&#x2009;h. Samples were then cleaned by Beckman Coulter SpriSelect Beads (Cat# B23318) using a 0.8x ratio and eluted 50&#x2009;&#x3BC;l Nuclease Free Water. Size-distribution was checked using Agilent Fragment Analyzer Large Fragment Kit (Cat# DNF-464-0500).</p>
      </sec>
      <sec id="Sec24">
        <title>PromethION library preparation and sequencing of Visium cDNA</title>
        <p id="Par39">Oxford Nanopore compatible library was produced using 350&#x2009;ng of either Sage Blue Pippin size-selected cDNA or non-selected cDNA derived from 10x Genomics Visium following the Genomic DNA by Ligation protocol (SQK-LSK109) from Oxford Nanopore with the following modifications. End-repair was carried out omitting NEBNext FFPE DNA Repair and incubations extended to 10&#x2009;min at 20&#x2009;&#xB0;C and 10&#x2009;min at 65&#x2009;&#xB0;C. Loading inputs on the PromethION was increased to 150&#x2009;fmol and sequenced for 20&#x2009;h, and basecalling was done using Guppy (3.2.10).</p>
      </sec>
      <sec id="Sec25">
        <title>Total hippocampus and PFC short-read Illumina library preparation</title>
        <p id="Par40">Illumina compatible libraries were produced from 1250&#x2009;ng total RNA using NEBNext Ultra II RNA Library Prep Kit (NEB Cat#E7770S) following manufactures protocol with the following modifications. Target insert size was 450&#x2009;bp for compatibility with paired end 150&#x2009;bp sequencing mode. Number of PCR cycles was reduced to 6 to limit the effect of PCR aberrations on the final library. Sequencing was performed on the Illumina NextSeq 500 instrument.</p>
      </sec>
      <sec id="Sec26">
        <title>Generation of circular consensus reads</title>
        <p id="Par41">Using the default SMRT-Link parameters, we performed circular consensus sequencing (CCS) with IsoSeq3 with the following modified parameters: maximum subread length 14,000&#x2009;bp, minimum subread length 10&#x2009;bp, and minimum number of passes 3.</p>
      </sec>
      <sec id="Sec27">
        <title>Primary hippocampal culture and transfection</title>
        <p id="Par42">Primary dissociated hippocampal cultures were prepared as previously described<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>, with minor modifications. Briefly, the hippocampus from P0 mouse pups was dissected on ice, digested with 0.25% trypsin for 30&#x2009;min at 37&#x2009;&#xB0;C with DMEM (Sigma), and dissociated into single cells by gentle trituration. The cells were seeded at a density of 2.5&#x2013;3.0&#x2009;&#xD7;&#x2009;10<sup>5</sup> cells per coverslip in Neurobasal-A (Sigma) supplemented with 10% (vol/vol) heat-inactivated FBS onto coverslips previously coated with 50&#x2009;&#x3BC;g/mL poly-D-lysine (Sigma) overnight at 4&#x2009;&#xB0;C and 25&#x2009;&#x3BC;g/mL laminin (Sigma) for 2&#x2009;h at 37&#x2009;&#xB0;C. The cells were maintained in a humidified incubator in 5% CO<sub>2</sub> at 37&#x2009;&#xB0;C. After 24&#x2009;h, the medium was replaced with Neurobasal-A supplemented with 2% B27 (Invitrogen), 1% FBS, 25&#x2009;&#x3BC;M uridine, and 70&#x2009;&#x3BC;M 5-fluorodeoxyuridine. After 6 days of in vitro (DIV) culture, the neurons were transiently transfected with 0.2&#x2009;&#x3BC;g of plasmid DNA per coverslip using calcium phosphate. One day after transfection cultured hippocampal cells were fixed for 30&#x2009;min with 4% paraformaldehyde, washed three times with PBS, and incubated for 5&#x2009;min in DAPI solution. Imaging was performed with a Zeiss LSM 880 Laser Scanning Confocal Microscope using an oil immersion 63&#xD7; objective. All images were collected at a 2,048&#x2009;&#xD7;&#x2009;2,048-pixel resolution. EGFP fusion constructs were generated as previously described<sup><xref ref-type="bibr" rid="CR74">74</xref></sup>.</p>
      </sec>
      <sec id="Sec28">
        <title>Alignment of bulk short-read data for junction validation</title>
        <p id="Par43">Illumina short reads for HIPP and PFC were aligned to the reference genome (mm10) using STAR using the following parameters:</p>
        <p id="Par44">-outFilterMultimapNmax 1 -outFilterIntronMotifs RemoveNoncanonical -outFilterMismatchNmax 5 -alignSJDBoverhangMin 6 -alignSJoverhangMin 6 -outFilterType BySJout -alignIntronMin 25 -alignIntronMax 1000000 -outSAMstrandField intronMotif -outSAMunmapped Within -runThreadN 32 -outStd SAM -alignMatesGapMax 1000000</p>
      </sec>
      <sec id="Sec29">
        <title>Alignment of single-cell short read data and analysis</title>
        <p id="Par45">The 10x cellranger pipeline (version 3.0.0) was run on the raw Illumina sequencing data to obtain single-cell expression matrices. For replicate 1, the raw expression matrices obtained through cellranger were used along with the DropletUtils package (v 1.6.1)<sup><xref ref-type="bibr" rid="CR75">75</xref></sup> to acquire &#x2018;eligible&#x2019; barcoded single cells (FDR&#x2009;&lt;&#x2009;=&#x2009;0.001) with UMI counts that fell below cellranger&#x2019;s filtering cutoff. These barcodes were incorporated into new matrices for importing into Seurat (v 3.1). For both hippocampal replicates and the first PFC replicate, cells that had unique gene counts over 5000 or less than 700, and greater than 20% mitochondrial gene expression were removed from further analysis. To adjust for the lower mean reads/cell for the second PFC replicate, the cutoff for minimum number of genes per cell was lowered to 350. Filtering on these parameters yielded 14,433 single cells for the hippocampus across two replicates, and 10,944 single cells for the PFC. We then used Seurat&#x2019;s &#x201C;merge&#x201D; feature<sup><xref ref-type="bibr" rid="CR76">76</xref></sup> to combine the replicates for each brain region. The number of UMIs, percentage of mitochondrial gene expression were regressed from each cell and then the gene expression matrix was log normalized and scaled to 10,000 reads per cell. Next, we clustered all the cells using 30 principal components (PCs) using the Louvain algorithm with a 0.6 resolution.</p>
      </sec>
      <sec id="Sec30">
        <title>Alignment of spatial short read data and analysis</title>
        <p id="Par46">The 10X spaceranger pipeline was run on raw Illumina sequencing data to obtain spatial expression matrices. Seurat&#x2019;s spatial analysis functions were used to obtain gene expression similarity clusters and identify barcodes corresponding to various brain regions.</p>
      </sec>
      <sec id="Sec31">
        <title>Integrated analysis with published data to identify cell-types</title>
        <p id="Par47">Published RNASeq P30 mouse brain data from Allen Brain Atlas<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> was used as a reference to identify cell identities of clusters based on shared gene expression patterns. Since the Allen institute data was generated using the SmartSeq2 protocol, Seurat&#x2019;s integrated anchor feature<sup><xref ref-type="bibr" rid="CR77">77</xref></sup> was used to align the two datasets and transfer cell-type labels (Fig. S<xref rid="MOESM1" ref-type="media">1e, f</xref>, S<xref rid="MOESM1" ref-type="media">2e, f</xref>).</p>
      </sec>
      <sec id="Sec32">
        <title>Integrated analysis with spatial transcriptomics data to identify cell-types</title>
        <p id="Par48">P7 HIPP single-cell data was used as a reference to transfer labels onto P8 spatial transcriptomics data in the barcoded region corresponding to the hippocampus using Seurat&#x2019;s integrated anchor feature<sup><xref ref-type="bibr" rid="CR78">78</xref></sup> using default parameters.</p>
      </sec>
      <sec id="Sec33">
        <title>Single-cell trajectory analysis</title>
        <p id="Par49">The velocyto python package (v 0.17.17)<sup><xref ref-type="bibr" rid="CR79">79</xref></sup> was used to obtain.loom files from both replicates of HIPP and PFC single-cell data. After importing the UMAP co-ordinates of the datasets, the scVelo<sup><xref ref-type="bibr" rid="CR79">79</xref></sup> package (v 0.2.0) and tutorial with default parameters were followed to acquire velocity plots (Fig. S<xref rid="MOESM1" ref-type="media">1c, d</xref>, S<xref rid="MOESM1" ref-type="media">2c, d</xref>). The cells involved in neurogenesis and neuronal differentiation in the dentate gyrus and hippocampus were subsetted based on cell-type identity, and slingshot trajectory analysis<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> was conducted on its first two principal components in an unsupervised manner (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>).</p>
      </sec>
      <sec id="Sec34">
        <title>Alignment of Pacific Biosciences long read data</title>
        <p id="Par50">Long read CCS fastqs sequences with PacBio were mapped and aligned to the reference genome (mm10) using STARlong and the following parameters:</p>
        <p id="Par51">-readFilesCommand zcat -runMode alignReads -outSAMattributes NH HI NM MD -readNameSeparator space --outFilterMultimapScoreRange 1 -outFilterMismatchNmax 2000 -scoreGapNoncan -20 -scoreGapGCAG -4 -scoreGapATAC -8 -scoreDelOpen -1 -scoreDelBase -1 -scoreInsOpen -1 -scoreInsBase -1 -alignEndsType Local -seedSearchStartLmax 50 -seedPerReadNmax 100000 -seedPerWindowNmax 1000 -alignTranscriptsPerReadNmax 100000 -alignTranscriptsPerWindowNmax 10000</p>
      </sec>
      <sec id="Sec35">
        <title>Alignment of spatial transcriptomics data sequenced using Oxford Nanopore</title>
        <p id="Par52">Long reads sequenced on the ONT PromethION were mapped and aligned using minimap2 using the following parameters: -t 20 -ax splice -secondary=no</p>
      </sec>
      <sec id="Sec36">
        <title>Filtering of long reads for full-length, spliced, barcoded reads</title>
        <p id="Par53">This was first described in our previous publication<sup><xref ref-type="bibr" rid="CR80">80</xref></sup> but we outline the process here as well. We first filtered long reads by retaining only alignments with the following procedure. If the read had exactly one alignment and the mapping quality of that alignment was at least 20 (in the sam format mapping quality definition), this alignment was kept. If the read has multiple alignments, but one alignment&#x2019;s mapping quality outscored the maximum of all other mapping qualities for that read by at least 20, the highest scoring alignment was retained. Afterwards, we removed alignments that overlapped annotated ribosomal RNA genes. For spliced alignments, we determined the splice site consensus for each intron in the alignment and only retained, alignments, for which every single intron respected the GT-AG, GC-AG, or ATAC consensus. These alignments we have previously referred to as a consensus-split-mapped molecule (CSMM). For each CSMM, we counted the number of splice sites it shared with each annotated gene. The vast majority of CSMMs share splice sites with exactly one gene. Each CSMM was assigned to the gene with which it shared most splice sites (or all such genes, in the case of a tie). Additionally, we filtered for complete reads using published CAGE peaks and polyA site data<sup><xref ref-type="bibr" rid="CR80">80</xref>,<xref ref-type="bibr" rid="CR81">81</xref></sup> by only keeping CSMMs that had start and end sites falling within 50&#x2009;bp of an annotated CAGE or polyA peak.</p>
      </sec>
      <sec id="Sec37">
        <title>Exon count assignment per cell-type</title>
        <p id="Par54">High confidence mapped and aligned reads were processed sequentially and compared to the Gencode M21 gene annotation using an in-house script. A Gencode-annotated exon (Fig. S<xref rid="MOESM1" ref-type="media">14a</xref>) was considered as being included in the read if both splice junctions were detected by the alignment. Due to the high error rate of ONT sequencing data, a variation of 3&#x2009;bp was allowed for each splice junction, whereas for PacBio variation allowed was 2&#x2009;bp, and overlapping exons were flagged (Fig. S<xref rid="MOESM1" ref-type="media">14b</xref>). In cases where a read spanned an exon, but its splice junctions were not detected, the exon was considered excluded (Fig. S<xref rid="MOESM1" ref-type="media">14c</xref>). Although ONT reads are known to often represent truncated versions of transcripts, terminal exons were counted but were only considered included when covered completely. Partially covered terminal exons were considered neither included nor excluded, and were discarded from the analysis (Fig. S<xref rid="MOESM1" ref-type="media">14d</xref>). Further, exon counts were aggregated to produce exclusion and inclusion rates for each particular cell group.</p>
      </sec>
      <sec id="Sec38">
        <title>Differential isoform tests</title>
        <p id="Par55">For isoform tests, a read was represented by a string denoting the TSS, introns, and polyA-site and each isoform was assigned an ID, with lower numbers corresponding to higher abundances. Next, counts for each isoform ID were assigned to individual cell-types. For each differential abundance test between two categories, genes were filtered out as &#x2018;untestable&#x2019; if reads did not reach sufficient depth (25 reads/gene category). For genes with sufficient depth, a maximum of an 11&#x2009;&#xD7;&#x2009;2 matrix of counts denoting isoform&#xD7;category was constructed with the first ten rows corresponding up to the first ten isoforms, and the last row comprised of collapsed counts from all the other isoforms (if any). <italic>P</italic>-values from a <italic>&#x3C7;</italic><sup>2</sup> test were reported per gene, along with a &#x394;&#x3A0; value per gene. The &#x394;&#x3A0; was constructed as the sum of change in percent isoform (&#x3A0;) of the top two isoforms in either positive or negative direction. After these numbers were reported for all testable genes for a comparison, the Benjamini Hochberg (BH)<sup><xref ref-type="bibr" rid="CR82">82</xref></sup> correction for multiple testing with a false discovery rate of 5% was applied to return a corrected <italic>p</italic>-value. If this FDR <italic>p</italic>-value was&#x2009;&lt;&#x2009;=&#x2009;0.05 and the &#x394;&#x3A0; was more than 0.1 in one direction, i.e., the change in percent inclusion of one or two isoforms was more than 10% from one category to the other, then the gene was considered to be significantly differentially spliced.</p>
      </sec>
      <sec id="Sec39">
        <title>Differential TSS tests</title>
        <p id="Par56">For each read, we determined the TSS as described above. The counts of each TSS in two conditions (e.g., excitatory and inhibitory neurons) were then summarized in a <italic>n</italic>&#x2009;&#xD7;&#x2009;2 table of counts. As with the isoform tests, this table was reduced to a 11&#x2009;&#xD7;&#x2009;2 table where the first ten rows represented the most abundant TSS and the 11<sup>th</sup> represented all the other TSS. Testing was performed as described above for isoforms.</p>
      </sec>
      <sec id="Sec40">
        <title>Differential polyA-site test</title>
        <p id="Par57">For each read, we determined the polyA-site as described above. The procedure for testing was the same as described above for differential TSS.</p>
      </sec>
      <sec id="Sec41">
        <title>Differential exon tests</title>
        <p id="Par58">Testing for differential exon inclusion followed a separate framework. For testing differential inclusion between two categories, a 2&#x2009;&#xD7;&#x2009;2 table of inclusion and exclusion counts per exon was constructed if it was not constitutively spliced (0.1&#x2009;&lt;&#x2009;=&#x2009;<italic>&#x3A8;</italic> &lt;&#x2009;=&#x2009;0.9) without considering counts in individual categories. An exon was considered for testing if the expected counts followed the criteria<sup><xref ref-type="bibr" rid="CR83">83</xref>,<xref ref-type="bibr" rid="CR84">84</xref></sup>
<inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{{{\mathrm{min}}(rowSums) \times {\mathrm{min}}(colSums)}}{{{\mathrm{Total}}}} \ge 5$$\end{document}</tex-math><mml:math id="M8"><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">min</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>r</mml:mi><mml:mi>o</mml:mi><mml:mi>w</mml:mi><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#xD7;</mml:mo><mml:mi mathvariant="normal">min</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>l</mml:mi><mml:mi>S</mml:mi><mml:mi>u</mml:mi><mml:mi>m</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Total</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#x2265;</mml:mo><mml:mn>5</mml:mn></mml:math><inline-graphic xlink:href="41467_2020_20343_Article_IEq4.gif"/></alternatives></inline-formula>, and the <italic>p</italic>-value from a <italic>&#x3C7;</italic><sup>2</sup> test was reported, along with a &#x394;<italic>&#x3A8;</italic> value. The &#x394;<italic>&#x3A8;</italic> was constructed as the difference in percent spliced in (PSI/<italic>&#x3A8;</italic>) across the two categories. After these numbers were reported for all testable exons for a comparison, since these tests are dependent, the Benjamini Yekutieli (BY)<sup><xref ref-type="bibr" rid="CR85">85</xref></sup> correction for multiple testing with a false discovery rate of 5% was applied to return a corrected <italic>p</italic>-value. If this <italic>p</italic>-value was&#x2009;&lt;&#x2009;=&#x2009;0.05 and the &#x394;<italic>&#x3A8;</italic> was more than 0.1 i.e., the change in <italic>&#x3A8;</italic> was more than 10% between the two categories, then the exon is considered to be significantly differentially included.</p>
      </sec>
      <sec id="Sec42">
        <title>Isolating non-overlapping exons from single-cell data for correlation with spatial ONT data</title>
        <p id="Par59">To confirm region-specific DIE in a technologically orthogonal fashion, we used spatial data sequenced with Oxford Nanopore as opposed to single-cell data sequenced with PacBio. Because of the relatively high error rate, truncated transcripts (~200&#x2009;bp difference in average length of ONT vs PacBio), and mis-mapping of overlapping splice sites, we chose to work with exons instead of full-length transcripts. We isolated exons from the single-cell PacBio data that showed region-specific DIE without <italic>p</italic>-value correction and extracted corresponding exons from the spatial data if they satisfied the following condition. If an exon was reported to have alternative donor and acceptor sites, it was only accepted if more than 90% of reads overlapping the exon mapped to that particular exon. We then used this list of exons to calculate region-specific DIE using spatial exon expression and correlated the &#x394;<italic>&#x3A8;</italic> values with the &#x394;<italic>&#x3A8;</italic> values from the single-cell data. Despite high technical variation, we got high concordance (85% change in the same direction, <italic>n</italic>&#x2009;=&#x2009;40).</p>
      </sec>
      <sec id="Sec43">
        <title>Building an enhanced annotation</title>
        <p id="Par60">We isolated polyadenylated, barcoded, and spliced long-reads,<list list-type="bullet"><list-item><p id="Par61">whose TSS were within 50&#x2009;bps of a published CAGE-peak<sup><xref ref-type="bibr" rid="CR80">80</xref></sup></p></list-item><list-item><p id="Par62">whose mapped read-end fell within 50&#x2009;bps of a published polyA-site<sup><xref ref-type="bibr" rid="CR81">81</xref></sup></p></list-item><list-item><p id="Par63">whose intron-chains were inconsistent with any annotated transcript or any truncated version of an annotated transcript<sup><xref ref-type="bibr" rid="CR86">86</xref>,<xref ref-type="bibr" rid="CR87">87</xref></sup></p></list-item><list-item><p id="Par64">whose internal exons (meaning both splice sites) were each supported by two or more single short reads (with &#x2265;2 splicing events) or paired-end Illumina read pairs from a bulk-sequencing experiment</p></list-item><list-item><p id="Par65">whose introns were each supported by two or more spliced Illumina reads from a bulk sequencing experiment</p></list-item><list-item><p id="Par66">who could not be interpreted as a truncated version of another such novel isoform</p></list-item></list></p>
        <p id="Par67">This resulted in an enhanced annotation, in which all added isoforms had a unique, previously absent intron-chain.</p>
        <p id="Par68">These isoforms as well as already annotated isoforms received read counts in each cell types according to the single-cell long-read dataset in each brain region. Novel isoforms intron-chains are by construction (see above) unique; however, annotated isoforms can differ only in their TSS or polyA-site. A long-read was therefore assigned to a GENCODE transcript that minimized the sum of abs(readEndMapping&#x2014;annotatedIsoformEnd) and abs(readStartMapping&#x2014;annotatedIsoformStart). In the case of a tie, only the divergence at the TSS was considered.</p>
        <p id="Par69">This annotation thus includes counts for thousands of isoforms in different cell types, such as &#x201C;P7Hipp_OPCs&#x201D; (representing oligodendrocyte precursor cells from a hippocampus at postnatal day 7) and &#x201C;P7PFC_OPCs&#x201D; (representing oligodendrocyte precursor cells from a pre-frontal cortex at postnatal day 7).</p>
      </sec>
      <sec id="Sec44">
        <title>Manual validation from the GENCODE team</title>
        <p id="Par70">Novel isoforms were manually verified and integrated into the GENCODE geneset<sup><xref ref-type="bibr" rid="CR88">88</xref></sup> in accordance with guidelines developed by the HAVANA group for the GENCODE / ENCODE projects<sup><xref ref-type="bibr" rid="CR89">89</xref></sup>. Novel introns not previously identified within the GENCODE geneset were independently confirmed by intron predictions taken from the Ensembl RNAseq pipeline using ENCODE data<sup><xref ref-type="bibr" rid="CR90">90</xref>,<xref ref-type="bibr" rid="CR91">91</xref></sup>, whilst novel transcription start sites were validated based on the Cap Analysis of Gene Expression (CAGE) libraries generated by FANTOM<sup><xref ref-type="bibr" rid="CR92">92</xref></sup>. Finally, each new transcript model was assigned a &#x2018;biotype&#x2019; indicative of its presumed functional categorization, with the biotypes matching to those used in GENCODE as described by Frankish et al.<sup><xref ref-type="bibr" rid="CR88">88</xref></sup>.</p>
      </sec>
      <sec id="Sec45">
        <title>Validation of cell-type-specific splicing using Basecope Duplex Detection Assay</title>
        <p id="Par71">Target transcriptomic regions for individual isoforms were isolated from the DIE analysis and probes were designed by Advanced Cell Diagnostics (ACD). Postnatal day 7 mice were transcardially perfused, and 12&#x2009;&#x3BC;m brain sections were processed according to the manufacturers recommendation for BaseScope Duplex Detection Assay (Protocol number 323800-USM, Advanced Cell Diagnostics, ACD) with a pre-treatment according to the protocol for fixed, frozen tissue (Protocol number 320534, Advanced Cell Diagnostics, ACD) with only 15&#x2009;min of Protease Plus incubation. Images were taken using a Leica DM5500 B with a Leica DFC295 camera.</p>
      </sec>
      <sec id="Sec46">
        <title>Reporting summary</title>
        <p id="Par72">Further information on research design is available in the&#xA0;<xref rid="MOESM3" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <sec id="Sec47">
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41467_2020_20343_MOESM1_ESM.pdf">
            <caption>
              <p>Supplemental Material</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41467_2020_20343_MOESM2_ESM.pdf">
            <caption>
              <p>Peer Review File</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="41467_2020_20343_MOESM3_ESM.pdf">
            <caption>
              <p>Reporting Summary</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Peer review information</bold>
<italic>Nature Communications</italic> thanks Mats Nilsson, Simone Codeluppi and the other anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.</p>
      </fn>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Supplementary information</title>
      <p><bold>Supplementary information</bold> is available for this paper at 10.1038/s41467-020-20343-5.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Jenny Xiang, Dong Xu, and Adrian Tan at the Genomics Resources Core facility at Weill Cornell Medicine for help with facilitating sequencing, and Ishaan Gupta for helping with initial processing of the samples. We also thank Christopher Mason and Daniel Butler for use of their PromethION machine. This work was supported by the Brain Initiative (grant 1RF1MH121267-01 to H.U.T), NIGMS (grant 1R01GM135247-01 to H.U.T), NINDS (grant 1R01NS105477 to M.E.R), NIDA (T32DA03980 to S.L.), and NIMH (grant R01MH118934 to G.P.), Australian NHMRC Early Career Fellowship (APP1156531 to S.A.H), RFBR (grant 19-04-01074 to A.P.), D.R. was supported by Programma per Giovani Ricercatori Rita Levi Montalcini granted by the Italian Ministry of Education, University, and Research, by the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation (CZF2019-002443), and by the NCI (2U24CA180996), S.A.S was supported by the Brain and Behavior Foundation NARSAD YIA and Sontag Foundation, P.F. was supported by NHGRI (grant 2U41HG007234), Wellcome (WT108749/Z/15/Z), and the European Molecular Biology Laboratory. E.D.J was supported by HHMI.</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>A.J. and H.U.T. devised the experiments. P.G.C., S.L., A.K.S., B.H., O.F., M.Y.W., W.L., J.M., J.G.C., A.H., and N.I.W. performed the experiments. A.J., A.M., A.P., D.R., S.R.W., A.F., and H.U.T devised the analyses. A.J., A.P., A.M., Q.W., T.H., S.A.H., A.S., and H.U.T. performed the analyses. All of the authors discussed and interpreted the results throughout the project. A.J. and H.U.T. wrote the paper with inputs from all of the other authors. C.D., Z.B., D.R., E.D.J., O.F., S.A.S., A.F., P.F., W.L., G.S.P., A.B.S, M.E.R., and H.U.T. supervised the project.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>All data used for this study is publicly available on GEO under the accession token GSE158450. All data supporting the findings of this study are provided within the paper and its&#xA0;<xref rid="MOESM1" ref-type="media">supplementary information</xref>. All additional information will be made available upon reasonable request to the authors.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>The source code for the methods and visualizations are available as functions in an R-package<sup><xref ref-type="bibr" rid="CR93">93</xref></sup> (<ext-link ext-link-type="uri" xlink:href="https://github.com/noush-joglekar/scisorseqr">https://github.com/noush-joglekar/scisorseqr</ext-link>) and processed single-cell and spatial data is available for download at <ext-link ext-link-type="uri" xlink:href="http://www.isoformAtlas.com">www.isoformAtlas.com</ext-link></p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par73">J.G.C., A.H., N.I.W., S.R.W., and Z.B. are employees of 10X Genomics. PF is a member of the scientific advisory boards of Fabric Genomics, Inc., and Eagle Genomics, Ltd. A.J., A.P., A.M., P.G.C., S.L., A.K.S., J.M., B.H., M.Y.W., A.N.S., S.A.H., T.H., Q.W., C.D., O.F., S.A.S., D.R., E.D.J., W.L., G.P., A.F., A.B.S., M.E.R., and H.U.T. declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raj</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Blencowe</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles</article-title>
          <source>Neuron</source>
          <year>2015</year>
          <volume>87</volume>
          <fpage>14</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2015.05.004</pub-id>
          <pub-id pub-id-type="pmid">26139367</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>ET</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Alternative isoform regulation in human tissue transcriptomes</article-title>
          <source>Nature</source>
          <year>2008</year>
          <volume>456</volume>
          <fpage>470</fpage>
          <lpage>476</lpage>
          <pub-id pub-id-type="doi">10.1038/nature07509</pub-id>
          <pub-id pub-id-type="pmid">18978772</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nilsen</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Graveley</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>Expansion of the eukaryotic proteome by alternative splicing</article-title>
          <source>Nature</source>
          <year>2010</year>
          <volume>463</volume>
          <fpage>457</fpage>
          <lpage>463</lpage>
          <pub-id pub-id-type="doi">10.1038/nature08909</pub-id>
          <pub-id pub-id-type="pmid">20110989</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell alternative splicing analysis with expedition reveals splicing dynamics during neuron differentiation</article-title>
          <source>Mol. Cell</source>
          <year>2017</year>
          <volume>67</volume>
          <fpage>148</fpage>
          <lpage>161.e5</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2017.06.003</pub-id>
          <pub-id pub-id-type="pmid">28673540</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forrest</surname>
              <given-names>ARR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A promoter-level mammalian expression atlas</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>507</volume>
          <fpage>462</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="doi">10.1038/nature13182</pub-id>
          <pub-id pub-id-type="pmid">24670764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayr</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Evolution and biological roles of alternative 3&#x2019;UTRs</article-title>
          <source>Trends Cell Biol.</source>
          <year>2016</year>
          <volume>26</volume>
          <fpage>227</fpage>
          <lpage>237</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tcb.2015.10.012</pub-id>
          <pub-id pub-id-type="pmid">26597575</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandberg</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Neilson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Sarma</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sharp</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Burge</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Proliferating cells express mRNAs with shortened 3&#x2032; untranslated regions and fewer microRNA target sites</article-title>
          <source>Science</source>
          <year>2008</year>
          <volume>320</volume>
          <fpage>1643</fpage>
          <lpage>1647</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1155390</pub-id>
          <pub-id pub-id-type="pmid">18566288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weyn-Vanhentenryck</surname>
              <given-names>SM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Precise temporal regulation of alternative splicing during neural development.</article-title>
          <source>Nat. Commun</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>2189</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-018-04559-0</pub-id>
          <pub-id pub-id-type="pmid">29875359</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <mixed-citation publication-type="other">Nutter, C. A. et al. Cell-type-specific dysregulation of RNA alternative splicing in short tandem repeat mouse knockin models of myotonic dystrophy. <italic>Genes Dev</italic>. 10.1101/gad.328963.119 (2019).</mixed-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fagnani</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Functional coordination of alternative splicing in the mammalian central nervous system</article-title>
          <source>Genome Biol</source>
          <year>2007</year>
          <volume>8</volume>
          <fpage>R108</fpage>
          <pub-id pub-id-type="doi">10.1186/gb-2007-8-6-r108</pub-id>
          <pub-id pub-id-type="pmid">17565696</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tilgner</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive transcriptome analysis using synthetic long-read sequencing reveals molecular co-association of distant splicing events</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2015</year>
          <volume>33</volume>
          <fpage>736</fpage>
          <lpage>742</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.3242</pub-id>
          <pub-id pub-id-type="pmid">25985263</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tilgner</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Microfluidic isoform sequencing shows widespread splicing coordination in the human transcriptome</article-title>
          <source>Genome Res.</source>
          <year>2018</year>
          <volume>28</volume>
          <fpage>231</fpage>
          <lpage>242</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.230516.117</pub-id>
          <pub-id pub-id-type="pmid">29196558</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anvar</surname>
              <given-names>SY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Full-length mRNA sequencing uncovers a widespread coupling between transcription initiation and mRNA processing</article-title>
          <source>Genome Biol.</source>
          <year>2018</year>
          <volume>19</volume>
          <fpage>46</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-018-1418-0</pub-id>
          <pub-id pub-id-type="pmid">29598823</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolisetty</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Rajadinakaran</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Graveley</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>Determining exon connectivity in complex mRNAs by nanopore sequencing</article-title>
          <source>Genome Biol.</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>204</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-015-0777-z</pub-id>
          <pub-id pub-id-type="pmid">26420219</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roy</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Graveley</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Zamore</surname>
              <given-names>PD</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Assessing long-distance RNA sequence connectivity via RNA-templated DNA-DNA ligation</article-title>
          <source>Elife</source>
          <year>2015</year>
          <volume>4</volume>
          <fpage>e03700</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.03700</pub-id>
          <pub-id pub-id-type="pmid">4442144</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Treutlein</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gokce</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Quake</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>S&#xFC;dhof</surname>
              <given-names>TC</given-names>
            </name>
          </person-group>
          <article-title>Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2014</year>
          <volume>111</volume>
          <fpage>E1291</fpage>
          <lpage>E1299</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1403244111</pub-id>
          <pub-id pub-id-type="pmid">24639501</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schreiner</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted combinatorial alternative splicing generates brain region-specific repertoires of neurexins</article-title>
          <source>Neuron</source>
          <year>2014</year>
          <volume>84</volume>
          <fpage>386</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2014.09.011</pub-id>
          <pub-id pub-id-type="pmid">25284007</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yeo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Holste</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kreiman</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Burge</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Variation in alternative splicing across human tissues</article-title>
          <source>Genome Biol.</source>
          <year>2004</year>
          <volume>5</volume>
          <fpage>R74</fpage>
          <pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r74</pub-id>
          <pub-id pub-id-type="pmid">15461793</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>YYL</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Darnell</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia</article-title>
          <source>Proc. Natl Acad. Sci.</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>13254</fpage>
          <lpage>13259</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.95.22.13254</pub-id>
          <pub-id pub-id-type="pmid">9789075</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKee</surname>
              <given-names>AE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain</article-title>
          <source>BMC Dev. Biol.</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>14</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-213X-5-14</pub-id>
          <pub-id pub-id-type="pmid">16033648</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regional variation of splicing QTLs in human brain.</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2020</year>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2020.06.002</pub-id>
          <pub-id pub-id-type="pmid">33245860</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darnell</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>RNA protein interaction in neurons</article-title>
          <source>Annu. Rev. Neurosci.</source>
          <year>2013</year>
          <volume>36</volume>
          <fpage>243</fpage>
          <lpage>270</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-neuro-062912-114322</pub-id>
          <pub-id pub-id-type="pmid">23701460</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vuong</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Zheng</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>The neurogenetics of alternative splicing</article-title>
          <source>Nat. Rev. Neurosci.</source>
          <year>2016</year>
          <volume>17</volume>
          <fpage>265</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn.2016.27</pub-id>
          <pub-id pub-id-type="pmid">27094079</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Norris</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Calarco</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Emerging roles of alternative pre-mRNA splicing regulation in neuronal development and function</article-title>
          <source>Front. Neurosci.</source>
          <year>2012</year>
          <volume>6</volume>
          <fpage>122</fpage>
          <pub-id pub-id-type="doi">10.3389/fnins.2012.00122</pub-id>
          <pub-id pub-id-type="pmid">22936897</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vaquero-Garcia</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title>
          <source>Elife</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>e11752</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.11752</pub-id>
          <pub-id pub-id-type="pmid">26829591</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell isoform RNA sequencing characterizes isoforms in thousands of cerebellar cells</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>1197</fpage>
          <lpage>1202</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4259</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive integration of single-cell data.</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902.e21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hochgerner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>L&#xF6;nnerberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Linnarsson</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Conserved properties of dentate gyrus neurogenesis across postnatal development revealed by single-cell RNA sequencing</article-title>
          <source>Nat. Neurosci.</source>
          <year>2018</year>
          <volume>21</volume>
          <fpage>290</fpage>
          <lpage>299</lpage>
          <pub-id pub-id-type="doi">10.1038/s41593-017-0056-2</pub-id>
          <pub-id pub-id-type="pmid">29335606</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular architecture of the mouse nervous system resource molecular architecture of the mouse nervous system</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <fpage>999</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.06.021</pub-id>
          <pub-id pub-id-type="pmid">30096314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="other">Yao, Z. et al. A taxonomy of transcriptomic cell types across the isocortex and hippocampal formation. Preprint at 10.1101/2020.03.30.015214 (2020).</mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyoshi</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic fate mapping reveals that the caudal ganglionic eminence produces a large and diverse population of superficial cortical interneurons</article-title>
          <source>J. Neurosci.</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>1582</fpage>
          <lpage>1594</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4515-09.2010</pub-id>
          <pub-id pub-id-type="pmid">20130169</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="other">Mayer, C. et al. Developmental diversification of cortical inhibitory interneurons. <italic>Nature</italic>10.1038/nature25999 (2018).</mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krienen</surname>
              <given-names>FM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Innovations present in the primate interneuron repertoire.</article-title>
          <source>Nature</source>
          <year>2020</year>
          <volume>586</volume>
          <fpage>262</fpage>
          <lpage>269</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-020-2781-z</pub-id>
          <pub-id pub-id-type="pmid">32999462</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular architecture of the mouse nervous system</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <fpage>999</fpage>
          <lpage>1014.e22</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.06.021</pub-id>
          <pub-id pub-id-type="pmid">30096314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tasic</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Adult mouse cortical cell taxonomy revealed by single cell transcriptomics</article-title>
          <source>Nat. Neurosci.</source>
          <year>2016</year>
          <volume>19</volume>
          <fpage>335</fpage>
          <lpage>346</lpage>
          <pub-id pub-id-type="doi">10.1038/nn.4216</pub-id>
          <pub-id pub-id-type="pmid">26727548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benjamini</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yekutieli</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The control of the false discovery rate in multiple testing under dependency</article-title>
          <source>Ann. Stat.</source>
          <year>2001</year>
          <volume>29</volume>
          <fpage>1165</fpage>
          <lpage>1188</lpage>
          <pub-id pub-id-type="doi">10.1214/aos/1013699998</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <mixed-citation publication-type="other">Wang, K. Z. Q. et al. PINK1 interacts with VCP/p97 and activates PKA to promote NSFL1C/p47 phosphorylation and dendritic arborization in neurons. <italic>eNeuro</italic><bold>5</bold>, ENEURO.0466-18 (2018).</mixed-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shih</surname>
              <given-names>YT</given-names>
            </name>
            <name>
              <surname>Hsueh</surname>
              <given-names>YP</given-names>
            </name>
          </person-group>
          <article-title>VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation</article-title>
          <source>Nat. Commun.</source>
          <year>2016</year>
          <volume>7</volume>
          <fpage>11020</fpage>
          <pub-id pub-id-type="doi">10.1038/ncomms11020</pub-id>
          <pub-id pub-id-type="pmid">26984393</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spilker</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A Jacob/Nsmf gene knockout results in hippocampal dysplasia and impaired BDNF signaling in dendritogenesis.</article-title>
          <source>PLoS Genet</source>
          <year>2016</year>
          <volume>12</volume>
          <fpage>e1005907</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1005907</pub-id>
          <pub-id pub-id-type="pmid">26977770</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Behnisch</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nuclear translocation of Jacob in hippocampal neurons after stimuli inducing long-term potentiation but not long-term depression</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e17276</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0017276</pub-id>
          <pub-id pub-id-type="pmid">21364755</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Irimia</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A highly conserved program of neuronal microexons is misregulated in autistic brains</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <fpage>1511</fpage>
          <lpage>1523</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.035</pub-id>
          <pub-id pub-id-type="pmid">25525873</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamanaka</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease</article-title>
          <source>Proc. Natl Acad. Sci. U.S.A.</source>
          <year>1994</year>
          <volume>91</volume>
          <fpage>9975</fpage>
          <lpage>9979</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.91.21.9975</pub-id>
          <pub-id pub-id-type="pmid">7937929</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <mixed-citation publication-type="other">Lun, M. P., Monuki, E. S. &amp; Lehtinen, M. K. Development and functions of the choroid plexus-cerebrospinal fluid system. <italic>Nat. Rev. Neurosci.</italic>10.1038/nrn3921 (2015).</mixed-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leppek</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Barna</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Functional 5&#x2032; UTR mRNA structures in eukaryotic translation regulation and how to find them</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <year>2018</year>
          <volume>19</volume>
          <fpage>158</fpage>
          <lpage>174</lpage>
          <pub-id pub-id-type="doi">10.1038/nrm.2017.103</pub-id>
          <pub-id pub-id-type="pmid">29165424</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Street</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics</article-title>
          <source>BMC Genomics</source>
          <year>2018</year>
          <volume>19</volume>
          <fpage>477</fpage>
          <pub-id pub-id-type="doi">10.1186/s12864-018-4772-0</pub-id>
          <pub-id pub-id-type="pmid">29914354</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eden</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Navon</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Steinfeld</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Lipson</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Yakhini</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>GOrilla: A tool for discovery and visualization of enriched GO terms in ranked gene lists</article-title>
          <source>BMC Bioinforma.</source>
          <year>2009</year>
          <volume>10</volume>
          <fpage>48</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-10-48</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Supek</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bo&#x161;njak</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>&#x160;kunca</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>&#x160;muc</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>REVIGO summarizes and visualizes long lists of gene ontology terms</article-title>
          <source>PLoS One</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e21800</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id>
          <pub-id pub-id-type="pmid">21789182</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borgesius</surname>
              <given-names>NZ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>&#x3B2;CaMKII plays a nonenzymatic role in hippocampal synaptic plasticity and learning by targeting &#x3B1;;CaMKII to synapses</article-title>
          <source>J. Neurosci.</source>
          <year>2011</year>
          <volume>31</volume>
          <fpage>10141</fpage>
          <lpage>10148</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5105-10.2011</pub-id>
          <pub-id pub-id-type="pmid">21752990</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brocke</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Srinivasan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schulman</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Developmental and Regional Expression of Multifunctional Ca*+/Calmodulin-Dependent Protein Kinase lsoforms in Rat Brain.</article-title>
          <source>J. Neurosci.</source>
          <year>1995</year>
          <volume>75</volume>
          <fpage>6797</fpage>
          <lpage>6808</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-10-06797.1995</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baucum</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Shonesy</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Rose</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Colbran</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Quantitative proteomics analysis of CaMKII phosphorylation and the CaMKII interactome in the mouse forebrain</article-title>
          <source>ACS Chem. Neurosci.</source>
          <year>2015</year>
          <volume>6</volume>
          <fpage>615</fpage>
          <lpage>631</lpage>
          <pub-id pub-id-type="doi">10.1021/cn500337u</pub-id>
          <pub-id pub-id-type="pmid">25650780</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Khan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Downing</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Molloy</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Architectural dynamics of CaMKII-actin networks</article-title>
          <source>Biophys. J.</source>
          <year>2019</year>
          <volume>116</volume>
          <fpage>104</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bpj.2018.11.006</pub-id>
          <pub-id pub-id-type="pmid">30527447</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schob</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cognitive impairment and autistic-like behaviour in SAPAP4-deficient mice</article-title>
          <source>Transl. Psychiatry</source>
          <year>2019</year>
          <volume>9</volume>
          <fpage>7</fpage>
          <pub-id pub-id-type="doi">10.1038/s41398-018-0327-z</pub-id>
          <pub-id pub-id-type="pmid">30664629</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dagley</surname>
              <given-names>LF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Quantitative proteomic profiling reveals novel region-specific markers in the adult mouse brain</article-title>
          <source>Proteomics</source>
          <year>2014</year>
          <volume>14</volume>
          <fpage>241</fpage>
          <lpage>261</lpage>
          <pub-id pub-id-type="doi">10.1002/pmic.201300196</pub-id>
          <pub-id pub-id-type="pmid">24259518</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beesley</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Herrera-Molina</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Smalla</surname>
              <given-names>K-H</given-names>
            </name>
            <name>
              <surname>Seidenbecher</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The Neuroplastin adhesion molecules: key regulators of neuronal plasticity and synaptic function</article-title>
          <source>J. Neurochem.</source>
          <year>2014</year>
          <volume>131</volume>
          <fpage>268</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1111/jnc.12816</pub-id>
          <pub-id pub-id-type="pmid">25040546</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>QF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fibroblast growth factor 13 is a microtubule-stabilizing protein regulating neuronal polarization and migration</article-title>
          <source>Cell</source>
          <year>2012</year>
          <volume>149</volume>
          <fpage>1549</fpage>
          <lpage>1564</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2012.04.046</pub-id>
          <pub-id pub-id-type="pmid">22726441</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puranam</surname>
              <given-names>RS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Disruption of Fgf13 causes synaptic excitatory&#x2013;inhibitory imbalance and genetic epilepsy and febrile seizures plus</article-title>
          <source>J. Neurosci.</source>
          <year>2015</year>
          <volume>35</volume>
          <fpage>8866</fpage>
          <lpage>8881</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3470-14.2015</pub-id>
          <pub-id pub-id-type="pmid">26063919</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sinden</surname>
              <given-names>DS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Knockout of the X-linked Fgf13 in the hypothalamic paraventricular nucleus impairs sympathetic output to brown fat and causes obesity</article-title>
          <source>FASEB J.</source>
          <year>2019</year>
          <volume>33</volume>
          <fpage>11579</fpage>
          <lpage>11594</lpage>
          <pub-id pub-id-type="doi">10.1096/fj.201901178R</pub-id>
          <pub-id pub-id-type="pmid">31339804</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pablo</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Pitt</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Fibroblast growth factor homologous factors: new roles in neuronal health and disease</article-title>
          <source>Neuroscientist</source>
          <year>2016</year>
          <volume>22</volume>
          <fpage>19</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="doi">10.1177/1073858414562217</pub-id>
          <pub-id pub-id-type="pmid">25492945</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Fibroblast growth factor homologous factor 13 regulates Na+ channels and conduction velocity in murine hearts</article-title>
          <source>Circ. Res.</source>
          <year>2011</year>
          <volume>109</volume>
          <fpage>775</fpage>
          <lpage>782</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.247957</pub-id>
          <pub-id pub-id-type="pmid">21817159</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pablo</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Presby</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Pitt</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Polarized localization of voltage-gated Na<sup>+</sup> channels is regulated by concerted FGF13 and FGF14 action</article-title>
          <source>Proc. Natl Acad. Sci. U.S.A</source>
          <year>2016</year>
          <volume>113</volume>
          <fpage>E2665</fpage>
          <lpage>E2674</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1521194113</pub-id>
          <pub-id pub-id-type="pmid">27044086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FGF13 selectively regulates heat nociception by interacting with Nav1.7</article-title>
          <source>Neuron</source>
          <year>2017</year>
          <volume>93</volume>
          <fpage>806</fpage>
          <lpage>821.e9</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2017.01.009</pub-id>
          <pub-id pub-id-type="pmid">28162808</pub-id>
        </element-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bublik</surname>
              <given-names>DR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulatory module involving FGF13, miR-504, and p53 regulates ribosomal biogenesis and supports cancer cell survival</article-title>
          <source>Proc. Natl Acad. Sci. U.S.A.</source>
          <year>2017</year>
          <volume>114</volume>
          <fpage>E496</fpage>
          <lpage>E505</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1614876114</pub-id>
          <pub-id pub-id-type="pmid">27994142</pub-id>
        </element-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FGF13 modulates the gating properties of the cardiac sodium channel Nav1.5 in an isoform-specific manner</article-title>
          <source>Channels</source>
          <year>2016</year>
          <volume>10</volume>
          <fpage>410</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="doi">10.1080/19336950.2016.1190055</pub-id>
          <pub-id pub-id-type="pmid">27246624</pub-id>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Munoz-Sanjuan</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Smallwood</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Nathans</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing</article-title>
          <source>J. Biol. Chem.</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>2589</fpage>
          <lpage>2597</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.275.4.2589</pub-id>
          <pub-id pub-id-type="pmid">10644718</pub-id>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bark</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Ryabinin</surname>
              <given-names>AE</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development</article-title>
          <source>Proc. Natl Acad. Sci. U.S.A.</source>
          <year>1995</year>
          <volume>92</volume>
          <fpage>1510</fpage>
          <lpage>1514</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.92.5.1510</pub-id>
          <pub-id pub-id-type="pmid">7878010</pub-id>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bark</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Developmentally regulated switch in alternatively spliced SNAP-25 isoforms alters facilitation of synaptic transmission</article-title>
          <source>J. Neurosci.</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>8796</fpage>
          <lpage>8805</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1940-04.2004</pub-id>
          <pub-id pub-id-type="pmid">15470145</pub-id>
        </element-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bark</surname>
              <given-names>IC</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Human cDNA clones encoding two different isoforms of the nerve terminal protein SNAP-25</article-title>
          <source>Gene</source>
          <year>1994</year>
          <volume>139</volume>
          <fpage>291</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="doi">10.1016/0378-1119(94)90773-0</pub-id>
          <pub-id pub-id-type="pmid">8112622</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>S&#xF8;rensen</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential control of the releasable vesicle pools by SNAP-25 splice variants and SNAP-23</article-title>
          <source>Cell</source>
          <year>2003</year>
          <volume>114</volume>
          <fpage>75</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00477-X</pub-id>
          <pub-id pub-id-type="pmid">12859899</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blue</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Curry</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Engels</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>EY</given-names>
            </name>
            <name>
              <surname>Giudice</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>How alternative splicing affects membrane-trafficking dynamics.</article-title>
          <source>J. Cell Sci.</source>
          <year>2018</year>
          <volume>131</volume>
          <fpage>jcs216465</fpage>
          <pub-id pub-id-type="doi">10.1242/jcs.216465</pub-id>
          <pub-id pub-id-type="pmid">29769303</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brodsky</surname>
              <given-names>FM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clathrin light chains: arrays of protein motifs that regulate coated-vesicle dynamics</article-title>
          <source>Trends Biochem. Sci.</source>
          <year>1991</year>
          <volume>16</volume>
          <fpage>208</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="doi">10.1016/0968-0004(91)90087-C</pub-id>
          <pub-id pub-id-type="pmid">1909824</pub-id>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakano</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wiechert</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>B&#xE1;nfi</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Overlapping activities of two neuronal splicing factors switch the GABA effect from excitatory to inhibitory by regulating REST</article-title>
          <source>Cell Rep.</source>
          <year>2019</year>
          <volume>27</volume>
          <fpage>860</fpage>
          <lpage>871.e8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2019.03.072</pub-id>
          <pub-id pub-id-type="pmid">30995482</pub-id>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furlanis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Traunm&#xFC;ller</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fucile</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Scheiffele</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Landscape of ribosome-engaged transcript isoforms reveals extensive neuronal-cell-class-specific alternative splicing programs</article-title>
          <source>Nat. Neurosci.</source>
          <year>2019</year>
          <volume>22</volume>
          <fpage>1709</fpage>
          <lpage>1717</lpage>
          <pub-id pub-id-type="doi">10.1038/s41593-019-0465-5</pub-id>
          <pub-id pub-id-type="pmid">31451803</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <mixed-citation publication-type="other">The Mouse Brain in Stereotaxic Coordinates, Compact - 3rd Edition. <ext-link ext-link-type="uri" xlink:href="https://www.elsevier.com/books/the-mouse-brain-in-stereotaxic-coordinates-compact/franklin/978-0-12-374244-5">https://www.elsevier.com/books/the-mouse-brain-in-stereotaxic-coordinates-compact/franklin/978-0-12-374244-5</ext-link> (2020).</mixed-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pablo</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Presby</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Pitt</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Polarized localization of voltage-gated Na<sup>+</sup> channels is regulated by concerted FGF13 and FGF14 action</article-title>
          <source>Proc. Natl Acad. Sci. U.S.A</source>
          <year>2016</year>
          <volume>113</volume>
          <fpage>E2665</fpage>
          <lpage>E2674</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1521194113</pub-id>
          <pub-id pub-id-type="pmid">27044086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lun</surname>
              <given-names>ATL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>EmptyDrops: distinguishing cells from empty droplets in droplet-based single-cell RNA sequencing data</article-title>
          <source>Genome Biol.</source>
          <year>2019</year>
          <volume>20</volume>
          <fpage>63</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-019-1662-y</pub-id>
          <pub-id pub-id-type="pmid">30902100</pub-id>
        </element-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smibert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
          <pub-id pub-id-type="pmid">29608179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive integration of single-cell data</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902.e21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>La Manno</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>RNA velocity of single cells</article-title>
          <source>Nature</source>
          <year>2018</year>
          <volume>560</volume>
          <fpage>494</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-018-0414-6</pub-id>
          <pub-id pub-id-type="pmid">30089906</pub-id>
        </element-citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergen</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Peidli</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wolf</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Theis</surname>
              <given-names>FJ</given-names>
            </name>
          </person-group>
          <article-title>Generalizing RNA velocity to transient cell states through dynamical modeling.</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2020</year>
          <volume>38</volume>
          <fpage>1408</fpage>
          <lpage>1414</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-020-0591-3</pub-id>
          <pub-id pub-id-type="pmid">32747759</pub-id>
        </element-citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lizio</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Gateways to the FANTOM5 promoter level mammalian expression atlas</article-title>
          <source>Genome Biol.</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>22</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-014-0560-6</pub-id>
          <pub-id pub-id-type="pmid">25723102</pub-id>
        </element-citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herrmann</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PolyASite 2.0: a consolidated atlas of polyadenylation sites from 3&#x2032; end sequencing</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2019</year>
          <volume>48</volume>
          <fpage>D174</fpage>
          <lpage>D179</lpage>
          <pub-id pub-id-type="pmid">7145510</pub-id>
        </element-citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benjamini</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hochberg</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple</article-title>
          <source>Test. J. R. Stat. Soc. Ser. B</source>
          <year>1995</year>
          <volume>57</volume>
          <fpage>289</fpage>
          <lpage>300</lpage>
        </element-citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cochran</surname>
              <given-names>WG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The &#x3C7;<sup>2</sup> test of goodness of fit.</article-title>
          <source>Ann. Math. Stat</source>
          <year>1952</year>
          <volume>23</volume>
          <fpage>315</fpage>
          <lpage>345</lpage>
          <pub-id pub-id-type="doi">10.1214/aoms/1177729380</pub-id>
        </element-citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cochran</surname>
              <given-names>WG</given-names>
            </name>
          </person-group>
          <article-title>Some methods for strengthening the common &#x3C7;<sup>2</sup> tests</article-title>
          <source>Biometrics</source>
          <year>1954</year>
          <volume>10</volume>
          <fpage>417</fpage>
          <pub-id pub-id-type="doi">10.2307/3001616</pub-id>
        </element-citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benjamini</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yekutieli</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The control of the false discovery rate in multiple testing under dependency</article-title>
          <source>Ann. Stat.</source>
          <year>2001</year>
          <volume>29</volume>
          <fpage>1165</fpage>
          <lpage>1188</lpage>
          <pub-id pub-id-type="doi">10.1214/aos/1013699998</pub-id>
        </element-citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tilgner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Grubert</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A single-molecule long-read survey of the human transcriptome</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2013</year>
          <volume>31</volume>
          <fpage>1009</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.2705</pub-id>
          <pub-id pub-id-type="pmid">24108091</pub-id>
        </element-citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tilgner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Grubert</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sharon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Snyder</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Defining a personal, allele-specific, and single-molecule long-read transcriptome</article-title>
          <source>Proc. Natl Acad. Sci. U.S.A.</source>
          <year>2014</year>
          <volume>111</volume>
          <fpage>9869</fpage>
          <lpage>9874</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1400447111</pub-id>
          <pub-id pub-id-type="pmid">24961374</pub-id>
        </element-citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frankish</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GENCODE reference annotation for the human and mouse genomes</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2019</year>
          <volume>47</volume>
          <fpage>767</fpage>
          <pub-id pub-id-type="doi">10.1093/nar/gky955</pub-id>
        </element-citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrow</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GENCODE: the reference human genome annotation for the ENCODE project</article-title>
          <source>Genome Res.</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>1760</fpage>
          <lpage>1774</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.135350.111</pub-id>
          <pub-id pub-id-type="pmid">22955987</pub-id>
        </element-citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yates</surname>
              <given-names>AD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ensembl 2020.</article-title>
          <source>Nucleic Acids Res</source>
          <year>2020</year>
          <volume>48</volume>
          <fpage>D682</fpage>
          <lpage>D688</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkz1138</pub-id>
          <pub-id pub-id-type="pmid">31691826</pub-id>
        </element-citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yue</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A comparative encyclopedia of DNA elements in the mouse genome</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>515</volume>
          <fpage>355</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="doi">10.1038/nature13992</pub-id>
          <pub-id pub-id-type="pmid">25409824</pub-id>
        </element-citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Forrest</surname>
              <given-names>ARR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A promoter-level mammalian expression atlas</article-title>
          <source>Nature</source>
          <year>2014</year>
          <volume>507</volume>
          <fpage>462</fpage>
          <lpage>470</lpage>
          <pub-id pub-id-type="doi">10.1038/nature13182</pub-id>
          <pub-id pub-id-type="pmid">24670764</pub-id>
        </element-citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <mixed-citation publication-type="other">Joglekar, A. A spatially resolved brain region- and cell type-specific isoform atlas of the postnatal mouse brain. 10.5281/ZENODO.4278162 (2020).</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
      <journal-title-group>
        <journal-title>Nature Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2041-1723</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33741943</article-id>
      <article-id pub-id-type="pmc">7979764</article-id>
      <article-id pub-id-type="publisher-id">21892</article-id>
      <article-id pub-id-type="doi">10.1038/s41467-021-21892-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Spatiotemporal single-cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9844-7852</contrib-id>
          <name>
            <surname>Mantri</surname>
            <given-names>Madhav</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Scuderi</surname>
            <given-names>Gaetano J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Abedini-Nassab</surname>
            <given-names>Roozbeh</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Michael F. Z.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McKellar</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9658-2847</contrib-id>
          <name>
            <surname>Shi</surname>
            <given-names>Hao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Grodner</surname>
            <given-names>Benjamin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9309-6296</contrib-id>
          <name>
            <surname>Butcher</surname>
            <given-names>Jonathan T.</given-names>
          </name>
          <address>
            <email>jtb47@cornell.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6085-7311</contrib-id>
          <name>
            <surname>De Vlaminck</surname>
            <given-names>Iwijn</given-names>
          </name>
          <address>
            <email>vlaminck@cornell.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, </institution></institution-wrap>Ithaca, NY USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Computational Biology Ph.D. Program, Cornell University, </institution></institution-wrap>Ithaca, NY USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.502998.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0550 3395</institution-id><institution>Department of Engineering, </institution><institution>University of Neyshabur, </institution></institution-wrap>Neyshabur, Iran </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>3</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>3</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>1771</elocation-id>
      <history>
        <date date-type="received">
          <day>4</day>
          <month>6</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>2</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2021</copyright-statement>
        <license license-type="OpenAccess">
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Single-cell RNA sequencing is a powerful tool to study developmental biology but does not preserve spatial information about tissue morphology and cellular interactions. Here, we combine single-cell and spatial transcriptomics with algorithms for data integration to study the development of the chicken heart from the early to late four-chambered heart stage. We create a census of the diverse cellular lineages in developing hearts, their spatial organization, and their interactions during development. Spatial mapping of differentiation transitions in cardiac lineages defines transcriptional differences between epithelial and mesenchymal cells within the epicardial lineage. Using spatially resolved expression analysis, we identify anatomically restricted expression programs, including expression of genes implicated in congenital heart disease. Last, we discover a persistent enrichment of the small, secreted peptide, thymosin beta-4, throughout coronary vascular development. Overall, our study identifies an intricate interplay between cellular differentiation and morphogenesis.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Using single-cell and spatial transcriptomics in chicken hearts, here, the authors generate a census of cellular interactions from early to late four-chambered heart stage, identifying a distinct epicardial-mesenchymal cell population with a&#xA0;migratory phenotype.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Differentiation</kwd>
        <kwd>Organogenesis</kwd>
        <kwd>Heart development</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par3">The heart is the first fully functional organ to develop and is vital for embryogenesis<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Cardiogenesis involves heterogeneous cell populations from multiple lineages that spatiotemporally interact to drive cardiac fate decisions<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. The heterogeneity of cell types during cardiac development makes it difficult to study cardiac fate decisions using traditional developmental biology techniques. Single-cell RNA-sequencing (scRNA-seq) has been used to study the cellular mechanisms involved in heart development, but does not preserve spatial information, and does not enable studies of the complex interplay between cellular differentiation and morphogenesis. Here, we combined spatially resolved RNA-seq with high-throughput scRNA-seq to study the spatiotemporal interactions and regulatory programs that drive embryonic chicken heart development. Current spatial transcriptomics approaches lack single-cell resolution, which we addressed here using approaches to integrate high-throughput spatial and single-cell transcriptomic data.</p>
      <p id="Par4">Chicken embryos were used as a cardiogenesis model system since the ex-utero development in an egg allows unique access to early cardiogenesis stages and the chicken heart anatomy resembles many aspects of human heart anatomy<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. We generated over 22,000 single-cell transcriptomes across four key Hamburger-Hamilton ventricular development stages (HH21-HH24, HH30-HH31, HH35-HH36, and HH40). The data encompasses common and rare cell types, including progenitor and mature cell types from multiple lineages. In addition, we performed spatially resolved RNA-seq on a total of 12 heart tissue sections at the same four stages.</p>
      <p id="Par5">In this study, the combination of single-cell and spatial transcriptomics uniquely enables us to unravel cellular interactions that drive cardiogenesis and reconstruct a high-resolution, spatially resolved gene expression census of developmental cardiac lineages. We characterize and spatially resolve progenitor and differentiated cell types, identify stage-specific transcriptional programs and cellular interactions, reconstruct differentiation lineages, and delineate important regulatory programs in cardiac development. We integrate scRNA-seq and spatial RNA-seq data using an anchor-based method to predict cell type annotations for spatially resolved transcriptomes. We use these cell-type predictions to construct proximity maps identifying changes in local cellular environments and uncovered spatially restricted regulatory programs. We furthermore construct a similarity map between single-cell and spatial transcriptomes, which enables us to spatially map lineage-associated differentiation trajectories within the tissue. This analysis identifies transcriptional differences between epithelial and mesenchymal cells, further clarifies the differentiation transitions within the epicardial lineage, and points to the utility of spatiotemporal single-cell RNA sequencing to study cardiogenesis.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>Spatially resolved single-cell transcriptomics census of developing embryonic chicken hearts</title>
        <p id="Par6">To study the complex interplay between differentiation and morphogenesis during cardiac development, we combined single-cell and spatial transcriptomics. We profiled four key Hamburger-Hamilton ventricular development stages of the chicken heart: (i) day 4 (HH21-HH24, whole ventricles), corresponding to the early chamber formation stage during the initiation of ventricular septation and only trabeculated myocardium, (ii) day 7 (HH30-HH31, left and right ventricles), one of the earliest stages of cardiac four-chamber formation with ventricular septation almost complete but the myocardium containing mostly fenestrated trabeculated sheets, (iii) day 10 (HH35-HH36, left and right ventricles), a mid-four chamber development stage with septation complete and mostly compact myocardium, and (iv) day 14 (~HH40, left and right ventricles), a late four-chamber development stage with completely compact myocardium and the main events of cardiogenesis essentially complete<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>.</p>
        <p id="Par7">To perform scRNA-seq (10x Genomics Chromium platform), we enzymatically digested cardiac ventricular tissue into single-cell suspensions (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>, see &#x201C;Methods&#x201D; section). The pooling of cells from up to 72 embryonic hearts enabled scRNA-seq on ventricular tissue at the early stages of development. To perform spatial transcriptomics (10x Genomics Visium platform), we cryosectioned 10 &#x3BC;m coronal tissue slices (chamber view) from embryonic hearts at the same four stages (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>, See &#x201C;Methods&#x201D; section). We generated single-cell transcriptomic data for 22,315 cells and spatial transcriptomics data for 12 tissue sections covering over 6800 barcoded spots (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1a</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1b</xref>). We found that spatial transcriptomes collected at the same developmental stage were strongly correlated (Pearson correlation; <italic>R</italic>&#x2009;&gt;&#x2009;0.98, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1d</xref>), and that spatial transcriptomes and single-cell transcriptomes collected at the same developmental stage were strongly correlated (Pearson correlation; R 0.88-0.91, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1e</xref>). The combination of scRNA-seq and spatial transcriptomics uniquely enabled us to spatially resolve cell-type-specific gene expression in cardiac tissues.<fig id="Fig1"><label>Fig. 1</label><caption><title>Spatially resolved single-cell transcriptomic atlas of developing embryonic chicken hearts.</title><p><bold>a</bold> Experimental workflow and analysis for single-cell RNA-seq and spatial RNA-seq of embryonic chicken (<italic>Gallus gallus</italic>) hearts at four stages of development. <bold>b</bold> UMAP projection of 22,315 single-cell transcriptomes clustered by gene expression and colored by cell type (Left). UMAP projection of single-cell transcriptomes colored by cell type and split by developmental stage from day 4 to day 14 (Right). <bold>c</bold> Spatial RNA-seq barcoded spots labeled by scRNA-seq cell type with maximum prediction score for four developmental stages. Only spots under tissue sections are shown. <bold>d</bold> Gene expression of cell type-specific markers. The size of the dot represents the percentage of cells in the clusters expressing the marker and the color intensity represents the average expression of the marker in that cluster. <bold>e</bold> Chord diagrams representing cell-type proximity maps showing the degree of colocalization of cell-type pairs within spots in spatial RNA-seq data across developmental stages.</p></caption><graphic xlink:href="41467_2021_21892_Fig1_HTML" id="d32e397"/></fig></p>
        <p id="Par8">To analyze single-cell transcriptomes, we filtered and preprocessed the data (see &#x201C;Methods&#x201D; section), performed batch correction using scanorama<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1c</xref>), performed dimensionality reduction and cell clustering, and then visualized the data by Uniform Manifold Approximation and Projection (UMAP, see &#x201C;Methods&#x201D; section). This analysis identified 15 distinct cardiac cell type clusters (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). We used canonical marker gene and differential gene expression analysis to assign cell types to cell clusters (Supplementary Data&#xA0;<xref rid="MOESM2" ref-type="media">1</xref>, Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>) and identified diverse cell clusters from myocardial, endocardial, and epicardial cardiac lineages in the ventricles (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1f</xref>). In addition to cardiac cell types, we detected a small number of erythrocytes, macrophages, and dendritic cells. Last, we identified a unique heterogeneous population of cells that express high levels of thymosin beta-4 (<italic>TMSB4X</italic>). A detailed overview of the cell-types identified is provided in the supplement (Supplementary Data&#xA0;<xref rid="MOESM2" ref-type="media">1</xref>).</p>
        <p id="Par9">Standalone analysis of the spatial transcriptomic data identified anatomical regions with differential transcriptional programs. To spatially resolve cell populations, the spatial transcriptomics data was integrated with the scRNA-seq data using Seurat-v3 anchor-based integration<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. This approach first identifies anchors between datasets, which represent pairwise correspondences between elements in the two datasets that appear to originate from the same biological state. The anchors are then used to harmonize the datasets by learning a joint structure with canonical correlation analysis and to transfer annotation information from one dataset to the other. Every spot in the spatial data could be considered a weighted mix of cell-types identified by scRNA-seq. We used the prediction scores from label transfer to obtain weights for each of the scRNA-seq-derived cell types for each spot (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2a&#x2013;o</xref>, see &#x201C;Methods&#x201D; section). To understand the spatial organization of cell types in broad anatomical regions, spots were labeled as cell types with a maximum prediction score and visualized on H&amp;E stained images of respective stages (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>).</p>
        <p id="Par10">Cell-type prediction scores for spatial transcriptomes were further used to estimate the abundance of pairs of specific cell types (see &#x201C;Methods&#x201D; section). As proximity is a necessity for physical interactions between two or more cells, these cell-type proximity maps can be used to guide the discovery of interactions between cell types from the same or different lineages. We constructed proximity maps for all cardiac cell type pairs and visualized them as chord diagrams (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e</xref>). We found a significant colocalization of myocardial cells with endocardial cells at day 7 and with vascular endothelial and fibroblast cells at day 10 and day 14. This was expected given that endocardial cells line the trabeculated myocardium at day 7 and that vascular endothelial cells and fibroblasts are present in the compact myocardium by day 10.</p>
      </sec>
      <sec id="Sec4">
        <title>Spatially resolved cardiac lineage analysis</title>
        <p id="Par11">Single-cell RNA sequencing enables us to profile transcriptional regulation of highly heterogeneous cell populations and facilitates the discovery of genes that identify cell subtypes, or that mark intermediate states during a biological process, as well as bifurcate between two alternative cellular fates. We hypothesized that characterizing differentiation transitions in a spatial context would identify cellular morphogenic events that occur during the differentiation process of ventricular development. To do so, we gathered and reclustered single-cell transcriptomes from the epicardial, endocardial, and myocardial lineages (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1f</xref>, Supplementary Data&#xA0;<xref rid="MOESM3" ref-type="media">2</xref>), and then reconstructed lineage differentiation trajectories. We used the trajectory reconstruction tools PHATE<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> (Potential of Heat-diffusion for Affinity-based Transition Embedding) and monocle<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> to learn the structure in scRNA-seq data and order cells by developmental state (pseudotime), placing them along a trajectory corresponding to cellular differentiation (Supplementary Note&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>). We then spatially projected information about cellular transitions from scRNA-seq onto the spatial maps by estimating the local PHATE1 dimension, a proxy for developmental time (see &#x201C;Methods&#x201D; section, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Spatiotemporal lineage analysis identifies heterogeneity in cardiac progenitor cells.</title><p><bold>a</bold> Overview of analysis pipeline for trajectory reconstruction for scRNA-seq and spatial RNA-seq data. <bold>b</bold> UMAP projection of single-cell transcriptomes from individual epicardial lineage cells clustered by gene expression and colored by cell type (left-top) and developmental stage (left-bottom). Feature plots showing expression of gene markers for individual epicardial lineage cells (right). <bold>c</bold> Epicardial lineages visualized by PHATE and labeled by cell type (top) and development stage (bottom). <bold>d</bold> Spatially resolved spatial RNA-seq spot pseudotime for epicardial lineage across developmental stages. Spot pseudotime was estimated using a similarity map between scRNA-seq cells and spatial RNA-seq spots. <bold>e</bold> single-molecule FISH of Day 7 (HH31) ventricular free walls stained for <italic>POSTN</italic> (green), <italic>TCF21</italic> (red), and DAPI (blue) with <italic>LUM</italic> (orange). <bold>f</bold> Single-molecule fluorescent in situ hybridization of Day 7 (HH31) ventricular free walls stained for <italic>POSTN</italic> (green), <italic>TCF21</italic> (red), and DAPI (blue) with <italic>AGRN</italic> (orange). The Blue channel is DAPI. Representative images of three to four biological replicates.</p></caption><graphic xlink:href="41467_2021_21892_Fig2_HTML" id="d32e524"/></fig></p>
        <p id="Par12">Lineage analysis for epicardial cells identified a rich spatiotemporal differentiation process. The embryonic heart stages analyzed in this study represent key timepoints of epicardial development ranging from before the epicardial-to-mesenchymal transition (EMT) (HH24&#x2013;day 4), during EMT and epicardial differentiation (HH31&#x2013;day 7), and during/after epicardial differentiation (HH36&#x2013;day 10 and HH40&#x2013;day 14)<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. We selected epi-epithelial (<italic>TCF21</italic>+ <italic>WT1</italic>+ <italic>TEK</italic>&#x2212;), epi-mesenchymal (<italic>TCF21</italic>+ <italic>TEK</italic>&#x2212;), fibroblast cells (<italic>TCF21</italic>+ <italic>POSTN</italic>+ <italic>TEK</italic>&#x2212;), and mural cells for epicardial lineage analysis. Clustering of 5,621 epicardial cells from the ventricular free wall identified five main cell clusters: an early epicardial progenitor cells cluster (C1), two intermediate precursor cell clusters (C2 and C3), a fibroblast-like cell cluster (C4), and a mural cell cluster (C5) (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>, left and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3a</xref>). Cells in cluster C1 were mainly derived from the HH24 (day 4) ventricles and expressed canonical epicardial progenitor markers such as transcription factor 21 (<italic>TCF21</italic>)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>, t-box transcription factor 18<sup><xref ref-type="bibr" rid="CR10">10</xref></sup> (<italic>TBX18</italic>), and Wilm&#x2019;s tumor 1 (<italic>WT1</italic>)<sup><xref ref-type="bibr" rid="CR11">11</xref></sup> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3c</xref>). They also expressed retinoic acid signaling-related transcript aldehyde dehydrogenase<sup><xref ref-type="bibr" rid="CR12">12</xref>,<xref ref-type="bibr" rid="CR13">13</xref></sup> (<italic>ALDH1A2</italic>), a well-known signaling pathway involved in epicardial development (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>, left and right). Last, these cells showed an enriched expression of midkine (<italic>MDK</italic>), another retinoic acid signaling related transcript and growth factor<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>, that has not been implicated before in epicardial development (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref>).</p>
        <p id="Par13">At the HH31 (day 7) stage when EMT is underway<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>, two main cell clusters were identified (C2 and C3). C2 cells were <italic>TCF21</italic>+, <italic>WT1</italic>+, <italic>TBX18</italic>+, and had an upregulated expression of <italic>MDK</italic> (Supplementary Fig&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3d</xref>, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). In comparison to the C1 cluster, this C2 cluster had an upregulated expression of bone morphogenetic protein 4 (<italic>BMP4</italic>), which is associated with an epicardial progenitor-like phenotype<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, and lumican (<italic>LUM</italic>), which is known to be expressed in the outermost epicardial layer of embryonic hearts<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>, right, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3e</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3f</xref>). In contrast to the C2 cluster, the <italic>TCF21</italic>+ C3 cell cluster was mostly <italic>TBX18</italic>&#x2212; and <italic>WT1</italic>&#x2212; (Supplementary Fig&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref>, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). Interestingly, these C3 cells expressed high levels of extracellular matrix transcripts implicated in cell migration, including fibronectin (<italic>FN1</italic>), periostin (POSTN), epidermal growth factor-like domain multiple 7 (<italic>EGFL7</italic>)<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>, and agrin (<italic>AGRN</italic>)<sup><xref ref-type="bibr" rid="CR19">19</xref>&#x2013;<xref ref-type="bibr" rid="CR22">22</xref></sup> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3g&#x2013;h</xref> and Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). This cluster also had upregulated expression of the well-known EMT regulator snail-1 (<italic>SNAI1</italic>)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and was TEK&#x2212; which is a TIE2 ortholog and an endocardial-derived TCF21+ fibroblast marker<sup><xref ref-type="bibr" rid="CR24">24</xref></sup> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref>, Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). Transferring cell type labels to spatial data suggested that only the epi-epithelial (epicardial subclusters C1 and C2) were spatially restricted to the outermost epicardial layer of the ventricular walls in day 7 and day 10 heart stages (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2a</xref>). However, epi-mesenchymal (epicardial subcluster C3) were not spatially restricted to the outer epicardial layer in day 7 hearts, indicating they reside within the myocardium as opposed to the outer epicardial layer (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2b</xref>). Therefore, this data further suggests these C3 HH31 day 7 staged cells represent a mesenchymal phenotype of epicardial progenitor-derived cells (EPDCs) that are most likely undergoing EMT and migrating into the myocardium while the C2 HH31 day 7 staged cells are epi-epithelial cells lining the epicardium.</p>
        <p id="Par14">By the day 10 (HH36) heart stage, <italic>TCF21</italic>+ <italic>TEK</italic>&#x2212; epicardial-derived fibroblasts (C4) express collagen type III (COL3A1) and decorin (DCN) and mural cells (C5) expressing <italic>ACTA2</italic>, <italic>MYH11</italic>, <italic>TAGLN</italic>, and <italic>RGS5</italic> are present within the myocardium (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref>). However, some cells in the outermost epicardial layer at the day 10 (HH36) stage still maintain an intermediate undifferentiated phenotype as suggested by our cell type label transferred spatial RNA-seq showing epi-epithelial cells localized to day 10 epicardium (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2a</xref>). By the day 14 (HH40) stage, most epicardial layer cells have differentiated to a fibroblast-like phenotype as suggested by their localization to day 14 epicardium, while other fibroblasts and mural cells localize throughout the myocardium as expected (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2c</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2d</xref>). PHATE-based trajectory reconstruction confirmed branching cell fates at day 7 and branch-merging and differentiation at day 10 (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c</xref>). Additional lineage trajectory analysis by monocle-v2<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> is presented in the supplement (see &#x201C;Methods&#x201D; section, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3i&#x2013;j</xref>). Pseudotime correlated well with stages in spatial data and identified significant within-stage variability at days 7 and 10 with a presence of undifferentiated cells in the epicardium lining and differentiated cells in the myocardium (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2d</xref>). Gene ontology enrichment analysis for genes that significantly correlated with pseudotime confirms an increase in extracellular matrix directing cues during epicardial development (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3k</xref>).</p>
        <p id="Par15">To support the epicardial lineage results, we performed multiplexed single-molecule fluorescent in situ hybridization (smFISH) assays on day 7 (HH31) heart sections (see &#x201C;Methods&#x201D; section). In agreement with our scRNAseq data, we identify <italic>TCF21</italic>+, <italic>POSTN</italic>+ cells residing within the compact myocardium of the ventricular free walls that are <italic>LUM</italic>&#x2212; suggesting the presence of EPDCs that have undergone EMT and reside within the myocardium (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4a</xref>, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2e</xref>). In contrast, cells that line the outermost epicardial layer are <italic>TCF21</italic>+, <italic>POSTN</italic>+, and <italic>LUM</italic>+, (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4a</xref>, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2e</xref>). Last, we found that EPDCs upregulate the expression of a variety of key extracellular matrix genes implicated in migration. We performed smFISH to demonstrate that these EPDCs are <italic>AGRN</italic>+ (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4b</xref>, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2f</xref>). Overall, these smFISH results validate the findings from scRNA-seq and spatial RNA-seq and are consistent with the possibility that these cell populations are derived from the epicardial lineage.</p>
        <p id="Par16">For the ventricular endocardial lineage, we did not capture intermediate cell types transitioning to endocardial-derived fibroblasts, endocardial-derived mural cells, or ventricular endocardium-derived vascular endothelial cells, possibly because this transition occurs rapidly in between the stages analyzed in this study<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR26">26</xref></sup>. We identified two cell clusters within the endocardial lineage: early endocardial cells (C1) from days 4 and 7, and mature endocardial cells (C2) from days 10 and 14 (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5a</xref>, left and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5d</xref>). The two ventricular endocardial cell subclusters expressed the endocardial marker (NPC2), the differentiated endothelial markers <italic>CDH5</italic>, <italic>PECAM1</italic>, <italic>PODXL</italic><sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, <italic>ENG</italic><sup><xref ref-type="bibr" rid="CR28">28</xref></sup>, and the retinoic acid signaling related transcript <italic>RARRES1</italic><sup><xref ref-type="bibr" rid="CR29">29</xref></sup> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5a</xref>, right). Endocardial cells lined the ventricular chambers of all heart stages in the spatial RNA-seq data, helping to confirm their ventricular endocardial origin (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2e</xref>). PHATE based trajectory and pseudotime analysis further confirmed these endocardial cell phenotypes across stages (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5b&#x2013;e</xref>).</p>
        <p id="Par17">In the myocardial lineage, we identified three clusters: an immature myocardial cell cluster (C1) predominantly containing cardiomyocytes from day 4 and 7, a mature cardiomyocyte cell cluster (C2) from mostly day 10 and 14, and a transcriptionally less active cardiomyocyte&#x2014;a cluster (C3) from day 4 and 7 (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5f</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5j</xref>, Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). All cells expressed mature cardiomyocyte markers like cardiac troponin (<italic>TNNC1</italic>), while immature myocardial cells differentially expressed the progenitor markers <italic>NKX2-5</italic><sup><xref ref-type="bibr" rid="CR30">30</xref></sup>, <italic>PITX2</italic><sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, and <italic>IRX4</italic><sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. The differentiated cardiomyocytes were enriched in myosin light chain-10 (<italic>MYL10</italic>) and myoglobin (<italic>MB</italic>) (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5f</xref>, right, and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5i</xref>). PHATE-based trajectory reconstruction of the myocardial lineage confirmed a progression from an immature phenotype (C1) to a more mature phenotype (C2), but the transcriptionally less active cardiomyocyte-like cells (C3) did not follow this trajectory (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5g</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5h</xref>). These trajectory analysis results corroborate the differentiation trajectory of cardiomyocytes in human fetal hearts reported recently<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>.</p>
      </sec>
      <sec id="Sec5">
        <title>Spatiotemporally resolved local cellular heterogeneity in developing cardiac tissue</title>
        <p id="Par18">To examine spatial transcriptional differences within the embryonic cardiac ventricles, we performed unsupervised clustering of spatial RNA-seq spots and labeled the clusters by anatomical region based on their location in the tissue. Using this analysis, we identified distinct spatial clusters derived from ventricles, atria, valves, and the outflow tract but also distinct layers of ventricular regions including epicardium, compact and trabecular myocardium regions, and endocardium (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6a</xref>). Differences in local gene expression can be explained by either difference in cellular composition or cell-type-specific gene expression. We used cell type prediction scores for spatial transcriptomes as a proxy for cellular composition and analyzed temporal changes in local cellular composition for the major anatomical regions within ventricular tissue (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>). We observed a decline in the proportion of the undifferentiated and immature cells and an increase in differentiated cells across stages in all ventricular regions, as expected. The average proportion of endothelial cells decreased in both ventricles, likely due to the compaction of trabecular cardiomyocytes and thickening of the compact myocardium throughout developmental time (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6e</xref>). Two to eight-cell types contributed to each local transcriptome (number of distinct cell types with a prediction score greater than 5%) with a low local cell-type heterogeneity in the valve region and high heterogeneity in the trabecular regions of the heart (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref>). On day 14, we observed spots with high heterogeneity interspersed in the compact ventricle, which surrounds vascular networks (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2j</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Spatial RNA-seq identifies spatially restricted genes in cardiac tissue during development.</title><p><bold>a</bold> Spatial RNA-seq barcoded spots clustered by gene expression and labeled by tissue anatomical compartment for four developmental stages. <bold>b</bold> Average cell type composition across various tissue anatomical compartments. <bold>c</bold> Spatial map showing the cell type heterogeneity for every spot in cardiac tissue across stages. Cell type was estimated by enumerating the number of distinct cell-types with prediction scores greater than 5%. <bold>d</bold>&#x2013;<bold>h</bold> Spatially resolved gene expression for spatially restricted genes. <bold>d</bold>
<italic>TBX5</italic> overexpressed in left ventricles on day 7 and day 10. <bold>e</bold>
<italic>TBX20</italic> showing no spatial restriction. <bold>f</bold>
<italic>CHGB</italic> overexpressed in right ventricles across stages. <bold>g</bold>
<italic>ACTG2</italic> overexpressed in right ventricles on day 7. <bold>h</bold>
<italic>MB</italic> expressed in compact myocardium on day 10 and day 14. MB expression increases with the developmental stage. <bold>i</bold> smFISH stained day 7 and day 14 hearts for TBX5 (red), <italic>TBX20</italic> (orange), <italic>TNNT2</italic> (green), and DAPI (blue) confirming <italic>TBX5</italic> overexpressed in left ventricles of day 7 hearts but not day 14 and <italic>TBX20</italic> showing no left or right ventricle expression differences. Representative images of three to four biological replicates.</p></caption><graphic xlink:href="41467_2021_21892_Fig3_HTML" id="d32e1044"/></fig></p>
        <p id="Par19">To detect region-specific markers, we performed differential gene expression analysis between anatomical regions on individual stages (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6a</xref>). Interestingly, we found stage-dependent transcriptional differences in left and right ventricles at both day 7 and day 10. These differences diminished by day 14 when the main cardiogenesis events were complete. T-box transcription factor 5 (<italic>TBX5</italic>) expression was significantly enriched in the left ventricle as compared to the right and this difference decreases with a stage from days 7 to day 14 (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3d</xref>). Chromogranin B (<italic>CHGB</italic>) expression was mostly restricted to the right ventricle from day 7 onwards and <italic>ACTG2</italic> expression to the right ventricle on day 7 (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3f</xref> and&#xA0;<xref rid="Fig3" ref-type="fig">3g</xref>). <italic>TBX5</italic> specifies the positioning of the left and right ventricular chambers and has been shown to be enriched in the left ventricle of developing chicken hearts<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. We note that the same study by Takeuchi et al. also reported right-ventricle specific expression of <italic>TBX20</italic>, but our spatial transcriptome data did not corroborate this finding (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3e</xref>). scRNA-seq datasets from day 7 to day 14 did not capture the sharp differences in <italic>TBX5</italic>, <italic>ACTG2</italic>, and <italic>CHGB</italic> ventricular expression, although they did seem to trend towards being expressed in a higher proportion of cells in their proposed ventricles (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6b</xref>). smFISH confirmed the upregulation of <italic>TBX5</italic> in the trabecular cardiomyocytes of the left ventricle and identified that this enrichment decreases with the developmental stage (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3i</xref>). smFISH experiments further confirmed a very low but equal expression of <italic>TBX20</italic> in the left and right ventricles across stages (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3i</xref>). Our analysis also identified that myoglobin (<italic>MB</italic>) expression was spatially restricted to the developing compact myocardial layers in the later stages, indicative of cardiomyocytes transitioning to a more mature phenotype with a greater demand for oxygen (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3h</xref>). By accounting for local cell-type composition, we found that this <italic>MB</italic> upregulation is a result of both an increase in mature myocytes and increased <italic>MB</italic> expression in myocyte cells in compact myocardium (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6c</xref>). On the contrary, the natriuretic peptide B (<italic>NPPB</italic>) gene was spatially restricted to developing trabeculated myocardial layers, as expected<sup><xref ref-type="bibr" rid="CR35">35</xref>&#x2013;<xref ref-type="bibr" rid="CR37">37</xref></sup> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6d</xref>).</p>
        <p id="Par20">We further explored spatial RNA-seq datasets to identify Spatio-temporal patterns in the expression of congenital heart defects (CHD) associated genes. Loss of function dominant mutations in over 50 human genes have been found to be associated with CHD. Expression of these genes occurs in highly specified temporal&#x2013;spatial patterns throughout development, a level of regulation that might predict there could be strong correlations between genotype and phenotype in CHD<sup><xref ref-type="bibr" rid="CR38">38</xref>&#x2013;<xref ref-type="bibr" rid="CR40">40</xref></sup>. We performed spatial RNA-seq analysis on genes implicated in CHD and found that the expression of crucial transcription factors like <italic>GATA5</italic> was enriched in the valve region, IRX4 expression was restricted to the ventricular tissue, and <italic>TBX5</italic> was enriched in the left ventricle (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a&#x2013;b</xref> and Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3d</xref>). <italic>PITX2</italic> gene which is a master regulator of laterality in early plate mesoderm and a critical component in determining organ laterality was enriched in the left side of the heart as expected (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4c</xref>). Expression of CHD-associated sarcomeric protein-coding genes like <italic>ACTC1</italic> and <italic>GJA5</italic> were enriched in both atrial and ventricular tissue but <italic>MYH7</italic> was restricted to atrial chambers only (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4d&#x2013;f</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Spatially resolved gene expression for congenital heart disease (CHD) associated genes.</title><p><bold>a</bold>
<italic>GATA5</italic>, (<bold>b</bold>) <italic>IRX4</italic>, (<bold>c</bold>) <italic>PITX2</italic>, (<bold>d</bold>) <italic>ACTC1</italic>, (<bold>e</bold>) <italic>MYH7</italic>, and (<bold>f</bold>) <italic>GJA5</italic>.</p></caption><graphic xlink:href="41467_2021_21892_Fig4_HTML" id="d32e1227"/></fig></p>
      </sec>
      <sec id="Sec6">
        <title>A persistent enrichment of thymosin beta-4 expression in coronary vascular cells</title>
        <p id="Par21">Unsupervised clustering of single-cell transcriptomes identified a heterogeneous cell cluster enriched in <italic>TMSB4X</italic> containing cells from all four developmental stages (<italic>TMSB4X</italic> High Cells in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">7a</xref>). <italic>TMSB4X</italic> encodes thymosin beta-4, a well-known pleiotropic, secreted small peptide, which plays an important role in the actin-cytoskeletal organization, cellular motility, survival, and differentiation<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. Because little is known about the spatiotemporal and cell-type-specific expression profile of thymosin beta-4 during cardiogenesis, we investigated the heterogeneity of cellular phenotypes and their transcriptional profile within the <italic>TMSB4X</italic> high cluster in depth.</p>
        <p id="Par22">We first re-clustered 1075 <italic>TMSB4X</italic> high cells from this cluster and examined its cell-type composition (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>). We found that cluster 1 mainly consisted of epicardial cells expressing <italic>TCF21</italic> and endocardial cells expressing endocardial markers <italic>IRX6</italic><sup><xref ref-type="bibr" rid="CR42">42</xref></sup> and <italic>NPC2</italic><sup><xref ref-type="bibr" rid="CR43">43</xref></sup> (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>, right). Cluster 2 mainly consisted of vascular mural cells that differentially express <italic>ACTA2</italic> (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>, right). Cluster 3 mainly consisted of coronary vascular endothelial cells that differentially express <italic>FABP5</italic> and <italic>TM4SF18</italic> (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>, right). <italic>TMSB4X</italic> was found to be enriched in valves and the ventricular wall at later stages in the spatial RNA-seq data (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">7b</xref>). Further analysis of scRNAseq data identified a slight increase in thymosin beta-4 expression with developmental stage and highest thymosin beta-4 expression within the coronary vascular endothelial cell subcluster 2 (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">7c</xref>). Cell type prediction scores identified that the &#x201C;<italic>TMSB4X</italic> high cells&#x201D; were detected within regions of the outermost layer of epicardium on day 4 and interspersed throughout the compact myocardium at day 14, which most likely represent coronary vascular cells (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2k</xref>). One other beta-thymosin, <italic>TMSB15B</italic>, was expressed but <italic>TMSB15B</italic> expression did not change with the stage (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">7e</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><title>A persistent enriched thymosin beta-4 expression in coronary vascular cells.</title><p><bold>a</bold> UMAP projection of 1,075 scRNA-seq <italic>TMSB4X</italic> high cells clustered by gene expression (left). Inset shows the UMAP projection of <italic>TMSB4X</italic> high cells labeled by developmental stage. Feature plots showing expression of gene markers for cell types in the &#x201C;<italic>TMSB4X</italic> high cells&#x201D; cluster: <italic>FABP5</italic> and <italic>TM4SF18</italic> for vascular endothelial, <italic>ACTA2</italic> and <italic>TCF21</italic> for mural cells, <italic>NPC2</italic> and <italic>IRX6</italic> for endocardial cells (right). <bold>b</bold> Volcano plot showing differentially expressed genes for <italic>TMSB4X</italic> high scRNA-seq cells computed using two-sided Wilcoxon Rank-Sum test. Dotted lines represent thresholds for significantly enriched genes (red): &#x2212;log<sub>2</sub> fold change &gt; 0.5 and <italic>p</italic>-value &lt;10<sup>&#x2212;5</sup>. <bold>c</bold>&#x2013;<bold>f</bold> smFISH images of the chicken heart ventricular free wall sections across four developmental stages labeled for cardiomyocyte cell marker <italic>TNNT2</italic> (green), endothelial cell marker <italic>CDH5</italic> (orange), thymosin beta-4 <italic>TMSB4X</italic> (red), and DAPI (blue). Representative images of three to four biological replicates. <bold>c</bold> Day 4 (HH24); Cells with high autofluorescence in all channels are Erythrocytes, (<bold>d</bold>) day 7 (HH31), (<bold>e</bold>) day 10 (HH36), (<bold>f</bold>) day 14 (HH40).</p></caption><graphic xlink:href="41467_2021_21892_Fig5_HTML" id="d32e1408"/></fig></p>
        <p id="Par23">Differential gene expression analysis of the <italic>TMSB4X</italic> high cell cluster identified significant upregulation of genes associated with cytoskeleton organization (vimentin (<italic>VIM</italic>), Rho GTPase (<italic>RHOA</italic>), actin beta (<italic>ACTB</italic>), actin gamma 1 (<italic>ACTG1</italic>), and Destin actin-depolymerizing factor (<italic>DSTN</italic>)) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5b</xref>). In addition, we observed upregulation of calcium-binding proteins calmodulin 1 (<italic>CALM1</italic>) and calmodulin 2 (<italic>CALM2</italic>), which are associated with cell cycle progression, proliferation, and signaling and are known to be activated by thymosin beta-4<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. Overall, we conclude that <italic>TMSB4X</italic> high cells exhibit increased cytoskeleton organization activity and calcium signaling, as confirmed by gene ontology analysis (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">7d</xref>).</p>
        <p id="Par24">To further characterize the specific cell types of these thymosin beta-4 high cells, we performed smFISH and immunohistochemistry experiments (see &#x201C;Methods&#x201D; section). At the day 4 (HH24) stage, the highest thymosin beta-4 mRNA expression was in the epicardium and endocardium (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5c</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8a</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8b</xref>). In day 7 (HH31) hearts, thymosin beta-4 mRNA expression was highest in developing coronary vascular endothelial cells as demonstrated by the overlap of the endothelial marker <italic>CDH5</italic> with <italic>TMSB4X</italic> and developing mural cells via overlap of <italic>PDGFRB</italic> with <italic>TMSB4X</italic> (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5d</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8a,</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8c</xref>). By the HH36 (day 10) stage, the highest thymosin beta-4 expression was observed in <italic>CDH5</italic>+ vascular endothelial cells and surrounding mural cells (<italic>CDH5</italic>&#x2212;, <italic>PDGFRB</italic>+) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5e</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8a,</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8d</xref>). By the HH40 (day 14) stage, <italic>TMSB4X</italic> expression remains high in <italic>CDH5</italic>+ vascular endothelial cells and a lower expression in <italic>PDGFRB</italic>+ <italic>CDH5</italic>&#x2212; mural cells (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5f</xref>, Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8a,</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8e</xref>). Immunohistochemistry assays further corroborated these findings (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">9a&#x2013;f</xref>). Together, combined spatially resolved transcriptomic and imaging data shows that <italic>TMSB4X</italic> is ubiquitously expressed by all cell types but enriched within coronary vascular cells from the initiation of coronary vasculature development through the maturation of the coronary vasculature during ventricular development.</p>
      </sec>
    </sec>
    <sec id="Sec7" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par25">We combined single-cell and spatial transcriptomics to create a hierarchical map of cellular lineages in the developing chicken heart. The dataset spans four developmental stages, 22,315 single-cell transcriptomes, and 12 spatial gene expression maps. By combining spatial and scRNA-seq assays using bioinformatic approaches, we analyzed cellular proximities within cardiac tissue, to measure changes in cellular composition with anatomical location, and to quantify anatomically restricted gene expression. Because cellular transitions in complex lineages do not occur in a synchronized manner, the data represents a broad range of cellular states even though we have investigated just four ventricular developmental stages. We mapped information about lineage differentiation transitions, obtained from pseudotime ordering of single-cell transcriptomes, on spatial maps, and were thereby able to demonstrate how cellular differentiation and morphological changes co-occur. Our analysis thus demonstrates how combined spatial and single-cell RNA-sequencing can be used to study both molecular and morphological aspects of development at high spatial and temporal resolution.</p>
      <p id="Par26">Our study provides insights into the transcriptional profiles of epicardial and epicardial-derived cells across ventricular development. The data suggest epicardial progenitor-derived cells (EPDCs) undergo EMT into the myocardium prior to fate specification since they maintain a progenitor-like transcriptional profile, which has been corroborated by other studies<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. What triggers these EPDCs to undergo EMT at specific developmental times and locations remains to be fully elucidated but our data suggests extracellular matrix cues are significantly involved in this process as we show an upregulation of many ECM factors implicated in cell migration, including <italic>AGRN</italic>, <italic>EGFL7</italic>, <italic>POSTN</italic>, and <italic>FN1</italic>. Just recently, studies have demonstrated agrin&#x2019;s critical role in regulating epicardial EMT<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Previous studies have also reported upregulation of POSTN and FN1 in EPDCs undergoing EMT in mice<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR47">47</xref></sup>. <italic>EGFL7</italic> is a secreted growth factor known to be expressed by endothelial cells and critical to angiogenesis<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> but has not been implicated in epicardial development. Interestingly, <italic>EGFL7</italic> transcripts have been shown to be present in a subset of murine neonatal fibroblasts that sharply declines during the murine neonatal heart regenerative window<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Further elucidation of the factors and programs involved in epicardial development will provide valuable insight for cardiac regenerative purposes in the adult context.</p>
      <p id="Par27">The data presented here furthermore provides much-needed clarity into the expression profile of thymosin beta-4 in specific cardiac cell types throughout ventricular development. The role of thymosin beta-4 in heart development has been under significant debate in the last decade. Cardiomyocyte-specific and endothelial-specific shRNA knockdowns of thymosin beta-4 have been shown to lead to cardiac abnormalities but no abnormalities were found for global, cardiomyocyte-specific, and endothelial-specific knockouts<sup><xref ref-type="bibr" rid="CR50">50</xref>&#x2013;<xref ref-type="bibr" rid="CR53">53</xref></sup>. These discrepancies are thought to be explained by compensatory mechanisms triggered when thymosin beta-4 is completely ablated in the knockouts, such as the use of other prevalent beta thymosins that have similar functional activity<sup><xref ref-type="bibr" rid="CR54">54</xref>,<xref ref-type="bibr" rid="CR55">55</xref></sup>. Our analysis demonstrates that thymosin beta-4 is ubiquitously expressed by all cell types but remains significantly enriched at the mRNA and protein levels in only the coronary vasculature cells at all the stages analyzed. A previous study in one late fetal human heart stage demonstrated high protein expression within vascular endothelial cells only low expression in cardiomyocytes<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>, in agreement with our observations. Beta thymosins have regenerative potential as demonstrated in adult myocardial infarction models<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. Since beta thymosins can affect many biological processes as pleiotropic secreted factors<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR57">57</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>, a deeper understanding of how beta thymosins and corresponding compensatory mechanisms influence the biological process of specific cardiac cell types during ventricular development could lead to the discovery of treatments for myocardial infarctions and congenital cardiac diseases.</p>
      <p id="Par28">Our analysis demonstrates several ways in which spatial RNA-seq can be used to improve the robustness of scRNA-seq, and vice versa. scRNA-seq requires surgical isolation of tissues of interest, making scRNA-seq prone to contamination by cells from adjacent tissues. Matched spatial RNA-seq can be used to identify such cellular contamination. For example, using spatial RNA-seq, we identified contamination of valve cells in ventricular scRNA-seq data collected at early stages. In addition to cellular contamination, scRNA-seq is sensitive to contamination by cell-free RNA released from cells that lyse during tissue dissociation, which is not the case for spatial RNA-seq. scRNA-seq data for matched tissue can be used to deconvolve spatial RNA-seq transcriptome to predict cell type compositions. These cell type predictions allow one to analyze and compare the relative composition of cell types per spot within and between tissues, albeit only for sections analyzed.</p>
      <p id="Par29">We note that previous scRNA-seq studies have studied the development of human and mouse hearts<sup><xref ref-type="bibr" rid="CR33">33</xref>,<xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR59">59</xref></sup>. These studies implemented low-throughput scRNA-seq methodologies and consequently suffered from limitations in cell-type resolution. A very recent study combined spatial transcriptomics combined with scRNA-seq to construct a spatiotemporal organ-wide gene expression and cell atlas of developing human hearts at three developmental stages in the first trimester: 4.5&#x2013;5 (&#x2248;HH28-31), 6.5 (&#x2248;HH34-37), and 9 post-conception weeks (&#x2248;HH40-later)<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. However, the study has limitations with respect to detecting rare cell types and identifying spatiotemporal cell-cell interactions due to the limited cell types being detected (total of only 3717 cells), limited genes being used in the in-situ sequencing (ISS) panel, and low resolution of the spatial transcriptomic technique (3115 spots containing ~30 cells per spot). Therefore, we were able to probe earlier stages and a broader range of stages of cardiac development, capture greater cell phenotypic heterogeneity, and show several aspects of epicardial and vascular development.</p>
      <p id="Par30">In conclusion, we have combined single-cell and spatial transcriptomics to explore the early development of chicken hearts at high molecular, spatial, and temporal resolution. We constructed a single cell, spatially resolved gene expression census, uncovered several regulatory mechanisms, and demonstrated that spatiotemporal single-cell RNA sequencing can be used to study the interplay between cellular differentiation and morphogenesis.</p>
    </sec>
    <sec id="Sec8">
      <title>Methods</title>
      <sec id="Sec9">
        <title>Sample preparation for single-cell transcriptomics</title>
        <p id="Par31">We used fertile bovans brown chicken (<italic>Gallus gallus</italic>) eggs to study the development of the heart on four key embryonic stages. Eggs were obtained from a farmer and were then incubated in a standard humidity and temperature-regulated egg incubator until the embryonic day of interest. The use of chick embryos at these developmental stages does not require ethical board approval. All embryos were quickly isolated and euthanized via decapitation. Ventricles were isolated aseptically, placed in ice-cold Hank&#x2019;s Balanced Salt Solution, and minced into 1&#x2013;2&#x2009;mm pieces. Six dozen day 4 (HH21-24) whole ventricles, four dozen day 7 (HH30-31) left and right ventricles, three dozen day 10 (HH35-36) left and right ventricles, and one dozen day 14 (HH40) left and right ventricles were pooled, respectively, for a total of seven samples to be analyzed via single-cell RNA sequencing. Ideally, scRNA-seq requires the tissue to be collected and used right away not to lose expression and get good cell viability. After a lot of practice on isolating hearts from early stages, we were able to isolate several dozen hearts in around an hour which was placed in Hank&#x2019;s Balanced Salt Solution on ice the whole time to minimize changes in expression in cells. Day 4 (HH21-24) and day 7 (HH30-31) ventricular samples were digested in 1.5&#x2009;mg/mL collagenase type II/ dispase (Roche) for one cycle of 20&#x2009;min and one cycle of 10&#x2009;min under mild agitation at 37&#x2009;&#xB0;C. Day 10 (HH35-36) and day 14 (HH40) ventricular samples were digested in 300&#x2009;U/mL collagenase type II (Worthington Biochemical Corporation) for four cycles of 10&#x2009;min under mild agitation at 37&#x2009;&#xB0;C. At the end of the digestions, the cells were passed through a 40&#x2009;&#xB5;m filter and centrifuged into a pellet. To remove most blood contaminants, samples were resuspended in an ammonium-chloride-potassium red blood cell lysis buffer (Thermo Fisher Scientific) and centrifuged again. Samples were then resuspended in phosphate-buffered saline with 0.04% bovine serum albumin (Thermo Fisher Scientific) at 1&#x2009;&#xD7;&#x2009;10<sup>6</sup> cells per mL. Cells from each sample were stained with Trypan Blue and cell viability was calculated on automated cell counters before loading the cells on 10x Chromium. The samples had a cell viability of around ~87&#x2013;89% for early stages and 92&#x2013;95% for later stages. Lower cell viability in earlier stages could be explained by the delay in tissue processing due to pooling dozens of hearts in a sample. We used these cell viabilities to adjust the number of cells loaded on 10x Chromium to get the desired number of transcriptomes from viable cells.</p>
      </sec>
      <sec id="Sec10">
        <title>Single-cell RNA sequencing library preparation</title>
        <p id="Par32">4000&#x2013;5000 cells per sample (for day 4 and day 7 samples) and 2000&#x2013;3000 cells per sample (for day 10 and day 14 samples) were targeted on the Chromium platform (10x Genomics) using one lane per time point. Single-cell mRNA libraries were built using the Chromium Next GEM Single Cell 3&#x2019; Library Construction V3 Kit for day 4 and day 7 samples and Chromium Next GEM Single Cell 3&#x2019; Library Construction V2 Kit for day 10 and day 14 samples, libraries sequenced on an Illumina NextSeq 500/550 using 75 cycle high output kits (Index 1&#x2009;=&#x2009;8, Read 1&#x2009;=&#x2009;28, and Read 2&#x2009;=&#x2009;55) for day 4 and day 7, 75 cycle high output kits (Index 1&#x2009;=&#x2009;8, Read 1&#x2009;=&#x2009;26, and Read 2&#x2009;=&#x2009;98) for day 10, and 75 cycle high output kits (Index 1&#x2009;=&#x2009;8, Read 1&#x2009;=&#x2009;26, and Read 2&#x2009;=&#x2009;58) for day 14. We observe a sequencing saturation of ~31% for day 4, ~50% for day 7 ventricles, ~91% for day 10 ventricles, and 94% and ~78% for day 14 ventricles. Sequencing data were aligned to chicken reference (assembly: GRCg6a) using the Cell Ranger 3.0.2 pipeline (10x Genomics).</p>
      </sec>
      <sec id="Sec11">
        <title>Reference genome and annotation</title>
        <p id="Par33"><italic>Gallus gallus</italic> genome and gene annotations (assembly: GRCg6a) were downloaded from Ensembl genome browser 97 and processed using the Cell Ranger 3.0.2 (10x Genomics) pipeline&#x2019;s mkref command. The reference was then used in the Cell Ranger &#x201C;count&#x201D; command to generate expression matrices.</p>
      </sec>
      <sec id="Sec12">
        <title>scRNA-seq data processing, batch correction, clustering, cell-type labeling, and data visualization</title>
        <p id="Par34">After excluding the cells with less than 200 unique genes or more than 20 percent mitochondrial transcripts, we analyzed 5653, 8463, 5190, and 3009 single-cell transcriptomes from day 4, day 7, day 10, and day 14, respectively. The 22,315 cells from 4 stages were transformed, normalized, and scaled using the Seurat V3 package, and then used for batch correction. During log-normalization, feature counts for each cell are divided by the total counts for that cell, then multiplied by the scale.factor (10<sup>6</sup>), and then natural-log transformed. Scanorama<sup><xref ref-type="bibr" rid="CR4">4</xref></sup> was used for dataset integration and batch correction using transformed and normalized expression values. We used the batch corrected values for further processing and analysis. The seurat-v3 package was used to select top variable genes for scRNA-seq clustering. We used the FindVariableFeatures function in Seurat to choose the top 2000 highly variable genes from the dataset using the &#x201C;vst&#x201D; selection method. We then performed mean centering and scaling, followed by principal component analysis (PCA) on a matrix composed of cells and batch-corrected scanorama-output values, and reduced the dimensions of the data to the top 20 principal components. Uniform Manifold Approximation and Projection (UMAP) was initialized in this PCA space to visualize the data on reduced UMAP dimensions. The cells were clustered on PCA space using the Lovain algorithm on k-nearest neighbors graph constructed using gene expression data as implemented in FindNeighbors and FindClusters commands in Seurat-v3. The method returned 17 cell clusters which were then visualized on UMAP space using the DimPlot command. Cell-type-specific canonical gene markers were used to label clusters differentially expressing those markers. To accurately label individual clusters, the Wilcox test was performed to find differentially expressed genes for each cluster. We used the FindAllMarkers function in Seurat to get a list of differentially expressed genes for each cluster. Gene expression was visualized using FeaturePlot, DoHeatMap, and VlnPlot functions from Seurat-v3. Cells were grouped into lineages using gene markers and then used for trajectory construction and pseudotime analysis.</p>
      </sec>
      <sec id="Sec13">
        <title>Sample preparation for 10x Visium spatial transcriptomics platform</title>
        <p id="Par35">Whole hearts were isolated using aseptic technique and placed in ice-cold sterile Hank&#x2019;s Balanced Salt Solution and then blood was carefully removed by perfusing the hearts through the apex. Fresh tissues were immediately embedded in Optimal Cutting Compound (OCT) media and frozen in liquid-nitrogen-cooled isopentane bath, cut into 10&#x2009;&#xB5;m sections using Thermo Scientific CryoStar NX50 cryostat, and mounted on 10x Visium slides, which were pre-cooled to &#x2212;20&#x2009;&#xB0;C.</p>
      </sec>
      <sec id="Sec14">
        <title>10x Visium spatial transcriptomics library preparation</title>
        <p id="Par36">We used the 10x Genomics Spatial RNAseq Visium platform for the spatial transcriptomics experiments. A 10x Genomics Visium Gene Expression slide has 4 capture areas each with an array of 5000 circular spots containing printed DNA oligos for mRNA capture. These oligos on each spot have a PCR handle, unique spatial barcode, Unique Molecular Identifier (UMI), and a poly-dT-VN tail for capturing the 3&#x2019; end of mRNA molecules. Each spot with a unique spatial barcode is 55&#x2009;&#xB5;m in diameter and the center to center distance between the spots is 110&#x2009;&#xB5;m. One 55&#x2009;&#xB5;m spot captures mRNA from 10 to 20 cells depending on cell size and packing density which is variable across the tissue. Tissue sections from fresh frozen chicken embryonic hearts were mounted for 4 stages (five sections from day 4-HH24, four sections for day 7-HH31, two sections for day 10-HH36, and one section for day 14-HH40) with one stage per capture area on a 10x Visium gene expression slide. The sample for day 4 had three biological replicates with two of them having technical replicates and the samples for day 7 and day 10 had four and two biological replicates, respectively. These sections are then fixed in pre-chilled methanol for 30&#x2009;min and then H&amp;E stained and imaged. H&amp;E staining is later used by the 10x Genomics Cell Ranger software to detect the spots which are covered by the tissue. Optimal permeabilization time for 10&#x2009;&#xB5;m thick chicken heart sections was found to be 12&#x2009;min using 10x Genomics Visium Tissue Optimization Kit. Spatially tagged cDNA libraries were built using the 10x Genomics Visium Spatial Gene Expression 3&#x2019; Library Construction V1 Kit. H&amp;E stained heart tissue sections were imaged using Zeiss PALM MicroBeam laser capture microdissection system and the images were stitched and processed using Fiji ImageJ software. cDNA libraries were sequenced on an Illumina NextSeq 500/550 using 150 cycle high output kits (Read 1&#x2009;=&#x2009;28, Read 2&#x2009;=&#x2009;120, Index 1&#x2009;=&#x2009;10, and Index 2&#x2009;=&#x2009;10). Fluidigm frames around the capture area on the Visium slide were aligned manually and spots covering the tissue were selected using Loop Browser 4.0.0 software (10x Genomics). Overall, tissue sections from day 4 to day 14 covered a total of 747, 1966, 1916, and 1967 spots on the capture area, respectively. Sequencing data were then aligned to the chicken reference genome using the Space Ranger 1.0.0 pipeline to derive a feature spot-barcode expression matrix (10x Genomics).</p>
      </sec>
      <sec id="Sec15">
        <title>Spatial RNA-seq data processing, integration, and visualization</title>
        <p id="Par37">Spatial RNAseq data from 6800 barcoded spatial spots from four 10x Visium capture areas was log-normalized using the Seurat V3.2 package and then used for batch correction. During log-normalization, feature counts for each spot are divided by the total counts for that cell, then multiplied by the scale.factor (10<sup>6</sup>), and then natural-log transformed. Seurat-v3.2 package was then used to select top variable genes for spatial RNA-seq clustering. We used the FindVariableFeatures function in Seurat to choose the top 2000 highly variable genes from the dataset using the &#x201C;vst&#x201D; selection method. We then performed mean centering and scaling, followed by principal component analysis (PCA) on a matrix composed of spots and gene expression (UMI) counts, and reduced the dimensions of the data to the top 20 principal components. Uniform Manifold Approximation and Projection (UMAP) was initialized in this PCA space to visualize the data on reduced UMAP dimensions. The spots were clustered on PCA space using the Shared Nearest Neighbor (SNN) algorithm implemented as FindNeighbors and FindClusters in Seurat v3.2 with parameters <italic>k</italic>&#x2009;=&#x2009;30, and resolution&#x2009;=&#x2009;0.5. The method returned spot clusters representing anatomical regions in the tissues, which were then visualized on UMAP space using the SpatialDimPlot command. To accurately label anatomical regions, the Wilcox test was performed to find differentially expressed genes for each region. We used the FindAllMarkers function in Seurat with its default parameters to get a list of differentially expressed genes for each cluster. Gene expression was visualized using the SpatialFeaturePlot function from Seurat v3.2. An anchor-based integration method implemented in Seurat-v3.2 was used for integration of spatial RNA-seq data with time-matched scRNA-seq data using FindIntegrationAnchors command and then cell type labels were transferred to spatial data using TransferData command. Cell type prediction values for Spatial RNA-seq spots were saved as an assay and used for further analysis. Cell type colocalization values were calculated by counting cell type pair abundances in spatial RNA-seq spots. Only cell types with the top four prediction scores in each spot were included. We also constructed a cell-spot similarity map by transferring cell barcode IDs to spatial barcoded spots. The cell-spot similarity matrix containing scRNA-seq cell similarity prediction for each spot in scRNA-seq data, which we further used to estimate pseudotime for spatial RNA-seq spots.</p>
      </sec>
      <sec id="Sec16">
        <title>Pseudotime analysis and trajectory construction</title>
        <p id="Par38">We used PHATE<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> (Potential of Heat-diffusion for Affinity-based Transition Embedding) to visualize developmental trajectories because of its ability to learn and maintain local and global distances in low dimensional space. We reclustered cells from individual lineages, performed PHATE dimension reduction on scanorama integrated values, and used PHATE1 dimension as a proxy for development time. PHATE reduction was performed using the phate command implemented in the R package: phateR. We also used monocle-v2<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup> to order the cells in epicardial, endocardial, and myocardial lineages along pseudotime and reconstruct lineage trajectories. We filtered the genes detected in the dataset and retained the top 2000 highly variable genes calculated using Seurat-v3 in our monocle analysis. We further filtered these genes to genes differentially expressed in cell type subclusters within the lineage using differentialGeneTest command and then reduced the dimension of the data using the DDRTree method. We used the ReduceDimension function in monocle-v2 to reduce the dimension to two DDRTree components, which is then used to define a pseudotime scale. The cells were then ordered along pseudotime using monocle&#x2019;s orderCells command, and the root of the trees was defined as the branch with maximum cells from Day 4 samples. The gene expression changes along pseudotime based trees were then visualized using PseudotimeHeatMap command in monocle-v2. To estimate pseudotime for spatial maps, we used the spot-cell similarity matrix and estimated pseudotime for individual lineages in spatial RNA-seq data. We defined spot pseudotime for a lineage as the average of scRNA-seq pseudotime (PHATE1 dimension or monocle pseudotime) for cells having a non-zero similarity prediction with that spot. This spot pseudotime was then visualized on spatial maps using the SpatialFeaturePlot command in Seurat-v3.2.</p>
      </sec>
      <sec id="Sec17">
        <title>Enrichment analysis for Gene Ontology (GO)</title>
        <p id="Par39">We used the genes differentially expressed between clusters in individual lineages to perform enrichment analysis for Gene Ontology. We selected significant genes using their p-value scores from differential expression test and used the classic fisher test implemented in topGO<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> R package for enrichment analysis of GO terms representing various Biological Processes (BP).</p>
      </sec>
      <sec id="Sec18">
        <title>smFISH split probe design strategy and Signal Amplification using HCR v3.0</title>
        <p id="Par40">A two-step hybridization strategy with split probe design and Hybridization Chain Reaction HCR v3.0<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> was used to label up to three transcripts in a single tissue section. Probes were designed using NCBI primer-blast which uses primer3 for designing internal hybridization oligo and BLASTn to check for binding specificity. We designed 19&#x2013;21&#x2009;bp primer pairs for an amplicon length of 38&#x2013;42&#x2009;bp, primer melting temperature between 57&#x2009;&#xB0;C and 63&#x2009;&#xB0;C, and primer GC content between 35% and 70%. 7&#x2013;13 sets of reverse complemented forward primers and reverse primers were then concatenated to flanking sequencing for HCR, ordered from IDT for each gene target, mixed together, and diluted in nuclease-free water to create a split probe pool stock solution at 10&#x2009;&#xB5;M for every target. The exact sequences of all probes used for the smFISH experiment have been provided in Supplementary Data&#xA0;<xref rid="MOESM4" ref-type="media">3</xref>. Hybridization Buffer (HB) was prepared with 2&#xD7; SSC, 5&#xD7; of Denhart Solution, 10% Ethylene Carbonate, 10% Dextran Sulfate, 0.01% SDS, 1uM of probe pool mix for the hybridization reaction. Hairpin pairs labeled with three different fluorophores namely Alexa-488, Alexa-546, and Alexa-647 (Molecular Instruments, Supplementary Data&#xA0;<xref rid="MOESM5" ref-type="media">4</xref>) were used for hybridization Chain Reaction v3.0. Amplification Buffer (AB) was prepared with 2&#xD7; SSC, 5&#xD7; of Denhart Solution, 10% Dextran Sulfate, 0.01% SDS, 0.06&#x2009;&#xB5;M of HCR hairpins for the amplification reaction. Two microliters of each fluorophore-labeled hairpins at 3&#x2009;&#xB5;M corresponding to the target genes were mixed, incubated at 95&#x2009;&#xB0;C for 1.5&#x2009;min, covered in aluminum foil, and left to cool down at room temperature for 30&#x2009;min to form hairpins before adding it to Amplification Buffer (AB).</p>
      </sec>
      <sec id="Sec19">
        <title>Multiplexed smFISH assays</title>
        <p id="Par41">Whole hearts were isolated using aseptic technique and placed in ice-cold sterile Hank&#x2019;s Balanced Salt Solution and then blood was carefully removed by perfusing the hearts through the apex. For day 7 (HH30), day 10 (HH36), and day 14 (HH40), fresh tissues were immediately embedded in Optimal Cutting Compound (OCT) media and frozen in liquid nitrogen-cooled isopentane, cut into 10&#x2009;&#xB5;m sections using a Thermo Scientific CryoStar NX50 cryostat, and mounted on &#x2212;20&#x2009;&#xB0;C cooled histological glass slides which were then stored at &#x2212;80&#x2009;&#xB0;C until used. For the day 4 (HH24) stage, whole embryos were isolated and fixed in 4% paraformaldehyde for about 16&#x2013;24&#x2009;h at 4&#x2009;&#xB0;C. Slides with tissue sections were then brought to room temperature until the sections melted and were then immediately fixed in 4% paraformaldehyde for 12&#x2009;min. Post fixation, the sections were washed for 5&#x2009;mins in 1&#xD7; PBS twice, incubated for 1&#x2009;h in 70% ethanol for tissue permeabilization, washed again for 5&#x2009;mins in 1&#xD7; PBS, and then used for primary hybridization. Twenty microliters hybridization mix (with probes) was then put on each slide to cover the tissue section placed inside a Biorad Frame Seal 9&#x2009;mm&#x2009;&#xD7;&#x2009;9&#x2009;mm chambers and incubated overnight at 37&#x2009;&#xB0;C inside a humidifying chamber. After primary hybridization, frame seals were removed and slides were washed in Hybridization Wash Buffer (0.215&#x2009;M NaCl, 0.02&#x2009;M Tris HCl pH 7.5, and 0.005&#x2009;M EDTA) for 20&#x2013;30&#x2009;min at 48&#x2009;&#xB0;C. Twenty microliters amplification mix was then put on each slide to cover the tissue section placed inside a Biorad Frame Seal 9&#x2009;mm&#x2009;&#xD7;&#x2009;9&#x2009;mm chambers and incubated for 6&#x2013;8&#x2009;h at room temperature in dark for signal amplification. After signal amplification, frame seals were removed, and slides were washed again in the wash buffer for 30&#x2013;40&#x2009;min at 48&#x2009;&#xB0;C. Last, tissue sections were then counterstained with DAPI for 10&#x2009;min at room temperature, washed for 5&#x2009;min in 1&#xD7; PBS, excess PBS cleaned using Kimwipe, immediately mounted on coverslips using Prolong glass antifade media, left overnight for treatment, and imaged the next day on a Zeiss Axio Observer Z1 Microscope using a Hamamatsu ORCA Fusion Gen III Scientific CMOS camera. smFISH images were processed and thresholded on Zen 3.1 software (Blue edition).</p>
      </sec>
      <sec id="Sec20">
        <title>Immunohistochemistry assays</title>
        <p id="Par42">Whole hearts were isolated using aseptic technique and placed in ice-cold sterile Hank&#x2019;s Balanced Salt Solution and then blood was carefully removed by perfusing the hearts through the apex. For day 7 (HH30), day 10 (HH36), and day 14 (HH40) heart samples after perfusion, tissues were fixed in 4% paraformaldehyde for about 16&#x2013;24&#x2009;h at 4&#x2009;&#xB0;C. For the day 4 (HH24) stage, whole embryos were isolated and fixed in 4% paraformaldehyde for about 16&#x2013;24&#x2009;h at 4&#x2009;&#xB0;C. Samples were then processed, embedded in paraffin, cut into 6&#x2009;&#xB5;m sections using a microtome, and mounted onto histological glass slides. Slides were incubated for 20&#x2009;min at 58&#x2009;&#xB0;C to melt paraffin, washed three times in xylene for 3&#x2009;min each, and then placed in decreasing ethanol concentrations to rehydrate slides. Samples then underwent an antigen retrieval step via incubation in 1&#xD7; citrate buffer for at least 10&#x2009;min at 95&#x2009;&#xB0;C. Samples were then permeabilized in 0.3% Triton X-100 in tris buffered saline for 15&#x2009;min, washed three times in 0.05% Tween-20 in tris buffered saline (TBST), blocked for 1&#x2009;h at room temperature in blocking buffer (1% bovine serum albumin and 5% goat serum in TBST), washed once in TBST, and incubated in primary antibodies diluted in antibody solution (1% bovine serum albumin in TBST) overnight at 4&#x2009;&#xB0;C. Primary antibodies used were mouse anti-MF20 antibody (1:100, 14650382, Invitrogen), rabbit anti-TMSB4X antibody (1:200, ab14335, Abcam), rabbit anti-CDH5 antibody (1:200, ab33168 Abcam), rabbit anti-ACTA2 antibody (1:200, ab5694, Abcam). After overnight primary incubation, samples were washed three times in TBST and then incubated in secondary antibodies for 1&#x2009;h at room temperature. The secondary antibodies were goat anti-mouse 488 (1:500, A11017, Invitrogen) and goat anti-rabbit 555 (1:500, A21430, Invitrogen). Lastly, samples were washed in TBST, stained with DAPI (1:1000, Thermofisher), and mounted. Images were acquired on a Zeiss Axio Observer Z1 Microscope using a Hamamatsu ORCA Fusion Gen III Scientific CMOS camera. Immunostaining images were processed and thresholded on Zen 3.1 software (Blue edition).</p>
      </sec>
      <sec id="Sec21">
        <title>Reporting summary</title>
        <p id="Par43">Further information on research design is available in the&#xA0;<xref rid="MOESM8" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <sec id="Sec22">
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41467_2021_21892_MOESM1_ESM.pdf">
            <caption>
              <p>Supplementary Information</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41467_2021_21892_MOESM2_ESM.xlsx">
            <caption>
              <p>Supplementary Data 1</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="41467_2021_21892_MOESM3_ESM.xlsx">
            <caption>
              <p>Supplementary Data 2</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="41467_2021_21892_MOESM4_ESM.xlsx">
            <caption>
              <p>Supplementary Data 3</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM5">
          <media xlink:href="41467_2021_21892_MOESM5_ESM.xlsx">
            <caption>
              <p>Supplementary Data 4</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM6">
          <media xlink:href="41467_2021_21892_MOESM6_ESM.pdf">
            <caption>
              <p>Description of Additional Supplementary Files</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM7">
          <media xlink:href="41467_2021_21892_MOESM7_ESM.pdf">
            <caption>
              <p>Peer Review File</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM8">
          <media xlink:href="41467_2021_21892_MOESM8_ESM.pdf">
            <caption>
              <p>Reporting Summary</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Peer review information</bold>
<italic>Nature Communications</italic> thanks Makoto Sahara, Nicola Smart and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.</p>
      </fn>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>These authors contributed equally: Madhav Mantri, Gaetano J. Scuderi.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41467-021-21892-z.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We would like to thank Peter Schweitzer and the Cornell Genomics Center for help with single-cell and spatial sequencing assays, the Cornell Bioinformatics facility for assistance with bioinformatics, and the Cornell Imaging facility for assistance with imaging assays. We also thank the members of the Butcher and De Vlaminck labs for valuable discussion. This work was supported by R01HL143247 (to J.T.B. and I.D.V), R33CA235302 (to I.D.V.), R21AI133331 (to I.D.V.), and DP2AI138242 (to I.D.V.).</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>M.M., G.J.S., J.T.B., and I.D.V. designed the study. M.M., G.J.S., and R.A. performed scRNAseq experiments. M.M. and G.J.S. performed spatial RNAseq experiments. M.M., G.J.S., H.S., and B.G. performed smFISH and immunostaining experiments. M.M., G.J.S., M.F.Z.W., and D.M. analyzed the data. M.M., G.J.S., J.T.B., and I.D.V. wrote the manuscript. All authors provided feedback and comments.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>The authors declare that all data supporting the findings of this study are available within the article and its supplementary information files or from the corresponding author upon reasonable request. The authors declare that all sequencing data supporting the findings of this study have been deposited in NCBI&#x2019;s Gene Expression Omnibus<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> GEO database under the accession code <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE149457">GSE149457</ext-link>. H&amp;E stained tissue images matched to spatial RNA-seq datasets and analysis scripts have been made available on GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/madhavmantri/chicken_heart">https://github.com/madhavmantri/chicken_heart</ext-link>) with the identifier (10.5281/zenodo.4517120)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>The data analysis scripts have been made available on the GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/madhavmantri/chicken_heart">https://github.com/madhavmantri/chicken_heart</ext-link>) with the identifier (10.5281/zenodo.4517120)<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par44">The authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buckingham</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meilhac</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zaffran</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Building the mammalian heart from two sources of myocardial cells</article-title>
          <source>Nat. Rev. Genet.</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>826</fpage>
          <lpage>835</lpage>
          <pub-id pub-id-type="doi">10.1038/nrg1710</pub-id>
          <pub-id pub-id-type="pmid">16304598</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunwoodie</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Combinatorial signaling in the heart orchestrates cardiac induction, lineage specification and chamber formation</article-title>
          <source>Semin. Cell Dev. Biol.</source>
          <year>2007</year>
          <volume>18</volume>
          <fpage>54</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="doi">10.1016/j.semcdb.2006.12.003</pub-id>
          <pub-id pub-id-type="pmid">17236794</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martinsen</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Reference guide to the stages of chick heart embryology</article-title>
          <source>Dev. Dyn.</source>
          <year>2005</year>
          <volume>233</volume>
          <fpage>1217</fpage>
          <lpage>1237</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.20468</pub-id>
          <pub-id pub-id-type="pmid">15986452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <mixed-citation publication-type="other">Hie, B., Bryson, B. &amp; Berger, B. Efficient integration of heterogeneous single-cell transcriptomes using Scanorama. <italic>Nat. Biotechnol</italic>. 10.1038/s41587-019-0113-3 (2019).</mixed-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smibert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
          <pub-id pub-id-type="pmid">29608179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive integration of single-cell data</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="other">Moon, K. R. et al. Visualizing structure and transitions in high-dimensional biological data. <italic>Nat. Biotechnol.</italic>10.1038/s41587-019-0336-3 (2019).</mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Qiu</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reversed graph embedding resolves complex single-cell trajectories</article-title>
          <source>Nat. Methods</source>
          <year>2017</year>
          <volume>14</volume>
          <fpage>979</fpage>
          <lpage>982</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4402</pub-id>
          <pub-id pub-id-type="pmid">28825705</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tandon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Miteva</surname>
              <given-names>YV</given-names>
            </name>
            <name>
              <surname>Kuchenbrod</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Cristea</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>Conlon</surname>
              <given-names>FL</given-names>
            </name>
          </person-group>
          <article-title>Tcf21 regulates the specification and maturation of proepicardial cells</article-title>
          <source>Development</source>
          <year>2012</year>
          <volume>140</volume>
          <fpage>2409</fpage>
          <lpage>2421</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.093385</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>XR</given-names>
            </name>
            <name>
              <surname>Regan</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Majesky</surname>
              <given-names>MW</given-names>
            </name>
          </person-group>
          <article-title>Tbx18 regulates development of the epicardium and coronary vessels</article-title>
          <source>Dev. Biol.</source>
          <year>2013</year>
          <volume>383</volume>
          <fpage>307</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ydbio.2013.08.019</pub-id>
          <pub-id pub-id-type="pmid">24016759</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <mixed-citation publication-type="other">von Gise, A. et al. WT1 regulates epicardial epithelial to mesenchymal transition through &#x3B2;-catenin and retinoic acid signaling pathways. <italic>Dev. Biol</italic>. 10.1016/j.ydbio.2011.05.668 (2011).</mixed-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xavier-Neto</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Signaling through retinoic acid receptors in cardiac development: doing the right things at the right times</article-title>
          <source>Biochim. et. Biophys. Acta</source>
          <year>2015</year>
          <volume>1849</volume>
          <fpage>94</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbagrm.2014.08.003</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guadix</surname>
              <given-names>JA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Wt1 controls retinoic acid signalling in embryonic epicardium through transcriptional activation of Raldh2s</article-title>
          <source>Development</source>
          <year>2011</year>
          <volume>138</volume>
          <fpage>1093</fpage>
          <lpage>1097</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.044594</pub-id>
          <pub-id pub-id-type="pmid">21343363</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="other">Kadomatsu, K., Kishida, S. &amp; Tsubota, S. The heparin-binding growth factor midkine: the biological activities and candidate receptors. <italic>J. Biochem</italic>. 10.1093/jb/mvt035 (2013).</mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="other">Velecela, V. et al. Epicardial cell shape and maturation are regulated by Wt1 via transcriptional control of Bmp4. <italic>Development</italic><bold>146</bold>, dev178723. 10.1242/dev.178723&#xA0;(2019).</mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dupuis</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>CB</given-names>
            </name>
          </person-group>
          <article-title>Small leucine-rich proteoglycans exhibit unique spatiotemporal expression profiles during cardiac valve development</article-title>
          <source>Dev. Dyn.</source>
          <year>2014</year>
          <volume>243</volume>
          <fpage>601</fpage>
          <lpage>611</lpage>
          <pub-id pub-id-type="doi">10.1002/dvdy.24100</pub-id>
          <pub-id pub-id-type="pmid">24272803</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="other">Villain, G. et al. MAGP-1 and fibronectin control EGFL7 functions by driving its deposition into distinct endothelial extracellular matrix locations. <italic>FEBS J</italic>. 10.1111/febs.14680 (2018).</mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="other">Schmidt, M. et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. <italic>Development</italic>10.1242/dev.002576 (2007).</mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tidball</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Distribution of collagens and fibronectin in the subepicardium during avian cardiac development</article-title>
          <source>Anat. Embryol.</source>
          <year>1992</year>
          <volume>185</volume>
          <fpage>155</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00185916</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benesh</surname>
              <given-names>EC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Bves and NDRG4 regulate Directional epicardial cell migration through autocrine extracellular matrix deposition</article-title>
          <source>Mol. Biol. Cell</source>
          <year>2013</year>
          <volume>24</volume>
          <fpage>3496</fpage>
          <lpage>3510</lpage>
          <pub-id pub-id-type="doi">10.1091/mbc.e12-07-0539</pub-id>
          <pub-id pub-id-type="pmid">24048452</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Snider</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Origin of cardiac fibroblasts and the role of periostin</article-title>
          <source>Circ. Res.</source>
          <year>2009</year>
          <volume>105</volume>
          <fpage>934</fpage>
          <lpage>947</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.109.201400</pub-id>
          <pub-id pub-id-type="pmid">19893021</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bassat</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The extracellular matrix protein agrin promotes heart regeneration in mice</article-title>
          <source>Nature</source>
          <year>2017</year>
          <volume>547</volume>
          <fpage>179</fpage>
          <lpage>184</lpage>
          <pub-id pub-id-type="doi">10.1038/nature22978</pub-id>
          <pub-id pub-id-type="pmid">28581497</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">Tao, G., Miller, L. J. &amp; Lincoln, J. Snai1 is important for avian epicardial cell transformation and motility. <italic>Dev. Dyn</italic>. 10.1002/dvdy.23967 (2013).</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="other">Fu, X., Liu, Q., Li, C., Li, Y. &amp; Wang, L. Cardiac fibrosis and cardiac fibroblast lineage-tracing: recent advances. <italic>Front. Physiol</italic>. 10.3389/fphys.2020.00416 (2020).</mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <mixed-citation publication-type="other">Zhang, H., Lui, K. O. &amp; Zhou, B. Endocardial cell plasticity in cardiac development, diseases and regeneration. <italic>Circ. Res</italic>. 10.1161/CIRCRESAHA.117.312136 (2018).</mixed-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endocardial cells form the coronary arteries by angiogenesis through myocardial-endocardial VEGF signaling</article-title>
          <source>Cell</source>
          <year>2012</year>
          <volume>151</volume>
          <fpage>1083</fpage>
          <lpage>1096</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2012.10.023</pub-id>
          <pub-id pub-id-type="pmid">23178125</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horrillo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Porras</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Ayuso</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez-Manch&#xF3;n</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Loss of endothelial barrier integrity in mice with conditional ablation of podocalyxin (Podxl) in endothelial cells</article-title>
          <source>Eur. J. Cell Biol.</source>
          <year>2016</year>
          <volume>95</volume>
          <fpage>265</fpage>
          <lpage>276</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejcb.2016.04.006</pub-id>
          <pub-id pub-id-type="pmid">27289182</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <mixed-citation publication-type="other">Lee, N. Y. &amp; Blobe, G. C. The interaction of endoglin with beta -arrestin2 regulates transforming growth factor-beta -mediated ERK activation and migration in endothelial cells. <italic>J. Biol. Chem</italic>. <bold>282</bold>, 21507&#x2013;21517. 10.1074/jbc.M700176200&#xA0;(2007).</mixed-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terai</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin?v?3 on vascular endothelial cells</article-title>
          <source>J. Cell. Physiol.</source>
          <year>2001</year>
          <volume>188</volume>
          <fpage>394</fpage>
          <lpage>402</lpage>
          <pub-id pub-id-type="doi">10.1002/jcp.1122</pub-id>
          <pub-id pub-id-type="pmid">11473366</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akazawa</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Komuro</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases</article-title>
          <source>Pharmacol. Therapeutics</source>
          <year>2005</year>
          <volume>107</volume>
          <fpage>252</fpage>
          <lpage>268</lpage>
          <pub-id pub-id-type="doi">10.1016/j.pharmthera.2005.03.005</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franco</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Campione</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The role of Pitx2 during cardiac development: linking left-right signaling and congenital heart diseases</article-title>
          <source>Trends Cardiov. Med.</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>157</fpage>
          <lpage>163</lpage>
          <pub-id pub-id-type="doi">10.1016/S1050-1738(03)00039-2</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>DO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Irx4 marks a multipotent, ventricular-specific progenitor cell</article-title>
          <source>Stem Cells</source>
          <year>2016</year>
          <volume>34</volume>
          <fpage>2875</fpage>
          <lpage>2888</lpage>
          <pub-id pub-id-type="doi">10.1002/stem.2486</pub-id>
          <pub-id pub-id-type="pmid">27570947</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cui</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell transcriptome analysis maps the developmental track of the human heart</article-title>
          <source>Cell Rep.</source>
          <year>2019</year>
          <volume>26</volume>
          <fpage>1934</fpage>
          <lpage>1950</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2019.01.079</pub-id>
          <pub-id pub-id-type="pmid">30759401</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeuchi</surname>
              <given-names>JK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tbx5 specifies the left/right ventricles and ventricular septum position during cardiogenesis</article-title>
          <source>Development</source>
          <year>2003</year>
          <volume>130</volume>
          <fpage>5953</fpage>
          <lpage>5964</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.00797</pub-id>
          <pub-id pub-id-type="pmid">14573514</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <mixed-citation publication-type="other">Li, G. et al. Transcriptomic profiling maps anatomically patterned subpopulations among single embryonic cardiac cells. <italic>Dev. Cell</italic>10.1016/j.devcel.2016.10.014 (2016).</mixed-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <mixed-citation publication-type="other">Li, G. et al. Single cell expression analysis reveals anatomical and cell cycle-dependent transcriptional shifts during heart development. <italic>Development</italic>10.1242/dev.173476 (2019).</mixed-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jensen</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>van der Wal</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Moorman</surname>
              <given-names>AFM</given-names>
            </name>
            <name>
              <surname>Christoffels</surname>
              <given-names>VM</given-names>
            </name>
          </person-group>
          <article-title>Excessive trabeculations in noncompaction do not have the embryonic identity</article-title>
          <source>Int. J. Cardiol.</source>
          <year>2017</year>
          <volume>227</volume>
          <fpage>325</fpage>
          <lpage>330</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2016.11.089</pub-id>
          <pub-id pub-id-type="pmid">27838129</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="other">Andersen, T. A. et al. Of mice and men: molecular genetics of congenital heart disease. <italic>Cell. Mol. Life Sci.</italic>10.1161/CIRCRESAHA.112.300853 (2013).</mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <mixed-citation publication-type="other">Fahed, A. C., Gelb, B. D., Seidman, J. G. &amp; Seidman, C. E. Genetics of congenital heart disease: the glass half empty. <italic>Circ. Res.</italic>10.1161/CIRCRESAHA.112.300853 (2013).</mixed-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <mixed-citation publication-type="other">de Soysa, T. Y. et al. Single-cell analysis of cardiogenesis reveals basis for organ-level developmental defects. <italic>Nature</italic>10.1038/s41586-019-1414-x (2019).</mixed-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bock-Marquette</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Saxena</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>DiMaio</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Srivastava</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Thymosin &#x3B2;4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair</article-title>
          <source>Nature</source>
          <year>2004</year>
          <volume>432</volume>
          <fpage>466</fpage>
          <lpage>472</lpage>
          <pub-id pub-id-type="doi">10.1038/nature03000</pub-id>
          <pub-id pub-id-type="pmid">15565145</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mummenhoff</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Houweling</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Christoffels</surname>
              <given-names>VM</given-names>
            </name>
            <name>
              <surname>R&#xFC;ther</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Expression of Irx6 during mouse morphogenesis</article-title>
          <source>Mech. Dev.</source>
          <year>2001</year>
          <volume>103</volume>
          <fpage>193</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="doi">10.1016/S0925-4773(01)00353-7</pub-id>
          <pub-id pub-id-type="pmid">11335133</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A 3D molecular atlas of the chick embryonic heart</article-title>
          <source>Dev. Biol.</source>
          <year>2019</year>
          <volume>456</volume>
          <fpage>40</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ydbio.2019.07.003</pub-id>
          <pub-id pub-id-type="pmid">31283921</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsang</surname>
              <given-names>WY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability</article-title>
          <source>Mol. Biol. Cell</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>3423</fpage>
          <lpage>3434</lpage>
          <pub-id pub-id-type="doi">10.1091/mbc.e06-04-0371</pub-id>
          <pub-id pub-id-type="pmid">16760425</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galoyan</surname>
              <given-names>AA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A hypothalamic activator of calmodulin-dependent enzymes is thymosin beta 4 (1-39)</article-title>
          <source>Neurochem. Res.</source>
          <year>1992</year>
          <volume>17</volume>
          <fpage>773</fpage>
          <lpage>777</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00969011</pub-id>
          <pub-id pub-id-type="pmid">1641059</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="other">Lupu, I. E., Redpath, A. N. &amp; Smart, N. Spatiotemporal analysis reveals overlap of key proepicardial markers in the developing murine heart. <italic>Stem Cell Rep.</italic>10.1016/j.stemcr.2020.04.002 (2020).</mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="other">Xiao, Y. et al. Hippo signaling plays an essential role in cell state transitions during cardiac fibroblast development. <italic>Dev. Cell</italic>10.1016/j.devcel.2018.03.019 (2018).</mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="other">Sun, X. et al. The extracellular matrix protein agrin is essential for epicardial epithelial-to-mesenchymal transition during heart development. <italic>bioRxiv</italic>10.1101/2020.09.25.313742 (2020).</mixed-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="other">Wang, Y. et al. Single-cell analysis of murine fibroblasts identifies neonatal to adult switching that regulates cardiomyocyte maturation. <italic>Nat. Commun</italic>. 10.1038/s41467-020-16204-w (2020).</mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smart</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thymosin &#x3B2;4 induces adult epicardial progenitor mobilization and neovascularization</article-title>
          <source>Nature</source>
          <year>2007</year>
          <volume>445</volume>
          <fpage>177</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05383</pub-id>
          <pub-id pub-id-type="pmid">17108969</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <mixed-citation publication-type="other">Rossdeutsch, A., Smart, N., Dub&#xE9;, K. N., Turner, M. &amp; Riley, P. R. Essential role for thymosin &#x3B2;4 in regulating vascular smooth muscle cell development and vessel wall stability. <italic>Circ. Res</italic>. 10.1161/CIRCRESAHA.111.259846 (2012).</mixed-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banerjee</surname>
              <given-names>I</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thymosin beta 4 is dispensable for murine cardiac development and function</article-title>
          <source>Circ. Res.</source>
          <year>2012</year>
          <volume>110</volume>
          <fpage>456</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.258616</pub-id>
          <pub-id pub-id-type="pmid">22158707</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <mixed-citation publication-type="other">Banerjee, I., Morris, T. M., Evans, S. M. &amp; Chen, J. Thymosin &#x3B2;4 is not required for embryonic viability or vascular development. <italic>Circ. Res</italic>. 10.1161/CIRCRESAHA.111.300197 (2013).</mixed-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sribenja</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wongkham</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Wongkham</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Roles and mechanisms of &#x3B2;-thymosins in cell migration and cancer metastasis: an update</article-title>
          <source>Cancer Invest.</source>
          <year>2013</year>
          <volume>31</volume>
          <fpage>103</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="doi">10.3109/07357907.2012.756111</pub-id>
          <pub-id pub-id-type="pmid">23320791</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huff</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller</surname>
              <given-names>CSG</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Netzker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hannappel</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>&#x3B2;-thymosins, small acidic peptides with multiple functions</article-title>
          <source>Int. J. Biochem. Cell Biol.</source>
          <year>2001</year>
          <volume>33</volume>
          <fpage>205</fpage>
          <lpage>220</lpage>
          <pub-id pub-id-type="doi">10.1016/S1357-2725(00)00087-X</pub-id>
          <pub-id pub-id-type="pmid">11311852</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saunders</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Dewing</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Sanchez-Elsner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>Expression and localisation of thymosin beta-4 in the developing human early fetal heart</article-title>
          <source>PLoS ONE</source>
          <year>2018</year>
          <volume>13</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0207248</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinkel</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thymosin beta4 is an essential paracrine factor of eEPCs in acute and chronic ischemia</article-title>
          <source>Circulation</source>
          <year>2008</year>
          <volume>117</volume>
          <fpage>2232</fpage>
          <lpage>2240</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.758904</pub-id>
          <pub-id pub-id-type="pmid">18427126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hinkel</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bock-Marquette</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hazopoulos</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Kupatt</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Thymosin &#x3B2;4: a key factor for protective effects of eEPCs in acute and chronic ischemia</article-title>
          <source>Ann. N. Y. Acad. Sci.</source>
          <year>2010</year>
          <volume>1194</volume>
          <fpage>105</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05489.x</pub-id>
          <pub-id pub-id-type="pmid">20536456</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DeLaughter</surname>
              <given-names>DM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell resolution of temporal gene expression during heart development</article-title>
          <source>Dev. Cell</source>
          <year>2016</year>
          <volume>39</volume>
          <fpage>480</fpage>
          <lpage>490</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2016.10.001</pub-id>
          <pub-id pub-id-type="pmid">27840107</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <mixed-citation publication-type="other">Asp, M. et al. A spatiotemporal organ-wide gene expression and cell atlas of the developing human heart. <italic>Cell</italic>10.1016/j.cell.2019.11.025 (2019).</mixed-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <mixed-citation publication-type="other">Alexa, A. &amp; Rahnenfuhrer, J. topGO: Enrichment Analysis for Gene Ontology. R package version 2.37.0. Rahnenfuhrer (2019).</mixed-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="other">Choi, H. M. T. et al. Third-generation in situ hybridization chain reaction: multiplexed, quantitative, sensitive, versatile, robust. <italic>Development</italic>10.1242/dev.165753 (2018).</mixed-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <mixed-citation publication-type="other">Edgar, R. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. <italic>Nucleic Acids Res.</italic>10.1093/nar/30.1.207 (2002).</mixed-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <mixed-citation publication-type="other">Mantri, M. &amp; Scuderi, G. J. Spatiotemporal single-cell RNA sequencing of developing chicken hearts identifies interplay between cellular differentiation and morphogenesis. Github:chicken_heart. 10.5281/zenodo.4517120 (2020).</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
      <journal-title-group>
        <journal-title>Genome Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1474-7596</issn>
      <issn pub-type="epub">1474-760X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34154649</article-id>
      <article-id pub-id-type="pmc">8218388</article-id>
      <article-id pub-id-type="publisher-id">2404</article-id>
      <article-id pub-id-type="doi">10.1186/s13059-021-02404-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Method</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>SPARK-X: non-parametric modeling enables scalable and robust detection of spatial expression patterns for large spatial transcriptomic studies</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Jiaqiang</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Shiquan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4331-7599</contrib-id>
          <name>
            <surname>Zhou</surname>
            <given-names>Xiang</given-names>
          </name>
          <address>
            <email>xzhousph@umich.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Department of Biostatistics, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI 48109 USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000000086837370</institution-id><institution>Center for Statistical Genetics, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI 48109 USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.43169.39</institution-id><institution-id institution-id-type="ISNI">0000 0001 0599 1243</institution-id><institution>Department of Epidemiology and Biostatistics, </institution><institution>Xi&#x2019;an Jiaotong University, </institution></institution-wrap>Xi&#x2019;an, Shaanxi 710061 P.R. China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>21</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>21</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>22</volume>
      <elocation-id>184</elocation-id>
      <history>
        <date date-type="received">
          <day>22</day>
          <month>10</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>7</day>
          <month>6</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2021</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Spatial transcriptomic studies are becoming increasingly common and large, posing important statistical and computational challenges for many analytic tasks. Here, we present SPARK-X, a non-parametric method for rapid and effective detection of spatially expressed genes in large spatial transcriptomic studies. SPARK-X not only produces effective type I error control and high power but also brings orders of magnitude computational savings. We apply SPARK-X to analyze three large datasets, one of which is only analyzable by SPARK-X. In these data, SPARK-X identifies many spatially expressed genes including those that are spatially expressed within the same cell type, revealing new biological insights.</p>
        <sec>
          <title>Supplementary Information</title>
          <p>The online version contains supplementary material available at 10.1186/s13059-021-02404-0.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Spatial transcriptomics</kwd>
        <kwd>SE analysis</kwd>
        <kwd>Covariance test</kwd>
        <kwd>Non-parametric modeling</kwd>
        <kwd>Slide-seq</kwd>
        <kwd>HDST</kwd>
        <kwd>SPARK</kwd>
        <kwd>SPARK-X</kwd>
        <kwd>Spatial expression pattern</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000051</institution-id>
              <institution>National Human Genome Research Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01HG009124</award-id>
          <award-id>R01HG011883</award-id>
          <principal-award-recipient>
            <name>
              <surname>Zhou</surname>
              <given-names>Xiang</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id>
              <institution>National Institute of General Medical Sciences</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01GM126553</award-id>
          <award-id>R01GM144960</award-id>
          <principal-award-recipient>
            <name>
              <surname>Zhou</surname>
              <given-names>Xiang</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008982</institution-id>
              <institution>National Science Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>DMS1712933</award-id>
          <principal-award-recipient>
            <name>
              <surname>Zhou</surname>
              <given-names>Xiang</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>National Institutes of Health </institution>
          </funding-source>
          <award-id>R01HD088558</award-id>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p id="Par2">Spatially resolved transcriptomic studies perform gene-expression profiling with spatial localization information on tissues and cell cultures [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. These studies allow us to examine the spatial expression patterns of genes on the tissue [<xref ref-type="bibr" rid="CR4">4</xref>&#x2013;<xref ref-type="bibr" rid="CR6">6</xref>], characterizing local structures and microenvironments [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] and detecting cell-cell interactions across spatial locations [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Spatial transcriptomic studies are enabled by various spatial transcriptomic technologies that are rapidly evolving. While early spatial transcriptomic technologies are often small in scale with relatively low spatial resolution [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>], recent technologies, such as Slide-seq [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] and high-definition spatial transcriptomics (HDST) [<xref ref-type="bibr" rid="CR15">15</xref>], have enabled transcriptome-wide profiling at micron resolution on tens or hundreds of thousands of spatial locations. The resulting large-scale spatial transcriptomic data, limited by sequencing depth, are also in sparse forms, with a prevalence of low counts and a substantial fraction of zero values (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The sheer scale of these recent spatial transcriptomic data, paired with their sparse form, has created enormous computational and statistical challenges for many spatial transcriptomic analytic tasks.</p>
      <p id="Par3">A key analytic task in spatial transcriptomic studies is to identify genes that display spatial expression patterns, commonly referred to as SE genes. Such SE analysis is an important first step towards characterizing the spatial and functional organization of complex tissues [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Common methods for performing SE analysis include trendsceek [<xref ref-type="bibr" rid="CR4">4</xref>], SpatialDE [<xref ref-type="bibr" rid="CR5">5</xref>], and SPARK [<xref ref-type="bibr" rid="CR6">6</xref>]. Unfortunately, even the latter two computationally efficient methods are not readily applicable for analyzing large-scale sparse spatial transcriptomic data that are being collected today [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Specifically, the computational complexity of both SpatialDE and SPARK scales cubically with respect to the number of spatial locations. Consequently, it would take days to months for either method to analyze large-scale spatial transcriptomic data. Similarly, the memory requirement of both SpatialDE and SPARK also scales cubically with respect to the number of spatial locations. Analyzing large-scale spatial transcriptomic data by either method would require dozens to thousands of GB physical RAM memory, which can be challenging to satisfy even on large computing clusters [<xref ref-type="bibr" rid="CR19">19</xref>]. Finally, the large-scale spatial transcriptomic data are often in the form of sparse counts with a prevalence of zero values. While the large fraction of zeros is not due to dropout events and can be effectively accounted for by an over-dispersed Poisson distribution (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S14), such sparse data is nevertheless challenging to model parametrically. Specifically, direct modeling of sparse count data with a negative binomial distribution or other over-dispersed Poisson distributions incurs algorithm stability issues [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], and, as will be shown below, can lead to a failure of convergence in more than 90% of genes in large-scale spatial transcriptomic data. On the other hand, approximate modeling of sparse count data by a Gaussian distribution as in SpatialDE and the Gaussian version of SPARK is not ideal either [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], as such parametric approximation leads to both power loss and failure of type I error control at small <italic>P</italic> values that are essential for detecting SE genes at the transcriptome-wide significance level.</p>
      <p id="Par4">Here, we present SPARK-X (SPARK-eXpedited), a scalable non-parametric test for SE analysis, that addresses the aforementioned challenges. SPARK-X builds upon a robust covariance test framework [<xref ref-type="bibr" rid="CR24">24</xref>&#x2013;<xref ref-type="bibr" rid="CR27">27</xref>] and extends it to incorporating a variety of spatial kernels for non-parametric spatial modeling of sparse count data from large spatial transcriptomic studies. With additional algebraic innovations, SPARK-X reduces computational complexity and physical RAM memory requirement for SE analysis from cubic to linear with respect to the number of spatial locations, resulting in several orders of computational speed improvements and several orders of physical RAM memory savings as compared to existing approaches. Importantly, due to its non-parametric nature, SPARK-X is algorithmically stable and statistically robust with respect to the underlying data generative process, providing calibrated type I error control and improved power across a range of data types collected through a variety of technical platforms. We illustrate the benefits of SPARK-X via applications to three large-scale spatial transcriptomic data collected by different technologies, one of which is only analyzable by SPARK-X. In the analysis, we identified many new SE genes including those that display spatial expression pattern within the same cell type. These SE genes are involved in synaptic organization and functional compartmentalization of the cerebellum and involved in lateral inhibition and odor discrimination in the olfactory system.</p>
    </sec>
    <sec id="Sec2">
      <title>Results</title>
      <sec id="Sec3">
        <title>Simulations</title>
        <p id="Par5">A method schematic of SPARK-X is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>A, with details provided in the &#x201C;<xref rid="Sec8" ref-type="sec">Methods</xref>&#x201D; section. We performed realistic simulations (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S16A) to evaluate the performance of SPARK-X and compare it with three existing approaches, the Poisson version of SPARK (SPARK), the Gaussian version of SPARK (SPARK-G) and SpatialDE. Simulation details are provided in the &#x201C;<xref rid="Sec8" ref-type="sec">Methods</xref>&#x201D;. Briefly, in each scenario, we generated coordinates for a fixed number of spatial locations through a random-point-pattern Poisson process and simulated 10,000 genes on the spatial locations based on a negative binomial distribution using parameters inferred from real data. We examined both type I error control under the null hypothesis and power for identifying SE genes under various alternatives. In the null simulations, all genes are non-SE genes with expression levels randomly distributed across spatial locations without any spatial patterns (Fig. <xref rid="Fig1" ref-type="fig">1</xref>D). In the alternative simulations, 9000 genes are non-SE genes, while 1000 genes are SE genes whose expression levels display one of the three spatial patterns (hotspot, streak and gradient; Fig. <xref rid="Fig1" ref-type="fig">1</xref>D). Because some methods fail to control for type I error, we measured power in the alternative simulations based on false discovery rate (FDR) to ensure fair comparison among methods&#x2014;though <italic>P</italic> values from SPARK-X are well calibrated across scenarios and thus can be directly used in place of FDR for declaring significance. In the simulations, we varied the number of samples; varied the sparsity of the data to be moderate (average 62.1% zeros; similar to early spatial transcriptomics data) or high (average 99.5% zeros; similar to recent Slide-seq data); varied SE strength for SE genes to be either weak, moderate, or strong; and varied a set of other relevant parameters.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Method schematic of SPARK-X and simulation results. <bold>A</bold> Schematic of the SPARK-X method. <bold>B</bold> Computational time of different methods for analyzing data with different sample sizes in the simulations. Plot shows computational time in minutes (y-axis) for analyzing 10,000 genes with different sample sizes (x-axis) for different methods. Compared methods include SPARK-X (red), SPARK (sky blue), SPARK-G (green) and SpatialDE (steel blue). <bold>C</bold> Random access memory (RAM) of different methods for analyzing data with different sample sizes in the simulations. Plot shows computational memory in gigabytes (y-axis) for analyzing 10,000 genes with different sample sizes (x-axis) for different methods. Computations are carried out using a single thread of an Intel Xeon E5-2683 2.00 GHz processor. SPARK-X is much more computationally efficient than SPARK, SPARK-G, and SpatialDE. For ease of computation, we did not apply SPARK to the data with sample size greater than 3000 and did not apply SPARK-G and SpatialDE to the data with sample size greater than 30,000. <bold>D</bold> Representative genes displaying random pattern and other three spatial expression patterns. <bold>E</bold> Quantile&#x2013;quantile plot of the observed &#x2212;log<sub>10</sub>(<italic>P</italic>) from different methods against the expected &#x2212;log<sub>10</sub>(<italic>P</italic>) under the null simulations with high sparsity (<italic>&#x3BC;</italic>&#x2009;=&#x2009;0.005). <italic>P</italic> values were combined across ten simulation replicates. Simulations were performed under moderate sample size (n = 10,000) and moderate dispersion (2.5). <bold>F</bold> Power plots show the proportion of true positives (y-axis) detected by different methods at a range of sample sizes (x-axis) for the alternative simulations with high sparsity at an FDR cutoff of 0.05. Simulations were performed under a moderate fraction of marked cells (20%) and moderate SE strength (threefold) for the hotspot and streak patterns or under moderate SE strength (30% cells displaying expression gradient) for the gradient pattern</p></caption><graphic xlink:href="13059_2021_2404_Fig1_HTML" id="MO1"/></fig></p>
        <p id="Par6">In the null simulations, we found that SPARK-X produces well-calibrated <italic>P</italic> values at transcriptome-wide significance levels (Fig. <xref rid="Fig1" ref-type="fig">1</xref>E and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2B), regardless of the data sparsity level. When data sparsity is moderate, both SPARK and SPARK-G yield reasonably calibrated <italic>P</italic> values as observed in previous studies [<xref ref-type="bibr" rid="CR6">6</xref>]. However, when data sparsity is high, SPARK fails to converge for all genes while SPARK-G produces inflated <italic>P</italic> values. The failure of SPARK for sparse data depends on the sparsity level of the input data and is presumably due to the numerical instability of the penalized quasi-likelihood algorithm when the outcome consists of low read counts with a high percentage of zero values. Such algorithmic issue is not restricted to SPARK and appears to be general for fitting algorithms of the generalized linear models such as the negative binomial model (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2). The failure of SPARK-G in controlling for type I error in sparse data is presumably due to the inaccurate approximation of sparse count data with a Gaussian distribution and the fact that the variance stability transformation can no longer properly remove the correlation between mean and variance there [<xref ref-type="bibr" rid="CR28">28</xref>]. SpatialDE produces overly conservative <italic>P</italic> values when data sparsity is moderate and unduly inflated <italic>P</italic> values when sparsity is high. The failure of SpatialDE in controlling type I errors in these settings is presumably due to its Gaussian modeling of count data, use of an asymptotic test in place of an exact test, and/or use of an <italic>ad hoc</italic> minimal <italic>P</italic> value combination rule. The <italic>P</italic> value calibration results in terms of genomic inflation factor for different methods are consistent across a range of sample sizes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1).</p>
        <p id="Par7">In the alternative simulations, we found that SPARK-X is as powerful as SPARK when data sparsity is moderate (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2C) and is more powerful than all other methods when data sparsity is high (Fig. <xref rid="Fig1" ref-type="fig">1</xref>F). Specifically, when data sparsity is moderate, both SPARK-X and SPARK are more powerful than SPARK-G and SpatialDE in detecting streak and hotspot patterns, regardless of sample size. SPARK-X, SPARK-G, and SPARK are more powerful than SpatialDE in detecting the gradient pattern when the sample size is small, though all four methods have comparable power when the sample size is moderate or large. When data sparsity is high, SPARK-X is more powerful than both SPARK-G and SpatialDE, while SPARK fails to converge for all genes. The power gain by SPARK-X over SPARK-G and SpatialDE for sparse data increases with increasing sample size. The power comparison results hold across a range of simulation settings (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S3 and S4), highlighting the robust performance of SPARK-X for analyzing large sparse spatial transcriptomic data.</p>
        <p id="Par8">Importantly, SPARK-X is much more computationally efficient than the other methods, with orders of magnitude improvement in terms of computation time and memory requirement (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B, C). For example, it takes SPARK-G and SpatialDE 1125 and 770&#x2009;min, respectively, to analyze a data with 10,000 genes and 20,000 spatial locations. In contrast, it only takes SPARK-X 1 min to analyze the same data. Similarly, while SPARK-G and SpatialDE require 21.2 and 55.3 gigabytes (GB) of physical RAM memory, respectively, SPARK-X only requires 0.32&#x2009;GB. The computation gain by SPARK-X is even more appreciable in data with larger samples. Indeed, with moderate computation resource, SPARK-X is the only method applicable to data with sample size exceeding around 30,000.</p>
      </sec>
      <sec id="Sec4">
        <title>SPARK-X enables powerful SE analysis in the Slide-seq cerebellum data</title>
        <p id="Par9">We applied SPARK-X along with SPARK-G and SpatialDE to analyze three published data obtained with three different spatial transcriptomic technologies: one by Slide-seq, one by Slide-seqV2, and the other by HDST (details in &#x201C;<xref rid="Sec8" ref-type="sec">Methods</xref>&#x201D;). We did not apply the Poisson version of SPARK to analyze any of these data due to its excessive computational requirements there.</p>
        <p id="Par10">The first data we examined is a mouse cerebellum data generated through Slide-seq [<xref ref-type="bibr" rid="CR13">13</xref>], consisting of gene expression measurements for 17,729 genes on 25,551 beads. Consistent with simulations, we found that SPARK-X produced calibrated <italic>P</italic> values under permuted null, while SPARK-G and SpatialDE did not (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). Also consistent with simulations, SPARK identified more SE genes as compared to SPARK-G and SpatialDE across a range of empirical FDRs (Fig. <xref rid="Fig2" ref-type="fig">2</xref>B, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S5 and S6). For example, at an FDR of 1%, SPARK-X identified 2336 SE genes, which is approximately ten times more than that detected by SPARK-G (which identified 212, among which 180 overlapped with SPARK-X; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5A). SpatialDE was unable to detect any SE genes in the data, consistent with its low power in large-scale sparse data as observed in the simulations.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Analyzing the mouse cerebellum Slide-seq data. <bold>A</bold> Quantile&#x2013;quantile plot of the observed &#x2212;log<sub>10</sub>(<italic>P</italic>) from different methods against the expected &#x2212;log<sub>10</sub>(<italic>P</italic>) under the null condition in the permuted Slide-seq data. <italic>P</italic> values were combined across ten permutation replicates. Compared methods include SPARK-X (red), SPARK-G (green) and SpatialDE (steel blue). <bold>B</bold> Power plot shows the number of genes with spatial expression pattern (y-axis) identified by different methods at a range of FDRs (x-axis) in the Slide-seq data. <bold>C</bold> Bar plots show the computation time and RAM usage of different methods for analyzing the mouse cerebellum Slide-seq data. <bold>D</bold> An illustration of the mouse cerebellum, where a cross-section shows its lobular organization. <bold>E</bold> Bar plot displays the percentage of SE genes identified by either SPARK-X (red) or SPARK-G (green) or both (orange) that were also validated in two gene lists: one from the Harmonizome database (left) and the other from literature (right; Wizeman et al). <bold>F</bold> Visualization of three representative SE genes identified only by SPARK-X in the Slide-seq data. The top panel shows in situ hybridization results for the three genes obtained from the Allen Brain Atlas. The bottom panel shows relative gene-expression levels (green, high; antique-white, low), with <italic>P</italic> values from SPARK-X displayed inside parentheses</p></caption><graphic xlink:href="13059_2021_2404_Fig2_HTML" id="MO2"/></fig></p>
        <p id="Par11">We provided three lines of evidence to support the validity of SE genes detected by SPARK-X. First, we found that SE genes only detected by SPARK-X expressed on comparable number of spots as compared to the SE genes detected by both methods (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5A). In contrast, most SE genes only detected by SPARK-G appeared to be expressed on very few spots (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5A and S5C), suggesting potentially false signals. Second, we obtained a list of 2632 genes related to mouse cerebellum from the Harmonizome database [<xref ref-type="bibr" rid="CR29">29</xref>]. Reassuringly, 22% of the unique SE genes identified by SPARK-X were in the Harmonizome list, while only 3% of the unique SE genes identified by SPARK-G were in the same list (Fig. <xref rid="Fig2" ref-type="fig">2</xref>E). Third, we obtained a list of 4152 cell type-specific genes identified in a recent single-cell RNA sequencing study in the mouse cerebellum [<xref ref-type="bibr" rid="CR30">30</xref>]. Again, 41% of the unique SE genes identified by SPARK-X were in the marker list, while only 19% of the unique SE genes identified by SPARK-G were in the same list (Fig. <xref rid="Fig2" ref-type="fig">2</xref>E). These three validation analyses provide convergence support for the higher power of SPARK-X.</p>
        <p id="Par12">We performed functional enrichment analyses on SE genes detected by SPARK-X and SPARK-G (&#x201C;<xref rid="Sec8" ref-type="sec">Methods</xref>&#x201D;). A total of 808 enriched Gene Ontology (GO) terms (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S5B and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S4) and 328 Reactome pathways were identified based on SPARK-X SE genes, while only 223 GO terms (overlap = 115) and 56 Reactome pathways (overlap = 46) were identified based on SPARK-G SE genes. Many enriched GO terms identified only by SPARK-X were directly related to synaptic organization of the cerebellum. For example, one enriched GO term was peripheral nervous system development (GO 0007422; <italic>P</italic> = 1.57 &#xD7; 10<sup>&#x2212;&#x2009;3</sup>). Its representative gene <italic>Fa2h</italic> encodes the fatty acid 2-hydroxylase and is highly enriched in oligodendrocytes (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D, F). Fatty acid 2-hydroxylase is known to play an important role in synthesizing myelin galactolipids on oligodendrocytes and facilitates the subsequent myelination that is essential for axon protection and signal transduction [<xref ref-type="bibr" rid="CR31">31</xref>]. Another enriched GO term was synapse organization (GO 0050808; <italic>P</italic> = 3.19 &#xD7; 10<sup>&#x2212;&#x2009;11</sup>). Its representative gene <italic>Cbln1</italic> encodes a cerebellum-specific precursor protein precerebellin and is highly enriched in the granular layer as supported by previous in situ hybridization evidence [<xref ref-type="bibr" rid="CR32">32</xref>] (Fig. <xref rid="Fig2" ref-type="fig">2</xref>F). Precerebellin is a unique synapse organizer for matching and maintaining pre- and post-synaptic elements between parallel fibers and Purkinje cells in the cerebellum and a key for the functional induction of long-term depression there [<xref ref-type="bibr" rid="CR33">33</xref>]. As a last example, the GO term of neurotransmitter secretion regulation is only identified by SPARK-X (GO 0046928; <italic>P</italic> = 2.56 &#xD7; 10<sup>&#x2212;&#x2009;5</sup>). Its representative gene <italic>Kcnc3</italic> encodes the Potassium voltage-gated channel subunit Kv3.3 and is enriched in the Purkinje cells (Fig. <xref rid="Fig2" ref-type="fig">2</xref>F). <italic>Kcnc3</italic> plays an important role in regulating the frequency, shape, and duration of action potentials in the Purkinje cells and facilitates motor coordination [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Overall, the new SE genes and GO terms identified by SPARK-X reveal important spatial and functional organization of the cerebellum that are missed by other SE methods, highlighting the benefits of running SE analysis with SPARK-X.</p>
      </sec>
      <sec id="Sec5">
        <title>SPARK-X enables detection of SE genes not explained by cell types in the Slide-seqV2 cerebellum data</title>
        <p id="Par13">The second data we examined is another mouse cerebellum data generated through Slide-seqV2 [<xref ref-type="bibr" rid="CR14">14</xref>], consisting of gene expression measurements for 20,117 genes on 11,626 beads. In the analysis, SPARK-X produced calibrated <italic>P</italic> values under permuted null, while SPARK-G and SpatialDE did not (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7A). SPARK-X identified 688 SE genes, which is approximately six times more than that detected by SPARK-G (which identified 112, among which 68 overlapped with SPARK-X; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7B). SpatialDE was unable to detect any SE genes in the data. Functional enrichment analyses on SE genes detected by SPARK-X identified 595 enriched GO terms and 61 Reactome pathways, many of which are again directly related to synaptic organization of the cerebellum (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7D and Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Table S5).</p>
        <p id="Par14">One important feature of SPARK-X is its ability to control for covariates in the SE analysis. Such feature, when paired with the high sensitivity of Slide-seqV2 technology, provides us with a unique opportunity to investigate the extent to which SE genes display spatial expression pattern beyond those explained by spatial distribution of cell types. To do so, we inferred cell type compositions on majority of the spatial locations (82.2%) using RCTD [<xref ref-type="bibr" rid="CR36">36</xref>] and treated the inferred compositions as covariates for SE analysis on these spatial locations (details in &#x201C;<xref rid="Sec8" ref-type="sec">Methods</xref>&#x201D;; Fig. <xref rid="Fig3" ref-type="fig">3</xref>A and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8A). SPARK-X identified 281 and 518 SE genes with and without controlling for cell type compositions, respectively (overlap = 258, Fig. <xref rid="Fig3" ref-type="fig">3</xref>C), with calibrated <italic>P</italic> values under permuted null in the corresponding analyses (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). The result suggests that approximately half of the SE genes can be accounted for by the spatial distribution of cell types, consistent with our parallel analysis result that 46.7% SE genes were cell type markers identified in a recent single-cell RNA sequencing study in the mouse cerebellum [<xref ref-type="bibr" rid="CR30">30</xref>]. For example, cell type marker genes, such as <italic>Cadm3</italic> and <italic>Gria1</italic> (Fig. <xref rid="Fig3" ref-type="fig">3</xref>D), were no longer SE genes conditional on the cell type composition, suggesting that their spatial expression patterns were primarily driven by the spatial distribution of the corresponding cell types. On the other hand, SE genes such as <italic>Ptprt</italic> and <italic>Aldoc</italic> remained significant after controlling for cell type compositions (Fig. <xref rid="Fig3" ref-type="fig">3</xref>D and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S8B). A careful examination shows that <italic>Ptprt</italic> is highly expressed in a subset of granule cells in the anterior lobe of the cerebellum while <italic>Aldoc</italic> is highly expressed in a subset of Purkinje cells in the posterior lobe (Fig. <xref rid="Fig3" ref-type="fig">3</xref>D). Such distinctive and complementary spatial expression patterns of <italic>Ptprt</italic> and <italic>Aldoc</italic> in the anterior versus posterior lobe highlight the regional specification and functional compartmentalization of the cerebellum. <italic>Ptprt</italic> encodes the protein tyrosine phosphatase receptor rho (PTP<italic>&#x3C1;</italic>) that regulates synapse formation through interacting with cell adhesion molecules [<xref ref-type="bibr" rid="CR37">37</xref>]. The expression pattern of <italic>Ptprt</italic> coincides with the granule cell lineage boundary between the anterior and posterior lobules around lobule VI [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>], supporting its potential role in the function of granule cells in sensorimotor transmission that is specialized in the anterior cerebellar cortex [<xref ref-type="bibr" rid="CR40">40</xref>]. On the other hand, <italic>Aldoc</italic> encodes aldolase C, which is a brain-specific glycolytic isozyme and a well-known cerebellum compartmentation maker. <italic>Aldoc</italic> is expressed in Purkinje cells in a longitudinal striped fashion in the cerebellum. Each <italic>Aldoc</italic> expressed stripe receives enhanced glutamatergic innervations from climbing fibers originated from specific subnuclei of the inferior olive and projects to distinct subdivision of the deep cerebellar nuclei that further sends inhibitory projections back to the inferior olive [<xref ref-type="bibr" rid="CR41">41</xref>&#x2013;<xref ref-type="bibr" rid="CR43">43</xref>]. Each <italic>Aldoc</italic> strip thus represents an anatomically connected olivocerebellar-nuclear module, with highly synchronous neuronal activity observable within each module and asynchronous activity between modules [<xref ref-type="bibr" rid="CR44">44</xref>]. Notably, both <italic>Ptprt</italic> and <italic>Aldoc</italic> were also detected as SE genes, along with many others, in a cell type SE specific analysis where we applied SPARK-X to a subset of spatial locations that are dominated by either Purkinje cells or granule cells to directly detect genes that display spatial expression pattern within a cell type (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S9). Overall, the structural and functional compartmentalization in the cerebellum revealed by cell type adjusted SE analysis highlights the utility of SPARK-X.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Analyzing the mouse cerebellum Slide-seqV2 data. <bold>A</bold> Spatial distribution of all major cell types in the Slide-seqV2 data. Cells are colored by cell types shown in the legend, where the cell type information were predicted using RCTD. <bold>B</bold> Quantile&#x2013;quantile plot of the observed &#x2212;log<sub>10</sub>(<italic>P</italic>) from different methods against the expected &#x2212;log<sub>10</sub>(<italic>P</italic>) under the null condition in the permuted Slide-seqV2 data. <italic>P</italic> values were combined across ten permutation replicates. Permutations were run with SPARK-X with (tan) or without (pale green) adjusting for cell types. <bold>C</bold> Venn diagram shows the overlap in SE genes identified by SPARK-X with (tan) or without (pale green) adjusting for cell types. <bold>D</bold> Spatial distribution of predicted cell types (left two panels; blue represents cell type) and spatial expression pattern of four representative SE genes (middle and right panels; green represents high expression while antique-white represents low expression) in Slide-seqV2 data. <italic>P</italic> values from SPARK-X with (left side of the arrow) or without (right side of the arrow) adjusting for cell types are shown inside parentheses</p></caption><graphic xlink:href="13059_2021_2404_Fig3_HTML" id="MO3"/></fig></p>
      </sec>
      <sec id="Sec6">
        <title>SPARK-X enables scalable SE analysis of the HDST olfactory bulb data</title>
        <p id="Par15">SPARK-X provides substantial computational gains over the other methods. For example, in the first data, it took SPARK-X 3&#x2009;min to analyze the whole data, while it took 56&#x2009;h for SPARK-G and 47&#x2009;h for SpatialDE, respectively (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). In the second data, it took SPARK-X 2&#x2009;min to analyze the whole data, while it took 13&#x2009;h for SPARK-G and 8&#x2009;h for SpatialDE, respectively (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S7C and Table S1). The computational gain of SPARK-X becomes even more apparent in the third data, which is a mouse olfactory bulb data collected through HDST, consisting of 19,913 genes measured on 177,455 spots (Fig. <xref rid="Fig4" ref-type="fig">4</xref>A). This data is particularly challenging for existing SE methods due to the large number of spots measured there. Specifically, it would take an estimated 114 and 80&#x2009;days if we use SPARK-G and SpatialDE to analyze the data. These two methods would also require 2100 and 3500&#x2009;GB of memory, respectively (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The high computational requirements for SPARK-G and SpatialDE thus exclude their use in the data. In contrast, SPARK-X requires 0.42&#x2009;GB memory and 3&#x2009;min of computing time and is the only SE method applicable to the data.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Analyzing mouse olfactory bulb HDST data. <bold>A</bold> H&amp;E image of mouse olfactory bulb (left panel) and matching morphological annotation (middle panel) in the HDST data. Spots are colored by morphological layer shown in the legend (right panel), where the layer annotations were from ref [<xref ref-type="bibr" rid="CR15">15</xref>]. H&amp;E image reproduced from ref. [<xref ref-type="bibr" rid="CR15">15</xref>] with permission. <bold>B</bold> Visualization of three representative SE genes identified only by SPARK-X in the HDST data. The top panels show in situ hybridization of the three genes obtained from the Allen Brain Atlas. The bottom panels show spatial expression patterns of the three genes at single-cell-level resolution (green, high expression; antique-white, low expression). <italic>P</italic> values from SPARK-X are shown inside parentheses. <bold>C</bold> Heatmap shows expression level of 125 SE genes (columns) across eight major morphological layers (rows). Colored bar at the bottom represents five gene clusters. RMS, rostral migratory system; E, ependymal cell zone; GCL, granule cell layer; IPL, internal plexiform layer; M/T, mitral layer; EPL, external plexiform layer; GL, glomerular layer; ONL, olfactory nerve layer</p></caption><graphic xlink:href="13059_2021_2404_Fig4_HTML" id="MO4"/></fig></p>
        <p id="Par16">In the analysis, SPARK-X identified a total 125 SE genes, with calibrated <italic>P</italic> values under permuted null (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10A). Almost all SE genes showed clear spatial expression patterns that were cross validated by in situ hybridization in the Allen Brain Atlas [<xref ref-type="bibr" rid="CR45">45</xref>] (Fig. <xref rid="Fig4" ref-type="fig">4</xref>B and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10E). The 125 SE genes are clustered into five clusters that were enriched in distinct morphological layers of the olfactory bulb (Fig. <xref rid="Fig4" ref-type="fig">4</xref>C and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10C). Functional enrichment analyses identified 377 enriched GO terms and 39 Reactome pathways, many of which are related to synaptic organization and signaling (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S10D and Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S6). For example, one enriched GO term is synaptic membrane (GO:0097060, <italic>P</italic> = 2.50 &#xD7; 10<sup>&#x2212;&#x2009;15</sup>), with a representative gene <italic>Kctd12</italic>. <italic>Kctd12</italic> encodes an auxiliary GABA<sub>B</sub> receptor subunit [<xref ref-type="bibr" rid="CR46">46</xref>] and is observed to be highly expressed in the olfactory nerve layer (Fig. <xref rid="Fig4" ref-type="fig">4</xref>B, C), consistent with its enrichment in the glomerulus [<xref ref-type="bibr" rid="CR47">47</xref>]. Another enriched GO term is the GABA-ergic synapse (GO: 0098982, <italic>P</italic> = 1.19 &#xD7; 10<sup>&#x2212;&#x2009;5</sup>) with a representative gene <italic>Gphn</italic>. <italic>Gphn</italic> encodes the protein gephyrin and is observed here to be highly expressed in the mitral layer and external plexiform layer. Similar to GABA-ergic synapse, glutamatergic synapse (GO: 0098978, <italic>P</italic> = 3.35 &#xD7; 10<sup>&#x2212;&#x2009;15</sup>) is also enriched. The representative gene of glutamatergic synapse, <italic>Dlg2</italic>, encodes a membrane-associated guanylate kinase and is observed here to be highly expressed in both the granule cell layer and the mitral layer. The complementary expression pattern of inhibitory GABA-ergic and excitatory glutamatergic neurons as represented by <italic>Gphn</italic> and <italic>Dlg2</italic> are consistent with the spatial organization of lateral inhibition: mitral cells activate granule cells that in turn inhibits nearby mitral cells, leading to robust odor processing and discrimination in the olfactory bulb [<xref ref-type="bibr" rid="CR48">48</xref>&#x2013;<xref ref-type="bibr" rid="CR52">52</xref>].</p>
        <p id="Par17">We performed conditional analysis to investigate the extent to which SE genes display spatial expression pattern beyond those explained by the spatial distribution of cell types. Specifically, we extracted 103,602 spots with confident cell type assignment in the original study (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11D) and treated the assigned cell types as covariates for SE analysis on these spatial locations (details in &#x201C;<xref rid="Sec8" ref-type="sec">Methods</xref>&#x201D;). SPARK-X identified 36 and 66 SE genes with and without controlling for cell types, respectively (overlap = 35, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11C), with calibrated <italic>P</italic> values under the permuted null in the corresponding analyses (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11A). The results suggest that more than half of the SE genes can be accounted for by the spatial distribution of cell types, consistent with our parallel analysis result that 59.1% SE genes were cell type markers identified in a recent single-cell RNA sequencing study in the mouse olfactory bulb [<xref ref-type="bibr" rid="CR53">53</xref>]. Careful examination of the detected SE genes suggests that genes that remained significant after controlling for cell types often display spatial expression pattern across multiple cell types or within the same cell type (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11E and S11F). For example, <italic>Camk1d</italic> is enriched in the ventral part of multiple olfactory bulb layers including the external plexiform layer and the glomerular layer. <italic>Camk1d</italic> is also detected as an SE gene when we applied SPARK-X to a subtype of inhibitory neurons, the olfactory bulb inner horizontal cells, to directly detect SE genes that display spatial expression pattern within the cell type. In particular, <italic>Camk1d</italic> is specifically enriched in a subset of these inhibitory neurons that reside outside the granule cell layer (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11F). As another example, <italic>Kcnip1</italic> is also an SE gene that is detected in both conditional analysis and cell type-specific analysis. <italic>Kcnip1</italic> displays similar spatial expression pattern as the <italic>Camk1d</italic> and its <italic>P</italic> value becomes slightly more significant after controlling for cell types (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S11E). <italic>Camk1d</italic> encodes the calcium/calmodulin-dependent protein kinase that operates in the calcium-triggered CaMKK-CaMK1 signaling cascade [<xref ref-type="bibr" rid="CR54">54</xref>] and <italic>Kcnip1</italic> encodes the cytosolic voltage-gated potassium channel-interacting protein that regulates neuronal membrane excitability [<xref ref-type="bibr" rid="CR55">55</xref>]. Their known roles in regulating signaling pathways in inhibitory neurons, paired with their restricted spatial expression in a subset of inhibitory neurons in the external plexiform and glomerular layers, suggest their potential involvement in lateral inhibition in the olfactory bulb.</p>
      </sec>
    </sec>
    <sec id="Sec7">
      <title>Discussion</title>
      <p id="Par18">We have presented a new method, SPARK-X, for identifying SE genes in large-scale sparse spatial transcriptomic data. In comparison to existing approaches, SPARK-X is highly computationally efficient, produces well-calibrated <italic>P</italic> values and ensures robust performance for large spatial transcriptomic data sets collected across a range of technologies. The modeling framework of SPARK-X is also flexible, allowing for potential future extensions towards transcriptome-wide joint modeling of correlated genes. We have illustrated the benefits of SPARK-X through in-depth analyses of three large spatial transcriptomic studies.</p>
      <p id="Par19">SPARK-X relies on a non-parametric covariance test for detecting spatial expression patterns. Its non-parametric feature distinguishes it from existing SE methods that are primarily parametric in nature. Non-parametric modeling in SPARK-X ensures its robust performance under various data generating processes in different spatial transcriptomic technologies, leading to calibrated <italic>P</italic> values and improved power for SE analysis. Such robust performance of SPARK-X is especially beneficial for analyzing spatial transcriptomic data that are both large-scale and sparse. Compared with small-sample studies, large-scale spatial transcriptomic studies are better powered, more reproducible, and are thus becoming increasingly common. We recognize, however, that many spatial transcriptomic studies are still carried out on moderate number of spatial locations and that some spatial transcriptomic data are non-sparse [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. Spatial transcriptomic data measured on a small number of spatial locations (e.g., hundreds or thousands) from early spatial transcriptomic technologies can often be modeled effectively through an over-dispersed Poisson distribution [<xref ref-type="bibr" rid="CR6">6</xref>]. Consequently, parametric modeling of spatial count data through generalized linear mixed model framework such as the Poisson version of SPARK performs well for these technologies. Indeed, as demonstrated through our simulations, SPARK and SPARK-X have comparable power for detecting the hotspot pattern under small-sample settings, though SPARK-X outperforms SPARK on other patterns or with larger samples. The benefits of SPARK-X over SPARK on detecting SE genes can also be observed in other small data sets collected from other technologies. For example, on a human heart Visium data, which contains 20,904 genes measured on 4247 spots (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S12), SPARK-X identified 1536 SE genes while SPARK identified 644 (533 overlapped; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S12C). Both these methods produced calibrated <italic>P</italic> values under permuted null (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S12A). On a human ovarian cancer Visium data, which contains 1198 genes measured on 3492 spots, SPARK-X identified 651 SE genes while SPARK identified 579 (474 overlapped; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S13C). Importantly, many cancer-related KEGG and Reactome pathways can only be identified based on the SE genes detected by SPARK-X (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S13G and Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S7), highlighting the benefits of SPARK-X analysis. Besides small data, some recent large spatial transcriptomic technologies yield non-sparse count. For example, the STARmap technology measures expression levels on tens of thousands of spatial locations but only for two dozen of genes. Consequently, the read depth per gene from STARmap can be reasonably high, resulting in non-sparse high-count data with almost no zero values (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). For such high-count non-sparse data, the Gaussian distribution as employed in SPARK-G is an effective approximation to the underlying over-dispersed Poisson data generating process. We applied both SPARK-G and SPARK-X on the mouse visual cortex STARmap data that consists of 23 known cell type marker and 5 activity-regulated genes measured on 32,845 cells (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figures S14 and S15). In the analysis, both SPARK-G and SPARK-X produced calibrated <italic>P</italic> values under permuted null and were able to detect all 28 genes as SE genes. Despite the similar performance of SPARK-G and SPARK-X for this non-sparse data, the memory saving by SPARK-X in this data remains substantial: while SPARK-G required 43.45&#x2009;GB, SPARK-X only used 0.19&#x2009;GB (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). Therefore, SPARK-X serves as an effective complement of existing SE analysis approaches, especially for large-scale spatial transcriptomic studies.</p>
      <p id="Par20">We have primarily used the projection covariance function to measure similarity in either gene expression or coordinates between location pairs. Such similarity measurement is expressed effectively as a product of two input variables from the location pair and quantifies their coordinated deviation from the mean. The product of two input variables is commonly used as a key ingredient in many covariance functions other than the projection covariance function [<xref ref-type="bibr" rid="CR57">57</xref>&#x2013;<xref ref-type="bibr" rid="CR59">59</xref>]. While the product of two input variables represents one important similarity measurement, other similarity measurements exist. For example, one could use the Euclidean distance, minimum [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>], powered minimum [<xref ref-type="bibr" rid="CR62">62</xref>], and other ways [<xref ref-type="bibr" rid="CR63">63</xref>&#x2013;<xref ref-type="bibr" rid="CR65">65</xref>] to measure similarity between two variables. Different similarity measurements used in various covariance functions [<xref ref-type="bibr" rid="CR64">64</xref>&#x2013;<xref ref-type="bibr" rid="CR66">66</xref>] can be easily incorporated into SPARK-X to achieve optimal detection of distinct spatial expression patterns. In the present study, we only used the projection covariance function as it allows us to achieve orders of magnitude of computational gains as compared with other approaches. The projection covariance function is also robust and well powered to detect a range of spatial expression patterns, both simple and complex, in simulations and real datasets. Despite these benefits of the projection covariance function, we note that the statistical power of the SPARK-X will likely benefit from the use of other covariance functions in addition to the projection covariance function. Due to computational reasons, we did not examine other covariance functions but instead explored the use of different transformations on the coordinates to incorporate into SPARK-X a wide range of distance covariance matrices. While the number of detected SE genes varies across different distance covariance matrices, combining the association evidence across all matrices as in SPARK-X achieves higher power than using any individual matrix alone (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3). Future methodological development for exploring the use of other covariance functions as well as other transformations in a computationally efficient manner may help improve the power of SPARK-X further.</p>
    </sec>
    <sec id="Sec8">
      <title>Methods</title>
      <sec id="Sec9">
        <title>Method overview</title>
        <p id="Par21">We aim to identify genes that display spatial expression patterns, commonly referred to as SE genes, in large-scale spatially resolved transcriptomic studies. These large-scale studies rely on various high-throughput spatial transcriptomic technologies [<xref ref-type="bibr" rid="CR13">13</xref>&#x2013;<xref ref-type="bibr" rid="CR15">15</xref>] and collect gene expression measurements on tens or hundreds of thousands of spatial locations. Gene expression measurements in these large-scale spatial transcriptomic studies are often in the form of low counts with a large fraction of zero values. For SE analysis, we examine one gene at a time and consider its expression measurements collected on <italic>n</italic> different spatial locations. We refer to the spatial locations as samples in the present study. Depending on the technology, a sample may be a single cell (in the case of STARmap technology) or a cell-sized local region (in the case of HDST technology) or a local region that consists of dozens of cells (in the case of Slide-seq and Visium technologies). The sampled locations have known spatial coordinates recorded during the experiment. We denote <bold><italic>s</italic></bold><sub><bold><italic>i</italic></bold></sub> as the <italic>d</italic>-vector of spatial coordinates for <italic>i</italic>th sample, with <italic>i</italic>&#x2009;&#x2208;&#x2009;(1, &#x2026;, <italic>n</italic>), and <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \boldsymbol{S}={\left({\boldsymbol{s}}_1^T,\cdots, {\boldsymbol{s}}_n^T\right)}^T $$\end{document}</tex-math><mml:math id="M2" display="inline"><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="(" separators=",,"><mml:msubsup><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mn>1</mml:mn><mml:mi>T</mml:mi></mml:msubsup><mml:mo>&#x22EF;</mml:mo><mml:msubsup><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mi>n</mml:mi><mml:mi>T</mml:mi></mml:msubsup></mml:mfenced><mml:mi>T</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq1.gif"/></alternatives></inline-formula> as the corresponding <italic>n</italic>&#x2009;&#xD7;&#x2009;<italic>d</italic> matrix of spatial coordinates. These spatial coordinates vary continuously over a two-dimensional space (<italic>d</italic> = 2; <bold><italic>s</italic></bold><sub><bold><italic>i</italic></bold></sub>&#x2009;=&#x2009;(<italic>s</italic><sub><italic>i</italic>1</sub>,&#x2009;<italic>s</italic><sub><italic>i</italic>2</sub>)&#x2009;&#x2208;&#x2009;<italic>R</italic><sup>2</sup>) or a three-dimensional space (<italic>d</italic> = 3; <bold><italic>s</italic></bold><sub><bold><italic>i</italic></bold></sub>&#x2009;=&#x2009;(<italic>s</italic><sub><italic>i</italic>1</sub>,&#x2009;<italic>s</italic><sub><italic>i</italic>2</sub>,&#x2009;<italic>s</italic><sub><italic>i</italic>3</sub>)&#x2009;&#x2208;&#x2009;<italic>R</italic><sup>3</sup>) depending on the technology. We denote <italic>y</italic><sub><italic>i</italic></sub>(<bold><italic>s</italic></bold><sub><bold><italic>i</italic></bold></sub>) as the gene-expression measurement for the <italic>i</italic>th sample and <bold><italic>y&#x2009;=</italic></bold>&#x2009;(<italic>y</italic><sub>1</sub>(<bold><italic>s</italic></bold><sub>1</sub>),&#x2009;<bold><italic>&#x22EF;</italic></bold>,&#x2009;<italic>y</italic><sub><italic>n</italic></sub>(<bold><italic>s</italic></bold><sub><italic>n</italic></sub>))<sup><italic>T</italic></sup> as the <italic>n</italic>-vector of gene expression across all samples. We assume that both <bold><italic>y</italic></bold> and each coordinate of <bold><italic>S</italic></bold> has been centered and scaled to have mean 0 and standard deviation of 1. Centering and scaling do not influence type I error control but can affect statistical power. Here, our goal is to test whether the expression level of the gene of focus display any spatial expression pattern. Equivalently, we aim to test whether <bold><italic>y</italic></bold> is dependent on the spatial coordinates <bold><italic>S</italic></bold>. We rely on a general class of covariance tests [<xref ref-type="bibr" rid="CR24">24</xref>&#x2013;<xref ref-type="bibr" rid="CR27">27</xref>], which includes the Hilber-Schmidt independence criteria test [<xref ref-type="bibr" rid="CR24">24</xref>] and the distance covariance test [<xref ref-type="bibr" rid="CR25">25</xref>] as special cases, to perform SE analysis in a non-parametric fashion. Non-parametric testing ensures robust performance and wide applicability of our method to spatial transcriptomic data that are collected from various technologies with potentially different data features and different data generating mechanisms. Our method builds upon the following intuition: if <bold><italic>y</italic></bold> is independent of <bold><italic>S</italic></bold>, then the spatial distance between two locations <italic>i</italic> and <italic>j</italic> would also be independent of the gene-expression difference between the two locations. Consequently, we can construct two sample by sample relationship matrices, one based on gene expression and one based on spatial coordinates, to examine whether these two matrices are more similar to each other than expected by chance alone.</p>
        <p id="Par22">Technically, we construct an expression covariance matrix based on the gene-expression levels as an <italic>n</italic> by <italic>n</italic> matrix <bold><italic>E&#x2009;=&#x2009;y</italic></bold>(<bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>y</italic></bold>)<sup><bold><italic>&#x2212;</italic></bold><bold>1</bold></sup><bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup>. We also construct a distance covariance matrix for all samples based on spatial locations as an <italic>n</italic> by <italic>n</italic> matrix <bold><italic>&#x3A3;&#x2009;=&#x2009;S</italic></bold>(<bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>S</italic></bold>)<sup><bold><italic>&#x2212;</italic></bold><bold>1</bold></sup><bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup>. We refer to both matrices as the covariance matrices as they are generated from the projection covariance function and possess the two key covariance matrix properties including being symmetric and positive semi-definite. A covariance matrix is also known as a kernel matrix and a covariance function is also known as a kernel function. The projection covariance function has been widely used in many applications in genetics [<xref ref-type="bibr" rid="CR67">67</xref>&#x2013;<xref ref-type="bibr" rid="CR69">69</xref>]. For both matrices, we center them as <bold><italic>E</italic></bold><sub><italic>C</italic></sub>&#x2009;<bold><italic>=&#x2009;HEH</italic></bold> and <bold><italic>&#x3A3;</italic></bold><sub><italic>C</italic></sub>&#x2009;<bold><italic>=&#x2009;H&#x3A3;H</italic></bold>, where <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \boldsymbol{H}=\left(\boldsymbol{I}-{\mathbf{1}}_n{\mathbf{1}}_n^{\boldsymbol{T}}/n\right) $$\end{document}</tex-math><mml:math id="M4" display="inline"><mml:mi mathvariant="bold-italic">H</mml:mi><mml:mo mathvariant="bold-italic">=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">I</mml:mi><mml:mo mathvariant="bold-italic">&#x2212;</mml:mo><mml:msub><mml:mn mathvariant="bold">1</mml:mn><mml:mi>n</mml:mi></mml:msub><mml:msubsup><mml:mn mathvariant="bold">1</mml:mn><mml:mi>n</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msubsup><mml:mo>/</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq2.gif"/></alternatives></inline-formula> with <bold><italic>I</italic></bold> being an <italic>n</italic> by <italic>n</italic> identity matrix and <bold>1</bold><sub><italic>n</italic></sub> being an <italic>n</italic>-vector of 1s. Centering does not alter results here as we have already centered both <bold><italic>y</italic></bold> and <bold><italic>S</italic></bold> before constructing these covariance matrices. We then construct the following test statistic:</p>
        <p id="Par23">
<disp-formula id="Equa"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ T= trace\left({\boldsymbol{E}}_C{\boldsymbol{\varSigma}}_C\right)/n. $$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mi>T</mml:mi><mml:mo>=</mml:mo><mml:mtext mathvariant="italic">trace</mml:mtext><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">E</mml:mi><mml:mi>C</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold-italic">&#x3A3;</mml:mi><mml:mi>C</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>/</mml:mo><mml:mi>n</mml:mi><mml:mo>.</mml:mo></mml:math><graphic xlink:href="13059_2021_2404_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par24">Intuitively, each element in either covariance matrix measures the similarity between pairs of locations in terms of their coordinated deviation from the mean. When <italic>y</italic> and <bold><italic>S</italic></bold> are independent of each other, the similarity measurement between a location pair in terms of gene expression will not be correlated with the similarity measurement between the location pair in terms of distance. Consequently, the test statistics <italic>T</italic>, which is effectively a summation of the products between the two similarity measurements across all location pairs, will be small. When <italic>y</italic> and <bold><italic>S</italic></bold> are not independent of each other, the similarity measurement in terms of gene expression will be correlated with the similarity measurement in terms of the distance across location pairs, thus leading to a large test statistics <italic>T</italic>. Formally, under the null hypothesis that <bold><italic>y</italic></bold> and <bold><italic>S</italic></bold> are independent of each other, <italic>T</italic> asymptotically follows a mixture of chi-square distributions [<xref ref-type="bibr" rid="CR27">27</xref>]</p>
        <p id="Par25">
<disp-formula id="Equb"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \frac{1}{n^2}{\sum}_{i,j}{\lambda}_{E,i}{\lambda}_{\varSigma, j}{z}_{ij}^2, $$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mfrac><mml:mn>1</mml:mn><mml:msup><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mfrac><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>&#x3BB;</mml:mi><mml:mrow><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>&#x3BB;</mml:mi><mml:mrow><mml:mi>&#x3A3;</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>z</mml:mi><mml:mi mathvariant="italic">ij</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo></mml:math><graphic xlink:href="13059_2021_2404_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par26">where <italic>&#x3BB;</italic><sub><italic>E</italic>, <italic>i</italic></sub> is the <italic>i</italic>th ordered non-zero eigenvalue of <bold><italic>E</italic></bold><sub><bold><italic>C</italic></bold></sub>; <italic>&#x3BB;</italic><sub><italic>&#x3A3;</italic>, <italic>j</italic></sub> is the <italic>j</italic>th ordered non-zero eigenvalue of <bold><italic>&#x3A3;</italic></bold><sub><bold><italic>C</italic></bold></sub>; and <inline-formula id="IEq3"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {z}_{ij}^2 $$\end{document}</tex-math><mml:math id="M10" display="inline"><mml:msubsup><mml:mi>z</mml:mi><mml:mi mathvariant="italic">ij</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq3.gif"/></alternatives></inline-formula> are independent and identically distributed <inline-formula id="IEq4"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\chi}_1^2 $$\end{document}</tex-math><mml:math id="M12" display="inline"><mml:msubsup><mml:mi>&#x3C7;</mml:mi><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq4.gif"/></alternatives></inline-formula> variables. An extremely large <italic>T</italic> that is rare under the above null distribution constitutes evidence against the null hypothesis. Consequently, we can compute a <italic>P</italic> value to measure the probability of encountering the same or a larger <italic>T</italic> as observed in the data based on the null distribution. The <italic>P</italic> value for testing the null hypothesis can be calculated using Davies&#x2019; exact method [<xref ref-type="bibr" rid="CR70">70</xref>].</p>
        <p id="Par27">We employ several important algebraic manipulations to ensure that both computational complexity and memory requirement of our method are linear with respect to the number of spatial locations. First, we note that the eigenvalues of <bold><italic>E</italic></bold><sub><bold><italic>C</italic></bold></sub>&#xA0;and&#xA0;<bold><italic>&#x3A3;</italic></bold><sub><bold><italic>C</italic></bold></sub> are equivalent to the eigenvalues of (<bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>y</italic></bold>&#xA0;)<sup><bold><italic>&#x2212;</italic></bold><bold>1</bold></sup><bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>Hy</italic></bold> (a scalar) and (<bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>S</italic></bold>)<sup><bold><italic>&#x2212;</italic></bold><bold>1</bold></sup><bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>HS</italic></bold> (a <italic>d</italic>&#x2009;&#xD7;&#x2009;<italic>d</italic> matrix) [<xref ref-type="bibr" rid="CR71">71</xref>], respectively. The computational cost for obtaining these eigenvalues based on the later forms is only <italic>O</italic>(<italic>nd</italic><sup>2</sup>). Second, we note that
<disp-formula id="Equc"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ Tr\left({\boldsymbol{E}}_{\boldsymbol{c}}{\boldsymbol{\Sigma}}_{\boldsymbol{c}}\right)= Tr\left(\boldsymbol{y}{\left({\boldsymbol{y}}^{\boldsymbol{T}}\boldsymbol{y}\right)}^{-\mathbf{1}}{\boldsymbol{y}}^{\boldsymbol{T}}\boldsymbol{H}\boldsymbol{\Sigma } \boldsymbol{H}\right)={\left({\boldsymbol{y}}^{\boldsymbol{T}}\boldsymbol{y}\right)}^{-\mathbf{1}} Tr\left({\boldsymbol{y}}^{\boldsymbol{T}}\boldsymbol{H}\boldsymbol{\Sigma } \boldsymbol{H}\boldsymbol{y}\right). $$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mi mathvariant="italic">Tr</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">E</mml:mi><mml:mi mathvariant="bold-italic">c</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">&#x3A3;</mml:mi><mml:mi mathvariant="bold-italic">c</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant="italic">Tr</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">y</mml:mi><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mn mathvariant="bold">1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">H</mml:mi><mml:mi mathvariant="bold">&#x3A3;</mml:mi><mml:mi mathvariant="bold-italic">H</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mn mathvariant="bold">1</mml:mn></mml:mrow></mml:msup><mml:mi mathvariant="italic">Tr</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">H</mml:mi><mml:mi mathvariant="bold">&#x3A3;</mml:mi><mml:mi mathvariant="bold-italic">Hy</mml:mi></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><graphic xlink:href="13059_2021_2404_Article_Equc.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par28">Consequently, we never need to compute <bold><italic>E</italic></bold>, <bold><italic>&#x3A3;</italic></bold> and their centered versions <bold><italic>E</italic></bold><sub><italic>C</italic></sub> and <bold><italic>&#x3A3;</italic></bold><sub><italic>C</italic></sub> throughout the algorithm. Instead, we only need to compute the key quantities <bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>y</italic></bold>, <bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>Hy</italic></bold>, <bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>S</italic></bold>, <bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>HS</italic></bold>, and <bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>H</italic></bold><bold>&#x3A3;</bold><bold><italic>Hy</italic></bold>, all of which require at most <italic>O</italic>(<italic>nd</italic><sup>2</sup>) computational complexity and <italic>O</italic>(<italic>nd</italic>) memory requirement. Specifically, these key quantities can be computed efficiently in the following forms:</p>
        <p id="Par29">
<disp-formula id="Equd"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\boldsymbol{y}}^{\boldsymbol{T}}\boldsymbol{Hy}={\left(\boldsymbol{Hy}\right)}^{\boldsymbol{T}}\left(\boldsymbol{Hy}\right)={\left(\boldsymbol{y}-\overline{y}\right)}^{\boldsymbol{T}}\left(\boldsymbol{y}-\overline{y}\right), $$\end{document}</tex-math><mml:math id="M16" display="block"><mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">Hy</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:mi mathvariant="bold-italic">Hy</mml:mi></mml:mfenced><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mfenced close=")" open="("><mml:mi mathvariant="bold-italic">Hy</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mi>y</mml:mi><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mover></mml:mrow></mml:mfenced><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mi>y</mml:mi><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mover></mml:mrow></mml:mfenced><mml:mo>,</mml:mo></mml:math><graphic xlink:href="13059_2021_2404_Article_Equd.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Eque"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\boldsymbol{S}}^{\boldsymbol{T}}\boldsymbol{HS}={\left(\boldsymbol{HS}\right)}^{\boldsymbol{T}}\left(\boldsymbol{HS}\right)={\left(\boldsymbol{S}-\frac{\mathbf{1}{\mathbf{1}}^{\boldsymbol{T}}}{\boldsymbol{n}}\boldsymbol{S}\right)}^{\boldsymbol{T}}\left(\boldsymbol{S}-\frac{\mathbf{1}{\mathbf{1}}^{\boldsymbol{T}}}{\boldsymbol{n}}\boldsymbol{S}\right), $$\end{document}</tex-math><mml:math id="M18" display="block"><mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">HS</mml:mi><mml:mo mathvariant="bold-italic">=</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:mi mathvariant="bold-italic">HS</mml:mi></mml:mfenced><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mfenced close=")" open="("><mml:mi mathvariant="bold-italic">HS</mml:mi></mml:mfenced><mml:mo mathvariant="bold-italic">=</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mo mathvariant="bold-italic">&#x2212;</mml:mo><mml:mfrac><mml:mrow><mml:mn mathvariant="bold">1</mml:mn><mml:msup><mml:mn mathvariant="bold">1</mml:mn><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup></mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi></mml:mfrac><mml:mi mathvariant="bold-italic">S</mml:mi></mml:mrow></mml:mfenced><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mo mathvariant="bold-italic">&#x2212;</mml:mo><mml:mfrac><mml:mrow><mml:mn mathvariant="bold">1</mml:mn><mml:msup><mml:mn mathvariant="bold">1</mml:mn><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup></mml:mrow><mml:mi mathvariant="bold-italic">n</mml:mi></mml:mfrac><mml:mi mathvariant="bold-italic">S</mml:mi></mml:mrow></mml:mfenced><mml:mo mathvariant="bold-italic">,</mml:mo></mml:math><graphic xlink:href="13059_2021_2404_Article_Eque.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equf"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\boldsymbol{y}}^{\boldsymbol{T}}\boldsymbol{H}\boldsymbol{\Sigma } \boldsymbol{H}\boldsymbol{y}={\boldsymbol{y}}^{\boldsymbol{T}}\boldsymbol{H}\boldsymbol{S}{\left({\boldsymbol{S}}^{\boldsymbol{T}}\boldsymbol{S}\right)}^{-\mathbf{1}}{\boldsymbol{S}}^{\boldsymbol{T}}\boldsymbol{H}\boldsymbol{y}={\left(\boldsymbol{y}-\overline{y}\right)}^{\boldsymbol{T}}\boldsymbol{S}{\left({\boldsymbol{S}}^{\boldsymbol{T}}\boldsymbol{S}\right)}^{-\mathbf{1}}{\boldsymbol{S}}^{\boldsymbol{T}}\left(\boldsymbol{y}-\overline{y}\right). $$\end{document}</tex-math><mml:math id="M20" display="block"><mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">H</mml:mi><mml:mi mathvariant="bold">&#x3A3;</mml:mi><mml:mi mathvariant="bold-italic">Hy</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">HS</mml:mi><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mn mathvariant="bold">1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">Hy</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mi>y</mml:mi><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mover></mml:mrow></mml:mfenced><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi></mml:mrow></mml:mfenced><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:mn mathvariant="bold">1</mml:mn></mml:mrow></mml:msup><mml:msup><mml:mi mathvariant="bold-italic">S</mml:mi><mml:mi mathvariant="bold-italic">T</mml:mi></mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold-italic">y</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mover accent="true"><mml:mi>y</mml:mi><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mover></mml:mrow></mml:mfenced><mml:mo>.</mml:mo></mml:math><graphic xlink:href="13059_2021_2404_Article_Equf.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par30">Finally, we note that the quantities involving <bold><italic>S</italic></bold>, including the computation of <bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>S</italic></bold> and <bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>HS</italic></bold> as well as the eigen decomposition of (<bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>S</italic></bold>)<sup><bold><italic>&#x2212;</italic></bold><bold>1</bold></sup><bold><italic>S</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>HS</italic></bold>, only need to be performed once at the beginning and need not to be re-computed for every gene in turn. The quantities involving <bold><italic>y</italic></bold>, including <bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>y</italic></bold>, <bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>Hy</italic></bold>, and <bold><italic>y</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>H</italic></bold><bold>&#x3A3;</bold><bold><italic>Hy</italic></bold>, would vary across genes but could be computed efficiently relying on the sparsity of <bold><italic>y</italic></bold>. Indeed, these three quantities can be computed with a computational complexity that scales linearly with respect to the number of samples with non-zero values, resulting in substantial computational savings for large sparse data. Therefore, our method has an overall computational complexity of <italic>O</italic>(<italic>nd</italic><sup>2</sup>&#x2009;+&#x2009;<italic>pn</italic>&#x2009;&#x2032;&#x2009;<italic>d</italic>) and memory requirement of <italic>O</italic>(<italic>nd</italic><sup>2</sup>), where <italic>p</italic> is the number of analyzed genes and <italic>n</italic>&#x2032; is the number of spatial locations with non-zero counts averaged across genes.</p>
        <p id="Par31">The statistical power of the above covariance test will inevitably depend on how the distance covariance matrix <bold><italic>&#x3A3;</italic></bold> is constructed and how it matches the true underlying spatial pattern displayed by the gene of interest. While the above projection kernel construction allows us to achieve orders of magnitude of computational gains as compared to other kernels such as the Gaussian and periodic kernels used in SPARK, it is likely not optimal in detecting every possible expression patterns encountered in real data. For example, the projection kernel is likely suboptimal in detecting focal expression patterns that are targeted by Gaussian kernels or periodical expression patterns that are targeted by periodic kernels. To ensure robust identification of SE genes across various possible spatial expression patterns, we consider different transformations of the spatial coordinates <bold><italic>s</italic></bold><sub><bold><italic>i</italic></bold></sub> and subsequent construction of different distance covariance matrices. Specifically, we applied five Gaussian transformations on the coordinates <bold><italic>s</italic></bold><sub><bold><italic>i</italic></bold></sub>&#x2009;=&#x2009;(<italic>s</italic><sub><italic>i</italic>1</sub>,&#x2009;<italic>s</italic><sub><italic>i</italic>2</sub>) to obtain five sets of transformed coordinates <bold><italic>s</italic></bold>&#x2032;<sub><bold><italic>i</italic></bold></sub>&#x2009;=&#x2009;(<italic>s</italic>&#x2032;<sub><italic>i</italic>1</sub>,&#x2009;<italic>s</italic>&#x2032;<sub><italic>i</italic>2</sub>) , with <inline-formula id="IEq5"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {s}_{i1}^{\prime }=\mathit{\exp}\left(\frac{-{s}_{i1}^2}{2{\sigma}_1^2}\right) $$\end{document}</tex-math><mml:math id="M22" display="inline"><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mo>&#x2032;</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mo mathvariant="italic">exp</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msubsup><mml:mi>&#x3C3;</mml:mi><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfrac></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq5.gif"/></alternatives></inline-formula> being the transformed x-coordinate and <inline-formula id="IEq6"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {s}_{i2}^{\prime }=\mathit{\exp}\left(\frac{-{s}_{i2}^2}{2{\sigma}_2^2}\right) $$\end{document}</tex-math><mml:math id="M24" display="inline"><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mo>&#x2032;</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mo mathvariant="italic">exp</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mo>&#x2212;</mml:mo><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:msubsup><mml:mi>&#x3C3;</mml:mi><mml:mn>2</mml:mn><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfrac></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq6.gif"/></alternatives></inline-formula> being the transformed y-coordinate in each set. In the transformation, we used different smoothness parameters <italic>&#x3C3;</italic><sub>1</sub> and <italic>&#x3C3;</italic><sub>2</sub> in each set to cover a range of possible local covariance patterns. In addition, we applied five cosine transformations on <bold><italic>s</italic></bold><sub><bold><italic>i</italic></bold></sub> to obtain another five sets of transformed coordinates <bold><italic>s</italic></bold>&#x2032;<sub><bold><italic>i</italic></bold></sub>, with <inline-formula id="IEq7"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {s}_{i1}^{\prime }=\cos \left(\frac{2\pi {s}_{i1}}{\phi_1}\right) $$\end{document}</tex-math><mml:math id="M26" display="inline"><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow><mml:mo>&#x2032;</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mo>cos</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#x3C0;</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>&#x3D5;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mfrac></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq7.gif"/></alternatives></inline-formula> being the transformed x-coordinate and <inline-formula id="IEq8"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {s}_{i2}^{\prime }=\cos \left(\frac{2\pi {s}_{i2}}{\phi_2}\right) $$\end{document}</tex-math><mml:math id="M28" display="inline"><mml:msubsup><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mo>&#x2032;</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mo>cos</mml:mo><mml:mfenced close=")" open="("><mml:mfrac><mml:mrow><mml:mn>2</mml:mn><mml:mi>&#x3C0;</mml:mi><mml:msub><mml:mi>s</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:msub><mml:mi>&#x3D5;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mfrac></mml:mfenced></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq8.gif"/></alternatives></inline-formula> being the transformed y-coordinate in each set. We also used different periodicity parameters <italic>&#x3D5;</italic><sub>1</sub> and <italic>&#x3D5;</italic><sub>2</sub> in each set to cover a range of possible periodic patterns. The transformation parameters <italic>&#x3C3;</italic><sub>1</sub>, <italic>&#x3C3;</italic><sub>2</sub>, <italic>&#x3D5;</italic><sub>1</sub>, and <italic>&#x3D5;</italic><sub>2</sub> are predetermined using the 20%, 40%, 60%, 80%, and 100% quantiles of the absolute values of the <italic>x</italic> and <italic>y</italic> coordinates in the data. Using the empirical quantiles of the data to construct different covariance matrices follows the main ideas of [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Compared to the alternative approach of fixing the transformation parameters to some predetermined values, using the quantiles of the data for transformation has the benefits of being invariant to any scale transformation of the original data and allows us to construct the distance covariance matrices in a data-dependent fashion.</p>
        <p id="Par32">We used each transformed <inline-formula id="IEq9"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {\boldsymbol{s}}_{\boldsymbol{i}}^{\prime } $$\end{document}</tex-math><mml:math id="M30" display="inline"><mml:msubsup><mml:mi mathvariant="bold-italic">s</mml:mi><mml:mi mathvariant="bold-italic">i</mml:mi><mml:mo>&#x2032;</mml:mo></mml:msubsup></mml:math><inline-graphic xlink:href="13059_2021_2404_Article_IEq9.gif"/></alternatives></inline-formula> to construct a distance covariance matrix as described above, resulting in a total of ten transformed distance covariance matrices in addition to the untransformed distance covariance matrix (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S17). Intuitively, the kernel constructed based on the untransformed coordinates is likely useful to detect linear expression pattern across the coordinates. The kernels constructed based on the cosine transformed coordinates are likely useful to detect periodic expression patterns on the tissue. While the kernels constructed based on the Gaussian transformed coordinates are likely useful to detect focal expression patterns on the tissue. Therefore, combining the original and transformed distance covariance matrices would allow us to detect a wide variety of spatial expression patterns encountered in real data. To do so, we computed a <italic>P</italic> value using Davies&#x2019; method for each distance covariance matrix. We then combined all eleven <italic>P</italic> values into a single <italic>P</italic> value through the Cauchy <italic>P</italic> value combination rule [<xref ref-type="bibr" rid="CR72">72</xref>, <xref ref-type="bibr" rid="CR73">73</xref>].</p>
        <p id="Par33">We have so far described the method in the absence of covariates. In the presence of covariates, we can replace the <italic>n</italic>-vector <bold>1</bold><sub><italic>n</italic></sub> in the <bold><italic>H</italic></bold> matrix with a corresponding covariate matrix <bold><italic>X</italic></bold> of dimensionality <italic>n</italic> by <italic>q</italic>. The covariate matrix contains a column of 1&#x2019;s that represents the intercept, with the remaining columns representing the measurements for the <italic>q</italic>-1 covariates. Therefore, the centering matrix becomes <bold><italic>H&#x2009;=</italic></bold>&#x2009;(<bold><italic>I&#x2009;&#x2212;&#x2009;X</italic></bold>(<bold><italic>X</italic></bold><sup><bold><italic>T</italic></bold></sup><bold><italic>X</italic></bold>)<sup><bold><italic>&#x2212;</italic></bold><bold>1</bold></sup><bold><italic>X</italic></bold><sup><bold><italic>T</italic></bold></sup>). Despite this change, the other steps remain the same.</p>
        <p id="Par34">We refer to the above method as SPARK-X (SPARK-eXpedited), which is implemented in the SPARK R package with underlying efficient C/C++ code linked through Rcpp and with multiple threads computing capability. The software, together with all the analysis code for reproducing the results presented in the present study, are freely available at <ext-link ext-link-type="uri" xlink:href="http://www.xzlab.org/software.html">www.xzlab.org/software.html</ext-link>.</p>
      </sec>
      <sec id="Sec10">
        <title>Simulation designs</title>
        <p id="Par35">We performed extensive simulations to comprehensively evaluate the performance of SPARK-X along with several other existing methods. To make simulations as realistic as possible, we simulated data based on parameters inferred from two published data sets that include a spatial transcriptomic (ST) data set [<xref ref-type="bibr" rid="CR11">11</xref>] and a Slide-seq data set (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S16). The two data sets represent two different gene-expression data structures, with the ST data representing a moderately sparse data with 60% of zero values and the Slide-seq data representing a highly sparse data with 99.4% of zero values (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). In the simulations, we first randomly simulated the coordinates for a fixed number of spatial locations (<italic>n</italic>) through a random-point-pattern Poisson process. On these spatial locations, we simulated expression levels for 10,000 genes based on a negative binomial distribution with details provided below. These 10,000 genes were all non-SE genes in the null simulations and consisted of 1000 SE genes and 9000 non-SE genes in the power simulations. For both non-SE genes and SE genes, we varied the dispersion parameter of the negative binomial distribution to be either 0.1, 0.2, or 1 for the moderately sparse setting and to be either 1, 2.5, or 5 for the highly sparse setting. These values were selected to match the scale of dispersion parameter estimated in the two real data sets. For the non-SE genes, we varied the mean parameter of the negative binomial distribution to be either 0.005 or 0.5. The low value of 0.005 corresponds to the median mean estimate in the Slide-seq data and represents a highly sparse gene-expression setting. The high value of 0.5 corresponds to the median mean estimate in the ST data and represents a moderately sparse gene-expression setting. For the SE genes, we simulated their expression levels to display three distinct spatial patterns (hotspot, streak, and gradient patterns, Fig. <xref rid="Fig1" ref-type="fig">1</xref>D).</p>
        <p id="Par36">Specifically, for the first two spatial patterns, we created either a circle (for hotspot pattern) or a band (for streak pattern) in the middle of the panel and marked spatial locations residing in these areas. The size of the circle and the size of the band were designed so that the marked spatial locations inside these areas represent a fixed proportion of all spatial locations, with the proportion set to be either 10%, 20%, or 30%. The expression measurements of the non-marked spatial locations were randomly generated from a negative binomial distribution with the mean parameter set to be 0.005 or 0.5. For the moderately sparse setting, the expression measurements of the marked spatial locations were generated from a negative binomial distribution with a mean parameter being either 1.5, 2, or 3 times higher than that in the non-marked spatial locations (for 500 SE genes) or 2/3, 1/2, or 1/3 of that in the non-marked spatial locations (for 500 SE genes), representing low, moderate, or high SE signal strength, respectively. For the highly sparse setting, the expression measurements of the marked spatial locations were generated from a negative binomial distribution with a mean parameter being either 2, 3, or 4 higher than that in the non-marked spatial locations (for 500 SE genes) or 1/2, 1/3, or 1/4 of that in the in the non-marked spatial locations (for 500 SE genes), representing low, moderate, or high SE signal strength, respectively.</p>
        <p id="Par37">For the gradient pattern, the expression levels of a fraction of spatial locations (=20%, 30%, or 40%) were set either in an increasing order (for 500 SE genes) or a decreasing order (for the other 500 SE genes) along the x-axis. The three fractions used correspond to low, moderate, or high SE signal strength in this setting, respectively. In particular, we generated the expression measurements for all spatial locations from a negative binomial distribution. For each SE gene, we randomly selected a fraction of spatial locations where we assigned their gene-expression values in either increasing or decreasing order back to them based on their x-axis coordinates. In contrast, the expression measurements for the non-SE genes were randomly assigned to all spatial locations, regardless of their spatial locations.</p>
        <p id="Par38">In all these simulations, we varied the number of spatial locations (n = 300, 500, 1000, 2000, or 3000 for the moderate sparsity setting and n = 3000, 10,000, 20,000, 30,000, or 50,000 for the highly sparse setting), the expression sparsity level (moderate or high, as measured by the mean parameter in the negative binomial distribution), the noise level (low, moderate or high noise, as measured by the dispersion parameter in the negative binomial distribution), the SE strength (weak, moderate, or strong, as measured by fold change in the mean parameter for the first two spatial patterns and by the fraction of spatial locations displaying expression gradient for the third spatial pattern), as well as the fraction of spatial locations in the focal/streak area for the first two spatial patterns.</p>
      </sec>
      <sec id="Sec11">
        <title>Real data analysis</title>
        <sec id="Sec12">
          <title>Slide-seq data</title>
          <p id="Par39">Slide-seq is a technology which enables transcriptome-wide measurements with 10-micron spatial resolution by transferring RNA from tissue sections onto a surface covered in DNA-barcoded beads with known positions and inferring the locations of RNA using a sequencing-by-ligation strategy. We obtained the Slide-seq dataset collected on the mouse cerebellum from Broad Institute&#x2019;s single-cell repository (<ext-link ext-link-type="uri" xlink:href="https://singlecell.broadinstitute.org/single_cell/">https://singlecell.broadinstitute.org/single_cell/</ext-link>) with ID SCP354. We used the file &#x201C;Puck_180430_6&#x201D; which contains 18,671 genes measured on 25,551 beads with known spatial location information. The bead size is approaching the size of mammalian cells (10 microns), though each bead may overlap with multiple cells. After filtering out mitochondrial genes and genes that are not expressed on any bead, we analyzed a final set of 17,729 genes on 25,551 beads. The data is highly sparse with 99.46% entries being 0 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).</p>
        </sec>
        <sec id="Sec13">
          <title>Slide-seqV2 data</title>
          <p id="Par40">Slide-seqV2 is a technology that builds upon on Slide-seq with modifications to library generation, bead synthesis, and array-indexing, thereby markedly improving the mRNA capture sensitivity. We obtained the Slide-seqV2 dataset collected on the mouse cerebellum from Broad Institute&#x2019;s single-cell repository with ID SCP948. The data contains 23,096 genes measured on 39,496 beads with known spatial location information. The bead size is the same as that in the Slide-seq data. Following [<xref ref-type="bibr" rid="CR36">36</xref>], we first cropped the region of interest and filtered out beads with UMIs less than 100. After filtering out mitochondrial genes and genes that are not expressed on any bead, we analyzed a final set of 20,117 genes on 11,626 beads. While the capture sensitivity is improved in the Slide-seqV2 as compared to Slide-seqV1, the Slide-seqV2 data is still highly sparse with 98.35% entries being zero (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).</p>
          <p id="Par41">We performed cell decomposition and conditional SE analysis on the Slide-seqV2 data. Specifically, we used the recently developed RCTD software [<xref ref-type="bibr" rid="CR36">36</xref>] (v.1.0.0) to infer cell type composition on each spatial location. Following the original RCTD paper, we used a single-nucleus RNA-seq data [<xref ref-type="bibr" rid="CR74">74</xref>] to serve as the reference panel for RCTD fitting, which contains 19 cell types. In the analysis, RCTD rejected 1494 beads and assigned cell type labels to 11,061 cells confidently from 9554 beads. We converted the inferred cell types into binary indicators and used them as covariates in SE analysis. Because RCTD produced confident cell type assignment using a set of 3338 genes (after RCTD filtering) on 11,061 cells (inferred from 9554 beads), we performed analysis on these genes and locations in the covariate adjusted SE analysis.</p>
          <p id="Par42">Besides conditional SE analysis, we also performed the cell type-specific SE analysis in the data. Specifically, we rely on the cell type composition estimates from RCTD to extract the locations that are dominated by Purkinje cells or granular cells. The Purkinje cells are primarily located in the thin Purkinje cell layer while the granule cells are primarily located in the thick granular layer; both layers are of highly irregular shapes. After removing genes with no expression on any of the selected cells, we performed SE analysis using SPARK-X for 3006 genes on 652 Purkinje cells and 3288 genes on 5891 granule cells.</p>
        </sec>
        <sec id="Sec14">
          <title>High-definition spatial transcriptomics data</title>
          <p id="Par43">High-definition spatial transcriptomics is a method to capture RNA from tissue sections on a dense, spatially barcoded bead array, allowing transcriptome-wide measurements with 2-micron resolution. We obtained the HDST dataset collected on the mouse olfactory bulb from Broad Institute&#x2019;s single-cell repository with ID SCP420. We used the file &#x201C;CN24_D1&#x201D; which contains 19,951 genes measured in 181,380 spots with known spatial location information. Each spot is a 2-micron well, approaching one fifth of the size of mammalian cells. We filtered out mitochondrial genes and genes that are not expressed on any spot and we removed spots with no gene-expression count. We analyzed a final set of 19,913 genes on 177,455 spots. The HDST data is extremely sparse with 99.96% of entries being 0 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). We performed clustering analysis on the detected SE genes. To do so, for each gene in turn, we log transformed the raw count and scaled the transformed value further to have a mean of zero and standard deviation of one across all spots. We then used the hierarchical agglomerative clustering algorithm in the R package <italic>amap</italic> (v.0.8&#x2013;18) to cluster identified SE genes into five gene groups.</p>
          <p id="Par44">We performed conditional SE analysis on a subset of the HDST data to examine the extent to which SE genes display spatial expression pattern beyond those explained by spatial distribution of cell types. To do so, we first extracted the most likely cell type for each spot based on the original publication and kept the spots with confident cell type assignment (<italic>P</italic>-adjust&lt;&#x2009;0.05). After filtering out mitochondrial genes and genes that are not expressed on any spots, we analyzed a final set of 17,121 genes on 103,602 spots. There are 63 cell types including non-neuronal cell types and multiple neuronal subtypes clustered in the original publication. We treated the assigned cell types as covariates for SE analysis on these spots.</p>
          <p id="Par45">We also performed cell type-specific SE analysis on a subtype of inhibitory neurons, the olfactory bulb inner horizontal cells (OBINH2). We selected these inhibitory neurons as they have the largest cell numbers among all cell types in the data. In the analysis, we extracted spatial locations that are labeled as OBINH2 neurons and removed genes that are not expressed on any of the extracted locations. In total, we analyzed 11,504 genes measured on 15,650 spatial locations in the cell type-specific SE analysis.</p>
        </sec>
        <sec id="Sec15">
          <title>10X Visium data</title>
          <p id="Par46">The 10X Visium is a platform that builds upon on the original Spatial Transcriptomics technology with improvements on both resolution (55-micron resolution, with smaller distance between barcoded regions) and experimental time. We obtained a Visium dataset collected on the human heart tissue from the 10X Visium spatial gene-expression repository (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Human_Heart">https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Human_Heart</ext-link>). The data contains 36,601 genes measured on 4247 spots with known spatial location information. Each spot is a 55-micron well. We filtered out mitochondrial genes and genes that are not expressed in any spot. We analyzed a final set of 20,904 genes on 4247 spots. The 10X Visium human heart data is relatively sparse with 90.81% of entries being 0 (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). In addition, we also obtained a Visium dataset collected on the human ovarian cancer tissue from the 10X Visium spatial gene-expression repository (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/spatial-gene-expression/datasets/1.2.0/Targeted_Visium_Human_OvarianCancer_Pan_Cancer">https://support.10xgenomics.com/spatial-gene-expression/datasets/1.2.0/Targeted_Visium_Human_OvarianCancer_Pan_Cancer</ext-link>). The data contains 1198 genes measured on the 3493 spots. After removing spot with no gene-expression count, we analyzed a final set of 1198 genes on 3492 spots. Since this data is generated with an enriched library prepared using the Human Pan-Cancer Panel, only 73.78% of entries are 0.</p>
        </sec>
        <sec id="Sec16">
          <title>STARmap data</title>
          <p id="Par47">Spatially resolved Transcript Amplicon Readout Mapping (STARmap) is a technology for 3D intact-tissue RNA sequencing. STARmap integrates hydrogel-tissue chemistry, targeted signal amplification, and in situ sequencing. We obtained the STARmap dataset collected on the mouse visual cortex from STARmap resources (<ext-link ext-link-type="uri" xlink:href="https://www.starmapresources.com/data">https://www.starmapresources.com/data</ext-link>). We used the data collected in the sequentially encoded experiment, which contains 28 genes measured in 33,598 cells with known 3D spatial location information. These 28 genes include 23 cell type markers and 5 activity-regulated genes. After filtering out cells with no gene-expression count, we analyzed a final set of 28 genes on 32,845 cells. The STARmap data are of high counts with almost no zero values (1.2% zeros; Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). We followed the procedures in the original paper [<xref ref-type="bibr" rid="CR75">75</xref>] for cell type clustering. Specifically, we first applied log transformation to the raw count data and obtained the relative gene-expression levels through adjusting for the log-scale total read counts. We then clustered cells into inhibitory neurons, excitatory neurons, and non-neuronal cells using <italic>Gad1</italic>, <italic>Slc17a7</italic>, and four non-neuronal genes (<italic>Flt1</italic>, <italic>Mbp</italic>, <italic>Ctss</italic>, <italic>Gja1</italic>) using the K-means clustering algorithm.</p>
          <p id="Par48">For each of the above datasets, we performed permutations to construct an empirical null distribution of <italic>P</italic> values for each method by permuting the bead/spot/cell coordinates either ten times (for Slide-seq, Slide-seqV2, HDST, and 10X Visium data) or a thousand times (for STARmap data). Afterwards, we examined control of type I errors by the different methods on the basis of the empirical null distribution of <italic>P</italic> values. We declared an SE gene as significant based on an empirical FDR threshold of 0.01. We note that standard <italic>P</italic> value cutoffs such as Bonferroni-corrected <italic>P</italic> value threshold can also be used for SPARK-X due to its calibrated type I error control.</p>
        </sec>
        <sec id="Sec17">
          <title>SE gene validation and functional gene set enrichment analysis</title>
          <p id="Par49">For the Slide-seq data, we obtained lists of genes that can be used to serve as unbiased validation for the SE genes identified by different methods. Specifically, we obtained the cerebellum gene list from the Harmonizome database [<xref ref-type="bibr" rid="CR29">29</xref>], which consists of 2632 cerebellum-related genes identified in two datasets (Allen Brain Atlas adult mouse brain tissue gene-expression profiles; and TISSUES curated tissue protein expression evidence scores). In addition, we obtained a gene list from Wizeman et al. [<xref ref-type="bibr" rid="CR30">30</xref>], which contains 4152 cell type markers genes in cerebellum. We used the two gene lists to validate the SE genes identified by different methods.</p>
          <p id="Par50">We also performed functional gene set enrichment analysis on the significant SE genes identified by SPARK-X and SPARK-G. We performed enrichment analyses using the R package clusterProfiler [<xref ref-type="bibr" rid="CR76">76</xref>] (v.3.12.0) with GO terms and Reactome pathways. In the package, we used the default &#x201C;BH&#x201D; method for multiple-testing correction and set the default number of permutations to be 1000. We declared enrichment significance based on an FDR of 0.05.</p>
        </sec>
        <sec id="Sec18">
          <title>Compared methods</title>
          <p id="Par51">We compared SPARK-X with three existing methods for detecting genes with spatial expression patterns: SPARK (v.1.1.0) [<xref ref-type="bibr" rid="CR6">6</xref>], SPARK-G (the Gaussian version of SPARK), and SpatialDE (v.1.1.3) [<xref ref-type="bibr" rid="CR5">5</xref>]. We did not include the trendsceek in the comparison due to its high computational burden. For example, it takes trendsceek 40&#x2009;h to analyze a simulated data with 10,000 genes measured on 300 locations, which is 5000 times slower than SPARK-X. The computational burden of trendsceek becomes even heavier on larger datasets. We applied all four methods to the simulated data with SPARK being restricted to the settings that have a sample size &#x2264; 3000 due to its heavy computational burden. We applied SPARK-X, SPARK-G, and SpatialDE to the Slide-seq and Slide-seqV2 data. The SPARK-G and SpatialDE are not scalable when the sample size is over approximately 30,000. Therefore, we did not apply these two methods to the HDST data. The SpatialDE gave out error when we applied it to the STARmap data; thus, we only present the results from SPARK-X and SPARK-G there. For SPARK and SpatialDE, we adopted their default settings to filter data. Specifically, for SPARK, we filtered out genes that are expressed in less than 10% of the spatial locations and selected spatial locations with at least ten total read counts; for SpatialDE, we filtered out genes with aggregate expression count less than three and selected spatial locations with at least ten total read counts. For the SPARK-G, we did not perform any additional filtering. The number of analyzed gene for each method is provided in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Information</title>
      <sec id="Sec19">
        <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13059_2021_2404_MOESM1_ESM.docx"><caption><p><bold>Additional file 1: Supplementary information.</bold> It includes all the supplementary figures and tables.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13059_2021_2404_MOESM2_ESM.xlsx"><caption><p><bold>Additional file 2: Supplementary Table 4.</bold> Enrichment analysis of SE genes for the mouse cerebellum Slide-seq data.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13059_2021_2404_MOESM3_ESM.xlsx"><caption><p><bold>Additional file 3: Supplementary Table 5.</bold> Enrichment analysis of SE genes for the mouse cerebellum Slide-seqV2 data.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="13059_2021_2404_MOESM4_ESM.xlsx"><caption><p><bold>Additional file 4: Supplementary Table 6.</bold> Enrichment analysis of SE genes for the mouse olfactory bulb HDST data.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="13059_2021_2404_MOESM5_ESM.xlsx"><caption><p><bold>Additional file 5: Supplementary Table 7.</bold> Enrichment analysis of SE genes for the human ovarian cancer Visium data.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="13059_2021_2404_MOESM6_ESM.docx"><caption><p><bold>Additional file 6.</bold> Review history.</p></caption></media></supplementary-material></p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Publisher&#x2019;s Note</bold>
        </p>
        <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We gratefully thank Mr. Dylan M. Cable for his technical assistance in the RCTD application.</p>
      <sec id="FPar1">
        <title>Review history</title>
        <p id="Par52">The review history is available as Additional file <xref rid="MOESM6" ref-type="media">6</xref>.</p>
      </sec>
      <sec id="FPar2">
        <title>Peer review information</title>
        <p id="Par53">Barbara Cheifet was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p>
      </sec>
    </ack>
    <notes notes-type="author-contribution">
      <title>Authors&#x2019; contributions</title>
      <p>XZ conceived the idea and provided funding support. JZ and XZ designed the experiments. JZ developed the method and implemented the software, with help from SS. JZ performed simulations and analyzed real data. JZ and XZ wrote the manuscript with input from SS. The authors read and approved the final manuscript.</p>
      <sec id="FPar3">
        <title>Authors&#x2019; information</title>
        <p id="Par54">Twitter handles: @ZhuJiaqiang (Jiaqiang Zhu); @SunShiquan (Shiquan Sun); @xzlab_org (Xiang Zhou).</p>
      </sec>
    </notes>
    <notes notes-type="funding-information">
      <title>Funding</title>
      <p>This study was supported by the National Institutes of Health (NIH) Grants R01HG009124, R01GM126553, R01HG011883, R01GM144960, and the National Science Foundation (NSF) Grant DMS1712933. J.Z. was also supported by NIH Grant R01HD088558 (PI Tung).</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Availability of data and materials</title>
      <p>All codes, processed data, and analysis results in this paper are publicly available at GitHub [<xref ref-type="bibr" rid="CR77">77</xref>] and Zenodo [<xref ref-type="bibr" rid="CR78">78</xref>]. The source code is released under the MIT license. Slide-seq data, Slide-seqV2 data, and HDST data are available at Broad Institute&#x2019;s single-cell repository (<ext-link ext-link-type="uri" xlink:href="https://singlecell.broadinstitute.org/single_cell/">https://singlecell.broadinstitute.org/single_cell/</ext-link>) with ID SCP354, SCP948, and SCP420. The 10X Visium data sets are available at <ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Human_Heart">https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Human_Heart</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/spatial-gene-expression/datasets/1.2.0/Targeted_Visium_Human_OvarianCancer_Pan_Cancer">https://support.10xgenomics.com/spatial-gene-expression/datasets/1.2.0/Targeted_Visium_Human_OvarianCancer_Pan_Cancer</ext-link>. The STARmap data set is available at <ext-link ext-link-type="uri" xlink:href="https://www.starmapresources.com/data">https://www.starmapresources.com/data</ext-link>.</p>
    </notes>
    <notes>
      <title>Declarations</title>
      <notes id="FPar4">
        <title>Ethics approval and consent to participate</title>
        <p id="Par55">No ethical approval was required for this study. All utilized public data sets were generated by other organizations that obtained ethical approval.</p>
      </notes>
      <notes id="FPar5">
        <title>Consent for publication</title>
        <p id="Par56">Not applicable.</p>
      </notes>
      <notes id="FPar6" notes-type="COI-statement">
        <title>Competing interests</title>
        <p id="Par57">The authors declare that they have no competing interests.</p>
      </notes>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Giacomello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Larsson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>F&#xFC;rth</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A spatiotemporal organ-wide gene expression and cell atlas of the developing human heart</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>179</volume>
          <issue>7</issue>
          <fpage>1647</fpage>
          <lpage>60. e19</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.11.025</pub-id>
          <pub-id pub-id-type="pmid">31835037</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ortiz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Jurek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>M&#xE4;rtin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lundeberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Meletis</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Molecular atlas of the adult mouse brain</article-title>
          <source>Sci Adv</source>
          <year>2020</year>
          <volume>6</volume>
          <issue>26</issue>
          <fpage>eabb3446</fpage>
          <pub-id pub-id-type="doi">10.1126/sciadv.abb3446</pub-id>
          <pub-id pub-id-type="pmid">32637622</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Merritt</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Ong</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Church</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Danaher</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Geiss</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hoang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>McKay-Fleisch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nguyen</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Norgaard</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sorg</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sprague</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Warren</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Webster</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zollinger</surname>
              <given-names>DR</given-names>
            </name>
            <name>
              <surname>Dunaway</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Mills</surname>
              <given-names>GB</given-names>
            </name>
            <name>
              <surname>Beechem</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Multiplex digital spatial profiling of proteins and RNA in fixed tissue</article-title>
          <source>Nat Biotechnol</source>
          <year>2020</year>
          <volume>38</volume>
          <issue>5</issue>
          <fpage>586</fpage>
          <lpage>599</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-020-0472-9</pub-id>
          <pub-id pub-id-type="pmid">32393914</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edsgard</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Johnsson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sandberg</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Identification of spatial expression trends in single-cell gene expression data</article-title>
          <source>Nat Methods.</source>
          <year>2018</year>
          <volume>15</volume>
          <issue>5</issue>
          <fpage>339</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4634</pub-id>
          <pub-id pub-id-type="pmid">29553578</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Svensson</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Teichmann</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stegle</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>SpatialDE: identification of spatially variable genes</article-title>
          <source>Nat Methods.</source>
          <year>2018</year>
          <volume>15</volume>
          <issue>5</issue>
          <fpage>343</fpage>
          <lpage>346</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4636</pub-id>
          <pub-id pub-id-type="pmid">29553579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Statistical analysis of spatial expression patterns for spatially resolved transcriptomic studies</article-title>
          <source>Nat Methods.</source>
          <year>2020</year>
          <volume>17</volume>
          <issue>2</issue>
          <fpage>193</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1038/s41592-019-0701-7</pub-id>
          <pub-id pub-id-type="pmid">31988518</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ji</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Thrane</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Meyers</surname>
              <given-names>RM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multimodal analysis of composition and spatial architecture in human squamous cell carcinoma</article-title>
          <source>Cell</source>
          <year>2020</year>
          <volume>182</volume>
          <issue>2</issue>
          <fpage>497</fpage>
          <lpage>514. e22</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2020.05.039</pub-id>
          <pub-id pub-id-type="pmid">32579974</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dries</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>G-C</given-names>
            </name>
          </person-group>
          <article-title>Identification of spatially associated subpopulations by combining scRNAseq and sequential fluorescence in situ hybridization data</article-title>
          <source>Nat Biotechnol</source>
          <year>2018</year>
          <volume>36</volume>
          <issue>12</issue>
          <fpage>1183</fpage>
          <lpage>1190</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4260</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ghazanfar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Patrick</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Z-G</given-names>
            </name>
            <name>
              <surname>Marioni</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>JYH</given-names>
            </name>
          </person-group>
          <article-title>Investigating higher-order interactions in single-cell data with scHOT</article-title>
          <source>Nat Methods.</source>
          <year>2020</year>
          <volume>17</volume>
          <issue>8</issue>
          <fpage>799</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="doi">10.1038/s41592-020-0885-x</pub-id>
          <pub-id pub-id-type="pmid">32661426</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arnol</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schapiro</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bodenmiller</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Saez-Rodriguez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stegle</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Modeling cell-cell interactions from spatial molecular data with spatial variance component analysis</article-title>
          <source>Cell Rep</source>
          <year>2019</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>202</fpage>
          <lpage>11. e6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2019.08.077</pub-id>
          <pub-id pub-id-type="pmid">31577949</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xE5;hl</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Salm&#xE9;n</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vickovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lundmark</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Magnusson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Giacomello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Westholm</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Huss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mollbrink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Linnarsson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Codeluppi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Borg</surname>
              <given-names>&#xC5;</given-names>
            </name>
            <name>
              <surname>Pont&#xE9;n</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Costea</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Sahl&#xE9;n</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mulder</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bergmann</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lundeberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fris&#xE9;n</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>
          <source>Science.</source>
          <year>2016</year>
          <volume>353</volume>
          <issue>6294</issue>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaf2403</pub-id>
          <pub-id pub-id-type="pmid">27365449</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>W-T</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Craessaerts</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pavie</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Frigerio</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Corthout</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lal&#xE1;kov&#xE1;</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>K&#xFC;hnemund</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Voytyuk</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Wolfs</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Spatial transcriptomics and in situ sequencing to study Alzheimer&#x2019;s disease</article-title>
          <source>Cell.</source>
          <year>2020</year>
          <volume>182</volume>
          <issue>4</issue>
          <fpage>976</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2020.06.038</pub-id>
          <pub-id pub-id-type="pmid">32702314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriques</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Stickels</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Goeva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vanderburg</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Macosko</surname>
              <given-names>EZ</given-names>
            </name>
          </person-group>
          <article-title>Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution</article-title>
          <source>Science.</source>
          <year>2019</year>
          <volume>363</volume>
          <issue>6434</issue>
          <fpage>1463</fpage>
          <lpage>1467</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaw1219</pub-id>
          <pub-id pub-id-type="pmid">30923225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stickels</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marshall</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Di Bella</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Arlotta</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Macosko</surname>
              <given-names>EZ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2</article-title>
          <source>Nat Biotechnol.</source>
          <year>2021</year>
          <volume>39</volume>
          <issue>3</issue>
          <fpage>313</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-020-0739-1</pub-id>
          <pub-id pub-id-type="pmid">33288904</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vickovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eraslan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Salmen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Klughammer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Stenbeck</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Schapiro</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-definition spatial transcriptomics for in situ tissue profiling</article-title>
          <source>Nat Methods.</source>
          <year>2019</year>
          <volume>16</volume>
          <issue>10</issue>
          <fpage>987</fpage>
          <lpage>990</lpage>
          <pub-id pub-id-type="doi">10.1038/s41592-019-0548-y</pub-id>
          <pub-id pub-id-type="pmid">31501547</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ruzzo</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities</article-title>
          <source>Sci Rep.</source>
          <year>2020</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1038/s41598-019-56847-4</pub-id>
          <pub-id pub-id-type="pmid">31913322</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="other">Maynard KR, Collado-Torres L, Weber LM, Uytingco C, Barry BK, Williams SR, Catallini JL, Tran MN, Besich Z, Tippani M, Chew J. Transcriptome-scale spatial gene expression in the human dorsolateral prefrontal cortex.&#xA0;Nat Neurosci.&#xA0;2021;24(3):425&#x2013;36.</mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dries</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Eng</surname>
              <given-names>C-HL</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Giotto: a toolbox for integrative analysis and visualization of spatial expression data</article-title>
          <source>Genome Biol</source>
          <year>2021</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="doi">10.1186/s13059-021-02286-2</pub-id>
          <pub-id pub-id-type="pmid">33397451</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Accurate and scalable construction of polygenic scores in large biobank data sets</article-title>
          <source>Am J Hum Genet.</source>
          <year>2020</year>
          <volume>106</volume>
          <issue>5</issue>
          <fpage>679</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2020.03.013</pub-id>
          <pub-id pub-id-type="pmid">32330416</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="other">BinTayyash N, Georgaka S, John S, Ahmed S, Boukouvalas A, Hensman J, et al.&#xA0;Non-parametric modelling of temporal and spatial counts data from RNA-seq experiments. Preprint at&#xA0;bioRxiv.&#xA0;2020. 10.1101/2020.07.29.227207.</mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>BD VWR</collab>
          </person-group>
          <source>Modern applied statistics with S</source>
          <year>2002</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Springer</publisher-name>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lea</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Tung</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>A flexible, efficient binomial mixed model for identifying differential DNA methylation in bisulfite sequencing data</article-title>
          <source>PLoS Genet</source>
          <year>2015</year>
          <volume>11</volume>
          <issue>11</issue>
          <fpage>e1005650</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1005650</pub-id>
          <pub-id pub-id-type="pmid">26599596</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hood</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Scott</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Peng</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Mukherjee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tung</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Differential expression analysis for RNAseq using Poisson mixed models</article-title>
          <source>Nucleic Acids Res</source>
          <year>2017</year>
          <volume>45</volume>
          <issue>11</issue>
          <fpage>e106</fpage>
          <lpage>e10e</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkx204</pub-id>
          <pub-id pub-id-type="pmid">28369632</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="other">Gretton A, Fukumizu K, Teo CH, Song L, Sch&#xF6;lkopf B, Smola AJ. A kernel statistical test of independence.&#xA0;In Nips, Vol. 20; 2007 Jan 1. p. 585&#x2013;92.</mixed-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szekely</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Rizzo</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Bakirov</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
          <article-title>Measuring and testing dependence by correlation of distances</article-title>
          <source>Ann Statist.</source>
          <year>2007</year>
          <volume>35</volume>
          <issue>6</issue>
          <fpage>2769</fpage>
          <lpage>2794</lpage>
          <pub-id pub-id-type="doi">10.1214/009053607000000505</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kosorok</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>On Brownian distance covariance and high dimensional data</article-title>
          <source>Ann Appl Stat.</source>
          <year>2009</year>
          <volume>3</volume>
          <issue>4</issue>
          <fpage>1266</fpage>
          <lpage>1269</lpage>
          <pub-id pub-id-type="doi">10.1214/09-AOAS312</pub-id>
          <pub-id pub-id-type="pmid">20574547</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="other">Zhang K, Peters J, Janzing D, Sch&#xF6;lkopf B. Kernel-based conditional independence test and application in causal discovery. In: Proceedings of the 27th Conference on Uncertainty in Artificial Intelligence;&#xA0;2011. p. 804&#x2013;13.&#xA0;</mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warton</surname>
              <given-names>DI</given-names>
            </name>
          </person-group>
          <article-title>Why you cannot transform your way out of trouble for small counts</article-title>
          <source>Biometrics.</source>
          <year>2018</year>
          <volume>74</volume>
          <issue>1</issue>
          <fpage>362</fpage>
          <lpage>368</lpage>
          <pub-id pub-id-type="doi">10.1111/biom.12728</pub-id>
          <pub-id pub-id-type="pmid">28504821</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <mixed-citation publication-type="other">Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database. 2016;2016. 10.1093/database/baw100.</mixed-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="other">Wizeman JW, Guo Q, Wilion EM, Li JY. Specification of diverse cell types during early neurogenesis of the mouse cerebellum. Elife. 2019;8. 10.7554/eLife.42388.</mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potter</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Kern</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Fullbright</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Bielawski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Scherer</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Yum</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Venkata</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Akbar Ali Khan</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Rohrer</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hama</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Central nervous system dysfunction in a mouse model of FA2H deficiency</article-title>
          <source>Glia.</source>
          <year>2011</year>
          <volume>59</volume>
          <issue>7</issue>
          <fpage>1009</fpage>
          <lpage>1021</lpage>
          <pub-id pub-id-type="doi">10.1002/glia.21172</pub-id>
          <pub-id pub-id-type="pmid">21491498</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirai</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Bao</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Parris</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yuzaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>JI</given-names>
            </name>
          </person-group>
          <article-title>Cbln1 is essential for synaptic integrity and plasticity in the cerebellum</article-title>
          <source>Nat Neurosci</source>
          <year>2005</year>
          <volume>8</volume>
          <issue>11</issue>
          <fpage>1534</fpage>
          <lpage>1541</lpage>
          <pub-id pub-id-type="doi">10.1038/nn1576</pub-id>
          <pub-id pub-id-type="pmid">16234806</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ito-Ishida</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Miura</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Emi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Iijima</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kohda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yuzaki</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cbln1 regulates rapid formation and maintenance of excitatory synapses in mature cerebellar Purkinje cells in vitro and in vivo</article-title>
          <source>J Neurosci</source>
          <year>2008</year>
          <volume>28</volume>
          <issue>23</issue>
          <fpage>5920</fpage>
          <lpage>5930</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1030-08.2008</pub-id>
          <pub-id pub-id-type="pmid">18524896</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hurlock</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Bose</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pierce</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Joho</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Rescue of motor coordination by Purkinje cell-targeted restoration of Kv3. 3 channels in Kcnc3-null mice requires Kcnc1</article-title>
          <source>J Neurosci</source>
          <year>2009</year>
          <volume>29</volume>
          <issue>50</issue>
          <fpage>15735</fpage>
          <lpage>15744</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4048-09.2009</pub-id>
          <pub-id pub-id-type="pmid">20016089</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hurlock</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Joho</surname>
              <given-names>RH</given-names>
            </name>
          </person-group>
          <article-title>Purkinje-cell-restricted restoration of Kv3. 3 function restores complex spikes and rescues motor coordination in Kcnc3 mutants</article-title>
          <source>J Neurosci</source>
          <year>2008</year>
          <volume>28</volume>
          <issue>18</issue>
          <fpage>4640</fpage>
          <lpage>4648</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5486-07.2008</pub-id>
          <pub-id pub-id-type="pmid">18448641</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <mixed-citation publication-type="other">Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, Irizarry RA. Robust decomposition of cell type mixtures in spatial transcriptomics.&#xA0;Nat Biotechnol. 2021:1&#x2013;10.</mixed-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lim</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Ryu</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>DY</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Myung</surname>
              <given-names>PK</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn</article-title>
          <source>EMBO J</source>
          <year>2009</year>
          <volume>28</volume>
          <issue>22</issue>
          <fpage>3564</fpage>
          <lpage>3578</lpage>
          <pub-id pub-id-type="doi">10.1038/emboj.2009.289</pub-id>
          <pub-id pub-id-type="pmid">19816407</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Consalez</surname>
              <given-names>GG</given-names>
            </name>
            <name>
              <surname>Hawkes</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>The compartmental restriction of cerebellar interneurons</article-title>
          <source>Front Neural Circuits</source>
          <year>2013</year>
          <volume>6</volume>
          <fpage>123</fpage>
          <pub-id pub-id-type="doi">10.3389/fncir.2012.00123</pub-id>
          <pub-id pub-id-type="pmid">23346049</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Besco</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Popesco</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Davuluri</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Frostholm</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rotter</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Genomic structure and alternative splicing of murine R2B receptor protein tyrosine phosphatases (PTP&#x3BA;, &#x3BC;, &#x3C1; and PCP-2)</article-title>
          <source>BMC Genomics.</source>
          <year>2004</year>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>14</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2164-5-14</pub-id>
          <pub-id pub-id-type="pmid">15040814</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <mixed-citation publication-type="other">Lackey EP, Heck DH, Sillitoe RV.&#xA0;Recent advances in understanding the mechanisms of cerebellar granule cell development and function and their contribution to behavior. F1000Research. 2018;7:1142.</mixed-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsutsumi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hidaka</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Isomura</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsuzaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sakimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Modular organization of cerebellar climbing fiber inputs during goal-directed behavior</article-title>
          <source>Elife.</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>e47021</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.47021</pub-id>
          <pub-id pub-id-type="pmid">31596238</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sugihara</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Shinoda</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Molecular, topographic, and functional organization of the cerebellar cortex: a study with combined aldolase C and olivocerebellar labeling</article-title>
          <source>J Neurosci</source>
          <year>2004</year>
          <volume>24</volume>
          <issue>40</issue>
          <fpage>8771</fpage>
          <lpage>8785</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1961-04.2004</pub-id>
          <pub-id pub-id-type="pmid">15470143</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cerminara</surname>
              <given-names>NL</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Sillitoe</surname>
              <given-names>RV</given-names>
            </name>
            <name>
              <surname>Apps</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Redefining the cerebellar cortex as an assembly of non-uniform Purkinje cell microcircuits</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2015</year>
          <volume>16</volume>
          <issue>2</issue>
          <fpage>79</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1038/nrn3886</pub-id>
          <pub-id pub-id-type="pmid">25601779</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsutsumi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yamazaki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyazaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sakimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kitamura</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Structure&#x2013;function relationships between aldolase C/zebrin II expression and complex spike synchrony in the cerebellum</article-title>
          <source>J Neurosci</source>
          <year>2015</year>
          <volume>35</volume>
          <issue>2</issue>
          <fpage>843</fpage>
          <lpage>852</lpage>
          <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2170-14.2015</pub-id>
          <pub-id pub-id-type="pmid">25589776</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lein</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Hawrylycz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Ao</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ayres</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bensinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bernard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boe</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Boguski</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Brockway</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Byrnes</surname>
              <given-names>EJ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Chi Chin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Crook</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Czaplinska</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dang</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Datta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Dee</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Desaki</surname>
              <given-names>AL</given-names>
            </name>
            <name>
              <surname>Desta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Diep</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Dolbeare</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Donelan</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Dougherty</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Ebbert</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Eichele</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Estin</surname>
              <given-names>LK</given-names>
            </name>
            <name>
              <surname>Faber</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Facer</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Fields</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Fliss</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Frensley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gates</surname>
              <given-names>SN</given-names>
            </name>
            <name>
              <surname>Glattfelder</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Halverson</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Hohmann</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Howell</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Jeung</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Karr</surname>
              <given-names>PT</given-names>
            </name>
            <name>
              <surname>Kawal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kidney</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Knapik</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Kuan</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Lake</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Laramee</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Larsen</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lemon</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Luong</surname>
              <given-names>LT</given-names>
            </name>
            <name>
              <surname>Michaels</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Morgan</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Mortrud</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Mosqueda</surname>
              <given-names>NF</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Orta</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Overly</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Pak</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Parry</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Pathak</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Pearson</surname>
              <given-names>OC</given-names>
            </name>
            <name>
              <surname>Puchalski</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Riley</surname>
              <given-names>ZL</given-names>
            </name>
            <name>
              <surname>Rockett</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Rowland</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Royall</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Sarno</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Schaffnit</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shapovalova</surname>
              <given-names>NV</given-names>
            </name>
            <name>
              <surname>Sivisay</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Slaughterbeck</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>BI</given-names>
            </name>
            <name>
              <surname>Sodt</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>NN</given-names>
            </name>
            <name>
              <surname>Stumpf</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Sunkin</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sutram</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tam</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Teemer</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Thaller</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Varnam</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Visel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Whitlock</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Wohnoutka</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Wolkey</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>VY</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yaylaoglu</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Youngstrom</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Feng Yuan</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Zwingman</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide atlas of gene expression in the adult mouse brain</article-title>
          <source>Nature.</source>
          <year>2007</year>
          <volume>445</volume>
          <issue>7124</issue>
          <fpage>168</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="doi">10.1038/nature05453</pub-id>
          <pub-id pub-id-type="pmid">17151600</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwenk</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Metz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zolles</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Turecek</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fritzius</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bildl</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Tarusawa</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Kulik</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Unger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ivankova</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Seddik</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Tiao</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Rajalu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Trojanova</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rohde</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Gassmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schulte</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Fakler</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Bettler</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Native GABA B receptors are heteromultimers with a family of auxiliary subunits</article-title>
          <source>Nature.</source>
          <year>2010</year>
          <volume>465</volume>
          <issue>7295</issue>
          <fpage>231</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="doi">10.1038/nature08964</pub-id>
          <pub-id pub-id-type="pmid">20400944</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonino</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cantino</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sasso&#xE8;-Pognetto</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cellular and subcellular localization of &#x3B3;-aminobutyric acidB receptors in the rat olfactory bulb</article-title>
          <source>Neurosci Lett</source>
          <year>1999</year>
          <volume>274</volume>
          <issue>3</issue>
          <fpage>195</fpage>
          <lpage>198</lpage>
          <pub-id pub-id-type="doi">10.1016/S0304-3940(99)00697-7</pub-id>
          <pub-id pub-id-type="pmid">10548423</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Margrie</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Sakmann</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Urban</surname>
              <given-names>NN</given-names>
            </name>
          </person-group>
          <article-title>Action potential propagation in mitral cell lateral dendrites is decremental and controls recurrent and lateral inhibition in the mammalian olfactory bulb</article-title>
          <source>Proc Natl Acad Sci</source>
          <year>2001</year>
          <volume>98</volume>
          <issue>1</issue>
          <fpage>319</fpage>
          <lpage>324</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.98.1.319</pub-id>
          <pub-id pub-id-type="pmid">11120888</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nunes</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kuner</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Disinhibition of olfactory bulb granule cells accelerates odour discrimination in mice</article-title>
          <source>Nat Commun</source>
          <year>2015</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>13</lpage>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <mixed-citation publication-type="other">Geramita MA, Burton SD, Urban NN. Distinct lateral inhibitory circuits drive parallel processing of sensory information in the mammalian olfactory bulb. Elife. 2016;5. 10.7554/eLife.16039.</mixed-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Isaacson</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Strowbridge</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>Olfactory reciprocal synapses: dendritic signaling in the CNS</article-title>
          <source>Neuron.</source>
          <year>1998</year>
          <volume>20</volume>
          <issue>4</issue>
          <fpage>749</fpage>
          <lpage>761</lpage>
          <pub-id pub-id-type="doi">10.1016/S0896-6273(00)81013-2</pub-id>
          <pub-id pub-id-type="pmid">9581766</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hamilton</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Heinbockel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ennis</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Szabo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Erdelyi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hayar</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Properties of external plexiform layer interneurons in mouse olfactory bulb slices</article-title>
          <source>Neuroscience.</source>
          <year>2005</year>
          <volume>133</volume>
          <issue>3</issue>
          <fpage>819</fpage>
          <lpage>829</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.03.008</pub-id>
          <pub-id pub-id-type="pmid">15896912</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tepe</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Pekarek</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Hunt</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell RNA-seq of mouse olfactory bulb reveals cellular heterogeneity and activity-dependent molecular census of adult-born neurons</article-title>
          <source>Cell Rep</source>
          <year>2018</year>
          <volume>25</volume>
          <issue>10</issue>
          <fpage>2689</fpage>
          <lpage>703.e3</lpage>
          <pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.034</pub-id>
          <pub-id pub-id-type="pmid">30517858</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verploegen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lammers</surname>
              <given-names>J-WJ</given-names>
            </name>
            <name>
              <surname>Koenderman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Coffer</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of CKLiK, a novel granulocyte Ca++/calmodulin-dependent kinase</article-title>
          <source>Blood J Am Soc Hematol</source>
          <year>2000</year>
          <volume>96</volume>
          <issue>9</issue>
          <fpage>3215</fpage>
          <lpage>3223</lpage>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>An</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Bowlby</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Betty</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>H-P</given-names>
            </name>
            <name>
              <surname>Mendoza</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Hinson</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Mattsson</surname>
              <given-names>KI</given-names>
            </name>
            <name>
              <surname>Strassle</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Trimmer</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Modulation of A-type potassium channels by a family of calcium sensors</article-title>
          <source>Nature.</source>
          <year>2000</year>
          <volume>403</volume>
          <issue>6769</issue>
          <fpage>553</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="doi">10.1038/35000592</pub-id>
          <pub-id pub-id-type="pmid">10676964</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maniatis</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>&#xC4;ij&#xF6;</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Vickovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Braine</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mollbrink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fagegaltier</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Andrusivov&#xE1;</surname>
              <given-names>&#x17D;</given-names>
            </name>
            <name>
              <surname>Saarenp&#xE4;&#xE4;</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Saiz-Castro</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cuevas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Watters</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lundeberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bonneau</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Phatnani</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis</article-title>
          <source>Science.</source>
          <year>2019</year>
          <volume>364</volume>
          <issue>6435</issue>
          <fpage>89</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aav9776</pub-id>
          <pub-id pub-id-type="pmid">30948552</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>H-T</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>C-J</given-names>
            </name>
          </person-group>
          <article-title>A study on sigmoid kernels for SVM and the training of non-PSD kernels by SMO-type methods</article-title>
          <source>Submitted Neural Comput</source>
          <year>2003</year>
          <volume>3</volume>
          <issue>1-32</issue>
          <fpage>16</fpage>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Heckman</surname>
              <given-names>NE</given-names>
            </name>
            <name>
              <surname>Wand</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>Local polynomial kernel regression for generalized linear models and quasi-likelihood functions</article-title>
          <source>J Am Stat Assoc</source>
          <year>1995</year>
          <volume>90</volume>
          <issue>429</issue>
          <fpage>141</fpage>
          <lpage>150</lpage>
          <pub-id pub-id-type="doi">10.1080/01621459.1995.10476496</pub-id>
        </element-citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Antoniadis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Paparoditis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sapatinas</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A functional wavelet&#x2013;kernel approach for time series prediction</article-title>
          <source>J R Stat Soc Series B (Statistical Methodology).</source>
          <year>2006</year>
          <volume>68</volume>
          <issue>5</issue>
          <fpage>837</fpage>
          <lpage>857</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1467-9868.2006.00569.x</pub-id>
        </element-citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <mixed-citation publication-type="other">Barla A, Odone F, Verri A. Histogram intersection kernel for image classification. In: Proceedings 2003 international conference on image processing (Cat. No. 03CH37429), Vol. 3. IEEE; 2003 Sep 14. p. III-513.</mixed-citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <mixed-citation publication-type="other">Wu J, Rehg JM. Beyond the euclidean distance: Creating effective visual codebooks using the histogram intersection kernel. In: 2009 IEEE 12th International Conference on Computer Vision. IEEE; 2009 Sep 29. p. 630&#x2013;7.</mixed-citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <mixed-citation publication-type="other">Boughorbel S, Tarel JP, Boujemaa N. Generalized histogram intersection kernel for image recognition. In: IEEE International Conference on Image Processing 2005, Vol. 3. IEEE; 2005 Sep 14. p. III-161.</mixed-citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Genton</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Classes of kernels for machine learning: a statistics perspective</article-title>
          <source>J Mach Learn Res</source>
          <year>2001</year>
          <volume>2</volume>
          <issue>Dec</issue>
          <fpage>299</fpage>
          <lpage>312</lpage>
        </element-citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vishwanathan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Smola</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Fast kernels for string and tree matching</article-title>
          <source>Kernel Methods Comput Biol</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>113</fpage>
          <lpage>130</lpage>
        </element-citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Sahami</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heilman</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <source>A web-based kernel function for measuring the similarity of short text snippets. Proceedings of the 15th international conference on World Wide Web</source>
          <year>2006</year>
        </element-citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <mixed-citation publication-type="other">Srebro N. How good is a kernel when used as a similarity measure?. In: International Conference on Computational Learning Theory. Berlin, Heidelberg: Springer; 2007 Jun 13. p. 323&#x2013;35.</mixed-citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Broadaway</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Cutler</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Duncan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>EB</given-names>
            </name>
            <name>
              <surname>Jhun</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bielak</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Peyser</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Kardia</surname>
              <given-names>SLR</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Epstein</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>A statistical approach for testing cross-phenotype effects of rare variants</article-title>
          <source>Am J Hum Genet</source>
          <year>2016</year>
          <volume>98</volume>
          <issue>3</issue>
          <fpage>525</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2016.01.017</pub-id>
          <pub-id pub-id-type="pmid">26942286</pub-id>
        </element-citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wessel</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schork</surname>
              <given-names>NJ</given-names>
            </name>
          </person-group>
          <article-title>Generalized genomic distance&#x2013;based regression methodology for multilocus association analysis</article-title>
          <source>Am J Hum Genet</source>
          <year>2006</year>
          <volume>79</volume>
          <issue>5</issue>
          <fpage>792</fpage>
          <lpage>806</lpage>
          <pub-id pub-id-type="doi">10.1086/508346</pub-id>
          <pub-id pub-id-type="pmid">17033957</pub-id>
        </element-citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhan</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Plantinga</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>A fast small-sample kernel independence test for microbiome community-level association analysis</article-title>
          <source>Biometrics.</source>
          <year>2017</year>
          <volume>73</volume>
          <issue>4</issue>
          <fpage>1453</fpage>
          <lpage>1463</lpage>
          <pub-id pub-id-type="doi">10.1111/biom.12684</pub-id>
          <pub-id pub-id-type="pmid">28295177</pub-id>
        </element-citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davies</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Algorithm</surname>
              <given-names>AS</given-names>
            </name>
          </person-group>
          <article-title>155: The distribution of a linear combination of &#x3C7;&lt;sup&gt;2&lt;/sup&gt; random variables</article-title>
          <source>J R Stat Soc Series C (Applied Statistics).</source>
          <year>1980</year>
          <volume>29</volume>
          <issue>3</issue>
          <fpage>323</fpage>
          <lpage>333</lpage>
        </element-citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Horn</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <source>Matrix analysis: Cambridge university press</source>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Morrison</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Boerwinkle</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>ACAT: a fast and powerful p value combination method for rare-variant analysis in sequencing studies</article-title>
          <source>Am J Hum Genet.</source>
          <year>2019</year>
          <volume>104</volume>
          <issue>3</issue>
          <fpage>410</fpage>
          <lpage>421</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2019.01.002</pub-id>
          <pub-id pub-id-type="pmid">30849328</pub-id>
        </element-citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <mixed-citation publication-type="other">Pillai NS, Meng X-L.&#xA0;An unexpected encounter with Cauchy and L&#xE9;vy. Ann Stat. 2016;44(5):2089&#x2013;97.&#xA0;</mixed-citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <mixed-citation publication-type="other">Kozareva V, Martin C, Osorno T, Rudolph, S, Guo C, Vanderburg C, Nadaf, N.M., Regev A, Regehr W, Macosko E. A transcriptomic atlas of the mouse cerebellum reveals regional specializations and novel cell types. Preprint at&#xA0;bioRxiv.&#xA0;2020. 10.1101/2020.03.04.976407.</mixed-citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <mixed-citation publication-type="other">Wang X, Allen WE, Wright MA, Sylwestrak EL, Samusik N, Vesuna S, et al.&#xA0;Three-dimensional intact-tissue sequencing of single-cell transcriptional states. Science. 2018;361(6400):eaat5691</mixed-citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>QY</given-names>
            </name>
          </person-group>
          <article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title>
          <source>OMICS.</source>
          <year>2012</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>284</fpage>
          <lpage>287</lpage>
          <pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id>
          <pub-id pub-id-type="pmid">22455463</pub-id>
        </element-citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <mixed-citation publication-type="other">Zhu J, Sun S, Zhou X. SPARK: spatial pattern recognition via kernels. Github. 2021; <ext-link ext-link-type="uri" xlink:href="https://github.com/xzhoulab/SPARK">https://github.com/xzhoulab/SPARK</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <mixed-citation publication-type="other">Zhu J, Sun S, Zhou X. SPARK-X: non-parametric modeling enables scalable and robust detection of spatial expression patterns for large spatial transcriptomic studies. Zenodo. 2021. 10.5281/zenodo.4903349.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
      <journal-title-group>
        <journal-title>Nature Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2041-1723</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33846360</article-id>
      <article-id pub-id-type="pmc">8042062</article-id>
      <article-id pub-id-type="publisher-id">22496</article-id>
      <article-id pub-id-type="doi">10.1038/s41467-021-22496-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Uncovering transcriptional dark matter via gene annotation independent single-cell RNA sequencing analysis</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Michael F. Z.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9844-7852</contrib-id>
          <name>
            <surname>Mantri</surname>
            <given-names>Madhav</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>Shao-Pei</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Scuderi</surname>
            <given-names>Gaetano J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McKellar</surname>
            <given-names>David W.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9309-6296</contrib-id>
          <name>
            <surname>Butcher</surname>
            <given-names>Jonathan T.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1999-7125</contrib-id>
          <name>
            <surname>Danko</surname>
            <given-names>Charles G.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6085-7311</contrib-id>
          <name>
            <surname>De Vlaminck</surname>
            <given-names>Iwijn</given-names>
          </name>
          <address>
            <email>vlaminck@cornell.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Nancy E. and Peter C. Meinig School of Biomedical Engineering, </institution><institution>Cornell University, </institution></institution-wrap>Ithaca, NY 14853 USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.5386.8</institution-id><institution-id institution-id-type="ISNI">000000041936877X</institution-id><institution>Baker Institute for Animal Health, College of Veterinary Medicine, </institution><institution>Cornell University, </institution></institution-wrap>Ithaca, NY 14853 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>12</day>
        <month>4</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>12</day>
        <month>4</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>2158</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>7</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>3</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2021</copyright-statement>
        <license>
          <ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Conventional scRNA-seq expression analyses rely on the availability of a high quality genome annotation. Yet, as we show here with scRNA-seq experiments and analyses spanning human, mouse, chicken, mole rat, lemur and sea urchin, genome annotations are often incomplete, in particular for organisms that are not routinely studied. To overcome this hurdle, we created a scRNA-seq analysis routine that recovers biologically relevant transcriptional activity beyond the scope of the best available genome annotation by performing scRNA-seq analysis on any region in the genome for which transcriptional products are detected. Our tool generates a single-cell expression matrix for all transcriptionally active regions (TARs), performs single-cell TAR expression analysis to identify biologically significant TARs, and then annotates TARs using gene homology analysis. This procedure uses single-cell expression analyses as a filter to direct annotation efforts to biologically significant transcripts and thereby uncovers biology to which scRNA-seq would otherwise be in the dark.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Conventional single-cell RNA sequencing analysis rely on genome annotations that may be incomplete or inaccurate especially for understudied organisms. Here the authors present a bioinformatic tool that leverages single-cell data to uncover biologically relevant transcripts beyond the best available genome annotation.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Genome informatics</kwd>
        <kwd>Sequence annotation</kwd>
        <kwd>Gene expression</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000060</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R21AI133331</award-id>
          <award-id>R01AI146165</award-id>
          <award-id>1R01AI151059</award-id>
          <principal-award-recipient>
            <name>
              <surname>De Vlaminck</surname>
              <given-names>Iwijn</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000052</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | NIH Office of the Director (OD)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>DP2AI138242</award-id>
          <principal-award-recipient>
            <name>
              <surname>De Vlaminck</surname>
              <given-names>Iwijn</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par3">Single-cell RNA sequencing (scRNA-seq) is a powerful tool to study development, tissue, and disease biology<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref></sup>. scRNA-seq analyses currently rely on the availability of high-quality genome annotations to define cell features and to perform cell clustering, dimensionality reduction, differential gene expression, and other analyses<sup><xref ref-type="bibr" rid="CR10">10</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref></sup>. Identifying genes and correctly annotating their locations and coding regions within the genome is a difficult task that collaborative projects such as Ensembl<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>, ENCODE<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>, and GENCODE<sup><xref ref-type="bibr" rid="CR17">17</xref></sup> are striving to achieve. Gene annotations are generated using homology analyses, updated based on experimental evidence, and manually curated for select organisms such as human, mouse, and zebrafish<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. For less routinely studied organisms, fewer RNA-seq datasets are available and gene annotations are dependent on purely computational approaches such as phylogenetic sequence comparison with minimal verification. Consequently, as we show here with scRNA-seq experiments and analyses spanning six species (human, mouse, chicken, gray mouse lemur, naked mole rat, and sea urchin), significant number of genes and cell-type-specific information is missed in current scRNA-seq workflows.</p>
      <p id="Par4">To overcome this hurdle, we propose a procedure to perform scRNA-seq data analysis in the absence of a high-quality gene annotation (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>). This procedure first identifies transcriptionally active regions (TARs) in scRNA-seq data using groHMM<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Briefly, groHMM uses a hidden Markov model to divide the genome into two states (transcribed and untranscribed) based on read coverage in each bin. These HMM-derived TARs capture the transcriptional activity in the sample, limited only by the scRNA-seq measurement and quality of the genome assembly. Single-cell TAR expression analyses are then performed, using both annotated TARs (aTARs) and unannotated TARs (uTARs), revealing the degree of biologically relevant information that exists both inside and outside of known gene annotations. As expected, we find that the degree of relevant information in uTARs is strongly dependent on organism, tissue, cell type, and stage of development. uTARs that are differentially expressed across different cell clusters are retrieved and annotated based on nucleotide sequence homology (&#x201C;Methods&#x201D;). We employed this approach to uncover uTARs that distinguish canonical cell types during early stages of chicken embryonic heart development, and that define cell types in the gray mouse lemur, naked mole rat spleen, and sea urchin embryo.<fig id="Fig1"><label>Fig. 1</label><caption><title>Generating de novo features based on genome coverage.</title><p><bold>a</bold> Workflow to generate TARs and to identify biologically meaningful uTARs. <bold>b</bold> Total genome assembly sequence length for human (hg38 and hg16), mouse (mm10), chicken (GRCg6a), gray mouse lemur (Mmur_3.0), naked mole rat (HetGla_1.0), and sea urchin (Spur_4.2). <bold>c</bold> Total number of annotated transcripts in existing annotations normalized to the assembly sequence length for humans (hg38 GENCODE v30, hg16 RefSeq), mouse (GENCODE vM21), chicken (GRCg6a Ensembl v96), gray mouse lemur (Mmur_3.0 RefSeq), naked mole rat (HetGla_1.0 RefSeq), and sea urchin (Spur_4.2 RefSeq). <bold>d</bold> Relative number of unique scRNA-seq reads outside of gene annotations contained in uTARs for each cell shown as violin plots (3849 cells in hg38 and hg19, 6113 in mouse, 14008 in chicken, 6321 in lemur, 2657 in naked mole rat, 2658 in sea urchin). Mean values (black dots) and 2 standard deviations above and below the mean (black bars) are shown. <bold>e</bold> Relative number of unique scRNA-seq reads outside of gene annotations for different human genome assemblies and annotations at different times (3849 cells). <bold>f</bold> Example of groHMM defined aTAR (red) and uTAR (maroon) features along hg16 chr22 with RefSeq hg16 gene annotations shown in blue. Sense strand coverage plotted in black while antisense strand coverage plotted in gray (log-e scale).</p></caption><graphic xlink:href="41467_2021_22496_Fig1_HTML" id="d32e376"/></fig></p>
      <p id="Par5">While groHMM has previously been used to annotate regions of transcriptional activity from nascent transcription in <italic>Arabidopsis</italic><sup><xref ref-type="bibr" rid="CR19">19</xref></sup> and other species<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> that are produced in bulk, our approach annotates transcriptional activity that is cell-type-specific within scRNA-seq data. The approach described here can be applied in two ways. First, our procedure enables more comprehensive single-cell analysis when a high-quality gene annotation is not available. Second, our results point to an application for scRNA-seq assays to create, curate, and correct gene annotations, where single-cell expression analysis is used as a filter to direct annotation efforts to those features which are biologically significant.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>Gene-annotation-independent scRNA-seq analysis</title>
        <p id="Par6">We developed a gene-annotation-independent scRNA-seq analysis and benchmarked it using publicly available and new datasets generated on the 10X Genomics platform and a Smart-seq2-generated dataset (&#x201C;Methods&#x201D;). We explored different genome assemblies and annotations, including recent assemblies for human, mouse, chicken, gray mouse lemur, naked mole rat, and sea urchin, as well as prior annotations for human (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c, d</xref>). The size of the genome assemblies ranged from ~1 billion base pairs to ~3 billion base pairs (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b</xref>). As a proxy for the completeness of different gene annotations, we compared the number of annotated transcripts relative to the size of the genome assembly (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c</xref>). We found that less routinely studied organisms such as the naked mole rat and sea urchin, as well as an older human genome annotation (RefSeq hg16 annotations for the hg16 reference assembly) have a lower number of annotated transcripts relative to the genome assembly size, as expected. We next quantified the number of sequences that align outside the gene annotation (assigned to uTARs, see below). For a recent human gene annotation (GENCODE v30 hg38), only 2% of reads aligned outside of the annotation. Considerably less effort has been devoted to the genome annotations of less routinely studied species, as is evident from the percentage of sequences that fall outside of the most current genome assemblies for gray mouse lemur (7.1%), naked mole rat (4.2%), and purple sea urchin (10.7%) (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1d</xref>). We examined older human genome assembly releases and found a decrease in the percentage of reads that mapped outside of annotations, as annotations improved from 2004 to 2019 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e</xref>).</p>
        <p id="Par7">We sought to perform scRNA-seq analysis based on all transcriptional products detected by the assay, including those that are not included in annotations. To identify TARs, we implemented a HMM after alignment of the RNA-seq data to the reference genome (&#x201C;Methods&#x201D;)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Figure&#xA0;<xref rid="Fig1" ref-type="fig">1f</xref> shows an example of TARs identified for human genome build 16 along a segment of chromosome 22 comprising <italic>IGLL5</italic>. Through comparison to the genome annotation, we labeled TARs as either annotated (aTARs) or unannotated (uTARs). Finally, we counted the number of transcripts for each TAR in each cell in a dataset, creating a digital expression matrix.</p>
        <p id="Par8">We used Seurat to analyze single-cell gene and TAR expression profiles<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup>. We performed dimensionality reduction and single-cell clustering analysis on both TAR and gene expression profiles to determine the extent of biologically significant information contained within uTARs. We analyzed the Tabula Muris<sup><xref ref-type="bibr" rid="CR7">7</xref></sup> 10X-generated dataset for the mouse spleen and kidney, human PBMC data available through 10X Genomics<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, a gray mouse lemur lung dataset, a publicly available naked mole rat spleen dataset<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, and a publicly available sea urchin dataset<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. In addition, we performed single-cell RNA-seq profiling of embryonic chicken heart tissue at different stages of development (days 4, 7, 10, and 14 post fertilization). Following data pre-processing (&#x201C;Methods&#x201D;), we implemented dimensionality reduction (principal component analysis, PCA) and used UMAP<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> to visualize cells in 2D. We labeled cell groups based on existing metadata or expression of canonical marker genes (&#x201C;Methods&#x201D;). We found a significant number of mm10 assembly bases annotated by uTAR features (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1a</xref>). Comparison of UMAP visualizations of single-cell gene and uTAR expression profiles revealed that significant cell-type-dependent structure is retained in the uTAR UMAPs (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1b</xref>). We computed silhouette values as a measure of the consistency within clusters of the data and found close agreement between silhouette values calculated for aTAR and gene-expression-based clustering, as expected, and also good agreement between uTAR and gene-expression-based clustering for several datasets (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). This observation suggests that scRNA-seq reads outside of gene annotations contain significant biological information that can accurately separate cell types. Dimensional reduction on human PBMC uTAR expression reveals significant structure for the older hg16 genome build, but not for the most recent hg38 build, as expected, given that hg16 is older and has less comprehensive annotation (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1b</xref>). Dimensional reduction on mouse spleen uTAR expression reveals structure in many cell types such as T and B cells while dimensional reduction on mouse kidney uTARs reveals less structure. For gray mouse lemur lung, naked mole rat spleen, and sea urchin embryo, we find that dimensional reduction on single-cell uTAR expression profiles reveals near-identical structures to that of annotated gene expression profiles. We conclude that for species that are not routinely studied and for which high-quality gene annotations are not available, extensive biologically significant information is missed by conventional scRNA-seq analysis. For chicken heart tissues, we find that cell-type clustering is conserved more strongly in uTARs for tissues collected at earlier stages in development. Day 4 uTARs perform the best in terms of separating cell types relative to other days while day 14 uTARs perform the worst. This observation reveals a high prevalence of unannotated transcripts in early progenitor cell types while the transcriptional programs of mature cell types in day 14 are captured much better by the current best annotation. This suggests that the current chicken gene annotations do not define the complete transcriptional state of early embryonic tissue where many progenitor and transitional cell types are present. The extent of cell-type-specific information that is missing from standard genome annotations depends on the genome annotation, organism, tissue type, and stage of development.<fig id="Fig2"><label>Fig. 2</label><caption><title>Reads in uTARs can separate cell types in different organisms.</title><p><bold>a</bold> UMAP dimensional reduction on annotated gene expression features (top row) and uTARs (second row) for mouse spleen, mouse kidney, different time points in chicken embryonic heart development, gray mouse lemur lung tissue, and sea urchin embryonic tissue. Cells are colored in each column based on gene expression clustering. Relative number of uTAR reads for each cell in every cluster also shown as violin plots (third row, colors correspond to UMAPs); 6113 cells in mouse spleen, 610 cells in mouse kidney, 4365 in chicken day 4, 2198 in chicken day 14, 6321 in gray mouse lemur lungs, 2657 in naked mole rat spleen, and 2658 in sea urchin embryo. <bold>b</bold> Silhouette coefficient values based on 2D UMAP coordinates of gene expression (blue), aTARs (red), and uTARs (maroon) for 11 samples. UMAPs for samples labeled with (*) are shown in Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1b</xref>. Cell labels are defined by gene annotation clustering. <bold>c</bold> Correlation between top 5 PC loadings and pseudo-bulk read coverage of uTARs across 11 samples. Horizontal line at uTAR PC loading&#x2009;=&#x2009;0.5, vertical line at uTAR pseudo-bulk read coverage&#x2009;=&#x2009;1e&#x2009;+&#x2009;4, r<sup>2</sup>&#x2009;=&#x2009;4.0e-3. Quadrant numbers represent the number of uTARs in respective quadrant. <bold>d</bold> Relative percentage of uTARs containing homology to any sequence (blue) and mRNA sequences (light blue) as a function of log-e fold change expression for each cell type in naked mole rat spleen data. BLAST sequence homology results relative to nucleotide collection database thresholds: mean uTAR peak query length&#x2009;=&#x2009;686&#x2009;&#xB1;&#x2009;731&#x2009;bps, uTAR peak percent identity&#x2009;&gt;&#x2009;71%, e-value&#x2009;&lt;&#x2009;0.053, bit score&#x2009;&gt;&#x2009;52.8.</p></caption><graphic xlink:href="41467_2021_22496_Fig2_HTML" id="d32e497"/></fig></p>
        <p id="Par9">We next evaluated the agreement between the most significant uTARs identified based on the total expression level from pseudo-bulk RNA-seq analysis and uTARs identified based on principal component (PC) loading values which correlate with their ability to resolve cell types in single-cell analysis. There is little overlap between uTARs with expression level greater than 10,000 reads (across all cells, pseudo-bulk analysis, &#x201C;Methods&#x201D;) and uTARs with the highest loading values in the first 5 PCs calculated from scRNA-seq analysis (PCs, loading values greater than 0.5, 329 out of 3618 uTARs shared, Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c</xref>). In addition, we observed no correlation between the total expression level of uTARs (pseudo-bulk read coverage) and their loading values in the first 5 PCs (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c</xref>, correlation <italic>r</italic><sup>2</sup>&#x2009;=&#x2009;4.0e-3, <italic>p</italic>-value&#x2009;&lt;&#x2009;2.2e-16). This analysis indicates that uTARs with high total expression are not necessarily those that best define cell types, demonstrating the utility of scRNA-seq analysis as a selection filter before annotation and validation.</p>
        <p id="Par10">We next used the Wilcoxon rank-sum test to identify uTARs differentially expressed in the naked mole rat spleen dataset (&#x201C;Methods&#x201D;). We identified the largest peak within each differentially expressed uTAR and identified homologous sequences to the peak sequence using BLAST (&#x201C;Methods&#x201D;). This analysis revealed that uTARs that are more differentially expressed in any cell type (i.e., higher average log-e fold change expression relative to all other cell types) are also more likely to have sequence homology to transcripts contained within the NCBI nucleotide collection database, many of which have high homology to mRNA transcripts (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2d</xref>). We proceed to name uTARs with high differential expression in our datasets based on the BLAST results with the highest e-values and bit scores.</p>
      </sec>
      <sec id="Sec4">
        <title>uTARs recover unannotated transcripts</title>
        <p id="Par11">We proceeded to extract and annotate uTAR features that define cell types. Cell clusters were first labeled by cell type, based on the expression of canonical gene markers or existing metadata. uTARs that were expressed in a minimum number of cells in each cluster (25% for mouse and chicken day 4, 50% for naked mole rat, lemur, and sea urchin) and at least 0.25-fold difference compared to the rest of the cells in log-e scale (0.25-fold change for chicken day 4, 0.50-fold change for naked mole rat and mouse, 0.75-fold change for lemur, 1-fold change for sea urchin) were identified. These differentially expressed uTARs were labeled based on nucleotide sequence homology using BLAST<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup> on coverage peaks within the uTAR (&#x201C;Methods&#x201D;).</p>
        <p id="Par12">We explored uTARs that were differentially expressed between immune cell types within the spleen from the Tabula Muris dataset (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref>). We uncovered an uTAR differentially expressed in natural killer cells containing reads with high sequence homology to <italic>GTH1</italic> which plays a role in protecting cells from reactive oxygen species<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. We also found an uTAR containing homology to <italic>PRPF8</italic>, differentially expressed in macrophages, which is a pre-mRNA splicing factor that is essential for the catalytic step II in pre-mRNA splicing<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>. In addition, we found uTARs containing homology to <italic>SNX29</italic> and <italic>ATF7IP2</italic>, which were both upregulated in a small population of dendritic cells in the mouse spleen. <italic>SNX29</italic> is broadly associated with microtubule motor activity and phosphatidylinositol binding, and <italic>ATF7IP2</italic> is a transcription factor that couples other transcription factors to the transcription machinery. Both genes have predicted mouse orthologs but are unannotated in the GENCODE vM21 genome annotation.<fig id="Fig3"><label>Fig. 3</label><caption><title>Biologically relevant information is contained in uTAR features.</title><p>Differential uTAR feature analysis for mouse spleen data (<bold>a</bold>), chicken heart day 4 data (<bold>b</bold>), gray mouse lemur <italic>EPCAM</italic>+ lung data (<bold>c</bold>), naked mole rat spleen data (<bold>d</bold>), and sea urchin embryo data (<bold>e</bold>). Dot plot (left) of differentially expressed uTAR features that are labeled based on sequence homology and cell clusters are numbered along the <italic>x</italic>-axis. Dot size corresponds to the percentage of cells that express the uTAR feature while darker blue color corresponds to higher level of log-e-normalized expression. UMAP (second left) colored and dimensionally reduced using gene expression features where cell clusters are labeled above the UMAP. Total coverage plot (top) of 5 uTARs along the length of the uTAR feature on the <italic>x</italic>-axis. The corresponding feature plot on UMAP projection is shown below the coverage plots where darker brown color correlates with higher log-e-normalized expression in each cell.</p></caption><graphic xlink:href="41467_2021_22496_Fig3_HTML" id="d32e598"/></fig></p>
        <p id="Par13">We explored whether differentially expressed uTARs found in early stages of embryonic heart development were also differentially expressed in later stages. Silhouette coefficient analysis of the chicken dataset shows that uTARs better separate cell types in early development (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>, b and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1b</xref>). We identified 18 differentially expressed uTARs in the day 4 chicken heart with high differential expression and labeled them based on sequence homology (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>, dot plot). These include <italic>CLEC14A</italic>, a potential tumor endothelial marker that plays a role in angiogenesis<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>, <italic>SOX5</italic>, a transcription factor that regulates embryonic development and cell fate differentiation<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>, and <italic>RUNX1T1</italic>, a transcriptional co-repressor that suppresses oncogenesis<sup><xref ref-type="bibr" rid="CR34">34</xref>,<xref ref-type="bibr" rid="CR35">35</xref></sup>. While <italic>SOX5</italic> and <italic>RUNX1T1</italic> are both annotated elsewhere in the chicken genome, we found uTARs with high sequence homology to these genes. The end of the <italic>SOX5</italic> uTAR is ~120&#x2009;kb upstream of the <italic>SOX5</italic> annotation, which is ~340&#x2009;kb in length, and the end of the <italic>RUNX1T1</italic> uTAR is ~50&#x2009;kb upstream of the annotated counterpart, which is ~87&#x2009;kb in length. This suggests that the <italic>SOX5</italic> and <italic>RUNX1T1</italic> uTARs may be additional exons of the existing annotations. When we examined the same set of differentially expressed uTARs in the day 14 chicken heart, we found that most were not differentially expressed (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1c</xref>) suggesting a role for these differentially expressed uTARs in early development. Additionally, some differentially expressed uTARs in day 4 also had lower total read coverage in the day 14 dataset such as <italic>RUNX1T1</italic> and <italic>CLEC14A</italic> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1c</xref>, coverage tracks). Thus, uTAR analysis can identify potentially novel development-stage-specific transcripts.</p>
        <p id="Par14">We also explored differentially expressed uTARs in the gray mouse lemur lung, naked mole rat spleen, and sea urchin embryo datasets. Several differentially expressed uTARs were found in the gray mouse lemur <italic>EPCAM</italic>+ lung cells including <italic>H3F3C</italic> and <italic>BST2</italic> (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref>). <italic>H3F3C</italic> is a novel unannotated gene that plays a role in maintaining nucleosome structure<sup><xref ref-type="bibr" rid="CR36">36</xref>,<xref ref-type="bibr" rid="CR37">37</xref></sup> while <italic>BST2</italic> is associated with interferon gamma and other cytokine signaling pathways in the immune system<sup><xref ref-type="bibr" rid="CR38">38</xref>,<xref ref-type="bibr" rid="CR39">39</xref></sup>. Differentially expressed naked mole rat uTARs were also identified within neutrophils, T cells, and macrophages (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3d</xref>). Homology analysis revealed that these included <italic>DUSP1</italic>, <italic>NATD1</italic>, and <italic>TRG</italic>. The <italic>DUSP1</italic> uTAR is a novel feature missing from the HetGla_1.0 with high total expression in neutrophils (5778 total unique scRNA-seq reads in 2657 cells). The protein encoded by <italic>DUSP1</italic> is a phosphatase with dual specificity for tyrosine and threonine and is a potential target for cancer therapy in humans<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>. We also found several uTARs that are highly expressed in the pigment cells of an embryonic sea urchin (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3e</xref>). They include several uncharacterized genes such as <italic>LOC115926763</italic> and <italic>LOC115920005</italic>. Therefore, our uTAR analysis reveals several unannotated features in understudied organisms such as the naked mole rat, gray mouse lemur, and sea urchin.</p>
        <p id="Par15">To test whether our analysis pipeline is compatible with full-length transcript data, we explored Smart-seq2 (SS2) full-length scRNA-seq data of gray mouse lemur testes tissue and detected several cell-type-specific uTARs (&#x201C;Methods&#x201D;). Dimensionality reduction on full-length uTAR features produces results in agreement with a gene-feature-based dimensional reduction, similar to our observation for short-read sequencing scRNA-seq data (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2a</xref>). We performed differential uTAR feature analysis for cell types within the testes tissue and found unannotated expression of <italic>CCER1</italic> in spermatocytes, <italic>TBXAS1</italic> in spermatogonium, and the ncRNA <italic>LOC105867359</italic> expressed in spermatids (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2b</xref>).</p>
        <p id="Par16">The approach we report here can be used to uncover potentially novel cell subtypes by examining the differential expression of uTARs in canonical cell types. To test this concept, we examined a 10X dataset for the gray mouse lemur spleen tissue and found that uTAR features can be used to separate canonical cell types such as T cells, monocytes, and neutrophils, as expected (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3a</xref>). Subsetting of plasma cells and clustering and dimensionality reduction based on uTAR expression revealed two distinct groups of plasma cells (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3b</xref>). One of these two groups of cells, which was not identified by conventional analysis, was characterized by elevated expression of an uTAR with high sequence homology to the natural killer complex genes (<italic>CD94</italic>, <italic>NKG2</italic>, <italic>Ly49L</italic>) and uTARs with homology to <italic>IGKV2</italic> (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3c</xref>) suggesting that these are <italic>IGKV2</italic>+ plasma cells. This observation suggests that uTAR expression analyses can reveal cell subtypes that are not identified using conventional analyses.</p>
        <p id="Par17">Our approach conservatively labels TARs as uTARs when they are completely outside of gene annotations and label TARs as aTARs when they overlap with gene annotations but have opposite directionality. We expanded the definition of uTARs to include directionality and repeated the analysis of uTAR expression in developing chicken heart and observed similar behavior as described above (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4</xref>). uTARs tended to cluster cell types better in early stages of embryonic development compared to later stages (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4a, b</xref>). We identified 34 differentially expressed uTARs in the day 4 developing chicken heart where most lose their differential expression in later time points of development (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4c</xref>). Of these uTARs, 11 overlap in position with an annotated gene but are transcribed from the antisense strand of a gene in the existing annotations. These features share a similar differential expression with the annotated counterpart in day 4 (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4d</xref>) suggesting that the transcription of these antisense uTARs are correlated with the transcription of the corresponding sense gene features.</p>
      </sec>
      <sec id="Sec5">
        <title>Spatial transcriptomics reveals spatial co-expression of uTARs and canonical gene markers</title>
        <p id="Par18">We used data generated on the 10X Genomics Visium spatial transcriptomics platform to visualize the spatial co-expression of differentially expressed uTARs with canonical gene markers. For this, 10&#x2009;&#xB5;m thick coronal tissue slices of embryonic heart at days 4 and 14 post fertilization were used for spatial transcriptomic analysis. The resulting data comprised 747 and 1995 barcoded spots for day 4 (5 hearts) and day 14 (1 heart), respectively. We found that the expression of a <italic>SH3BGR-</italic>related uTAR colocalized with that of the canonical cardiomyocyte marker <italic>TNNT2</italic> at both day 4 and day 14 (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a</xref>, left), in line with observations from scRNA-seq (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1c</xref>). We also observed clear expression of <italic>RUNX1T1</italic> uTAR in the day 4 tissue section but no expression in the day 14 section, in concordance with the scRNA-seq data that suggested stage-dependent expression of this uTAR (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a</xref>, right). Expression of the <italic>RUNX1T1</italic> uTAR at day 4 colocalized with a subset of <italic>COL1A1</italic>+ spots which is a marker for epicardial cells. Interestingly, the annotated <italic>RUNX1T1</italic> gene has almost no expression in the spatial data revealing a discrepancy between annotated gene expression and uTAR expression. We quantified the correlation between the spatial expression of 11 uTARs in the day 4 sample and several canonical gene markers such as <italic>HBZ</italic> for red blood cells, <italic>TNNT2</italic> for myocytes, and <italic>COL1A1</italic> for epicardial progenitors (Pearson correlation, log-e-normalized spot expression). We then performed hierarchical clustering on correlation values (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4b</xref>). We found that spatial uTAR expression in several cell types colocalized with canonical markers for those cells. Immune and immature fibroblast cell types are two of the three least abundant cell types according to the scRNA-seq data. As a result, their spatial correlation was low due to zero expression in most spots in the spatial data. Altogether, spatial transcriptomic data agreed with our findings of cell-type- and stage-specific expression of highly expressed uTARs.<fig id="Fig4"><label>Fig. 4</label><caption><title>Spatial transcriptomics to map uTAR expression in chicken embryonic hearts.</title><p><bold>a</bold> Spatial log-e-normalized expression of canonical <italic>TNNT2</italic> myocytes marker, <italic>SH3BGR</italic> uTAR, canonical <italic>COL1A1</italic> epicardial cells marker, <italic>RUNX1T1</italic> uTAR, and annotated <italic>RUNX1T1</italic> gene for chicken embryonic heart at day 4 (5 hearts) and day 14 (1 heart) post fertilization. <bold>b</bold> Dendrogram computed on Pearson correlation of log-e-normalized spatial expression for canonical gene markers and uTARs (underlined) in a day 4 chicken heart tissue section.</p></caption><graphic xlink:href="41467_2021_22496_Fig4_HTML" id="d32e882"/></fig></p>
      </sec>
    </sec>
    <sec id="Sec6" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par19">Current scRNA-seq analysis relies on the availability of high-quality gene annotation to identify cell types, study dynamic transcriptional behavior over time, and predict gene interactions. We developed a method to identify uTARs that distinguish cell types in single-cell transcriptomic data. This approach is most relevant for the analysis of scRNA-seq datasets from less routinely studied organisms, and datasets from developing tissues that often comprise, as we show here, transcriptional products that are not represented in gene annotations. We present proof-of-principle applications of this procedure to study unannotated transcripts in embryonic development and to explore previously unknown genomic features in several species.</p>
      <p id="Par20">The strategy we propose broadly identifies TARs, without attempting to filter, curate, or characterize those regions, and then employs single-cell expression analyses to identify regions outside of the gene annotation that are relevant for the identification of cell states or types. Other TARs may encode transcripts that are broadly expressed in all cell types. This strategy allows focusing annotation, curation, and validation efforts to those regions that are biologically significant. Our procedure expands the scope of scRNA-seq to tissues of understudied species, cell types, and development stages, enhancing the range of new biology that can be uncovered using these powerful approaches. In addition, our work points to an application for scRNA-seq to refine existing gene annotations, or to create de novo gene annotations.</p>
    </sec>
    <sec id="Sec7">
      <title>Methods</title>
      <sec id="Sec8">
        <title>Generation of chicken embryonic heart scRNA-seq data</title>
        <p id="Par21">Fertile white leghorn chicken eggs were incubated using an egg incubator that controls humidity and temperature until the embryonic day of interest. Chicken embryonic ventricular free walls were excised aseptically in ice-cold Hank&#x2019;s balanced salt solution (HBSS) and then minced into 1&#x2009;mm tissue fragments. Six dozen day 4, Hamburger-Hamilton developmental stage 21-23 (HH21-23) whole ventricles, four dozen day 7 (HH30-31) left and right ventricles, three dozen day 10 (HH35-36) left and right ventricles, and one dozen day 14 (HH40) left and right ventricles were, respectively, pooled for seven total samples to be analyzed via single-cell RNA sequencing. The day 4 and day 7 ventricular tissue fragments were digested under constant mild agitation at 37&#x2009;&#xB0;C in 1.5&#x2009;mg/mL collagenase type II/dispase (Roche) for one cycle of 20&#x2009;min and one cycle of 10&#x2009;min, while the day 10 and day 14 ventricular tissue fragments were digested in 300&#x2009;U/mL collagenase type II (Worthington Biochemical Corporation) for four cycles of 10&#x2009;min to dissociate the cells from the tissue. Cells were then passed through a 40&#x2009;&#xB5;m filter and centrifuged into a pellet. For all samples, blood was removed by resuspension in an ACK lysis buffer followed by centrifugation and two washes in 1X phosphate buffered saline with 0.04% bovine serum albumin (1XPBS/BSA). For the day 14 samples, cells underwent fluorescence-activated cell sorting (FACs) to sort for live, non-apoptotic cells. Prior to FACs, the day 14 samples were first stained for 10&#x2009;min in 4&#x2009;&#xB5;g/mL Calcein AM at 37&#x2009;&#xB0;C in HBSS with 2% fetal bovine serum (HBSS/FBS), washed in HBSS/FBS, centrifuged, stained with 1&#x2009;&#xB5;g/mL of 7AAD on ice in HBSS/FBS for at least 30&#x2009;min, and then immediately cell sorted in HBSS/FBS. For all samples, single-cell suspensions were then resuspended at 1&#x2009;&#xD7;&#x2009;10<sup>6</sup> cells/mL in 1XPBS/BSA prior to single-cell RNA sequencing. The 10X Genomics gene expression Library v2 Kit was used to isolate the day 10 and day 14 samples. The 10X Genomics gene expression Library v3 Kit was used to isolate 4DPF and 7DPF samples. Illumina NextSeq500 paired-end sequencing was used to sequence each sample. Chicken uTARs were generated by combining sequence alignment files for all samples. scRNA-seq analysis is shown for the right ventricle of day 7, 10, and 14.</p>
      </sec>
      <sec id="Sec9">
        <title>Sequence alignment and generation of expression matrices</title>
        <p id="Par22">FASTQ sequence files were processed (adapter trimming, barcode tagging) using the Drop-seq<sup><xref ref-type="bibr" rid="CR42">42</xref></sup> suite of computational tools and were aligned to respective genomes using STAR without gene annotation indexing. Gene expression matrices were generated based on gene annotations and TAR expression matrices were generated based on TAR annotations (described below) using Drop-seq tools.</p>
      </sec>
      <sec id="Sec10">
        <title>Identifying TARs from alignment files using groHMM</title>
        <p id="Par23">We used groHMM<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> to predict transcribed regions from aligned scRNA-seq data in a strand-specific manner without annotations. Uniquely mapped reads from multiple scRNA-seq data were merged (i.e., without consideration for coverage of individual cells). We downsampled the combined alignment file of the Tabula Muris dataset and kept 5% of all uniquely aligned reads to account for the computational memory constraints of the groHMM tool. Then, we used groHMM to scan the mapped read counts along the genome with window size 50&#x2009;bp without overlap. The emission probabilities were modeled by a gamma distribution. The gamma distribution parameters and transition probabilities were learned using the Baum-Welch expectation maximization (EM) algorithm. We predicted the transcribed regions from both the sense and antisense strands. Predicted transcribed regions within 500&#x2009;bp were merged using bedtools<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> merge (parameters: -s -d 500). The coverage of each region was calculated using bedtools coverage (parameters: -s -counts -split). Transcribed regions with at least <italic>n</italic> reads were kept and used as TAR features in the following analysis, where <italic>n</italic> is set as 1/10,000,000 of uniquely mapped reads in the combined alignment file derived from SAMtools<sup><xref ref-type="bibr" rid="CR44">44</xref></sup> view (parameters: -q 255).</p>
        <p id="Par24">TARs identified using the groHMM algorithm were labeled as annotated TAR (aTAR) or unannotated TAR (uTAR) features based on their overlap with existing gene annotations. The refFlat genome annotation format was used in all cases where the genomic start and end position of each transcript is recorded. HMM features that have any overlap with an existing gene annotation transcript based strictly on transcription start and stop sites were labeled as &#x201C;aTAR&#x201D;, without accounting for strandedness. HMM features that overlap with an existing gene annotation but were on opposing strands were also labeled &#x201C;aTAR&#x201D;. All other HMM features were labeled as &#x201C;uTAR&#x201D;.</p>
      </sec>
      <sec id="Sec11">
        <title>Single-cell transcriptome analysis</title>
        <p id="Par25">We used the Seurat suite of scRNA-seq tools<sup><xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR22">22</xref></sup> to analyze gene expression and TAR expression data. Cells were filtered based on the number of gene expression features, and TAR features were filtered based on being expressed in at least two cells. Cell filtering parameters were different for each dataset to optimize downstream analysis and to account for different protocols. Tabula Muris cells were filtered and labeled based on metadata information provided in the paper. Human PBMC cells were filtered based on having between 201 and 2599 gene features and less than 5% mitochondrial transcripts according to the hg38 assembly and GENCODEv30 annotations. Chicken cells were filtered based on having more than 200 gene features and less than 20% mitochondrial transcripts. Gray mouse lemur cells were filtered based on having between 201 and 2499 gene features. Naked mole rat cells were filtered based on having between 401 and 2499 gene features. Sea urchin cells were filtered based on having between 401 and 2499 gene features. Gene and TAR combined expression matrices were log-normalized and scaled before further processing. For the human PBMC dataset, 4000 variable features (including genes and TARs) were found based on mean&#x2013;variance ratios. PCA was performed on variable gene features, aTARs, and uTARs in the human PBMC dataset. PCA was performed using all genes, aTARs, and uTARs in the other datasets. Cells were clustered using a KNN graph-based clustering approach with the first 10 PCs derived from gene expression reduction. UMAP projections were derived from the first 10 PCs using either gene expression, aTAR expression, or uTAR expression.</p>
      </sec>
      <sec id="Sec12">
        <title>Identifying differentially expressed uTARs</title>
        <p id="Par26">We used the Wilcoxon rank-sum test to identify differentially expressed genes and TARs in every cell cluster, filtered based on increased expression as compared to all other cells. Canonical marker gene analysis was performed to identify cell clusters in days 4 and 14 chicken heart, naked mole rat spleen, and gray mouse lemur lung datasets. Differential mouse spleen uTARs were filtered by being in at least 25% of cells in the cluster and more than 0.5 log-e fold change compared to the rest of the cells. Differential day 4 chicken uTARs were further filtered by being in at least 25% of cells in the cluster and more than 0.25 log-e fold change compared to the rest of the cells. Lemur lung differential uTARs were further filtered based on being in at least 50% of cells in the cluster and more than 0.75 log-e fold change compared to the rest of the cells. Naked mole rat differential uTARs were further filtered based on being in at least 50% of cells in the cluster and more than 0.5 log-e fold change compared to the rest of the cells. Sea urchin differential uTARs were further filtered based on being in at least 50% of cells in the cluster and more than 1 log-e fold change compared to the rest of the cells. Lemur SS2 testes differential uTARs were filtered based on being in at least 25% of cells in the cluster and more than 0.25 log-e fold change compared to the rest of the cells (top 5 differentially expressed uTARs shown in Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2b</xref>, dot plot). Differential uTARs for the 10X lemur plasma cells from spleen were filtered based on being in at least 25% of cells in the cluster and more than 0.25 log-e fold change compared to the rest of the cells (4 uTARs shown in Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3c</xref>, dot plot).</p>
      </sec>
      <sec id="Sec13">
        <title>uTAR annotation using BLAST</title>
        <p id="Par27">The total coverage of each differentially expressed uTAR is extracted using SAMtools depth and the coverage along the length of the uTAR is smoothed using locally weighted smoothing (LOESS) with the span set to 0.25. We then find the coordinates of the full-width at half-maximum (FWHM) of the largest peak along the length of the uTAR. The nucleotide FASTA sequence along this coordinate is extracted using samtools faidx. We then feed these sequences into BLASTn against the nucleotide collection (nt) database. BLASTn results are filtered for hits that have a maximum e-value of 0.01 and a minimum bit score of 50. Differentially expressed uTARs are then labeled based on hits with the highest bit score. uTARs that do not have hits that fit the e-value and bit score thresholds are labeled as unknown/undetermined. For the 10X lemur plasma cells, nucleotide FASTA sequences of uTARs were fed into IgBLAST against the human germline gene database. uTARs are similarly labeled based on hits with the highest bit score. For the SS2 lemur testes data, nucleotide FASTA sequences of full-length uTARs were fed into BLASTn against the nt database.</p>
      </sec>
      <sec id="Sec14">
        <title>Pseudo-bulk versus single-cell-derived uTAR comparison</title>
        <p id="Par28">uTAR pseudo-bulk coverage was calculated using bedtools coverage on the merged alignment files for each experiment. uTAR PC loadings were calculated based on the sum of absolute PC loading values in the first 5 PCs based on uTAR PC analysis.</p>
      </sec>
      <sec id="Sec15">
        <title>10X Genomics Visium spatial transcriptome sample and library generation</title>
        <p id="Par29">Whole hearts were dissected, placed in sterile HBSS, and perfused through the apex to remove blood. Fresh samples were embedded in Optimal Cutting Compound (OCT) and frozen with liquid-nitrogen-cooled isopentane before sectioning into 10&#x2009;&#xB5;m slices using Thermo Scientific&#x2122; CryoStar NX50 cryostat. Sections were mounted on &#x2212;20&#x2009;&#xB0;C-cooled Visium slides. Five sections were mounted for day 4, four sections for day 7, two sections for day 10, and one section for day 14 post fertilization. cDNA libraries were generated using 10X Genomics Visium Spatial Gene Expression 3&#x2B9; Library Construction V1 Kit. A 10X Genomics Visium Spatial Gene Expression slide has four capture areas. Each capture area has 5000 circular spots that are 55&#x2009;&#xB5;m in diameter with a center-to-center distance of 110&#x2009;&#xB5;m. Each spot contains DNA oligos consisting of a PCR handle, spot-specific spatial barcodes, unique molecular identify (UMI), and poly-dT-VN tail for mRNA capture. Hematoxylin and eosin stained heart sections were imaged using Zeiss PALM MicroBeam laser capture microscope and images were processed using Fiji from ImageJ. Illumina NextSeq 500/550 was used to sequence the spatially tagged cDNA libraries with 150 cycle high-output kits (Read 1&#x2009;=&#x2009;120, Read 2&#x2009;=&#x2009;5, Index 1&#x2009;=&#x2009;14, and Index 2&#x2009;=&#x2009;8). Sequencing files were processed using 10X Genomics Space Ranger pipeline. TAR annotations were generated by running groHMM on the combined Space-Ranger-derived alignment files across the four time points. TAR and GRCg6a Ensembl v96 annotations were combined to create one set of genome annotation. Spatially tagged TAR and gene expression matrices were generated with the combined annotation set following the Space Ranger pipeline.</p>
      </sec>
      <sec id="Sec16">
        <title>Spatial transcriptome processing and visualization</title>
        <p id="Par30">We used Seurat spatial transcriptome tools to visualize spatially tagged expression data. Feature expression matrices were log-e-normalized before further processing. We identified spatial uTARs that overlap with differentially expressed scRNA-seq uTARs in chromosome position and strandedness. If several spatial uTARs overlap with a scRNA-seq uTAR, we visualized and calculated spatial correlations based on the spatial uTAR with the highest total expression.</p>
      </sec>
      <sec id="Sec17">
        <title>Smart-seq2 analysis of gray mouse lemur testes data</title>
        <p id="Par31">STAR aligned paired-end sequencing files were collected for each cell in the dataset. Read fragments from the paired-end sequencing data are collected using bedtools bamtobed with the &#x201C;-bedpe&#x201D; option set. We ran groHMM on read fragments to generate TARs. TARs were labeled as aTARs and uTARs in the same way as 10X-generated datasets. Labeled TAR annotation file in the gtf format is generated by a custom script provided in the TAR-scRNA-seq Git repository. The featureCounts<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> tool, with strandedness option set to 1 (-s 1) and paired-end option set (-p), was used to generate a count of each TAR features for every cell in the dataset. Count vectors were aggregated to generate a TAR expression matrix. We have included in our GitHub repository a script (scripts/SingleCellHMM_MW_SS2.bash) that will generate TAR annotations in refFlat and gtf formats from SS2 paired-end sequencing data.</p>
      </sec>
      <sec id="Sec18">
        <title>TAR-scRNA-seq tool and scripts</title>
        <p id="Par32">The snakemake<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> pipeline along with the bash and R scripts used in the TAR-scRNA-seq tool is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/fw262/TAR-scRNA-seq">https://github.com/fw262/TAR-scRNA-seq</ext-link> with the identifier (10.5281/zenodo.4567436).</p>
      </sec>
      <sec id="Sec19">
        <title>Reporting summary</title>
        <p id="Par33">Further information on research design is available in the&#xA0;<xref rid="MOESM3" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <sec id="Sec20">
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41467_2021_22496_MOESM1_ESM.pdf">
            <caption>
              <p>Supplementary Information</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="41467_2021_22496_MOESM2_ESM.pdf">
            <caption>
              <p>Peer Review File</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="41467_2021_22496_MOESM3_ESM.pdf">
            <caption>
              <p>Reporting Summary</p>
            </caption>
          </media>
        </supplementary-material>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Peer review information</bold>
<italic>Nature Communications</italic> thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.</p>
      </fn>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41467-021-22496-3.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank P. Schweitzer and colleagues at the Cornell Biotechnology Resource Center (BRC) for help with sequencing assays. We thank Phillip S. Burnham, Hao Shi, Alexandre P. Cheng, Adrienne Chang, Benjamin Grodner, Olga Botvinnik, Camille Sophie Ezran, Angela Wu, Mark Krasnow, and the Lemur Cell Atlas Consortium for discussions and feedback. This work was supported by R33CA235302 (to I.D.V.), R21AI133331 (to I.D.V.), DP2AI138242 (to I.D.V.), R01AI146165 (to I.D.V.), 1R01AI151059 (to I.D.V.), and a National Sciences and Engineering Research Council of Canada fellowship PGS-D2 (to M.F.Z.W). The animal icons were created by Gan Khoon Lay (human), Vectorstall (mouse), Ines Simoes (chicken), Ph&#x1EA1;m Thanh L&#x1ED9;c (mouse lemur), Nova Hedberg (naked mole rat), and Vega Asensio (sea urchin) as part of the Noun Project[<ext-link ext-link-type="uri" xlink:href="https://thenounproject.com/">https://thenounproject.com/</ext-link>] under the CC BY 3.0 license[<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/3.0/">https://creativecommons.org/licenses/by/3.0/</ext-link>].</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>M.F.Z.W., J.T.B., C.G.D., and I.D.V. designed the study. M.F.Z.W., M.M., and G.J.S. carried out the experiments. M.F.Z.W., M.M., S.C., and D.M. analyzed the data. M.F.Z.W. and I.D.V. wrote the manuscript. All authors provided feedback and comments.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>Publicly available datasets: FASTQ files for the human PBMC dataset were downloaded directly from the 10X Genomics library of single-cell gene expression data. Tabula Muris alignment files (BAMs) for 10X Genomics droplet-generated data were downloaded from the Gene Expression Omnibus (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109774">GSE109774</ext-link>) and FASTQ files were extracted using the 10X Genomics bamtofastq tool<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>. Mouse uTARs were generated based on combining alignment files across all droplet-generated data and scRNA-seq analysis for kidney (10X_P4_5) and spleen (10X_P4_6) samples are shown. FASTQ files for the naked mole rat and sea urchin datasets were downloaded from GEO listed in their respective publications (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM3885302">GSM3885302</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE134350">GSE134350</ext-link>, respectively). Naked mole rat uTARs were generated based on combining alignment files for the spleen samples (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291380">SRR9291380</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291381">SRR9291381</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291382">SRR9291382</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291383">SRR9291383</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291384">SRR9291384</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291385">SRR9291385</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291386">SRR9291386</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291387">SRR9291387</ext-link>) and scRNA-seq analysis for sample <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9291380">SRR9291380</ext-link> (nmr_1.1) is shown. Sea urchin embryo uTARs were generate based on combining alignment files generated from <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9693264">SRR9693264</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9693265">SRR9693265</ext-link>, and <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9693266">SRR9693266</ext-link> and scRNA-seq analysis for sample <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRR9693264">SRR9693264</ext-link> (D1) is shown. Gray mouse lemur lung tissue uTARs were generated from the Tabula Microcebus consortium by combining MLCA_ANTOINE_LUNG_EPCAM_POS_S12, MLCA_ANTOINE_LUNG_CD31_POS_S11, and MLCA_ANTOINE_LUNG_P3_S7 datasets, and scRNA-seq analysis for MLCA_ANTOINE_LUNG_EPCAM_POS_S12 is shown. Gray mouse lemur spleen tissue uTARs were generated from the Tabula Microcebus consortium from the MLCA_ANTOINE_SPLEEN dataset. Gray mouse lemur SS2 testes data were collected from the Tabula Microcebus consortium.</p>
      <p>The chicken-related sequencing data discussed in this publication have been deposited in NCBI&#x2019;s Gene Expression Omnibus and are accessible through GEO Series accession number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE149457">GSE149457</ext-link>. H&amp;E stained tissue images for spatial RNA-seq datasets have been made available through the Git repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/fw262/TAR-scRNA-seq">https://github.com/fw262/TAR-scRNA-seq</ext-link>).</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>Code used to generate figures in this manuscript are available in the Git repository under the folder &#x201C;scripts_for_figures.&#x201D; Git repository: <ext-link ext-link-type="uri" xlink:href="https://github.com/fw262/TAR-scRNA-seq">https://github.com/fw262/TAR-scRNA-seq</ext-link><sup><xref ref-type="bibr" rid="CR48">48</xref></sup>.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par34">The authors declare no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rosenberg</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding</article-title>
          <source>Science</source>
          <year>2018</year>
          <volume>360</volume>
          <fpage>176</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aam8999</pub-id>
          <pub-id pub-id-type="pmid">29545511</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gierahn</surname>
              <given-names>TM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput</article-title>
          <source>Nat. Methods</source>
          <year>2017</year>
          <volume>14</volume>
          <fpage>395</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4179</pub-id>
          <pub-id pub-id-type="pmid">28192419</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jaitin</surname>
              <given-names>DA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types</article-title>
          <source>Science</source>
          <year>2014</year>
          <volume>343</volume>
          <fpage>776</fpage>
          <lpage>779</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1247651</pub-id>
          <pub-id pub-id-type="pmid">24531970</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>AM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells</article-title>
          <source>Cell</source>
          <year>2015</year>
          <volume>161</volume>
          <fpage>1187</fpage>
          <lpage>1201</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2015.04.044</pub-id>
          <pub-id pub-id-type="pmid">26000487</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive single-cell transcriptional profiling of a multicellular organism</article-title>
          <source>Science</source>
          <year>2017</year>
          <volume>357</volume>
          <fpage>661</fpage>
          <lpage>667</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aam8940</pub-id>
          <pub-id pub-id-type="pmid">28818938</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Picelli</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Smart-seq2 for sensitive full-length transcriptome profiling in single cells</article-title>
          <source>Nat. Methods</source>
          <year>2013</year>
          <volume>10</volume>
          <fpage>1096</fpage>
          <lpage>1098</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.2639</pub-id>
          <pub-id pub-id-type="pmid">24056875</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Tabula Muris Consortium.</collab>
            <etal/>
          </person-group>
          <article-title>Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris</article-title>
          <source>Nature</source>
          <year>2018</year>
          <volume>562</volume>
          <fpage>367</fpage>
          <lpage>372</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-018-0590-4</pub-id>
          <pub-id pub-id-type="pmid">30283141</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gonz&#xE1;lez-Silva</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Quevedo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Varela</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Tumor functional heterogeneity unraveled by scRNA-seq technologies</article-title>
          <source>Trends Cancer</source>
          <year>2020</year>
          <volume>6</volume>
          <fpage>13</fpage>
          <lpage>19</lpage>
          <pub-id pub-id-type="doi">10.1016/j.trecan.2019.11.010</pub-id>
          <pub-id pub-id-type="pmid">31952776</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xue</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic programs in human and mouse early embryos revealed by single-cell RNA sequencing</article-title>
          <source>Nature</source>
          <year>2013</year>
          <volume>500</volume>
          <fpage>593</fpage>
          <lpage>597</lpage>
          <pub-id pub-id-type="doi">10.1038/nature12364</pub-id>
          <pub-id pub-id-type="pmid">23892778</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Trapnell</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Single-cell transcriptome sequencing: recent advances and remaining challenges.</article-title>
          <source>F1000Res</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>Faculty Rev-182</fpage>
          <pub-id pub-id-type="doi">10.12688/f1000research.7223.1</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Menon</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration</article-title>
          <source>Nat. Commun.</source>
          <year>2019</year>
          <volume>10</volume>
          <fpage>4902</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-019-12780-8</pub-id>
          <pub-id pub-id-type="pmid">31653841</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanton</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Organoid single-cell genomic atlas uncovers human-specific features of brain development</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>574</volume>
          <fpage>418</fpage>
          <lpage>422</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1654-9</pub-id>
          <pub-id pub-id-type="pmid">31619793</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>HuBMAP Consortium.</collab>
          </person-group>
          <article-title>The human body at cellular resolution: the NIH Human Biomolecular Atlas Program</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>574</volume>
          <fpage>187</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1629-x</pub-id>
          <pub-id pub-id-type="pmid">31597973</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saunders</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular diversity and specializations among the cells of the adult mouse brain</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <fpage>1015</fpage>
          <lpage>1030.e16</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.028</pub-id>
          <pub-id pub-id-type="pmid">30096299</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yates</surname>
              <given-names>AD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ensembl 2020</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2020</year>
          <volume>48</volume>
          <fpage>D682</fpage>
          <lpage>D688</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkz1138</pub-id>
          <pub-id pub-id-type="pmid">31691826</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hong</surname>
              <given-names>EL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Principles of metadata organization at the ENCODE data coordination center.</article-title>
          <source>Database (Oxford)</source>
          <year>2016</year>
          <volume>2016</volume>
          <fpage>baw001</fpage>
          <pub-id pub-id-type="doi">10.1093/database/baw001</pub-id>
          <pub-id pub-id-type="pmid">26980513</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrow</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>GENCODE: the reference human genome annotation for The ENCODE Project</article-title>
          <source>Genome Res.</source>
          <year>2012</year>
          <volume>22</volume>
          <fpage>1760</fpage>
          <lpage>1774</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.135350.111</pub-id>
          <pub-id pub-id-type="pmid">22955987</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chae</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Danko</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Kraus</surname>
              <given-names>WL</given-names>
            </name>
          </person-group>
          <article-title>groHMM: a computational tool for identifying unannotated and cell type-specific transcription units from global run-on sequencing data</article-title>
          <source>BMC Bioinformatics</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>222</fpage>
          <pub-id pub-id-type="doi">10.1186/s12859-015-0656-3</pub-id>
          <pub-id pub-id-type="pmid">26173492</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kindgren</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ivanov</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marquardt</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Native elongation transcript sequencing reveals temperature dependent dynamics of nascent RNAPII transcription in Arabidopsis</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2020</year>
          <volume>48</volume>
          <fpage>2332</fpage>
          <lpage>2347</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkz1189</pub-id>
          <pub-id pub-id-type="pmid">31863587</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Duarte</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Civelek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Guertin</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Defining data-driven primary transcript annotations with primaryTranscriptAnnotation in R</article-title>
          <source>Bioinformatics</source>
          <year>2020</year>
          <volume>36</volume>
          <fpage>2926</fpage>
          <lpage>2928</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa011</pub-id>
          <pub-id pub-id-type="pmid">31917388</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smibert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
          <pub-id pub-id-type="pmid">29608179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive integration of single-cell data</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902.e21</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">pbmc4k - Datasets - Single Cell Gene Expression - Official 10x Genomics Support. <ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-gene-expression/datasets/2.1.0/pbmc4k">https://support.10xgenomics.com/single-cell-gene-expression/datasets/2.1.0/pbmc4k</ext-link>. Accessed 31 October 2019.</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hilton</surname>
              <given-names>HG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell transcriptomics of the naked mole-rat reveals unexpected features of mammalian immunity</article-title>
          <source>PLoS Biol.</source>
          <year>2019</year>
          <volume>17</volume>
          <fpage>e3000528</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.3000528</pub-id>
          <pub-id pub-id-type="pmid">31751331</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foster</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Teo</surname>
              <given-names>YV</given-names>
            </name>
            <name>
              <surname>Neretti</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Oulhen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Wessel</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Single cell RNA-seq in the sea urchin embryo show marked cell-type specificity in the Delta/Notch pathway</article-title>
          <source>Mol. Reprod. Dev.</source>
          <year>2019</year>
          <volume>86</volume>
          <fpage>931</fpage>
          <lpage>934</lpage>
          <pub-id pub-id-type="doi">10.1002/mrd.23181</pub-id>
          <pub-id pub-id-type="pmid">31199038</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becht</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dimensionality reduction for visualizing single-cell data using UMAP.</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>38</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johnson</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>NCBI BLAST: a better web interface</article-title>
          <source>Nucleic Acids Res.</source>
          <year>2008</year>
          <volume>36</volume>
          <fpage>W5</fpage>
          <lpage>W9</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkn201</pub-id>
          <pub-id pub-id-type="pmid">18440982</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Altschul</surname>
              <given-names>SF</given-names>
            </name>
            <name>
              <surname>Gish</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Lipman</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>Basic local alignment search tool</article-title>
          <source>J. Mol. Biol.</source>
          <year>1990</year>
          <volume>215</volume>
          <fpage>403</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id>
          <pub-id pub-id-type="pmid">2231712</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Board</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Menon</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Glutathione transferases, regulators of cellular metabolism and physiology</article-title>
          <source>Biochim. Biophys. Acta</source>
          <year>2013</year>
          <volume>1830</volume>
          <fpage>3267</fpage>
          <lpage>3288</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbagen.2012.11.019</pub-id>
          <pub-id pub-id-type="pmid">23201197</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wickramasinghe</surname>
              <given-names>VO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulation of constitutive and alternative mRNA splicing across the human transcriptome by PRPF8 is determined by 5&#x2B9; splice site strength</article-title>
          <source>Genome Biol.</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>201</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-015-0749-3</pub-id>
          <pub-id pub-id-type="pmid">26392272</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mura</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Identification and angiogenic role of the novel tumor endothelial marker CLEC14A</article-title>
          <source>Oncogene</source>
          <year>2012</year>
          <volume>31</volume>
          <fpage>293</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="doi">10.1038/onc.2011.233</pub-id>
          <pub-id pub-id-type="pmid">21706054</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rakhmanov</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High levels of SOX5 decrease proliferative capacity of human B cells, but permit plasmablast differentiation</article-title>
          <source>PLoS ONE</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>e100328</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0100328</pub-id>
          <pub-id pub-id-type="pmid">24945754</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>SOX5 promotes epithelial&#x2013;mesenchymal transition in osteosarcoma via regulation of Snail</article-title>
          <source>J. BUON</source>
          <year>2017</year>
          <volume>22</volume>
          <fpage>258</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">28365963</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alfayez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vishnubalaji</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Alajez</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>Runt-related Transcription Factor 1 (RUNX1T1) suppresses colorectal cancer cells through regulation of cell proliferation and chemotherapeutic drug resistance</article-title>
          <source>Anticancer Res.</source>
          <year>2016</year>
          <volume>36</volume>
          <fpage>5257</fpage>
          <lpage>5263</lpage>
          <pub-id pub-id-type="doi">10.21873/anticanres.11096</pub-id>
          <pub-id pub-id-type="pmid">27798886</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shi</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Long non-coding RNA RUNX1-IT1 plays a tumour-suppressive role in colorectal cancer by inhibiting cell proliferation and migration</article-title>
          <source>Cell Biochem. Funct.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>11</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1002/cbf.3368</pub-id>
          <pub-id pub-id-type="pmid">30499136</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schenk</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jenke</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zilbauer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wirth</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Postberg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>H3.5 is a novel hominid-specific histone H3 variant that is specifically expressed in the seminiferous tubules of human testes</article-title>
          <source>Chromosoma</source>
          <year>2011</year>
          <volume>120</volume>
          <fpage>275</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="doi">10.1007/s00412-011-0310-4</pub-id>
          <pub-id pub-id-type="pmid">21274551</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiraishi</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Roles of histone H3.5 in human spermatogenesis and spermatogenic disorders</article-title>
          <source>Andrology</source>
          <year>2018</year>
          <volume>6</volume>
          <fpage>158</fpage>
          <lpage>165</lpage>
          <pub-id pub-id-type="doi">10.1111/andr.12438</pub-id>
          <pub-id pub-id-type="pmid">29179259</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahauad-Fernandez</surname>
              <given-names>WD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells</article-title>
          <source>Sci. Rep.</source>
          <year>2018</year>
          <volume>8</volume>
          <fpage>17608</fpage>
          <pub-id pub-id-type="doi">10.1038/s41598-018-35710-y</pub-id>
          <pub-id pub-id-type="pmid">30514852</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tiwari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>de la Torre</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>McGavern</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Nayak</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Beyond tethering the viral particles: immunomodulatory functions of tetherin (BST-2)</article-title>
          <source>DNA Cell Biol.</source>
          <year>2019</year>
          <volume>38</volume>
          <fpage>1170</fpage>
          <lpage>1177</lpage>
          <pub-id pub-id-type="doi">10.1089/dna.2019.4777</pub-id>
          <pub-id pub-id-type="pmid">31502877</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>C-M</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J-Y</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>Q-Y</given-names>
            </name>
          </person-group>
          <article-title>DUSP1 promotes senescence of retinoblastoma cell line SO-Rb5 cells by activating AKT signaling pathway</article-title>
          <source>Eur. Rev. Med. Pharm. Sci.</source>
          <year>2018</year>
          <volume>22</volume>
          <fpage>7628</fpage>
          <lpage>7632</lpage>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teng</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>DUSP1 induces apatinib resistance by activating the MAPK pathway in gastric cancer</article-title>
          <source>Oncol. Rep.</source>
          <year>2018</year>
          <volume>40</volume>
          <fpage>1203</fpage>
          <lpage>1222</lpage>
          <pub-id pub-id-type="pmid">29956792</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Macosko</surname>
              <given-names>EZ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets</article-title>
          <source>Cell</source>
          <year>2015</year>
          <volume>161</volume>
          <fpage>1202</fpage>
          <lpage>1214</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2015.05.002</pub-id>
          <pub-id pub-id-type="pmid">26000488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quinlan</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>841</fpage>
          <lpage>842</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id>
          <pub-id pub-id-type="pmid">20110278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The sequence alignment/map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>
          <source>Bioinformatics</source>
          <year>2014</year>
          <volume>30</volume>
          <fpage>923</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id>
          <pub-id pub-id-type="pmid">24227677</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>K&#xF6;ster</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rahmann</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Snakemake&#x2014;a scalable bioinformatics workflow engine</article-title>
          <source>Bioinformatics</source>
          <year>2012</year>
          <volume>28</volume>
          <fpage>2520</fpage>
          <lpage>2522</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bts480</pub-id>
          <pub-id pub-id-type="pmid">22908215</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <mixed-citation publication-type="other">10x Genomics Support - Official 10x Genomics Support. <ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/docs/bamtofastq">https://support.10xgenomics.com/docs/bamtofastq</ext-link>. Accessed 28 January 2020.</mixed-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <mixed-citation publication-type="other">fw262. <italic>fw262/TAR-scRNA-seq: Initial Release</italic>. 10.5281/zenodo.4567437 (Zenodo, 2021).</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">eLife</journal-id>
      <journal-id journal-id-type="iso-abbrev">Elife</journal-id>
      <journal-id journal-id-type="publisher-id">eLife</journal-id>
      <journal-title-group>
        <journal-title>eLife</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2050-084X</issn>
      <publisher>
        <publisher-name>eLife Sciences Publications, Ltd</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33448928</article-id>
      <article-id pub-id-type="pmc">7810465</article-id>
      <article-id pub-id-type="publisher-id">62270</article-id>
      <article-id pub-id-type="doi">10.7554/eLife.62270</article-id>
      <article-categories>
        <subj-group subj-group-type="display-channel">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Immunology and Inflammation</subject>
        </subj-group>
        <subj-group subj-group-type="heading">
          <subject>Medicine</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline</article-title>
      </title-group>
      <contrib-group>
        <contrib id="author-204503" contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Janosevic</surname>
            <given-names>Danielle</given-names>
          </name>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3215-6942</contrib-id>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="author-notes" rid="equal-contrib1">&#x2020;</xref>
          <xref ref-type="other" rid="fund5"/>
          <xref ref-type="other" rid="fund8"/>
          <xref ref-type="other" rid="fund6"/>
          <xref ref-type="fn" rid="con1"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204504" contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Myslinski</surname>
            <given-names>Jered</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="author-notes" rid="equal-contrib1">&#x2020;</xref>
          <xref ref-type="fn" rid="con2"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204505" contrib-type="author">
          <name>
            <surname>McCarthy</surname>
            <given-names>Thomas W</given-names>
          </name>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7734-2821</contrib-id>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="fn" rid="con3"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204506" contrib-type="author">
          <name>
            <surname>Zollman</surname>
            <given-names>Amy</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="fn" rid="con4"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204507" contrib-type="author">
          <name>
            <surname>Syed</surname>
            <given-names>Farooq</given-names>
          </name>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0284-0631</contrib-id>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="fn" rid="con5"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204508" contrib-type="author">
          <name>
            <surname>Xuei</surname>
            <given-names>Xiaoling</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
          <xref ref-type="fn" rid="con6"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-69305" contrib-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Hongyu</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
          <xref ref-type="fn" rid="con7"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-141110" contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Yun-Long</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
          <xref ref-type="fn" rid="con8"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204509" contrib-type="author">
          <name>
            <surname>Collins</surname>
            <given-names>Kimberly S</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="fn" rid="con9"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204510" contrib-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>Ying-Hua</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="fn" rid="con10"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204511" contrib-type="author">
          <name>
            <surname>Winfree</surname>
            <given-names>Seth</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="fn" rid="con11"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204512" contrib-type="author">
          <name>
            <surname>El-Achkar</surname>
            <given-names>Tarek M</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
          <xref ref-type="fn" rid="con12"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204513" contrib-type="author">
          <name>
            <surname>Maier</surname>
            <given-names>Bernhard</given-names>
          </name>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8174-0873</contrib-id>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="fn" rid="con13"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204514" contrib-type="author">
          <name>
            <surname>Melo Ferreira</surname>
            <given-names>Ricardo</given-names>
          </name>
          <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2063-9744</contrib-id>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="fn" rid="con14"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204515" contrib-type="author">
          <name>
            <surname>Eadon</surname>
            <given-names>Michael T</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="other" rid="fund3"/>
          <xref ref-type="fn" rid="con15"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-203129" contrib-type="author" corresp="yes">
          <name>
            <surname>Hato</surname>
            <given-names>Takashi</given-names>
          </name>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0446-6575</contrib-id>
          <email>thato@iu.edu</email>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="other" rid="fund1"/>
          <xref ref-type="other" rid="fund7"/>
          <xref ref-type="fn" rid="con16"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <contrib id="author-204516" contrib-type="author" corresp="yes">
          <name>
            <surname>Dagher</surname>
            <given-names>Pierre C</given-names>
          </name>
          <email>pdaghe2@iu.edu</email>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
          <xref ref-type="other" rid="fund2"/>
          <xref ref-type="other" rid="fund4"/>
          <xref ref-type="fn" rid="con17"/>
          <xref ref-type="fn" rid="conf1"/>
        </contrib>
        <aff id="aff1">
          <label>1</label>
          <institution>Department of Medicine, Indiana University School of Medicine</institution>
          <addr-line>Indianapolis</addr-line>
          <country>United States</country>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>Department of Pediatrics and the Herman B. Wells Center, Indiana University School of Medicine</institution>
          <addr-line>Indianapolis</addr-line>
          <country>United States</country>
        </aff>
        <aff id="aff3">
          <label>3</label>
          <institution>Department of Medical and Molecular Genetics, Indiana University School of Medicine</institution>
          <addr-line>Indianapolis</addr-line>
          <country>United States</country>
        </aff>
        <aff id="aff4">
          <label>4</label>
          <institution>Roudebush Indianapolis Veterans Affairs Medical Center</institution>
          <addr-line>Indianapolis</addr-line>
          <country>United States</country>
        </aff>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>van der Meer</surname>
            <given-names>Jos WM</given-names>
          </name>
          <role>Senior Editor</role>
          <aff>
            <institution>Radboud University Medical Centre</institution>
            <country>Netherlands</country>
          </aff>
        </contrib>
        <contrib contrib-type="editor">
          <name>
            <surname>Giamarellos-Bourboulis</surname>
            <given-names>Evangelos J</given-names>
          </name>
          <role>Reviewing Editor</role>
          <aff>
            <institution>Attikon University Hospital</institution>
            <country>Greece</country>
          </aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="con" id="equal-contrib1">
          <label>&#x2020;</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
      </author-notes>
      <pub-date date-type="pub" publication-format="electronic">
        <day>15</day>
        <month>1</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>e62270</elocation-id>
      <history>
        <date date-type="received" iso-8601-date="2020-08-19">
          <day>19</day>
          <month>8</month>
          <year>2020</year>
        </date>
        <date date-type="accepted" iso-8601-date="2020-12-13">
          <day>13</day>
          <month>12</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2021, Janosevic et al</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Janosevic et al</copyright-holder>
        <ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:href="elife-62270.pdf"/>
      <abstract>
        <p>Sepsis is a dynamic state that progresses at variable rates and has life-threatening consequences. Staging patients along the sepsis timeline requires a thorough knowledge of the evolution of cellular and molecular events at the tissue level. Here, we investigated the kidney, an organ central to the pathophysiology of sepsis. Single-cell RNA-sequencing in a murine endotoxemia model revealed the involvement of various cell populations to be temporally organized and highly orchestrated. Endothelial and stromal cells were the first responders. At later time points, epithelial cells upregulated immune-related pathways while concomitantly downregulating physiological functions such as solute homeostasis. Sixteen hours after endotoxin, there was global cell&#x2013;cell communication failure and organ shutdown. Despite this apparent organ paralysis, upstream regulatory analysis showed significant activity in pathways involved in healing and recovery. This rigorous spatial and temporal definition of murine endotoxemia will uncover precise biomarkers and targets that can help stage and treat human sepsis.</p>
      </abstract>
      <kwd-group kwd-group-type="author-keywords">
        <kwd>sepsis</kwd>
        <kwd>acute kidney injury</kwd>
        <kwd>single-cell RNA-seq</kwd>
      </kwd-group>
      <kwd-group kwd-group-type="research-organism">
        <title>Research organism</title>
        <kwd>Human</kwd>
        <kwd>Mouse</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="fund1">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id>
              <institution>NIH Office of the Director</institution>
            </institution-wrap>
          </funding-source>
          <award-id>K08-DK113223</award-id>
          <principal-award-recipient>
            <name>
              <surname>Hato</surname>
              <given-names>Takashi</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="fund2">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id>
              <institution>NIH Office of the Director</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01-DK080063</award-id>
          <principal-award-recipient>
            <name>
              <surname>Dagher</surname>
              <given-names>Pierre C</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="fund3">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id>
              <institution>NIH Office of the Director</institution>
            </institution-wrap>
          </funding-source>
          <award-id>K08-DK107864</award-id>
          <principal-award-recipient>
            <name>
              <surname>Eadon</surname>
              <given-names>Michael T</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="fund4">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000738</institution-id>
              <institution>U.S. Department of Veterans Affairs</institution>
            </institution-wrap>
          </funding-source>
          <award-id>1I01BX002901</award-id>
          <principal-award-recipient>
            <name>
              <surname>Dagher</surname>
              <given-names>Pierre C</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="fund5">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006975</institution-id>
              <institution>Indiana Clinical and Translational Sciences Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>UL1TR002529</award-id>
          <principal-award-recipient>
            <name>
              <surname>Janosevic</surname>
              <given-names>Danielle</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="fund6">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id>
              <institution>NIH Office of the Director</institution>
            </institution-wrap>
          </funding-source>
          <award-id>T32DK120524</award-id>
          <principal-award-recipient>
            <name>
              <surname>Janosevic</surname>
              <given-names>Danielle</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="fund7">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id>
              <institution>NIH Office of the Director</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01-AI148282</award-id>
          <principal-award-recipient>
            <name>
              <surname>Hato</surname>
              <given-names>Takashi</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group id="fund8">
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006975</institution-id>
              <institution>Indiana Clinical and Translational Sciences Institute</institution>
            </institution-wrap>
          </funding-source>
          <award-id>T32HL091816</award-id>
          <principal-award-recipient>
            <name>
              <surname>Janosevic</surname>
              <given-names>Danielle</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement>
      </funding-group>
      <custom-meta-group>
        <custom-meta specific-use="meta-only">
          <meta-name>Author impact statement</meta-name>
          <meta-value>Single-cell RNA-sequencing identifies the precise cellular and molecular events that occur along the sepsis timeline in the kidney, pointing to potential biomarkers and therapeutic targets.</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Acute kidney injury (AKI) is a common complication of sepsis that doubles the mortality risk. In addition to failed homeostasis, kidney injury can contribute to multi-organ dysfunction through distant effects. Indeed, the injured kidney is a significant source of inflammatory chemokines, cytokines, and reactive oxygen species that can have both local as well as remote deleterious effects (<xref rid="bib22" ref-type="bibr">Husain-Syed et al., 2016</xref>; <xref rid="bib30" ref-type="bibr">Lee et al., 2018</xref>; <xref rid="bib9" ref-type="bibr">Deutschman and Tracey, 2014</xref>; <xref rid="bib35" ref-type="bibr">Poston and Koyner, 2019</xref>). Therefore, understanding the complex pathophysiology of kidney injury is crucial for the comprehensive treatment of sepsis and its complications.</p>
      <p>We have recently shown that renal injury in endotoxemia progresses through multiple phases. These include an early inflammatory burst followed by a broad antiviral response that culminated in protein translation shutdown and organ failure (<xref rid="bib17" ref-type="bibr">Hato et al., 2019</xref>). In a non-lethal and reversible model of endotoxemia, organ failure was followed by spontaneous recovery. The exact cellular and molecular contributors to this multifaceted response remain unknown. Indeed, the kidney is architecturally a highly complex organ in which epithelial, endothelial, immune, and stromal cells are at constant interplay. Therefore, we now examined the spatial and temporal progression of endotoxin injury to the kidney using single-cell RNA sequencing (scRNA-seq). Our data revealed that cell&#x2013;cell communication failure is a major contributor to organ dysfunction in endotoxemia. Remarkably, this phase of communication failure was also a transition point where recovery pathways were activated. We believe this spatially and temporally-anchored approach to the pathophysiology of endotoxemia is crucial for identifying potential sepsis biomarkers and therapeutic targets.</p>
    </sec>
    <sec sec-type="results" id="s2">
      <title>Results</title>
      <sec id="s2-1">
        <title>ScRNA-seq identifies various renal cell populations</title>
        <p>We harvested a cumulative amount of 63,287 renal cells obtained at 0, 1, 4, 16, 27, 36, and 48 hr after endotoxin (LPS) administration. The majority of renal epithelial, immune and endothelial cell types were represented (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <ext-link ext-link-type="uri" xlink:href="https://connect.rstudio.iu.edu/content/18/">https://connect.rstudio.iu.edu/content/18/</ext-link>). Note the absence of podocyte and mesangial cells, which can be a limitation of warm dissociation procedure (<xref rid="bib8" ref-type="bibr">Denisenko et al., 2020</xref>). Cluster identities were assigned and grouped using known classical phenotypic markers (<xref ref-type="fig" rid="fig1">Figure 1B</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1&#x2014;figure supplement 1A</xref>;&#xA0;<xref rid="bib7" ref-type="bibr">Clark et al., 2019</xref>; <xref rid="bib27" ref-type="bibr">Lake et al., 2019</xref>; <xref rid="bib29" ref-type="bibr">Lee et al., 2015</xref>; <xref rid="bib34" ref-type="bibr">Park et al., 2018</xref>; <xref rid="bib36" ref-type="bibr">Ransick et al., 2019</xref>). Interestingly, the UMAP-based computational layout of epithelial clusters recapitulated the normal tubular segmental order of the nephron. This indicates that cell type-defining gene expression patterns gradually change among neighboring tubular segments along the nephron. The expression of cluster-defining markers varied significantly during the injury and recovery phases of endotoxemia (<xref ref-type="fig" rid="fig1s1">Figure 1&#x2014;figure supplement 1B</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Therefore, we also identified a set of genes that are conserved across time for a given cell type (<xref ref-type="fig" rid="fig1s1">Figure 1&#x2014;figure supplement 1C</xref>).</p>
        <fig id="fig1" position="float" orientation="portrait">
          <label>Figure 1.</label>
          <caption>
            <title>ScRNA-seq identifies various renal cell populations.</title>
            <p>(<bold>A</bold>) Integrated UMAP of kidney cell clusters from control and LPS-treated mice (0, 1, 4, 16, 27, 36, and 48 hr after LPS injection).&#xA0;Actual anatomical layout of kidney nephronal segments is shown below UMAP. (<bold>B</bold>) Dot plot of representative genes defining indicated cell types. (<bold>C</bold>) Backmapping of cells from the integrated UMAP onto unintegrated UMAPs of select time points. Highlighted are the proliferating cell cluster (red circle) and S3T2 cluster (blue box). For visibility the actual size of the proliferating cells cluster was purposefully exaggerated. Inset at the 0 hr timepoint shows the proximal tubular clusters with the non-edited proliferating cells subcluster circled in red. CD, collecting duct. CD-IC, collecting duct-intercalated cells. CD-PC, collecting duct-principle cells. CNT, connecting tubule. DCT, distal convoluted tubule. Endo, endothelial cells. Exp, expression. Glom, glomerulus. LOH, Loop of Henle. LPS, endotoxin. Ly, lymphocytes. M&#x3C6; -DC, macrophage-dendritic cells. Ne, neutrophil. Peri/St, mixed pericyte and stromal cells. Prolif. Cells, proliferating cells. PT, proximal tubule. S1, first segment of PT. S2, second segment of PT. S3, third segment of PT. S3T2, S3 type 2 cells.</p>
          </caption>
          <graphic xlink:href="elife-62270-fig1"/>
          <p content-type="supplemental-figure">
            <fig id="fig1s1" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 1&#x2014;figure supplement 1.</label>
              <caption>
                <title>Cluster-defining markers across the endotoxemia timeline.</title>
                <p>(<bold>A</bold>) Integrated UMAP of kidney cell clusters showing both assigned identity and original cluster number from control and LPS-treated mice (0, 1, 4, 16, 27, 36, and 48 hr after LPS injection). (<bold>B&#x2013;C</bold>) Dot plots of top five cluster-defining (shown at 16 hr) and conserved marker genes (all time points integrated). CD, collecting duct. CD-IC, collecting duct-intercalated cells. CD-PC, collecting duct-principle cells. CNT, connecting tubule. DCT, distal convoluted tubule. Endo, endothelial cells. LOH, Loop of Henle. LPS, endotoxin. Ly, lymphocytes. M&#x3D5;-DC, macrophage-dendritic cells. Ne, neutrophil. Peri/St, mixed pericyte and stromal cells. Prolif. Cells, proliferative cells. PT, proximal tubule. S1, first segment of PT. S2, second segment of PT. S3, third segment of PT. S3T2, S3 type 2 cells. Other/UE, mixed clusters, ureteric epithelium.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig1-figsupp1"/>
            </fig>
          </p>
          <p content-type="supplemental-figure">
            <fig id="fig1s2" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 1&#x2014;figure supplement 2.</label>
              <caption>
                <title>Characterization of proliferating cells.</title>
                <p>(<bold>A</bold>) Feature plots of Jun and Fos, markers for dissociation-induced stress response.&#xA0;Note that proliferating cells (red circles) showed minimal expression of Jun and Fos. (<bold>B</bold>) Mice were injected with thimidine analog CldU and the kidneys were harvested at baseline (control, 0 hr) and 24 hr after LPS. Arrows point to CldU positive cells shown in red. Nuclei are stained blue with DAPI. Green is tubular autofluorescence. CldU, 5-chloro-2&#x2019;deoxyuridine.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig1-figsupp2"/>
            </fig>
          </p>
        </fig>
        <p>In the integrated UMAP (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), we noted the presence of a proliferative cell cluster (<italic>Cdk1</italic> and <italic>MKi67</italic> expression). The stress markers <italic>Jun</italic> and <italic>Fos</italic> that are typically associated with the dissociation procedure (<xref rid="bib42" ref-type="bibr">van den Brink et al., 2017</xref>; <xref rid="bib8" ref-type="bibr">Denisenko et al., 2020</xref>) were not strongly expressed in this proliferating cell cluster (<xref ref-type="fig" rid="fig1s2">Figure 1&#x2014;figure supplement 2A</xref>). By back mapping to time-specific unintegrated UMAPs, we determined that these proliferating cells could be traced to specific cell types at various points along the endotoxemia timeline (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). At baseline, proliferating indices localized to the proximal tubular cluster in uninjured tissues (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). This was confirmed microscopically after in vivo thymidine analog injection (<xref ref-type="fig" rid="fig1s2">Figure 1&#x2014;figure supplement 2B</xref>). Within the first hour after LPS, these proliferative indices were expressed primarily in S1 cells. These cells are the site of LPS uptake in the kidney as we have previously shown (<xref rid="bib15" ref-type="bibr">Hato et al., 2015</xref>; <xref rid="bib16" ref-type="bibr">Hato et al., 2018</xref>; <xref rid="bib23" ref-type="bibr">Kalakeche et al., 2011</xref>). At later time points, proliferative indices are seen in lymphocytes (16 hr) and S3 cells (36 hr) (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The migration of proliferation indices among various cell types highlights the spatial and temporal nature of the renal response to LPS. These proliferative indices likely reflect cell cycle activity which may be involved in injury, repair or recovery processes (<xref rid="bib47" ref-type="bibr">Yang et al., 2010</xref>).</p>
      </sec>
      <sec id="s2-2">
        <title>Integration of scRNA-seq and spatial transcriptomics localizes subtypes of S3 proximal tubules</title>
        <p>Among the proximal tubular cells, we noted the presence of a distinct cluster expressing Angiotensinogen (Agt) and other unique identifiers such as <italic>Rnf24, Slc22a7</italic>, and <italic>Slc22a13</italic> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This is likely the proximal tubular S3-Type 2 (S3T2) reported by others (<xref rid="bib5" ref-type="bibr">Cao et al., 2018</xref>; <xref rid="bib36" ref-type="bibr">Ransick et al., 2019</xref>). This cluster maintained a separate and distinct identity throughout most of the endotoxemia timeline (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). Because the location of S3T2 is currently unknown, we performed in-situ spatial transcriptomics on endotoxemic mouse kidneys (<xref rid="bib38" ref-type="bibr">St&#xE5;hl et al., 2016</xref>). We then integrated our scRNA-seq with the in-situ RNA-seq to map our scRNA-seq clusters onto the tissue (<xref ref-type="fig" rid="fig2s1">Figure 2&#x2014;figure supplement 1A and B</xref>). We found that the S3 cluster localizes to the cortex while S3T2 is in the outer stripe of the outer medulla (OS-OM; <xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2&#x2014;figure supplement 1B</xref>). We confirmed the location of S3T2 to the OS-OM with single-molecular FISH (<xref ref-type="fig" rid="fig2s1">Figure 2&#x2014;figure supplement 1C</xref>). The differential gene expression between S3 and S3T2 is likely dictated by regional differences in the microenvironments of the cortex and the outer stripe. The small number of cells in this S3T2 cluster in our scRNA-seq data may be the result of a cortical dissociation bias. Finally, because angiotensinogen (<italic>Agt</italic>) was strongly expressed in S3T2, we also examined the expression of other components of the renin-angiotensin system as shown in <xref ref-type="fig" rid="fig2s2">Figure 2&#x2014;figure supplement 2</xref>.</p>
        <fig id="fig2" position="float" orientation="portrait">
          <label>Figure 2.</label>
          <caption>
            <title>Integration of scRNA-seq and spatial transcriptomics localizes subtypes of S3 proximal tubules.</title>
            <p>(<bold>A</bold>) Violin plots of S3T2 defining markers. (<bold>B</bold>) Integration of spatial transcriptomics and scRNA-seq. Spatial transcriptomics were performed on a slice of mouse kidney. This yielded seven clusters that were expanded to 15 cell types by integrating spatial transcriptomics with scRNAseq data from LPS-treated mice. See also Figure S3.</p>
          </caption>
          <graphic xlink:href="elife-62270-fig2"/>
          <p content-type="supplemental-figure">
            <fig id="fig2s1" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 2&#x2014;figure supplement 1.</label>
              <caption>
                <title>Spatial transcriptomics validation.</title>
                <p>(<bold>A&#x2013;B</bold>) Spatial transcriptomics of murine kidney showing unsupervised clustering (b-left panel) and expanded clustering after integration with single cell data (b-right panel).&#xA0;Insets of A show gene expression of select glomerular and tubular markers. Gray dots are gene expression values which fall below displayed scale. Inset of b-right panel highlights S3 and S3T2 clusters. Note that S3T2 spots are strictly localized to the OS OM. In contrast, S3 spots are primarily located in the lower cortex, adjacent to the OS OM and do not extend to the upper cortex. They are clearly distinct from S2 spots that span the cortex, including the upper cortex. (<bold>C</bold>) Single molecular FISH (smFISH) coexpression of Aqp1 (red) and Agt (punctate green) in control kidney and after 1 hr of LPS (Cortex and outer stripe of outer medulla shown). Diffuse green objects are RBC and tubular autofluorescence. Endo/Glom, glomerular endothelial cells, H&amp;E, hematoxylin and eosin stain, OS-OM, outer stripe of outer medulla, M, medulla.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig2-figsupp1"/>
            </fig>
          </p>
          <p content-type="supplemental-figure">
            <fig id="fig2s2" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 2&#x2014;figure supplement 2.</label>
              <caption>
                <title>Cellular expression of the RAS axis along the endotoxemia timeline.</title>
                <p>Feature plots showing expression of components of the RAS axis at specified time points. Labeled in the upper left panel are the segments of the proximal tubule, and stromal cells which express genes related to the renin-angiotensin axis.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig2-figsupp2"/>
            </fig>
          </p>
        </fig>
      </sec>
      <sec id="s2-3">
        <title>Cell trajectory and velocity field analyses of scRNA-seq characterize subpopulations of immune cells</title>
        <p>The immune cell content of the septic kidney was time-dependent and showed a five-fold increase in immune cells over 48 hr after LPS, primarily macrophages (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). We noted two distinct macrophage clusters denoted as Macrophage A and Macrophage B (M&#x3C6;-A, M&#x3C6;-B). Both of these clusters expressed classical macrophage markers such as Cd11b (<italic>Itgam</italic>) (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). However, they differed in the expression of <italic>Adgre1</italic> (F4/80, M&#x3C6;-A) and <italic>Ccr2</italic> (M&#x3C6;-B). The accumulated macrophages were predominantly M&#x3C6;-A. We noted the absence of proliferation markers (<italic>Cdk1, MKi67</italic>) in this cluster, raising the possibility that this may be an infiltrative macrophage type (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). The M&#x3C6;-B cluster, located in the UMAP between M&#x3C6;-A and conventional dendritic cells (cDC) expressed also cDC markers such as MHC-II subunit genes (<italic>H2-Ab1</italic>) and Cd11c (<italic>Itgax</italic>) indicating that it is an intermediary macrophage type (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). This continuum between macrophages and dendritic cells in the kidney has been reported (<xref rid="bib25" ref-type="bibr">Kr&#xFC;ger et al., 2004</xref>; <xref rid="bib44" ref-type="bibr">Woltman et al., 2007</xref>; <xref rid="bib21" ref-type="bibr">Huen and Cantley, 2017</xref>; <xref rid="bib12" ref-type="bibr">Gottschalk and Kurts, 2015</xref>). Interestingly, M&#x3C6;-B cells expressed proliferation markers (<italic>Cdk1, MKi67</italic>) and thus, may be differentiating toward a M&#x3C6;-A or cDC phenotype (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Pseudotime and velocity field analysis suggested that at earlier time points (1 hr) M&#x3C6;-B was differentiating toward M&#x3C6;-A phenotype. At later time points (36 hr) the velocity field suggested that M&#x3C6;-B was differentiating toward cDC but pseudotime analysis was inconclusive (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). Similarly, the M&#x3C6;-A cluster showed two subclusters on the RNA velocity map (<xref ref-type="fig" rid="fig3s1">Figure 3&#x2014;figure supplement 1A</xref>). One of the subclusters showed increased expression of alternatively activated macrophage (M2) markers such as <italic>Arg1</italic> (Arginase 1) and <italic>Mrc1</italic> (Cd206) (<xref rid="bib28" ref-type="bibr">Lee et al., 2011</xref>) at later time points (36 hr, <xref ref-type="fig" rid="fig3s1">Figure 3&#x2014;figure supplement 1B</xref>). Therefore, RNA velocity analysis may be a useful tool in distinguishing macrophage subtypes in scRNA-seq data.</p>
        <fig id="fig3" position="float" orientation="portrait">
          <label>Figure 3.</label>
          <caption>
            <title>Endotoxemia induces dynamic changes in renal immune cell composition, pseudotime states and RNA velocity.</title>
            <p>(<bold>A</bold>) Integrated UMAP of the immune cell clusters from control and LPS-treated mice (0, 1, 4, 16, 27, 36, and 48 hr after LPS injection). Other one and Other two are Cd45+ cells with mixed epithelial and immune markers. (<bold>B</bold>) Stacked bar plot with fractions of immune cells (relative to total number of cells) shown in the y-axis, at 0, 1, 4, 36, and 48 hr after LPS. The total number of immune cells is indicated at the top of the bar for each time point. (<bold>C</bold>) Integrated violin plots from all time points for indicated genes defining subtypes of macrophages and DCs. (<bold>D</bold>) Feature plots of proliferation markers expression from integrated time points in the immune cell subsets. (<bold>E</bold>) Integrated cell trajectory analyses and RNA velocity fields for macrophages and dendritic cells shown at indicated time points. cDC, conventional dendritic cell. Hrs, hours. M&#x3D5;-A, macrophage-A. M&#x3D5;-B, macrophage-B. Ne, neutrophil. NK, natural killer cells. NKT, natural killer T-cells. pDC, plasmacytoid dendritic cell. T-cell, Cd3+ T-lymphocytes.</p>
          </caption>
          <graphic xlink:href="elife-62270-fig3"/>
          <p content-type="supplemental-figure">
            <fig id="fig3s1" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 3&#x2014;figure supplement 1.</label>
              <caption>
                <title>Immune cell subset characteristics.</title>
                <p>(<bold>A</bold>) RNA velocity analysis reveals two distinct subfields within the M&#x3D5;-A cluster. The subfield circled in red showed expression of M2 macrophage-related genes at later time points (<bold>B</bold>). (<bold>C</bold>) Violin plots of Cd4, Cd8 and Ifn-g expression across immune cell subtypes. cDC, conventional dendritic cell. Hrs, hours. M&#x3D5;-A, macrophage-A. M&#x3D5;-B, macrophage-B. M2, alternatively activated macrophages. Ne, neutrophil. NK, natural killer cells. NKT, natural killer T-cells. pDC, plasmacytoid dendritic cell. T-cell, Cd3+ T-lymphocytes.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig3-figsupp1"/>
            </fig>
          </p>
        </fig>
        <p>In T-cells, while <italic>Cd4</italic> expression was minimal at all time points, the expression of <italic>Cd8</italic> was robust and relatively preserved over time (<xref ref-type="fig" rid="fig3s1">Figure 3&#x2014;figure supplement 1C</xref>). We also noted an increase in a distinct plasmacytoid dendritic cell cluster at 1 hr (pDC). These pDCs, along with natural killer (NK) cells, are known to signal through the interferon-gamma pathway and stimulate Cd8 expression (<xref rid="bib14" ref-type="bibr">Guillerey et al., 2012</xref>; <xref rid="bib18" ref-type="bibr">Hemann et al., 2019</xref>). This supports the early antiviral response we have previously reported in this endotoxemia model (<xref rid="bib17" ref-type="bibr">Hato et al., 2019</xref>).</p>
      </sec>
      <sec id="s2-4">
        <title>Pseudotime and velocity field analyses identify cell-specific phenotypic changes along the endotoxemia timeline</title>
        <p>We next examined the phenotypic changes in epithelial and endothelial populations along the enodotoxemia timeline (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). At each time point, cells exhibited various states of gene expression that are well defined with pseudotime analysis. In fact, pseudotime accurately predicted future states as observed in real time. The endothelium exhibited changes in states as early as 1 hr, while S1 showed changes at later time points (4 hr). Importantly, the 16 hr timepoint was a turning point after which most cells returned to their baseline states indicating recovery (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). At later time points, many cell types lost function-defining markers while acquiring novel ones. For example, S1 and S3 lost classical markers like <italic>Slc5a2</italic> (SGLT2) and <italic>Aqp1</italic> and expressed new genes involved in antigen presentation such as <italic>H2-Ab1</italic> (MHC-II) and <italic>Cd74</italic> (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4&#x2014;figure supplement 1A and B</xref>). Similar changes were reported by others in bulk kidney RNA (<xref rid="bib40" ref-type="bibr">Tran et al., 2011</xref>;&#xA0;<xref ref-type="fig" rid="fig4s2">Figure 4&#x2014;figure supplement 2</xref>). Moreover, the highly distinct phenotypes that differentiated S1 from S2/S3 at baseline merged into one phenotype for all three sub-segments by 16 hr after LPS (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). However, despite the apparent convergent phenotype at 16 hr, additional analytical approaches such as RNA velocity revealed significant differences in RNA splicing kinetics between S1 and S3 segments at this time point. In addition, RNA velocity revealed the presence of two subclusters within the S3 segment at 16 hr (<xref ref-type="fig" rid="fig4">Figure 4D</xref>). These two velocity subclusters did not correlate with the two states seen in pseudotime analysis. Overall, the distinct changes observed in the RNA velocity field point to the significance of altered splicing activities at 16 hr. This is also supported by our nascent proteomics analysis in which molecules involved in RNA splicing were overrepresented at this time point (<xref rid="bib17" ref-type="bibr">Hato et al., 2019</xref>).</p>
        <fig id="fig4" position="float" orientation="portrait">
          <label>Figure 4.</label>
          <caption>
            <title>Pseudotime and velocity field analyses identify cell-specific phenotypic changes along the endotoxemia timeline.</title>
            <p>(<bold>A</bold>) Cell trajectory analysis for S1, S3, and endothelial cells shown at indicated time points. Highlighted in red circles are significant state transitions in respective cell types. The last cell trajectory shown for each cell type is integrated from all time points. It highlights the correspondence between pseudotime and real time. (<bold>B</bold>) Feature plots of selectgenes shown at indicated time points highlighting proximal tubular phenotypic changes. (<bold>C</bold>) Time-specific S1, S2, and S3PT cells (red, orange, yellow) overlaid on composite t-SNE map of all PT cells (gray). (<bold>D</bold>) RNA velocity fields for S1, S2, and S3 proximal tubular cells are shown at indicated time points. Two velocity subfields V1 and V2 in S3 cells are circled in green. Projections of two pseudotime S3 states (light blue, dark blue dots) onto the S3 velocity fields do not show a 1:1 correspondence with the two velocity subfields V1 and V2. V1, velocity subfield 1. V2, velocity subfield 2.</p>
          </caption>
          <graphic xlink:href="elife-62270-fig4"/>
          <p content-type="supplemental-figure">
            <fig id="fig4s1" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 4&#x2014;figure supplement 1.</label>
              <caption>
                <title>Transporter gene expression across the nephron during endotoxemia.</title>
                <p>Dot plots of select transporter genes shown at 0 hr (<bold>A</bold>) and 16 hr (<bold>B</bold>).</p>
              </caption>
              <graphic xlink:href="elife-62270-fig4-figsupp1"/>
            </fig>
          </p>
          <p content-type="supplemental-figure">
            <fig id="fig4s2" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 4&#x2014;figure supplement 2.</label>
              <caption>
                <title>Similarity analysis between bulk and single-cell RNA-seq data.</title>
                <p>(<bold>A</bold>) Jaccard similarity index analysis performed on the current single-cell RNA-seq data and publicly available bulk kidney transcriptomic dataset (GSE30576). Differentially expressed genes over indicated time points are similar between the two datasets as highlighted in blue rectangles. (<bold>B</bold>) Select gene expression levels from GSE30576 dataset with indicated patterns (*, **, ***). Control, 18 hr post LPS, and 42 hr recovery groups are shown.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig4-figsupp2"/>
            </fig>
          </p>
        </fig>
      </sec>
      <sec id="s2-5">
        <title>Endotoxemia induces an organ-wide host defense phenotype in the kidney</title>
        <p>Within 1 hr of LPS exposure, most cell types showed decreased expression of select genes involved in ribosomal function, translation and mitochondrial processes such as <italic>Eef2</italic> and <italic>Rpl</italic> genes (<xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5&#x2014;figure supplement 1A</xref>). This reduction peaked at 16 hr and recovered by 27 hr. Concomitantly, most cell types exhibited increased expression of several genes involved in inflammatory and antiviral responses such as <italic>Tnfsf9</italic>, <italic>Cxcl1, Ifit1,</italic> and <italic>Irf7</italic>. However, this increase was not synchronized among all cell populations. Indeed, it occurred as early as 1 hr in endothelial cells, macrophages and pericyte/stromal cells, all acting as first responders. In contrast, epithelial cells were late responders, with increases in inflammatory and antiviral responses occurring between 4 and 16 hr. Importantly, 4 hr after LPS administration, cluster-specific Gene Ontology terms were indistinguishable among the majority of cell types with enrichment in terms related to defense, immune and bacterium responses (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). One noted exception was the S3T2 cells (outer stripe S3) which did not enrich as robustly as other cell types in these terms. It mostly maintained an expression profile related to ribosomes, translation and drug transport throughout the endotoxemia timeline (<xref ref-type="fig" rid="fig5s2">Figure 5&#x2014;figure supplement 2</xref>). Other players of interest in sepsis pathophysiology such as prostaglandin and coagulation factors are described in <xref ref-type="fig" rid="fig5s1">Figure 5&#x2014;figure supplement 1B</xref>. We found that multiple cell types including epithelial, endothelial, immune and stromal cells contribute to the flow of these pathways at baseline and after injury. Because NF-&#x3BA;B is a major upstream transcription factor in the TLR4-endotoxin pathway, we show its spatial and temporal expression in the kidney by immunohistochemistry (<xref ref-type="fig" rid="fig5s3">Figure 5&#x2014;figure supplement 3</xref>). As we previously reported (<xref rid="bib17" ref-type="bibr">Hato et al., 2019</xref>), activation of NF-&#x3BA;B as evidenced by nuclear translocation was maximal in most tubules and interstitial cells/endothelial cells 1 hr after endotoxin.</p>
        <fig id="fig5" position="float" orientation="portrait">
          <label>Figure 5.</label>
          <caption>
            <title>Endotoxemia induces an organ-wide host defense phenotype in the kidney.</title>
            <p>(<bold>A</bold>) Heatmaps of select cell types with top 100 differentially expressed genes across the endottoxemia timeline (0&#x2013;48 hr). Select genes are shown for each cell type. (<bold>B</bold>) Time dependent enrichment of gene ontology terms for indicated cell types. GO terms are sorted in order of statistical significance. Hrs, hours. GO, gene ontology biological processes.</p>
          </caption>
          <graphic xlink:href="elife-62270-fig5"/>
          <p content-type="supplemental-figure">
            <fig id="fig5s1" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 5&#x2014;figure supplement 1.</label>
              <caption>
                <title>Comparisons of transcriptomic profiles of selected cell types across the endotoxemia timeline.</title>
                <p>(<bold>A</bold>) Venn diagram showing differentially expressed genes across time (0&#x2013;48 hr) for indicated cell types. (<bold>B</bold>) Heatmaps of genes involved in coagulation, complement and arachidonic acid related pathways in all cell types. Individual components of the complement cascade (the flow of which is denoted by red arrows) and coagulation cascade (denoted by blue arrows) are originated in distinct cell types.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig5-figsupp1"/>
            </fig>
          </p>
          <p content-type="supplemental-figure">
            <fig id="fig5s2" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 5&#x2014;figure supplement 2.</label>
              <caption>
                <title>S3T2 GO terms.</title>
                <p>Time dependent enrichment of gene ontology terms for S3T2 cells. GO terms are sorted in order of statistical significance. GO, gene ontology biological processes.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig5-figsupp2"/>
            </fig>
          </p>
          <p content-type="supplemental-figure">
            <fig id="fig5s3" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 5&#x2014;figure supplement 3.</label>
              <caption>
                <title>Representative images of immunohistochemical staining for NF-&#x3BA;B are shown under indicated conditions.</title>
                <p>Insets point to magnified views of select areas. At baseline, the expression of NF-&#x3BA;B is minimal in all cell types and primarily cytoplasmic. One hour after LPS, diffuse nuclear staining for NF-&#x3BA;B was observed in the majority of cell types including interstitial/immune, distal segment and some proximal tubules. Four hours after LPS, nuclear NF-&#x3BA;B signal was predominantly in interstitial/immune cells. At 16 hr after LPS, nuclear NF-&#x3BA;B signal was primarily in proximal tubules albeit in a patchy pattern. At this time point, NF-&#x3BA;B signal was reduced in interstitial/immune cells. By 27 hr, NF-&#x3BA;B signal started to return to baseline.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig5-figsupp3"/>
            </fig>
          </p>
        </fig>
        <p>At the 48 hr time point, while S1 cells mostly recovered to baseline, the macrophages showed increased expression of genes involved in phagocytosis, cell motility and leukotrienes, broadly representative of activated macrophages (e.g. <italic>Csf1r, Lst1, Capzb, S100a4, Cotl1, Alox5ap</italic>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). Intriguingly, at this late time point, the pericyte/stromal cells are enriched in unique terms related to specific leukocyte and immune cell types such as lymphocyte-mediated immunity, T-cell mediated cytotoxicity and antigen processing and presentation (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). This suggests that the pericyte may function as a transducer between epithelia and other immune cells.</p>
      </sec>
      <sec id="s2-6">
        <title>Endotoxemia alters cellular crosstalk causing time-specific global communication failure</title>
        <p>We next examined comprehensively cell&#x2013;cell communication along the endotoxemia timeline (<xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6&#x2014;figure supplement 1</xref>, <ext-link ext-link-type="uri" xlink:href="https://connect.rstudio.iu.edu/content/19/">https://connect.rstudio.iu.edu/content/19/</ext-link>; the full list is available in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). We show select examples of cell type-specific receptor&#x2013;ligand pairs known to be involved in sepsis physiology (<xref rid="bib19" ref-type="bibr">Higgins et al., 2018</xref>). For example, we found that S1 and endothelial cells communicate with the <italic>Angpt1</italic> (Angiopoetin 1) and <italic>Tek</italic> (Tie2) ligand-receptor pair at baseline and throughout the endotoxemia timeline (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). In contrast, <italic>C3</italic> was strongly expressed in pericyte/stromal cells, while its receptor <italic>C3ar1</italic> localized to macrophage/DCs. This communication, present at baseline, did increase with time with additional players such as S1 participating in the cross talk (<xref ref-type="fig" rid="fig6s1">Figure 6&#x2014;figure supplement 1A</xref>). Another strong communication was noted between endothelial cells and macrophage/lymphocytes using the <italic>Ccl2</italic> and <italic>Ccr2</italic> receptor&#x2013;ligand pair. The architectural layout of these four cell types, with pericytes and endothelial cells residing between proximal tubule and macrophage/DCs may explain these complex communication patterns (<xref rid="bib46" ref-type="bibr">Wu et al., 2019</xref>). Such communication patterns among these four cell types may also explain macrophage clustering around S1 tubules at later time points in endotoxemia as we previously reported (<xref rid="bib16" ref-type="bibr">Hato et al., 2018</xref>).</p>
        <fig id="fig6" position="float" orientation="portrait">
          <label>Figure 6.</label>
          <caption>
            <title>Endotoxemia alters cellular crosstalk causing time-specific global communication failure.</title>
            <p>(<bold>A</bold>) Schematic description of a cell&#x2013;cell communication circular plot. Dots in the outer track of the circle represent specific ligands or receptors and are positioned identically for all cell types. The height of dots correlates with statistical significance (all dots are less than adjusted p-value&lt;0.05). The identity of each dot is given in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. (<bold>B</bold>) Receptor&#x2013;ligand pairs for indicated cell types are displayed in circular plots. The data was generated using the CellPhone database. For clarity, communication between one cell type and all others is shown (purple lines: 0 hr for S1, blue lines: 1 hr for Peri/St and yellow lines: 4 hr for endothelial cells). Other cell&#x2013;cell communications in each circular plot are shown in light gray in the background. In each circular plot, the red line connects the specific receptor&#x2013;ligand pair highlighted in panel C. (<bold>C</bold>) Feature plots of receptor&#x2013;ligand pairs between specified cell types as highlighted by the red line in panel B. In each feature plot, the ligand is shown in purple and the receptor in red. (<bold>D</bold>) Circular plots displaying receptor&#x2013;ligand interactions between all cell types at specified time points. Examples of change in communication patterns are shown in the red circles in the outer track of the plot at 0, 4 and 48 hr. Note the dramatic drop in cell communication at 16 hr.</p>
          </caption>
          <graphic xlink:href="elife-62270-fig6"/>
          <p content-type="supplemental-figure">
            <fig id="fig6s1" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 6&#x2014;figure supplement 1.</label>
              <caption>
                <title>Expanded cell&#x2013;cell communication examples.</title>
                <p>(<bold>A</bold>) Feature plots illustrating cell and time-dependent expression changes of select receptor ligand pairs (shown at 0 hr unless otherwise specified). Schematic illustrates specific receptor&#x2013;ligand pairs involved in cross-talk between S1, endothelium, immune and stromal cells. (<bold>B</bold>) Heatmaps of receptor&#x2013;ligand pairs at select time points. The heatmap intensity denotes the number of interactions between cell types (x-axis) using receptor ligand pairs (y-axis). Red boxes highlight select pairs across time.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig6-figsupp1"/>
            </fig>
          </p>
        </fig>
        <p>When examined comprehensively, receptor&#x2013;ligand signaling progressed from a broad pattern at baseline into a more discrete and specialized one 4 hr after LPS (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). Sixteen hours after LPS, we noted a dramatic drop in cell&#x2013;cell communication between all cell types (<xref ref-type="fig" rid="fig6s1">Figure 6&#x2014;figure supplement 1B</xref>). This communication failure may contribute to the transcription and translation shutdown we recently reported at this time point (<xref rid="bib17" ref-type="bibr">Hato et al., 2019</xref>). In our reversible endotoxemia model, cell&#x2013;cell communication recovered by 27&#x2013;48 hr.</p>
      </sec>
      <sec id="s2-7">
        <title>Global communication failure is accompanied by increased activity of genes involved in recovery</title>
        <p>Transcription factors and their downstream targets (regulons) are important regulators of a myriad of pathways involved in the pathophysiology of sepsis. Therefore, we next examined the activity of regulons along the endotoxemia timeline in all renal cells. Surprisingly, we noted in many cell types an increase in regulon activity of key transcription factors at the 16 hr time point (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). In S1, many of the regulons active at this time point are involved in cell differentiation, development, transcription and proliferation (<italic>Sox4, Sox9, Hoxb7, Srf</italic>; <xref ref-type="fig" rid="fig7">Figure 7A&#x2013;C</xref>). As discussed above, this time point corresponds to translation shutdown as well as cell&#x2013;cell communication failure. Therefore, this 16 hr time point is not merely a time of complete shutdown and failure of the kidney. Rather, it is also a crucial transition point where key regulators of recovery and healing are activated.</p>
        <fig id="fig7" position="float" orientation="portrait">
          <label>Figure 7.</label>
          <caption>
            <title>Global communication failure is accompanied by increased activity of genes involved in recovery.</title>
            <p>(<bold>A</bold>) SCENIC-derived heatmap of regulons for S1 tubules. Highlighted are select transcription factors with active regulons at the 16 hr time point. (<bold>B</bold>) Gene ontology pathway enrichment analysis derived from all regulons active at the 16 hr time point (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). (<bold>C</bold>) t-SNE of proximal tubule S1 time-specific regulon activity. Select transcription factor expression (orange) and its corresponding regulon expression (blue) are shown. As shown for Sox4, note the temporal differences between the expression of the transcription factor itself and its regulon. (<bold>D</bold>) Heatmap of human sepsis kidney samples stratified based on aggregates of murine time-specific orthologues. The color scale indicates the degree of correlation based on Spearman&#x2019;s &#x3C1;. GO, gene ontology biological processes. (<bold>E</bold>) SOFA score distribution of subjects (x-axis subject ID corresponds to panel D subject ID). GO, gene ontology. SOFA, sequential organ failure assessment.</p>
          </caption>
          <graphic xlink:href="elife-62270-fig7"/>
          <p content-type="supplemental-figure">
            <fig id="fig7s1" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 7&#x2014;figure supplement 1.</label>
              <caption>
                <title>Characteristics of subjects.</title>
                <p>(<bold>A</bold>) Age distribution of subjects (22 subjects are sorted based on gene expression as shown in main <xref ref-type="fig" rid="fig7">Figure 7D and E</xref>. p=0.223). (<bold>B</bold>) Distribution of serum creatinine changes from baseline to peak levels (p=0.865). (<bold>C</bold>) Time from AKI diagnosis to renal biopsy (p=0.518). (D - E) Summary of documented microorganisms and infection source. See <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref> for detail.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig7-figsupp1"/>
            </fig>
          </p>
          <p content-type="supplemental-figure">
            <fig id="fig7s2" specific-use="child-fig" orientation="portrait" position="anchor">
              <label>Figure 7&#x2014;figure supplement 2.</label>
              <caption>
                <title>Serum biomarkers and chemokine/cytokine levels.</title>
                <p>(<bold>A</bold>) Serum creatinine levels at indicated time points after 5 mg/kg LPS i.v.&#xA0;n&#xA0;=&#xA0;3, *p&lt;0.05 vs other time points. (<bold>B, C</bold>) Serum cystatin C and NGAL levels. n&#xA0;=&#xA0;4. (<bold>D&#x2013;F</bold>) Comparison of serum chemokine/cytokine levels under indicated time points after 5 m/gkg LPS i.v. as determined by 32 multiplex assay (Milliplex, n&#xA0;=&#xA0;4 per time point). (<bold>G</bold>) Bulk kidney tissue chemokine/cytokine levels.</p>
              </caption>
              <graphic xlink:href="elife-62270-fig7-figsupp2"/>
            </fig>
          </p>
        </fig>
      </sec>
      <sec id="s2-8">
        <title>The murine endotoxemia timeline allows staging of human sepsis</title>
        <p>Finally, we asked whether our mouse endotoxemia timeline could be used to stratify human sepsis AKI. To this end, we selected the differentially expressed genes for each time point across the mouse endotoxemia timeline (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). We then examined the orthologues of these defining genes in human kidney biopsies of patients with the clinical diagnosis of sepsis and AKI (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). As shown in <xref ref-type="fig" rid="fig7">Figure 7D</xref>, our approach using the mouse data succeeded in partially stratifying the human biopsies into early, mid and late sepsis-related AKI (see also Materials&#xA0;and&#xA0;methods). The severity of clinical sepsis as determined by Sequential Organ Failure Assessment Score (SOFA) correlated well with the gene expression-based patient stratification (<xref ref-type="fig" rid="fig7">Figure 7E</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7&#x2014;figure supplement 1</xref>). For example, patients whose gene expression matched that of later time points in the murine endotoxemia timeline (e.g. recovery) had the lowest SOFA score. These findings suggest that underlying injury mechanisms are partially conserved, and the mouse timeline may be valuable in staging and defining biomarkers and therapeutics in human sepsis.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s3">
      <title>Discussion</title>
      <p>In this work, we provide comprehensive transcriptomic profiling of the kidney in a murine endotoxemia model. To our knowledge, this is the first description of spatial and temporal endotoxin-induced transcriptomic changes in the kidney that extend from early injury well into the recovery phase. Our data cover nearly all renal cell types and are time-anchored, thus providing a detailed and precise view of the evolution of endotoxemia in the kidney at the cellular and molecular levels.</p>
      <p>Using a combination of analytical approaches, we identified marked phenotypic changes in multiple cell populations in response to endotoxin. The proximal tubular S1 segment exhibited significant alterations consisting of early loss of traditional function-defining markers (e.g. transporters such as SGLT2). Such deranged expression of tubular transporters may explain the frequently observed alterations in water, electrolytes, acid base, and glucose homeostasis. Furthermore, the global cell&#x2013;cell communication failure likely underlies kidney shutdown that cannot be ascribed solely to hypoperfusion and ischemic injury (e.g. hyperdynamic sepsis). Concomitantly, we observed novel epithelial expression of immune-related genes such as those involved in antigen presentation. This indicates a dramatic switch in epithelial function from transport and homeostasis to immunity and defense. These phenotypic changes were reversible, underscoring the remarkable resilience and plasticity of the renal epithelium. Our data regarding loss of transport function and acquisition of immune-related functions have also been reported by others in bulk kidney tissue (<xref rid="bib40" ref-type="bibr">Tran et al., 2011</xref>). Despite the significant agreement between our data and these earlier studies, some differences were noted in the time course of these changes that may be related to different dosage of endotoxin and choice of time points. Our data extends these earlier studies in bulk tissue by providing spatial resolution at the single cell level. In addition, our combined analytical tools clearly identified unique subclusters within each epithelial cell population (e.g. cortical S3 and OS S3). These subclusters likely represent cell populations that may be in part influenced by the complex microenvironments in the kidney.</p>
      <p>Similarly, we also identified unique features in immune-cell populations. For example, the combined use of RNA velocity field and pseudotime analyses uncovered differences in macrophage subtypes relating to RNA kinetics and cell differentiation trajectories. Of note is that these subtypes only partially matched the traditional flow cytometry-based classification of macrophages (e.g. M1/M2). Therefore, the use of scRNA-seq is a powerful approach that will add to and complement our current understanding of the immune cell repertoire in the kidney.</p>
      <p>Additional approaches such as receptor-ligand crosstalk and gene regulatory network analyses identified unique cell- and time-dependent players involved in the pathophysiology of endotoxemia. Importantly, the expression of genes involved in vectorial transport, inflammation, vascular health, coagulation and complement cascades varied greatly along the endotoxemia timeline, and required simultaneous contributions from multiple cell types. However, these complex interactions collapsed at the 16 hr time point. This indeed is a remarkable juncture in the endotoxemia timeline that we have previously investigated in other models of murine sepsis including cecal ligation and puncture/CLP (<xref rid="bib17" ref-type="bibr">Hato et al., 2019</xref>). It is the time where profound translation failure and organ shutdown occur. Our current data point to massive cell-cell communication failure as a key feature of this time point. Surprisingly, it is also at this time point that reparative pathways started to emerge. It is thus a defining point in sepsis that may have significant clinical implications. For example, the recovery process begins at the time when traditional markers such as serum creatinine is still increasing (<xref ref-type="fig" rid="fig7s2">Figure 7&#x2014;figure supplement 2</xref>). Importantly, molecules involved in this recovery (e.g. Sox9) can be future targets at the bedside and thus have clinical potential to treat sepsis-associated AKI.</p>
      <p>Our work points to the urgent need for defining a more accurate and precise human sepsis timeline. Such definition will guide the development of biomarkers and therapies that are cell and time specific. In our data, the gene expression changes in murine endotoxemia did partially map to tissues from septic patients, thus allowing temporal stratification of human sepsis. These precisely time- and space-anchored data will provide the community with rich and comprehensive foundations that will propel further investigations into human sepsis.</p>
      <sec id="s3-1">
        <title>Limitations</title>
        <p>We recognize that endotoxemia and other murine models may not perfectly recapitulate human sepsis. Nevertheless, these models partially exhibit molecular similarities to various stages of human sepsis. Cecal ligation and puncture (CLP) may mimic human sepsis better than endotoxemia. However, CLP is a polymicrobial model that may be intractable at the molecular level. It carries very high mortality and is thus more useful for survival interventions. In contrast, endotoxemia is a well-defined ligand-receptor pathway that can be dissected with precision. With the endotoxin dose used in this study, it is also a reversible model that allows the investigation of recovery pathways. Another limitation of our study is the use of young healthy mice thus losing the contributions of age and comorbidities to the pathophysiology of sepsis.</p>
      </sec>
    </sec>
    <sec sec-type="materials|methods" id="s4">
      <title>Materials and methods</title>
      <table-wrap id="keyresource" orientation="portrait" position="anchor">
        <label>Key resources table</label>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th valign="top" rowspan="1" colspan="1">Reagent type <break/>(species) or resource</th>
              <th valign="top" rowspan="1" colspan="1">Designation</th>
              <th valign="top" rowspan="1" colspan="1">Source or reference</th>
              <th valign="top" rowspan="1" colspan="1">Identifiers</th>
              <th valign="top" rowspan="1" colspan="1">Additional information</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">RNAscope probe-Mm-Agt</td>
              <td valign="top" rowspan="1" colspan="1">Advance Cell Diagnosis</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. 426941</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">RNAscope probe-Mm-Aqp1</td>
              <td valign="top" rowspan="1" colspan="1">Advance Cell Diagnosis</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. 504741-C2</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">Milliplex MAP Mouse Cytokine/Chemokine Magnetic Bead Panel&#x2013;Premixed 32 Plex</td>
              <td valign="top" rowspan="1" colspan="1">Millipore</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. MCYTMAG-70K-PX32</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">Annexin V dead cell removal kit</td>
              <td valign="top" rowspan="1" colspan="1">Stem Cell Technologies</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. 17899</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">Multi-Tissue Dissociation Kit 2</td>
              <td valign="top" rowspan="1" colspan="1">Miltenyi Biotec</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. 130-110-203</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">Chromium Single Cell 3' Library and gel bead kit</td>
              <td valign="top" rowspan="1" colspan="1">10x Genomics</td>
              <td valign="top" rowspan="1" colspan="1">Cat. no. 1000121</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">NovaSeq 6000 S1 reagent kit</td>
              <td valign="top" rowspan="1" colspan="1">Illumina</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. 20012865</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial assay, kit</td>
              <td valign="top" rowspan="1" colspan="1">Visium Spatial Gene Expression library preparation slide</td>
              <td valign="top" rowspan="1" colspan="1">10x Genomics</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. 1000200</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Chemical compound, drug</td>
              <td valign="top" rowspan="1" colspan="1">Red blood cell lysing buffer Hybri-Max</td>
              <td valign="top" rowspan="1" colspan="1">Sigma</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. R7757</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Antibody</td>
              <td valign="top" rowspan="1" colspan="1">NFkB P65 (D14E12 rabbit monoclonal)</td>
              <td valign="top" rowspan="1" colspan="1">Cell Signaling</td>
              <td valign="top" rowspan="1" colspan="1">Cat. 8242S</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Chemical compound, drug</td>
              <td valign="top" rowspan="1" colspan="1">CldU</td>
              <td valign="top" rowspan="1" colspan="1">Sigma</td>
              <td valign="top" rowspan="1" colspan="1">Cat. C6891</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Strain, strain background (<italic>Escherichia coli</italic>)</td>
              <td valign="top" rowspan="1" colspan="1">LPS <italic>E. coli</italic> serotype o111:B4</td>
              <td valign="top" rowspan="1" colspan="1">Sigma</td>
              <td valign="top" rowspan="1" colspan="1">Cat. No. L2630 <break/>Lot No. 095M4163V</td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Biological samples</td>
              <td valign="top" rowspan="1" colspan="1">Human renal biopsy bulk AKI RNAseq data</td>
              <td valign="top" rowspan="1" colspan="1"/>
              <td valign="top" rowspan="1" colspan="1">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30507610">30507610</ext-link></td>
              <td valign="top" rowspan="1" colspan="1">GEO: GSE122274</td>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">Monocle</td>
              <td valign="top" rowspan="1" colspan="1">
                <xref rid="bib6" ref-type="bibr">Cao et al., 2019</xref>
              </td>
              <td valign="top" rowspan="1" colspan="1">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30787437">30787437</ext-link></td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">Seurat</td>
              <td valign="top" rowspan="1" colspan="1"><xref rid="bib39" ref-type="bibr">Stuart et al., 2019</xref>; <xref rid="bib4" ref-type="bibr">Butler et al., 2018</xref></td>
              <td valign="top" rowspan="1" colspan="1">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_016341">SCR_016341</ext-link></td>
              <td valign="top" rowspan="1" colspan="1">
                <ext-link ext-link-type="uri" xlink:href="https://satijalab.org/">https://satijalab.org/</ext-link>
              </td>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">SCENIC</td>
              <td valign="top" rowspan="1" colspan="1">
                <xref rid="bib1" ref-type="bibr">Aibar et al., 2017</xref>
              </td>
              <td valign="top" rowspan="1" colspan="1">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28991892">28991892</ext-link></td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">Cellphone DB</td>
              <td valign="top" rowspan="1" colspan="1"><xref rid="bib11" ref-type="bibr">Efremova et al., 2020</xref>; <xref rid="bib43" ref-type="bibr">Vento-Tormo et al., 2018</xref></td>
              <td valign="top" rowspan="1" colspan="1"/>
              <td valign="top" rowspan="1" colspan="1">
                <ext-link ext-link-type="uri" xlink:href="https://www.cellphonedb.org/">https://www.cellphonedb.org/</ext-link>
              </td>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">RNA velocity</td>
              <td valign="top" rowspan="1" colspan="1">
                <xref rid="bib26" ref-type="bibr">La Manno et al., 2018</xref>
              </td>
              <td valign="top" rowspan="1" colspan="1">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30089906">30089906</ext-link></td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">SingleR</td>
              <td valign="top" rowspan="1" colspan="1">
                <xref rid="bib3" ref-type="bibr">Aran et al., 2019</xref>
              </td>
              <td valign="top" rowspan="1" colspan="1">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30643263">30643263</ext-link></td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">Harmony and Palantir</td>
              <td valign="top" rowspan="1" colspan="1"><xref rid="bib33" ref-type="bibr">Nowotschin et al., 2019</xref>; <xref rid="bib37" ref-type="bibr">Setty et al., 2019</xref></td>
              <td valign="top" rowspan="1" colspan="1">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30959515">30959515</ext-link>
<break/>PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/30899105">30899105</ext-link></td>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Software, algorithm</td>
              <td valign="top" rowspan="1" colspan="1">R</td>
              <td valign="top" rowspan="1" colspan="1">R Project for Statistical Computing</td>
              <td valign="top" rowspan="1" colspan="1">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001905">SCR_001905</ext-link></td>
              <td valign="top" rowspan="1" colspan="1">
                <ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link>
              </td>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Commercial protocol</td>
              <td valign="top" rowspan="1" colspan="1">RNAscope multiplex Fluorescent Reagent Kit v2</td>
              <td valign="top" rowspan="1" colspan="1">Advance Cell Diagnosis Inc</td>
              <td valign="top" rowspan="1" colspan="1"/>
              <td valign="top" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Other</td>
              <td valign="top" rowspan="1" colspan="1">Dead cell removal protocol using Annexin V</td>
              <td valign="top" rowspan="1" colspan="1">
                <ext-link ext-link-type="uri" xlink:href="https://cdn.stemcell.com/media/files/pis/DX21956-PIS_1_0_1.pdf?_ga=2.34218465.1547447083.1547219505%E2%80%93776976877.1534951026">https://cdn.stemcell.com/media/files/pis/DX21956-PIS_1_0_1.pdf?_ga=2.34218465.1547447083.1547219505%E2%80%93776976877.1534951026</ext-link>
              </td>
              <td valign="top" rowspan="1" colspan="1"/>
              <td valign="top" rowspan="1" colspan="1">Commercial protocol</td>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Other</td>
              <td valign="top" rowspan="1" colspan="1">Chromium Single Cell 3&#x2019; Reagent Kits V3 User Guide</td>
              <td valign="top" rowspan="1" colspan="1">
                <ext-link ext-link-type="uri" xlink:href="https://assets.ctfassets.net/an68im79xiti/51xGuiJhVKOeIIceW88gsQ/1db2c9b5c9283d183ff4599fb489a720/CG000183_ChromiumSingleCell3__v3_UG_Rev-A.pdf">https://assets.ctfassets.net/an68im79xiti/51xGuiJhVKOeIIceW88gsQ/1db2c9b5c9283d183ff4599fb489a720/CG000183_ChromiumSingleCell3__v3_UG_Rev-A.pdf</ext-link>
              </td>
              <td valign="top" rowspan="1" colspan="1"/>
              <td valign="top" rowspan="1" colspan="1">Commercial protocol</td>
            </tr>
            <tr>
              <td valign="top" rowspan="1" colspan="1">Other</td>
              <td valign="top" rowspan="1" colspan="1">Dissociation of mouse kidney using the Multi Tissue Dissociation Kit 2</td>
              <td valign="top" rowspan="1" colspan="1">
                <ext-link ext-link-type="uri" xlink:href="https://www.miltenyibiotec.com/upload/assets/IM0015569.PDF">https://www.miltenyibiotec.com/upload/assets/IM0015569.PDF</ext-link>
              </td>
              <td valign="top" rowspan="1" colspan="1"/>
              <td valign="top" rowspan="1" colspan="1">Commercial protocol</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <sec id="s4-1">
        <title>Experimental model and subject details</title>
        <p>Animal model: Male C57BL/6J mice were obtained from the Jackson Laboratory. Mice were 8&#x2013;10 weeks of age and weighed 20&#x2013;25 g. They were subjected to a single dose of 5 mg/kg LPS tail vein injection <italic>E. coli</italic> serotype 0111:B4 Sigma. This dose of endotoxin carries no mortality and results in rapid induction of cytokines/chemokines and causes <italic>reversible AKI</italic> as shown by serum creatinine (<xref ref-type="fig" rid="fig7s2">Figure 7&#x2014;figure supplement 2</xref>). Animals were sacrificed at 0, 1, 4, 16, 27, 36, and 48 hr after LPS (both kidneys per animal for each time point).</p>
      </sec>
      <sec id="s4-2">
        <title>Study approval</title>
        <p>All animal protocols were approved by the Indiana University Institutional Animal Care Committee and conform to the NIH (<italic>Guide for the Care and Use of Laboratory Animals</italic>, National Academies Press, 2011). The study in humans was approved by the Indiana University Institutional Review Board (protocol no. 1601431846). As only archived human biopsies were used in this study, the Institutional Review Board determined that informed consent was not required.</p>
      </sec>
      <sec id="s4-3">
        <title>Isolation of single cell homogenate from murine kidneys</title>
        <p>Murine kidneys were transported in RPMI1640 (Corning), on ice immediately after surgical procurement. Kidneys were rinsed with PBS and minced into eight sections. Each sample was then enzymatically and mechanically digested for 30 min (Multi-Tissue Dissociation Kit two and GentleMACS dissociator/tube rotator, Miltenyi Biotec). The samples were prepared per protocol &#x2018;Dissociation of mouse kidney using the Multi Tissue Dissociation Kit 2&#x2019; with the following modifications: After termination of the program &#x2018;Multi_E_2&#x2019;, we added 10 mL RPMI1640 (Corning) and 10% BSA (Sigma-Aldrich) to the mixture, filtered and homogenate was centrifuged (300 g for 5 min at 4&#xB0;C). The cell pellet was resuspended in 1 mL of RBC lysis buffer (Sigma), incubated on ice for 3 min, and cell pellet washed three times (300 g for 5 min at 4&#xB0;C). Annexin V dead cell removal (Stem Cell Technologies) was performed using magnetic bead separation after final wash, and the pellet resuspended in RPMI1640/BSA 0.04%. Viability and counts were assessed using Trypan blue (Gibco) and brought to a final concentration of 1 million cells/mL, exceeding 80% viability as specified by 10x Genomics processing platform.</p>
      </sec>
      <sec id="s4-4">
        <title>Single cell library preparation</title>
        <p>The sample was targeted to 10,000 cell recovery and applied to a single cell master mix with lysis buffer and reverse transcription reagents, following the Chromium Single Cell 3&#x2019; Reagent Kits V3 User Guide, CG000183 Rev A (10X Genomics). This was followed by cDNA synthesis and library preparation. All libraries were sequenced in Illumina NovaSeq6000 platform in paired-end mode (28 bp + 91 bp). Fifty thousand reads per cell were generated and 91% of the sequencing reads reached Q30 (99.9% base call accuracy). The total number of recovered cells for all time points was 63,287 cells, and per experiment was 9191 (0 hr), 9460 (1 hr), 9865 (4 hr), 5165 (16 hr), 7678 (27 hr), 10,119 (36 hr), and 11,809 (48 hr after LPS).</p>
      </sec>
      <sec id="s4-5">
        <title>Single cell data processing</title>
        <p>The 10x Genomics Cellranger (v. 2.1.0) pipeline was utilized to demultiplex raw base call files to FASTQ files and reads aligned to the mm10 murine genome using STAR (<xref rid="bib10" ref-type="bibr">Dobin et al., 2013</xref>). Cellranger computational output was then analyzed in R (v.3.5.0) using the Seurat package v. 3.0.1 (<xref rid="bib39" ref-type="bibr">Stuart et al., 2019</xref>). Seurat objects were created for non-integrated and integrated (inclusive of all time points) using the following filtering metrics: gene counts were set between 200&#x2013;3000 and mitochondrial gene percentages less than 50 to exclude doublets and poor quality cells. Gene counts were log transformed and scaled to 10<sup>4</sup>. The top 20 principal components were used to perform unsupervised clustering analysis, and visualized using UMAP dimensionality reduction (resolution 1.0). Using the Seurat package, annotation and grouping of clusters to cell type was performed manually by inspection of differentially expressed genes (DEGs) for each cluster, based on canonical marker genes in the literature (<xref rid="bib24" ref-type="bibr">Kretzler and Ju, 2015</xref>; <xref rid="bib27" ref-type="bibr">Lake et al., 2019</xref>; <xref rid="bib29" ref-type="bibr">Lee et al., 2015</xref>; <xref rid="bib34" ref-type="bibr">Park et al., 2018</xref>; <xref rid="bib45" ref-type="bibr">Wu et al., 2018</xref>). In some experiments, we used edgeR negative binomial regression to model gene counts and performed differential gene expression and pathway enrichment analyses (topKEGG, topGO, <xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5&#x2014;figure supplement 1A</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5&#x2014;figure supplement 2</xref>, and DAVID 6.8, <xref ref-type="fig" rid="fig7">Figure 7B</xref>). (<xref rid="bib2" ref-type="bibr">Alessandr&#xEC; et al., 2019</xref>; <xref rid="bib20" ref-type="bibr">Huang et al., 2009</xref>).</p>
        <p>The immune cell subset was derived from the filtered, integrated Seurat object. UMAP resolution was set to 0.4, which yielded 14 clusters. The clusters were manually assigned based on inspection of DEGs for each cluster, and cells grouped if canonical markers were biologically redundant. We confirmed manual labeling with an automated labeling program in R, SingleR (<xref rid="bib3" ref-type="bibr">Aran et al., 2019</xref>).</p>
        <p>To compare our scRNA-seq data against publicly available bulk kidney array data (GSE30576), affymetrix ID was converted to Gene Name and those without a match were discarded. edgeRs glmQLFTest was used to generate comparisons for each individual one-to-one group comparison within the samples. In scRNA-seq data, pseudobulk kidneys were generated by randomly selecting 2000 cells from each condition as a group (seed 999) followed by one-to-one group comparison. The output of these comparisons were DE gene lists which were sorted by FDR. These lists were split into those in which the logFC was positive or negative and the top 500 genes were extracted. Jaccard heatmaps were generated by using the gene lists from each condition comparison to find the number of shared genes for each condition and generating a Jaccard index using hclust complete method.</p>
      </sec>
      <sec id="s4-6">
        <title>Upstream regulatory network analysis</title>
        <p>SCENIC analysis (<xref rid="bib1" ref-type="bibr">Aibar et al., 2017</xref>) was performed using the default setting and mm9-500bp-upstream-7species.mc9nr.feather database was used for data display.</p>
      </sec>
      <sec id="s4-7">
        <title>Pseudotemporal ordering of single cells</title>
        <p>We performed pseudotime analysis on the integrated Seurat object containing all cell types as well as the immune cell subset. Cells from each of the seven time points were included and were split into individual gene expression data files organized by previously defined cell type. These individual datasets were analyzed separately through the R package Monocle using default parameters. Outputs were obtained detailing the pseudotime cell distributions for each cell type. Positional information for the monocle plot was used to subset and color cells for downstream analyses (<xref rid="bib41" ref-type="bibr">Trapnell et al., 2014</xref>). We performed a separate temporal ordering analysis of S1, S2, and S3 proximal tubule segments across all time points and visualized using t-SNE, produced by Harmony and Palantir R packages (<xref rid="bib37" ref-type="bibr">Setty et al., 2019</xref>).</p>
      </sec>
      <sec id="s4-8">
        <title>RNA velocity analysis</title>
        <p>BAM files were fed through the velocyto pipeline (<xref rid="bib26" ref-type="bibr">La Manno et al., 2018</xref>) to obtain. loom files for each experimental condition. These loom files along with their associated UMAP positions and principal component tables extracted from the merged Seurat file were then fed individually into the RNA Velocity pipeline as described in the Velocyto.R Dentate Gyrus/loom tutorial. The default settings described in the tutorial were used except for tSNE positions that were overwritten with the associated UMAP positions from the merged Seurat object, as well as the principal component table. This generated an RNA velocity figure mapped using the merged Seurat object cell positions. Similar analysis was done for the immune subsetted data.</p>
      </sec>
      <sec id="s4-9">
        <title>Cell&#x2013;cell communication analysis</title>
        <p>We applied the Cellphone database (<xref rid="bib11" ref-type="bibr">Efremova et al., 2020</xref>) of known receptor-ligand pairs to assess cell&#x2013;cell communication in our integrated dataset. Gene expression data from the integrated Seurat file was split by time point and genes renamed to Human gene names then reformatted into the input format described on the CellphoneDB website. Individual time point samples were fed into the web document on the cellphone dB website using 50 iterations, precision of 3, and 0.1 ratio of cells in a cluster expressing a gene. Output files for each time point obtained from the website were merged, then interactions trimmed based on significant sites and only selecting secreted interactions.</p>
        <p>To visualize cellular cross talk, we applied this data to a circular plot. The interactions from the merged, trimmed cellphone dB file were sorted by cluster interaction then consolidated into 17 final cell types. Each cell type contained a list of significant interacting pairs (with p&lt;0.05) and their associated strength values (the larger the value the smaller the p value). These were then visualized using R Circlize package (<xref rid="bib13" ref-type="bibr">Gu et al., 2014</xref>).</p>
      </sec>
      <sec id="s4-10">
        <title>Human sepsis staging</title>
        <p>To determine time-defining murine DEGs, we randomly selected 2000 cells for every time point from all clusters and normalized the data using edgeR function calcNormFactors. DEGs were determined between one time point versus all others and significant genes filtered by selecting for FDR&#xA0;&lt;&#xA0;0.05 (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Human specimens were derived from OCT cores of kidney biopsy or nephrectomy samples (GSE139061). All biopsy specimens (N&#xA0;=&#xA0;22) had a primary pathology diagnosis of AKI and were acquired in clinical care of patients with a diagnosis of sepsis (<xref rid="bib17" ref-type="bibr">Hato et al., 2019</xref>). Some of the reference nephrectomies were obtained from University of Michigan through the Kidney Precision Medicine Project. These reference nephrectomies were from unaffected portions of tumor nephrectomies or deceased donors. A bulk 20 &#xB5;m cross-section was cut from each OCT core and RNA was extracted using the Arcturus Picopure extraction kit (KIT0214). Libraries were prepared with the Takara SMARTer Stranded Total RNA-Seq Kit v2 Pico Input. Sequencing was performed on an Illumina HiSeq 4000. The murine genes from each time point were translated to their respective human orthologues using the biomaRt package and ensembl database. Each gene had its expression fold change calculated for each time point in relation to all other time points in the mouse. Separately for each human biopsy specimen, the expression of each gene was calculated as a fold change compared to the mean of all reference samples (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). A spearman correlation assessed alignment between the fold changes of the mouse and human data. Data were displayed as a heatmap. The genes used to generate the heatmap are shown in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>.</p>
      </sec>
      <sec id="s4-11">
        <title>Spatial transcriptomics</title>
        <p>A mouse kidney was immediately frozen in Optimal Cutting Temperature media. A 10 &#xB5;m frozen tissue section was cut and affixed to a Visium Spatial Gene Expression library preparation slide (10X Genomics). The specimen was fixed in methanol and stained with hematoxylin-eosin reagents. Images of hematoxylin-eosin-labeled tissues were collected as mosaics of 10x fields using a Keyence BZ-X810 fluorescence microscope equipped with a Nikon 10X CFI Plan Fluor objective. The tissue was then permeabilized for 12 min and RNA was isolated. The cDNA libraries were prepared and then sequenced on an Illumina NovaSeq 6000. Using Seurat 3.1.4, we identified anchors between the integrated single cell object and the spatial transcriptomics datasets and used those to transfer the cluster data from the single cell to the spatial transcriptomics. For each spatial transcriptomics spot, this transfer assigns a score to each single cell cluster. We selected the cluster with the highest score in each spot to represent its single cell associated cluster. Using a Loupe Browser, expression data was visualized overlying the hematoxylin-eosin image.</p>
      </sec>
      <sec id="s4-12">
        <title>Single-molecule RNA in situ hybridization</title>
        <p>Formalin-fixed paraffin-embedded cross sections were prepared with a thickness of 5 &#xB5;m. The slides were baked for 60 min at 60&#xB0;C. Tissues were incubated with Xylene for 5 min x2, 100% ETOH for 2 min x2, and dried at room temperature. RNA in situ hybridization was performed using RNAscope multiplex Fluorescent Reagent Kit v2 (Advance Cell Diagnosis Inc) as per the manufacturer instructions. Probe sets were obtained from Advance Cell Diagnosis Inc (murine Agt Cat. No. 426941, Aqp1 Cat. No. 504741-C2). TSA Cyanine 3 Plus and Fluorescein Plus Evaluation kit (PerkinElmer, Inc) was used as secondary probes for the detection of RNA signals. All slides were counterstained with DAPI and coverslips were mounted using fluorescent mounting media (ProLong Gold Antifade Reagent, Life Technologies). The images were collected with a LSM800 confocal microscope (Carl Zeiss).</p>
      </sec>
      <sec id="s4-13">
        <title>In vivo thiamine analog labeling</title>
        <p>Animals were injected with CldU (Sigma) 50 &#xB5;g/g i.p. twice before harvesting the kidney tissues (&#x2212;12 hr and &#x2212;2 hr). Fixed tissues were deparaffinized and stained with rat anti-BrdU antibody, which binds to CldU (BU1/72, Abcam ab6326).</p>
      </sec>
      <sec id="s4-14">
        <title>Cytokine/chemokine multiplex</title>
        <p>Analysis of serum and kidney homogenate cytokines/chemokines was performed using Milliplex MAP Mouse Cytokine/Chemokine Magnetic Bead Panel&#x2013;Premixed 32 Plex (MCYTMAG-70K-PX32; Millipore). Kidney tissue proteins were extracted with RIPA buffer, and total protein concentrations were adjusted to 0.4 &#x3BC;g/&#x3BC;l per well according to the manufacturer&#x2019;s instructions. Analysis was performed by the Multiplex Analysis Core at Indiana University.</p>
      </sec>
      <sec id="s4-15">
        <title>Immunohistochemistry</title>
        <p>Kidney tissues were fixed with 4% paraformaldehyde, deparaffinized and 5 &#xB5;m sections cut. Low pH antigen retrieval was performed and tissue was stained for NF-&#x3BA;B p65 (D14E12 rabbit monoclonal, 1:800 dilution, Cell Signaling 8242S), envision+ rabbit DAB chromogen detection system (Dako) was used. Images were collected using Keyence BZ-X810 microscope.</p>
      </sec>
      <sec id="s4-16">
        <title>Quantification and statistical analysis</title>
        <p>No blinding was used for animal experiments. All data were analyzed using R software packages, with relevant statistics described in results, methods and figure legends.</p>
      </sec>
      <sec sec-type="data-availability" id="s4-17">
        <title>Data availability</title>
        <p>The scRNA-seq data and Visium spatial transcriptomics data were deposited in the NCBI&#x2019;s Gene Expression Omnibus database (GEO GSE151658, GSE154107).</p>
        <p>Scripts are available through GitHub:&#xA0;<ext-link ext-link-type="uri" xlink:href="https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-featureplot">https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-featureplot</ext-link>&#xA0;(<xref rid="bib31" ref-type="bibr">McCarthy, 2020</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:c1402a9e87a2c0949b2e2a57925a2023a1028dae;origin=https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-featureplot;visit=swh:1:snp:aedc6f0707a011aaa0c267c5f53a5e08ccdba76e;anchor=swh:1:rev:2e4dde0759965ce51220bdb5d76dcd4da0c528be/">swh:1:rev:2e4dde0759965ce51220bdb5d76dcd4da0c528be</ext-link>)&#xA0;and&#xA0;<ext-link ext-link-type="uri" xlink:href="https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-CellphoneDB-CirclePlot">https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-CellphoneDB-CirclePlot</ext-link>&#xA0;(<xref rid="bib32" ref-type="bibr">Myslinski, 2020</xref>; copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:52c9f383a40029c7e6b5152a46c412697b85fa81;origin=https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-CellphoneDB-CirclePlot;visit=swh:1:snp:6e538690a1dfba10a8c7345dc92446f6789a3b01;anchor=swh:1:rev:b2e0e84daaae3846d2f2eaa57376080fee8954f9/">swh:1:rev:b2e0e84daaae3846d2f2eaa57376080fee8954f9</ext-link>).</p>
      </sec>
    </sec>
  </body>
  <back>
    <sec sec-type="funding-information">
      <title>Funding Information</title>
      <p>This paper was supported by the following grants:</p>
      <list list-type="bullet">
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source>
<award-id>K08-DK113223</award-id> to Takashi Hato.</p>
        </list-item>
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source>
<award-id>R01-DK080063</award-id> to Pierre C Dagher.</p>
        </list-item>
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source>
<award-id>K08-DK107864</award-id> to Michael T Eadon.</p>
        </list-item>
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000738</institution-id><institution>U.S. Department of Veterans Affairs</institution></institution-wrap></funding-source>
<award-id>1I01BX002901</award-id> to Pierre C Dagher.</p>
        </list-item>
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006975</institution-id><institution>Indiana Clinical and Translational Sciences Institute</institution></institution-wrap></funding-source>
<award-id>UL1TR002529</award-id> to Danielle Janosevic.</p>
        </list-item>
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source>
<award-id>T32DK120524</award-id> to Danielle Janosevic.</p>
        </list-item>
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source>
<award-id>R01-AI148282</award-id> to Takashi Hato.</p>
        </list-item>
        <list-item>
          <p><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006975</institution-id><institution>Indiana Clinical and Translational Sciences Institute</institution></institution-wrap></funding-source>
<award-id>T32HL091816</award-id> to Danielle Janosevic.</p>
        </list-item>
      </list>
    </sec>
    <ack id="ack">
      <title>Acknowledgements</title>
      <p>We thank the Kidney Precision Medicine Project for making data available from human kidney reference nephrectomy specimens. We thank Daria Barwinska, Constance Temm and Connor Gulbronson for assistance with specimen validation, tissue staining and imaging. Measurement of serum creatinine concentration was performed by John Moore, Yang Yan, et al. at the University of Alabama at Birmingham/UCSD O&#x2019;Brien Center Core for Acute Kidney Injury Research (NIH P30DK079337) using isotope dilution liquid chromatography&#x2013;tandem mass spectrometry. This work was supported by NIH K08-DK113223 and R01-AI148282 to TH, NIH R01-DK080063 and Veterans Affairs Merit (1I01B &#xD7; 002901) to PCD, K08-DK107864 to MTE, the Indiana Clinical and Translational Sciences Institute (UL1TR002529), T32HL091816 and T32DK120524 to DJ.</p>
    </ack>
    <sec id="s5" sec-type="additional-information">
      <title>Additional information</title>
      <fn-group content-type="competing-interest">
        <title>
          <bold>Competing interests</bold>
        </title>
        <fn fn-type="COI-statement" id="conf1">
          <p>No competing interests declared.</p>
        </fn>
      </fn-group>
      <fn-group content-type="author-contribution">
        <title>
          <bold>Author contributions</bold>
        </title>
        <fn fn-type="con" id="con1">
          <p>Data curation, Formal analysis, Funding acquisition, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing.</p>
        </fn>
        <fn fn-type="con" id="con2">
          <p>Formal analysis, Visualization.</p>
        </fn>
        <fn fn-type="con" id="con3">
          <p>Software, Formal analysis, Visualization.</p>
        </fn>
        <fn fn-type="con" id="con4">
          <p>Data curation, Investigation.</p>
        </fn>
        <fn fn-type="con" id="con5">
          <p>Investigation.</p>
        </fn>
        <fn fn-type="con" id="con6">
          <p>Data curation.</p>
        </fn>
        <fn fn-type="con" id="con7">
          <p>Data curation.</p>
        </fn>
        <fn fn-type="con" id="con8">
          <p>Data curation, Methodology.</p>
        </fn>
        <fn fn-type="con" id="con9">
          <p>Data curation.</p>
        </fn>
        <fn fn-type="con" id="con10">
          <p>Data curation.</p>
        </fn>
        <fn fn-type="con" id="con11">
          <p>Data curation.</p>
        </fn>
        <fn fn-type="con" id="con12">
          <p>Data curation.</p>
        </fn>
        <fn fn-type="con" id="con13">
          <p>Data curation.</p>
        </fn>
        <fn fn-type="con" id="con14">
          <p>Formal analysis.</p>
        </fn>
        <fn fn-type="con" id="con15">
          <p>Data curation, Funding acquisition.</p>
        </fn>
        <fn fn-type="con" id="con16">
          <p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing.</p>
        </fn>
        <fn fn-type="con" id="con17">
          <p>Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing.</p>
        </fn>
      </fn-group>
      <fn-group content-type="ethics-information">
        <title>
          <bold>Ethics</bold>
        </title>
        <fn fn-type="other">
          <p>Human subjects: The study in humans was approved by the Indiana University Institutional Review Board (protocol no. 1601431846). As only archived human biopsies were used in this study, the Institutional Review Board determined that informed consent was not required.</p>
        </fn>
        <fn fn-type="other">
          <p>Animal experimentation: All animal protocols were approved by the Indiana University Institutional Animal Care Committee and conform to the NIH (Guide for the Care and Use of Laboratory Animals, National Academies Press, 2011).</p>
        </fn>
      </fn-group>
    </sec>
    <sec id="s6" sec-type="supplementary-material">
      <title>Additional files</title>
      <supplementary-material content-type="local-data" id="supp1">
        <label>Supplementary file 1.</label>
        <caption>
          <title>Cluster-defining markers.</title>
        </caption>
        <media mime-subtype="xlsx" mimetype="application" xlink:href="elife-62270-supp1.xlsx" orientation="portrait" id="d39e1956" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="supp2">
        <label>Supplementary file 2.</label>
        <caption>
          <title>Receptor-ligand interaction.</title>
        </caption>
        <media mime-subtype="xlsx" mimetype="application" xlink:href="elife-62270-supp2.xlsx" orientation="portrait" id="d39e1963" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="supp3">
        <label>Supplementary file 3.</label>
        <caption>
          <title>SCENIC regulon activity.</title>
        </caption>
        <media mime-subtype="xlsx" mimetype="application" xlink:href="elife-62270-supp3.xlsx" orientation="portrait" id="d39e1970" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="supp4">
        <label>Supplementary file 4.</label>
        <caption>
          <title>Differentially expressed genes for each time point across the mouse endotoxemia timeline.</title>
        </caption>
        <media mime-subtype="xlsx" mimetype="application" xlink:href="elife-62270-supp4.xlsx" orientation="portrait" id="d39e1977" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="supp5">
        <label>Supplementary file 5.</label>
        <caption>
          <title>Human kidney biopsy data.</title>
        </caption>
        <media mime-subtype="xlsx" mimetype="application" xlink:href="elife-62270-supp5.xlsx" orientation="portrait" id="d39e1984" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="supp6">
        <label>Supplementary file 6.</label>
        <caption>
          <title>Human kidney biopsy data: genes used for generating <xref ref-type="fig" rid="fig7">Figure 7D</xref> heatmap.</title>
        </caption>
        <media mime-subtype="xlsx" mimetype="application" xlink:href="elife-62270-supp6.xlsx" orientation="portrait" id="d39e1994" position="anchor"/>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="transrepform">
        <label>Transparent reporting form</label>
        <media mime-subtype="pdf" mimetype="application" xlink:href="elife-62270-transrepform.pdf" orientation="portrait" id="d39e1998" position="anchor"/>
      </supplementary-material>
    </sec>
    <sec id="s7" sec-type="data-availability">
      <title>Data availability</title>
      <p>The scRNA-seq data and spatial transcriptomics data have been deposited in the NCBI's Gene Expression Omnibus database (GEO GSE151658, GSE154107). We also provide interactive websites: <ext-link ext-link-type="uri" xlink:href="https://connect.rstudio.iu.edu/content/18/">https://connect.rstudio.iu.edu/content/18/</ext-link>
<ext-link ext-link-type="uri" xlink:href="https://connect.rstudio.iu.edu/content/19/">https://connect.rstudio.iu.edu/content/19/</ext-link> Scripts are available through GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-featureplot">https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-featureplot</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:2e4dde0759965ce51220bdb5d76dcd4da0c528be/">https://archive.softwareheritage.org/swh:1:rev:2e4dde0759965ce51220bdb5d76dcd4da0c528be/</ext-link>) and <ext-link ext-link-type="uri" xlink:href="https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-CellphoneDB-CirclePlot">https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-CellphoneDB-CirclePlot</ext-link> (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:rev:b2e0e84daaae3846d2f2eaa57376080fee8954f9/">https://archive.softwareheritage.org/swh:1:rev:b2e0e84daaae3846d2f2eaa57376080fee8954f9/</ext-link>).</p>
      <p>The following datasets were generated:</p>
      <p>
        <element-citation publication-type="data" id="dataset1">
          <person-group person-group-type="author">
            <name>
              <surname>Janosevic</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year iso-8601-date="2020">2020</year>
          <data-title>The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline</data-title>
          <source>NCBI Gene Expression Omnibus</source>
          <pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE151658">GSE151658</pub-id>
        </element-citation>
      </p>
      <p>
        <element-citation publication-type="data" id="dataset2">
          <person-group person-group-type="author">
            <name>
              <surname>Eadon</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Janosevic</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year iso-8601-date="2020">2020</year>
          <data-title>The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline</data-title>
          <source>NCBI Gene Expression Omnibus</source>
          <pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE154107">GSE154107</pub-id>
        </element-citation>
      </p>
      <p>The following previously published dataset was used:</p>
      <p>
        <element-citation publication-type="data" id="dataset3">
          <person-group person-group-type="author">
            <name>
              <surname>Eadon</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <year iso-8601-date="2019">2019</year>
          <data-title>Transcriptomic signatures of kidney injury in human renal biopsy specimens</data-title>
          <source>NCBI Gene Expression Omnibus</source>
          <pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE139061">GSE139061</pub-id>
        </element-citation>
      </p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aibar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gonz&#xE1;lez-Blas</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Moerman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Huynh-Thu</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Imrichova</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hulselmans</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rambow</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Marine</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Geurts</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aerts</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>van den Oord</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Atak</surname>
              <given-names>ZK</given-names>
            </name>
            <name>
              <surname>Wouters</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Aerts</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <year>2017</year>
          <article-title>SCENIC: single-cell regulatory network inference and clustering</article-title>
          <source>Nature Methods</source>
          <volume>14</volume>
          <fpage>1083</fpage>
          <lpage>1086</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4463</pub-id>
          <pub-id pub-id-type="pmid">28991892</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alessandr&#xEC;</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Arigoni</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Calogero</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Differential expression analysis in Single-Cell transcriptomics</article-title>
          <source>Methods in Molecular Biology</source>
          <volume>1979</volume>
          <fpage>425</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-4939-9240-9_25</pub-id>
          <pub-id pub-id-type="pmid">31028652</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aran</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Looney</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fong</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chak</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Naikawadi</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Wolters</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Abate</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Butte</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Bhattacharya</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage</article-title>
          <source>Nature Immunology</source>
          <volume>20</volume>
          <fpage>163</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="doi">10.1038/s41590-018-0276-y</pub-id>
          <pub-id pub-id-type="pmid">30643263</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smibert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
          <source>Nature Biotechnology</source>
          <volume>36</volume>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
          <pub-id pub-id-type="pmid">29608179</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cusanovich</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Ramani</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Aghamirzaie</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pliner</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Daza</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>McFaline-Figueroa</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Packer</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Christiansen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Steemers</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Adey</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Trapnell</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shendure</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Joint profiling of chromatin accessibility and gene expression in thousands of single cells</article-title>
          <source>Science</source>
          <volume>361</volume>
          <fpage>1380</fpage>
          <lpage>1385</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aau0730</pub-id>
          <pub-id pub-id-type="pmid">30166440</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Spielmann</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ibrahim</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Hill</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Mundlos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Christiansen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Steemers</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Trapnell</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shendure</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>The single-cell transcriptional landscape of mammalian organogenesis</article-title>
          <source>Nature</source>
          <volume>566</volume>
          <fpage>496</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-0969-x</pub-id>
          <pub-id pub-id-type="pmid">30787437</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clark</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Knepper</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Representation and relative abundance of cell-type selective markers in whole-kidney RNA-Seq data</article-title>
          <source>Kidney International</source>
          <volume>95</volume>
          <fpage>787</fpage>
          <lpage>796</lpage>
          <pub-id pub-id-type="doi">10.1016/j.kint.2018.11.028</pub-id>
          <pub-id pub-id-type="pmid">30826016</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Denisenko</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hou</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>de Kock</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Lassmann</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Poppe</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cl&#xE9;ment</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Lister</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Forrest</surname>
              <given-names>ARR</given-names>
            </name>
          </person-group>
          <year>2020</year>
          <article-title>Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows</article-title>
          <source>Genome Biology</source>
          <volume>21</volume>
          <elocation-id>130</elocation-id>
          <pub-id pub-id-type="doi">10.1186/s13059-020-02048-6</pub-id>
          <pub-id pub-id-type="pmid">32487174</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deutschman</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Tracey</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <year>2014</year>
          <article-title>Sepsis: current dogma and new perspectives</article-title>
          <source>Immunity</source>
          <volume>40</volume>
          <fpage>463</fpage>
          <lpage>475</lpage>
          <pub-id pub-id-type="doi">10.1016/j.immuni.2014.04.001</pub-id>
          <pub-id pub-id-type="pmid">24745331</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dobin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Schlesinger</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Drenkow</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zaleski</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Batut</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Chaisson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gingeras</surname>
              <given-names>TR</given-names>
            </name>
          </person-group>
          <year>2013</year>
          <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>
          <source>Bioinformatics</source>
          <volume>29</volume>
          <fpage>15</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
          <pub-id pub-id-type="pmid">23104886</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Efremova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vento-Tormo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Teichmann</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Vento-Tormo</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <year>2020</year>
          <article-title>CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes</article-title>
          <source>Nature Protocols</source>
          <volume>15</volume>
          <fpage>1484</fpage>
          <lpage>1506</lpage>
          <pub-id pub-id-type="doi">10.1038/s41596-020-0292-x</pub-id>
          <pub-id pub-id-type="pmid">32103204</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gottschalk</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kurts</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <year>2015</year>
          <article-title>The debate about dendritic cells and macrophages in the kidney</article-title>
          <source>Frontiers in Immunology</source>
          <volume>6</volume>
          <elocation-id>435</elocation-id>
          <pub-id pub-id-type="doi">10.3389/fimmu.2015.00435</pub-id>
          <pub-id pub-id-type="pmid">26388867</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Eils</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Schlesner</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Brors</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <year>2014</year>
          <article-title>Circlize implements and enhances circular visualization in R</article-title>
          <source>Bioinformatics</source>
          <volume>30</volume>
          <fpage>2811</fpage>
          <lpage>2812</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btu393</pub-id>
          <pub-id pub-id-type="pmid">24930139</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guillerey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mouri&#xE8;s</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Polo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Doyen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Law</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kastner</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Leclerc</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dadaglio</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <year>2012</year>
          <article-title>Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice</article-title>
          <source>Blood</source>
          <volume>120</volume>
          <fpage>90</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2012-02-410936</pub-id>
          <pub-id pub-id-type="pmid">22611152</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Winfree</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kalakeche</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Dube</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yoshimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Plotkin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Dagher</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <year>2015</year>
          <article-title>The macrophage mediates the renoprotective effects of endotoxin preconditioning</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>26</volume>
          <fpage>1347</fpage>
          <lpage>1362</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2014060561</pub-id>
          <pub-id pub-id-type="pmid">25398784</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zollman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Plotkin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>El-Achkar</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Maier</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Pay</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Dube</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cabral</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Yoshimoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McClintick</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dagher</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Endotoxin preconditioning reprograms S1 tubules and macrophages to protect the kidney</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>29</volume>
          <fpage>104</fpage>
          <lpage>117</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2017060624</pub-id>
          <pub-id pub-id-type="pmid">29018138</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Maier</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Syed</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Myslinski</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zollman</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Plotkin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Eadon</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Dagher</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Bacterial Sepsis triggers an antiviral response that causes translation shutdown</article-title>
          <source>Journal of Clinical Investigation</source>
          <volume>129</volume>
          <fpage>296</fpage>
          <lpage>309</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI123284</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hemann</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Turnbull</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Langlois</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Savan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gale</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Interferon-&#x3BB; modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus</article-title>
          <source>Nature Immunology</source>
          <volume>20</volume>
          <fpage>1035</fpage>
          <lpage>1045</lpage>
          <pub-id pub-id-type="doi">10.1038/s41590-019-0408-z</pub-id>
          <pub-id pub-id-type="pmid">31235953</pub-id>
        </element-citation>
      </ref>
      <ref id="bib19">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higgins</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>De Ceunynck</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kellum</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Chaudhry</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Schulman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Libermann</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shapiro</surname>
              <given-names>NI</given-names>
            </name>
            <name>
              <surname>Christiani</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Flaumenhaft</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Parikh</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Tie2 protects the vasculature against Thrombus formation in systemic inflammation</article-title>
          <source>Journal of Clinical Investigation</source>
          <volume>128</volume>
          <fpage>1471</fpage>
          <lpage>1484</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI97488</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>daW</given-names>
            </name>
            <name>
              <surname>Sherman</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Lempicki</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <year>2009</year>
          <article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title>
          <source>Nucleic Acids Research</source>
          <volume>37</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id>
          <pub-id pub-id-type="pmid">19033363</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huen</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Cantley</surname>
              <given-names>LG</given-names>
            </name>
          </person-group>
          <year>2017</year>
          <article-title>Macrophages in renal injury and repair</article-title>
          <source>Annual Review of Physiology</source>
          <volume>79</volume>
          <fpage>449</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev-physiol-022516-034219</pub-id>
          <pub-id pub-id-type="pmid">28192060</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Husain-Syed</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Slutsky</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Ronco</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <year>2016</year>
          <article-title>Lung-Kidney Cross-Talk in the critically ill patient</article-title>
          <source>American Journal of Respiratory and Critical Care Medicine</source>
          <volume>194</volume>
          <fpage>402</fpage>
          <lpage>414</lpage>
          <pub-id pub-id-type="doi">10.1164/rccm.201602-0420CP</pub-id>
          <pub-id pub-id-type="pmid">27337068</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalakeche</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hato</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Rhodes</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dunn</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>El-Achkar</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Plotkin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Sandoval</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Dagher</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <year>2011</year>
          <article-title>Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>22</volume>
          <fpage>1505</fpage>
          <lpage>1516</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2011020203</pub-id>
          <pub-id pub-id-type="pmid">21784899</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kretzler</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ju</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <year>2015</year>
          <article-title>A transcriptional map of the renal tubule: linking structure to function</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>26</volume>
          <fpage>2603</fpage>
          <lpage>2605</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2015030242</pub-id>
          <pub-id pub-id-type="pmid">25817354</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kr&#xFC;ger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Benke</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Eitner</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lang</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wirtz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hamilton-Williams</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Engel</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Giese</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>M&#xFC;ller-Newen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Floege</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kurts</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <year>2004</year>
          <article-title>Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>15</volume>
          <fpage>613</fpage>
          <lpage>621</lpage>
          <pub-id pub-id-type="doi">10.1097/01.ASN.0000114553.36258.91</pub-id>
          <pub-id pub-id-type="pmid">14978163</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>La Manno</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Soldatov</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hochgerner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Petukhov</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lidschreiber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kastriti</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>L&#xF6;nnerberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Furlan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Borm</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>van Bruggen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Barker</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sundstr&#xF6;m</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Castelo-Branco</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cramer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Adameyko</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Linnarsson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kharchenko</surname>
              <given-names>PV</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>RNA velocity of single cells</article-title>
          <source>Nature</source>
          <volume>560</volume>
          <fpage>494</fpage>
          <lpage>498</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-018-0414-6</pub-id>
          <pub-id pub-id-type="pmid">30089906</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lake</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hoshi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Plongthongkum</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Salamon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Knoten</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vijayan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Venkatesh</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Gaut</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>A single-nucleus RNA-sequencing pipeline to decipher the molecular anatomy and pathophysiology of human kidneys</article-title>
          <source>Nature Communications</source>
          <volume>10</volume>
          <elocation-id>2832</elocation-id>
          <pub-id pub-id-type="doi">10.1038/s41467-019-10861-2</pub-id>
          <pub-id pub-id-type="pmid">31249312</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Huen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nishio</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nishio</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Ruhrberg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cantley</surname>
              <given-names>LG</given-names>
            </name>
          </person-group>
          <year>2011</year>
          <article-title>Distinct macrophage phenotypes contribute to kidney injury and repair</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>22</volume>
          <fpage>317</fpage>
          <lpage>326</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2009060615</pub-id>
          <pub-id pub-id-type="pmid">21289217</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Chou</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Knepper</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <year>2015</year>
          <article-title>Deep sequencing in microdissected renal tubules identifies nephron Segment-Specific transcriptomes</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>26</volume>
          <fpage>2669</fpage>
          <lpage>2677</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2014111067</pub-id>
          <pub-id pub-id-type="pmid">25817355</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Cozzi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Bush</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Rabb</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Distant organ dysfunction in acute kidney injury: a review</article-title>
          <source>American Journal of Kidney Diseases</source>
          <volume>72</volume>
          <fpage>846</fpage>
          <lpage>856</lpage>
          <pub-id pub-id-type="doi">10.1053/j.ajkd.2018.03.028</pub-id>
          <pub-id pub-id-type="pmid">29866457</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <element-citation publication-type="software">
          <person-group person-group-type="author">
            <name>
              <surname>McCarthy</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <year>2020</year>
          <data-title>kidney-endotoxin-sepsis-timeline-featureplot</data-title>
          <source>Software Heritage</source>
          <version designator="swh:1:dir:c1402a9e87a2c0949b2e2a57925a2023a1028dae">swh:1:dir:c1402a9e87a2c0949b2e2a57925a2023a1028dae</version>
          <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:c1402a9e87a2c0949b2e2a57925a2023a1028dae;origin=https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-featureplot;visit=swh:1:snp:aedc6f0707a011aaa0c267c5f53a5e08ccdba76e;anchor=swh:1:rev:2e4dde0759965ce51220bdb5d76dcd4da0c528be/">https://archive.softwareheritage.org/swh:1:dir:c1402a9e87a2c0949b2e2a57925a2023a1028dae;origin=https://github.com/hato-lab/kidney-endotoxin-sepsis-timeline-featureplot;visit=swh:1:snp:aedc6f0707a011aaa0c267c5f53a5e08ccdba76e;anchor=swh:1:rev:2e4dde0759965ce51220bdb5d76dcd4da0c528be/</ext-link>
        </element-citation>
      </ref>
      <ref id="bib32">
        <element-citation publication-type="software">
          <person-group person-group-type="author">
            <name>
              <surname>Myslinski</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>2020</year>
          <data-title>kidney-endotoxin-sepsis-timeline-CellphoneDB-CirclePlot</data-title>
          <source>Software Heritage</source>
          <version designator="swh:1:dir:52c9f383a40029c7e6b5152a46c412697b85fa81">swh:1:dir:52c9f383a40029c7e6b5152a46c412697b85fa81</version>
          <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:52c9f383a40029c7e6b5152a46c412697b85fa81;Origin=https://github.com/hato-Lab/kidney-Endotoxin-Sepsis-Timeline-CellphoneDB-CirclePlot;Visit=Swh:1:snp:6e538690a1dfba10a8c7345dc92446f6789a3b01;Anchor=Swh:1:rev:b2e0e84daaae3846d2f2eaa57376080fee8954f9/">https://archive.softwareheritage.org/swh:1:dir:52c9f383a40029c7e6b5152a46c412697b85fa81;Origin=https://github.com/hato-Lab/kidney-Endotoxin-Sepsis-Timeline-CellphoneDB-CirclePlot;Visit=Swh:1:snp:6e538690a1dfba10a8c7345dc92446f6789a3b01;Anchor=Swh:1:rev:b2e0e84daaae3846d2f2eaa57376080fee8954f9/</ext-link>
        </element-citation>
      </ref>
      <ref id="bib33">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nowotschin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Setty</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuo</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Garg</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Simon</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Saiz</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boutet</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Church</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Hoodless</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Hadjantonakis</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Pe'er</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>The emergent landscape of the mouse gut endoderm at single-cell resolution</article-title>
          <source>Nature</source>
          <volume>569</volume>
          <fpage>361</fpage>
          <lpage>367</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1127-1</pub-id>
          <pub-id pub-id-type="pmid">30959515</pub-id>
        </element-citation>
      </ref>
      <ref id="bib34">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shrestha</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Werth</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Barasch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Suszt&#xE1;k</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease</article-title>
          <source>Science</source>
          <volume>360</volume>
          <fpage>758</fpage>
          <lpage>763</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aar2131</pub-id>
          <pub-id pub-id-type="pmid">29622724</pub-id>
        </element-citation>
      </ref>
      <ref id="bib35">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poston</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Koyner</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Sepsis associated acute kidney injury</article-title>
          <source>BMJ</source>
          <volume>2</volume>
          <elocation-id>k4891</elocation-id>
          <pub-id pub-id-type="doi">10.1136/bmj.k4891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib36">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ransick</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lindstr&#xF6;m</surname>
              <given-names>NO</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Alvarado</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Black</surname>
              <given-names>HG</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>AP</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Single-Cell profiling reveals sex, lineage, and regional diversity in the mouse kidney</article-title>
          <source>Developmental Cell</source>
          <volume>51</volume>
          <fpage>399</fpage>
          <lpage>413</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.005</pub-id>
          <pub-id pub-id-type="pmid">31689386</pub-id>
        </element-citation>
      </ref>
      <ref id="bib37">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Setty</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kiseliovas</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Levine</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gayoso</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mazutis</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pe'er</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Characterization of cell fate probabilities in single-cell data with palantir</article-title>
          <source>Nature Biotechnology</source>
          <volume>37</volume>
          <fpage>451</fpage>
          <lpage>460</lpage>
          <pub-id pub-id-type="doi">10.1038/s41587-019-0068-4</pub-id>
          <pub-id pub-id-type="pmid">30899105</pub-id>
        </element-citation>
      </ref>
      <ref id="bib38">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xE5;hl</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Salm&#xE9;n</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vickovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lundmark</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Magnusson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Giacomello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Westholm</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Huss</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mollbrink</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Linnarsson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Codeluppi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Borg</surname>
              <given-names>&#xC5;</given-names>
            </name>
            <name>
              <surname>Pont&#xE9;n</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Costea</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Sahl&#xE9;n</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Mulder</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bergmann</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Lundeberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fris&#xE9;n</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <year>2016</year>
          <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>
          <source>Science</source>
          <volume>353</volume>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaf2403</pub-id>
          <pub-id pub-id-type="pmid">27365449</pub-id>
        </element-citation>
      </ref>
      <ref id="bib39">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hafemeister</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mauck</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Stoeckius</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Smibert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Comprehensive integration of Single-Cell data</article-title>
          <source>Cell</source>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="bib40">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tran</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tam</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bardia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bhasin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Kher</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zsengeller</surname>
              <given-names>ZK</given-names>
            </name>
            <name>
              <surname>Akhavan-Sharif</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Khankin</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Saintgeniez</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Burstein</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Karumanchi</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stillman</surname>
              <given-names>IE</given-names>
            </name>
            <name>
              <surname>Arany</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Parikh</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <year>2011</year>
          <article-title>PGC-1&#x3B1; promotes recovery after acute kidney injury during systemic inflammation in mice</article-title>
          <source>Journal of Clinical Investigation</source>
          <volume>121</volume>
          <fpage>4003</fpage>
          <lpage>4014</lpage>
          <pub-id pub-id-type="doi">10.1172/JCI58662</pub-id>
        </element-citation>
      </ref>
      <ref id="bib41">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Trapnell</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cacchiarelli</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Grimsby</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Pokharel</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Morse</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lennon</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Livak</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Mikkelsen</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Rinn</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <year>2014</year>
          <article-title>The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells</article-title>
          <source>Nature Biotechnology</source>
          <volume>32</volume>
          <fpage>381</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.2859</pub-id>
          <pub-id pub-id-type="pmid">24658644</pub-id>
        </element-citation>
      </ref>
      <ref id="bib42">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van den Brink</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Sage</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>V&#xE9;rtesy</surname>
              <given-names>&#xC1;bel</given-names>
            </name>
            <name>
              <surname>Spanjaard</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Peterson-Maduro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baron</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Robin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>van Oudenaarden</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <year>2017</year>
          <article-title>Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations</article-title>
          <source>Nature Methods</source>
          <volume>14</volume>
          <fpage>935</fpage>
          <lpage>936</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4437</pub-id>
          <pub-id pub-id-type="pmid">28960196</pub-id>
        </element-citation>
      </ref>
      <ref id="bib43">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vento-Tormo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Efremova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Botting</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Turco</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Vento-Tormo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>KB</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Stephenson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pola&#x144;ski</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Goncalves</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gardner</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Holmqvist</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Henriksson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sharkey</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Millar</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Innes</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wilbrey-Clark</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Payne</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Ivarsson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Lisgo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Filby</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rowitch</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Bulmer</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Stubbington</surname>
              <given-names>MJT</given-names>
            </name>
            <name>
              <surname>Haniffa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Moffett</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Teichmann</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Single-cell reconstruction of the early maternal-fetal interface in humans</article-title>
          <source>Nature</source>
          <volume>563</volume>
          <fpage>347</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-018-0698-6</pub-id>
          <pub-id pub-id-type="pmid">30429548</pub-id>
        </element-citation>
      </ref>
      <ref id="bib44">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Woltman</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>de Fijter</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Zuidwijk</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Vlug</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Bajema</surname>
              <given-names>IM</given-names>
            </name>
            <name>
              <surname>van der Kooij</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>van Ham</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>van Kooten</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <year>2007</year>
          <article-title>Quantification of dendritic cell subsets in human renal tissue under normal and pathological conditions</article-title>
          <source>Kidney International</source>
          <volume>71</volume>
          <fpage>1001</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="doi">10.1038/sj.ki.5002187</pub-id>
          <pub-id pub-id-type="pmid">17361115</pub-id>
        </element-citation>
      </ref>
      <ref id="bib45">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Malone</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Donnelly</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Kirita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Uchimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ramakrishnan</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Gaut</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Humphreys</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <year>2018</year>
          <article-title>Single-Cell transcriptomics of a human kidney allograft biopsy specimen defines a diverse inflammatory response</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>29</volume>
          <fpage>2069</fpage>
          <lpage>2080</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2018020125</pub-id>
          <pub-id pub-id-type="pmid">29980650</pub-id>
        </element-citation>
      </ref>
      <ref id="bib46">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kirita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Donnelly</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Humphreys</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <year>2019</year>
          <article-title>Advantages of Single-Nucleus over Single-Cell RNA sequencing of adult kidney: rare cell types and novel cell states revealed in fibrosis</article-title>
          <source>Journal of the American Society of Nephrology</source>
          <volume>30</volume>
          <fpage>23</fpage>
          <lpage>32</lpage>
          <pub-id pub-id-type="doi">10.1681/ASN.2018090912</pub-id>
          <pub-id pub-id-type="pmid">30510133</pub-id>
        </element-citation>
      </ref>
      <ref id="bib47">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Besschetnova</surname>
              <given-names>TY</given-names>
            </name>
            <name>
              <surname>Brooks</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Bonventre</surname>
              <given-names>JV</given-names>
            </name>
          </person-group>
          <year>2010</year>
          <article-title>Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury</article-title>
          <source>Nature Medicine</source>
          <volume>16</volume>
          <fpage>535</fpage>
          <lpage>543</lpage>
          <pub-id pub-id-type="doi">10.1038/nm.2144</pub-id>
          <pub-id pub-id-type="pmid">20436483</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="sa1" article-type="decision-letter">
    <front-stub>
      <article-id pub-id-type="doi">10.7554/eLife.62270.sa1</article-id>
      <title-group>
        <article-title>Decision letter</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Giamarellos-Bourboulis</surname>
            <given-names>Evangelos J</given-names>
          </name>
          <role>Reviewing Editor</role>
          <aff>
            <institution>Attikon University Hospital</institution>
            <country>Greece</country>
          </aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Giamarellos-Bourboulis</surname>
            <given-names>Evangelos J</given-names>
          </name>
          <role>Reviewer</role>
          <aff>
            <institution>Attikon University Hospital</institution>
            <country>Greece</country>
          </aff>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Bermejo-Martin</surname>
            <given-names>Jesus</given-names>
          </name>
          <role>Reviewer</role>
          <aff>
            <country>Spain</country>
          </aff>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Weis</surname>
            <given-names>Sebastian</given-names>
          </name>
          <role>Reviewer</role>
          <aff>
            <country>Germany</country>
          </aff>
        </contrib>
      </contrib-group>
    </front-stub>
    <body>
      <boxed-text position="float" orientation="portrait">
        <p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p>
      </boxed-text>
      <p>
        <bold>Acceptance summary:</bold>
      </p>
      <p>This study is deconvoluting the cellular changes that occur in the kidney in terms of kind and function in mice challenged with bacterial endotoxin. This model is a proxy for sepsis, a most serious clinical infectious condition. The investigators have used single cell sequencing and did compare their findings to those seen in renal biopsies of patients with kidney injury in sepsis. The study provides new data on the changes in immunological, endothelial and parenchymal cells.</p>
      <p>
        <bold>Decision letter after peer review:</bold>
      </p>
      <p>Thank you for submitting your article "The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline" for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Evangelos J Giamarellos-Bourboulis as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Jos van der Meer as the Senior Editor. The reviewers have agreed to reveal their identity: Jesus Bermejo-Martin (Reviewer #2); Sebastian Weis (Reviewer #3).</p>
      <p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p>
      <p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p>
      <p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p>
      <p>Summary:</p>
      <p>This is an elegant study deconvoluting the cellular changes in the kidney (kind and function) along the course of a sepsis-like disease model on mice challenged with LPS. For achieving this objective, the authors have employed a single cell sequencing approach, and compared their findings to those observed in renal biopsies from patients suffering from AKI secondary to sepsis. This work provides interesting new data on the changes on immunological, endothelial and parenchymal cells composition and function following the LPS challenge, revealing important new insight on the dynamics and nature of this changes.</p>
      <p>Essential revisions:</p>
      <p>1) One main limitation is that it is not possible to fully understand the storyline of the authors which becomes confusing at some points. Several parts of the Results start with the verb "Note" as if they are figures and not text. It is also very difficult to understand what the need of archived renal tissue from humans was and the participation of this analysis in the storyline.</p>
      <p>2) The authors do not provide explanation on the purification of cell populations and on the methods, they used to avoid cell contamination.</p>
      <p>3) We would like to see in the Discussion the comparison of the data of single cell RNA analysis with previously published array data.</p>
      <p>4)The authors work with a model of LPS injection. This is all fine and can be done and provides useful information. However, it explicitly does not reflect the pathophysiology of sepsis that is defined as a deregulated host response to infection. Therefore, any reliable sepsis model needs to apply pathogens, which is not done. What we here look at, is TLR4 activation by LPS as a model of inflammatory stress. This needs to be changed. The best way would be by using an additional animal sepsis model confirming the LPS data. As an alternative, the manuscript should be rewritten in a way that it is evident, that the model is a pure TLR4 activation model of inflammatory stress and not sepsis. The discussion should be adopted accordingly. As such a short term "initial inflammatory burst" will be seen in an LPS model but would hardly reflect clinical reality.</p>
      <p>5) In the same vein, there are additional problems concerning animal models in sepsis that need to be discussed here: for example, patients suffering from sepsis use to be aged individuals suffering from chronic conditions such as diabetes, hypertension, etc. Ageing and chronic diseases impact on the host immune system and tissues. The authors seem to employ mice with no prior comorbidities. Please address this limitation in the Discussion.</p>
      <p>6) The authors should clarify how many mice were used to obtain the SCS results. A sentence in the Materials and methods, Results and Abstract would help. Does "mice" mean two, or more? This could help to assess data validity.</p>
      <p>7) A correlate is missing between SCS findings and clinical / biological parameters obtained in parallel from the mice: creatinine, inflammatory proteins / cytokines, urine volume, etc.</p>
      <p>8) The authors should provide disease severity, mortality, organ damage markers, cytokine levels for their animal model so that the reader can better assess the severity of the model.</p>
      <p>9) Is there any data on the consequences of the different states with regard to kidney function. This would be very interesting to see.</p>
      <p>10) The authors state that kidneys from septic patients have been used. Please provide clinical characteristics (SOFA; source of infection; microbiology, main clinical parameters; age, gender, comorbidity etc.) of these patients and of the controls. Were they really patients with sepsis that received a kidney biopsy? This is rarely done. Please explain.</p>
      <p>11) It is unclear, why the authors swing for some lines to SARS-CoV-2. This is not the topic of the manuscript. LPS has no role in SARS-CoV-2 and no viral infections are being studies here. This should be removed.</p>
      <p>12) As the authors provide IHC data (Figure 1&#x2014;figure supplement 2) and as there is a LPS directly regulates NF-&#x3BA;B function, we would suggest to specifically add data for NF-&#x3BA;B activation with IHC.</p>
      <p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p>
      <p>Thank you for submitting your work entitled "The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline" for consideration by <italic>eLife</italic>. Your article has been reviewed by a Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.</p>
      <p>Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in <italic>eLife</italic>.</p>
      <p>The main reasons for rejection are that the reviewers and the reviewing editor feel that you ignored the advice as given in the reviews. Not only our strong advice regarding the phrasing of sepsis and the LPS challenge was not followed, but other issues were not addressed (see the review below).</p>
      <p>In principle eLife only allows one round of revision, but if you feel you could fully comply with our criticism and send us a revised paper within two weeks, we would be willing to reconsider our decision.</p>
      <p>Reviewer #3:</p>
      <p>Janosevic et al., submit the first revision of their manuscript entitled "The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline". For the general assessment I kindly refer to my first review.</p>
      <p>The first joint review was rather positive and encouraged the submission of an adapted version of the manuscript. The authors however have only partly included the reviews recommendations despite some clear indications what would need to be changed.</p>
      <p>In more detail.</p>
      <p>i) The authors do not discuss their single cell RNA data with previously published data, as requested.</p>
      <p>ii) Although that the reviewer stated specifically that the presented work is not sepsis and ask for a change, this was not followed convincingly in the revised version. In the point-to-point reply two references are given. Yet the two well-known and contradicting papers (from the same datasets) by Seok and the Takao study do not investigate the correlation between sepsis and endotoxin application. Instead, the comparison is focused on the comparability of human and murine models with opposing results. At least for me, this does not support the notion to use LPS as a model of sepsis.</p>
      <p>iii) The issue that sepsis patients are likely to have older age and comorbidities which is not the case in the young mice are not being discussed as a limitation, as requested.</p>
      <p>iv) the clinical data is sparse. If patients' samples are being used, the authors should be able to retrieve the requested information.</p>
      <p>v) Data for NfKB activation using IHC is not provided.</p>
      <p>vi) Consequences with regard to kidney function are not discussed.</p>
      <p>vii) Disease severity/mortality is not provided as requested.</p>
      <p>It is unclear to me and unfortunate why the authors decided so, however, as the critics from the first round stand, I cannot recommend it for publication at the current stage.</p>
    </body>
  </sub-article>
  <sub-article id="sa2" article-type="reply">
    <front-stub>
      <article-id pub-id-type="doi">10.7554/eLife.62270.sa2</article-id>
      <title-group>
        <article-title>Author response</article-title>
      </title-group>
    </front-stub>
    <body>
      <disp-quote content-type="editor-comment">
        <p>Essential revisions:</p>
        <p>1) One main limitation is that it is not possible to fully understand the storyline of the authors which becomes confusing at some points. Several parts of the Results start with the verb "Note" as if they are figures and not text. It is also very difficult to understand what the need of archived renal tissue from humans was and the participation of this analysis in the storyline.</p>
      </disp-quote>
      <p>Our findings show space- and time-dependent changes in the kidney following endotoxin challenge with an organized participation of various cell populations. This has relevance to the design and administration of therapy to precisely target unique cell populations at specific time points. We also showed phenotypic changes such as loss of transporters that can alter the function of the renal epithelium and may explain some clinical findings in septic patients. Furthermore, we showed that all these changes culminate in cell-cell communication failure at exactly the same time point characterized by translation shutdown as we have previously shown. Importantly, several genes and pathways involved in tissue healing become activated at this time point, indicating that it is a time of transition from injury to recovery.</p>
      <p>As to the archived renal tissue, it was obtained from patients with the diagnosis of acute renal failure in the setting of sepsis without specific chronological information as to the timing of sepsis. We show that time-specific gene expression changes in the mouse sepsis timeline can be partially mapped to some of the human samples. This allowed a staging of the human samples from early to late phases of sepsis. We believe this may have important therapeutic implications.</p>
      <disp-quote content-type="editor-comment">
        <p>2) The authors do not provide explanation on the purification of cell populations and on the methods, they used to avoid cell contamination.</p>
      </disp-quote>
      <p>The single-cell RNA-seq procedure used in this paper attempted to capture all cell populations in the kidney. Therefore, the tissue dissociation step was not followed by flow sorting or other attempts to enrich any specific cell types. Cell populations thereafter were identified and grouped based on gene expression.</p>
      <disp-quote content-type="editor-comment">
        <p>3) We would like to see in the Discussion the comparison of the data of single cell RNA analysis with previously published array data.</p>
      </disp-quote>
      <p>Our scRNA-seq data were well in line with published array data from bulk kidney tissue (Tran et al., 2011). For example, the changes in the thick ascending loop sodium/potassium/chloride transporter (Slc12a1/NKCC2), proximal tubular aquaporin (Aqp1), and genes involved in antigen presentation (H2-Ab1, Cd74) were comparable to those reported in bulk tissue as shown in <xref ref-type="fig" rid="respfig1">Author response image 1</xref>. scRNA-seq has the advantage of localizing these changes to specific cell populations.</p>
      <fig id="respfig1" orientation="portrait" position="float">
        <label>Author response image 1.</label>
        <caption>
          <title>Bulk kidney microarray data.</title>
        </caption>
        <graphic xlink:href="elife-62270-resp-fig1"/>
      </fig>
      <disp-quote content-type="editor-comment">
        <p>4) The authors work with a model of LPS injection. This is all fine and can be done and provides useful information. However, it explicitly does not reflect the pathophysiology of sepsis that is defined as a deregulated host response to infection. Therefore, any reliable sepsis model needs to apply pathogens, which is not done. What we here look at, is TLR4 activation by LPS as a model of inflammatory stress. This needs to be changed. The best way would be by using an additional animal sepsis model confirming the LPS data. As an alternative, the manuscript should be rewritten in a way that it is evident, that the model is a pure TLR4 activation model of inflammatory stress and not sepsis. The discussion should be adopted accordingly. As such a short term "initial inflammatory burst" will be seen in an LPS model but would hardly reflect clinical reality.</p>
      </disp-quote>
      <p>We agree with the reviewers that LPS/endotoxemia model may not capture the full spectrum of Gram-negative sepsis in humans. However, as we and others have shown, it does recapitulate several key events in the sepsis timeline, and correlates well with the CLP model (Seok et al., 2013; Takao et al., 2015). As the reviewers&#x2019; state, it is a precise model that follows signaling events initiated by endotoxin/TLR4 interaction. It is a highly reproducible model that is also reversible, and therefore can be used to identify pathways involved in tissue recovery and healing. In fact, murine models of endotoxemia and its variants have been found to have significant similarities in gene expression changes to human sepsis. This has been elegantly demonstrated in Takao et al., 2015. This is also supported in our data by the successful mapping of gene expression changes in the endotoxemic mouse to human tissues from septic patients (Figure 7D). We have now changed the word &#x201C;sepsis&#x201D; to endotoxemia in several parts of the manuscript.</p>
      <disp-quote content-type="editor-comment">
        <p>5) In the same vein, there are additional problems concerning animal models in sepsis that need to be discussed here: for example, patients suffering from sepsis use to be aged individuals suffering from chronic conditions such as diabetes, hypertension, etc. Ageing and chronic diseases impact on the host immune system and tissues. The authors seem to employ mice with no prior comorbidities. Please address this limitation in the Discussion.</p>
      </disp-quote>
      <p>We agree with the reviewers and are aware of such models. For example, one such model uses CLP in aged rats or mice. This model was originally introduced with the goal of inducing measurable renal injury which is not always apparent in traditional CLP (Doi et al., 2009). These models are primarily used to test the effect of therapeutics on renal function and animal survival. However, they pose more challenges in identifying specific and canonical molecular pathways because of their polymicrobial nature, comorbidities, and hemodynamic effects.</p>
      <disp-quote content-type="editor-comment">
        <p>6) The authors should clarify how many mice were used to obtain the SCS results. A sentence in the Materials and methods, Results and Abstract would help. Does "mice" mean two, or more? This could help to assess data validity.</p>
      </disp-quote>
      <p>We pool kidneys from 3 mice per time point. The pooled 3 kidneys are run as one sample for cost purposes.</p>
      <disp-quote content-type="editor-comment">
        <p>7) A correlate is missing between SCS findings and clinical / biological parameters obtained in parallel from the mice: creatinine, inflammatory proteins / cytokines, urine volume, etc.</p>
      </disp-quote>
      <p>Please see below (response to #8).</p>
      <disp-quote content-type="editor-comment">
        <p>8) The authors should provide disease severity, mortality, organ damage markers, cytokine levels for their animal model so that the reader can better assess the severity of the model.</p>
      </disp-quote>
      <p>We have previously characterized this endotoxemia model extensively, including parameters such as survival, reversibility, renal function (serum creatinine, BUN), tubular injury (KIM1, NGAL), as well as tissue and serum cytokines (Kalakeche et al., 2011; Hato et al., 2015; Hato et al., 2017; Hato et al., 2018; Hato et al., 2019). The dose of endotoxin used in this model does not result in significant hemodynamic alterations (Nakano et al., 2015). We now provide additional new data on such clinical/biological parameters that characterize this murine model (New Figure 7&#x2014;figure supplement 1).</p>
      <disp-quote content-type="editor-comment">
        <p>9) Is there any data on the consequences of the different states with regard to kidney function. This would be very interesting to see.</p>
      </disp-quote>
      <p>Kidney tissue from septic patients typically does not show significant morphological changes that can explain the observed profound organ shutdown. Furthermore, organ shutdown in septic patients occurs even in hyperdynamic states where tissue perfusion is not compromised. Similarly, animal models of sepsis such as endotoxemia or CLP do not exhibit marked morphological changes in the kidney.</p>
      <p>Therefore, we propose that the molecular changes reported in this paper (e.g. dysregulated translation and cell-cell communication failure) may underlie the observed organ failure. Furthermore, some of the tubular phenotypic changes we report e.g. loss of aquaporins and glucose transporters may explain dysregulated urinary concentrating mechanisms and altered glucose metabolism reported in sepsis.</p>
      <disp-quote content-type="editor-comment">
        <p>10) The authors state that kidneys from septic patients have been used. Please provide clinical characteristics (SOFA; source of infection; microbiology, main clinical parameters; age, gender, comorbidity etc.) of these patients and of the controls. Were they really patients with sepsis that received a kidney biopsy? This is rarely done. Please explain.</p>
      </disp-quote>
      <p>We agree with the reviewers. The human biopsies used in this paper were not research or protocol biopsies. In fact, these are leftover tissues stored and typically discarded at later times by the pathologist. We made every effort to retrieve any available clinical data associated with each biopsy. Such clinical data from chart reviews were frequently scarce and incomplete. Furthermore, some of these biopsies were from other institutions and no detailed clinical data were forwarded to our pathologist with the biopsies. Nevertheless, we have now included all available data such as SOFA scores and microbiology when available (New Supplementary file 5). We also agree that typically kidney biopsies are not performed in septic patients. The indications for biopsy in our cohort were variable and included delayed recovery, distinguishing interstitial nephritis and tubular necrosis, or exclusion of underlying glomerulonephritis. The final diagnosis in all these biopsies was acute tubular necrosis in the setting of sepsis.</p>
      <disp-quote content-type="editor-comment">
        <p>11) It is unclear, why the authors swing for some lines to SARS-CoV-2. This is not the topic of the manuscript. LPS has no role in SARS-CoV-2 and no viral infections are being studies here. This should be removed.</p>
      </disp-quote>
      <p>We agree with the reviewer and have removed the SARS-CoV-2-related data. It was originally included because of the observed increased angiotensinogen in S3 cells, which prompted us to examine the broad expression of the renin-angiotensin system. We thought this may be of general interest due to the SARSCoV-2 pandemic, but we agree that it may not help the flow of the manuscript.</p>
      <disp-quote content-type="editor-comment">
        <p>12) As the authors provide IHC data (Figure 1&#x2014;figure supplement 2) and as there is a LPS directly regulates NF-&#x3BA;B function, we would suggest to specifically add data for NF-&#x3BA;B activation with IHC.</p>
      </disp-quote>
      <p>The IHC imaging data in Figure 1&#x2014;figure supplement 2 was shown to specifically localize the proliferating cell cluster observed in the scRNA-seq data. The imaging confirmed that the localization of these cells in tubules versus interstitium varies along the sepsis timeline. The expression of Nf-<sub>&#x3BA;</sub>B in the kidney in sepsis/endotoxemia has been extensively investigated (Song et al., 2019; Belen-Sanz et al., 2010; Guijarro et al., 2001). Furthermore, the expression of several components of the Nf-<sub>&#x3BA;</sub>B pathway can be localized to specific cells along the sepsis timeline using the following link to our data (e.g. <italic>Rela, Relb, Nfkbia, Nfkb1</italic>): https://connect.rstudio.iu.edu/content/18/ . The activation of Nf-<sub>&#x3BA;</sub>B is evident in endothelial and stromal cells at the 1 hour time point and then is evident in immune cells and epithelial cells at later time points. c-Jun and Fos expression levels are commonly used to identify cells exhibiting stress related to the organ dissociation procedure (Denisenko et al., 2020; van den Brink et al.,2017).</p>
      <p>[Editors&#x2019; note: what follows is the authors&#x2019; response to the second round of review.]</p>
      <disp-quote content-type="editor-comment">
        <p>Reviewer #3:</p>
        <p>Janosevic et al., submit the first revision of their manuscript entitled "The orchestrated cellular and molecular responses of the kidney to endotoxin define a precise sepsis timeline". For the general assessment I kindly refer to my first review.</p>
        <p>The first joint review was rather positive and encouraged the submission of an adapted version of the manuscript. The authors however have only partly included the reviews recommendations despite some clear indications what would need to be changed.</p>
      </disp-quote>
      <p>We would like to thank the reviewer for recognizing the strengths of the manuscript. We would also like to thank the reviewer for providing clear and practical suggestions to improve the manuscript. Finally, we apologize for our previous incomplete response to the reviewer&#x2019;s comments. Indeed, we had provided in the response some of the required data. We have now added all responses, discussions and new data in the manuscript.</p>
      <disp-quote content-type="editor-comment">
        <p>In more detail.</p>
        <p>i) The authors do not discuss their single cell RNA data with previously published data, as requested.</p>
      </disp-quote>
      <p>To our knowledge, our work is the first examination of endotoxin-induced kidney injury covering from very early phases (1 hour~) to recovery (48 hours) at the single-cell resolution. We searched for publicly available datasets for murine endotoxemia models, which were all done in bulk kidneys. The closest time course we could find was by Tran et al., 2011 in which 10 mg/kg LPS ip (<italic>E. coli</italic> serotype O111:B4) was used in C57BL/6 mice and gene expression profiles were examined at 0, 18 and 42 hours post LPS (Our endotoxemia model consists of 5 mg/kg LPS iv, <italic>E. coli</italic> serotype O111:B4, and gene expression profiles were examined at 0, 1, 4, 16, 27, 36 and 48 hours). As shown in new Figure 4&#x2014;figure supplement 2 and discussed in the Results section, Discussion and Materials and methods we demonstrate that overall gene expression changes are similar between our study and Tran et al. We accomplished this analysis by reconstructing pseudobulk kidneys from our single-cell RNA-seq data and cross-examining time-dependent gene expression changes between the two datasets using Jaccard similarity index.</p>
      <disp-quote content-type="editor-comment">
        <p>ii) Although that the reviewer stated specifically that the presented work is not sepsis and ask for a change, this was not followed convincingly in the revised version. In the point-to-point reply two references are given. Yet the two well-known and contradicting papers (from the same datasets) by Seok and the Takao study do not investigate the correlation between sepsis and endotoxin application. Instead, the comparison is focused on the comparability of human and murine models with opposing results. At least for me, this does not support the notion to use LPS as a model of sepsis.</p>
      </disp-quote>
      <p>We fully agree with the reviewer that the terms endotoxemia and sepsis should not be used interchangeably. We corrected the use of these terms; our murine model now is consistently referred to as endotoxemia, not sepsis. The term sepsis appears in the main text only when we discuss human clinical sepsis.</p>
      <disp-quote content-type="editor-comment">
        <p>iii) The issue that sepsis patients are likely to have older age and comorbidities which is not the case in the young mice are not being discussed as a limitation, as requested.</p>
      </disp-quote>
      <p>We agree with the reviewer that age and other comorbidities are important factors in the pathophysiology of human sepsis. These comorbidities are not accounted for in our murine model of endotoxemia. We now dedicated a whole paragraph at the end of Discussion addressing all these limitations.</p>
      <disp-quote content-type="editor-comment">
        <p>iv) the clinical data is sparse. If patients' samples are being used, the authors should be able to retrieve the requested information.</p>
      </disp-quote>
      <p>We have made a serious and honest effort to retrieve all clinical data that were available. Note that these were not research biopsies and some of them originated from outside institutions. We compiled all available data in Supplementary file 5 showing SOFA score, source of infection, microbiology, clinical context, age, gender, and comorbidity. We also provide a statistical correlation between gene-based patient stratification into early and late phases of sepsis, and their SOFA score (new Figure 7E and new Figure 7&#x2014;figure supplement 1, subsection &#x201C;The murine endotoxemia timeline allows staging of human sepsis&#x201D;).</p>
      <disp-quote content-type="editor-comment">
        <p>v) Data for NfKB activation using IHC is not provided.</p>
      </disp-quote>
      <p>We now provide NfkB IHC in new Figure 5&#x2014;figure supplement 3 and subsection &#x201C;Endotoxemia induces an organ-wide host defense phenotype in the kidney&#x201D;. The data show nuclear translocation of NfkB as early as 1 hour after endotoxin in most cell types. These data are in line with our previously published ribo-seq data (Hato et al., 2019; specifically supplemental Figure 3 and Figure 6).</p>
      <disp-quote content-type="editor-comment">
        <p>vi) Consequences with regard to kidney function are not discussed.</p>
      </disp-quote>
      <p>We now addressed possible consequences of endotoxin-induced gene expression changes on global kidney function and clinical parameters (Discussion; please also see Figure 4&#x2014;figure supplement 1).</p>
      <disp-quote content-type="editor-comment">
        <p>vii) Disease severity/mortality is not provided as requested.</p>
      </disp-quote>
      <p>The endotoxin model used here results in transient kidney injury. The animals invariably recover and the mortality is nil. We use this nonlethal model to elucidate molecular mechanisms of renal recovery. With regard to disease severity, serum creatinine is arguably the gold standard for defining the severity of kidney failure. We provide serum creatinine data as well as other markers of tubular injury as shown in Figure 7&#x2014;figure supplement 2. Histological changes are not readily detectable (e.g. Supplemental Figure 9 in Hato et al., 2015) unless leveraging advanced molecular imaging techniques such as two-photon intravital fluorescence lifetime imaging (Hato et al., 2017). Others have worked with higher doses of LPS and examined its renal outcomes. For example, in the study by Tran et al., 2011, 10 mg/kg LPS resulted in heterogeneous renal outcomes (&#x201C;The majority of mice recovered normal function by 42 hours after LPS, but some had persistent AKI&#x201D;) and the survival was greater than 80%. Even with the 10 mg/kg LPS, light microscopy showed only minor to no changes in their study. We provide in subsection &#x201C;Experimental Model and Subject Details<italic>&#x201D;</italic> describing the severity and mortality of our endotoxin model. Figure 7&#x2014;figure supplement 2 also includes tissue and serum cytokine levels as requested by the reviewer.</p>
      <p>Finally, we would like to take this opportunity to emphasize the rationale behind defining 16 hrs and above as late and recovery phases in our murine model of endotoxemia. This definition is based on the single-cell RNA sequencing data in which resolution of tissue injury becomes apparent after the 16 hour time point (see Author response image 2). We have also previously demonstrated that this dose of endotoxin alters gene expression and culminates in profound protein translation shutdown in the kidney at 16 hours (Hato et al., 2019). Therefore, our molecular-based timeline is anchored around gene expression changes and protein translation shutdown, and their recovery. In contrast, standard biochemical markers (e.g. serum creatinine) resulting from altered gene expression are observed at later time points.</p>
      <fig id="respfig2" orientation="portrait" position="float">
        <label>Author response image 2.</label>
        <caption>
          <title>Timeline of murine LPS model.</title>
          <p>(<bold>A</bold>) Adapted from Figure 4. Single-cell RNA-seq data demonstrating overall time-dependent gene expression changes in proximal tubules after LPS challenge. Proximal tubules exhibit major phenotypic changes at 4 hrs (red circle) and they show the most extreme phenotype at 16 hrs (blue circle). By 27 hrs, the overall phenotype returns toward baseline, suggesting that tubules are in recovery phase (gray circles). (<bold>B</bold>) Changes in gene expression levels of Kidney Injury Marker 1/KIM1 (an AKI biomarker). (<bold>C</bold>) Serum creatinine levels exhibit known lag (Adapted from Figure 7&#x2014;figure supplement 2).</p>
        </caption>
        <graphic xlink:href="elife-62270-resp-fig2"/>
      </fig>
    </body>
  </sub-article>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
      <journal-title-group>
        <journal-title>Genome Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1474-7596</issn>
      <issn pub-type="epub">1474-760X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33685491</article-id>
      <article-id pub-id-type="pmc">7938609</article-id>
      <article-id pub-id-type="publisher-id">2286</article-id>
      <article-id pub-id-type="doi">10.1186/s13059-021-02286-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Method</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Giotto: a toolbox for integrative analysis and visualization of spatial expression data</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <name>
            <surname>Dries</surname>
            <given-names>Ruben</given-names>
          </name>
          <address>
            <email>rdries@bu.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Zhu</surname>
            <given-names>Qian</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dong</surname>
            <given-names>Rui</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eng</surname>
            <given-names>Chee-Huat Linus</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Huipeng</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Kan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>Yuntian</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>Tianxiao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sarkar</surname>
            <given-names>Arpan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bao</surname>
            <given-names>Feng</given-names>
          </name>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>George</surname>
            <given-names>Rani E.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pierson</surname>
            <given-names>Nico</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cai</surname>
            <given-names>Long</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2283-4714</contrib-id>
          <name>
            <surname>Yuan</surname>
            <given-names>Guo-Cheng</given-names>
          </name>
          <address>
            <email>guo-cheng.yuan@mssm.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.65499.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 9910</institution-id><institution>Department of Pediatric Oncology, </institution><institution>Dana-Farber Cancer Institute and Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Boston University School of Medicine, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.20861.3d</institution-id><institution-id institution-id-type="ISNI">0000000107068890</institution-id><institution>Division of Biology and Biological Engineering, California Institute of Technology, </institution></institution-wrap>Pasadena, CA USA </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.12527.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 0662 3178</institution-id><institution>Tsinghua University, </institution></institution-wrap>Beijing, China </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Departments of Statistics and Molecular and Cellular Biology, </institution><institution>Harvard University, </institution></institution-wrap>Cambridge, MA USA </aff>
        <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Harvard Stem Cell Institute, </institution></institution-wrap>Boston, MA USA </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>8</day>
        <month>3</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>8</day>
        <month>3</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>22</volume>
      <elocation-id>78</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>12</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>2</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2021</copyright-statement>
        <license license-type="OpenAccess">
          <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Spatial transcriptomic and proteomic technologies have provided new opportunities to investigate cells in their native microenvironment. Here we present Giotto, a comprehensive and open-source toolbox for spatial data analysis and visualization. The analysis module provides end-to-end analysis by implementing a wide range of algorithms for characterizing tissue composition, spatial expression patterns, and cellular interactions. Furthermore, single-cell RNAseq data can be integrated for spatial cell-type enrichment analysis. The visualization module allows users to interactively visualize analysis outputs and imaging features. To demonstrate its general applicability, we apply Giotto to a wide range of datasets encompassing diverse technologies and platforms.</p>
        <sec>
          <title>Supplementary Information</title>
          <p>The online version contains supplementary material available at 10.1186/s13059-021-02286-2.</p>
        </sec>
      </abstract>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
              <institution>National Institutes of Health</institution>
            </institution-wrap>
          </funding-source>
          <award-id>UH3CA255134</award-id>
          <award-id>R01AG066028</award-id>
          <principal-award-recipient>
            <name>
              <surname>Cai</surname>
              <given-names>Long</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Introduction</title>
      <p id="Par2">Most tissues consist of multiple cell types that operate together to perform their functions. The behavior of each cell is in turn mediated by its tissue environment. With the rapid development of single-cell RNAseq (scRNAseq) technologies in the last decade, most attention has gone to unraveling the composition of cell types with each tissue. However, recent studies have also shown that identical cell types may have tissue-specific expression patterns [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>], indicating that the tissue environment plays an important role in mediating cell states. Since spatial information is lost during the process of tissue dissociation and cell isolation, the scRNAseq technology is intrinsically limited for studying the structural organization of a complex tissue and interactions between cells and their tissue environment.</p>
      <p id="Par3">Recently, a number of technological advances have enabled transcriptomic/proteomic profiling in a spatially resolved manner [<xref ref-type="bibr" rid="CR3">3</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>] such that cellular features (for example transcripts or proteins) can be assigned to single cells for which the original cell location information is retained (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a, inset). Applications of these technologies have revealed distinct spatial patterns that previously are only inferred through indirect means [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. There is an urgent need for standardized spatial analysis tools that can facilitate comprehensive exploration of the current and upcoming spatial datasets [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. To fill this important gap, we present the first comprehensive, standardized, and user-friendly toolbox, called Giotto, that allows researchers to process, (re-)analyze, and interactively visualize spatial transcriptomic and proteomic datasets. Giotto implements a rich set of algorithms to enable robust spatial data analysis and further provides an easy-to-use workspace for interactive data visualization and exploration. As such, the Giotto toolbox serves as a convenient entry point for spatial transcriptomic/proteomic data analysis and visualization. We have applied Giotto to a wide range of public datasets to demonstrate its general applicability.
<fig id="Fig1"><label>Fig. 1</label><caption><p>The Giotto framework to analyze and visualize spatial expression data<bold>. a</bold> Schematic representation of the Giotto workflow to analyze and visualize spatial expression data. Giotto Analyzer requires a count matrix and physical coordinates for the corresponding cells. It follows standard scRNAseq processing and analysis steps to identify differentially expressed genes and cell types. In the following step, a spatial grid and neighborhood network is created which is further used to incorporate the spatial information of the single-cell environment and which is used for spatial analysis. <bold>b</bold> Cell coordinates, annotations, and clustering information are utilized and incorporated in the Giotto Viewer. This interactive viewer allows users to explore the link between cells&#x2019; physical positions and their clustering pattern in the expression space (UMAP or tSNE). The addition of raw subcellular transcript coordinates, staining images, or cell segmentation information is also supported. <bold>c</bold> Overview of the selected broad range of different spatial technologies and datasets which were analyzed and visualized with Giotto. For each dataset the number of features (genes or proteins) and number of cells are shown before filtering. The technologies depicted are sequential fluorescence in situ hybridization plus (seqFISH+), Visium 10X (Visium), Slide-seq, cyclic-ouroboros single-molecule fluorescence in situ hybridization (osmFISH), multiplexed error-robust fluorescent in situ hybridization (merFISH), spatially resolved transcript amplicon readout mapping (STARmap), tissue-based cyclic immunofluorescence (t-CyCIF), Multiplex Ion Beam Imaging (MIBI), and CO-Detection by indexing (CODEX)</p></caption><graphic xlink:href="13059_2021_2286_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec2">
      <title>Results</title>
      <sec id="Sec3">
        <title>Overview of the Giotto toolbox</title>
        <p id="Par4">Giotto provides a comprehensive spatial analysis toolbox that contains two independent yet fully integrated modules (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a, b). The first module (Giotto Analyzer) provides step-by-step instructions about the different steps in analyzing spatial single-cell expression data, whereas the second module (Giotto Viewer) provides a responsive and interactive viewer of such data on the user&#x2019;s local computer. These two modules can be used either independently or iteratively.</p>
        <p id="Par5">Giotto Analyzer requires as minimal input a gene-by-cell count matrix and the spatial coordinates for the centroid position of each cell (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a). At the basic level, Giotto Analyzer can be used to perform common steps often similar to scRNAseq analysis, such as pre-processing, feature selection, dimension reduction, and unsupervised clustering; on the other hand, the main strength comes from its ability to integrate gene expression and spatial information in order to gain insights into the structural and functional organization of a tissue and its expression patterns. To this end, Giotto Analyzer creates a spatial grid and neighborhood network connecting cells that are physically close to each other. These objects function as the basis to perform analyses that are associated with cell neighborhoods.</p>
        <p id="Par6">Giotto Analyzer is written in the popular language R. The core data structure is the Giotto object, which is specifically designed for spatial expression data analysis based on the flexible S4 object system in R. The Giotto object stores all necessary (spatial) information and is sufficient to perform all calculations and analyses (Additional&#xA0;file&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1A). This allows the user to quickly evaluate and create their own flexible pipeline for both spatial visualization and data analysis. The Giotto Viewer module is designed to both interactively explore the outputs of Giotto Analyzer and to visualize additional information such as cell morphology and transcript locations (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b). Giotto Viewer provides an interactive workspace allowing users to easily explore the data in both physical and expression space and identify relationships between different data modalities. Taken together, these two modules provide an integrated toolbox for spatial expression data analysis and visualization.</p>
        <p id="Par7">The spatial omics field is diverse and rapidly expanding; each technology has its strength and weaknesses. In order to demonstrate the general applicability of Giotto, we selected and analyzed 10 public datasets obtained from 9 state-of-the-art technologies (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>c, Additional&#xA0;file&#xA0;<xref rid="MOESM2" ref-type="media">2</xref>: Table S1), which differ in terms of resolution (single-cell vs multiple cells), physical dimension (2D vs 3D), molecular modality (protein vs RNA), number of cells and genes, and tissue of origin. Throughout this paper, we use these datasets to highlight the rich set of analysis tools that are supported by Giotto.</p>
      </sec>
      <sec id="Sec4">
        <title>Cell type identification and data visualization</title>
        <p id="Par8">Giotto Analyzer starts by identifying different cell types that are present in a spatial transcriptomic or proteomic dataset. As an illustrating example for the first common steps, we considered the seqFISH+ mouse somatosensory cortex dataset, which profiled 10,000 genes in hundreds of cells at single-cell resolution using super-resolved imaging [<xref ref-type="bibr" rid="CR9">9</xref>]. The input gene-by-cell count matrix was first pre-processed through a sequence of steps including normalization, quality control of raw counts, and adjustment for batch effects or technical variations. Then downstream analyses were carried out for highly variable gene selection (Additional&#xA0;file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1B), dimensionality reduction (such as PCA, tSNE [<xref ref-type="bibr" rid="CR19">19</xref>], and UMAP [<xref ref-type="bibr" rid="CR20">20</xref>]), and clustering (such as Louvain [<xref ref-type="bibr" rid="CR21">21</xref>] and Leiden clustering algorithms [<xref ref-type="bibr" rid="CR22">22</xref>]) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1C). Cluster-specific marker genes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1D-E) were identified through a number of algorithms (such as Scran [<xref ref-type="bibr" rid="CR23">23</xref>] and MAST [<xref ref-type="bibr" rid="CR24">24</xref>]) and a new algorithm based on Gini coefficients [<xref ref-type="bibr" rid="CR25">25</xref>]. Whereas the strongest marker genes are typically identified by all three methods, each method has its own strength in detecting specific types of genes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2A-G, see Methods and Additional&#xA0;file&#xA0;<xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes for details). In total, we identified 12 distinct cell types, including layer-specific excitatory neurons (eNeurons) (<italic>Syt17</italic> in layer 2/3, <italic>Grm2</italic> in layer 4, <italic>Islr2</italic> in layer 5/6), two types of inhibitory neurons (iNeurons) (<italic>Lhx6</italic> vs <italic>Adarb2</italic>), astrocytes (<italic>Gli3</italic>), oligodendrocytes (<italic>Plekhh</italic>), oligodendrocyte precursors (OPCs) (<italic>Sox10</italic>), endothelial cells (<italic>Cldn5</italic>), mural (<italic>Vtn</italic>), and microglia (<italic>Itgam</italic>) cells. The distribution of these cell types can then be visualized in both expression and physical space (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1F).</p>
        <p id="Par9">Next, we analyzed additional complex imaging-based spatial transcriptomic datasets generated by merFISH [<xref ref-type="bibr" rid="CR14">14</xref>], STARmap [<xref ref-type="bibr" rid="CR7">7</xref>], and osmFISH [<xref ref-type="bibr" rid="CR11">11</xref>]. In the merFISH dataset, 12 selected thin slices from a 3D mouse pre-optic cortex sample were imaged, resulting in a total of roughly 75,000 cells and 155 genes. Here Giotto was used to identify 8 distinct clusters. Based on known marker genes, we were able to annotate these clusters as microglia (<italic>Selplg</italic>), ependymal cells (<italic>Cd24a</italic>), astrocytes (<italic>Aqp4</italic>), endothelial cells (<italic>Fn1</italic>), mature (Mbp), and immature (<italic>Pdgfra</italic>) oligodendrocytes, excitatory (<italic>Slc17a6</italic>) and inhibitory (<italic>Gad1</italic>) neurons, respectively, which is in agreement with the original paper [<xref ref-type="bibr" rid="CR14">14</xref>] (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>a, b, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes). Cells that did not fall into these clusters were collectively assigned to an &#x201C;ambiguous&#x201D; group, as done in the original paper. Next, to visualize the results, Giotto can create an interactive 3D plot for the whole dataset or specifically highlight one or more selected 2D slices (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>c). Together with overlaying gene expression information (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>d, e), such visualization enables the user to explore tissue structure and concomitant gene expression variation in a detailed manner.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Analysis and visualization of large-scale spatial transcriptomic and proteomic datasets. <bold>a</bold> Visualization in both expression (top) and physical (bottom) space of the cell types identified by Giotto Analyzer in the pre-optic hypothalamic merFISH dataset, which consists of 12 slices from the same 3D sample (distance unit&#x2009;=&#x2009;1&#x2009;&#x3BC;m). <bold>b</bold> Heatmap showing the marker genes for the identified cell populations in <bold>a, c</bold> Visualization in both expression and physical space of two representative slices within the <italic>z</italic>-orientation (100&#x2009;&#x3BC;m and 400&#x2009;&#x3BC;m). <bold>d, e</bold> Overlay of gene expression in both expression and physical space for the selected slices in <bold>c, f</bold>. Visualization in both expression (top) and spatial (bottom) space of the clusters identified by Giotto Analyzer in the pancreatic ductal adenocarcinoma (PDAC) tissue-CyCIF dataset, which covers multiple tissues, including pancreas, small intestine, and cancer cells (distance unit&#x2009;=&#x2009;1&#x2009;&#x3BC;m). <bold>g</bold> Heatmap showing the marker proteins for the identified cell clusters in <bold>f, h</bold>. Visualization in both expression and physical space of two selected windows (red squares in <bold>f</bold>) in the normal pancreas and small-intestinal regions. <bold>i</bold>, <bold>j</bold> Overlay of gene expression in both expression and physical space for the selected windows in <bold>h</bold></p></caption><graphic xlink:href="13059_2021_2286_Fig2_HTML" id="MO2"/></fig></p>
        <p id="Par10">In a similar manner, we analyzed the mouse visual cortex STARmap (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3 A-D) and mouse somatosensory cortex osmFISH (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4 A-D) datasets (see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes for details). Both datasets show the typical anatomical multi-layered structure of the cortex. In the 3D STARmap analysis, we present an additional functionality that allows the user to create 2D virtual sections of a 3D sample (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S3 A, C and E), which could be useful for more refined structural analysis, as demonstrated in our analysis of the STARmap dataset (see section &#x201C;<xref rid="Sec7" ref-type="sec">Giotto identifies distinct cellular neighborhoods and interactions</xref>&#x201D; and Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes for details).</p>
        <p id="Par11">Due to the similarity of data structure, it is straightforward to apply Giotto to analyze large-scale spatial proteomic datasets such as CyCIF, CODEX, and MIBI (see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes for details). As an illustrating example, we analyzed a public dataset obtained by CyCIF [<xref ref-type="bibr" rid="CR10">10</xref>]. The dataset profiled the spatial distribution of 21 proteins and 3 cellular compartment or organelle markers at single-cell resolution in a human pancreatic ductal adenocarcinoma (PDAC) sample that spanned across three distinct tissues: the pancreas, small intestine, and tumor. In total, 160,000 cells were profiled. Giotto identified 13 coarse clusters which include mesenchymal, epithelial, immune, and cancer cells (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>f, g). Next, we zoomed into each tissue to refine the cell type structure in the pancreas and small intestine separately (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>h). For example, we can now see clearly that the pancreas is structured in distinct zones enriched with epithelial (<italic>E-cadherin</italic>) and mesenchymal or stromal (<italic>Vimentin</italic>) cells, respectively. On the other hand, the small intestine shows a clear proliferating zone (PCNA) and the activation of Wnt signaling (<italic>b-catenin</italic>) in intestinal epithelial cells (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>i, j). Both observations are consistent with the original paper [<xref ref-type="bibr" rid="CR10">10</xref>]. Applying the same approach to analyze a mouse spleen dataset from CODEX [<xref ref-type="bibr" rid="CR12">12</xref>] allowed us to identify zones enriched with CD8(+) T cells (Zone 1) and enriched with erythroblasts and F4/80 macrophages (Zone 2) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S4 E-I). As such, the employment of Giotto to quickly zoom in to different regions is useful for uncovering the organization of spatial tissues or expression levels in a hierarchical manner.</p>
      </sec>
      <sec id="Sec5">
        <title>Analysis of data with lower spatial resolution</title>
        <p id="Par12">Recently, a number of lower-resolution spatial transcriptomic technologies have been developed, such as 10X Genomics Visium [<xref ref-type="bibr" rid="CR26">26</xref>], Slide-seq [<xref ref-type="bibr" rid="CR8">8</xref>], and DBiT-seq [<xref ref-type="bibr" rid="CR27">27</xref>]. Despite their lower spatial resolution, these technologies are useful because they are currently more accessible. To overcome the challenge of lower resolution, Giotto implements a number of algorithms for estimating the enrichment of a cell type in different regions (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a). In this approach, a continuous value representing the likelihood of the presence of a cell type of interest is assigned to a spatial location which contains multiple cells. To this end, Giotto requires additional input representing the gene signatures of known cell types. Currently, the input gene signatures for the known cell types can either be provided by the user directly as cell type marker gene lists, or be automatically inferred by Giotto based on an additional scRNAseq data matrix input. Giotto then evaluates the match between each cell type&#x2019;s gene signatures and the expression pattern at each spatial location and reports an enrichment score by using one of the three algorithms: PAGE [<xref ref-type="bibr" rid="CR28">28</xref>], RANK, and Hypergeometric testing (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>a, see &#x201C;Methods&#x201D; for details). PAGE calculates an enrichment score based on the fold change of cell type marker genes for each spot. RANK does not require predefined marker genes but instead creates a full ranking of genes ordered by the cell-type specificity score in the scRNAseq data matrix, and computes a ranking-based statistic. Hypergeometric test computes a <italic>p</italic> value based on the overlap between each cell-type-specific marker gene set and the set of spot-specific genes, i.e., those that are expressed at significantly higher levels at certain spots than others (see &#x201C;Methods&#x201D;). As negative controls, enrichment scores are also calculated for scrambled spatial transcriptomic data. This allows us to evaluate the statistical significance of an observed enrichment score.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Cell-type enrichment analysis on spatial expression data<bold>. a</bold> Schematic of cell-type enrichment analysis pipeline. The inputs are spatial expression data and cell-type-specific gene signatures. These two sources of information are integrated to infer cell type enrichment scores. Giotto implements three methods for enrichment analysis: PAGE, RANK, and Hypergeometric. <bold>b</bold> Single-cell resolution seqFISH+ data are used to simulate coarse-resolution spatial transcriptomic data generated from spot-like squares by projecting onto a regular spatial grid (500&#x2009;&#xD7;&#x2009;500 pixels). Colored squares indicate those that contain cells. External scRNAseq data are visualized by UMAP. <bold>c</bold> Comparison of cell-type enrichment scores (left, inferred by PAGE) and observed frequency of various cell types (right, based on seqFISH+ data). The agreement between the two is quantified by area under curve (AUC) scores (green circles). <bold>d</bold> Cell type enrichment analysis for the mouse Visium brain dataset (distance unit&#x2009;=&#x2009;1 pixel, 1 pixel &#x2248; 1.46&#x2009;&#x3BC;m). Enrichment scores for selected cell types are displayed (top left) and compared with the expression level of known marker genes (bottom left). For comparison, a snapshot of the anatomic structure image obtained from mouse Allen Brain Atlas is displayed. Known locations for the selected cell types are highlighted</p></caption><graphic xlink:href="13059_2021_2286_Fig3_HTML" id="MO3"/></fig></p>
        <p id="Par13">To rigorously evaluate the performance of these cell-type enrichment algorithms, we created a simulated dataset based on the aforementioned seqFISH+ dataset, for which the cell type annotation has been established at the single-cell resolution. To mimic the effect of spatial barcoding, such as that being used in Visium, the merged fields of view were divided into spot-like squares from a regular spatial grid (500&#x2009;&#xD7;&#x2009;500 pixels, ~&#x2009;51.5&#x2009;&#x3BC;m) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>b). For cells located in each square, their gene expression profiles were averaged, thereby creating a new dataset with lower spatial resolution. To apply cell-type enrichment analysis, we obtained scRNAseq data and derived marker gene lists for somatosensory cortex associated cell types from a previous study [<xref ref-type="bibr" rid="CR29">29</xref>]. To facilitate cross-platform comparison, we focused on the six major cell types that were annotated by both studies: astrocytes, microgila, endothelial mural, excitatory neurons, inhibitory neurons, and oligodendrocytes (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>b). For each cell type, we assigned an enrichment score and <italic>p</italic> value for each spot by using one of the three enrichment analysis methods mentioned above (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>c). To quantify the performance of each method, we evaluated the area under curve (AUC) score, which was obtained by using the ranking of enrichment score values to predict the presence of a cell type at each spot. Both PAGE and RANK provide high accuracy (median AUC&#x2009;=&#x2009;0.95 and 0.96, respectively, Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>c, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5 and S6A). Even if a spot contains only one cell from a given type, it can often be identified (47 out of 67, ~&#x2009;70%). The only cell type that cannot be well predicted by this approach is inhibitory neurons, whose gene signatures are less distinct than others.</p>
        <p id="Par14">In comparison, the hypergeometric test and Spearman correlation methods are less accurate (median AUC&#x2009;=&#x2009;0.86 and 0.72, respectively, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5 and S6A, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes). We also compared it with RCTD [<xref ref-type="bibr" rid="CR30">30</xref>], which is a newly developed method for deconvolution. RCTD also performed well (median AUC value of 0.95, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S5. and S6A), but it was considerably slower than the other methods (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S6C). The four methods that performed well were also robust to changes in number of transcripts (UMIs) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S6B).</p>
        <p id="Par15">Next, we applied cell-type enrichment analysis to a publicly available mouse brain Visium dataset (downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/">https://www.10xgenomics.com/</ext-link>). Spatial transcriptomic information was obtained by using 2698 spatially barcoded array spots, each covering a circled area with 55&#x2009;&#x3BC;m in diameter. To comprehensively perform enrichment analysis, cell type annotations and corresponding gene signatures were obtained from a public scRNAseq dataset [<xref ref-type="bibr" rid="CR31">31</xref>]. Here, we applied PAGE to identify the spatial patterns of the major cell taxonomies identified previously [<xref ref-type="bibr" rid="CR31">31</xref>]. We found that a number of cell types are spatially restricted to distinct anatomical regions (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>d, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S6D). The spatial patterns of the enrichment scores are consistent with the literature for a number of cell types, such as peptidergic cells, granule neurons, ependyma astrocytes, and medium spiny neurons (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>d) [<xref ref-type="bibr" rid="CR32">32</xref>&#x2013;<xref ref-type="bibr" rid="CR34">34</xref>]. Similar but less obvious trends can be observed by inspecting the expression pattern of specific marker genes (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>d), which is consistent with the fact that cell types are typically defined by the concerted activities of multiple genes. Of note, the enrichment analysis also correctly predicted the absence of cell types that should not be present in the sample, such as cerebellum, olfactory bulb, and spinal cord cells (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S6D).</p>
        <p id="Par16">To test the general applicability of the enrichment analysis algorithms, we re-analyzed a Slide-seq dataset [<xref ref-type="bibr" rid="CR8">8</xref>] (see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes for details), where the read coverage is lower than Visium. This dataset profiles the mouse cerebellum, containing 21,000 beads and 10,500 genes at a coverage of 80 UMIs per bead. Cell-type gene signature information was obtained from a public scRNAseq dataset for a similar region [<xref ref-type="bibr" rid="CR31">31</xref>]. Analysis of this scRNAseq dataset identified 15 different cell types. We applied the RANK method for enrichment analysis (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S7A) and noticed distinct spatial enrichment of cell types in the Slide-seq data that are consistent with prior knowledge. For example, the Purkinje cells were correctly mapped to the Purkinje layer, granule cells were correctly mapped to the nuclear layer, and GABAergic interneurons were mapped to the molecular layer (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S7B). For comparison, we also applied RCTD to analyze the same dataset and obtained similar results (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S7B, C).</p>
      </sec>
      <sec id="Sec6">
        <title>Giotto uncovers different layers of spatial expression variability</title>
        <p id="Par17">A key component of Giotto Analyzer is the implementation of a wide range of computational methods to identify spatial patterns based on gene expression. On a fundamental level, Giotto Analyzer represents the spatial relationship among different cells as a spatial grid or network (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a). To create a spatial grid, each image field is partitioned into regular squares and the gene expression patterns associated with cells within each square are averaged. As such, the spatial grid is a coarse-resolution representation of the data. A spatial network preserves single-cell resolution, and it is created by connecting neighboring cells through a Delaunay triangulation network (see &#x201C;Methods&#x201D;). As an alternative approach to create a spatial network, the user can create a spatial network by selecting the <italic>k</italic>-nearest neighbors or using a fixed distance cut-off, which allows the user to fine-tune the influence of neighboring cells in more downstream applications (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8A). However, as shown in Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes, our analysis results are typically insensitive to the specific choice of parameter values.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Layers of spatial gene expression variability. <bold>a</bold> Schematic representation of the subsequent steps needed to dissect the different layers of spatial gene expression variability. The original cell locations, a spatial grid, or a spatial network is required to identify individual genes with spatial coherent expression patterns. Those spatial genes can then be used as input to compute continuous spatial co-expression patterns or to find discrete spatial domains with HMRF. <bold>b&#x2013;d</bold> Spatial gene expression analysis of the seqFISH+ somatosensory cortex dataset (distance unit&#x2009;=&#x2009;1 pixel, 1 pixel &#x2248; 103&#x2009;nm). <bold>b</bold> Examples of identified spatial genes within the somatosensory multi-layered cortex. The outer layers are on the left, while more inner layers are on the right. <bold>c</bold> Overlap between the top 1000 spatial genes identified from the 5 methods implemented in Giotto. <bold>d</bold> Visualization of spatial domains identified by the HMRF model. The layered anatomical structure (L1&#x2013;6) of the somatosensory cortex is indicated on top. <bold>e, f</bold> Spatial gene expression analysis of the Visium kidney dataset (distance unit&#x2009;=&#x2009;1 pixel, 1 pixel &#x2248; 1.46&#x2009;&#x3BC;m). <bold>e</bold> Heatmap showing the spatial gene co-expression results. Identified spatial co-expression modules are indicated with different colors on top. <bold>f</bold> Metagene visualizations for all the identified spatial gene co-expression modules from <bold>e, g</bold> Selected gene visualizations for each identified spatial metagene in <bold>e</bold> and <bold>f</bold></p></caption><graphic xlink:href="13059_2021_2286_Fig4_HTML" id="MO4"/></fig></p>
        <p id="Par18">A basic and often first important task in spatial transcriptomic or proteomic analysis is to identify genes whose expression displays a coherent spatial pattern. To this end, Giotto implements a number of methods, including SpatialDE [<xref ref-type="bibr" rid="CR35">35</xref>], Trendsceek [<xref ref-type="bibr" rid="CR36">36</xref>], SPARK [<xref ref-type="bibr" rid="CR37">37</xref>], and two novel methods that are based on spatial network calculations. More specifically, the latter two methods are based on statistical enrichment of spatial network neighbors in the high gene expression state after binarization therefore named as BinSpect (Binary Spatial Extraction). The two methods, called BinSpect-<italic>k</italic>means and BinSpect-rank, respectively, differ in the way of binarization (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8B, Methods). To evaluate the performance of these methods, we applied each to the seqFISH+ dataset, where many genes are expected to display layer-specific patterns that are consistent with the anatomical structure of the somatosensory cortex (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>b, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8C). For each method, we selected the top 1000 genes as candidates for spatially coherent genes. Of note, a large subset of these genes was identified by at least four of the methods (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>c), these include previously established layer-specific genes such as <italic>Cux2</italic>, <italic>Grm2</italic>, and <italic>Rprm</italic>, indicating that genes with a known and strong spatially coherent expression pattern can be found in a robust manner. On the other hand, subsets of genes were detected by only one or a combination of specific method(s) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8D-G, see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes), suggesting it may be beneficial to combine results from all methods for comprehensiveness. The main advantage of the BinSpect methods introduced here is that they are significantly faster compared to SpatialDE (~&#x2009;6&#x2013;8&#xD7;), SPARK (~&#x2009;29&#x2013;45&#xD7;), and Trendsceek (~&#x2009;816&#x2013;3300&#xD7;) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8H-I, see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes).</p>
        <p id="Par19">Next, to assess how effective each method could retrieve known spatial patterns, we performed a quantitative evaluation based on simulated patterns. In this evaluation, we excluded trendsceek since its speed inhibited its use in large-scale simulation studies. Since each method was based on different assumptions or statistical models, we established an unbiased simulation strategy based on real high-quality data (seqFISH+), which did not rely on a simplified and arbitrary representation of spatial expression data, but instead incorporated all known and unknown variability factors observed in a large subset of genes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S9, see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes for details). These results show that BinSpect (<italic>k</italic>means and rank) perform systematically better at retrieving known spatial genes, especially when additional noise is introduced. This observation is consistent irrespective of the spatial expression pattern that is evaluated (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8J).</p>
        <p id="Par20">Giotto implements two approaches to systematically summarize the spatial patterns of a large number of spatial genes (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a). First, Giotto identifies spatial domains with coherent gene expression patterns by implementing our recently developed hidden Markov random field (HMRF) model [<xref ref-type="bibr" rid="CR38">38</xref>]. An HMRF model detects spatial domains by comparing the gene expression patterns of each cell with its neighborhood to search for coherent patterns (see &#x201C;Methods&#x201D; for details). The inference is based on the joint probability of the intrinsic factor (expression pattern of each cell) and the extrinsic factor (domain state distribution of the surrounding cells) [<xref ref-type="bibr" rid="CR38">38</xref>]. The analysis starts with the identification of spatial genes using one of the previously described methods. Then we apply our HMRF model to infer the spatial domain state for each cell or spot. In applying HMRF to the seqFISH+ dataset, our analysis identified 9 distinct spatial domains that were consistent with the anatomic layer structure (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>d). For example, Domain D7 is similar to Layer L1, and Domain D2 is similar to Layer L2/3. Of note, such layered structure is not completely reflected by the distribution of different cell types (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1F), as numerous cell types (such as inhibitory neurons and endothelial cells) are distributed across multiple layers.</p>
        <p id="Par21">In addition, Giotto also implements a summary view of spatial gene expression patterns based on co-expression analysis. As an illustrating example, we analyzed a Visium dataset obtained from the kidney coronal section, which has known and distinguishable anatomic structures [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. Using the BinSpect-<italic>k</italic>means algorithm in Giotto, we selected the top 500 spatially coherent genes. To identify spatial patterns, we created a co-expression matrix as follows. First, we spatially smoothed the gene expression data through spatial neighbor averaging, and then created co-expression modules by clustering the spatially smoothed data (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>e). Next, the spatial pattern of each module was summarized by a metagene defined by averaging the expression of all associated genes, which were stored and visualized (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>f). These spatial metagene profiles resemble the known anatomical structures of the mouse kidney and its surrounding environment, which is further corroborated by the spatial co-expressed genes in each module (see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes). Moreover, individual genes representing the co-expression patterns were easily extracted and displayed (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>g), providing researchers the opportunity to explore these spatial co-expression patterns in an unbiased manner on a transcriptome wide level. In addition, Giotto also provides a co-expression network based on single-cell expression data so that users can further filter or distinguish spatial co-expression within a local neighborhood from co-expression within the same cell. Finally, these global co-expression patterns are largely insensitive to the characteristics of the underlying spatial network (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S10A-D, see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes for details).</p>
      </sec>
      <sec id="Sec7">
        <title>Giotto identifies distinct cellular neighborhoods and interactions</title>
        <p id="Par22">Most cells reside within complex tissue structures, where they can communicate with their neighboring cells through specific molecules and signaling pathways. Hence, gene expression within each cell is likely driven by the combination of an intrinsic (cell-type-specific) component and an extrinsic component mediated by cell-cell communications (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>a). Giotto Analyzer provides a number of tools to explore and extract information related to the cell neighborhood organization, cell-cell communication, and the effect of neighboring cell types on gene expression. To identify distinct cell-type/cell-type interacting patterns, Giotto evaluates the enrichment of the frequency that each pair of cell types is proximal to each other. When analyzing the seqFISH+ somatosensory cortex data, we observed that layer-specific neurons usually interact with each other, which agrees with the known multi-layered organization of the cortex (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>b). Such homo-typic (same cell types) relationships are in agreement with what has been observed by others, including in other tissues [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Here we also notice that astrocytes and oligodendrocytes, L2/3 and L4 excitatory neurons, and L5 and L6 excitatory neurons form frequent hetero-typic (two different cell types) interactions. This is again in line with the expected anatomical structure of the cortex, due to positioning of the cortex layers and the increased presence of astrocytes and oligodendrocytes close to where they originate in the subventrical zone (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1F and Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>F). These observations are robust to changes in number of spatial neighbors (<italic>k</italic>) (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S11A, see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes) and are furthermore observed in both the seqFISH+ and osmFISH somatosensory cortex datasets (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S11B, see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes).
<fig id="Fig5"><label>Fig. 5</label><caption><p>Cell neighborhood and cell-to-cell communication analyses. <bold>a</bold> Schematic of a multicellular tissue with an organized cellular structure (left) and environment specific gene expression (right). <bold>b</bold> A network representation of the pairwise interacting cell types identified by Giotto in the seqFISH+ somatosensory cortex dataset. Enriched or depleted interactions are depicted in red and green, respectively. Width of the edges indicates the strength of enrichment or depletion. <bold>c</bold> Visualization of the cell-to-cell communication analysis strategy. For each ligand-receptor pair from a known database a combined co-expression score was calculated for all cells of two interacting cell types (e.g., yellow and blue cells, left). This co-expression score was compared with a background distribution of co-expression scores based on spatial permutations (<italic>n</italic>&#x2009;=&#x2009;1000). A cell-cell communication score based on adjusted <italic>p</italic> value and log2 fold change was used to rank a ligand-receptor pair across all identified cells of interacting cell types (right). <bold>d</bold> Heatmap (left) showing the ranking results for the ligand-receptor analysis as in <bold>c</bold> (<italic>y</italic>-axis) versus the same analysis but without spatial information (<italic>x</italic>-axis) for all the ligand-receptor pairs. AUC plot (right) indicating the percentage of expression ranks that need to be considered to recover all the first spatial ranks. <bold>e</bold> Dotplot for ligand-receptor pairs that exhibit differential cell-cell communication scores due to spatial cell-cell interactions. The size of the dot is correlated with the adjusted <italic>p</italic> value and the color indicates increased (red) or decreased (blue) activity. Dots highlighted with a green box are used as examples in <bold>f</bold>. <bold>f</bold> Heatmaps showing the increased expression of indicated ligand-receptor pairs between cells of two interacting cell types. <bold>g</bold> Barplot showing gene expression changes in subsets of endothelial cells (left) stratified based on their spatial interaction with other indicated cell types (right, schematic visualization)</p></caption><graphic xlink:href="13059_2021_2286_Fig5_HTML" id="MO5"/></fig></p>
        <p id="Par23">To extend this type of analysis to less defined tissues, we also analyzed a public MIBI dataset profiling the spatial proteomic patterns in triple negative breast cancer (TNBC) patients [<xref ref-type="bibr" rid="CR13">13</xref>]. Over 200,000 cells from 41 patients were analyzed together to generate over 20 cell populations (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S12A). Of note, the preferred mode of hetero-typic cell-type interactions is highly patient specific (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S12B, C). For example, in patients 4 and 5, the Keratin-marked epithelial cells and immune cells are well segregated from each other, whereas patients 10 and 17 feature a rather mixed environment between T cells, Keratin, and Ki67 cancer cells. (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S12B, C). These observations are consistent with prior findings [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
        <p id="Par24">Giotto builds further on the concept of interacting cell types and aims to identify which known ligand-receptor pairs show increased or decreased co-expression, as a reasonable proxy for activity, in two cell types that spatially interact with each other (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>c). By creating a background distribution through spatially aware permutations (see &#x201C;Methods&#x201D;), Giotto can identify which ligand-receptor pairs are potentially more or less active when cells from two cell types are spatially adjacent to each other. By comparing with a spatially unaware permutation method, similar as previously done [<xref ref-type="bibr" rid="CR42">42</xref>], we can see that the predictive power is limited without spatial information (AUC&#x2009;=&#x2009;0.43) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>c,d). This analysis is relatively stable to different numbers of spatial neighbors (<italic>k</italic>) within the spatial network (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S11C, see Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Supplementary Notes) and is observed for multiple ligand-receptor pairs spread out over multiple cell type pairs (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>e). Two potential examples of increased co-expression of a ligand-receptor pair are seen in spatially interacting astrocytes and <italic>Lhx6+</italic> inhibitory neurons displaying increased expression of <italic>Ddr2</italic>-<italic>Col1a1</italic> and <italic>Bmp6</italic>-<italic>Bmpr1b</italic> in corresponding endothelial cells and oligodendrocytes, respectively (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>f).</p>
        <p id="Par25">More generally, Giotto implements a number of statistical tests (<italic>t</italic>-test, limma, Wilcoxon, and a spatial permutation test) to identify genes whose expression level variation within a cell type is significantly associated with an interacting cell type (see &#x201C;Methods&#x201D;). After correcting for multiple hypothesis testing, we identified 73 such genes (|log2 FC|&#x2009;&gt;&#x2009;2 and FDR&#x2009;&lt;&#x2009;0.1), which we refer to as the interaction changed genes (ICGs). These ICGs are distributed among different interacting cell type pairs (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S11D). For example, we noticed that endothelial cells interacting with Lhx6 iNeuron were associated with increased expression of <italic>Jakmip1</italic> and <italic>Golgb1</italic>, whereas both <italic>Dact2</italic> and <italic>Ddx27</italic> expression levels were increased in cells from the same cell type but interacting with L4 eNeurons (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>g). On the opposite direction, interaction with astrocytes was associated with decreased expression of <italic>Abl1</italic> and <italic>Zswim8</italic>. Of note, all these subsets of endothelial cells do not show any difference in expression of their known marker genes, such as <italic>Pltp</italic>, <italic>Cldn5</italic>, and <italic>Apcdd1 (</italic>Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>g, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2D<italic>)</italic>.</p>
      </sec>
      <sec id="Sec8">
        <title>Giotto Viewer: interactive visualization and exploration of spatial transcriptomic data</title>
        <p id="Par26">Giotto Viewer is designed for interactive visualization and exploration of spatial transcriptomic data. Compared to the figure outputs from Giotto Analyzer, the objective of Giotto Viewer is to provide an interactive and user-friendly workspace where the user can easily explore the data and integrate the results from various analyses from Giotto Analyzer, and further incorporate additional information that cannot be easily quantified, such as cell staining images.</p>
        <p id="Par27">Giotto Viewer is a web-based application running in a local environment. It supports a multi-panel view of the spatial expression data. Each panel can be configured to display either the cells in physical or the expression space and overlays gene expression information on top. Complex geometries such as the 2D cell morphology and the associated large antibody staining images of the cells can be toggled easily within each panel. We use a Google Map-like algorithm to facilitate efficient navigation of large data (in terms of either images or cell numbers, see &#x201C;Methods&#x201D;). Importantly, panels are interlinked and interactive through sharing of cell ID and annotation information (see &#x201C;Methods&#x201D;). This allows seamless integration of different views and facilitates synchronous updates across all panels. We were able to apply Giotto Viewer to display over 500,000 data points (or mRNA transcripts) within a group of cells on one screen without any problem. Indicating the Giotto viewer is capable of handling large datasets.</p>
        <p id="Par28">As an illustrating example, we used Giotto Viewer to visualize the Visium brain dataset. By default, Giotto Viewer creates two panels, representing the data in physical and gene expression space, respectively (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>a, left). Any property that is contained in a Giotto object, such as gene expression levels, spatial cell-type enrichment values, cell-type or spatial domain annotations, can be selected for visualization. Additional imaging-related information, such as cell staining and segmentation, can also be overlaid. The size and location of field of view can be easily adjusted via the zoom and pan functions. At one end of the spectrum, the image content at each single spot can be visualized (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>a, right), revealing the underlying H&amp;E staining pattern. An animated video is provided to illustrate how the user can interactively explore the data and high-level annotations (Additional&#xA0;file&#xA0;4: Supplementary Video).
<fig id="Fig6"><label>Fig. 6</label><caption><p>Giotto Viewer provides an interactive workspace to visualize and compare multiple cell annotations. <bold>a</bold> Visualization of the Visium brain dataset. Two interlinked panels are displayed, showing the data in the physical (left) and expression space (middle). A zoomed-in view shows underlying cell staining pattern at individual spots (right). <bold>b&#x2013;e</bold> Visualization of the seqFISH+ mouse somatosensory cortex dataset. <bold>b</bold> Four interlinked panels are displayed, showing the spatial domain (top) and cell type (bottom) distribution in both physical (left) and expression space (right). <bold>c</bold> A zoomed-in view of <bold>b</bold> focusing on the L1&#x2013;3 regions. Cells in domain D7 are selected (indicated by red outline in left panels and highlighted in the right panels) to enable comparison between spatial domain and cell type annotations. <bold>d</bold> Expression patterns of representative domain-specific genes. <bold>e</bold> Subcellular transcript localization patterns of all (top) or selected genes (middle and bottom) in a representative cell. Each dot represents an individual transcript</p></caption><graphic xlink:href="13059_2021_2286_Fig6_HTML" id="MO6"/></fig></p>
        <p id="Par29">
<media xlink:href="13059_2021_2286_MOESM4_ESM.mp4" id="MOESM4"><caption><p><bold>Additional&#xA0;file&#xA0;4: Supplementary Video.</bold> Supplementary video demonstrating the usage and options of Giotto Viewer.</p></caption></media></p>
        <p id="Par30">To demonstrate the utility of Giotto Viewer for exploring and integrating a large amount of information generated by Giotto Analyzer, we used the aforementioned seqFISH+ dataset again. Through the analysis described above, we identified various annotations such as cell types, spatially coherent genes, and spatial domains. Therefore, it is of interest to compare the cell type and spatial domain annotation to investigate their relationship. To this end, we created four interlinked panels corresponding to cell type and spatial domain annotations represented in the physical and expression space, respectively (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>b). The view of these panels can be synchronously updated through zoom and pan operations, enabling the user to easily explore the data and inspect any area of interest as desired. For example, as the user zooms in to the L1&#x2013;L2/3 region (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>c), it becomes apparent that domain D7 consists of a mixture of cell types including astrocytes, microglias, and interneurons. Giotto Viewer also provides a lasso tool that allows users to select cells of interest for further analyses. The borders of the selected cells are highlighted and can be easily traced across different panels. As an example, cells from domain D7 are selected and highlighted (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>c). By inspecting the pattern in the interlinked panels, it becomes obvious that this domain contains cells from multiple cell types. As such, both cell type and spatial domain differences contribute to cellular heterogeneity.</p>
        <p id="Par31">To gain further insights into the difference between cell type and spatial domain annotations, we saved the selected cells to an output file. The corresponding information was directly loaded into Giotto Analyzer for further analysis. This allowed us to identify a number of additional marker genes, such as <italic>Cacng3</italic> and <italic>Scg3</italic> (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>d). The seamless iteration between data analysis and visualization is a unique strength of Giotto.</p>
        <p id="Par32">In addition, Giotto Viewer also provides the functionality to explore subcellular transcript or protein localization patterns. As an example, we used Giotto Viewer to visualize the exact locations of individual transcripts in selected cells from the seqFISH+ dataset (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>e, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S12). To facilitate real-time exploration of the transcript localization data, which is much larger than other data components, we adopted a position-based caching of transcriptomic data (see &#x201C;Methods&#x201D;). From the original staining image (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S13A), the users can zoom in on any specific region or select specific cells and visualize the locations of either all detected transcripts (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S13B) or selected genes of interest (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S13C). The spatial extent of all transcripts is useful for cell morphology analysis (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S13B), whereas the localization pattern of individual genes may provide functional insights into the corresponding genes (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S13C). For example, transcripts of <italic>Snrnp70</italic> and <italic>Car10</italic> are preferentially localized to the cell nucleus (delineated by DAPI background), while <italic>Agap2</italic> and <italic>Kif5a</italic> transcripts are distributed closer to the cell periphery (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S13C).</p>
      </sec>
    </sec>
    <sec id="Sec9">
      <title>Discussion</title>
      <p id="Par33">Single-cell analysis has entered a new phase&#x2014;from characterizing cellular heterogeneity to interpreting the role of spatial organization. To overcome the challenge for data analysis and visualization, we have developed Giotto as a standardized toolbox, which implements a rich set of algorithms to address the common tasks for spatial transcriptomics/proteomic data analysis, including cell-type enrichment analysis, spatially coherent gene detection, spatial pattern recognition, and cell neighborhood and interaction analyses. Through analyzing diverse public datasets, we have demonstrated that Giotto can be broadly applied in conjunction with a wide range of spatial transcriptomic and proteomic technologies.</p>
      <p id="Par34">Giotto has a number of strengths, including modularization, interactive visualization, reproducibility, robustness, and flexibility. It differs from existing spatial data analysis and/or visualization pipelines [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR43">43</xref>&#x2013;<xref ref-type="bibr" rid="CR46">46</xref>] and is complementary to alternative strategies that computationally infer spatial information from single-cell RNAseq analysis [<xref ref-type="bibr" rid="CR47">47</xref>]. To our knowledge, Giotto is the first demonstrated general-purpose toolbox for spatial transcriptomic/proteomic data analysis, while the other methods are designed for specific data types [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR48">48</xref>&#x2013;<xref ref-type="bibr" rid="CR50">50</xref>] or tasks, such as the identification of cell types [<xref ref-type="bibr" rid="CR43">43</xref>], marker genes [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], or domain patterns [<xref ref-type="bibr" rid="CR38">38</xref>]. Although both Seurat and Scanpy have now adopted spatial transcriptomic analysis functionalities, an important distinction is that our design of the Giotto object is specifically targeted for spatial transcriptomic data analysis, whereas the data structure in the other packages were originally designed for single-cell RNAseq analysis. The flexible design of Giotto makes it an ideal platform for incepting new algorithms. In addition, Giotto provides a convenient venue to integrate external information such as single-cell RNAseq data. As single-cell multi-omics data become more available, such integration may greatly enhance mechanistic understanding of the cell-state variation in development and diseases.</p>
    </sec>
    <sec id="Sec10">
      <title>Methods</title>
      <sec id="Sec11">
        <title>Giotto analyzer</title>
        <p id="Par35">Giotto Analyzer is an open-source R package that at its center creates a S4 Giotto object (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S1A), which stores a gene expression matrix, the accompanying cell locations, and optionally any associated tissue images for visualization purposes. It contains multiple functions that can either extract or add new information to this object in a flexible manner. In this way users can either follow the default settings or build their own stepwise pipeline to extract and visualize spatial information. In the next part, the core steps and functions of Giotto Analyzer are explained and names of functions are depicted in italic.</p>
      </sec>
      <sec id="Sec12">
        <title>Quality control, pre-processing, and normalization</title>
        <p id="Par36">A Giotto object can be created with the function <italic>createGiottoObject</italic>, which requires as minimum input an expression matrix and the spatial coordinates of corresponding cell centroids. If a dataset is composed of multiple fields of view or tiles, they can be stitched together by using <italic>stitchFieldCoordinates</italic> or <italic>stitchTileCoordinates</italic>, respectively. Next, this Giotto object can be filtered with <italic>filterGiotto</italic> to exclude low-quality cells or lowly expressed or detected genes. As a guide for setting the filtering parameters, the cell and gene distributions can be viewed with <italic>filterDistributions</italic> and the effect of multiple parameters can be tested with <italic>filterCombinations</italic>. Raw counts can further be normalized with <italic>normalizeGiotto</italic>, which can adjust for library size, log transform the matrix, and/or perform rescaling. Next the function <italic>addStatistics</italic> computes general cell and gene statistics such as the total number of detected genes and counts per cell. To adjust for variation due to the former technical covariates the <italic>adjustGiottoMatrix</italic> can be applied to the normalized data. If the dataset does not have single-cell resolution, the above steps can still proceed while treating each spatially barcoded spot as a cell.</p>
      </sec>
      <sec id="Sec13">
        <title>Feature selection</title>
        <p id="Par37">To identify informative genes for clustering the <italic>calculateHVG</italic> can be used. Highly variable genes can be detected in two different manners. In the first method, all genes are divided in a predefined number (default&#x2009;=&#x2009;20) of equal sized bins based on their expression. Within each bin the coefficient of variation for each gene is calculated and these are subsequently converted to <italic>z</italic>-scores. Genes above a predefined <italic>z</italic>-score threshold (default&#x2009;=&#x2009;1.5) are selected for further analysis. For the second method, a loess regression model is calculated to predict the coefficient of variation based on the log-normalized expression values. Genes that show higher degree of variability than predicted are considered highly variable genes. Genes can be further filtered based on average expression values or detection percentage, which is returned by the <italic>addStatistics</italic> function.</p>
      </sec>
      <sec id="Sec14">
        <title>Dimensionality reduction</title>
        <p id="Par38">To reduce dimensions of the expression dataset users can perform principal component analysis (PCA) with <italic>runPCA</italic>. Significant PCs can be estimated with the <italic>signPCA</italic> function using a scree plot or the jackstraw method [<xref ref-type="bibr" rid="CR51">51</xref>]. Further nonlinear dimension reduction can be performed with uniform manifold approximation and projection (UMAP) [<xref ref-type="bibr" rid="CR20">20</xref>] and t-distributed stochastic neighbor embedding (t-SNE) [<xref ref-type="bibr" rid="CR19">19</xref>] directly on the expression matrix or on the PCA space using <italic>runUMAP</italic> and <italic>runtSNE</italic>, respectively.</p>
      </sec>
      <sec id="Sec15">
        <title>Clustering</title>
        <p id="Par39">First a shared or <italic>k</italic>-nearest neighbor (sNN or kNN) network needs to be constructed with <italic>createNearestNetwork</italic> which uses as input either processed expression values or their projection onto a selected dimension reduction space, such as that obtained from PCA. Louvain and Leiden clustering [<xref ref-type="bibr" rid="CR22">22</xref>] are implemented as <italic>doLouvainCluster</italic> and <italic>doLeidenCluster</italic> and can be directly applied on the created expression-based network. Further subclustering on all or a selected set of clusters can be performed in an analogous manner with <italic>doLouvainSubCluster</italic> or <italic>doLeidenSubCluster</italic>. Alternative clustering options such as <italic>k</italic>means and hierarchical clustering are also available as <italic>doKmeans</italic> and <italic>doHclust</italic>. To aid in further fine-tuning, the clustering results users can compute cluster correlation scores with <italic>getClusterSimilarity</italic> and decide to merge clusters with <italic>mergeClusters</italic> based on a user defined correlation threshold and cluster size parameters.</p>
      </sec>
      <sec id="Sec16">
        <title>Marker gene detection</title>
        <p id="Par40">Giotto provides 3 different ways within the function <italic>findMarkers</italic> to identify marker genes for one or more clusters: scran, mast, and gini. The first two methods have been previously published [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR52">52</xref>] and are implemented as <italic>findScranMarkers</italic> and <italic>findMastMarkers</italic>. In addition, we also developed a novel method based on the Gini-coefficient [<xref ref-type="bibr" rid="CR25">25</xref>] and implemented it as f<italic>indGiniMarkers</italic>, as schematically illustrated in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S2B. First, we calculate the average log-normalized expression for each gene in each cluster and represent the result as a matrix <italic>X</italic>, with <italic>X</italic>(<italic>i, j</italic>) representing the average expression of <italic>i</italic>th gene in <italic>j</italic>th cluster. Similarly, we calculate the detection fraction of each gene in each cluster and represent the result as a matrix <italic>Y</italic>, with <italic>Y</italic>(<italic>i, j</italic>) representing the detection fraction of <italic>i</italic>th gene in <italic>j</italic>th cluster. For each gene <italic>i</italic>, we calculate two related quantities <italic>G</italic><sub>expr</sub>(<italic>i</italic>) and <italic>G</italic><sub>det</sub>(<italic>i</italic>), by computing the Gini-coefficient associated with row <italic>X</italic>(<italic>i</italic>,.) and <italic>Y</italic>(<italic>i</italic>,.), respectively. Gini-coefficient of a vector <italic>x</italic>&#x2009;=&#x2009;[<italic>x</italic><sub>1</sub>,<italic>x</italic><sub>2</sub>, &#x2026;, <italic>x</italic><sub><italic>n</italic></sub>] is defined as:</p>
        <p id="Par41">
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ G(x)=\frac{\sum_{i=1}^n{\sum}_{j=1}^n\mid {x}_i-{x}_j\mid }{2\ {n}^2\ \overline{x}} $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi>G</mml:mi><mml:mfenced close=")" open="("><mml:mi>x</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:msubsup><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:mo>&#x2223;</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>&#x2212;</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>&#x2223;</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mspace width="0.25em"/><mml:msup><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mspace width="0.25em"/><mml:mover accent="true"><mml:mi>x</mml:mi><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mover></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="13059_2021_2286_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par42">In the meantime, for each gene <italic>i</italic>, we also rank the clusters based on either gene expression <italic>X</italic>(<italic>i</italic>,.) or detection rate <italic>Y</italic>(<italic>i</italic>,.), and the corresponding ranks are denoted by <italic>R</italic><sub>expr</sub>(<italic>i</italic>,.) and <italic>R</italic><sub>det</sub>(<italic>i</italic>,.), respectively. The ranks are subsequently rescaled between 0.1 and 1. Finally, an aggregated score <italic>G</italic><sub>final</sub>(<italic>i</italic>, <italic>j</italic>) is defined as follows:</p>
        <p id="Par43">
<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {G}_{\mathrm{final}}\left(i,j\right)={G}_{\mathrm{expr}}(i)\times {G}_{\mathrm{det}}(i)\times {R}_{\mathrm{expr}}\left(i,j\right)\times {R}_{\mathrm{det}}\left(i,j\right) $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:msub><mml:mi>G</mml:mi><mml:mtext>final</mml:mtext></mml:msub><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mtext>expr</mml:mtext></mml:msub><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced><mml:mo>&#xD7;</mml:mo><mml:msub><mml:mi>G</mml:mi><mml:mi>det</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced><mml:mo>&#xD7;</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mtext>expr</mml:mtext></mml:msub><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced><mml:mo>&#xD7;</mml:mo><mml:msub><mml:mi>R</mml:mi><mml:mi>det</mml:mi></mml:msub><mml:mfenced close=")" open="(" separators=","><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mfenced></mml:math><graphic xlink:href="13059_2021_2286_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par44">The marker genes associated with a cluster <italic>j</italic> are then identified as those with top values of <italic>G</italic><sub>final</sub>(<italic>.</italic>, <italic>j</italic>). We have found this to be a fast and simple approach for effectively identifying genes that are both specific and sufficiently expressed in a particular cluster. In addition, an automated version to perform systematic pairwise comparisons between each cluster and all other clusters is also implemented as <italic>findMarkers_one_vs_all</italic>.</p>
      </sec>
      <sec id="Sec17">
        <title>Enrichment analysis of spatial expression data</title>
        <p id="Par45">Three enrichment methods are implemented into Giotto for enrichment analysis:</p>
        <sec id="Sec18">
          <title>Enrichment analysis by using PAGE (Parametric Analysis of Gene Set Enrichment) [<xref ref-type="bibr" rid="CR28">28</xref>]</title>
          <p id="Par46">In this method, a known set of <italic>m</italic> cell-type-specific marker genes is used as input. The objective is to evaluate if these genes are more highly expressed at each spot as compared to other spots. Specifically, for each spot, we define an enrichment score corresponding to a set of marker genes as follows. First, for each gene in the entire genome, we calculate the expression fold change of this gene by using the expression value in this spot versus the mean expression of all spots. Genes associated with high fold change values are annotated as spot-specific genes. The mean and standard deviation of these fold change values are denoted by <italic>&#x3BC;</italic> and <italic>&#x3B4;</italic>, respectively. For comparison, we also calculated the mean fold change associated with the set of marker genes, denoted by <italic>S</italic><sub><italic>m</italic></sub>. The enrichment score (ES) is then defined as follows:</p>
          <p id="Par47">
<disp-formula id="Equc"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{ES}=\frac{\left({S}_m-\mu \right)\times \sqrt{m}}{\delta } $$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mi>ES</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>&#x2212;</mml:mo><mml:mi>&#x3BC;</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#xD7;</mml:mo><mml:msqrt><mml:mi>m</mml:mi></mml:msqrt></mml:mrow><mml:mi>&#x3B4;</mml:mi></mml:mfrac></mml:math><graphic xlink:href="13059_2021_2286_Article_Equc.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par48">A higher ES value indicates a cell type is more likely to be associated with the spot in question. To estimate the null distribution, we repeat the analysis by using 1000 random gene sets with the same size. The resulting values are fit by a normal distribution. This null distribution is used to derive <italic>p</italic> values associated with the enrichment scores for the real data. The PAGE algorithm is implemented as <italic>runPAGEEnrich</italic>.</p>
        </sec>
        <sec id="Sec19">
          <title>Enrichment analysis based on rank of gene expression</title>
          <p id="Par49">In this method, a known list of marker genes is not required. Instead, an external single-cell RNAseq dataset is used as input along with the cell-type annotation for each cell. A schematic of this method is illustrated in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S7A. The scRNAseq data matrix is used as input to define cell-type-specific gene signatures. A fold-change gene ranking is computed for each cell type (scRNAseq) and a relative gene ranking is computed for each spot or bead (Slide-seq is indicated here as an example), which is then used to derive enrichment scores. More precisely, Giotto automatically identifies cell-type-specific gene signatures (<italic>makeSignMatrixRank</italic>) by computing the fold change for each gene, <italic>g</italic>, defined as the ratio between its mean expression level within a cell type and the mean level across all cell types, followed by evaluating its relative rank <italic>R1</italic><sub><italic>g</italic></sub> among all genes. In the meantime, genes are also ranked based on location specificity, <italic>R2</italic><sub><italic>g</italic></sub>, using the spatial expression data. This is obtained by calculating the fold change comparing its expression level at a specific spot versus the overall mean and then ranking the results. The mutual rank [<xref ref-type="bibr" rid="CR53">53</xref>] of gene <italic>g</italic> is then computed as</p>
          <p id="Par50">
<disp-formula id="Equd"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {R}_g=\sqrt{R{1}_g\times R{2}_g} $$\end{document}</tex-math><mml:math id="M8" display="block"><mml:msub><mml:mi>R</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mi>R</mml:mi><mml:msub><mml:mn>1</mml:mn><mml:mi>g</mml:mi></mml:msub><mml:mo>&#xD7;</mml:mo><mml:mi>R</mml:mi><mml:msub><mml:mn>2</mml:mn><mml:mi>g</mml:mi></mml:msub></mml:mrow></mml:msqrt></mml:math><graphic xlink:href="13059_2021_2286_Article_Equd.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par51">which is then converted to a rank-biased precision (<italic>RBP</italic>) score [<xref ref-type="bibr" rid="CR54">54</xref>], which is defined as follows:</p>
          <p id="Par52">
<disp-formula id="Eque"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{RB}{\mathrm{P}}_g=\left(1-p\right)\times {p}^{\left({R}_g-1\right)} $$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mi>RB</mml:mi><mml:msub><mml:mi mathvariant="normal">P</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x2212;</mml:mo><mml:mi>p</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#xD7;</mml:mo><mml:msup><mml:mi>p</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>R</mml:mi><mml:mi>g</mml:mi></mml:msub><mml:mo>&#x2212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:msup></mml:math><graphic xlink:href="13059_2021_2286_Article_Eque.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par53">where <italic>p</italic> is a constant set at 0.99. Intuitively, the RBP score is used to select genes that are highly ranked in terms of both cell-type specificity and location specificity. The tuning parameter <italic>p</italic> in the above equation is introduced to control the relative weight of highly ranked genes. In the end, the enrichment score (ES) is determined by the sum of genes with top-ranked RBP scores:
<disp-formula id="Equf"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{ES}=\sum \limits_{k=1}^{100}{\mathrm{RBP}}_k $$\end{document}</tex-math><mml:math id="M12" display="block"><mml:mi>ES</mml:mi><mml:mo>=</mml:mo><mml:munderover><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mn>100</mml:mn></mml:munderover><mml:msub><mml:mi>RBP</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math><graphic xlink:href="13059_2021_2286_Article_Equf.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par54">The RANK method is implemented as the <italic>runRankEnrich</italic> function. To estimate the null distribution, we randomly shuffle the ranking of genes in the scRNAseq dataset for 1000 times of each cell type and then apply the above analysis to the shuffled data. The resulting values are fit by a gamma distribution, using the &#x201C;<italic>fitdistrplus</italic>&#x201D; package in R. This null distribution is used to derive <italic>p</italic> values associated with the enrichment scores for the real data.</p>
        </sec>
        <sec id="Sec20">
          <title>Enrichment analysis by using hypergeometric distribution</title>
          <p id="Par55">This method also requires a known set of <italic>m</italic> cell-type-specific marker genes as input, but it evaluates enrichment by simply using a hypergeometric test. A contingency table is constructed by dividing all genes into four non-overlapping categories, based on marker gene annotation and binarization of gene expression values. The latter is determined by top 5% expression genes for each spot. Based on this contingency table, a <italic>p</italic> value is calculated. Here the enrichment score is defined as &#x2212;log10 (<italic>p</italic> value).</p>
        </sec>
      </sec>
      <sec id="Sec21">
        <title>Simulation analysis of seqFISH+ data</title>
        <p id="Par56">We coarse grain seqFISH+ dataset to simulate spatial expression data of a multiple cellular level. The dataset is gridded by 500 pixels by 500 pixels (~&#x2009;51.5&#x2009;&#x3BC;m) length (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>b). This length is quite similar with the diameter of spots from Visium spatial expression dataset (55&#x2009;&#x3BC;m). Then the gene expression for each grid is calculated as the sum of normalized single-cell expressions within the grid. After normalization of gene expression for coarse-gridded data, we perform enrichment analysis by using somatosensory cortex single-cell RNAseq data from [<xref ref-type="bibr" rid="CR29">29</xref>] (GSE60361). scRNAseq data is normalized by <italic>normalizeGiotto</italic> using Giotto. Marker genes for each cell type are identified by using <italic>findMarkers_one_vs_all</italic> with parameter: method&#x2009;=&#x2009;&#x201C;scran&#x201D;, expression_values&#x2009;=&#x2009;&#x201C;normalized&#x201D;. We then intersect those marker genes with genes in seqFISH+ data. Top 100 intersect marker genes for each cell type are kept for further enrichment analysis.</p>
        <p id="Par57">To match the cell-type annotations between seqFISH+ and scRNAseq data, we aggregated the major clusters annotated by Giotto pipeline. &#x201C;L2/3 eNeuron,&#x201D; &#x201C;L4 eNeuron,&#x201D; &#x201C;L5 eNeuron,&#x201D; and &#x201C;L6 eNeuron&#x201D; were marked as excitatory neuron (eNeuron). &#x201C;Adarb2 iNeuron&#x201D; and &#x201C;Lhx6 iNeuron&#x201D; were marked as inhibitory neurons (iNeuron). &#x201C;Endothelial&#x201D; and &#x201C;mural&#x201D; were marked as &#x201C;endothelial_mural&#x201D;. The percentage of cell type for each grid was calculated to evaluate the performance of enrichment methods. Top 100 marker genes identified were used for PAGE and hypergeometric analysis by <italic>createSpatialEnrich</italic> with parameters: enrich_method&#x2009;=&#x2009;&#x201C;PAGE&#x201D; and enrich_method&#x2009;=&#x2009;&#x201C;hypergeometric,&#x201D; respectively. The single-cell expression matrix as well as cell labels were used for rank matrix generation by using <italic>makeSignMatrixRank</italic> with default parameters and enrichment analysis by using <italic>createSpatialEnrich</italic> with parameter: enrich_method&#x2009;=&#x2009;&#x201C;rank.&#x201D;</p>
      </sec>
      <sec id="Sec22">
        <title>Spatial grid and neighborhood network</title>
        <p id="Par58">A spatial grid is defined as a Cartesian coordinate system with defined units of width and height and is created with the function <italic>createSpatialGrid</italic>. The gene expression levels of cells within each grid box are averaged. Another representation of the spatial relationship is the spatial neighborhood network (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4</xref>a), where each node represents a cell, and each pair of neighboring cells is connected through an edge. The number of neighbors can be defined by setting (a minimal) <italic>k</italic> and/or radial distance from the centroid position of each cell, and the edge weights can be either binary or continuous. Alternatively, a Delaunay network can be created, which does not require <italic>k</italic> or radial distance to be specified and is based on Delaunay triangulation. The Delaunay triangulation and its related concept of Voronoi Tessellation was previously applied to study species distribution in the field of eco-geography with the goal to partition a space according to certain neighborhood relations of a given set of points (e.g., cells) in this space. It has been used and adopted in various fields of biology, including to analyze tissue distribution at the single-cell level [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
      </sec>
      <sec id="Sec23">
        <title>Spatially coherent gene detection</title>
        <p id="Par59">In total, Giotto currently has five different methods to identify spatial coherent gene expression patterns. Three previously published methods SpatialDE [<xref ref-type="bibr" rid="CR35">35</xref>], Trendsceek [<xref ref-type="bibr" rid="CR36">36</xref>], and SPARK [<xref ref-type="bibr" rid="CR37">37</xref>] can be run with the functions <italic>spatialDE</italic>, <italic>trendSceek</italic>, and <italic>spark</italic>. The two new methods introduced here are based on statistical enrichment of binarized expression data in neighboring cells within the spatial network, as schematically illustrated in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S8B. First, for each gene, expression values are binarized using <italic>k</italic>means clustering (<italic>k</italic>&#x2009;=&#x2009;2) or simple thresholding on rank (default&#x2009;=&#x2009;30%), which is the only difference between these two methods. Next, a contingency table is calculated based on the binarized expression values between neighboring cells and used as input for a Fisher exact test to obtain an odds ratio estimate and <italic>p</italic> value. In this way, a gene is considered a spatial gene if it is usually found to be highly expressed in proximal or neighboring cells. In addition to the odds ratio and <italic>p</italic> value for each gene, the average gene expression, the number of highly expressing cells, and the number of hub cells are computed and provided. A hub cell is considered a cell with high expression of a gene of interest and which has multiple high expressing neighboring cells of that gene. These features can be used by the user to further rank and explore spatial genes with different characteristics. We have named the latter method BinSpect (Binary Spatial extract) and implemented it as <italic>binSpect</italic>, within this function the user can choose to use <italic>k</italic>means or threshold ranking to binarize the expression matrix.</p>
      </sec>
      <sec id="Sec24">
        <title>Spatial pattern simulation data</title>
        <p id="Par60">Our strategy for simulating spatial patterns is schematically illustrated in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S9. To generate known spatial patterns based on real spatial data, we first randomly select a large number of genes (<italic>n</italic>&#x2009;=&#x2009;100) from the seqFISH+ dataset, each with their own unique expression distribution, drop-outs, expression levels, and other unknown factors of variation. We then create a fixed spatial pattern, ordered the cells according to their gene expression levels, and created two groups. One group (group G) contains all the highest expressing cells and is equal to the size of the spatial pattern and another group (group R) contains all the other remaining cells. Cells within group G are given a probability Pr, while cells in group R are given the probability 1&#x2009;&#x2212;&#x2009;Pr. This probability is then used to randomly assign each cell to the fixed pattern, such that with Pr&#x2009;=&#x2009;1 all the highest expressing cells are being randomly positioned into the spatial pattern, while with Pr&#x2009;=&#x2009;0.5 this process is completely random. This assignment is repeated multiple times (<italic>n</italic>&#x2009;=&#x2009;6) so that a distribution is obtained for a range of probability levels Pr&#x2009;=&#x2009;{0.5, 0.65. 0.8, 0.9, 0.95, 0.99, 1}. Thus, for each pattern, we create 4200 simulations (100 genes &#xD7; 7 probability levels &#xD7; 6 random samples). This analysis is carried out using the function <italic>runPatternSimulation</italic>.</p>
      </sec>
      <sec id="Sec25">
        <title>Spatial co-expression patterns</title>
        <p id="Par61">To identify robust patterns of co-expressed spatial genes the functions <italic>detectSpatialCorGenes</italic> and <italic>clusterSpatialCorGenes</italic> can be used on the identified individual spatial genes. The first function spatially smooths gene expression through a grid averaging or <italic>k</italic>-nearest neighbor approach and then calculates the gene-to-gene correlation (default&#x2009;=&#x2009;Pearson) scores. In addition, it also calculates gene-to-gene correlation within the original single cells to distinguish between spatial and cell intrinsic correlation. The second function performs hierarchical clustering to cluster the gene-to-gene co-expression network into modules and creates metagene scores by averaging all the genes for each identified co-expression module, which can subsequently be viewed using the standard viewing options provided in Giotto.</p>
      </sec>
      <sec id="Sec26">
        <title>Spatial domain detection</title>
        <p id="Par62">Spatial domains are identified with a hidden Markov random field (HMRF) model as previously described [<xref ref-type="bibr" rid="CR38">38</xref>]. In brief, HMRF is a graph-based model that infers the state of each cell as the joint probability of the cell&#x2019;s intrinsic state (inferred from the cell&#x2019;s own gene expression vector), and the cell&#x2019;s extrinsic state, which is based on the distribution of the states of the cell&#x2019;s neighbors. The notion of state is the spatial domain in our case. The neighborhood graph defines the extent of the neighbor cell influence, together with the parameter beta that defines the strength of the interaction of cells. At the end, HMRF assigns each cell to one of <italic>k</italic> spatial domains (<italic>k</italic> to be defined by the user). This HMRF model is implemented in Python and incorporated in Giotto by using the consecutive wrapper functions <italic>doHMRF</italic>, <italic>viewHMRF</italic>, and <italic>addHMRF</italic> to discover, visualize, and select HMRF domain annotations respectively.</p>
      </sec>
      <sec id="Sec27">
        <title>Identification of proximal or interacting cell types</title>
        <p id="Par63">To identify cell types that are found to be preferentially located in a spatially proximal manner, as a proxy for potential cell-cell interactions, we use a random permutation (default <italic>n</italic>&#x2009;=&#x2009;1000) strategy of the cell type labels within a defined spatial network. First, we label the edges of the spatial network as homo- or hetero-typic, if they connect cells of identical or different annotated cell types, respectively. Then we determine the ratio of observed-over-expected frequencies between two cell types, where the expected frequencies are calculated from the permutations. Associated <italic>p</italic> values are calculated by observing how often the observed value were higher or lower than the simulated values for respectively increased or decreased frequencies. A wrapper for this analysis is implemented in Giotto Analyzer as <italic>cellProximityEnrichment</italic>.</p>
      </sec>
      <sec id="Sec28">
        <title>Gene expression changes within cellular neighborhood</title>
        <sec id="Sec29">
          <title>Spatially informed ligand-receptor pairing</title>
          <p id="Par64">To investigate how cells communicate within their microenvironment, Giotto can incorporate known ligand-receptor information from existing databases [<xref ref-type="bibr" rid="CR55">55</xref>]. By calculating the increased spatial co-expression of such gene pairs in neighboring cells from two cell types, it estimates which ligand-receptor pairs might be used more (or less) for communication between interacting cells from two cell types. This is implemented in the function <italic>spatCellCellcom</italic>, which is short for spatially informed cell-to-cell communication. More specifically, for each ligand-receptor pair, a cell-cell-communication score S is calculated for every pair of cell types. In particular, for ligand L, receptor R, cell type A, and cell type B, S(L,R,A,B) is defined as the weighted average expression of R and L in all the interacting A and Bs, or in other words in the subset of A and B cells that are proximal to each other (based on spatial network).</p>
          <p id="Par65">
<disp-formula id="Equg"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \overline{S\left(L,R,A,B\right)}=\frac{1}{n}{\sum}_{i=1}^n{L}_i+\frac{1}{m}{\sum}_{j=1}^m{R}_j; $$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mover accent="true"><mml:mrow><mml:mi>S</mml:mi><mml:mfenced close=")" open="(" separators=",,,"><mml:mi>L</mml:mi><mml:mi>R</mml:mi><mml:mi>A</mml:mi><mml:mi>B</mml:mi></mml:mfenced></mml:mrow><mml:mo stretchy="true">&#xAF;</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>n</mml:mi></mml:mfrac><mml:msubsup><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:msub><mml:mi>L</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>m</mml:mi></mml:mfrac><mml:msubsup><mml:mo>&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>m</mml:mi></mml:msubsup><mml:msub><mml:mi>R</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>;</mml:mo></mml:math><graphic xlink:href="13059_2021_2286_Article_Equg.gif" position="anchor"/></alternatives></disp-formula></p>
          <p id="Par66">where <italic>n</italic> represents the number of A-type cells that interact with B-type cells, <italic>m</italic> represents the number of B-type cells that interact with A-type cells, <italic>L</italic><sub><italic>i</italic></sub> represents the expression level of the ligand in the <italic>i</italic>th A-type cell, and <italic>R</italic><sub><italic>j</italic></sub> represents the expression level of the receptor in the <italic>j</italic>th B-type cell. Next, to assess if the calculated score <italic>S</italic> is statistically significant, a random null distribution is computed. This background distribution is created by shuffling cell locations within the same cell type for A and B for 1000 (= default) times. In each round, a permutation score <italic>Sp</italic> is calculated using the same formula. Associated <italic>p</italic> values were calculated as the probability of <italic>Sp</italic> to be greater or smaller than the actual observed score <italic>S</italic>. The <italic>p</italic> values for all ligand-receptor pairs in all cell-type pairs were subsequently adjusted for multiple hypothesis testing. A final differential activity score was calculated by multiplying the log2 fold change with the adjusted <italic>p</italic> values. The ligand-receptor pair information was retrieved from FANTOM5 [<xref ref-type="bibr" rid="CR55">55</xref>].</p>
        </sec>
        <sec id="Sec30">
          <title>Expression-informed ligand-receptor pairing</title>
          <p id="Par67">This analysis can be performed with <italic>exprCellCellcom</italic>, short for expression-informed cell-to-cell communication, and is analogous to the method for &#x201C;spatially informed ligand-receptor pairing&#x201D; (described above) except that no spatial information is used. This means that ligand-receptor expression levels are calculated for all cells from two cell types and that the background null distribution is similarly computed by reshuffling all cell labels. This approach is used to mimic scRNAseq-based analysis.</p>
        </sec>
        <sec id="Sec31">
          <title>Comparison between spatially and expression-informed ligand-receptor pairing</title>
          <p id="Par68">We perform a direct comparison between expression-informed ligand-receptor pairing (with the function <italic>exprCellCellcom</italic>) and spatially informed ligand-receptor pairing (with the function <italic>spatCellCellcom</italic>). For both analyses, we rank all ligand-receptor pairs according to their interaction-induced expression changes in all pairs of cell types. This means that for <italic>spatCellCellcom</italic>, we use the cells from two cell types that proximally interact (based on the spatial network), and for <italic>exprCellCellcom</italic>, we use all cells from two cell types. Next, we compute the AUC to examine how efficient the expression ranked ligand-receptor pairs can predict the top-ranked spatially informed ligand-receptor pair.</p>
        </sec>
        <sec id="Sec32">
          <title>Cell-type interaction mediated gene expression changes</title>
          <p id="Par69">To identify all potential gene expression changes associated with specific cell-type interactions in an unbiased manner, Giotto implements 4 differential expression tests to identify such interaction changed genes (ICG), including <italic>t</italic>-test, limma test, Wilcoxon rank sum test, and spatial permutation test. For each cell type, we divide the annotated cells into two complementary subgroups, with one containing the subset which neighbor cells from another specific cell type. Differentially expressed genes between these groups are identified by using each of the statistical tests mentioned above. To adjust for multiple hypothesis testing, a background null distribution is created by reshuffling the cells within the same cell type. This analysis is implemented as the function <italic>findInteractionChangedGenes</italic> or the shorter version <italic>findICG.</italic> Additional filtering can be achieved by using filterInteractionChangedGenes or filterICG in order to reduce errors due to low (interacting) cell number, fold change or absolute expression differences.</p>
        </sec>
      </sec>
      <sec id="Sec33">
        <title>Giotto viewer</title>
        <p id="Par70">Giotto Viewer is a web-based application that can be installed on any Linux-, Windows-, or MAC OS-based computer. The Giotto Viewer canvas consists of a cell object layer, containing all the differently shaped cells, an image layer corresponding to staining images, and an annotation property layer that specifies the cluster membership and gene expression information. Below is a setup overview:</p>
        <sec id="Sec34">
          <title>Input files</title>
          <p id="Par71">The minimal input files for Giotto Viewer contain the gene expression matrix and the cell centroid spatial coordinates. Such information can be either provided manually in tabular format, or directly loaded through the output files of Giotto Analyzer. If available, additional input files such as cell segmentations (ROI files), staining images (TIFF files), and transcript locations (TXT files) can also be incorporated. Giotto Viewer provides tools to process such information for visualization (see next sections).</p>
          <p id="Par72">To streamline setup, we provide guidelines for setting up various platforms.
<list list-type="simple"><list-item><label>(i)</label><p id="Par73">SeqFISH/MerFISH: this applies to SeqFISH/merFISH where multi-field imaging data, transcript locations, and cell segmentations are available. Giotto Viewer first extracts multi-channel images (where a channel may correspond to Nissl, DAPI, polyA) from TIFF using ImageMagick library (<ext-link ext-link-type="uri" xlink:href="https://imagemagick.org/">https://imagemagick.org/</ext-link>). Images within the same channel are then stitched. For stitching, Giotto provides an option to stitch images across multiple fields of view (FOV) with gaps in between. The layout can be manually controlled by modifying a coordinate offset file specifying the relative positions of FOVs. To automate these various actions, an initial setup is done using &#x201C;giotto_setup_image --require-stitch=y --image=y --image-multi-channel=y --segmentation=y --multi-fov=y --output-json=step1.json&#x201D; which creates a template that sets up the sequence of tasks to be performed. Details of the template such as specifying the image file, the stitch offset file, and tiling are next achieved through &#x201C;giotto_step1_modify_json&#x201D; script. Lastly, sequence of tasks is performed through &#x201C;smfish_step1_setup&#x201D;. An overview of the Giotto Viewer processing steps is in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Fig. S14.</p><p id="Par74">Cell boundary segmentation is a necessary step for assignment of each transcript to its corresponding cells. However, this task is highly dependent on the specific technology platform therefore not implemented in Giotto. On the other hand, Giotto Viewer can accept user-provided cell boundary segmentation information as input, in the form of Region-of-Interest (ROI) files, for visualization. Giotto Viewer extracts information from the ROI files by adapting a JAVA program based on the ImageJ framework.</p><p id="Par75">The next step is tiling the stitched staining image. The purpose of tiling is to support a Google Maps-like algorithm to facilitate multi-level zooming and navigation. Conceptually, this is achieved by tiling of the large image to smaller chunks at various zoom levels to efficiently display a very large image (our stitched image frequently exceeds several hundred megabytes). This is implemented in Giotto Viewer by using the tileup package in Ruby (<ext-link ext-link-type="uri" xlink:href="https://github.com/rktjmp/tileup">https://github.com/rktjmp/tileup</ext-link>). This creates a set of tiled images corresponding to 6 zoom levels with 1.5&#xD7; increment. The size of each tile is fixed at 256 by 256 pixels.</p></list-item></list><list list-type="simple"><list-item><label>(ii)</label><p id="Par76">For the Visium platform with an accompanying image, the highest resolution raw H&amp;E staining image is first padded to be square dimension. Next, a template is setup: &#x201C;giotto_setup_image --require-stitch=n --image=y --image-multi-channel=n --segmentation=n --multi-fov=n --output-json=step1.json&#x201D;. The next two steps &#x201C;giotto_step1_modify_json&#x201D; and &#x201C;smfish_step1_setup&#x201D; are proceeded as usual.</p></list-item><list-item><label>(iii)</label><p id="Par77">Other platforms with no image nor cell segmentations (e.g., Slide-seq). We run &#x201C;giotto_setup_image --require-stitch=n --image=n --image-multi-channel=n --segmentation=n --multi-fov=n --output-json=step1.json&#x201D;, followed by the subsequent two steps (described in ii). Giotto Viewer renders cells as circles in the physical space, and there is not an image background overlay.</p></list-item></list></p>
        </sec>
        <sec id="Sec35">
          <title>Panels</title>
          <p id="Par78">Giotto Viewer supports a multi-panel view configuration, which means that users can load and visualize any number of panels simultaneously (default number&#x2009;=&#x2009;2), and add different types of data to each panel. To permit flexibility, there are four types of panels implemented in the Giotto Viewer: <italic>PanelTsne</italic>, <italic>PanelPhysical</italic>, and <italic>PanelPhysicalSimple</italic>, <italic>PanelPhysical10X</italic>. <italic>PanelTsne</italic> requires cell coordinates in the expression space as input. <italic>PanelPhysical</italic> lays out the cells in the physical space in the segmented cell shapes. <italic>PanelPhysicalSimple</italic> is a simplified version of <italic>PanelPhysical</italic> except that cell segmentation and staining images are not required, and instead renders cell objects as fixed size circle markers. <italic>PanelPhysical10X</italic> is unique to Visium in that it also registers the spot-level details of the Visium platform. The number of panels and the panel types can be specified, for example, through: &#x201C;giotto_setup_viewer --num-panel=2 --input-preprocess-json=step1.json --panel-1=PanelPhysical10X --panel-2=PanelTsne --output-json=step2.json --input-annotation-list=annotation_list.txt&#x201D;.</p>
        </sec>
        <sec id="Sec36">
          <title>Annotations</title>
          <p id="Par79">Cell annotations, such as spatial domains and cell types, are required input for Giotto Viewer. In brief, Giotto Viewer supports both continuous- and discrete-value annotations. Annotations generated by Giotto Analyzer can be directly imported by using the <italic>exportGiottoFunction().</italic></p>
          <p id="Par80">Once panels, annotations, images are all prepared, then website files are created using: &#x201C;smfish_read_config -c step2.json -o test.js -p test.html -q test.css&#x201D;. A python webserver is next launched (python3 -m http.server) and the viewer can be viewed at http://localhost:8000/test.html.</p>
        </sec>
        <sec id="Sec37">
          <title>Implementation of interactive visualization of multi-layer spatial transcriptomic information</title>
          <p id="Par81">The Giotto Viewer package is written in Javascript utilizing a number of state-of-the-art toolboxes including Leaflet.js (<ext-link ext-link-type="uri" xlink:href="https://leafletjs.com/">https://leafletjs.com/</ext-link>), Turf.js (<ext-link ext-link-type="uri" xlink:href="https://turfjs.org/">https://turfjs.org/</ext-link>), Bootstrap (<ext-link ext-link-type="uri" xlink:href="https://getbootstrap.com/">https://getbootstrap.com/</ext-link>), and jQuery (<ext-link ext-link-type="uri" xlink:href="https://jquery.com/">https://jquery.com/</ext-link>). The Leaflet.js toolbox is used to efficiently visualize and explore multiple layers of information in the data, based on a Google Maps-like algorithm. Leaflet.js recognizes tiles prepared previously by the tileup package and implements caching of tiles and tile handling, allowing it to display large stitched images.</p>
          <p id="Par82">As described above, Giotto Viewer contains 4 types of panels: <italic>PanelTsne, PanelPhysical</italic>, and <italic>PanelPhysicalSimple</italic>, <italic>PanelPhysical10X.</italic> The implementation of these 4 panels follows closely the paradigm of object-oriented design in Javascript, specified by the MDN Web Docs and ECMAScript. Briefly, the various panel types are motivated by the fact that depending on data availability, properties of cells change from dataset to dataset, so different ways of cell representation should be considered. In the presence of cell staining images, images should serve as background overlays to the data. If segmentation information is available, cells should be represented in their true cell shape. Yet when neither staining nor segmentation is available, Giotto Viewer represents cells as basic geometric shapes (circles) so that the viewer can still run in the absence of staining or segmentation data. We design the panel classes with these considerations in mind. Giotto Viewer makes it easy for users to specify the number of panels, the type of each panel, and the layout configuration. Users can specify such information in a JSON formatted configuration file. A script then automatically generates the HTML, CSS, and JS files of the comparative viewer that is ready for exploration in a standard web browser.</p>
          <p id="Par83">To enable interactivity, panels are linked to each other. This is implemented by first defining mouseover and mouseout events for each cell object. The exact specification of events depends on the type of panel, the action chosen by the user, and the context in which the action is performed. Next, we maintain equivalent cell objects across panels by creating a master look-up table to link cell IDs in different panels. This is useful to facilitate interactive data exploration and comparison, synchronous updates of zoom and view positions during data exploration. Finally, the order and dependency with which interactions are executed are enforced by constantly polling element states and proceeding each step only when states are changed. In the API, the functions <italic>addInteractions(), addTooltips()</italic> enable the easy specification of cross-panel interactions. In the JSON configuration file, interactions between panels are simply defined by the user using the &#x201C;interact_X: [panel ids]&#x201D; and &#x201C;sync_X: [panel ids]&#x201D; lines.</p>
          <p id="Par84">Giotto Viewer provides an intuitive utility to select a subset of cells of interest for visualization and further analysis. The toggle lasso utility allows a user to hand-draw an enclosed shape in any displayed panel to select cells directly. We implement this function by modifying the Leaflet-lasso.js toolbox to add support for the selection of the dynamic polygon-shaped markers. Giotto Viewer can also highlight Individual cells with summary information displayed. This is achieved by using built-in functions in the Turf.js toolbox.</p>
        </sec>
        <sec id="Sec38">
          <title>Visualizing subcellular transcript localization</title>
          <p id="Par85">To visualize subcellular transcript localization information, an additional layer is created in Leaflet.js. To efficiently handle the large amount of data, we implemented new functions to cache only a small subset of transcripts that fall within the current viewing area, to be rendered by the Leaflet engine and thereby saving the system resources.</p>
        </sec>
        <sec id="Sec39">
          <title>Visualizing cell-type enrichment data</title>
          <p id="Par86">Continuous annotations providing cell type enrichment per spot are exported from Giotto Analyzer to Giotto Viewer via the <italic>exportGiotto()</italic> function. Then as with all other annotations, these are added to the setup JSON used to generate the website files. The cell type enrichments will appear under the &#x201C;Annotations&#x201D; tab of the viewer panel.</p>
        </sec>
        <sec id="Sec40">
          <title>Selecting and exporting cells</title>
          <p id="Par87">To encourage iterative analysis between the Giotto Viewer and Giotto Analyzer, users may select any cells of interest with the Lasso button. Then clicking &#x201C;Save&#x201D; will save the cell IDs that can be read in Giotto Analyzer within the R environment.</p>
        </sec>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Information</title>
      <sec id="Sec41">
        <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13059_2021_2286_MOESM1_ESM.docx"><caption><p><bold>Additional file 1.</bold> Supplementary Figures. Supplementary figures and legends.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13059_2021_2286_MOESM2_ESM.docx"><caption><p><bold>Additional file 2: Table S1.</bold> Table of different technologies and datasets that were analyzed with Giotto.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13059_2021_2286_MOESM3_ESM.docx"><caption><p><bold>Additional file 3.</bold> Supplementary Notes. Supplementary notes and additional information about data analysis with Giotto.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="13059_2021_2286_MOESM5_ESM.docx"><caption><p><bold>Additional file 5.</bold> Review history.</p></caption></media></supplementary-material></p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Publisher&#x2019;s Note</bold>
        </p>
        <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
      <fn>
        <p>Ruben Dries and Qian Zhu contributed equally to this work.</p>
      </fn>
    </fn-group>
    <ack>
      <sec id="FPar1">
        <title>Review history</title>
        <p id="Par88">The review history is available as Additional&#xA0;file&#xA0;<xref rid="MOESM5" ref-type="media">5</xref>.</p>
      </sec>
      <sec id="FPar2">
        <title>Peer review information</title>
        <p id="Par89">Barbara Cheifet was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p>
      </sec>
    </ack>
    <notes notes-type="author-contribution">
      <title>Authors&#x2019; contributions</title>
      <p>R.Dr. conceived the project and developed the Giotto analysis software. Q.Z., A.S. and T.Z. developed the Giotto viewer software. G.Y. supervised the project and helped interpret and present the results. R.Do., Q.Z., and R.Dr. developed and implemented spatial enrichment algorithms. H.L. and R.Dr. developed and implemented in silico slicing. Y.F. and R.Dr. implemented 3D visualization. R.Dr., Q.Z., R.Do., H.L., and K.L. analyzed datasets and validated methods. C.H.L.E., F.B., R.E.G., N.P., and L.C. tested the software and provided feedback. R.Dr., Q.Z., and G.Y. wrote the manuscript with input from all authors. All authors read and approved the final manuscript.</p>
    </notes>
    <notes notes-type="funding-information">
      <title>Funding</title>
      <p>This research was supported by NIH grants UH3HL145609 and R01AG066028 to L.C. and G.Y.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Availability of data and materials</title>
      <p>General information, examples, and tutorials are available at http://<ext-link ext-link-type="uri" xlink:href="http://www.spatialgiotto.com">www.spatialgiotto.com</ext-link>. Users can follow to replicate the analyses in this paper and to learn more about the parameters of specific functions in the Giotto package. Giotto v1.0.2 was used for generating the analyses in this paper. The tutorials give a detailed description of parameters surrounding functions of interest. Dataset examples give a dataset-centric recipe for connecting various analysis components. Download and setup instructions are available. A Docker image has been created and is readily available [<xref ref-type="bibr" rid="CR56">56</xref>] for ease of access and testing. In addition, more detailed information about both the stable and development version of Giotto is available on <ext-link ext-link-type="uri" xlink:href="https://rubd.github.io/Giotto_site/">https://rubd.github.io/Giotto_site/</ext-link>, which is associated with the Giotto source code from our github repository [<xref ref-type="bibr" rid="CR57">57</xref>] and under MIT license. These links also provide additional information about installation issues, documentation, extensive information about how to use Giotto, a news section, and guidelines for external contributions.</p>
      <p>The following datasets were used for demonstrations: seqFISH+ data was obtained from the Cai lab [<xref ref-type="bibr" rid="CR9">9</xref>], merFISH data was downloaded from <ext-link ext-link-type="uri" xlink:href="https://datadryad.org/stash/dataset/doi:10.5061/dryad.8t8s248">https://datadryad.org/stash/dataset/doi:10.5061/dryad.8t8s248</ext-link> [<xref ref-type="bibr" rid="CR14">14</xref>], osmFISH data was downloaded from <ext-link ext-link-type="uri" xlink:href="https://linnarssonlab.org/osmFISH/">https://linnarssonlab.org/osmFISH/</ext-link> [<xref ref-type="bibr" rid="CR11">11</xref>], STARmap data was downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.starmapresources.com/data">https://www.starmapresources.com/data</ext-link> [<xref ref-type="bibr" rid="CR7">7</xref>], Visium 10X brain and kidney datasets were downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/resources/datasets/">https://www.10xgenomics.com/resources/datasets/</ext-link>, Slide-seq data was obtained from <ext-link ext-link-type="uri" xlink:href="https://portals.broadinstitute.org/single_cell/study/slide-seq-study">https://portals.broadinstitute.org/single_cell/study/slide-seq-study</ext-link> [<xref ref-type="bibr" rid="CR8">8</xref>], t-cyCIF data was downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.cycif.org/data/">https://www.cycif.org/data/</ext-link> [<xref ref-type="bibr" rid="CR10">10</xref>] MIBI data was downloaded from <ext-link ext-link-type="uri" xlink:href="https://www.angelolab.com/mibi-data">https://www.angelolab.com/mibi-data</ext-link> [<xref ref-type="bibr" rid="CR13">13</xref>] and CODEX data was downloaded from <ext-link ext-link-type="uri" xlink:href="http://welikesharingdata.blob.core.windows.net/forshare/index.html">http://welikesharingdata.blob.core.windows.net/forshare/index.html</ext-link> [<xref ref-type="bibr" rid="CR12">12</xref>]. Ready to use and preformatted datasets can be found on <ext-link ext-link-type="uri" xlink:href="https://github.com/RubD/spatial-datasets">https://github.com/RubD/spatial-datasets</ext-link> and can be automatically downloaded with the <italic>getSpatialDataset</italic> function in Giotto.</p>
    </notes>
    <notes id="FPar3">
      <title>Ethics approval and consent to participate</title>
      <p id="Par90">Not applicable.</p>
    </notes>
    <notes id="FPar4" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par91">The authors declare that they have no competing interests.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Fei</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mapping the mouse cell atlas by microwell-Seq</article-title>
          <source>Cell.</source>
          <year>2018</year>
          <volume>173</volume>
          <fpage>1307</fpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.05.012</pub-id>
          <pub-id pub-id-type="pmid">29775597</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <mixed-citation publication-type="other">Tabula Muris Consortium, overall coordination, logistical coordination, organ collection and processing, library preparation and sequencing, Computational data analysis, et al. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature. 2018;562:367&#x2013;72.</mixed-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="other">Lubeck E, Coskun AF, Zhiyentayev T, Ahmad M, Cai L. Single-cell in situ RNA profiling by sequential hybridization. Nat. Methods. 2014. p. 360&#x2013;361.</mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Boettiger</surname>
              <given-names>AN</given-names>
            </name>
            <name>
              <surname>Moffitt</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhuang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells</article-title>
          <source>Science</source>
          <year>2015</year>
          <volume>348</volume>
          <fpage>aaa6090</fpage>
          <pub-id pub-id-type="doi">10.1126/science.aaa6090</pub-id>
          <pub-id pub-id-type="pmid">25858977</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xE5;hl</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Salm&#xE9;n</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vickovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lundmark</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Magnusson</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>
          <source>Science.</source>
          <year>2016</year>
          <volume>353</volume>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaf2403</pub-id>
          <pub-id pub-id-type="pmid">27365449</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lubeck</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>In situ transcription profiling of single cells reveals spatial organization of cells in the mouse hippocampus</article-title>
          <source>Neuron.</source>
          <year>2016</year>
          <volume>92</volume>
          <fpage>342</fpage>
          <lpage>357</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuron.2016.10.001</pub-id>
          <pub-id pub-id-type="pmid">27764670</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <mixed-citation publication-type="other">Wang X, Allen WE, Wright MA, Sylwestrak EL, Samusik N, Vesuna S, et al. Three-dimensional intact-tissue sequencing of single-cell transcriptional states. Science. 2018;361. Available from: 10.1126/science.aat5691</mixed-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriques</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Stickels</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Goeva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vanderburg</surname>
              <given-names>CR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution</article-title>
          <source>Science.</source>
          <year>2019</year>
          <volume>363</volume>
          <fpage>1463</fpage>
          <lpage>1467</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaw1219</pub-id>
          <pub-id pub-id-type="pmid">30923225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eng</surname>
              <given-names>C-HL</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Dries</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Koulena</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Takei</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH+</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>568</volume>
          <fpage>235</fpage>
          <lpage>239</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1049-y</pub-id>
          <pub-id pub-id-type="pmid">30911168</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <mixed-citation publication-type="other">Lin J-R, Izar B, Wang S, Yapp C, Mei S, Shah PM, et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. Elife. 2018;7. Available from: 10.7554/eLife.31657</mixed-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Codeluppi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Borm</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>La Manno</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>van Lunteren</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Svensson</surname>
              <given-names>CI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Spatial organization of the somatosensory cortex revealed by osmFISH</article-title>
          <source>Nat Methods</source>
          <year>2018</year>
          <volume>15</volume>
          <fpage>932</fpage>
          <lpage>935</lpage>
          <pub-id pub-id-type="doi">10.1038/s41592-018-0175-z</pub-id>
          <pub-id pub-id-type="pmid">30377364</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goltsev</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Samusik</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Kennedy-Darling</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bhate</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hale</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vazquez</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Deep profiling of mouse splenic architecture with CODEX multiplexed imaging</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <fpage>968</fpage>
          <lpage>981</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.010</pub-id>
          <pub-id pub-id-type="pmid">30078711</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Keren</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Bosse</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marquez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Angoshtari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Varma</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <fpage>1373</fpage>
          <lpage>1387</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.08.039</pub-id>
          <pub-id pub-id-type="pmid">30193111</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="other">Moffitt JR, Bambah-Mukku D, Eichhorn SW, Vaughn E, Shekhar K, Perez JD, et al. Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region. Science. 2018;362. Available from: 10.1126/science.aau5324</mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Farrell</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Gennert</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schier</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Regev</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Spatial reconstruction of single-cell gene expression data</article-title>
          <source>Nat Biotechnol</source>
          <year>2015</year>
          <volume>33</volume>
          <fpage>495</fpage>
          <lpage>502</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.3192</pub-id>
          <pub-id pub-id-type="pmid">25867923</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Achim</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Pettit</surname>
              <given-names>J-B</given-names>
            </name>
            <name>
              <surname>Saraiva</surname>
              <given-names>LR</given-names>
            </name>
            <name>
              <surname>Gavriouchkina</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Larsson</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Arendt</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin</article-title>
          <source>Nat Biotechnol</source>
          <year>2015</year>
          <volume>33</volume>
          <fpage>503</fpage>
          <lpage>509</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.3209</pub-id>
          <pub-id pub-id-type="pmid">25867922</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="other">Regev A, Teichmann SA, Lander ES, Amit I, Benoist C, Birney E, et al. The human cell atlas. Elife. 2017;6. Available from: 10.7554/eLife.27041</mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <mixed-citation publication-type="other">HuBMAP Consortium.&#xA0;The human body at cellular resolution: the NIH Human Biomolecular Atlas Program.&#xA0;Nature. 2019;574:187&#x2013;92.</mixed-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <mixed-citation publication-type="other">Maaten L van der, Hinton G. Visualizing Data using t-SNE. J Mach Learn Res 2008;9:2579&#x2013;2605.</mixed-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <mixed-citation publication-type="other">Becht E, McInnes L, Healy J, Dutertre C-A, Kwok IWH, Ng LG, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2018; Available from: 10.1038/nbt.4314</mixed-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <mixed-citation publication-type="other">Blondel VD, Guillaume J-L, Lambiotte R, Lefebvre E. Fast unfolding of communities in large networks. Journal of Statistical Mechanics: Theory and Experiment. 2008. p. P10008. Available from: 10.1088/1742-5468/2008/10/p10008</mixed-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <mixed-citation publication-type="other">Traag VA, Waltman L, van Eck NJ. From Louvain to Leiden: guaranteeing well-connected communities. Sci Rep 2019;9:5233.</mixed-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">Lun A, Bach K, Kim JK, Scialdone A, Haghverdi L. Package &#x201C;scran.&#x201D; 2017; Available from:&#xA0;<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/scran.html">https://bioconductor.org/packages/release/bioc/html/scran.html</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finak</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>McDavid</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Yajima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gersuk</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Shalek</surname>
              <given-names>AK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data</article-title>
          <source>Genome Biol</source>
          <year>2015</year>
          <volume>16</volume>
          <fpage>278</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-015-0844-5</pub-id>
          <pub-id pub-id-type="pmid">26653891</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Pinello</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>G-C</given-names>
            </name>
          </person-group>
          <article-title>GiniClust: detecting rare cell types from single-cell gene expression data with Gini index</article-title>
          <source>Genome Biol</source>
          <year>2016</year>
          <volume>17</volume>
          <fpage>144</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-016-1010-4</pub-id>
          <pub-id pub-id-type="pmid">27368803</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <mixed-citation publication-type="other">Datasets - 10x Genomics. [cited 2020 Sep 27]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.10xgenomics.com/resources/datasets/">https://www.10xgenomics.com/resources/datasets/</ext-link></mixed-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <mixed-citation publication-type="other">Liu Y, Yang M, Deng Y, Su G, Enninful A, Guo CC, Tebaldi T, Zhang D, Kim D, Bai Z, Norris E, Pan A, Li J, Xiao Y, Halene S,&#xA0;Fan R.&#xA0;High-Spatial-Resolution Multi-Omics Sequencing via Deterministic Barcoding in Tissue. Cell. 2020;183(6):1665-1681.e18.</mixed-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>S-Y</given-names>
            </name>
            <name>
              <surname>Volsky</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>PAGE: parametric analysis of gene set enrichment</article-title>
          <source>BMC Bioinformatics</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>144</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-6-144</pub-id>
          <pub-id pub-id-type="pmid">15941488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mu&#xF1;oz-Manchado</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Codeluppi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>L&#xF6;nnerberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>La Manno</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jur&#xE9;us</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq</article-title>
          <source>Science.</source>
          <year>2015</year>
          <volume>347</volume>
          <fpage>1138</fpage>
          <lpage>1142</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaa1934</pub-id>
          <pub-id pub-id-type="pmid">25700174</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <mixed-citation publication-type="other">Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ. Robust decomposition of cell type mixtures in spatial transcriptomics. bioRxiv. biorxiv.org; 2020; Available from: <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2020.05.07.082750v1.abstract">https://www.biorxiv.org/content/10.1101/2020.05.07.082750v1.abstract</ext-link></mixed-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <mixed-citation publication-type="other">Zeisel A, Hochgerner H, L&#xF6;nnerberg P, Johnsson A, Memic F, van der Zwan J, et al. Molecular architecture of the mouse nervous system. Cell. 2018. 999&#x2013;1014.e22. Available from: 10.1016/j.cell.2018.06.021</mixed-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <mixed-citation publication-type="other">Zetler G. Distribution of peptidergic neurons in mammalian brain. Aspects of Neuroendocrinology. Springer Berlin Heidelberg; 1970. p. 287&#x2013;95.</mixed-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yager</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Wunsch</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ferguson</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>The ins and outs of the striatum: role in drug addiction</article-title>
          <source>Neuroscience.</source>
          <year>2015</year>
          <volume>301</volume>
          <fpage>529</fpage>
          <lpage>541</lpage>
          <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.06.033</pub-id>
          <pub-id pub-id-type="pmid">26116518</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roales-Buj&#xE1;n</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>P&#xE1;ez</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Guerra</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rodr&#xED;guez</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>V&#xED;o</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ho-Plagaro</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Astrocytes acquire morphological and functional characteristics of ependymal cells following disruption of ependyma in hydrocephalus</article-title>
          <source>Acta Neuropathol</source>
          <year>2012</year>
          <volume>124</volume>
          <fpage>531</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="doi">10.1007/s00401-012-0992-6</pub-id>
          <pub-id pub-id-type="pmid">22576081</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Svensson</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Teichmann</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Stegle</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>SpatialDE: identification of spatially variable genes</article-title>
          <source>Nat Methods</source>
          <year>2018</year>
          <volume>15</volume>
          <fpage>343</fpage>
          <lpage>346</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4636</pub-id>
          <pub-id pub-id-type="pmid">29553579</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edsg&#xE4;rd</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Johnsson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sandberg</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Identification of spatial expression trends in single-cell gene expression data</article-title>
          <source>Nat Methods</source>
          <year>2018</year>
          <volume>15</volume>
          <fpage>339</fpage>
          <lpage>342</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4634</pub-id>
          <pub-id pub-id-type="pmid">29553578</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sun</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Statistical analysis of spatial expression patterns for spatially resolved transcriptomic studies</article-title>
          <source>Nat Methods</source>
          <year>2020</year>
          <volume>17</volume>
          <fpage>193</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1038/s41592-019-0701-7</pub-id>
          <pub-id pub-id-type="pmid">31988518</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <mixed-citation publication-type="other">Zhu Q, Shah S, Dries R, Cai L, Yuan G-C. Identification of spatially associated subpopulations by combining scRNAseq and sequential fluorescence in situ hybridization data. Nat Biotechnol. 2018; Available from: 10.1038/nbt.4260</mixed-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ban</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Min</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Baek</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kwon</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Popescu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jung</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Optical properties of acute kidney injury measured by quantitative phase imaging</article-title>
          <source>Biomed Opt Express</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>921</fpage>
          <lpage>932</lpage>
          <pub-id pub-id-type="doi">10.1364/BOE.9.000921</pub-id>
          <pub-id pub-id-type="pmid">29541494</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ransick</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lindstr&#xF6;m</surname>
              <given-names>NO</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>J-J</given-names>
            </name>
            <name>
              <surname>Alvarado</surname>
              <given-names>GF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell profiling reveals sex, lineage, and regional diversity in the mouse kidney</article-title>
          <source>Dev Cell</source>
          <year>2019</year>
          <volume>51</volume>
          <fpage>399</fpage>
          <lpage>413</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2019.10.005</pub-id>
          <pub-id pub-id-type="pmid">31689386</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Zanotelli</surname>
              <given-names>VRT</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>HR</given-names>
            </name>
            <name>
              <surname>Mechera</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Soysal</surname>
              <given-names>SD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The single-cell pathology landscape of breast cancer</article-title>
          <source>Nature.</source>
          <year>2020</year>
          <volume>578</volume>
          <fpage>615</fpage>
          <lpage>620</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1876-x</pub-id>
          <pub-id pub-id-type="pmid">31959985</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vento-Tormo</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Efremova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Botting</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Turco</surname>
              <given-names>MY</given-names>
            </name>
            <name>
              <surname>Vento-Tormo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Meyer</surname>
              <given-names>KB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cell reconstruction of the early maternal-fetal interface in humans</article-title>
          <source>Nature.</source>
          <year>2018</year>
          <volume>563</volume>
          <fpage>347</fpage>
          <lpage>353</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-018-0698-6</pub-id>
          <pub-id pub-id-type="pmid">30429548</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hafemeister</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Mauck</surname>
              <given-names>WM</given-names>
              <suffix>3rd</suffix>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive integration of single-cell data</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schapiro</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jackson</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>Raghuraman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Zanotelli</surname>
              <given-names>VRT</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data</article-title>
          <source>Nat Methods</source>
          <year>2017</year>
          <volume>14</volume>
          <fpage>873</fpage>
          <lpage>876</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.4391</pub-id>
          <pub-id pub-id-type="pmid">28783155</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fern&#xE1;ndez Navarro</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lundeberg</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>St&#xE5;hl</surname>
              <given-names>PL</given-names>
            </name>
          </person-group>
          <article-title>ST viewer: a tool for analysis and visualization of spatial transcriptomics datasets</article-title>
          <source>Bioinformatics.</source>
          <year>2019</year>
          <volume>35</volume>
          <fpage>1058</fpage>
          <lpage>1060</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bty714</pub-id>
          <pub-id pub-id-type="pmid">30875427</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <mixed-citation publication-type="other">starfish. Github; [cited 2019 Jul 8]. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/spacetx/starfish">https://github.com/spacetx/starfish</ext-link></mixed-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nitzan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Karaiskos</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Friedman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rajewsky</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Gene expression cartography</article-title>
          <source>Nature.</source>
          <year>2019</year>
          <volume>576</volume>
          <fpage>132</fpage>
          <lpage>137</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1773-3</pub-id>
          <pub-id pub-id-type="pmid">31748748</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stoltzfus</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Filipek</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gern</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Olin</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Leal</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CytoMAP: a spatial analysis toolbox reveals features of myeloid cell organization in lymphoid tissues</article-title>
          <source>Cell Rep</source>
          <year>2020</year>
          <volume>107523</volume>
          <fpage>31</fpage>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <mixed-citation publication-type="other">Queen R, Cheung K, Lisgo S, Coxhead J, Cockell S. Spaniel: analysis and interactive sharing of Spatial Transcriptomics data. bioRxiv. 2019 [cited 2020 May 27]. p. 619197. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/619197v1.abstract">https://www.biorxiv.org/content/10.1101/619197v1.abstract</ext-link></mixed-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <source>The STViewer, a visual method with sentiment analysis: retrieve information and visualize social media text better. Proceedings of the 2nd International Conference on Computer Science and Software Engineering</source>
          <year>2019</year>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Association for Computing Machinery</publisher-name>
          <fpage>50</fpage>
          <lpage>56</lpage>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chung</surname>
              <given-names>NC</given-names>
            </name>
            <name>
              <surname>Storey</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Statistical significance of variables driving systematic variation in high-dimensional data</article-title>
          <source>Bioinformatics.</source>
          <year>2015</year>
          <volume>31</volume>
          <fpage>545</fpage>
          <lpage>554</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btu674</pub-id>
          <pub-id pub-id-type="pmid">25336500</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lun</surname>
              <given-names>ATL</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Marioni</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor</article-title>
          <source>F1000Res.</source>
          <year>2016</year>
          <volume>5</volume>
          <fpage>2122</fpage>
          <pub-id pub-id-type="pmid">27909575</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Obayashi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Rank of correlation coefficient as a comparable measure for biological significance of gene coexpression</article-title>
          <source>DNA Res</source>
          <year>2009</year>
          <volume>16</volume>
          <fpage>249</fpage>
          <lpage>260</lpage>
          <pub-id pub-id-type="doi">10.1093/dnares/dsp016</pub-id>
          <pub-id pub-id-type="pmid">19767600</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moffat</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zobel</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Rank-biased precision for measurement of retrieval effectiveness</article-title>
          <source>ACM Trans Inf Syst Secur</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>1</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="doi">10.1145/1416950.1416952</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramilowski</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Harshbarger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kloppmann</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lizio</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Satagopam</surname>
              <given-names>VP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A draft network of ligand&#x2013;receptor-mediated multicellular signalling in human</article-title>
          <source>Nat Commun</source>
          <year>2015</year>
          <volume>6</volume>
          <fpage>7866</fpage>
          <pub-id pub-id-type="doi">10.1038/ncomms8866</pub-id>
          <pub-id pub-id-type="pmid">26198319</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <mixed-citation publication-type="other">Dries R, Zhu Q, Dong R, Eng CHL, Li H, Liu K, Fu Y, Zhao T, Sarkar A, Bao F, George RE, Pierson N, Cai L, Yuan GC. Giotto on Zenodo. Giotto Docker. 2020 [cited 2020 Oct 23]. Available from: <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4381091">https://zenodo.org/record/4381091</ext-link></mixed-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <mixed-citation publication-type="other">Dries R, Zhu Q, Dong R, Eng CHL, Li H, Liu K, Fu Y, Zhao T, Sarkar A, Bao F, George RE, Pierson N, Cai L, Yuan GC. Giotto on GitHub. Giotto Analyzer. 2020 [cited 2020 Oct 23]. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/RubD/Giotto">https://github.com/RubD/Giotto</ext-link></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article dtd-version="1.3" xml:lang="en" article-type="research-article">
  <!--The publisher of this article does not allow downloading of the full text in XML form.-->
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genome Res</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genome Res</journal-id>
      <journal-id journal-id-type="hwp">genome</journal-id>
      <journal-id journal-id-type="publisher-id">GENOME</journal-id>
      <journal-title-group>
        <journal-title>Genome Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1088-9051</issn>
      <issn pub-type="epub">1549-5469</issn>
      <publisher>
        <publisher-name>Cold Spring Harbor Laboratory Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34301623</article-id>
      <article-id pub-id-type="pmc">8494226</article-id>
      <article-id pub-id-type="medline">9509184</article-id>
      <article-id pub-id-type="doi">10.1101/gr.271205.120</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Method</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A graph neural network model to estimate cell-wise metabolic flux using single-cell RNA-seq data</article-title>
        <alt-title alt-title-type="left-running">Alghamdi et al.</alt-title>
        <alt-title alt-title-type="right-running">Single-cell metabolic flux estimation</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Alghamdi</surname>
            <given-names>Norah</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="FN1" ref-type="author-notes">6</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8113-8252</contrib-id>
          <name>
            <surname>Chang</surname>
            <given-names>Wennan</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="af2" ref-type="aff">2</xref>
          <xref rid="FN1" ref-type="author-notes">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dang</surname>
            <given-names>Pengtao</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="af2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>Xiaoyu</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wan</surname>
            <given-names>Changlin</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="af2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gampala</surname>
            <given-names>Silpa</given-names>
          </name>
          <xref rid="af3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>Zhi</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="af2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Jiashi</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Qin</given-names>
          </name>
          <xref rid="af4" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zang</surname>
            <given-names>Yong</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="af5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fishel</surname>
            <given-names>Melissa</given-names>
          </name>
          <xref rid="af3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>Sha</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="af5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9553-0925</contrib-id>
          <name>
            <surname>Zhang</surname>
            <given-names>Chi</given-names>
          </name>
          <xref rid="af1" ref-type="aff">1</xref>
          <xref rid="af2" ref-type="aff">2</xref>
        </contrib>
      </contrib-group>
      <aff id="af1"><label>1</label>Department of Medical and Molecular Genetics and Center for Computational Biology and Bioinformatics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA;</aff>
      <aff id="af2"><label>2</label>Department of Electrical and Computer Engineering, Purdue University, Indianapolis, Indiana 46202, USA;</aff>
      <aff id="af3"><label>3</label>Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA;</aff>
      <aff id="af4"><label>4</label>Department of Biomedical Informatics, Ohio State University, Columbus, Ohio 43210, USA;</aff>
      <aff id="af5"><label>5</label>Department of Biostatistics, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA</aff>
      <author-notes>
        <fn id="FN1" fn-type="equal">
          <label>6</label>
          <p>These authors contributed equally to this work.</p>
        </fn>
        <corresp>Corresponding authors: <email>czhang87@iu.edu</email>, <email>mfishel@iu.edu</email>, <email>shacao@iu.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <month>10</month>
        <year>2021</year>
      </pub-date>
      <volume>31</volume>
      <issue>10</issue>
      <fpage>1867</fpage>
      <lpage>1884</lpage>
      <history>
        <date date-type="received">
          <day>3</day>
          <month>9</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>7</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://genome.cshlp.org/site/misc/terms.xhtml" ext-link-type="uri">&#xA9; 2021 Alghamdi et al.; Published by Cold Spring Harbor Laboratory Press</ext-link>
</copyright-statement>
        <copyright-year>2021</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
          <license-p>This article, published in <italic toggle="yes">Genome Research</italic>, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="1867.pdf"/>
      <abstract>
        <p>The metabolic heterogeneity and metabolic interplay between cells are known as significant contributors to disease treatment resistance. However, with the lack of a mature high-throughput single-cell metabolomics technology, we are yet to establish systematic understanding of the intra-tissue metabolic heterogeneity and cooperative mechanisms. To mitigate this knowledge gap, we developed a novel computational method, namely, single-cell flux estimation analysis (scFEA), to infer the cell-wise fluxome from single-cell RNA-sequencing (scRNA-seq) data. scFEA is empowered by a systematically reconstructed human metabolic map as a factor graph, a novel probabilistic model to leverage the flux balance constraints on scRNA-seq data, and a novel graph neural network&#x2013;based optimization solver. The intricate information cascade from transcriptome to metabolome was captured using multilayer neural networks to capitulate the nonlinear dependency between enzymatic gene expressions and reaction rates. We experimentally validated scFEA by generating an scRNA-seq data set with matched metabolomics data on cells of perturbed oxygen and genetic conditions. Application of scFEA on this data set showed the consistency between predicted flux and the observed variation of metabolite abundance in the matched metabolomics data. We also applied scFEA on five publicly available scRNA-seq and spatial transcriptomics data sets and identified context- and cell group&#x2013;specific metabolic variations. The cell-wise fluxome predicted by scFEA empowers a series of downstream analyses including identification of metabolic modules or cell groups that share common metabolic variations, sensitivity evaluation of enzymes with regards to their impact on the whole metabolic flux, and inference of cell&#x2013;tissue and cell&#x2013;cell metabolic communications.</p>
      </abstract>
      <funding-group>
        <award-group id="funding-1">
          <funding-source>
            <institution-wrap>
              <institution>National Science Foundation (NSF) </institution>
              <institution-id institution-id-type="doi">10.13039/100000001</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>DBI IIBR 2047631</award-id>
        </award-group>
        <award-group id="funding-2">
          <funding-source>
            <institution-wrap>
              <institution>National Institutes of Health (National Institute of General Medical Sciences) </institution>
              <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>1R01GM131399-01</award-id>
        </award-group>
        <award-group id="funding-3">
          <funding-source>
            <institution-wrap>
              <institution>NSF </institution>
              <institution-id institution-id-type="doi">10.13039/100000001</institution-id>
            </institution-wrap>
          </funding-source>
          <award-id>IIS 1850360</award-id>
        </award-group>
        <award-group id="funding-4">
          <funding-source>Showalter Young Investigator Award</funding-source>
        </award-group>
        <award-group id="funding-5">
          <funding-source>Precision Health Initiative of Indiana University</funding-source>
        </award-group>
      </funding-group>
      <counts>
        <page-count count="18"/>
      </counts>
    </article-meta>
  </front>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
      <journal-title-group>
        <journal-title>Genome Biology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1474-7596</issn>
      <issn pub-type="epub">1474-760X</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33971932</article-id>
      <article-id pub-id-type="pmc">8108367</article-id>
      <article-id pub-id-type="publisher-id">2362</article-id>
      <article-id pub-id-type="doi">10.1186/s13059-021-02362-7</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Method</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>SpatialDWLS: accurate deconvolution of spatial transcriptomic data</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dong</surname>
            <given-names>Rui</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2283-4714</contrib-id>
          <name>
            <surname>Yuan</surname>
            <given-names>Guo-Cheng</given-names>
          </name>
          <address>
            <email>guo-cheng.yuan@mssm.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Department of Pediatric Oncology, Dana-Farber Cancer Institute, </institution><institution>Harvard Medical School, </institution></institution-wrap>Boston, MA 02215 USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.38142.3c</institution-id><institution-id institution-id-type="ISNI">000000041936754X</institution-id><institution>Massachusetts General Hospital Cancer Center, </institution><institution>Harvard Medical School, </institution></institution-wrap>Charlestown, MA 02129 USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Genetics and Genomic Sciences, Charles Bronfman Institute for Personalized Medicine, </institution><institution>Icahn School of Medicine at Mount Sinai, </institution></institution-wrap>New York, NY 10029 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>5</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>10</day>
        <month>5</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>22</volume>
      <elocation-id>145</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>2</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>4</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2021</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Recent development of spatial transcriptomic technologies has made it possible to characterize cellular heterogeneity with spatial information. However, the technology often does not have sufficient resolution to distinguish neighboring cell types. Here, we present spatialDWLS, to quantitatively estimate the cell-type composition at each spatial location. We benchmark the performance of spatialDWLS by comparing it with a number of existing deconvolution methods and find that spatialDWLS outperforms the other methods in terms of accuracy and speed. By applying spatialDWLS to a human developmental heart dataset, we observe striking spatial temporal changes of cell-type composition during development.</p>
        <sec>
          <title>Supplementary Information</title>
          <p>The online version contains supplementary material available at 10.1186/s13059-021-02362-7.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Spatial transcriptomics</kwd>
        <kwd>Single cell</kwd>
        <kwd>Deconvolution</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id>
              <institution>NIH Office of the Director</institution>
            </institution-wrap>
          </funding-source>
          <award-id>UH3HL145609</award-id>
          <principal-award-recipient>
            <name>
              <surname>Yuan</surname>
              <given-names>Guo-Cheng</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000049</institution-id>
              <institution>National Institute on Aging</institution>
            </institution-wrap>
          </funding-source>
          <award-id>R01AG066028</award-id>
          <principal-award-recipient>
            <name>
              <surname>Yuan</surname>
              <given-names>Guo-Cheng</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p id="Par2">Rapid development in spatial transcriptomics has enabled systematic characterization of cellular heterogeneity while preserving spatial context [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR6">6</xref>]. Compared to the commonly-used single-cell RNA-seq technology, the main advantage of spatial transcriptomic technologies is that they can be used to profile gene expression in a small number of or even single cells while preserving spatial information. This is crucial for mapping the structural organization of tissues and facilitates mechanistic studies of cell-environment interactions. On the other hand, identifying the spatial distributions of various cell types can be challenging, since many existing methods do not have single-cell resolution, such as Spatial Transcriptomics [<xref ref-type="bibr" rid="CR4">4</xref>], 10X Genomics Visium, Slide-seq [<xref ref-type="bibr" rid="CR2">2</xref>], DBiT-seq [<xref ref-type="bibr" rid="CR6">6</xref>], and Nanostring GeoMx. This is an important barrier for data analysis and interpretation which limits the utility of these technologies. Therefore, it is desirable to develop computational methods to infer the composition of cell types at each location, a task that is often referred to as cell-type deconvolution.</p>
      <p id="Par3">A number of methods have been developed for deconvolving bulk RNAseq data [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR13">13</xref>]. In principle, these methods can be directly applied to spatial expression analysis as well, treating the data from each location as a bulk sample. However, there are two main limitations for this approach. First, the number of cells within each spot is typically small. For example, each spot in the 10X Genomics Visium platform has the diameter of 55&#x2009;&#x3BC;m, corresponding to a spatial resolution of 5&#x2013;10 cells. The application of a bulk RNAseq deconvolution method to such a small sample size would result in noise from unrelated cell types. Second, as spatial expression datasets usually contain thousands of spots, it would be time and memory consuming if deconvolution methods designed for bulk RNA-seq&#xA0;are applied on spatial expression datasets. Recently, several methods have been developed specifically for spatial transcriptomic data deconvolution [<xref ref-type="bibr" rid="CR14">14</xref>&#x2013;<xref ref-type="bibr" rid="CR16">16</xref>]. Here, we introduce a novel method spatialDWLS for this task and benchmark with existing methods.</p>
    </sec>
    <sec id="Sec2">
      <title>Results</title>
      <sec id="Sec3">
        <title>Overview of spatialDWLS</title>
        <p id="Par4">SpatialDWLS is an extension of dampened weighted least squares (DWLS) [<xref ref-type="bibr" rid="CR9">9</xref>], which we developed previously for deconvolution of RNAseq data. In short, DWLS uses a weighted least squares approach to infer cell-type composition, where the weight is selected to minimize the overall relative error rate. Because only a small number of cell types may be associated with a specific location, we combine a recently developed cell-type enrichment analysis method [<xref ref-type="bibr" rid="CR17">17</xref>] to enhance specificity. In a nutshell, spatialDWLS contains two steps (Fig. <xref rid="Fig1" ref-type="fig">1</xref>a). First, it identifies cell types that likely to be present at each location [<xref ref-type="bibr" rid="CR17">17</xref>]. Second, the cell type composition at each location is inferred by applying DWLS to infer the fraction of each selected cell type [<xref ref-type="bibr" rid="CR9">9</xref>]. The details are described in the &#x201C;Methods&#x201D; section.
<fig id="Fig1"><label>Fig. 1</label><caption><p>An overview of the spatialDWLS method. <bold>a</bold> A schematic representation of the spatialDWLS workflow. The input contains a spatial transcriptomic dataset (gene expression matrix and cell location coordinates) and a set of known cell-type specific gene signatures. For each spot, the cell types that are likely to be present are identified by using cell-type enrichment analysis. Then, a modified DWLS method is applied to infer cell type position at each spot. <bold>b</bold> Comparison of the accuracy of different deconvolution methods. Single-cell resolution seqFISH+ data are coarse-grain averaged to generate lower-resolution spatial transcriptomic data. The true frequency of a cell-type (indicated as blue squares in the top left panel) at each spot is compared with the inferred frequency (indicated as red squares in the five other panels) by using different methods. The relationship is also represented as a scatter plot, with <italic>x</italic>-axis representing the true frequency and the <italic>y</italic>-axis representing the inferred frequency. The overall performance is quantified as the root mean square error (RMSE). The oligodendrocyte cell-type is used here as a representative example. <bold>c</bold> The overall RMSE error is further decomposed into two components, corresponding to regions where the cell type is absent (red) and present (green), respectively. <bold>d</bold> Comparison of the computing speed of different methods. Running times for analyzing a mouse brain Visium dataset are shown</p></caption><graphic xlink:href="13059_2021_2362_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec4">
        <title>Evaluation and benchmarks of spatialDWLS</title>
        <p id="Par5">To evaluate the performance of spatialDWLS, we created a simulated spatial transcriptomic dataset based on coarse-graining average of single-cell resolution data. Specifically, we analyzed a public seqFISH+ dataset [<xref ref-type="bibr" rid="CR1">1</xref>], which contains the expression profile of 10,000 genes in 523 cells from the mouse somatosensory cortex at the single-cell resolution. To mimic the outcome of a lower-resolution profiling strategy, we divided each field of view (FOV) into squared spots of ~&#x2009;51.5&#x2009;&#x3BC;m on each side and aggregated the transcript counts that fell&#xA0;into each spot. On average, about seven cells are included in each spot. The resulting dataset has a total number of 71 spots, each covering an average of 7.3 cells. The original dataset serves as the ground-truth for benchmarking.</p>
        <p id="Par6">To apply spatialDWLS, we obtained cell-type specific gene signatures from a publicly available single-cell RNAseq (scRNAseq) dataset [<xref ref-type="bibr" rid="CR18">18</xref>]. In total, this dataset contains 1691 cells and 6 major cell types are identified. Based on the scRNAseq derived cell-type gene signatures, we applied spatialDWLS to deconvolve the above simulated dataset. The cell-type percentage at each location varies from 5.9 to 100%.</p>
        <p id="Par7">To evaluate the performance of our spatialDWLS method, we compared the predicted and true cell type proportion and found good agreement overall (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b&#x2013;c&#xA0;and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1a-b). For example, the root mean square error (RMSE) associated with oligodendrocytes is only 0.03 with the predicted values approximately center around ground-truth (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). In order to separately evaluate the sensitivity and specificity, we divided the simulated spots into subsets where the cell type&#xA0;was present or absent and evaluated the RMSE errors for each subset. The fact that both errors have small magnitude indicates spatialDWLS has both high degrees of sensitivity and specificity (Fig. <xref rid="Fig1" ref-type="fig">1</xref>c). As a benchmark, we applied four published deconvolution methods, including MuSiC [<xref ref-type="bibr" rid="CR8">8</xref>], RCTD [<xref ref-type="bibr" rid="CR14">14</xref>], SPOTlight [<xref ref-type="bibr" rid="CR15">15</xref>], and stereoscope [<xref ref-type="bibr" rid="CR16">16</xref>] to analyze the same dataset. All the other methods led to higher error (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1a, b), although the differences with MuSiC and RCTD appear modest.</p>
        <p id="Par8">Next, we applied spatialDWLS to analyze a 10X Genomics Visium dataset mapping the spatial transcriptomic profile in mouse brain. This dataset contains 2698 spatially barcoded circular spots each 55&#x2009;&#x3BC;m in diameter. To comprehensively deconvolve cell type composition, we used the mouse nervous system atlas scRNAseq data as a reference [<xref ref-type="bibr" rid="CR19">19</xref>], which contains gene expression signature of 21 major cell types. While it is impossible to quantify the prediction accuracy because the ground-truth is unknown, the resulting spatial distributions are highly consistent with the mouse Allen Brain Atlas (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2a, b). For example, the peptidergic cells were correctly mapped to the hypothalamus region; the granule neurons were correctly mapped to the dentate gyrus region, and the medium spiny neurons were correctly mapped to the basal ganglia (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2a, b).</p>
        <p id="Par9">The spatialDWLS analysis took 23&#x2009;min CPU time on a small computer cluster (Intel Xeon CPU E5-2650 32 processors 2.00GHz and 380Gb memory). To compare the computational efficiency of different methods, we applied each of the&#xA0;other methods to analyze the same dataset using the same computer. Furthermore, to assess scalability we subsampled the mouse brain dataset varying from 500 to 2000 spots and examined the relationship between CPU time and sample size. We found that spatialDWLS and MuSiC were more computationally efficient, each taking about 23 min CPU time to analyze the 2000-spot dataset. In comparison, both RCTD and SPOTlight were about 2 times slower for the larger sample size, whereas stereoscope was at least 10 times slower (Fig. <xref rid="Fig1" ref-type="fig">1</xref>d). Taken together, these analyses suggest spatialDWLS is more accurate and computationally efficient than these other methods.</p>
      </sec>
      <sec id="Sec5">
        <title>Apply spatialDWLS on human heart spatial transcriptomic dataset</title>
        <p id="Par10">During embryonic development, the spatial-temporal distribution of cell types changes dramatically. Therefore, it is of interest to test whether spatialDWLS could aid the discovery of such dynamic changes. Recently, Asp and colleagues studied the development of human heart in early embryos (4.5&#x2013;5, 6.5, and 9 post-conception weeks) by using the Spatial Transcriptomics (ST) technology [<xref ref-type="bibr" rid="CR20">20</xref>] (Fig. <xref rid="Fig2" ref-type="fig">2</xref>a). Since the data does not have single-cell resolution, they were not able to identify cell-type distribution directly from the ST data. In order to apply spatialDWLS, we utilized the scRNAseq derived gene signatures from this study as reference. All the cell types were mapped to expected locations (Fig. <xref rid="Fig2" ref-type="fig">2</xref>b and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3a-c).
<fig id="Fig2"><label>Fig. 2</label><caption><p>Deconvolution analysis identifies spatial-temporal change of cell-type composition during human&#xA0;heart development. <bold>a</bold> A schematic overview of the analysis. Spatial Transcriptomic data for developing heart were collected at three developmental stages by Asp et al. 2019. In parallel, single-cell RNAseq analysis was carried out to identify cell-type specific gene signatures. The spatialDWLS method was applied to infer the distribution of different cell-types across developmental stages. <bold>b</bold> The resulting estimates of the spatial distribution of different cell types. One representative sample was selected from each developmental stage. <bold>c</bold> A summary of the cell-type composition for all samples grouped by the corresponding developmental stages. <bold>d</bold> The assortativity analysis indicates an increased level of spatial clustering among similar cell types during heart development</p></caption><graphic xlink:href="13059_2021_2362_Fig2_HTML" id="MO2"/></fig></p>
        <p id="Par11">In order to quantitatively compare the change of spatial-temporal organization of cell type composition during embryonic heart development, we first examined the overall abundance of different cell types (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c). We found that the abundance of ventricular cardiomyocytes increases dramatically during development (from an average of 25% in weeks 4.5&#x2013;5 to 53% in week 9) (Fig. <xref rid="Fig2" ref-type="fig">2</xref>c). Notably, the abundance of atrial cardiomyocytes does not show this trend, which probably reflects the atrium compartments expand less dramatically compared to the ventricle compartments. Next, we compared the spatial organization patterns across developmental stages. Normal heart function relies on the coordinated activity of billions of cardiac cells; therefore, we were interested to test whether spatially neighboring cells tend to belong to the same cell type. This is quantified by using a metric called the assortativity coefficient [<xref ref-type="bibr" rid="CR21">21</xref>], which is commonly used in social network analysis to characterize the tendency of friendship formed by similar individuals. In the current context, we considered the spatial network connecting neighboring cells. We further modified the definition of assortativity coefficient in order to account for the cellular heterogeneity within each spot location (see the &#x201C;Methods&#x201D; section for details). We found that the assortativity coefficient increased from 0.23 at weeks 4.5&#x2013;5 to 0.50 at week 9 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>d), suggesting the spatial organization becomes increasingly spatially coherent during heart development.</p>
      </sec>
    </sec>
    <sec id="Sec6">
      <title>Conclusions</title>
      <p id="Par12">SpatialDWLS is an accurate and computationally efficient method for estimating the spatial distribution of cell types from spatial transcriptomic data. Thus, it provides a valuable enabling toolkit for investigating cell-cell interactions from various spatial transcriptomic technology platforms that do not have single-cell resolution. Compared to existing deconvolution methods [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR16">16</xref>], the key difference is spatialDWLS contains an additional filtering step to remove irrelevant cell-types thereby enhancing specificity. The spatialDWLS method can be easily accessed in Giotto [<xref ref-type="bibr" rid="CR17">17</xref>], which is a user-friendly software package containing a large number of computational tools for spatial transcriptomic data analysis and visualization.</p>
    </sec>
    <sec id="Sec7">
      <title>Methods</title>
      <sec id="Sec8">
        <title>Cell type selection of spatial expression data by enrichment analysis</title>
        <p id="Par13">We use an enrichment based weighted least squares approach for deconvolution of spatial expression datasets. First, enrichment analysis using Parametric Analysis of Gene Set Enrichment (PAGE) method [<xref ref-type="bibr" rid="CR22">22</xref>] is applied on spatial expression dataset as previously reported [<xref ref-type="bibr" rid="CR17">17</xref>]. The marker genes can be identified via differential expression gene analysis of Giotto based on the scRNAseq data provided by users. Alternatively, users can also provide marker gene expression for each cell type for deconvolution. The number of cell-type specific marker genes is denoted by <italic>m</italic>. For each gene, we calculate the fold change as the ratio between its expression value at each spot and the mean expression of all spots. The mean fold change of the <italic>m</italic> marker genes is calculated and denoted as <italic>S</italic><sub><italic>m</italic></sub>. As background control, the mean and standard deviation of the fold change values across all genes are denoted as &#x3BC; and &#x3B4;, respectively. The enrichment score (ES) is defined as follows:
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{ES}=\frac{\left({S}_m-\mu \right)\ast \sqrt{m}}{\delta } $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi>ES</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>m</mml:mi></mml:msub><mml:mo>&#x2212;</mml:mo><mml:mi>&#x3BC;</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#x2217;</mml:mo><mml:msqrt><mml:mi>m</mml:mi></mml:msqrt></mml:mrow><mml:mi>&#x3B4;</mml:mi></mml:mfrac></mml:math><graphic xlink:href="13059_2021_2362_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par14">Then, we binarize the enrichment matrix with the cutoff value of ES = 2 to select cell types that are likely to be present at each point.</p>
      </sec>
      <sec id="Sec9">
        <title>Estimating cell type composition by using a weighted least squares approach</title>
        <p id="Par15">In previous work, we developed DWLS [<xref ref-type="bibr" rid="CR9">9</xref>] for deconvolution of scRNAseq data. This method is extended here to deconvolve spatial transcriptomic data using the signature gene identification step described above. In short, DWLS uses a weighted least squares approach to infer cell-type composition, where the weight is selected to minimize the overall relative error rate. In addition, a damping constant <italic>d</italic> is used to enhance numerical stability, whose value is determined by using a cross-validation procedure. Here, we use the same sets of weights and damping constant across spots within same clusters to reduce technical variation. Finally, since the number of cells present at each spot is generally small, we perform another round deconvolution&#xA0;after removing those cell types that are predicted to present at a low frequency by imposing an additional thresholding (min frequency = 0.02 by default).</p>
      </sec>
      <sec id="Sec10">
        <title>Coarse-grained spatial transcriptomic data for model performance evaluation</title>
        <p id="Par16">The somatosensory cortex seqFISH+ data were abstained from <ext-link ext-link-type="uri" xlink:href="https://github.com/CaiGroup/seqFISH-PLUS">https://github.com/CaiGroup/seqFISH-PLUS</ext-link>. To simulate spot-like data, we defined the square with 500 pixels time 500 pixels (~&#x2009;51.5&#x2009;&#x3BC;m) as one spot-like region. Then, average expression level was calculated for each spot-like region. Due to the small sample size, we only considered the 6 major clusters: excitatory neurons (eNeuron), inhibitory neurons (iNeuron), astrocytes, oligodendrocytes (Olig), microglia cells, and endothelial-mural cells (endo_mural).</p>
      </sec>
      <sec id="Sec11">
        <title>Benchmark comparison among different methods</title>
        <p id="Par17">Coarse-grained seqFISH+ dataset was used for benchmarking the accuracy of different deconvolution methods, including spatialDWLS, MuSiC, RCTD, SPOTlight, and stereoscope. For each published method, the default parameter setting was used for comparison. If the users are required to set parameters manually, we used the values suggested in the vignettes of the corresponding software. Cell-type annotations for the original, single-cell resolution data were used as the ground-truth. All five methods used the same scRNA-seq dataset as a reference in deconvolution.</p>
        <p id="Par18">For spatialDWLS, we clustered the spot-like regions by using Leiden clustering as implemented in Giotto (Version 1.0.3) by using the following commands <italic>createNearestNetwork(dimensions_to_use = 1:10, k = 4)</italic> and <italic>doLeidenCluster(resolution = 0.4, n_iterations = 1000)</italic>.</p>
        <p id="Par20">Then, marker genes of major clusters were identified by using the <italic>findMarkers_one_vs_all</italic> function with parameter setting: <italic>method = &#x2018;gini&#x2019;, expression_values = &#x2018;normalized&#x2019;</italic>. Top 100 ranked genes for each cell type were selected as marker genes. Average marker gene expression was calculated based on the cell type annotation of scRNA-seq. Then, deconvolution was applied by using the <italic>runDWLSDeconv</italic> function.</p>
        <p id="Par21">MuSiC [<xref ref-type="bibr" rid="CR8">8</xref>] (version 0.1.1) was used for deconvolution by using whole single cell RNA-seq matrix. <italic>ExpressionSet</italic> classes were generated for both single cell RNA-seq (<italic>SC.eset</italic>) and spatial expression datasets (<italic>ST.eset</italic>). Then, cell type proportion was estimated by using <italic>music_prop(bulk.eset = ST.eset, sc.eset = SC.eset).</italic></p>
        <p id="Par22">Then, to perform deconvolution by using SPOTlight [<xref ref-type="bibr" rid="CR15">15</xref>] (version 0.1.0), signature genes were identified based on the major cell type annotation by using <italic>Seurat::FindAllMarkers(logfc.threshold = 1, min.pct = 0.9).</italic></p>
        <p id="Par23">Deconvolution was performed by using <italic>spotlight_deconvolution(se_sc = SC, counts_spatial = ST, cluster_markers = cluster_markers_all, clust_vr = &#x201C;label&#x201D;).</italic></p>
        <p id="Par24">Next, we used stereoscope [<xref ref-type="bibr" rid="CR16">16</xref>] (version 0.2.0) for the deconvolution of simulated dataset. Deconvolution was performed with&#xA0;the parameter: <italic>stereoscope run -scc SC.tsv -scl cell_labels.tsv -stc ST.tsv -sce 5000.</italic></p>
        <p id="Par25">Finally, we used RCTD [<xref ref-type="bibr" rid="CR14">14</xref>] (version 1.1.0) to evaluate the cell type composition for simulated seqFISH+ dataset. Signature genes were identified by using &#x201C;<italic>dgeToSeurat</italic>,&#x201D; and then &#x201C;<italic>create.RCTD</italic>&#x201D; and &#x201C;run.RCTD&#x201D; were used to decompose the cell type composition. Finally, cell type percentage for each spot was calculated using the &#x201C;<italic>sweep</italic>&#x201D; function.</p>
        <p id="Par26">The computational efficiency of different methods was benchmarked by using the Visium brain dataset. All analyses were done on the same computer, which had Intel Xeon CPU E5-2650 2.00GHz and 380Gb memory. Of note, the Visium data cannot be used to evaluate accuracy because the ground-truth is not known.</p>
      </sec>
      <sec id="Sec12">
        <title>Root mean square error (RMSE) calculation</title>
        <p id="Par27">Based on the cell type annotation of seqFISH+ dataset, we calculated the true cell type percentage for simulated spatial expression datasets. For a specific cell type, we divided spot-like regions into two groups based on the presence or absence of this cell type. RMSEs were calculated separately for these two groups.</p>
      </sec>
      <sec id="Sec13">
        <title>Analysis of a spatial transcriptomic dataset from the mouse brain</title>
        <p id="Par28">The Visium dataset was obtained from the 10X Genomics website (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Adult_Mouse_Brain">https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Adult_Mouse_Brain</ext-link>), which corresponds to a coronal section of the mouse brain. Then, Giotto was used for data analysis as (<ext-link ext-link-type="uri" xlink:href="http://www.spatialgiotto.com/giotto.visium.brain.html">http://www.spatialgiotto.com/giotto.visium.brain.html</ext-link>). Only spots within tissue were kept for further analysis. Then, we filtered out low quality spots and genes by using filterGiotto with the&#xA0;parameter: <italic>expression_threshold = 1, gene_det_in_min_cells = 50, min_det_genes_per_cell = 1000</italic>.</p>
        <p id="Par29">After normalization and highly variable gene calculation, we performed neighborhood analysis with parameter: <italic>createNearestNetwork (dimensions_to_use = 1:10, k = 15)</italic> and clustered spots with the&#xA0;parameter: <italic>doLeidenCluster(resolution = 0.4, n_iterations = 1000)</italic>. Finally, we used marker genes and scRNA-seq reported in Zeisel et al. [<xref ref-type="bibr" rid="CR18">18</xref>] to deconvolute the Visium dataset.</p>
      </sec>
      <sec id="Sec14">
        <title>Analysis of a spatial transcriptomic dataset from developing human&#xA0;heart</title>
        <p id="Par30">The human&#xA0;heart spatial transcriptomics datasets were obtained from [<xref ref-type="bibr" rid="CR20">20</xref>]. Then, we filtered out low quality spots and genes by using filterGiotto with&#xA0;the parameter: <italic>expression_threshold = 1, gene_det_in_min_cells = 10, min_det_genes_per_cell = 200</italic>.</p>
        <p id="Par31">After normalization and highly variable gene&#xA0;detection, we performed neighborhood analysis with theparameter: <italic>createNearestNetwork(dimensions_to_use = 1:10, k = 10)</italic> and clustered spots with&#xA0;the parameter: <italic>doLeidenCluster(resolution = 0.4, n_iterations = 1000)</italic>.</p>
        <p id="Par33">In addition, we use the scRNA-seq data from the same website with spatial transcriptomics datasets. Based on the clusters reported, we re-analyzed signature genes by using Giotto with the&#xA0;parameter: <italic>findMarkers_one_vs_all(method = 'scran')</italic>.</p>
        <p id="Par34">The average expression of marker genes was used for the deconvolution of heart ST datasets.</p>
      </sec>
      <sec id="Sec15">
        <title>Assortativity analysis</title>
        <p id="Par35">To evaluate the degree of spatial coherence, we extended the assortativity analysis [<xref ref-type="bibr" rid="CR21">21</xref>], a method commonly used in the network analysis to evaluate the tendency of similar networks nodes are connected to each other. Here, we generated a spatial network by connecting spots that are immediately next to each other. The&#xA0;assortativity coefficient represents the normalized deviation of edges connecting the same cell type than expected by chance. More precisely, it is defined by the following formula:
<disp-formula id="Equi"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ Q=\frac{\sum_k{q}_{kk}-{\sum}_k{a}_k^2}{1-{\sum}_k{a}_k^2} $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mi>Q</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>k</mml:mi></mml:msub><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">kk</mml:mi></mml:msub><mml:mo>&#x2212;</mml:mo><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>k</mml:mi></mml:msub><mml:msubsup><mml:mi>a</mml:mi><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x2212;</mml:mo><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>k</mml:mi></mml:msub><mml:msubsup><mml:mi>a</mml:mi><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="13059_2021_2362_Article_Equi.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par36">where
<disp-formula id="Equj"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {q}_{kk}=\frac{\sum_i{\sum}_j{w}_k^i{w}_k^j{e}_{ij}}{\sum_i{\sum}_j{e}_{ij}} $$\end{document}</tex-math><mml:math id="M6" display="block"><mml:msub><mml:mi>q</mml:mi><mml:mi mathvariant="italic">kk</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>j</mml:mi></mml:msub><mml:msubsup><mml:mi>w</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msubsup><mml:msubsup><mml:mi>w</mml:mi><mml:mi>k</mml:mi><mml:mi>j</mml:mi></mml:msubsup><mml:msub><mml:mi>e</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>e</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub></mml:mrow></mml:mfrac></mml:math><graphic xlink:href="13059_2021_2362_Article_Equj.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par37">and
<disp-formula id="Equk"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {a}_k=\frac{1}{N}{\sum}_i{w}_k^i $$\end{document}</tex-math><mml:math id="M8" display="block"><mml:msub><mml:mi>a</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>N</mml:mi></mml:mfrac><mml:msub><mml:mo>&#x2211;</mml:mo><mml:mi>i</mml:mi></mml:msub><mml:msubsup><mml:mi>w</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:math><graphic xlink:href="13059_2021_2362_Article_Equk.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par38">In the above, <inline-formula id="IEq1"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {w}_k^i $$\end{document}</tex-math><mml:math id="M10" display="inline"><mml:msubsup><mml:mi>w</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:math><inline-graphic xlink:href="13059_2021_2362_Article_IEq1.gif"/></alternatives></inline-formula> represents the fraction of cell-type <italic>k</italic> at the <italic>i</italic>th spot, <italic>N</italic> represents the total number of spots, and <italic>e</italic><sub><italic>ij</italic></sub> is defined as
<disp-formula id="Equl"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {e}_{ij}=\left\{\begin{array}{c}1,\mathrm{if}\ i\ \mathrm{and}\ j\ \mathrm{are}\ \mathrm{neighboring}\ \mathrm{spots}\\ {}0,\mathrm{otherwise}\end{array}\right. $$\end{document}</tex-math><mml:math id="M12" display="block"><mml:msub><mml:mi>e</mml:mi><mml:mi mathvariant="italic">ij</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mtable><mml:mtr><mml:mtd><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mtext>if</mml:mtext><mml:mspace width="0.25em"/><mml:mi>i</mml:mi><mml:mspace width="0.25em"/><mml:mtext>and</mml:mtext><mml:mspace width="0.25em"/><mml:mi>j</mml:mi><mml:mspace width="0.25em"/><mml:mi>are</mml:mi><mml:mspace width="0.25em"/><mml:mtext>neighboring spots</mml:mtext></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mtext>otherwise</mml:mtext></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:math><graphic xlink:href="13059_2021_2362_Article_Equl.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par39">If the values of <inline-formula id="IEq2"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ {w}_k^i $$\end{document}</tex-math><mml:math id="M14" display="inline"><mml:msubsup><mml:mi>w</mml:mi><mml:mi>k</mml:mi><mml:mi>i</mml:mi></mml:msubsup></mml:math><inline-graphic xlink:href="13059_2021_2362_Article_IEq2.gif"/></alternatives></inline-formula> are binary, then the above definition reduces to the original formula in [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Information</title>
      <sec id="Sec16">
        <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13059_2021_2362_MOESM1_ESM.pdf"><caption><p><bold>Additional file 1: Figure S1-S3.</bold></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13059_2021_2362_MOESM2_ESM.docx"><caption><p><bold>Additional file 2.</bold> Review history.</p></caption></media></supplementary-material></p>
      </sec>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Publisher&#x2019;s Note</bold>
        </p>
        <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>We gratefully thank Dr. Ruben Dries for his helpful discussion and Ms.&#xA0;Natalie Del Rossi for her technical assistance.</p>
      <sec id="FPar1">
        <title>Review history</title>
        <p id="Par40">The review history is available as Additional file <xref rid="MOESM2" ref-type="media">2</xref>.</p>
      </sec>
      <sec id="FPar2">
        <title>Peer review information</title>
        <p id="Par41">Barbara Cheifet was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p>
      </sec>
    </ack>
    <notes notes-type="author-contribution">
      <title>Authors&#x2019; contributions</title>
      <p>GCY conceived the idea and supervised the work. RD and GCY designed the spatialDWLS package. RD implemented the package and performed the analysis. RD and GCY wrote and revised the manuscript. All authors read and approved the final manuscript.</p>
      <sec id="FPar3">
        <title>Authors&#x2019; information</title>
        <p id="Par42">Twitter handle: @gc_yuan (Guo-Cheng Yuan).</p>
      </sec>
    </notes>
    <notes notes-type="funding-information">
      <title>Funding</title>
      <p>This research was supported by NIH grants UH3HL145609 and R01AG066028 to G.-C.Y.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Availability of data and materials</title>
      <p>All codes, data, and analysis results in this paper are publicly available at GitHub [<xref ref-type="bibr" rid="CR23">23</xref>] and at Zenodo [<xref ref-type="bibr" rid="CR24">24</xref>]. The source code is released under the MIT license. Furthermore, the spatialDWLS method is implemented as the <italic>runDWLSDeconv</italic> function in Giotto (<ext-link ext-link-type="uri" xlink:href="https://github.com/RubD/Giotto">https://github.com/RubD/Giotto</ext-link>), and detailed tutorial and vignette are available at Giotto websites (<ext-link ext-link-type="uri" xlink:href="http://www.spatialgiotto.com">http://www.spatialgiotto.com</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://rubd.github.io/Giotto_site/">https://rubd.github.io/Giotto_site/</ext-link>).</p>
    </notes>
    <notes>
      <title>Declarations</title>
      <notes id="FPar4">
        <title>Ethics approval and consent to participate</title>
        <p id="Par43">Not applicable.</p>
      </notes>
      <notes id="FPar5" notes-type="COI-statement">
        <title>Competing interests</title>
        <p id="Par44">The authors declare that they have no competing interests.</p>
      </notes>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eng</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Dries</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Koulena</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Takei</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yun</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cronin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Karp</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Cai</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH</article-title>
          <source>Nature</source>
          <year>2019</year>
          <volume>568</volume>
          <issue>7751</issue>
          <fpage>235</fpage>
          <lpage>239</lpage>
          <pub-id pub-id-type="doi">10.1038/s41586-019-1049-y</pub-id>
          <pub-id pub-id-type="pmid">30911168</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriques</surname>
              <given-names>SG</given-names>
            </name>
            <name>
              <surname>Stickels</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Goeva</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Vanderburg</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Macosko</surname>
              <given-names>EZ</given-names>
            </name>
          </person-group>
          <article-title>Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution</article-title>
          <source>Science</source>
          <year>2019</year>
          <volume>363</volume>
          <issue>6434</issue>
          <fpage>1463</fpage>
          <lpage>1467</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaw1219</pub-id>
          <pub-id pub-id-type="pmid">30923225</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Wright</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Sylwestrak</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Samusik</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Vesuna</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Evans</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ramakrishnan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nolan</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Bava</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Deisseroth</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Three-dimensional intact-tissue sequencing of single-cell transcriptional states</article-title>
          <source>Science</source>
          <year>2018</year>
          <volume>361</volume>
          <issue>6400</issue>
          <fpage>eaat5691</fpage>
          <pub-id pub-id-type="doi">10.1126/science.aat5691</pub-id>
          <pub-id pub-id-type="pmid">29930089</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stahl</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Salmen</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vickovic</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lundmark</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Navarro</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Magnusson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Giacomello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Asp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Westholm</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Huss</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>
          <source>Science</source>
          <year>2016</year>
          <volume>353</volume>
          <issue>6294</issue>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaf2403</pub-id>
          <pub-id pub-id-type="pmid">27365449</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moffitt</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Hao</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bambah-Mukku</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Dulac</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zhuang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>High-performance multiplexed fluorescence in situ hybridization in culture and tissue with matrix imprinting and clearing</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2016</year>
          <volume>113</volume>
          <issue>50</issue>
          <fpage>14456</fpage>
          <lpage>14461</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1617699113</pub-id>
          <pub-id pub-id-type="pmid">27911841</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Enninful</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Tebaldi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Bai</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Norris</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xiao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Halene</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue</article-title>
          <source>Cell</source>
          <year>2020</year>
          <volume>183</volume>
          <issue>6</issue>
          <fpage>1665</fpage>
          <lpage>1681</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2020.10.026</pub-id>
          <pub-id pub-id-type="pmid">33188776</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhong</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Wan</surname>
              <given-names>YW</given-names>
            </name>
            <name>
              <surname>Pang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Digital sorting of complex tissues for cell type-specific gene expression profiles</article-title>
          <source>BMC Bioinformatics</source>
          <year>2013</year>
          <volume>14</volume>
          <issue>1</issue>
          <fpage>89</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-14-89</pub-id>
          <pub-id pub-id-type="pmid">23497278</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Susztak</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Bulk tissue cell type deconvolution with multi-subject single-cell expression reference</article-title>
          <source>Nat Commun</source>
          <year>2019</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>380</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-018-08023-x</pub-id>
          <pub-id pub-id-type="pmid">30670690</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsoucas</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dong</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>Accurate estimation of cell-type composition from gene expression data</article-title>
          <source>Nat Commun</source>
          <year>2019</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>2975</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-019-10802-z</pub-id>
          <pub-id pub-id-type="pmid">31278265</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Gentles</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Feng</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hoang</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Diehn</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Alizadeh</surname>
              <given-names>AA</given-names>
            </name>
          </person-group>
          <article-title>Robust enumeration of cell subsets from tissue expression profiles</article-title>
          <source>Nat Methods</source>
          <year>2015</year>
          <volume>12</volume>
          <issue>5</issue>
          <fpage>453</fpage>
          <lpage>457</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.3337</pub-id>
          <pub-id pub-id-type="pmid">25822800</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Severson</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pignon</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Novak</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aster</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Rodig</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Signoretti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>XS</given-names>
            </name>
          </person-group>
          <article-title>Comprehensive analyses of tumor immunity: implications for cancer immunotherapy</article-title>
          <source>Genome Biol</source>
          <year>2016</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>174</fpage>
          <pub-id pub-id-type="doi">10.1186/s13059-016-1028-7</pub-id>
          <pub-id pub-id-type="pmid">27549193</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gong</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Szustakowski</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data</article-title>
          <source>Bioinformatics</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>8</issue>
          <fpage>1083</fpage>
          <lpage>1085</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btt090</pub-id>
          <pub-id pub-id-type="pmid">23428642</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <mixed-citation publication-type="other">Dong M, Thennavan A, Urrutia E, Li Y, Perou CM, Zou F, et al. SCDC: bulk gene expression deconvolution by multiple single-cell RNA sequencing references.&#xA0;Brief Bioinform.&#xA0;2021;22(1):416&#x2013;27.&#xA0;10.1093/bib/bbz166.</mixed-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <mixed-citation publication-type="other">Cable DM, Murray E, Zou LS, Goeva A, Macosko EZ, Chen F, Irizarry RA. Robust decomposition of cell type mixtures in spatial transcriptomics. Nat Biotechnol. 2021. 10.1038/s41587-021-00830-w. Online ahead of print.</mixed-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <mixed-citation publication-type="other">Elosua-Bayes M, Nieto P, Mereu E, Gut I,&#xA0;Heyn H.&#xA0;&#xA0;SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes.&#xA0;Nucleic Acids Res. 2021 Feb 5:gkab043. 10.1093/nar/gkab043. Online ahead of print.</mixed-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <mixed-citation publication-type="other">Andersson A, Bergenstr&#xE5;hle J, Asp M, Bergenstr&#xE5;hle L, Jurek A, Navarro JF, Lundeberg J: Spatial mapping of cell types by integration of transcriptomics data. 2019. bioRxiv.&#xA0;10.1101/2019.12.13.874495.</mixed-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <mixed-citation publication-type="other">Dries R, Zhu Q, Dong R, Eng CL, Li H, Liu K, Fu Y, Zhao T, Sarkar A, Bao F, George RE, Pierson N, Cai L,&#xA0;Yuan GC.&#xA0;&#xA0;Giotto: a toolbox for integrative analysis and visualization of spatial expression data. Genome Biol. 2021;22(1):78. 10.1186/s13059-021-02286-2.</mixed-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Munoz-Manchado</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Codeluppi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lonnerberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>La Manno</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Jureus</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Marques</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Munguba</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>He</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Betsholtz</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq</article-title>
          <source>Science</source>
          <year>2015</year>
          <volume>347</volume>
          <issue>6226</issue>
          <fpage>1138</fpage>
          <lpage>1142</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaa1934</pub-id>
          <pub-id pub-id-type="pmid">25700174</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zeisel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hochgerner</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Lonnerberg</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Johnsson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Memic</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>van der Zwan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Haring</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Braun</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Borm</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>La Manno</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular architecture of the mouse nervous system</article-title>
          <source>Cell</source>
          <year>2018</year>
          <volume>174</volume>
          <issue>4</issue>
          <fpage>999</fpage>
          <lpage>1014</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2018.06.021</pub-id>
          <pub-id pub-id-type="pmid">30096314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asp</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Giacomello</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Larsson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Furth</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Qian</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wardell</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Custodio</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Reimegard</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Salmen</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A spatiotemporal organ-wide gene expression and cell atlas of the developing human heart</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>179</volume>
          <issue>7</issue>
          <fpage>1647</fpage>
          <lpage>1660</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.11.025</pub-id>
          <pub-id pub-id-type="pmid">31835037</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Mixing patterns in networks</article-title>
          <source>Phys Rev E Stat Nonlin Soft Matter Phys</source>
          <year>2003</year>
          <volume>67</volume>
          <issue>2</issue>
          <fpage>026126</fpage>
          <pub-id pub-id-type="doi">10.1103/PhysRevE.67.026126</pub-id>
          <pub-id pub-id-type="pmid">12636767</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>SY</given-names>
            </name>
            <name>
              <surname>Volsky</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title>PAGE: parametric analysis of gene set enrichment</article-title>
          <source>BMC Bioinformatics</source>
          <year>2005</year>
          <volume>6</volume>
          <issue>1</issue>
          <fpage>144</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2105-6-144</pub-id>
          <pub-id pub-id-type="pmid">15941488</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <mixed-citation publication-type="other">Dong R, Yuan GC. SpatialDWLS on GitHub [Internet]: Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/rdong08/spatialDWLS_dataset">https://github.com/rdong08/spatialDWLS_dataset</ext-link>.</mixed-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <mixed-citation publication-type="other">Dong R, Yuan GC. SpatialDWLS on Zenodo [Internet]: Available from: <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/record/4706209#.YIDBoalKjv5">https://zenodo.org/record/4706209#.YIDBoalKjv5</ext-link>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="discussion">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diabetes</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diabetes</journal-id>
      <journal-id journal-id-type="hwp">diabetes</journal-id>
      <journal-id journal-id-type="publisher-id">Diabetes</journal-id>
      <journal-title-group>
        <journal-title>Diabetes</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0012-1797</issn>
      <issn pub-type="epub">1939-327X</issn>
      <publisher>
        <publisher-name>American Diabetes Association</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34176785</article-id>
      <article-id pub-id-type="pmc">8576419</article-id>
      <article-id pub-id-type="publisher-id">i210003</article-id>
      <article-id pub-id-type="doi">10.2337/dbi21-0003</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Diabetes Symposium</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7814-3859</contrib-id>
          <name>
            <surname>Ludwig</surname>
            <given-names>Mette Q.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Todorov</surname>
            <given-names>Petar V.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Egerod</surname>
            <given-names>Kristoffer L.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9249-7760</contrib-id>
          <name>
            <surname>Olson</surname>
            <given-names>David P.</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0207-4831</contrib-id>
          <name>
            <surname>Pers</surname>
            <given-names>Tune H.</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="cor1" ref-type="corresp"/>
        </contrib>
        <aff id="aff1"><sup>1</sup>Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark</aff>
        <aff id="aff2"><sup>2</sup>Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI</aff>
        <aff id="aff3"><sup>3</sup>Division of Pediatric Endocrinology, Department of Pediatrics, Michigan Medicine, Ann Arbor, MI</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Corresponding author: Tune H. Pers, <email>tune.pers@sund.ku.dk</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>27</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
      <volume>70</volume>
      <issue>9</issue>
      <fpage>1945</fpage>
      <lpage>1955</lpage>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>3</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>6</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2021 by the American Diabetes Association</copyright-statement>
        <copyright-year>2021</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="vor" start_date="2021-06-27">https://www.diabetesjournals.org/content/license</ali:license_ref>
          <license-p>Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at <ext-link ext-link-type="uri" xlink:href="https://www.diabetesjournals.org/content/license">https://www.diabetesjournals.org/content/license</ext-link>.</license-p>
        </license>
      </permissions>
      <self-uri xlink:title="pdf" xlink:href="dbi210003.pdf"/>
      <abstract>
        <p>The dorsal vagal complex (DVC) in the hindbrain, composed of the area postrema, nucleus of the solitary tract, and dorsal motor nucleus of the vagus, plays a critical role in modulating satiety. The incretins glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) act directly in the brain to modulate feeding, and receptors for both are expressed in the DVC. Given the impressive clinical responses to pharmacologic manipulation of incretin signaling, understanding the central mechanisms by which incretins alter metabolism and energy balance is of critical importance. Here, we review recent single-cell approaches used to detect molecular signatures of GLP-1 and GIP receptor&#x2013;expressing cells in the DVC. In addition, we discuss how current advancements in single-cell transcriptomics, epigenetics, spatial transcriptomics, and circuit mapping techniques have the potential to further characterize incretin receptor circuits in the hindbrain.</p>
      </abstract>
      <counts>
        <fig-count count="2"/>
        <table-count count="1"/>
        <equation-count count="0"/>
        <ref-count count="81"/>
        <page-count count="11"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p content-type="flushleft">The incretins glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are peptide hormones released by intestinal enteroendocrine cells in response to a meal (<xref rid="B1" ref-type="bibr">1</xref>). In addition to augmenting insulin secretion during an oral glucose load, both hormones modulate satiety (<xref rid="B1" ref-type="bibr">1</xref>). GLP-1 receptor agonists (GLP1RA) are approved for the treatment of obesity (<xref rid="B2" ref-type="bibr">2</xref>), and GLP-1 and GIP receptor coagonists show pronounced synergistic effects on weight loss in clinical trials (<xref rid="B3" ref-type="bibr">3</xref>). Moreover, genome-wide association studies (GWAS) for BMI (a surrogate measure to approximate adiposity) have associated coding variants in the GIP receptor (<italic toggle="yes">GIPR</italic>) with lowered body weight (<xref rid="B4" ref-type="bibr">4</xref>), further supporting a weight-modulatory role of GIPR in human obesity.</p>
      <p>Intracerebroventricular injection of either GIP or GLP-1 reduces body weight and combined intracerebroventricular injection of GIP and GLP-1 (at subeffective doses for each individual peptide) synergistically reduces body weight in mice (<xref rid="B5" ref-type="bibr">5</xref>). Due to the rapid degradation of endogenous GLP-1 and GIP by dipeptidyl peptidase 4, it is unlikely that intestinal-derived incretins reach receptors in the brain. However, the brain mediates the anorexic effects induced by degradation-resistant incretin receptor agonists; for instance, knockdown of <italic toggle="yes">Glp1r</italic> in the central nervous system abolishes weight loss in mice treated peripherally with GLP1RA (<xref rid="B6" ref-type="bibr">6</xref>). Interestingly, both peripherally and centrally administered GIPR antagonists have been shown to protect against obesity in rodents and nonhuman primates (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>), indicating that the cellular mechanisms through which GIPR signaling improves metabolic function remain undefined.</p>
      <p>Neurons in the hindbrain and especially the dorsal vagal complex (DVC) are optimally positioned to play a key role in mediating incretin&#x2019;s effects on food intake. The DVC is located in the medulla oblongata by the fourth ventricle and comprises the area postrema (AP), the nucleus of the solitary tract (NTS), and the dorsal motor nucleus of the vagus (DMV). The AP senses circulating metabolic signals (<xref rid="B9" ref-type="bibr">9</xref>), and the NTS processes and relays intestinal information to the brain (<xref rid="B10" ref-type="bibr">10</xref>). Studies in rodents and/or nonhuman primates have shown that <italic toggle="yes">GLP1R</italic> is expressed in the AP, NTS, and DMV (<xref rid="B11" ref-type="bibr">11</xref>&#x2013;<xref rid="B16" ref-type="bibr">16</xref>) and that <italic toggle="yes">Gipr</italic> is expressed in the AP (<xref rid="B15" ref-type="bibr">15</xref>&#x2013;<xref rid="B17" ref-type="bibr">17</xref>). In addition, the NTS houses a small population of GLP-1&#x2013;producing neurons (<xref rid="B18" ref-type="bibr">18</xref>). Moreover, GLP1R in glutamatergic and not GABAergic neurons are required for weight loss induced by peripherally administered GLP1RA in mice (<xref rid="B14" ref-type="bibr">14</xref>). Indeed, <italic toggle="yes">Glp1r</italic> is predominantly expressed in glutamatergic neurons in the AP and NTS (<xref rid="B14" ref-type="bibr">14</xref>), and administration of GLP1RA in the fourth ventricle suppresses feeding (<xref rid="B19" ref-type="bibr">19</xref>). Furthermore, peripherally administered GLP1RA-induced transcriptional changes are particularly pronounced in the AP compared with the NTS and extra-DVC brain areas (<xref rid="B16" ref-type="bibr">16</xref>). However, some studies have suggested an involvement of GABAergic NTS neurons and question whether AP cells are necessary for GLP1RA to exert control on feeding (<xref rid="B19" ref-type="bibr">19</xref>&#x2013;<xref rid="B22" ref-type="bibr">22</xref>), leaving the role of the DVC unclear.</p>
      <p>Here we argue that elucidating the mechanisms by which incretins affect feeding requires a more detailed understanding of the incretin receptor circuits in the hindbrain. Whereas immunohistochemistry, in situ hybridization, flow cytometry, and traditional large-scale molecular profiling approaches can provide information on the spatial distribution and expression levels of incretin receptors, they provide limited information on the cell types expressing the receptors. Given the cellular heterogeneity of the DVC, large-scale molecular approaches operating at single-cell resolution are imperative to further map the role of hindbrain incretin signaling in body weight regulation. Here, we describe recent advancements in transcriptional characterization of GLP-1 and GIP receptor cells in the DVC and outline how single-cell transcriptomics, epigenetics, spatial transcriptomics, and circuit mapping techniques have the potential to further our understanding of incretin signaling in hindbrain circuits.</p>
      <sec id="s2">
        <title>Mapping the Distribution of Incretin Receptors Using Single-Cell Transcriptomics</title>
        <p content-type="flushleft">Due to the development of robust protocols using minimal amounts of biological input material and the introduction of easy-to-use commercial systems, RNA sequencing (RNA-seq) has become the preferred choice for single-cell profiling. Below we describe key concepts and considerations that need to be taken into account when profiling incretin receptor circuits in the hindbrain.</p>
        <sec id="s3">
          <title>Hindbrain Single-Cell RNA-seq Data Generation and Analysis</title>
          <p content-type="flushleft">The first step in generating single-cell RNA-seq (scRNA-seq) data is to dissociate tissue into a solution of single cells or single nuclei. Single-nucleus RNA-seq (snRNA-seq) has emerged as the preferred protocol for single-cell sequencing analysis of the hindbrain based on its applicability to frozen tissue samples and because nuclei are less vulnerable to mechanical stresses imposed by whole-cell dissociation protocols. Although nucleus-based approaches do not assay cytosolic RNAs, RNAs in whole cells and nuclei are similarly distributed so that nuclei-based protocols are expected to provide an equally good estimate of the cells&#x2019; transcriptional state (<xref rid="B23" ref-type="bibr">23</xref>). Typically, data from 2,000&#x2013;3,000 nuclei can be obtained from a single mouse DVC isolated from a frozen brain sample. The RNA from each cell is captured and processed to &#x201C;sequencing-ready libraries&#x201D; that integrate a unique barcode (cell barcode) for all transcripts originating from a given cell and a transcript-specific unique molecular identifier to control for PCR-induced amplification biases. Single-cell level barcoding can be achieved in multiple ways, but most approaches capture individual cells in an isolated reaction environment until the cell barcode is encoded. This can be achieved through serial dilution into reaction wells, FACS, micropipetting, and valve-based, nanowell-based, or droplet-based microfluidics. An alternative approach is combinatorial indexing where cells are repeatedly mixed into different wells to attain a unique combination of barcodes. Whereas valve- and nanowell-based protocols enable complex operations such as in-well imaging and capture of full-length RNAs, allowing detection of splice isoforms (e.g., the human <italic toggle="yes">GLP1R</italic> and <italic toggle="yes">GIPR</italic> are transcribed into at least four and eight splice variants, respectively [<xref rid="B24" ref-type="bibr">24</xref>]), they typically have lower throughput in terms of the total number of cells as compared with droplet- and combinatorial indexing&#x2013;based techniques. Due to their scalability and ease of use, microfluidic-based techniques have become a popular choice for scRNA-seq. See ref. <xref rid="B25" ref-type="bibr">25</xref> for a comparison of specific techniques.</p>
          <p>Tissue dissociation, cell capture, barcoding, and library construction are followed by massively parallel sequencing and data analysis. Transcripts are mapped to a reference genome, and a count matrix of the captured transcripts is constructed. Following quality control steps and data normalization, cells are clustered and marker genes for each cluster are identified. Cell type labels can be automatically inferred from one of the growing numbers of DVC scRNA-seq data sets becoming available with use of data integration tools (<xref rid="B26" ref-type="bibr">26</xref>). Downstream analyses of hindbrain single-cell data include but are not limited to identification of differentially expressed genes between treatment groups, network-based analyses to identify sets of coregulated genes within a given cell type, integration with GWAS data to identify cell types expressing marker genes that colocalize with genetic association signals for metabolic traits, and mapping of intercellular signaling between cell types (<xref rid="B27" ref-type="bibr">27</xref>). See ref. <xref rid="B28" ref-type="bibr">28</xref> for a review of best-practice recommendations in single-cell data analysis.</p>
        </sec>
        <sec id="s4">
          <title>Key Questions in Hindbrain Single-Cell Transcriptomics Studies</title>
          <p content-type="flushleft">Four important questions arise when using single-cell experiments to study incretin receptor expression in the hindbrain.</p>
          <sec id="s5">
            <title>What Should I Pay Attention to During the Study Design?</title>
            <p content-type="flushleft">We anticipate that most hindbrain single-cell sequencing studies will be designed to investigate stimulus-induced gene expression changes, e.g., transcriptional characterization of cell types directly and indirectly responding to incretin dual agonist treatment in model organisms. Ensuring a sufficient number of biological replicates per group is key, and we advise using power calculations based on established DVC single-cell data sets to estimate that number. Next, because the induced transcriptional changes can be subtle, and despite the emergence of computational approaches, technical variation can introduce batch effects (<xref rid="B26" ref-type="bibr">26</xref>). Thus, to ensure preservation of biological variation, we recommend using &#x201C;cell hashing&#x201D; techniques that allow cells or nuclei from a greater number of samples to be pooled and processed together not only to reduce batch effects but also to minimize cell doublets and experiment costs (<xref rid="B29" ref-type="bibr">29</xref>).</p>
          </sec>
          <sec id="s6">
            <title>Which Technique Should I Use?</title>
            <p content-type="flushleft">If the aim is to map hindbrain cell types, then a single-nucleus droplet-based approach typically constitutes an appropriate choice due to its minimal tissue-handling requirements and the capability to work with frozen tissue and because it facilitates unbiased capture of activity-regulated transcription factor genes&#x2014;a class of genes typically being transcribed shortly after neuron activation. If the experimental focus is on specific cell types that can be genetically labeled with fluorophores, then FACS purification followed by scRNA-seq represents an efficient way to profile the genetically defined cell type. CITE-seq (cellular indexing of transcriptomes and epitopes by sequencing) (<xref rid="B30" ref-type="bibr">30</xref>) and inCITE-seq (intranuclear CITE-seq) (<xref rid="B31" ref-type="bibr">31</xref>) are two related techniques, which provide quantitative information on cellular and intranuclear protein levels, respectively, along with transcriptome measurements. Such approaches can for instance be applied to quantify the protein abundance of activity-regulated transcription factors in characterization of cell types responding to physiological stimuli such as incretin receptor agonists.</p>
          </sec>
          <sec id="s7">
            <title>How Many Cells Do I Need and What Sequencing Depth Should I Aim for When Profiling the Incretin Response in the Hindbrain?</title>
            <p content-type="flushleft">Typically, the number of cells and sequencing read depth are traded off against each other (<xref rid="B32" ref-type="bibr">32</xref>). Heterogeneous structures like the hindbrain require a larger number of cells to be profiled than more homogeneous tissues. However, incretin receptor&#x2013;expressing cells constitute a small fraction of the total number of cells in the DVC and we suggest using one of the following two sorting strategies to profile stimulus-induced expression changes in GLP1R- and GIPR-positive hindbrain cells: <italic toggle="yes">1</italic>) a transgenic animal model reporter line expressing a nuclear membrane protein such as SUN1 driven by the promoter for <italic toggle="yes">Glp1r</italic>, <italic toggle="yes">Gipr</italic>, or a gene marking the focal cell type; or <italic toggle="yes">2</italic>) the Probe-Seq approach (<xref rid="B33" ref-type="bibr">33</xref>), which relies on fluorescent in situ hybridization (FISH) to label intranuclear <italic toggle="yes">GLP1R</italic> or <italic toggle="yes">GIPR</italic> RNAs.</p>
          </sec>
          <sec id="s8">
            <title>What Drawbacks Should I Be Aware of When Using Single-Cell Sequencing to Explore Hindbrain Incretin Receptor Circuits?</title>
            <p content-type="flushleft"><italic toggle="yes">Glp1r</italic> and <italic toggle="yes">Gipr</italic> are expressed at relatively low levels and detected in only &#x223C;0.7% and 1% of the cells in the mouse DVC, respectively (<xref rid="B16" ref-type="bibr">16</xref>). Unbiased profiling studies investigating incretin receptor signaling in response to relevant physiological stimuli will be costly unless effective sorting-based enrichment of the target cells is used; however, such sorting-based approaches can be difficult to set up and apply. Finally, single-cell sequencing results are only descriptive; identified genes will need to be validated in a relevant physiological context using reverse genetics approaches, and relevant cell types will need to be validated in vivo using direct manipulation of cell activity in response to defined physiologic stimuli.</p>
          </sec>
        </sec>
      </sec>
      <sec id="s9">
        <title>Single-Cell Profiling of Incretin Receptor&#x2013;Expressing Cell Populations in the DVC</title>
        <p content-type="flushleft">Targeted studies combining genetic mouse models and immunohistochemistry have made valuable insights about incretin receptor expression in the hindbrain. For example, the majority of <italic toggle="yes">Glp1r</italic> AP and NTS neurons coexpress solute carrier family 17 member 6 (<italic toggle="yes">Slc17a6</italic>) and tyrosine hydroxylase (<italic toggle="yes">Th</italic>) (<xref rid="B14" ref-type="bibr">14</xref>,<xref rid="B34" ref-type="bibr">34</xref>), suggesting that glutamatergic and dopaminergic/noradrenergic neurotransmission may be important mediators of central GLP1RA action. However, unbiased and comprehensive transcriptional characterization of incretin receptor&#x2013;expressing cells in the hindbrain is still in its infancy. Below we combine and expand on findings from two recent studies using single-cell techniques to profile DVC cell populations in mouse models.</p>
        <sec id="s10">
          <title>Insights From Mouse Single-Cell Transcriptomics Studies</title>
          <p content-type="flushleft">Zhang et al. (<xref rid="B15" ref-type="bibr">15</xref>) profiled the transcriptomes of 3,657 cells from the AP and proximal NTS of mice to unravel groups of AP neurons mediating nausea-associated behaviors. To understand cell populations involved in body weight control, we (Ludwig et al. [<xref rid="B16" ref-type="bibr">16</xref>]) characterized the transcriptomes of 72,128 cells from AP-centric DVC tissue of mice with diet-induced obesity that were <italic toggle="yes">1</italic>) treated with GLP1RA peripherally, <italic toggle="yes">2</italic>) given vehicle and fed ad libitum, or <italic toggle="yes">3</italic>) weight matched to the GLP1RA-treated group for 7 days.</p>
          <p>Both studies identified expression of <italic toggle="yes">Glp1r</italic> in glutamatergic neurons and <italic toggle="yes">Gipr</italic> in GABAergic neurons in the AP (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>). In addition, Ludwig et al. detected <italic toggle="yes">Glp1r</italic> in GABAergic AP neurons and glutamatergic NTS neurons and <italic toggle="yes">Gipr</italic> in oligodendrocytes, which may have been undetected by Zhang et al. due to a less dense coverage of these cell populations. Here, we integrated cells from these two atlases into a single DVC cell population map (see <ext-link xlink:href="https://github.com/perslab/Ludwig-Diabetes-2021/" ext-link-type="uri">https://github.com/perslab/Ludwig-Diabetes-2021/</ext-link> for Methods). This atlas comprises a total of 8 glial cell types and 27 neuronal populations (<xref rid="F1" ref-type="fig">Fig. 1</xref>); for a complete list of marker genes see <ext-link xlink:href="https://doi.org/10.2337/figshare.14748642" ext-link-type="uri">Supplementary Table 1</ext-link>. We note that since the dissections in both studies are AP-focused, populations in the NTS and DMV may have been missed, such as <italic toggle="yes">Glp1r</italic>-expressing GABAergic NTS neurons and <italic toggle="yes">Glp1r</italic>-expressing DMV neurons.</p>
          <fig position="float" id="F1" fig-type="figure">
            <label>Figure 1</label>
            <caption>
              <p>Combined DVC single-cell transcriptomics atlas highlights distinct groups of incretin receptor cells. <italic toggle="yes">A</italic>: Graphical illustration of snRNA-seq of the DVC. <italic toggle="yes">B</italic>: UMAP plot of 75,785 DVC cells from two independent studies (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref>). The receptors found among the top 100 most specifically expressed genes in oligodendrocytes, the only incretin receptor&#x2013;expressing glial cell type, are plotted by the normalized transcript counts in the focal cell type (green) and remaining cells (gray). <italic toggle="yes">C</italic>: UMAP plot of 51,212 DVC neurons from the combined atlas. The cell population classifications from the atlas provided by Ludwig et al. (<xref rid="B16" ref-type="bibr">16</xref>) have been maintained except for Glu4 neurons, which were split into three clusters (Glu4a-c) following the classification by Zhang et al. (<xref rid="B15" ref-type="bibr">15</xref>). The expression of receptors being part of the top 100 most specifically expressed genes in incretin receptor&#x2013;expressing neurons is depicted in terms of the normalized transcript counts in the focal neuronal population (red, AP; blue, NTS) and remaining neurons (gray). OPCs, oligodendrocyte precursor cells; VLMCs, vascular and leptomeningeal cells.</p>
            </caption>
            <graphic xlink:href="dbi210003f1" position="float"/>
          </fig>
        </sec>
        <sec id="s11">
          <title>Transcriptional Signatures of Incretin Receptor Cells and Their Potential Role in Energy Balance Control</title>
          <p content-type="flushleft">In the AP, <italic toggle="yes">Glp1r</italic> is expressed in a subset of glutamatergic neurons (Glu4a-c in <xref rid="F1" ref-type="fig">Fig. 1<italic toggle="yes">C</italic></xref>) distinct from calcitonin receptor (<italic toggle="yes">Calcr</italic>)-expressing and receptor activity modifying protein 3 (<italic toggle="yes">Ramp3</italic>)-expressing neurons (Glu10 in <xref rid="F1" ref-type="fig">Fig. 1<italic toggle="yes">C</italic></xref>), highlighting that GLP-1 and amylin/calcitonin activate different cell populations. Glu4a neurons were marked by solute carrier family 6 member 2 (<italic toggle="yes">Slc6a2</italic>), Glu4b by thymocyte selection&#x2013;associated high mobility group box (<italic toggle="yes">Tox</italic>), and Glu4c neurons by GDNF family receptor &#x3B1;-like (<italic toggle="yes">Gfral</italic>). In all three neuronal populations, at least one of the enzymes involved in dopamine and/or noradrenaline synthesis was expressed (<italic toggle="yes">Th</italic>, dopamine &#x3B2;-hydroxylase [<italic toggle="yes">Dbh</italic>], and DOPA decarboxylase [<italic toggle="yes">Ddc</italic>]). Furthermore, Glu4b neurons expressed the melanocortin 4 receptor (<italic toggle="yes">Mc4r</italic>), which reduces feeding upon activation in the DVC (<xref rid="B35" ref-type="bibr">35</xref>) and is upregulated in the AP following GLP1RA administration (<xref rid="B16" ref-type="bibr">16</xref>). Glu4a and Glu4c neurons expressed the calcium-sensing receptor (<italic toggle="yes">Casr</italic>), which contributes to AP-mediated nausea, consistent with the finding that <italic toggle="yes">Slc6a2</italic>-, <italic toggle="yes">Gfral</italic>-, and <italic toggle="yes">Glp1r</italic>-expressing AP neurons activate aversive calcitonin gene&#x2013;related peptide (<italic toggle="yes">Cgrp</italic>) neurons in the parabrachial nucleus (PBN) (<xref rid="B15" ref-type="bibr">15</xref>). It remains unclear whether <italic toggle="yes">Glp1r</italic>-expressing AP neurons also activate anorectic circuits independent of nausea. In the AP, <italic toggle="yes">Glp1r</italic> was also expressed in a small population of GABAergic neurons (GABA7 in <xref rid="F1" ref-type="fig">Fig. 1<italic toggle="yes">C</italic></xref>) that expressed the receptor for the anorexic peptide cholecystokinin (<italic toggle="yes">Cckar</italic>) at high specificity. This population has, however, not been confirmed using in situ hybridization or immunohistochemistry. In the NTS, <italic toggle="yes">Glp1r</italic> is expressed in glutamatergic neurons (Glu11 in <xref rid="F1" ref-type="fig">Fig. 1<italic toggle="yes">C</italic></xref>) where the gastrin-releasing peptide receptor (<italic toggle="yes">Grpr</italic>) was the top marker gene. These neurons expressed <italic toggle="yes">Th</italic>, <italic toggle="yes">Ddc</italic>, and <italic toggle="yes">Dbh</italic> and may play a role in decreased preferences for palatable foods seen after intraparenchymal NTS injection of GLP1RA (<xref rid="B36" ref-type="bibr">36</xref>), as DBH-immunoreactive NTS neurons project to the nucleus accumbens (a key brain area in food reward processing) (<xref rid="B37" ref-type="bibr">37</xref>). In contrast to the AP, <italic toggle="yes">Glp1r</italic> NTS neurons coexpressed <italic toggle="yes">Calcr</italic>, suggesting that calcitonin and GLP-1 activate partly overlapping NTS cell populations. In addition, these neurons expressed <italic toggle="yes">Mc4r</italic>. Following treatment with GLP1RA, genes specific to glutamatergic <italic toggle="yes">Glp1r</italic>-expressing AP and NTS neurons were upregulated, including <italic toggle="yes">Bdnf</italic>, <italic toggle="yes">Ptprn</italic>, and <italic toggle="yes">Pam</italic>, which also colocalize with GWAS-associated loci for BMI (<xref rid="B16" ref-type="bibr">16</xref>,<xref rid="B38" ref-type="bibr">38</xref>,<xref rid="B39" ref-type="bibr">39</xref>). In contrast, genes expressed in glial cells including astrocytes and oligodendrocytes were downregulated following GLP1RA treatment (<xref rid="B16" ref-type="bibr">16</xref>). The fact that <italic toggle="yes">Glp1r</italic> expression was not detected in glial cells in current DVC single-cell atlases suggests that glial cells respond indirectly to treatment, although other studies have described a role of <italic toggle="yes">Glp1r</italic>-expressing NTS astrocytes in GLP1RA-mediated feeding suppression (<xref rid="B40" ref-type="bibr">40</xref>). Moreover, GLP1RA administration did not alter expression of genes specific to GLP-1&#x2013;producing glucagon (<italic toggle="yes">Gcg</italic>) neurons in the NTS (Glu14 in <xref rid="F1" ref-type="fig">Fig. 1<italic toggle="yes">C</italic></xref>) (<xref rid="B16" ref-type="bibr">16</xref>), consistent with the observation that GLP-1 neurons are not necessary for GLP1RA-induced weight loss but when activated may act synergistically to reduce food intake (<xref rid="B41" ref-type="bibr">41</xref>).</p>
          <p><italic toggle="yes">Gipr</italic> is expressed in oligodendrocytes and GABAergic AP neurons (GABA5) (<xref rid="F1" ref-type="fig">Fig. 1<italic toggle="yes">B</italic> and <italic toggle="yes">C</italic></xref>). The top marker of <italic toggle="yes">Gipr</italic>-expressing GABAergic neurons was the transcription factor paired box 5 (<italic toggle="yes">Pax5</italic>). GLP1RA administration did not alter gene expression in <italic toggle="yes">Gipr</italic> neurons (<xref rid="B16" ref-type="bibr">16</xref>). Since GABAergic neurons in the AP mainly innervate targets in the AP and proximal NTS (<xref rid="B15" ref-type="bibr">15</xref>), including TH-immunoreactive AP neurons (<xref rid="B42" ref-type="bibr">42</xref>), this suggests that GIP may presynaptically modulate the action of other metabolic peptides in the DVC. Interestingly, a single-cell transcriptomics study of the AP and NTS of fed and fasted mice published during revision of this article suggests that oligodendrocytes are particularly sensitive to changes in energy status (<xref rid="B43" ref-type="bibr">43</xref>), indicating a potential metabolic role for GIPR signaling in DVC oligodendrocytes.</p>
          <p>In sum, while many questions regarding GLP-1 and GIP action in the DVC remain to be answered, single-cell transcriptomics has provided a number of important answers: a map of the transcriptional heterogeneity in DVC cell populations that express combinations of the receptors for GLP-1, GIP, amylin, calcitonin, and growth/differentiation factor 15 (GDF15) and identification of marker genes for 27 DVC neuronal populations that can be used for cell type&#x2013;specific manipulations. Key issues to resolve include mapping of additional NTS and DMV cell populations, screening of incretin receptor expression in less prevalent DVC cell populations and extra-DVC hindbrain nuclei, delineation of species differences in incretin receptor circuits, and elucidation of how incretin receptor&#x2013;expressing cell types interact when activated.</p>
        </sec>
      </sec>
      <sec id="s12">
        <title>Mapping <italic toggle="yes">cis</italic>-Regulatory Factors Regulating Incretin Action in the Hindbrain</title>
        <p content-type="flushleft">Heritability of obesity is predominantly driven by common genetic variants found mostly within intergenic, gene-regulatory regions distributed throughout the human genome (<xref rid="B44" ref-type="bibr">44</xref>). Consequently, insights into hindbrain circuits mediating genetic susceptibility to metabolic disease in humans can be inferred by identifying <italic toggle="yes">cis</italic>-regulatory elements across relevant hindbrain cell types. Below we outline some of the most popular methods to map candidate <italic toggle="yes">cis</italic>-regulatory elements and their target genes, and we review our recent effort to map chromatin accessibility in the DVC to identify candidate cell populations mediating genetic risk for obesity.</p>
        <sec id="s13">
          <title>Single-Cell Techniques for Mapping cis-Regulatory Elements and Their Target Genes</title>
          <p content-type="flushleft">Enhancers are an important class of <italic toggle="yes">cis</italic>-regulatory DNA elements that bind transcription factors and regulate the expression of proximal genes. However, enhancers remain unidentified for the far majority of rodent and human cell types (<xref rid="B45" ref-type="bibr">45</xref>). Active enhancers typically reside in DNA stretches devoid of closed chromatin and can be characterized by high levels of active histone modifications, low levels of DNA cytosine methylation, and physical interactions with gene promoter regions (<xref rid="B45" ref-type="bibr">45</xref>) (<xref rid="F2" ref-type="fig">Fig. 2<italic toggle="yes">A</italic></xref>). Profiling of open chromatin at single-cell resolution can be accomplished by scATAC-seq (single-cell assay for transposase-accessible chromatin using sequencing) (<xref rid="B46" ref-type="bibr">46</xref>), which uses a hyperactive Tn5 transposase that simultaneously cuts and tags DNA at accessible regions with sequencing adaptors, enabling DNA in open chromatin to be profiled (<xref rid="B47" ref-type="bibr">47</xref>). Single-cell profiling of chromatin components such as acetylation of lysine 27 at the histone H3 protein (H3K27ac) (a marker for active transcription) or binding of a transcription factor can be performed using scCUT&amp;Tag-seq (single-cell cleavage under targets &amp; tagmentation using sequencing) (<xref rid="B48" ref-type="bibr">48</xref>). Here the protein of interest is bound by an antibody that recruits a Tn5 transposase&#x2013;protein A fusion protein whereby sequencing adaptors are integrated at chromatin-protein binding sites. Single-cell bisulfite-sequencing (scBS-seq) can be applied to measure the DNA methylation landscape through the conversion of cytosine to uracil, leaving methylated cytosines unaffected (<xref rid="B49" ref-type="bibr">49</xref>). Lastly, the single-cell Hi-C technique can be used to determine chromatin interactions (such as enhancer-promoter contacts) by cross-linking and then fragmenting the DNA in a way that allows sequencing and identification of DNA that are in close proximity in the three-dimensional chromosomal organization but distant in terms of genomic distance (<xref rid="B50" ref-type="bibr">50</xref>).</p>
          <fig position="float" id="F2" fig-type="figure">
            <label>Figure 2</label>
            <caption>
              <p>Single-cell epigenetic techniques and landscape of incretin receptor DVC cells. <italic toggle="yes">A</italic>: Graphical illustration of the epigenetic features regulating enhancer activity. Enhancers typically reside in DNA stretches found in open chromatin, with high levels of active histone marks, devoid of cytosine methylation and in physical proximity to gene promoter regions. These features can be measured at single-cell resolution using the indicated assays. <italic toggle="yes">B</italic>: Graphical illustration of how single-cell epigenetic profiling can predict cell type&#x2013;specific enhancers mediating genetic risk to human obesity. Colocalization of a BMI-associated genetic variant with the active enhancer in cell type A suggests that the genetic variant exerts its effect on obesity risk by modifying expression of the associated effector gene X in cell type A (and not cell type B). <italic toggle="yes">C</italic>: UMAP plots of 22,545 cells and 11,651 neurons from the snATAC-seq atlas provided by Ludwig et al. (<xref rid="B16" ref-type="bibr">16</xref>). The top four most enriched motifs in incretin receptor&#x2013;expressing cells are shown by their position weight matrices; at each position of a given motif, the relative distribution of a given nucleotide is depicted. SNP, single nucleotide polymorphism; TF, transcription factor.</p>
            </caption>
            <graphic xlink:href="dbi210003f2" position="float"/>
          </fig>
          <p>Integration of results from these epigenetic profiling techniques into computational models enables prediction of cell type&#x2013;specific <italic toggle="yes">cis</italic>-regulatory elements mediating genetic risk for obesity (<xref rid="F2" ref-type="fig">Fig. 2<italic toggle="yes">B</italic></xref>). In epigenetic single-cell data, cell clusters are typically annotated with cell type labels through correlation of epigenetic marks at promoter regions and gene bodies with single-cell transcriptomics data from the same tissue with use of label-transfer algorithms (<xref rid="B26" ref-type="bibr">26</xref>). A subsequent key step is to map enhancers to genes. While perturbation screens are ultimately needed to establish a causal link between an enhancer and its target gene, enhancer-gene pairs can to some extent be predicted by correlating chromatin accessibility or differentially methylated DNA at promoters with enhancer activity at less proximal sites (<xref rid="B51" ref-type="bibr">51</xref>,<xref rid="B52" ref-type="bibr">52</xref>). Fulco et al. (<xref rid="B53" ref-type="bibr">53</xref>) showed that by profiling multiple epigenetic layers (chromatin accessibility, H3K27ac marks, and three-dimensional chromatin conformation), enhancer-gene prediction can be substantially improved. Having mapped cell type&#x2013;specific enhancers, machine learning frameworks can be used to estimate whether genetic variants impact a transcription factor&#x2019;s ability to bind a given regulatory element (e.g., by using single-cell chromatin data [<xref rid="B54" ref-type="bibr">54</xref>]). While we anticipate that animal models will be valuable for predicting human <italic toggle="yes">cis</italic>-regulatory elements in incretin receptor circuits, the divergence between animal and human DNA segments must be considered. Between 65 and 80% (dependent on the sequence homology threshold) of mouse <italic toggle="yes">cis</italic>-regulatory elements have human orthologs, with the majority of these also being <italic toggle="yes">cis</italic>-regulatory elements in humans (<xref rid="B55" ref-type="bibr">55</xref>,<xref rid="B56" ref-type="bibr">56</xref>).</p>
        </sec>
        <sec id="s14">
          <title>Mapping Chromatin Accessibility and Overlap With Obesity GWAS Signals in the DVC</title>
          <p content-type="flushleft">As part of the above-mentioned DVC snRNA-seq study, Ludwig et al. (<xref rid="B16" ref-type="bibr">16</xref>) profiled the chromatin accessibility landscape of the DVC in mice with diet-induced obesity exposed to GLP1RA or control treatments for 7 days. The resulting snATAC-seq atlas comprised 253,452 accessible chromatin regions across 22,545 cells spanning 8 distinct glial and 22 neuronal cell populations (<xref rid="F2" ref-type="fig">Fig. 2<italic toggle="yes">C</italic></xref>). Transcription factors, potentially involved in establishing and maintaining cellular identities of incretin receptor cells, were identified from enriched transcription factor binding sites (henceforth referred to here as &#x201C;motifs&#x201D;) at accessible chromatin sites (the top four motifs are depicted in <xref rid="F2" ref-type="fig">Fig. 2<italic toggle="yes">C</italic></xref>). Glutamatergic <italic toggle="yes">Glp1r</italic>-expressing AP and NTS neurons contained motifs for the PHOX2A and PHOX2B transcription factors, which are known to regulate transcription of <italic toggle="yes">Dbh</italic> (<xref rid="B57" ref-type="bibr">57</xref>), consistent with the noradrenergic profile of these neurons. Upon administration of GLP1RA, the accessibility of motifs for activity-regulated transcription factor genes in glutamatergic <italic toggle="yes">Glp1r</italic> AP neurons increased, highlighting GLP1RA-induced reorganization of chromatin in these cells. GABAergic <italic toggle="yes">Gipr</italic> neurons displayed a chromatin accessibility landscape distinct from that of <italic toggle="yes">Glp1r</italic> neurons with an enrichment of ZIC1 and NEUROD1 motifs across the accessible regions.</p>
          <p>To investigate whether BMI-associated genetic variants nonrandomly colocalized with cell population&#x2013;specific genes and motifs, Ludwig et al. (<xref rid="B16" ref-type="bibr">16</xref>) separately integrated DVC snRNA-seq and snATAC-seq data with BMI GWAS data. They found that glutamatergic DVC neurons, including <italic toggle="yes">Glp1r</italic>-expressing AP and NTS neurons, were enriched for BMI-associated genetic variants, suggesting a role of GLP1R neurons in the predisposition to obesity.</p>
          <p>In sum, whereas the current mouse chromatin accessibility atlas of DVC cell populations provides initial understanding of specific transcription factors maintaining cellular identity and regulating GLP1RA-induced activity, key human DVC-centric analyses remain to be done, namely, <italic toggle="yes">1</italic>) mapping of active enhancers under all relevant physiological conditions, <italic toggle="yes">2</italic>) identification of activity-dependent transcription factors and their target genes, and <italic toggle="yes">3</italic>) identification of BMI-associated variants that perturb binding to active enhancers.</p>
        </sec>
      </sec>
      <sec id="s15">
        <title>Spatial Transcriptomics and Sequencing-Based Circuit Mapping of the Hindbrain</title>
        <p content-type="flushleft">In addition to assessing cellular identities at the transcriptional and epigenetic level, maturing single-cell spatial transcriptomics and circuit-mapping technologies have the potential to shed light on the spatial locations and physical interactions of incretin receptor cells within and outside the hindbrain. In the following, we will describe some of the currently available protocols for assessing the spatial organization of incretin receptor&#x2013;expressing cell types and sequencing-based methods for tracing their connectivity.</p>
        <sec id="s16">
          <title>Toward Spatial Profiling of Incretin Receptor Expression in the Hindbrain</title>
          <p content-type="flushleft">Spatial transcriptomics facilitates the assignment of cell types to their spatial locations. The majority of these methods can be categorized as those that rely on FISH and those that use massively parallel sequencing to profile the transcriptome (<xref rid="B58" ref-type="bibr">58</xref>) (<xref rid="T1" ref-type="table">Table 1</xref>). FISH-based methods enable subcellular resolution (&#x2264;1 &#x3BC;m) and are sensitive enough to localize lowly expressed genes such as incretin receptors. Depending on the technique, anywhere from ten to a few thousand genes can be profiled in large (1 cm<sup>2</sup>) sections of tissue sections. Computational tools can adequately integrate image-based spatial transcriptomics with scRNA-seq to locate cell types (<xref rid="B59" ref-type="bibr">59</xref>) or impute unmeasured genes (<xref rid="B59" ref-type="bibr">59</xref>&#x2013;<xref rid="B61" ref-type="bibr">61</xref>). In parallel with FISH-based spatial transcriptomics, techniques that use sequencing are rapidly improving. Currently available commercial devices and published protocols offer spatial barcoding arrays with resolution from 55 &#x3BC;m to 10 &#x3BC;m (<xref rid="B62" ref-type="bibr">62</xref>,<xref rid="B63" ref-type="bibr">63</xref>), while emerging methods push this limit down to 1 &#x3BC;m (<xref rid="B64" ref-type="bibr">64</xref>), making the resolution comparable with that offered by FISH-based imaging. A major benefit of sequencing-based spatial transcriptomics is its ability to sample the entire transcriptome without the need to define a set of genes a priori, although this comes at the cost of lower sensitivity. While sequencing-based spatial transcriptomics has been performed to construct a spatial atlas of brain areas from adult mice (<xref rid="B65" ref-type="bibr">65</xref>), this data set does not adequately capture the DVC. Future studies will be needed to reveal the spatial organization of incretin receptor cells in the hindbrain and how incretin treatment and other metabolic perturbations potentially alter local cell-to-cell communication.</p>
          <table-wrap position="float" id="T1">
            <label>Table 1</label>
            <caption>
              <p>Summary of spatial transcriptomics profiling technologies</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th rowspan="1" colspan="1">Modality</th>
                  <th align="center" rowspan="1" colspan="1">Method</th>
                  <th align="center" rowspan="1" colspan="1">Reference no.</th>
                  <th align="center" rowspan="1" colspan="1">Pixel resolution</th>
                  <th align="center" rowspan="1" colspan="1">Number of unique genes</th>
                  <th align="center" rowspan="1" colspan="1">Capture area</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td rowspan="4" colspan="1">Imaging</td>
                  <td align="center" rowspan="1" colspan="1">RNAscope</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B77" ref-type="bibr">77</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">&#x2264;1 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">12</td>
                  <td align="center" rowspan="1" colspan="1">&#x2265;1 cm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;MERFISH</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B78" ref-type="bibr">78</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">&#x2264;1 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">10,000</td>
                  <td align="center" rowspan="1" colspan="1">1 cm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;seqFISH</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B79" ref-type="bibr">79</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">&#x2264;1 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">10,000</td>
                  <td align="center" rowspan="1" colspan="1">1 cm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;CARTANA</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B80" ref-type="bibr">80</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">&#x2264;1 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">600</td>
                  <td align="center" rowspan="1" colspan="1">1 cm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="6" colspan="1">Massively parallel sequencing</td>
                  <td align="center" rowspan="1" colspan="1">&#x2003;10x Genomics Visium</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B81" ref-type="bibr">81</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">55 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">2,500</td>
                  <td align="center" rowspan="1" colspan="1">0.44 cm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;Slide-seqV2</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B62" ref-type="bibr">62</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">10 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">2,000</td>
                  <td align="center" rowspan="1" colspan="1">7 mm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;DBiT-seq</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B63" ref-type="bibr">63</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">10 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">2,000</td>
                  <td align="center" rowspan="1" colspan="1">1 mm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;</td>
                  <td rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">25 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">&#x2014;</td>
                  <td align="center" rowspan="1" colspan="1">6.25 mm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;</td>
                  <td rowspan="1" colspan="1"/>
                  <td align="center" rowspan="1" colspan="1">50 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">3,700</td>
                  <td align="center" rowspan="1" colspan="1">25 mm<sup>2</sup></td>
                </tr>
                <tr>
                  <td rowspan="1" colspan="1">&#x2003;Seq-Scope</td>
                  <td align="center" rowspan="1" colspan="1">
<xref rid="B64" ref-type="bibr">64</xref>
</td>
                  <td align="center" rowspan="1" colspan="1">1 &#x3BC;m</td>
                  <td align="center" rowspan="1" colspan="1">500</td>
                  <td align="center" rowspan="1" colspan="1">2.2&#x2013;5.5 mm &#xD7; 125 mm</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="tblfn1">
                <p>Imaging technologies such as RNAscope, MERFISH, seqFISH, and CARTANA have large capture areas and excellent resolution while requiring the use of a predefined probe set limited to a smaller number of unique genes. Massively parallel sequencing approaches have smaller capture areas and sample from the entire transcriptome, although they capture a fraction of unique genes with reduced sensitivity compared with imaging methods. DBiT-seq, deterministic barcoding in tissue for spatial omics sequencing; MERFISH, multiplexed error-robust fluorescence in situ hybridization; seqFISH, sequential barcode fluorescence in situ hybridization; Seq-Scope, Sequence-Scope.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="s17">
          <title>Toward Mapping of Incretin Receptor&#x2013;Mediated Neuronal Circuits</title>
          <p content-type="flushleft">In contrast to GABAergic AP neurons, which mostly innervate cells within the AP and proximal NTS (<xref rid="B15" ref-type="bibr">15</xref>), glutamatergic AP and NTS neurons project to targets outside the DVC (<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B66" ref-type="bibr">66</xref>). Thus, in addition to determination of the molecular signatures and spatial locations of incretin receptor&#x2013;expressing cells and their response to agonists, there is a need to identify the circuits in which these cells reside. Conventional mapping techniques using cell filling fluorophores, antigenic tags, or viral expression of fluorescent proteins have provided critical information regarding the connectivity of the DVC and its subregions (<xref rid="B67" ref-type="bibr">67</xref>,<xref rid="B68" ref-type="bibr">68</xref>). The development of Cre-dependent viral tracing tools has further refined these approaches by allowing cell-specific anterograde tracing from genetically defined DVC cell populations to their projection targets (<xref rid="B66" ref-type="bibr">66</xref>). Monosynaptic rabies tracing technologies have also allowed investigators to map afferent inputs to defined cell types within the brain (<xref rid="B69" ref-type="bibr">69</xref>,<xref rid="B70" ref-type="bibr">70</xref>).</p>
          <p>Recent approaches have harnessed the power of single-cell transcriptomics for better understanding of connectivity in defined neural circuits. MAPseq (multiplexed analysis of projections by sequencing) takes advantage of the ability to virally express a library of short random barcoded RNAs in a defined brain region and then harvest the injected region and projection terminal areas for sequence analysis (<xref rid="B71" ref-type="bibr">71</xref>). As each neuron is labeled with a unique barcode, the presence of barcoded RNAs can be used to rapidly construct a terminal field map with single-neuron resolution (<xref rid="B71" ref-type="bibr">71</xref>). BARseq (barcoded anatomy resolved by sequencing) combines MAPseq with in situ sequencing to preserve spatial organization of the terminal neurons (<xref rid="B72" ref-type="bibr">72</xref>). MAPseq and BARseq are not replacements for conventional tracing approaches but, rather, serve as complementary methods that can provide a level of specificity that is not easily achievable by conventional techniques. retro-seq combines scRNA-seq with recently developed retrograde viral vectors (<xref rid="B73" ref-type="bibr">73</xref>). In this approach, injection of a neuronal projection area with a virus that has the capacity to travel in a retrograde fashion results in &#x201C;tagging&#x201D; the cell body of interest with expression of a transgene, allowing for subsequent identification and downstream processing (<xref rid="B73" ref-type="bibr">73</xref>). For example, to catalog the specific AP and NTS neuronal populations that project to the PBN, a retrograde virus expressing a robust fluorophore could be injected into the PBN. After allowing for retrograde transport and transgene expression, AP and NTS cells that project to the PBN will express the virally encoded fluorophore and would then be amenable to isolation and sequencing. These approaches will also require additional reagents/molecular tools that will allow simultaneous yet independent manipulation of neighboring cell types. Moreover, establishing a local circuit diagram for incretin receptor-expressing cells in the AP and NTS will benefit from the application of additional functional techniques including electrophysiology and channelrhodopsin-assisted circuit mapping. In sum, integration of conventional mapping techniques with cell-specific labeling approaches and sequencing has the promise to deepen our understanding of the neural circuits in which incretin receptor&#x2013;expressing cells reside and operate.</p>
        </sec>
      </sec>
      <sec id="s18">
        <title>Future Avenues</title>
        <p content-type="flushleft">We are just in the beginning of understanding how hindbrain incretin-sensing circuits control satiety and respond to physiological stimuli. Although we have described single-cell sequencing as measures of only one modality, single-cell approaches for profiling different layers of information in the same cell are starting to emerge and have great potential to improve our understanding of cellular mechanisms controlling energy balance. Several single-cell and spatial methods have the capacity for simultaneous assessment of gene expression with chromatin accessibility, histone modifications, or DNA methylation (<xref rid="B74" ref-type="bibr">74</xref>&#x2013;<xref rid="B76" ref-type="bibr">76</xref>), allowing one to directly link the epigenome with gene expression abundance. Likewise, it is possible to jointly profile multiple layers of epigenetic marks at single-cell resolution (<xref rid="B76" ref-type="bibr">76</xref>). We anticipate that with the emergence of multimodal profiling techniques and sophisticated machine learning prediction models all relevant enhancer-gene pairs across the hindbrain will gradually be mapped.</p>
        <p>Once enhancers have been mapped they can be overlaid with human GWAS data; cell types with enriched colocalization of active enhancers and fine-mapped genetic association signals will provide important starting points to identify causal genes and hindbrain circuits mediating genetic susceptibility to human obesity. Whereas induced pluripotent stem cells appear as the most promising and efficient model systems, we envision that future approaches will use combinations of animal models, induced pluripotent stem cells, and postmortem brain setups to map enhancers and their target genes. With the growing number of transgenic mouse models, the ability to resolve molecular heterogeneity at the single cell level, and the increasing number of genetic variants associated with obesity, there is an unprecedented opportunity to further understand the role of incretin-responsive circuits in metabolic health and disease.</p>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>Article Information</title>
      <p><bold>Acknowledgments.</bold> The authors thank the reviewers for their valuable and constructive feedback. The authors also acknowledge the Single-Cell Omics Platform at the Novo Nordisk Foundation Center for Basic Metabolic Research for technical expertise and support.</p>
      <p><bold>Funding.</bold> Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center, based at the University of Copenhagen, and partially funded by an unconditional donation from the Novo Nordisk Foundation (<ext-link xlink:href="https://www.cbmr.ku.dk/" ext-link-type="uri">https://www.cbmr.ku.dk/</ext-link>) (grant NNF18CC0034900). The authors acknowledge the Novo Nordisk Foundation (grant NNF16OC0021496 to T.H.P.) and the Lundbeck Foundation (grant R190-2014-3904 to T.H.P.). Furthermore, this work was supported by a research grant from the Danish Diabetes Academy, which is funded by the Novo Nordisk Foundation (grant NNF17SA0031406). Finally, this work has been supported by the National Institute of Diabetes and Digestive and Kidney Diseases (grants R01 DK104999 and P01 DK117821).</p>
      <p><bold>Duality of Interest.</bold> No potential conflicts of interest relevant to this article were reported.</p>
      <p><bold>Author Contributions.</bold> M.Q.L., P.V.T., K.L.E., D.P.O., and T.H.P. wrote the manuscript. T.H.P. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p>
      <p><bold>Prior Presentation.</bold> Parts of this work were presented at the 81st Scientific Sessions of the American Diabetes Association, virtual meeting, 25&#x2013;29 June 2021.</p>
    </ack>
    <fn-group>
      <fn fn-type="supplementary-material">
        <p>This article contains supplementary material online at <ext-link xlink:href="https://doi.org/10.2337/figshare.14748642" ext-link-type="uri">https://doi.org/10.2337/figshare.14748642</ext-link>.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Baggio</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Drucker</surname>
<given-names>DJ</given-names></string-name></person-group>. <article-title>Biology of incretins: GLP-1 and GIP</article-title>. <source>Gastroenterology</source>
<year>2007</year>;<volume>132</volume>:<fpage>2131</fpage>&#x2013;<lpage>2157</lpage><pub-id pub-id-type="pmid">17498508</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Srivastava</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Apovian</surname>
<given-names>CM</given-names></string-name></person-group>. <article-title>Current pharmacotherapy for obesity</article-title>. <source>Nat Rev Endocrinol</source>
<year>2018</year>;<volume>14</volume>:<fpage>12</fpage>&#x2013;<lpage>24</lpage><pub-id pub-id-type="pmid">29027993</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Frias</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Nauck</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Van</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial</article-title>. <source>Lancet</source>
<year>2018</year>;<volume>392</volume>:<fpage>2180</fpage>&#x2013;<lpage>2193</lpage><pub-id pub-id-type="pmid">30293770</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Turcot</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Highland</surname>
<given-names>HM</given-names></string-name>, <etal/>.; <collab>CHD Exome+ Consortium</collab>; <collab>EPIC-CVD Consortium</collab>; <collab>ExomeBP Consortium</collab>; <collab>Global Lipids Genetic Consortium</collab>; <collab>GoT2D Genes Consortium</collab>; <collab>EPIC InterAct Consortium</collab>; <collab>INTERVAL Study</collab>; <collab>ReproGen Consortium</collab>; <collab>T2D-Genes Consortium</collab>; <collab>MAGIC Investigators</collab>; <collab>Understanding Society Scientific Group</collab></person-group>. <article-title>Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity</article-title>. <source>Nat Genet</source>
<year>2018</year>;<volume>50</volume>:<fpage>26</fpage>&#x2013;<lpage>41</lpage><pub-id pub-id-type="pmid">29273807</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>NamKoong</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Jang</surname>
<given-names>BT</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Cho</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Choi</surname>
<given-names>HJ</given-names></string-name></person-group>. <article-title>Central administration of GLP-1 and GIP decreases feeding in mice</article-title>. <source>Biochem Biophys Res Commun</source>
<year>2017</year>;<volume>490</volume>:<fpage>247</fpage>&#x2013;<lpage>252</lpage><pub-id pub-id-type="pmid">28610922</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Sisley</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gutierrez-Aguilar</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Scott</surname>
<given-names>M</given-names></string-name>, <string-name><surname>D&#x2019;Alessio</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Sandoval</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Seeley</surname>
<given-names>RJ</given-names></string-name></person-group>. <article-title>Neuronal GLP1R mediates liraglutide&#x2019;s anorectic but not glucose-lowering effect</article-title>. <source>J Clin Invest</source>
<year>2014</year>;<volume>124</volume>:<fpage>2456</fpage>&#x2013;<lpage>2463</lpage><pub-id pub-id-type="pmid">24762441</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Killion</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Yie</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models</article-title>. <source>Sci Transl Med</source>
<year>2018</year>;<volume>10</volume>:<fpage>eaat3392</fpage><pub-id pub-id-type="pmid">30567927</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Kaneko</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>H-Y</given-names></string-name>, <etal/></person-group>. <article-title>Gut-derived GIP activates central Rap1 to impair neural leptin sensitivity during overnutrition</article-title>. <source>J Clin Invest</source>
<year>2019</year>;<volume>129</volume>:<fpage>3786</fpage>&#x2013;<lpage>3791</lpage><pub-id pub-id-type="pmid">31403469</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Gabery</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Salinas</surname>
<given-names>CG</given-names></string-name>, <string-name><surname>Paulsen</surname>
<given-names>SJ</given-names></string-name>, <etal/></person-group>. <article-title>Semaglutide lowers body weight in rodents via distributed neural pathways</article-title>. <source>JCI Insight</source>
<year>2020</year>;<volume>5</volume>:<fpage>133429</fpage><pub-id pub-id-type="pmid">32213703</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Grill</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Hayes</surname>
<given-names>MR</given-names></string-name></person-group>. <article-title>Hindbrain neurons as an essential hub in the neuroanatomically distributed control of energy balance</article-title>. <source>Cell Metab</source>
<year>2012</year>;<volume>16</volume>:<fpage>296</fpage>&#x2013;<lpage>309</lpage><pub-id pub-id-type="pmid">22902836</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Merchenthaler</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Lane</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Shughrue</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system</article-title>. <source>J Comp Neurol</source>
<year>1999</year>;<volume>403</volume>:<fpage>261</fpage>&#x2013;<lpage>280</lpage><pub-id pub-id-type="pmid">9886047</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Heppner</surname>
<given-names>KM</given-names></string-name>, <string-name><surname>Kirigiti</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Secher</surname>
<given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Expression and distribution of glucagon-like peptide-1 receptor mRNA, protein and binding in the male nonhuman primate (Macaca mulatta) brain</article-title>. <source>Endocrinology</source>
<year>2015</year>;<volume>156</volume>:<fpage>255</fpage>&#x2013;<lpage>267</lpage><pub-id pub-id-type="pmid">25380238</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Jensen</surname>
<given-names>CB</given-names></string-name>, <string-name><surname>Pyke</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Rasch</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Dahl</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Knudsen</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Secher</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Characterization of the glucagonlike peptide-1 receptor in male mouse brain using a novel antibody and in situ hybridization</article-title>. <source>Endocrinology</source>
<year>2018</year>;<volume>159</volume>:<fpage>665</fpage>&#x2013;<lpage>675</lpage><pub-id pub-id-type="pmid">29095968</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Adams</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Pei</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Sandoval</surname>
<given-names>DA</given-names></string-name>, <etal/></person-group>. <article-title>Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor&#x2013;expressing glutamatergic neurons</article-title>. <source>Diabetes</source>
<year>2018</year>;<volume>67</volume>:<fpage>1538</fpage>&#x2013;<lpage>1548</lpage><pub-id pub-id-type="pmid">29776968</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Zhang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kaye</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Cai</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Prescott</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Liberles</surname>
<given-names>SD</given-names></string-name></person-group>. <article-title>Area postrema cell types that mediate nausea-associated behaviors</article-title>. <source>Neuron</source>
<year>2021</year>;<volume>109</volume>:<fpage>461</fpage>&#x2013;<lpage>472.e5</lpage><pub-id pub-id-type="pmid">33278342</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Ludwig</surname>
<given-names>MQ</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Gordian</surname>
<given-names>D</given-names></string-name>, <etal/></person-group>. <article-title>A genetic map of the mouse dorsal vagal complex and its role in obesity</article-title>. <source>Nat Metab</source>
<year>2021</year>;<volume>3</volume>:<fpage>530</fpage>&#x2013;<lpage>545</lpage><pub-id pub-id-type="pmid">33767443</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Adriaenssens</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Biggs</surname>
<given-names>EK</given-names></string-name>, <string-name><surname>Darwish</surname>
<given-names>T</given-names></string-name>, <etal/></person-group>. <article-title>Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake</article-title>. <source>Cell Metab</source>
<year>2019</year>;<volume>30</volume>:<fpage>987</fpage>&#x2013;<lpage>996.e6</lpage><pub-id pub-id-type="pmid">31447324</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Holt</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Richards</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Cook</surname>
<given-names>DR</given-names></string-name>, <etal/></person-group>. <article-title>Preproglucagon neurons in the nucleus of the solitary tract are the main source of brain GLP-1, mediate stress-induced hypophagia, and limit unusually large intakes of food</article-title>. <source>Diabetes</source>
<year>2019</year>;<volume>68</volume>:<fpage>21</fpage>&#x2013;<lpage>33</lpage><pub-id pub-id-type="pmid">30279161</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Hayes</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Leichner</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation</article-title>. <source>Cell Metab</source>
<year>2011</year>;<volume>13</volume>:<fpage>320</fpage>&#x2013;<lpage>330</lpage><pub-id pub-id-type="pmid">21356521</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Baraboi</surname>
<given-names>E-D</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ferguson</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Richard</surname>
<given-names>D</given-names></string-name></person-group>. <article-title>Lesions of area postrema and subfornical organ alter exendin-4-induced brain activation without preventing the hypophagic effect of the GLP-1 receptor agonist</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>
<year>2010</year>;<volume>298</volume>:<fpage>R1098</fpage>&#x2013;<lpage>R1110</lpage><pub-id pub-id-type="pmid">20106992</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Secher</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Jelsing</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Baquero</surname>
<given-names>AF</given-names></string-name>, <etal/></person-group>. <article-title>The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss</article-title>. <source>J Clin Invest</source>
<year>2014</year>;<volume>124</volume>:<fpage>4473</fpage>&#x2013;<lpage>4488</lpage><pub-id pub-id-type="pmid">25202980</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Fortin</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Lipsky</surname>
<given-names>RK</given-names></string-name>, <string-name><surname>Lhamo</surname>
<given-names>R</given-names></string-name>, <etal/></person-group>. <article-title>GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats</article-title>. <source>Sci Transl Med</source>
<year>2020</year>;<volume>12</volume>:<fpage>eaay8071</fpage><pub-id pub-id-type="pmid">32132220</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Bakken</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Hodge</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>JA</given-names></string-name>, <etal/></person-group>. <article-title>Single-nucleus and single-cell transcriptomes compared in matched cortical cell types</article-title>. <source>PLoS One</source>
<year>2018</year>;<volume>13</volume>:<fpage>e0209648</fpage><pub-id pub-id-type="pmid">30586455</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Thierry-Mieg</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Thierry-Mieg</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>AceView: a comprehensive cDNA-supported gene and transcripts annotation</article-title>. <source>Genome Biol</source>
<year>2006</year>;<volume>7</volume>(<issue>Suppl. 1</issue>):<fpage>S12.1</fpage>&#x2013;<lpage>14</lpage><pub-id pub-id-type="pmid">16925834</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Ziegenhain</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Vieth</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Parekh</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Comparative analysis of single-cell RNA sequencing methods</article-title>. <source>Mol Cell</source>
<year>2017</year>;<volume>65</volume>:<fpage>631</fpage>&#x2013;<lpage>643.e4</lpage><pub-id pub-id-type="pmid">28212749</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Luecken</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>B&#xFC;ttner</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chaichoompu</surname>
<given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>Benchmarking atlas-level data integration in single-cell genomics. 27 May 2020 [preprint]</article-title>. <source>bioRxiv</source>:<comment>2020.05.22.111161</comment></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Armingol</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Officer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Harismendy</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Lewis</surname>
<given-names>NE</given-names></string-name></person-group>. <article-title>Deciphering cell-cell interactions and communication from gene expression</article-title>. <source>Nat Rev Genet</source>
<year>2021</year>;<volume>22</volume>:<fpage>71</fpage>&#x2013;<lpage>88</lpage><pub-id pub-id-type="pmid">33168968</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Luecken</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Theis</surname>
<given-names>FJ</given-names></string-name></person-group>. <article-title>Current best practices in single-cell RNA-seq analysis: a tutorial</article-title>. <source>Mol Syst Biol</source>
<year>2019</year>;<volume>15</volume>:<fpage>e8746</fpage><pub-id pub-id-type="pmid">31217225</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Gaublomme</surname>
<given-names>JT</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>B</given-names></string-name>, <string-name><surname>McCabe</surname>
<given-names>C</given-names></string-name>, <etal/></person-group>. <article-title>Nuclei multiplexing with barcoded antibodies for single-nucleus genomics</article-title>. <source>Nat Commun</source>
<year>2019</year>;<volume>10</volume>:<fpage>2907</fpage><pub-id pub-id-type="pmid">31266958</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Stoeckius</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hafemeister</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Stephenson</surname>
<given-names>W</given-names></string-name>, <etal/></person-group>. <article-title>Simultaneous epitope and transcriptome measurement in single cells</article-title>. <source>Nat Methods</source>
<year>2017</year>;<volume>14</volume>:<fpage>865</fpage>&#x2013;<lpage>868</lpage><pub-id pub-id-type="pmid">28759029</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Chung</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Parkhurst</surname>
<given-names>CN</given-names></string-name>, <string-name><surname>Magee</surname>
<given-names>EM</given-names></string-name>, <etal/></person-group>. <article-title>Simultaneous single cell measurements of intranuclear proteins and gene expression</article-title>. <source>bioRxiv</source>. <year>2021</year>
<month>Jan</month>
<day>19</day>;<comment>2021.01.18.427139</comment>.</mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Zhang</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Ntranos</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Tse</surname>
<given-names>D</given-names></string-name></person-group>. <article-title>Determining sequencing depth in a single-cell RNA-seq experiment</article-title>. <source>Nat Commun</source>
<year>2020</year>;<volume>11</volume>:<fpage>774</fpage><pub-id pub-id-type="pmid">32034137</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Amamoto</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Garcia</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>West</surname>
<given-names>ER</given-names></string-name>, <etal/></person-group>. <article-title>Probe-Seq enables transcriptional profiling of specific cell types from heterogeneous tissue by RNA-based isolation</article-title>. <source>ELife</source>
<year>2019</year>;<volume>8</volume>:<fpage>e51452</fpage><pub-id pub-id-type="pmid">31815670</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Cork</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Richards</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Holt</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Gribble</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Reimann</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Trapp</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Distribution and characterisation of glucagon-like peptide-1 receptor expressing cells in the mouse brain</article-title>. <source>Mol Metab</source>
<year>2015</year>;<volume>4</volume>:<fpage>718</fpage>&#x2013;<lpage>731</lpage><pub-id pub-id-type="pmid">26500843</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Williams</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>Kaplan</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Grill</surname>
<given-names>HJ</given-names></string-name></person-group>. <article-title>The role of the dorsal vagal complex and the vagus nerve in feeding effects of melanocortin-3/4 receptor stimulation</article-title>. <source>Endocrinology</source>
<year>2000</year>;<volume>141</volume>:<fpage>1332</fpage>&#x2013;<lpage>1337</lpage><pub-id pub-id-type="pmid">10746636</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Richard</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Anderberg</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>G&#xF6;teson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gribble</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Reimann</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Skibicka</surname>
<given-names>KP</given-names></string-name></person-group>. <article-title>Activation of the GLP-1 receptors in the nucleus of the solitary tract reduces food reward behavior and targets the mesolimbic system</article-title>. <source>PLoS One</source>
<year>2015</year>;<volume>10</volume>:<fpage>e0119034</fpage><pub-id pub-id-type="pmid">25793511</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Olson</surname>
<given-names>VG</given-names></string-name>, <string-name><surname>Heusner</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Bland</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>During</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Weinshenker</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Palmiter</surname>
<given-names>RD</given-names></string-name></person-group>. <article-title>Role of noradrenergic signaling by the nucleus tractus solitarius in mediating opiate reward</article-title>. <source>Science</source>
<year>2006</year>;<volume>311</volume>:<fpage>1017</fpage>&#x2013;<lpage>1020</lpage><pub-id pub-id-type="pmid">16484499</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Locke</surname>
<given-names>AE</given-names></string-name>, <string-name><surname>Kahali</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Berndt</surname>
<given-names>SI</given-names></string-name>, <etal/>.; <collab>LifeLines Cohort Study</collab>; <collab>ADIPOGen Consortium</collab>; <collab>AGEN-BMI Working Group</collab>; <collab>CARDIOGRAMplusC4D Consortium</collab>; <collab>CKDGen Consortium</collab>; <collab>GLGC</collab>; <collab>ICBP</collab>; <collab>MAGIC Investigators</collab>; <collab>MuTHER Consortium</collab>; <collab>MIGen Consortium</collab>; <collab>PAGE Consortium</collab>; <collab>ReproGen Consortium</collab>; <collab>GENIE Consortium</collab>; <collab>International Endogene Consortium</collab></person-group>. <article-title>Genetic studies of body mass index yield new insights for obesity biology</article-title>. <source>Nature</source>
<year>2015</year>;<volume>518</volume>:<fpage>197</fpage>&#x2013;<lpage>206</lpage><pub-id pub-id-type="pmid">25673413</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Kichaev</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Bhatia</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Loh</surname>
<given-names>P-R</given-names></string-name>, <etal/></person-group>. <article-title>Leveraging polygenic functional enrichment to improve GWAS power</article-title>. <source>Am J Hum Genet</source>
<year>2019</year>;<volume>104</volume>:<fpage>65</fpage>&#x2013;<lpage>75</lpage><pub-id pub-id-type="pmid">30595370</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Reiner</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Mietlicki-Baase</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>McGrath</surname>
<given-names>LE</given-names></string-name>, <etal/></person-group>. <article-title>Astrocytes regulate GLP-1 receptor-mediated effects on energy balance</article-title>. <source>J Neurosci</source>
<year>2016</year>;<volume>36</volume>:<fpage>3531</fpage>&#x2013;<lpage>3540</lpage><pub-id pub-id-type="pmid">27013681</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Brierley</surname>
<given-names>DI</given-names></string-name>, <string-name><surname>Holt</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Singh</surname>
<given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Central and peripheral GLP-1 systems independently suppress eating</article-title>. <source>Nat Metab</source>
<year>2021</year>;<volume>3</volume>:<fpage>258</fpage>&#x2013;<lpage>273</lpage><pub-id pub-id-type="pmid">33589843</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Guan</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>QP</given-names></string-name>, <string-name><surname>Shioda</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ochiai</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Nakai</surname>
<given-names>Y</given-names></string-name></person-group>. <article-title>GABAergic synaptic innervation of catecholaminergic neurons in the area postrema of the rat</article-title>. <source>Acta Anat (Basel)</source>
<year>1996</year>;<volume>156</volume>:<fpage>46</fpage>&#x2013;<lpage>52</lpage><pub-id pub-id-type="pmid">8960298</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Dowsett</surname>
<given-names>GKC</given-names></string-name>, <string-name><surname>Lam</surname>
<given-names>BYH</given-names></string-name>, <string-name><surname>Tadross</surname>
<given-names>JA</given-names></string-name>, <etal/></person-group>. <article-title>A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing</article-title>. <source>Mol Metab</source>
<year>2021</year>;<volume>53</volume>:<fpage>101240</fpage><pub-id pub-id-type="pmid">33962048</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Gusev</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SH</given-names></string-name>, <string-name><surname>Trynka</surname>
<given-names>G</given-names></string-name>, <etal/>.; <collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>; <collab>SWE-SCZ Consortium</collab>; <collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>; <collab>SWE-SCZ Consortium</collab></person-group>. <article-title>Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases</article-title>. <source>Am J Hum Genet</source>
<year>2014</year>;<volume>95</volume>:<fpage>535</fpage>&#x2013;<lpage>552</lpage><pub-id pub-id-type="pmid">25439723</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Nord</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>West</surname>
<given-names>AE</given-names></string-name></person-group>. <article-title>Neurobiological functions of transcriptional enhancers</article-title>. <source>Nat Neurosci</source>
<year>2020</year>;<volume>23</volume>:<fpage>5</fpage>&#x2013;<lpage>14</lpage><pub-id pub-id-type="pmid">31740812</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Buenrostro</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Giresi</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Zaba</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>HY</given-names></string-name>, <string-name><surname>Greenleaf</surname>
<given-names>WJ</given-names></string-name></person-group>. <article-title>Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position</article-title>. <source>Nat Methods</source>
<year>2013</year>;<volume>10</volume>:<fpage>1213</fpage>&#x2013;<lpage>1218</lpage><pub-id pub-id-type="pmid">24097267</pub-id></mixed-citation>
      </ref>
      <ref id="B47">
        <label>47.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Klemm</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Shipony</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Greenleaf</surname>
<given-names>WJ</given-names></string-name></person-group>. <article-title>Chromatin accessibility and the regulatory epigenome</article-title>. <source>Nat Rev Genet</source>
<year>2019</year>;<volume>20</volume>:<fpage>207</fpage>&#x2013;<lpage>220</lpage><pub-id pub-id-type="pmid">30675018</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Kaya-Okur</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Codomo</surname>
<given-names>CA</given-names></string-name>, <etal/></person-group>. <article-title>CUT&amp;Tag for efficient epigenomic profiling of small samples and single cells</article-title>. <source>Nat Commun</source>
<year>2019</year>;<volume>10</volume>:<fpage>1930</fpage><pub-id pub-id-type="pmid">31036827</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Smallwood</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>HJ</given-names></string-name>, <string-name><surname>Angermueller</surname>
<given-names>C</given-names></string-name>, <etal/></person-group>. <article-title>Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity</article-title>. <source>Nat Methods</source>
<year>2014</year>;<volume>11</volume>:<fpage>817</fpage>&#x2013;<lpage>820</lpage><pub-id pub-id-type="pmid">25042786</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Nagano</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Lubling</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Stevens</surname>
<given-names>TJ</given-names></string-name>, <etal/></person-group>. <article-title>Single-cell Hi-C reveals cell-to-cell variability in chromosome structure</article-title>. <source>Nature</source>
<year>2013</year>;<volume>502</volume>:<fpage>59</fpage>&#x2013;<lpage>64</lpage><pub-id pub-id-type="pmid">24067610</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Cusanovich</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Hill</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Aghamirzaie</surname>
<given-names>D</given-names></string-name>, <etal/></person-group>. <article-title>A single-cell atlas of in vivo mammalian chromatin accessibility</article-title>. <source>Cell</source>
<year>2018</year>;<volume>174</volume>:<fpage>1309</fpage>&#x2013;<lpage>1324.e18</lpage><pub-id pub-id-type="pmid">30078704</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>W</given-names></string-name>, <etal/></person-group>. <article-title>DNA methylation atlas of the mouse brain at single-cell resolution. 30 April 2020 [preprint]</article-title>. <source>bioRxiv</source>:<comment>2020.04.30.069377</comment></mixed-citation>
      </ref>
      <ref id="B53">
        <label>53.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Fulco</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Nasser</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Jones</surname>
<given-names>TR</given-names></string-name>, <etal/></person-group>. <article-title>Activity-by-contact model of enhancer-promoter regulation from thousands of CRISPR perturbations</article-title>. <source>Nat Genet</source>
<year>2019</year>;<volume>51</volume>:<fpage>1664</fpage>&#x2013;<lpage>1669</lpage><pub-id pub-id-type="pmid">31784727</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <label>54.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Corces</surname>
<given-names>MR</given-names></string-name>, <string-name><surname>Shcherbina</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Kundu</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer&#x2019;s and Parkinson&#x2019;s diseases</article-title>. <source>Nat Genet</source>
<year>2020</year>;<volume>52</volume>:<fpage>1158</fpage>&#x2013;<lpage>1168</lpage><pub-id pub-id-type="pmid">33106633</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <label>55.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Moore</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Purcaro</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Pratt</surname>
<given-names>HE</given-names></string-name>, <etal/>.; <collab>ENCODE Project Consortium</collab></person-group>. <article-title>Expanded encyclopaedias of DNA elements in the human and mouse genomes</article-title>. <source>Nature</source>
<year>2020</year>;<volume>583</volume>:<fpage>699</fpage>&#x2013;<lpage>710</lpage><pub-id pub-id-type="pmid">32728249</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <label>56.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Yue</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Breschi</surname>
<given-names>A</given-names></string-name>, <etal/>.; <collab>Mouse ENCODE Consortium</collab></person-group>. <article-title>A comparative encyclopedia of DNA elements in the mouse genome</article-title>. <source>Nature</source>
<year>2014</year>;<volume>515</volume>:<fpage>355</fpage>&#x2013;<lpage>364</lpage><pub-id pub-id-type="pmid">25409824</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Yang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>HS</given-names></string-name>, <string-name><surname>Seo</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Brunet</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>KS</given-names></string-name></person-group>. <article-title>Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene</article-title>. <source>J Neurochem</source>
<year>1998</year>;<volume>71</volume>:<fpage>1813</fpage>&#x2013;<lpage>1826</lpage><pub-id pub-id-type="pmid">9798905</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <label>58.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Waylen</surname>
<given-names>LN</given-names></string-name>, <string-name><surname>Nim</surname>
<given-names>HT</given-names></string-name>, <string-name><surname>Martelotto</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Ramialison</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>From whole-mount to single-cell spatial assessment of gene expression in 3D</article-title>. <source>Commun Biol</source>
<year>2020</year>;<volume>3</volume>:<fpage>602</fpage><pub-id pub-id-type="pmid">33097816</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Stuart</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Butler</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hoffman</surname>
<given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>Comprehensive integration of single-cell data</article-title>. <source>Cell</source>
<year>2019</year>;<volume>177</volume>:<fpage>1888</fpage>&#x2013;<lpage>1902.e21</lpage><pub-id pub-id-type="pmid">31178118</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <label>60.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Nitzan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Karaiskos</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Friedman</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Rajewsky</surname>
<given-names>N</given-names></string-name></person-group>. <article-title>Gene expression cartography</article-title>. <source>Nature</source>
<year>2019</year>;<volume>576</volume>:<fpage>132</fpage>&#x2013;<lpage>137</lpage><pub-id pub-id-type="pmid">31748748</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <label>61.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Abdelaal</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mourragui</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mahfouz</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Reinders</surname>
<given-names>MJT</given-names></string-name></person-group>. <article-title>SpaGE: Spatial Gene Enhancement using scRNA-seq</article-title>. <source>Nucleic Acids Res</source>
<year>2020</year>;<volume>48</volume>:<fpage>e107</fpage><pub-id pub-id-type="pmid">32955565</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <label>62.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Stickels</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>Highly sensitive spatial transcriptomics at near-cellular resolution with Slide-seqV2</article-title>. <source>Nat Biotechnol</source>
<year>2021</year>;<volume>39</volume>:<fpage>313</fpage>&#x2013;<lpage>319</lpage><pub-id pub-id-type="pmid">33288904</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <label>63.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>Y</given-names></string-name>, <etal/></person-group>. <article-title>High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue</article-title>. <source>Cell</source>
<year>2020</year>;<volume>183</volume>:<fpage>1665</fpage>&#x2013;<lpage>1681.e18</lpage><pub-id pub-id-type="pmid">33188776</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <label>64.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Cho</surname>
<given-names>C-S</given-names></string-name>, <string-name><surname>Xi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Park</surname>
<given-names>S-R</given-names></string-name>, <etal/></person-group>. <article-title>Seq-Scope: submicrometer-resolution spatial transcriptomics for single cell and subcellular studies. 27 January 2021 [preprint]</article-title>. <source>bioRxiv</source>:<comment>2021.01.25.427807</comment></mixed-citation>
      </ref>
      <ref id="B65">
        <label>65.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Ortiz</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Navarro</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Jurek</surname>
<given-names>A</given-names></string-name>, <string-name><surname>M&#xE4;rtin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lundeberg</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Meletis</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Molecular atlas of the adult mouse brain</article-title>. <source>Sci Adv</source>
<year>2020</year>;<volume>6</volume>:<fpage>eabb3446</fpage><pub-id pub-id-type="pmid">32637622</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <label>66.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Cheng</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Gonzalez</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>W</given-names></string-name>, <etal/></person-group>. <article-title>Calcitonin receptor neurons in the mouse nucleus tractus solitarius control energy balance via the non-aversive suppression of feeding</article-title>. <source>Cell Metab</source>
<year>2020</year>;<volume>31</volume>:<fpage>301</fpage>&#x2013;<lpage>312.e5</lpage><pub-id pub-id-type="pmid">31955990</pub-id></mixed-citation>
      </ref>
      <ref id="B67">
        <label>67.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Han</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Tellez</surname>
<given-names>LA</given-names></string-name>, <string-name><surname>Perkins</surname>
<given-names>MH</given-names></string-name>, <etal/></person-group>. <article-title>A neural circuit for gut-induced reward</article-title>. <source>Cell</source>
<year>2018</year>;<volume>175</volume>:<fpage>665</fpage>&#x2013;<lpage>678.e23</lpage><pub-id pub-id-type="pmid">30245012</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <label>68.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Holt</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Pomeranz</surname>
<given-names>LE</given-names></string-name>, <string-name><surname>Beier</surname>
<given-names>KT</given-names></string-name>, <string-name><surname>Reimann</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Gribble</surname>
<given-names>FM</given-names></string-name>, <string-name><surname>Rinaman</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>Synaptic inputs to the mouse dorsal vagal complex and its resident preproglucagon neurons</article-title>. <source>J Neurosci</source>
<year>2019</year>;<volume>39</volume>:<fpage>9767</fpage>&#x2013;<lpage>9781</lpage><pub-id pub-id-type="pmid">31666353</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <label>69.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Callaway</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Luo</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>Monosynaptic circuit tracing with glycoprotein-deleted rabies viruses</article-title>. <source>J Neurosci</source>
<year>2015</year>;<volume>35</volume>:<fpage>8979</fpage>&#x2013;<lpage>8985</lpage><pub-id pub-id-type="pmid">26085623</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <label>70.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Lavin</surname>
<given-names>TK</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wickersham</surname>
<given-names>IR</given-names></string-name></person-group>. <article-title>Monosynaptic tracing: a step-by-step protocol</article-title>. <source>J Chem Neuroanat</source>
<year>2019</year>;<volume>102</volume>:<fpage>101661</fpage><pub-id pub-id-type="pmid">31408693</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <label>71.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Kebschull</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Garcia da Silva</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Reid</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Peikon</surname>
<given-names>ID</given-names></string-name>, <string-name><surname>Albeanu</surname>
<given-names>DF</given-names></string-name>, <string-name><surname>Zador</surname>
<given-names>AM</given-names></string-name></person-group>. <article-title>High-throughput mapping of single-neuron projections by sequencing of barcoded RNA</article-title>. <source>Neuron</source>
<year>2016</year>;<volume>91</volume>:<fpage>975</fpage>&#x2013;<lpage>987</lpage><pub-id pub-id-type="pmid">27545715</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <label>72.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>Y-C</given-names></string-name>, <string-name><surname>Zhan</surname>
<given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>High-throughput mapping of long-range neuronal projection using in situ sequencing</article-title>. <source>Cell</source>
<year>2019</year>;<volume>179</volume>:<fpage>772</fpage>&#x2013;<lpage>786.e19</lpage><pub-id pub-id-type="pmid">31626774</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <label>73.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Tasic</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Graybuck</surname>
<given-names>LT</given-names></string-name>, <etal/></person-group>. <article-title>Shared and distinct transcriptomic cell types across neocortical areas</article-title>. <source>Nature</source>
<year>2018</year>;<volume>563</volume>:<fpage>72</fpage>&#x2013;<lpage>78</lpage><pub-id pub-id-type="pmid">30382198</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <label>74.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Kashima</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sakamoto</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Kaneko</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Seki</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Suzuki</surname>
<given-names>A</given-names></string-name></person-group>. <article-title>Single-cell sequencing techniques from individual to multiomics analyses</article-title>. <source>Exp Mol Med</source>
<year>2020</year>;<volume>52</volume>:<fpage>1419</fpage>&#x2013;<lpage>1427</lpage><pub-id pub-id-type="pmid">32929221</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <label>75.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Zhu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>YE</given-names></string-name>, <string-name><surname>Lucero</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Behrens</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Ren</surname>
<given-names>B</given-names></string-name></person-group>. <article-title>Joint profiling of histone modifications and transcriptome in single cells from mouse brain</article-title>. <source>Nat Methods</source>
<year>2021</year>;<volume>18</volume>:<fpage>283</fpage>&#x2013;<lpage>292</lpage><pub-id pub-id-type="pmid">33589836</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <label>76.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Luo</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Xie</surname>
<given-names>F</given-names></string-name>, <etal/></person-group>. <article-title>Single nucleus multi-omics links human cortical cell regulatory genome diversity to disease risk variants. 12 December 2019 [preprint]</article-title>. <source>bioRxiv</source>:<comment>2019.12.11.873398</comment></mixed-citation>
      </ref>
      <ref id="B77">
        <label>77.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Wang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Flanagan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>N</given-names></string-name>, <etal/></person-group>. <article-title>RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues</article-title>. <source>J Mol Diagn</source>
<year>2012</year>;<volume>14</volume>:<fpage>22</fpage>&#x2013;<lpage>29</lpage><pub-id pub-id-type="pmid">22166544</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <label>78.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Moffitt</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Zhuang</surname>
<given-names>X</given-names></string-name></person-group>. <article-title>RNA imaging with multiplexed error-robust fluorescence in situ hybridization (MERFISH)</article-title>. <source>Methods Enzymol</source>
<year>2016</year>;<volume>572</volume>:<fpage>1</fpage>&#x2013;<lpage>49</lpage><pub-id pub-id-type="pmid">27241748</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <label>79.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>Shah</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Lubeck</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Cai</surname>
<given-names>L</given-names></string-name></person-group>. <article-title>In situ transcription profiling of single cells reveals spatial organization of cells in the mouse hippocampus</article-title>. <source>Neuron</source>
<year>2016</year>;<volume>92</volume>:<fpage>342</fpage>&#x2013;<lpage>357</lpage><pub-id pub-id-type="pmid">27764670</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <label>80.</label>
        <mixed-citation publication-type="webpage">
<person-group person-group-type="author">
<string-name><surname>Hern&#xE1;ndez</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Qian</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Lal&#xE1;kov&#xE1;</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Verheyen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hilscher</surname>
<given-names>M</given-names></string-name>, <string-name><surname>K&#xFC;hnemund</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Application note: mapping brain cell types with CARTANA <italic toggle="yes">in situ</italic> sequencing on the Nikon Ti2-E microscope</article-title>. <comment>Accessed 19 May 2021. Available from <ext-link xlink:href="https://www.nature.com/articles/d42473-019-00264-8" ext-link-type="uri">https://www.nature.com/articles/d42473-019-00264-8</ext-link></comment></mixed-citation>
      </ref>
      <ref id="B81">
        <label>81.</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name><surname>St&#xE5;hl</surname>
<given-names>PL</given-names></string-name>, <string-name><surname>Salm&#xE9;n</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Vickovic</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>. <source>Science</source>
<year>2016</year>;<volume>353</volume>:<fpage>78</fpage>&#x2013;<lpage>82</lpage><pub-id pub-id-type="pmid">27365449</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-8021</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33833776</article-id>
      <article-id pub-id-type="pmc">8021700</article-id>
      <article-id pub-id-type="doi">10.3389/fgene.2021.636743</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Genetics</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>DEEPsc: A Deep Learning-Based Map Connecting Single-Cell Transcriptomics and Spatial Imaging Data</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Maseda</surname>
            <given-names>Floyd</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/1256062/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Cang</surname>
            <given-names>Zixuan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="corresp" rid="c001">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/995198/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nie</surname>
            <given-names>Qing</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
          <xref ref-type="corresp" rid="c002">
            <sup>*</sup>
          </xref>
          <uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/869389/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Department of Mathematics, University of California, Irvine</institution>, <addr-line>Irvine, CA</addr-line>, <country>United States</country></aff>
      <aff id="aff2"><sup>2</sup><institution>The NSF-Simons Center for Multiscale Cell Fate Research, University of California, Irvine</institution>, <addr-line>Irvine, CA</addr-line>, <country>United States</country></aff>
      <aff id="aff3"><sup>3</sup><institution>Department of Developmental and Cell Biology, University of California, Irvine</institution>, <addr-line>Irvine, CA</addr-line>, <country>United States</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Chunhe Li, Fudan University, China</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Shihua Zhang, Academy of Mathematics and Systems Science (CAS), China; Xiaoqiang Sun, Sun Yat-sen University, China</p>
        </fn>
        <corresp id="c001">*Correspondence: Zixuan Cang, <email>zcang@uci.edu</email></corresp>
        <corresp id="c002">Qing Nie, <email>qnie@uci.edu</email></corresp>
        <fn fn-type="other" id="fn004">
          <p>This article was submitted to Systems Biology, a section of the journal Frontiers in Genetics</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>3</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>636743</elocation-id>
      <history>
        <date date-type="received">
          <day>02</day>
          <month>12</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>2</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2021 Maseda, Cang and Nie.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Maseda, Cang and Nie</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Single-cell RNA sequencing (scRNA-seq) data provides unprecedented information on cell fate decisions; however, the spatial arrangement of cells is often lost. Several recent computational methods have been developed to impute spatial information onto a scRNA-seq dataset through analyzing known spatial expression patterns of a small subset of genes known as a reference atlas. However, there is a lack of comprehensive analysis of the accuracy, precision, and robustness of the mappings, along with the generalizability of these methods, which are often designed for specific systems. We present a system-adaptive deep learning-based method (DEEPsc) to impute spatial information onto a scRNA-seq dataset from a given spatial reference atlas. By introducing a comprehensive set of metrics that evaluate the spatial mapping methods, we compare DEEPsc with four existing methods on four biological systems. We find that while DEEPsc has comparable accuracy to other methods, an improved balance between precision and robustness is achieved. DEEPsc provides a data-adaptive tool to connect scRNA-seq datasets and spatial imaging datasets to analyze cell fate decisions. Our implementation with a uniform API can serve as a portal with access to all the methods investigated in this work for spatial exploration of cell fate decisions in scRNA-seq data. All methods evaluated in this work are implemented as an open-source software with a uniform interface.</p>
      </abstract>
      <kwd-group>
        <kwd>spatial gene expression atlas</kwd>
        <kwd>scRNA-seq data</kwd>
        <kwd>spatial information imputation</kwd>
        <kwd>deep learning</kwd>
        <kwd>metric learning</kwd>
        <kwd>comprehensive evaluation metric</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
          <award-id rid="cn001">U01AR073159</award-id>
          <award-id rid="cn001">P30AR075047</award-id>
        </award-group>
        <award-group>
          <funding-source id="cn002">Simons Foundation<named-content content-type="fundref-id">10.13039/100000893</named-content></funding-source>
          <award-id rid="cn002">594598, QN</award-id>
        </award-group>
        <award-group>
          <funding-source id="cn003">National Science Foundation<named-content content-type="fundref-id">10.13039/100000001</named-content></funding-source>
          <award-id rid="cn003">DMS1763272</award-id>
          <award-id rid="cn003">MCB2028424</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="8"/>
        <table-count count="2"/>
        <equation-count count="2"/>
        <ref-count count="54"/>
        <page-count count="14"/>
        <word-count count="0"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="S1">
      <title>Introduction</title>
      <p>While cells of a biological system have access to the same genetic blueprint, they navigate through different developmental paths toward various cell fates. These diverse fate programs of cells are controlled by their own states, interactions with spatially neighboring cells, and other environmental cues (<xref rid="B11" ref-type="bibr">Guo et al., 2010</xref>). To decipher the processes of cell fate acquisitions, observations of the transcriptomics with single-cell resolution in spatial context are desired. The advent of sophisticated single-cell RNA sequencing (scRNA-seq) techniques now allows investigation of the transcriptomic landscape of tens of thousands of genes across tissues at the resolution of individual cells (<xref rid="B36" ref-type="bibr">Rosenberg et al., 2018</xref>; <xref rid="B42" ref-type="bibr">Svensson et al., 2018</xref>). However, a drawback to scRNA-seq methods is the necessity of dissociating the sample in question, thereby destroying any spatial context which can be crucial to the understanding of cellular development and dynamics (<xref rid="B53" ref-type="bibr">Yuan et al., 2017</xref>). In current common workflows of scRNA-seq data analysis, unsupervised clustering of cells is carried out, followed by identifying marker genes associated with each cell cluster (<xref rid="B26" ref-type="bibr">Luecken and Theis, 2019</xref>). While the list of marker genes for each cell cluster can be screened for genes associated with known spatial regions to estimate the spatial origin of the cluster, the spatial arrangement of individual cells remains unclear (<xref rid="B19" ref-type="bibr">Kiselev et al., 2019</xref>; <xref rid="B26" ref-type="bibr">Luecken and Theis, 2019</xref>). Several existing methods attempt to impute a pseudospatial or pseudotemporal axis onto the data (<xref rid="B15" ref-type="bibr">Joost et al., 2016</xref>; <xref rid="B34" ref-type="bibr">Puram et al., 2017</xref>; <xref rid="B32" ref-type="bibr">Pandey et al., 2018</xref>; <xref rid="B48" ref-type="bibr">Wang et al., 2019</xref>); however, little related to physical space is immediately discernible from scRNA-seq data alone.</p>
      <p>The loss of spatial information in scRNA-seq data can be partially mitigated by referring to spatial staining data (<xref rid="B39" ref-type="bibr">Sprague et al., 2006</xref>; <xref rid="B10" ref-type="bibr">Fowlkes et al., 2008</xref>). Another promising solution is the emerging spatial transcriptomics methods such as osmFISH (<xref rid="B7" ref-type="bibr">Codeluppi et al., 2018</xref>), MERFISH (<xref rid="B30" ref-type="bibr">Moffitt et al., 2018</xref>), seqFISH (<xref rid="B38" ref-type="bibr">Shah et al., 2016</xref>), seqFISH+ (<xref rid="B9" ref-type="bibr">Eng et al., 2019</xref>), STARmap (<xref rid="B49" ref-type="bibr">Wang et al., 2018</xref>), and Slide-seq (<xref rid="B35" ref-type="bibr">Rodriques et al., 2019</xref>) that obtain <italic>in situ</italic> spatial expression patterns. Compared to scRNA-seq, current spatial techniques often cover fewer cells or genes or with a suboptimal resolution and depth. It is therefore a trending theme to combine the strengths of both methods to achieve a high coverage and individual-cell resolution while retaining the spatial arrangement (<xref rid="B53" ref-type="bibr">Yuan et al., 2017</xref>; <xref rid="B19" ref-type="bibr">Kiselev et al., 2019</xref>). Due to these differences among the scRNA-seq and spatial techniques, and biological systems, it is challenging to derive a generally applicable computation method to integrate the two kinds of data.</p>
      <p>Several recent computational methods have been developed to impute spatial data onto existing scRNA-seq datasets through analyzing known spatial expression patterns of a small subset of genes, termed a &#x201C;spatial reference atlas.&#x201D; Seminal methods were developed independently by <xref rid="B1" ref-type="bibr">Achim et al. (2015)</xref> and <xref rid="B37" ref-type="bibr">Satija et al. (2015)</xref> and were applied to the <italic>Platynereis dumerilii</italic> brain and zebrafish embryo, respectively, using binarized reference atlases derived from <italic>in situ</italic> hybridization (ISH) images. DistMap, another method that uses a binarized ISH-based reference atlas, was developed by <xref rid="B16" ref-type="bibr">Karaiskos et al. (2017)</xref> and applied to the <italic>Drosophila</italic> embryo. <xref rid="B1" ref-type="bibr">Achim et al. (2015)</xref> use an empirical correspondence score between each cell-location pair based on the specificity ratio of genes. <xref rid="B37" ref-type="bibr">Satija et al. (2015)</xref> (Seurat v1) fits a bimodal mixture model to the scRNA-seq data and then projects cells to their spatial origins using a probabilistic score. DistMap applies Matthew&#x2019;s correlation coefficients to the binarized spatial imaging and scRNA-seq data to assign a cell-location score (<xref rid="B16" ref-type="bibr">Karaiskos et al., 2017</xref>). Several methods have also been developed which use spatial reference atlases directly measuring the RNA counts that are comparable to scRNA-seq data without binarization (<xref rid="B33" ref-type="bibr">Peng et al., 2016</xref>; <xref rid="B12" ref-type="bibr">Halpern et al., 2017</xref>). More recently, computational methods have been developed for imputing gene expression in spatial data (<xref rid="B24" ref-type="bibr">Lopez et al., 2019</xref>), transferring cell type label from scRNA-seq data to spatial data (<xref rid="B54" ref-type="bibr">Zhu et al., 2018</xref>; <xref rid="B8" ref-type="bibr">Dries et al., 2019</xref>; <xref rid="B2" ref-type="bibr">Andersson et al., 2020</xref>), <italic>de novo</italic> spatial placement of single cells (<xref rid="B31" ref-type="bibr">Nitzan et al., 2019</xref>), and inferring spatial distances between single cells (<xref rid="B5" ref-type="bibr">Cang and Nie, 2020</xref>).</p>
      <p>In addition to the methods designed specifically for integrating spatial data and scRNA-seq data, other computational methods have been developed recently for general data integration. Such methods focus on the general task of integrating RNA sequencing datasets obtained from the same biological system through different technologies, <italic>in situ</italic> data being one possibility among many, into one large dataset offering a more complete description of the system under study. These methods include newer versions of Seurat (<xref rid="B4" ref-type="bibr">Butler et al., 2018</xref>; <xref rid="B41" ref-type="bibr">Stuart et al., 2019</xref>), LIGER (<xref rid="B51" ref-type="bibr">Welch et al., 2019</xref>), Harmony (<xref rid="B21" ref-type="bibr">Korsunsky et al., 2019</xref>), and Scanorama (<xref rid="B13" ref-type="bibr">Hie et al., 2019</xref>) which are mainly based on correlation analyses and matrix factorizations. Another more specific task is to transfer high-level information such as cell types between datasets. Many machine learning- and deep learning-based methods have been developed for this task by formulating a supervised learning problem with the high-level information being the target (<xref rid="B20" ref-type="bibr">Kiselev et al., 2018</xref>; <xref rid="B23" ref-type="bibr">Lieberman et al., 2018</xref>; <xref rid="B25" ref-type="bibr">Lopez et al., 2018</xref>; <xref rid="B47" ref-type="bibr">Wagner and Yanai, 2018</xref>; <xref rid="B43" ref-type="bibr">Tan and Cahan, 2019</xref>; <xref rid="B3" ref-type="bibr">Boufea et al., 2020</xref>; <xref rid="B14" ref-type="bibr">Hu et al., 2020</xref>; <xref rid="B27" ref-type="bibr">Ma and Pellegrini, 2020</xref>).</p>
      <p>Since the spatial characteristics of different biological systems could be significantly different, we aim to develop a system-adaptive method specifically designed for imputing spatial information onto scRNA-seq data. To this end, unlike other spatial integration methods that use predefined algorithms for computing scores, we learn a specialized correspondence score between cells and locations for a given biological system. This can then be regarded as a general metric learning task (<xref rid="B22" ref-type="bibr">Kulis, 2013</xref>). In addition to linear methods that learn a pseudometric (<xref rid="B50" ref-type="bibr">Weinberger and Saul, 2009</xref>), there has been increasing interest in applying deep learning to metric learning (<xref rid="B17" ref-type="bibr">Kaya and Bilge, 2019</xref>; <xref rid="B6" ref-type="bibr">Chicco, 2020</xref>). These methods are mostly designed for cases where the pair of data points to be compared are in the same space. Though the common genes from the spatial data and scRNA-seq data are used here, directly treating them as in the same space may cause inaccuracy due to differences in the original datasets such as scaling and noise.</p>
      <p>Here we develop a system-adaptive deep learning-based method (DEEPsc) for imputing spatial data onto scRNA-seq data. A DEEPsc network accepts a low-dimensional feature vector corresponding to a single position in the spatial reference atlas along with a corresponding feature vector of the gene expression of a single cell and returns a likelihood the input cell originated from the input position. The network is trained and validated using positions in the spatial reference atlas as simulated scRNA-seq data. The network is also validated through the task of predicting the scRNA-seq data from the spatial reference atlas or the other way around. In addition, we implemented several strong baseline methods using different norms and linear metric learning for benchmark comparison. We further develop a comprehensive measure, which was previously lacking, for evaluating how well a given method maps scRNA-seq data to known spatial origins, called a performance score. This score contains three components that measure the accuracy, precision, and robustness of a method, respectively. Using this score on four biological systems, we show that DEEPsc maintains a comparable accuracy to four existing methods while achieving a better balance between precision and robustness.</p>
    </sec>
    <sec id="S2">
      <title>Results</title>
      <sec id="S2.SS1">
        <title>A Deep-Leaning Based Method to Connect scRNA-seq Datasets and Spatial Imaging Data</title>
        <p>Given any spatial reference atlas consisting of binary or continuous gene expression levels for a biological system on a set of locations with known spatial coordinates, and a scRNA-seq dataset consisting of binary or continuous gene expression levels for the same biological system, we introduce a <bold>D</bold>eep-learning based <bold>E</bold>nvironment for the <bold>E</bold>xtraction of <bold>P</bold>ositional information from <bold>sc</bold>RNA-seq data (DEEPsc) to impute the spatial information onto the scRNA-seq data.</p>
        <p>In DEEPsc, we first select a common set of genes from the reference atlas and scRNA-seq data, then perform dimensionality reduction via principal component analysis (PCA) on the reduced reference atlas to shorten training time (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The scRNA-seq data is then projected into the same PCA space on which we learn a metric for comparison between cells and spatial positions. The DEEPsc network accepts a concatenated feature vector for a single cell and a single position and returns a likelihood the input cell originated from the input position. The network contains two fully connected hidden layers with <italic>N</italic> nodes each, where <italic>N</italic> is the number of principal components kept from PCA, and a single node in the output layer. Sigmoid activation functions are applied to each node, including the output node, so that the resulting output is in [0,1] and can be interpreted as a likelihood that the input cell originated from the input spatial position. To train the DEEPsc network, we use the spatial position feature vectors as simulated scRNA-seq data for comparison (<xref ref-type="fig" rid="F1">Figure 1B</xref>). Each simulated cell is compared pairwise with every position in the spatial reference atlas; if the simulated cell is an exact match to a given position, the target output is 1 (a high likelihood of origin), and if the simulated cell and chosen position are not an exact match, the target output is 0 (a low likelihood of origin). Training is terminated when the error on a randomly chosen validation set is no longer improving.</p>
        <fig id="F1" position="float">
          <label>FIGURE 1</label>
          <caption>
            <p>The general workflow of training and implementing DEEPsc. <bold>(A)</bold> Given a spatial reference atlas of gene expression levels for some biological system and a scRNA-seq dataset, genes common to both are selected, and dimensionality of the data is reduced (e.g., by PCA, UMAP). Each spatial position in the reference atlas and each cell in the scRNA-seq dataset is associated with a feature vector in the reduced space. <bold>(B)</bold> The DEEPsc architecture takes as input the feature vectors of one single cell and one spatial position, returning a likelihood between 0 (low likelihood) and 1 (high likelihood) that the cell originated from the spatial position. A DEEPsc network is trained using the spatial position feature vectors as simulated scRNA-seq data. The target output is a 1 (high likelihood of origin) if the simulated input cell matches the input position, and 0 (low likelihood of origin) if they do not match. <bold>(C)</bold> Once the DEEPsc network is sufficiently trained, a feature vector associated with a cell in the scRNA-seq dataset can be fed into the network with each spatial position individually. The resulting likelihoods are displayed as a heatmap depicting the likelihood of origin of the cell from each position. The position with the highest likelihood is chosen as the origin of the cell. This process is repeated for each cell in the scRNA-seq dataset.</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g001"/>
        </fig>
        <p>After training the DEEPsc network, a feature vector associated with an actual cell from the scRNA-seq data is fed in as input and compared to each position in the reference atlas individually. We display the results as a heatmap on the schematic diagram of the biological system, choosing the spatial position with the largest likelihood of origin according to DEEPsc as the determined origin of the cell. This process is repeated for each cell in the scRNA-seq dataset to assign spatial origins of all cells (<xref ref-type="fig" rid="F1">Figure 1C</xref>).</p>
      </sec>
      <sec id="S2.SS2">
        <title>Quantifying Spatial Mapping Performance</title>
        <p>Each of the highlighted methods to impute spatial data onto scRNA-seq data, including DEEPsc, can be essentially boiled down to the following: For some tissue with a well-defined standard spatial structure, given known binary or continuous expression levels of <italic>G</italic> genes at each of <italic>P</italic> spatial locations (the reference atlas), calculate a correspondence score, <italic>S</italic>, of how similar each of <italic>C</italic> cells in an scRNA-seq dataset is to each of the <italic>P</italic> positions in the atlas. That is, define a function, <italic>S</italic>:[0,1]<italic><sup>G</sup></italic>&#xD7;[0,1]<italic><sup>G</sup></italic>&#x2192;[0,1], such that <italic>S</italic>(<italic>c</italic><sub><italic>i</italic></sub>,<italic>p</italic><sub><italic>j</italic></sub>);<italic>i</italic> = 1,2,&#x2026;,<italic>C</italic>;<italic>j</italic> = 1,2,&#x2026;,<italic>P</italic>; which describes the likelihood that cell <italic>c</italic><sub><italic>i</italic></sub> originated from position <italic>p</italic><sub><italic>j</italic></sub>, based on the similarity of the expression vectors of the cell and position.</p>
        <p>To quantify how well a given method performs for a given spatial reference atlas, we use the reference atlas itself as simulated single cell data; that is, we generate a simulated scRNA-seq dataset with <italic>C=P</italic> cells, each an exact copy of a reference atlas position. This allows us to treat the simulated scRNA-seq data as having a known spatial origin, against which we can compare the output of each method. We define a system-adaptive, comprehensive performance score, consisting of three penalty terms: accuracy, which determines whether or not the known spatial origin was given a high likelihood of origin; precision, which determines whether or not other locations were given low likelihoods of origin; and robustness, which determines how sensitive a mapping method is to random noise in the input data. Each penalty term is represented by a number in [0,1], with 0 being no penalty and 1 being a worst-case scenario. The performance score is defined as <inline-formula><mml:math id="INEQ5"><mml:mrow><mml:mi>E</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mi>P</mml:mi></mml:mfrac><mml:mo>&#x2062;</mml:mo><mml:mrow><mml:munder><mml:mo movablelimits="false">&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munder><mml:msub><mml:mi>E</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula>, where</p>
        <disp-formula id="S2.Ex1">
          <mml:math id="M1">
            <mml:mrow>
              <mml:mrow>
                <mml:msub>
                  <mml:mi>E</mml:mi>
                  <mml:mi>i</mml:mi>
                </mml:msub>
                <mml:mo>=</mml:mo>
                <mml:mrow>
                  <mml:mn>1</mml:mn>
                  <mml:mo>-</mml:mo>
                  <mml:mrow>
                    <mml:mfrac>
                      <mml:mn>1</mml:mn>
                      <mml:mn>3</mml:mn>
                    </mml:mfrac>
                    <mml:mo>&#x2062;</mml:mo>
                    <mml:mrow>
                      <mml:mo>(</mml:mo>
                      <mml:mrow>
                        <mml:munder>
                          <mml:munder accentunder="true">
                            <mml:mrow>
                              <mml:mn>1</mml:mn>
                              <mml:mo movablelimits="false">-</mml:mo>
                              <mml:msub>
                                <mml:mi>S</mml:mi>
                                <mml:mrow>
                                  <mml:mi>i</mml:mi>
                                  <mml:mo movablelimits="false">.</mml:mo>
                                  <mml:mi>i</mml:mi>
                                </mml:mrow>
                              </mml:msub>
                            </mml:mrow>
                            <mml:mo movablelimits="false">&#x23DF;</mml:mo>
                          </mml:munder>
                          <mml:mrow>
                            <mml:mi>A</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>c</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>c</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>u</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>r</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>a</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>c</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>y</mml:mi>
                          </mml:mrow>
                        </mml:munder>
                        <mml:mo>+</mml:mo>
                        <mml:mrow>
                          <mml:mo>|</mml:mo>
                          <mml:munder>
                            <mml:munder accentunder="true">
                              <mml:mfrac>
                                <mml:mrow>
                                  <mml:mn>1</mml:mn>
                                  <mml:mo movablelimits="false">-</mml:mo>
                                  <mml:mrow>
                                    <mml:msubsup>
                                      <mml:mo movablelimits="false">&#x2211;</mml:mo>
                                      <mml:mrow>
                                        <mml:mi>j</mml:mi>
                                        <mml:mo movablelimits="false">=</mml:mo>
                                        <mml:mn>1</mml:mn>
                                      </mml:mrow>
                                      <mml:mi>P</mml:mi>
                                    </mml:msubsup>
                                    <mml:msub>
                                      <mml:mi>S</mml:mi>
                                      <mml:mrow>
                                        <mml:mi>i</mml:mi>
                                        <mml:mo movablelimits="false">,</mml:mo>
                                        <mml:mi>j</mml:mi>
                                      </mml:mrow>
                                    </mml:msub>
                                  </mml:mrow>
                                </mml:mrow>
                                <mml:mrow>
                                  <mml:mi>P</mml:mi>
                                  <mml:mo movablelimits="false">-</mml:mo>
                                  <mml:mn>1</mml:mn>
                                </mml:mrow>
                              </mml:mfrac>
                              <mml:mo movablelimits="false">&#x23DF;</mml:mo>
                            </mml:munder>
                            <mml:mrow>
                              <mml:mi>P</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>r</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>e</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>c</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>i</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>s</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>i</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>o</mml:mi>
                              <mml:mo>&#x2062;</mml:mo>
                              <mml:mi>n</mml:mi>
                            </mml:mrow>
                          </mml:munder>
                          <mml:mo>|</mml:mo>
                        </mml:mrow>
                        <mml:mo>+</mml:mo>
                        <mml:munder>
                          <mml:munder accentunder="true">
                            <mml:msup>
                              <mml:mrow>
                                <mml:mo movablelimits="false">(</mml:mo>
                                <mml:mrow>
                                  <mml:mn>1</mml:mn>
                                  <mml:mo movablelimits="false">-</mml:mo>
                                  <mml:msup>
                                    <mml:mi mathvariant="normal">&#x3C3;</mml:mi>
                                    <mml:mo movablelimits="false">*</mml:mo>
                                  </mml:msup>
                                </mml:mrow>
                                <mml:mo movablelimits="false">)</mml:mo>
                              </mml:mrow>
                              <mml:mn>4</mml:mn>
                            </mml:msup>
                            <mml:mo movablelimits="false">&#x23DF;</mml:mo>
                          </mml:munder>
                          <mml:mrow>
                            <mml:mi>R</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>o</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>b</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>u</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>s</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>t</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>n</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>e</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>s</mml:mi>
                            <mml:mo>&#x2062;</mml:mo>
                            <mml:mi>s</mml:mi>
                          </mml:mrow>
                        </mml:munder>
                      </mml:mrow>
                      <mml:mo>)</mml:mo>
                    </mml:mrow>
                  </mml:mrow>
                </mml:mrow>
              </mml:mrow>
              <mml:mo>,</mml:mo>
            </mml:mrow>
          </mml:math>
        </disp-formula>
        <p><italic>S</italic><sub><italic>i</italic>,<italic>j</italic></sub> = <italic>S</italic>(<italic>c</italic><sub><italic>i</italic></sub>,<italic>p</italic><sub><italic>j</italic></sub>) is the correspondence score of cell <italic>c</italic><sub><italic>i</italic></sub> to position <italic>p</italic><sub><italic>j</italic></sub>, and <italic>E</italic><sub><italic>i</italic></sub> is interpreted as the error in the mapping of cell <italic>c</italic><sub><italic>i</italic></sub>. The quantity &#x3C3;<sup>&#x2217;</sup> in the robustness term is calculated by determining the accuracy and precision penalty terms with no Gaussian noise added to the input data, then calculating the same two penalties with various levels of Gaussian noise with standard deviation &#x3C3; &#x2208; [0,1]. The quantity &#x3C3;<sup>&#x2217;</sup> is defined to be the level of Gaussian noise required to raise the mean of the accuracy and precision penalties by 0.1 from their values with no added noise, or &#x3C3;<sup>&#x2217;</sup> = 1, whichever is smallest. The exponent of four in the robustness term was chosen empirically such that the robustness term does not dominate the performance score, keeping in mind that expression levels are normalized to [0,1] before calculating the correspondence scores, so e.g., &#x3C3;<sup>&#x2217;</sup> = 0.5 means a method requires noise on the order of half of the expression levels to raise the precision and accuracy penalties by 0.1. The performance score has a range of [0,1], where a performance score of <italic>E=1</italic> represents an ideal mapping that maps a cell to its known location with high confidence, to all other locations with low confidence, and does so in a manner robust to noise. An illustration of each term in the performance score is shown in <xref ref-type="fig" rid="F2">Figure 2</xref>.</p>
        <fig id="F2" position="float">
          <label>FIGURE 2</label>
          <caption>
            <p>Explanation of the terms constituting the performance score. In each hypothetical mapping heatmap, the known location of the input cell is highlighted in black. <bold>(A)</bold> The accuracy score measures whether or not the known location receives a high likelihood; the precision score measures whether or not other locations receive low likelihoods. <bold>(B)</bold> The robustness score measures how much the accuracy and precision scores change if random noise is added to the input cell. A mapping method which is accurate, precise, and robust is given a high performance score while a mapping method that lacks in any or all of the three areas is given a lower performance score.</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g002"/>
        </fig>
        <p>This performance score is limited by the fact that it relies on ground truth knowledge of the spatial origin of a single cell/spot to determine the performance of a given mapping method. However, this ground truth knowledge is not available for actual scRNA-seq data. To more directly quantify the mapping performance on actual scRNA-seq datasets, we use a measure of predictive reproducibility, obtained from a <italic>k</italic>-fold cross validation scheme, in which we randomly split the common genes in the reference atlas and scRNA-seq data into <italic>k</italic> folds and calculate the correspondence score for each method using all but one fold. The correspondence scores are then used as coefficients in a weighted sum to predict the value of the dropped-out genes in each fold for each cell (scRNA-seq predictive reproducibility) or each spatial position (atlas predictive reproducibility) and determine the error in the predicted expression level. The predicted expression of gene <italic>k</italic> in cell <italic>c</italic><sub><italic>i</italic></sub> is computed as <inline-formula><mml:math id="INEQ14"><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>c</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>i</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo movablelimits="false">&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>P</mml:mi></mml:munderover><mml:mrow><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>&#x2062;</mml:mo><mml:msubsup><mml:mi>p</mml:mi><mml:mi>j</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:munderover><mml:mo movablelimits="false">&#x2211;</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>P</mml:mi></mml:munderover><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula> and the predicted expression of gene <italic>k</italic> in position <italic>p</italic><sub><italic>j</italic></sub> is computed as <inline-formula><mml:math id="INEQ15"><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>p</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>j</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:munderover><mml:mo movablelimits="false">&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>C</mml:mi></mml:munderover><mml:mrow><mml:mrow><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>&#x2062;</mml:mo><mml:msubsup><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:munderover><mml:mo movablelimits="false">&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>C</mml:mi></mml:munderover><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula> where <inline-formula><mml:math id="INEQ16"><mml:msubsup><mml:mi>S</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> is the correspondence score between cell <italic>c</italic><sub><italic>i</italic></sub> and position <italic>p</italic><sub><italic>j</italic></sub> with genes in folds not containing gene <italic>k</italic> and <inline-formula><mml:math id="INEQ17"><mml:msubsup><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> and <inline-formula><mml:math id="INEQ18"><mml:msubsup><mml:mi>p</mml:mi><mml:mi>j</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula> are the known expression values of gene <italic>k</italic> from the scRNA-seq and the spatial atlas data, respectively. To accommodate the sparsity of data, we compute the predictive reproducibility scores separately for cells or positions with zero expression values and with positive expression values. For example, we measure the predictive reproducibility for the task of reproducing gene <italic>k</italic> in scRNA-seq data on cells with zero expression using <inline-formula><mml:math id="INEQ19"><mml:mrow><mml:msubsup><mml:mi>R</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>c</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi mathvariant="normal">_</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>z</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>e</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>r</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mrow><mml:munder><mml:mo movablelimits="false">&#x2211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>&#x2208;</mml:mo><mml:msubsup><mml:mi>I</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>c</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi mathvariant="normal">_</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>z</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>e</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>r</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:mrow></mml:munder><mml:mrow><mml:mrow><mml:mo>|</mml:mo><mml:mrow><mml:msubsup><mml:mover accent="true"><mml:mi>c</mml:mi><mml:mo stretchy="false">^</mml:mo></mml:mover><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup></mml:mrow><mml:mo>|</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:msubsup><mml:mi>I</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>c</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi mathvariant="normal">_</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>z</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>e</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>r</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math></inline-formula> where <inline-formula><mml:math id="INEQ20"><mml:mrow><mml:msubsup><mml:mi>I</mml:mi><mml:mrow><mml:mi>s</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>c</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi mathvariant="normal">_</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>z</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>e</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>r</mml:mi><mml:mo>&#x2062;</mml:mo><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:mi>i</mml:mi><mml:mo>:</mml:mo><mml:mrow><mml:msubsup><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>k</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math></inline-formula>. Taking the average over all common genes results in a single score <italic>R</italic><sub><italic>sc_ zero</italic></sub>, and in the same manner, we define <italic>R</italic><sub><italic>sc_ nonzero</italic></sub>, <italic>R</italic><sub><italic>atlas_ zero</italic></sub>, and <italic>R</italic><sub><italic>atlas_ nonzero</italic></sub>. When producing predictive reproducibility scores, we use the same k-fold split across all methods to ensure a fair comparison.</p>
      </sec>
      <sec id="S2.SS3">
        <title>Comparisons of Multiple Methods Using Simulated scRNA-seq Data</title>
        <p>Using the performance score, we benchmarked the methods developed by <xref rid="B1" ref-type="bibr">Achim et al. (2015)</xref> and <xref rid="B37" ref-type="bibr">Satija et al. (2015)</xref> (Seurat v1), <xref rid="B16" ref-type="bibr">Karaiskos et al. (2017)</xref> (DistMap), and <xref rid="B33" ref-type="bibr">Peng et al. (2016)</xref> together with our DEEPsc method and applied them to four different biological systems: the zebrafish embryo (<xref rid="B37" ref-type="bibr">Satija et al., 2015</xref>), the <italic>Drosophila</italic> embryo (<xref rid="B16" ref-type="bibr">Karaiskos et al., 2017</xref>), the murine hair follicle (<xref rid="B15" ref-type="bibr">Joost et al., 2016</xref>), and the murine frontal cortex, downloaded from the 10x Genomics Spatial Gene Expression Datasets. The reference atlas for the zebrafish embryo contains the binarized expression of 47 genes on 64 spatial bins that assemble half of the hemisphere of the 6hpf embryo (<xref rid="B37" ref-type="bibr">Satija et al., 2015</xref>). The <italic>Drosophila</italic> embryo reference atlas contains 84 genes on 3,039 spatial positions (<xref rid="B16" ref-type="bibr">Karaiskos et al., 2017</xref>). The spatial reference atlas generated with the Visium technology (<xref rid="B40" ref-type="bibr">St&#xE5;hl et al., 2016</xref>) for the murine frontal cortex contains 32,285 genes on 961 spatial positions (a subset presenting the frontal cortex from the original data), from which we kept 2755 genes from the 3,000 most variable genes in spatial data that are also present in scRNA-seq data. Segmenting a standard diagram of the follicle into 233 spatial positions and using FISH imaging of eight genes identified as spatially localized (<xref rid="B15" ref-type="bibr">Joost et al., 2016</xref>), we manually defined a continuous reference atlas for the follicle (section &#x201C;Materials and Methods&#x201D;). For mapping methods requiring a binary reference atlas, we defined a cutoff expression of 0.2 to be considered on in this follicle reference atlas of follicle. We further implemented several baseline methods for benchmark comparisons, including several methods using predefined metrics where the correspondence score <italic>S</italic> is defined to be the 2-norm, infinity norm, or mean percent difference in the space of common genes between the input cell and spatial position. We also implemented a large margin nearest neighbor (LMNN) method that learns a linear metric (section &#x201C;Materials and Methods&#x201D;). <xref ref-type="fig" rid="F3">Figure 3</xref> shows a scatter plot of the penalty terms constituting the performance score of each implemented method on each of the four biological systems, as well as the average for each method across all four systems. <xref rid="T1" ref-type="table">Table 1</xref> includes the numerical values for each penalty term, as well as the calculated performance score for each method. <xref ref-type="fig" rid="F4">Figure 4</xref> includes example heatmaps of simulated cells for each of the biological systems. The penalty terms for the individual locations are shown in <xref ref-type="fig" rid="F5">Figure 5</xref>.</p>
        <fig id="F3" position="float">
          <label>FIGURE 3</label>
          <caption>
            <p>Summary of the robustness, precision, and accuracy scores of the implemented methods on four different biological systems <bold>(A)</bold>, as well as the simple average across all four <bold>(B)</bold>. These scores are each defined to be one minus the corresponding penalty term in the performance score, so that a higher score is better. Since most methods have near perfect accuracy scores, the x-axis shows a mean of the precision and accuracy scores. The y-axis shows the robustness scores for each method. Due to memory constraints, we were unable to run Seurat v1 on the cortex dataset.</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g003"/>
        </fig>
        <table-wrap id="T1" position="float">
          <label>TABLE 1</label>
          <caption>
            <p>Numerical values of each of the three constituent terms of the performance score, as determined from simulated scRNA-seq data for each biological system, as well as the average across all systems.</p>
          </caption>
          <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
            <thead>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Method</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Accuracy (Author)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Precision Term</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Robustness Term</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Performance Score</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" colspan="5" rowspan="1">
                  <bold>Follicle</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0043</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3484</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4116</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7452</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0795</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1076</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5704</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7475</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0043</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4076</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3723</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7386</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5118</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4439</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6814</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3255</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2686</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8020</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0005</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2299</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3613</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8028</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2829</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8722</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6150</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0002</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8455</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7181</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0272</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2684</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.1904</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.8380</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="5" rowspan="1">
                  <bold>Zebrafish</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4645</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2516</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7613</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0156</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0604</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.9747</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3989</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8670</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4296</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8568</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2902</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0003</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9302</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0536</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1588</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9292</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4249</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0095</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8552</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0315</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1689</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9332</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0339</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1281</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0230</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9383</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="5" rowspan="1">
                  <bold>Drosophila</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3407</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0759</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8611</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6605</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0848</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7516</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3496</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0024</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8827</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4313</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8562</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2310</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0130</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9186</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0006</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1671</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9441</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3597</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0013</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8797</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0052</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0987</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.9653</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0087</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0179</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1827</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9303</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="5" rowspan="1">
                  <bold>Cortex</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6357</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0859</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7594</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4778</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8407</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4400</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8533</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3008</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1546</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8482</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0006</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3042</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8984</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4332</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3817</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7284</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0143</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3376</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8827</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1167</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0289</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.9515</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="5" rowspan="1">
                  <bold>Average</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0011</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4473</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2063</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7818</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1850</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0693</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2103</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8246</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0011</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4085</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0937</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8323</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.4532</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1110</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8119</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">2-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2869</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1091</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8748</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0001</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0712</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.2479</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8936</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3752</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3162</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7696</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0000</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.0128</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.3627</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8748</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.0175</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1328</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.1063</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.9145</bold>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <attrib>
              <italic>For each term, a value closer to zero signifies lower error. For the performance score, a value closer to one indicates a better performing method. The best method for each term is bolded for each system.</italic>
            </attrib>
          </table-wrap-foot>
        </table-wrap>
        <fig id="F4" position="float">
          <label>FIGURE 4</label>
          <caption>
            <p>Example mappings of simulated single cells produced by various existing methods on four different biological systems, with DEEPsc mappings for comparison. The simulated input cell for the murine follicle system corresponds to position 228. For the Zebrafish system (for which Seurat was introduced), the simulated input cell corresponds to position 34. For Drosophila (for which DistMap was introduced), the simulated input cell corresponds to position 1982. For the murine frontal cortex, the simulated input cell corresponds to position 458. Each known position is highlighted in black in each of the heatmaps.</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g004"/>
        </fig>
        <fig id="F5" position="float">
          <label>FIGURE 5</label>
          <caption>
            <p>Heatmap representation of the various components of the performance score on a per position basis in <bold>(A)</bold> the follicle system, <bold>(B)</bold> the Zebrafish, <bold>(C)</bold> the Drosophila embryo, and <bold>(D)</bold> the murine frontal cortex. We were unable to run Seurat v1 on the Drosophila embryo and cortex data due to memory constraint. The penalty terms for each simulated cell, including robustness, were computed individually and plotted as a heatmap.</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g005"/>
        </fig>
        <p>The majority of methods were able to project the simulated scRNA-seq cells to their known spatial origins with high accuracy. Specifically, Seurat v1 and DistMap achieve high performance scores in the zebrafish embryo and Drosophila embryo datasets that they were originally applied to, respectively. Designed to be a system-adaptive method, DEEPsc has the best average performance score across the four datasets (<xref rid="T1" ref-type="table">Table 1</xref>). Moreover, while some methods are stronger in terms robustness or precision, DEEPsc attains a balance between robustness and precision (<xref ref-type="fig" rid="F3">Figure 3</xref>). This balance is especially important when investigating the impact of cellular spatial neighborhood on cell fate acquisition. It is desired to narrow down the inferred spatial neighborhood (precision) and at the same time reduce the sensitivity to noise (robustness). The high precision and robustness of DEEPsc is consistently observed across all locations in the dataset (<xref ref-type="fig" rid="F5">Figure 5</xref>). Finally, it is worth mentioning that DEEPsc has a significantly higher robustness in the follicle dataset which has the smallest number of genes and is the noisiest among the four datasets.</p>
      </sec>
      <sec id="S2.SS4">
        <title>Applications to Real scRNA-seq Datasets</title>
        <p>We now map actual scRNA-seq data for each system and calculate the predictive reproducibility for each method (<xref rid="T2" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="F6">Figure 6</xref>). For the follicle, the scRNA-seq data contains 1,422 cells with 26,024 genes measured containing the eight genes in the spatial atlas (<xref rid="B15" ref-type="bibr">Joost et al., 2016</xref>). For the Drosophila embryo, we used the scRNA-seq dataset with 1,297 cells and 8,924 genes among which all the 84 spatial genes are present (<xref rid="B16" ref-type="bibr">Karaiskos et al., 2017</xref>). For the Zebrafish embryo, there are 1,152 cells and 11,978 genes in the scRNA-seq dataset with all the 47 spatial genes included (<xref rid="B37" ref-type="bibr">Satija et al., 2015</xref>). For the murine frontal cortex, we used the scRNA-seq dataset provided by the Allen Institute (<xref rid="B44" ref-type="bibr">Tasic et al., 2016</xref>), generated with SMART-Seq2, which contains 14,249 cells and 34,617 genes, from which a set of 2,755 genes were found to be present in the top 3,000 highly variable genes in spatial atlas. These four datasets cover different situations. The follicle data contains a moderate number of locations, and the cells form well-defined layered structures such that there could be long and thin spatial regions that contain the same cells. The zebrafish embryo spatial data has a suboptimal resolution such that each spatial location consists of multiple cells. This data helps to evaluate the methods in treating coarse spatial atlases. The Drosophila embryo data contains rich spatial characteristics. There is a well-defined global ventral-dorsal/anterior-posterior coordinate system. Locally, there is also a striped pattern in the lateral side of the embryo. The frontal cortex data examines spatial gene expression at the transcriptomics level, and functions as a demonstration that DEEPsc is able to maintain a high performance on high-dimensional datasets.</p>
        <table-wrap id="T2" position="float">
          <label>TABLE 2</label>
          <caption>
            <p>Predictive reproducibility of each method for real scRNA-seq data.</p>
          </caption>
          <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
            <thead>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Method (Author)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Follicle</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Zebrafish</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Drosophila</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Cortex</td>
                <td valign="top" align="center" rowspan="1" colspan="1">Average</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" colspan="6" rowspan="1">
                  <bold>R<sub>sc_zero</sub></bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.8772</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5537</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7798</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8019</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7531</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8335</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6842</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7589</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8404</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6641</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7850</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8055</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7738</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8219</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6375</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7859</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8092</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7636</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Two-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8017</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6973</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7874</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8114</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7745</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8641</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6180</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7807</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8141</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7692</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8357</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5657</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7790</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8079</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7471</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8254</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6795</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7917</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8120</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7772</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8344</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7335</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7961</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.8165</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7951</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="6" rowspan="1">
                  <bold>R<sub>sc_nonzero</sub></bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7495</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7698</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8126</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6693</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7503</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7640</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6975</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7308</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7705</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7619</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8103</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6685</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7528</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7801</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7663</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8114</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6680</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7565</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Two-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7891</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7386</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8083</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6667</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7507</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7496</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7636</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.8128</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.6695</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7489</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7740</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7721</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8115</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6690</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7567</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7730</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7477</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8117</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6643</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7492</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7352</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7026</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8080</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6691</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7287</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="6" rowspan="1">
                  <bold>R<sub>atlas_zero</sub></bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7680</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9042</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9264</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8360</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8587</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7681</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9088</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8385</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7674</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9005</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9259</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8374</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8578</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7707</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9006</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9267</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8406</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8597</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Two-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7681</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9003</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9278</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8411</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8593</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7623</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9050</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9259</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8343</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8569</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7714</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9035</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9261</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.8438</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8612</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7677</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8937</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.9289</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8359</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8566</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7881</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.9148</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.9257</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8415</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.8675</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="6" rowspan="1">
                  <bold>R<sub>atlas_nonzero</sub></bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Achim)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7598</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6658</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8523</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5124</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6976</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Seurat v1 (Satija)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7570</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6776</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7173</bold>
                </td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DistMap (Karaiskos)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7584</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6709</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8527</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5127</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6987</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">(Peng)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7570</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6682</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8530</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.5135</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6979</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Two-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7582</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6755</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8530</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5135</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7001</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Inf-norm (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7583</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6745</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8534</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5130</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6998</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">% difference (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7573</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6669</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8524</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5134</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6975</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LMNN (baseline)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7573</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.6764</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.8564</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5129</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7008</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">DEEPsc (ours)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7724</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">
                  <bold>0.7079</bold>
                </td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.8527</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.5125</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.7114</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <attrib>
              <italic>A value closer to one signifies higher predictive reproducibility. A missing entry signifies that we were not able to run the relevant method on the given dataset. The best method for each term is bolded for each system.</italic>
            </attrib>
          </table-wrap-foot>
        </table-wrap>
        <fig id="F6" position="float">
          <label>FIGURE 6</label>
          <caption>
            <p>Ridgeline plots of the zero <bold>(A)</bold> and nonzero <bold>(B)</bold> scRNA-seq predictive reproducibility of individual cells in the scRNA-seq datasets and zero <bold>(C)</bold> and nonzero <bold>(D)</bold> atlas predictive reproducibility of individual positions in the spatial atlas for the four studied systems. We were unable to run Seurat v1 on the Drosophila embryo and cortex data due to memory constraints.</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g006"/>
        </fig>
        <p>For the baseline models, we linearly normalized each gene in the log-normalized scRNA-seq dataset onto the interval [0,1]. Continuous spatial atlases with expression values in the [0,1] range were used for the follicle, Drosophila embryo, and murine frontal cortex systems, the latter two having been linearly normalized to [0,1] in the same fashion as the scRNA-seq data. Since a continuous spatial atlas for Zebrafish embryo is lacking, we applied a spatial convolution to the binary atlas and added a small amount of Gaussian noise to simulate a continuous atlas. The 2-norm, Inf-norm, percent difference, and LMNN baseline models are then applied to the vectors of the commonly expressed genes in the spatial atlas and scRNA-seq data. For DEEPsc, we first applied a PCA reduction to the spatial atlas, and then applied the same linear transformation to the normalized expression values of the common genes in the scRNA-seq data. The feature vectors for the locations in the spatial atlas and the cells in the scRNA-seq data in the PCA space were then fed to the neural network. For the four existing methods, we followed the procedure as described in the associated original publications, scaling the resulting correspondence scores to [0,1] for direct comparison with baseline methods. For all the methods, we compute the predictive reproducibility by iterating over all common genes, attempting to reconstruct the expression of one gene using the k-fold cross validation scheme described in the previous section. We used <italic>k=4</italic> for the follicle and Drosophila embryo dataset, and <italic>k=5</italic> for the zebrafish embryo and cortex dataset.</p>
        <p>DEEPsc has a comparable accuracy compared to other methods, and it also has a consistent performance across different systems (<xref rid="T2" ref-type="table">Table 2</xref> and <xref ref-type="fig" rid="F6">Figure 6</xref>). This consistent performance further demonstrates the system-adaptive advantage of DEEPsc and the benefit of using adaptive metrics over predefined ones. We also notice that similar to the simulated case, DEEPsc also achieves a balance between precision and robustness in the case of real scRNA-seq data. For example, while it exhibits high precision by mapping the example cell to a specific local spot in the Zebrafish embryo or a local strip in Drosophila embryo, it also robustly maps a cell to the entire outer bulge of the follicle instead of only part of it (<xref ref-type="fig" rid="F7">Figure 7</xref>). The high precision ensures that we can resolve the heterogeneity in the spatial environment and further relate them to the heterogeneity in cell fates. The high robustness prevents the identification of false correlations. Overall, DEEPsc achieves a high predictive reproducibility across all cells in the scRNA-seq dataset.</p>
        <fig id="F7" position="float">
          <label>FIGURE 7</label>
          <caption>
            <p>Example mappings of real single cells produced by various existing methods on four different biological systems, with DEEPsc mappings for comparison. The input cell for the murine follicle system is cell 710 from the Joost dataset. For the Zebrafish system (for which Seurat v1 was introduced), the input cell is cell 877 from the scRNA-seq dataset (<xref rid="B37" ref-type="bibr">Satija et al., 2015</xref>). For Drosophila (for which DistMap was introduced), the input cell is cell 130 from the scRNA-seq dataset (<xref rid="B16" ref-type="bibr">Karaiskos et al., 2017</xref>). For the murine frontal cortex, the input cell is cell 885 from the Allen reference dataset (<xref rid="B44" ref-type="bibr">Tasic et al., 2016</xref>).</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g007"/>
        </fig>
      </sec>
      <sec id="S2.SS5">
        <title>Comparison of Dimensionality Reduction Methods</title>
        <p>Dimension reduction is a crucial initial step of DEEPsc. A dimension reduction method that can be trained on one dataset and deterministically applied to another is needed due to the separated training and predicting steps. Here, we explore two different representative dimension reduction methods in the linear and nonlinear categories, PCA and Uniform Manifold Approximation and Projection (UMAP; <xref rid="B28" ref-type="bibr">McInnes et al., 2018</xref>). To compare these two methods, we trained several networks with varying amounts of added noise on the reference atlases of the four studied biological systems (<xref ref-type="fig" rid="F8">Figure 8</xref>). We compared PCA (8 principal components), UMAP30 (n_components = 8, n_neighbors = 30), and UMAP5 (n_components = 8, n_neighbors = 5). While on the follicle system all three reduction methods performed virtually identically, on all three other systems PCA outperformed the other reduction methods by achieving a higher robustness score while maintaining similar accuracy.</p>
        <fig id="F8" position="float">
          <label>FIGURE 8</label>
          <caption>
            <p>A comparison of the performance of DEEPsc networks using different dimensionality reduction methods on each of the biological systems for various levels of added noise during training. We compare principal component analysis (PCA) to Uniform Manifold Approximation and Projection (UMAP) with n_neighbors = 30 (UMAP30) and n_neighbors = 5 (UMAP5). Each of these methods reduce the dimensionality of the initial dataset to n_dimensions = 8. These scores are each defined to be one minus the corresponding penalty term in the performance score, so that a higher score is better. Since most methods have near perfect accuracy scores, the x-axis shows a mean of the precision and accuracy scores. The y-axis shows the robustness scores for each method.</p>
          </caption>
          <graphic xlink:href="fgene-12-636743-g008"/>
        </fig>
      </sec>
    </sec>
    <sec id="S3">
      <title>Discussion</title>
      <p>We have developed the DEEPsc framework, which trains a deep neural network using the known expression levels of a small subset of genes in a spatial context, then imputes that spatial information onto a non-spatial scRNA-seq dataset. Instead of using a predefined metric, DEEPsc finds a metric adaptive to data. This framework is system-adaptive and designed to be robust to noise. DEEPsc consistently performs at or above the level of several existing methods across all four biological systems studied herein, including systems for which existing methods were originally developed (<xref ref-type="fig" rid="F3">Figure 3</xref> and <xref rid="T1" ref-type="table">Tables 1</xref>, <xref rid="T2" ref-type="table">2</xref>), based on our comprehensive performance measure. While DEEPsc achieves comparable accuracy and precision to other methods, it is significantly more robust to noise.</p>
      <p>The source of DEEPsc&#x2019;s ability to perform well across multiple biological systems is likely the generality of its neural network architecture and the multiple checks for robustness employed during training on the reference atlas. The various parameters for training a DEEPsc network, though chosen empirically, appear to translate to multiple systems effectively, so we expect DEEPsc to continue to perform well across more biological systems in future study.</p>
      <p>One notable weakness of DEEPsc is the significant amount of training time required to produce a final mapping. While most existing reference atlas methods simply involve a deterministic calculation to produce a mapping, DEEPsc requires an initial training, and the training time depends on the number of locations in the spatial atlas. The training process of DEEPsc can be effectively accelerated by iterating over a subset of possible location pairs. Due to the dimension reduction step, DEEPsc can still be trained efficiently on datasets with large amount of genes, for example, the spatial transcriptomics data on the murine frontal cortex. Though the predefined metrics including the 2-norm and inf-norm perform well in terms of accuracy and precision, they are less robust to noise. This is further the case for LMNN as it tries to amplify any small variations. This drawback in robustness is mitigated by DEEPsc by controlling the balance between precision and robustness.</p>
      <p>Learning a metric from high-dimensional datasets can be generally useful for analysis and integration of omics datasets. A future research interest is to decrease training time in such framework by developing a better method for reducing the size of the training set to a small, targeted fraction of relevant examples, particularly for very large atlases such as those derived from spatial transcriptomics assays. Since the size of the training set can increase quadratically with the number of positions in the atlas, it is beneficial to develop a more efficient training pipeline. We have developed a method of sparsifying the training set (section &#x201C;Materials and Methods&#x201D;), so that its size only increases linearly with the number of positions in the atlas, though further improvement may be warranted. The largest atlas studied here was that of Drosophila (<italic>P=3039</italic>), the training of which took several hours even with the sparsified training set. Typical numbers of distinct spatial locations in a spatial transcriptomics dataset can be orders of magnitude larger.</p>
      <p>DEEPsc aside, the performance score we have created can serve as a comprehensive measure of mapping performance for future work. The performance score is able to be calculated for any mapping method that assigns a likelihood of origin from each spatial location, particularly within the reference atlas framework. It is not dependent on any specific system or mapping method, and the individual terms which constitute it allow for a detailed analysis and comparison of various methods. Potential improvements might include incorporating some amount of spatial awareness into the calculation. Currently each spatial position is treated as completely independent from every other spatial position, so the precision term, for example, can yield unintuitive results if a method maps a cell, for example, with high probability to two positions on opposite sides of a system and low probability everywhere else, compared to a different method mapping the same cell with high probability to five positions in a tightly clustered, spatially compact region of the system. If, for example, the various correspondence scores for each position with high probability were weighted by their physical distance from other cells with high probability, this term might more accurately reflect the intuitive idea of precision. Other improvements might include simplifying the calculation of the robustness term to require fewer intensive calculations.</p>
    </sec>
    <sec id="S4">
      <title>Conclusion</title>
      <p>DEEPsc achieves an accuracy comparable to several existing methods while attaining improved precision and robustness. It also has a more consistent performance across the four different biological systems tested thanks to the system-adaptive design. As spatially resolved gene expression data becomes more readily available, our method will serve as a useful tool to infer spatial origins from non-spatial scRNA-seq data.</p>
      <p>Additionally, our comprehensive performance score and the collection of reproductions of previously developed methods in a single software framework will serve as useful tools for future comparisons of spatial mapping methods. This systematic approach to imputing spatial information to scRNA-seq data is crucial to studying the spatial impact on cell fate dynamics.</p>
    </sec>
    <sec sec-type="materials|methods" id="S5">
      <title>Materials and Methods</title>
      <sec id="S5.SS1">
        <title>Data Preparation for DEEPsc</title>
        <p>Given a matrix of scRNA-seq read counts where each row is a different gene and each column is a different cell, and a matrix representing a spatial reference atlas where each row is a different gene and each column is a different spatial position, we first select common genes by eliminating rows in each corresponding to genes not in the other matrix. Once we have eliminated genes not in common, we are left with a number of cells (<italic>C</italic>) &#xD7; number of genes (<italic>G</italic>) matrix for the scRNA-seq data and a number of positions (<italic>P</italic>) &#xD7; number of genes (<italic>G</italic>) matrix for the spatial reference atlas.</p>
        <p>We then apply dimensionality reduction to the atlas in the form of a PCA projection, selecting a user-configurable number of principal components to serve as feature vectors. We find in our analysis that keeping the top eight principal components yields satisfactory results. The same PCA coefficients are used to project the scRNA-seq matrix into these principal components. After projection, both matrices are normalized by dividing by the largest element in each, so that the elements are all in [0,1].</p>
        <p>For the comparisons in section &#x201C;Comparison of Dimensionality Reduction Methods,&#x201D; we use the UMAP implementation by <xref rid="B29" ref-type="bibr">Meehan et al. (2021)</xref>, found on the MATLAB Central File Exchange at <ext-link ext-link-type="uri" xlink:href="https://www.mathworks.com/matlabcentral/fileexchange/71902">https://www.mathworks.com/matlabcentral/fileexchange/71902</ext-link>. Specifically, we ran the run_umap() function on the spatial reference atlas with n_dimensions = 8 and n_neighbors = 30 or n_neighbors = 5 for UMAP30 and UMAP5, respectively.</p>
      </sec>
      <sec id="S5.SS2">
        <title>Training a DEEPsc Network</title>
        <p>To train the DEEPsc network, we use the spatial position feature vectors themselves as simulated scRNA-seq data. The training data is a set of P<sup>2</sup> vectors of length <italic>2N</italic>, where <italic>N</italic> is the reduced dimensionality of the reference atlas. The first <italic>N</italic> components correspond to a feature vector of one position in the reference atlas (functioning as a simulated cell) and the last <italic>N</italic> components correspond to some other position in the reference atlas. Each simulated cell is compared pairwise with every position in the spatial reference atlas; if the simulated cell is an exact match to a given position, the target output is chosen to be 1 (a high likelihood of origin), and if the simulated cell and chosen position are not an exact match, the target output is chosen to be 0 (a low likelihood of origin).</p>
        <p>The DEEPsc architecture is an artificial neural network with <italic>2N</italic> inputs, two fully connected hidden layers with N nodes each and a single node in the output layer. Sigmoid activation functions are attached to each node, including the output node, so that the resulting output is in [0,1] and can be interpreted as a likelihood that the input cell originated from the input spatial position. To preserve robustness and avoid overfitting the training data, a layer of Gaussian noise is added to the simulated cells so that the network is pushed to learn complex nonlinear relationships among the spatial positions in the reference atlas rather than simply activate when an exact match is encountered. This Gaussian noise layer allows the user to configure the standard deviation of the added noise, as well as to configure the probability that any noise will be added in a given training epoch. We find empirically that a noise level of about 0.10 and a probability of 0.5 yield reasonable robustness to noise, though this may vary from system to system.</p>
        <p>Since the training data will naturally consist of many more non-matches than matches, and thus the target data will contain many more zeros than ones, we use a novel custom objective function,</p>
        <disp-formula id="S5.Ex2">
          <mml:math id="M2">
            <mml:mrow>
              <mml:mrow>
                <mml:mi>L</mml:mi>
                <mml:mo>&#x2062;</mml:mo>
                <mml:mrow>
                  <mml:mo>(</mml:mo>
                  <mml:mi>Y</mml:mi>
                  <mml:mo>,</mml:mo>
                  <mml:mi>T</mml:mi>
                  <mml:mo>)</mml:mo>
                </mml:mrow>
              </mml:mrow>
              <mml:mo>=</mml:mo>
              <mml:mrow>
                <mml:munderover>
                  <mml:mo movablelimits="false">&#x2211;</mml:mo>
                  <mml:mrow>
                    <mml:mi>i</mml:mi>
                    <mml:mo>=</mml:mo>
                    <mml:mn>1</mml:mn>
                  </mml:mrow>
                  <mml:mi>P</mml:mi>
                </mml:munderover>
                <mml:mrow>
                  <mml:msup>
                    <mml:mrow>
                      <mml:mo>(</mml:mo>
                      <mml:mrow>
                        <mml:msub>
                          <mml:mi>y</mml:mi>
                          <mml:mi>i</mml:mi>
                        </mml:msub>
                        <mml:mo>-</mml:mo>
                        <mml:msub>
                          <mml:mi>t</mml:mi>
                          <mml:mi>i</mml:mi>
                        </mml:msub>
                      </mml:mrow>
                      <mml:mo>)</mml:mo>
                    </mml:mrow>
                    <mml:mn>2</mml:mn>
                  </mml:msup>
                  <mml:mo>&#x2062;</mml:mo>
                  <mml:mfrac>
                    <mml:mn>1</mml:mn>
                    <mml:mrow>
                      <mml:mn>1.001</mml:mn>
                      <mml:mo>-</mml:mo>
                      <mml:msub>
                        <mml:mi>t</mml:mi>
                        <mml:mi>i</mml:mi>
                      </mml:msub>
                    </mml:mrow>
                  </mml:mfrac>
                </mml:mrow>
              </mml:mrow>
            </mml:mrow>
          </mml:math>
        </disp-formula>
        <p>where <italic>y</italic><sub><italic>i</italic></sub> is the network&#x2019;s predicted output and <italic>t</italic><sub><italic>i</italic></sub> is the target output (<italic>t</italic><sub><italic>i</italic></sub> = 1 if exact match and <italic>t</italic><sub><italic>i</italic></sub> = 0 if not), to more heavily penalize the network when it gives a false negative (low likelihood when it should be high) than when it gives a false positive (high likelihood when it should be low). This acts to counteract the tendency of the network to &#x201C;learn&#x201D; to simply return 0 for every single input and &#x201C;ignore&#x201D; any comparably rare training data with <italic>t</italic><sub><italic>i</italic></sub> = 1.</p>
        <p>To further account for the sparsity of exact matches in the training set, we split it into a test and validation set, the former consisting of a configurable fraction of the inputs corresponding to exact matches as well as a configurable multiple of the inputs corresponding to non-matches. If <italic>trainFrac = 0.9</italic> and <italic>trainingMultiple = 99</italic>, for example, 90% of the exact matches will be added to the training set and 99x more non-matches will be added, so that the exact matches make up 1% of the training set. The rest of the inputs are reserved for the (generally much larger) validation set. This is beneficial in reducing training time because it allows us to train with a much smaller fraction of the <italic>P</italic><sup>2</sup> input vectors, giving preference to the exact matches. Indeed, this reduces the size of the actual training set to scale linearly with the size of the atlas rather than quadratically.</p>
        <p>Training is performed in MATLAB using the <italic>trainNetwork()</italic> function in the Deep Learning Toolbox (<xref rid="B45" ref-type="bibr">The Mathworks, Inc, 2019a</xref>), for which we implemented the above-described custom network layers. Since the input data is already normalized in preprocessing, we disable the default normalization of <italic>trainNetwork().</italic> We use the default Glorot (<xref rid="B52" ref-type="bibr">Xavier and Yoshua, 2010</xref>) initialization of weights and biases in the fully connected layers. We then train each network for a maximum of 50,000 epochs of standard gradient descent with a learning rate of &#x3B7;=0.01, shuffle the order of the data each epoch, and use the ADAM optimization method (<xref rid="B18" ref-type="bibr">Kingma and Ba, 2014</xref>) with the default parameters &#x3B2;<sub>1</sub> = 0.9, &#x3B2;<sub>2</sub> = 0.999, and <italic>&#x3B5;</italic> = 10<sup>&#x2212;8</sup>. In addition to the custom objective function layer we describe above, <italic>trainNetwork()</italic> by default adds an <italic>L</italic><sup>2</sup>-regularization term to the loss with a regularization factor of &#x3BB;=0.0001. We monitor the RMSE of the validation set throughout training and manually stop training if it is no longer improving before the maximum number of epochs has been reached. The <italic>trainNetwork()</italic> function also allows for parallel computation via the Parallel Computing Toolbox (<xref rid="B46" ref-type="bibr">The Mathworks, Inc, 2019b</xref>), which is highly recommended but not strictly required for training.</p>
      </sec>
      <sec id="S5.SS3">
        <title>Creating a Reference Atlas for the Murine Follicle</title>
        <p>To create a spatial reference atlas for the murine follicle system, we patterned the spatial coordinates of each position in the atlas off of a standard diagram of a mouse follicle found in Figure 1 of <xref rid="B15" ref-type="bibr">Joost et al. (2016)</xref>. We constructed a Voronoi diagram around each of the cell centers and made manual adjustments to the vertices as we saw fit aesthetically. We then selected the eight genes in the atlas from the systematic staining catalog made available by Joost. We chose the genes based on a combination of high image quality and spatial diversity. Gene expression levels in [0,1] were chosen manually to best represent the images, though to eliminate any implicit bias we also added a small level of Gaussian noise to the atlas. For all methods requiring a binary atlas, we chose a cutoff of 0.2 to represent &#x201C;on&#x201D; expression in this atlas.</p>
      </sec>
      <sec id="S5.SS4">
        <title>Large Margin Nearest Neighbor Baseline</title>
        <p>To implement a LMNN baseline for benchmarking comparison, we used code from the MATLAB Toolbox for Dimensionality Reduction found at <ext-link ext-link-type="uri" xlink:href="https://lvdmaaten.github.io/drtoolbox/">https://lvdmaaten.github.io/drtoolbox/</ext-link> and modified it for our uses. Specifically, we used the <italic>lmnn()</italic> function in the &#x201C;techniques&#x201D; subfolder, and modified the code to set <italic>mu = 1</italic>, i.e., to remove the &#x201C;pull&#x201D; term, as well as setting the number of targets to 1 (the point itself) and treating all other points as imposters. Further, we modified the slack variables to enforce a minimum separation of <inline-formula><mml:math id="INEQ38"><mml:msqrt><mml:mi>D</mml:mi></mml:msqrt></mml:math></inline-formula>, where <italic>D</italic> is the dimensionality of the space (<italic>D=G</italic> for our applications). For the numerical experiments of the LMNN method with the cortex dataset, a PCA dimension reduction (50 PCs) was performed before applying LMNN to accommodate the large number of genes.</p>
      </sec>
    </sec>
    <sec sec-type="data-availability" id="S6">
      <title>Data Availability Statement</title>
      <p>The original data used in this paper can be accessed through the following links: (1) zebrafish embryo spatial data: downloaded from (<ext-link ext-link-type="uri" xlink:href="https://www.dropbox.com/s/ev78jelev0jgu5s/seurat_files_zfin.zip?dl=1">https://www.dropbox.com/s/ev78jelev0jgu5s/seurat_files_zfin.zip?dl=1</ext-link>) (<xref rid="B37" ref-type="bibr">Satija et al., 2015</xref>); (2) zebrafish embryo scRNA-seq data: GEO accession codes: <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="GSE66688">GSE66688</ext-link> (<xref rid="B37" ref-type="bibr">Satija et al., 2015</xref>); (3) Drosophila embryo spatial and scRNA-seq data: accessible at the Dream Single cell Transcriptomics Challenge through Synapse ID (syn15665609) (<xref rid="B16" ref-type="bibr">Karaiskos et al., 2017</xref>); (4) mouse frontal cortex spatial data: downloaded from 10x Genomics Spatial Gene Expression Datasets (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Mouse_Brain_Sagittal_Anterior">https://support.10xgenomics.com/spatial-gene-expression/datasets/1.1.0/V1_Mouse_Brain_Sagittal_Anterior</ext-link>); (5) mouse frontal cortex scRNA-seq data: downloaded from (<ext-link ext-link-type="uri" xlink:href="https://www.dropbox.com/s/cuowvm4vrf65pvq/allen_cortex.rds?dl=1">https://www.dropbox.com/s/cuowvm4vrf65pvq/allen_cortex.rds?dl=1</ext-link>) (<xref rid="B44" ref-type="bibr">Tasic et al., 2016</xref>); (6) follicle scRNA-seq data and spatial imaging data from which the reference atlas was derived: downloaded from the supplementary of the associated publication (<xref rid="B15" ref-type="bibr">Joost et al., 2016</xref>). All software developed for the purposes of this comparison are made freely available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/fmaseda/DEEPsc">https://github.com/fmaseda/DEEPsc</ext-link>.</p>
    </sec>
    <sec id="S7">
      <title>Author Contributions</title>
      <p>FM carried out computer implementation and data analysis. ZC and QN supervised the project. FM and ZC wrote the original manuscript. All authors conceived and designed the work, interpreted the simulation results, and contributed to the writing of the final manuscript.</p>
    </sec>
    <sec sec-type="COI-statement" id="conf1">
      <title>Conflict of Interest</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding.</bold> The work was partially supported by the NIH grants U01AR073159 and P30AR075047, NSF grants DMS1763272 and MCB2028424, and a grant from the Simons Foundation (594598, QN).</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Achim</surname><given-names>K.</given-names></name><name><surname>Pettit</surname><given-names>J.-B.</given-names></name><name><surname>Saraiva</surname><given-names>L. R.</given-names></name><name><surname>Gavriouchkina</surname><given-names>D.</given-names></name><name><surname>Larsson</surname><given-names>T.</given-names></name><name><surname>Arendt</surname><given-names>D.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin.</article-title>
<source><italic>Nat. Biotechnol.</italic></source>
<volume>33</volume>
<fpage>503</fpage>&#x2013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3209</pub-id>
<pub-id pub-id-type="pmid">25867922</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>A.</given-names></name><name><surname>Bergenstr&#xE5;hle</surname><given-names>J.</given-names></name><name><surname>Asp</surname><given-names>M.</given-names></name><name><surname>Bergenstr&#xE5;hle</surname><given-names>L.</given-names></name><name><surname>Jurek</surname><given-names>A.</given-names></name><name><surname>Navarro</surname><given-names>J. F.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography.</article-title>
<source><italic>Commun. Biol.</italic></source>
<volume>3</volume>:<issue>565</issue>. <pub-id pub-id-type="doi">10.1038/s42003-020-01247-y</pub-id>
<pub-id pub-id-type="pmid">33037292</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boufea</surname><given-names>K.</given-names></name><name><surname>Seth</surname><given-names>S.</given-names></name><name><surname>Batada</surname><given-names>N. N.</given-names></name></person-group> (<year>2020</year>). <article-title>scID uses discriminant analysis to identify transcriptionally equivalent cell types across single-Cell RNA-seq data with batch effect.</article-title>
<source><italic>iScience</italic></source>
<volume>23</volume>:<issue>100914</issue>. <pub-id pub-id-type="doi">10.1016/j.isci.2020.100914</pub-id>
<pub-id pub-id-type="pmid">32151972</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname><given-names>A.</given-names></name><name><surname>Hoffman</surname><given-names>P.</given-names></name><name><surname>Smibert</surname><given-names>P.</given-names></name><name><surname>Papalexi</surname><given-names>E.</given-names></name><name><surname>Satija</surname><given-names>R.</given-names></name></person-group> (<year>2018</year>). <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species.</article-title>
<source><italic>Nat. Biotechnol.</italic></source>
<volume>36</volume>
<fpage>411</fpage>&#x2013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
<pub-id pub-id-type="pmid">29608179</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cang</surname><given-names>Z.</given-names></name><name><surname>Nie</surname><given-names>Q.</given-names></name></person-group> (<year>2020</year>). <article-title>Inferring spatial and signaling relationships between cells from single cell transcriptomic data.</article-title>
<source><italic>Nat. Commun.</italic></source>
<volume>11</volume>:<issue>2084</issue>. <pub-id pub-id-type="doi">10.1038/s41467-020-15968-5</pub-id>
<pub-id pub-id-type="pmid">32350282</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chicco</surname><given-names>D.</given-names></name></person-group> (<year>2020</year>). <article-title>Siamese neural networks: an overview.</article-title>
<source><italic>Methods Mol. Biol.</italic></source>
<volume>2190</volume>
<fpage>73</fpage>&#x2013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-0716-0826-5_3</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Codeluppi</surname><given-names>S.</given-names></name><name><surname>Borm</surname><given-names>L. E.</given-names></name><name><surname>Zeisel</surname><given-names>A.</given-names></name><name><surname>La Manno</surname><given-names>G.</given-names></name><name><surname>Van Lunteren</surname><given-names>J. A.</given-names></name><name><surname>Svensson</surname><given-names>C. I.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Spatial organization of the somatosensory cortex revealed by osmFISH.</article-title>
<source><italic>Nat. Methods</italic></source>
<volume>15</volume>
<fpage>932</fpage>&#x2013;<lpage>935</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-018-0175-z</pub-id>
<pub-id pub-id-type="pmid">30377364</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dries</surname><given-names>R.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Eng</surname><given-names>C.-H. L.</given-names></name><name><surname>Sarkar</surname><given-names>A.</given-names></name><name><surname>Bao</surname><given-names>F.</given-names></name><name><surname>George</surname><given-names>R. E.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Giotto, a pipeline for integrative analysis and visualization of single-cell spatial transcriptomic data.</article-title>
<source><italic>bioRxiv</italic></source>
<comment>[preprint]</comment>. <pub-id pub-id-type="doi">10.1101/701680</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eng</surname><given-names>C.-H. L.</given-names></name><name><surname>Lawson</surname><given-names>M.</given-names></name><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Dries</surname><given-names>R.</given-names></name><name><surname>Koulena</surname><given-names>N.</given-names></name><name><surname>Takei</surname><given-names>Y.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH+.</article-title>
<source><italic>Nature</italic></source>
<volume>568</volume>
<fpage>235</fpage>&#x2013;<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1049-y</pub-id>
<pub-id pub-id-type="pmid">30911168</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowlkes</surname><given-names>C. C.</given-names></name><name><surname>Hendriks</surname><given-names>C. L. L.</given-names></name><name><surname>Ker&#xE4;nen</surname><given-names>S. V. E.</given-names></name><name><surname>Weber</surname><given-names>G. H.</given-names></name><name><surname>R&#xFC;bel</surname><given-names>O.</given-names></name><name><surname>Huang</surname><given-names>M.-Y.</given-names></name><etal/></person-group> (<year>2008</year>). <article-title>A quantitative spatiotemporal Atlas of gene expression in the <italic>Drosophila</italic> blastoderm.</article-title>
<source><italic>Cell</italic></source>
<volume>133</volume>
<fpage>364</fpage>&#x2013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.01.053</pub-id>
<pub-id pub-id-type="pmid">18423206</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>G.</given-names></name><name><surname>Huss</surname><given-names>M.</given-names></name><name><surname>Tong</surname><given-names>G. Q.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Li Sun</surname><given-names>L.</given-names></name><name><surname>Clarke</surname><given-names>N. D.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.</article-title>
<source><italic>Dev. Cell</italic></source>
<volume>18</volume>
<fpage>675</fpage>&#x2013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2010.02.012</pub-id>
<pub-id pub-id-type="pmid">20412781</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpern</surname><given-names>K. B.</given-names></name><name><surname>Shenhav</surname><given-names>R.</given-names></name><name><surname>Matcovitch-Natan</surname><given-names>O.</given-names></name><name><surname>T&#xF3;th</surname><given-names>B.</given-names></name><name><surname>Lemze</surname><given-names>D.</given-names></name><name><surname>Golan</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Single-cell spatial reconstruction reveals global division of labour in the mammalian liver.</article-title>
<source><italic>Nature</italic></source>
<volume>542</volume>
<fpage>352</fpage>&#x2013;<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1038/nature21065</pub-id>
<pub-id pub-id-type="pmid">28166538</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hie</surname><given-names>B.</given-names></name><name><surname>Bryson</surname><given-names>B.</given-names></name><name><surname>Berger</surname><given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Efficient integration of heterogeneous single-cell transcriptomes using Scanorama.</article-title>
<source><italic>Nat. Biotechnol.</italic></source>
<volume>37</volume>
<fpage>685</fpage>&#x2013;<lpage>691</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0113-3</pub-id>
<pub-id pub-id-type="pmid">31061482</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Hu</surname><given-names>G.</given-names></name><name><surname>Lyu</surname><given-names>Y.</given-names></name><name><surname>Susztak</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Iterative transfer learning with neural network for clustering and cell type classification in single-cell RNA-seq analysis.</article-title>
<source><italic>bioRxiv</italic></source>
<comment>[preprint]</comment>. <pub-id pub-id-type="doi">10.1038/s42256-020-00233-7</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joost</surname><given-names>S.</given-names></name><name><surname>Zeisel</surname><given-names>A.</given-names></name><name><surname>Jacob</surname><given-names>T.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>La manno</surname><given-names>G.</given-names></name><name><surname>L&#xF6;nnerberg</surname><given-names>P.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Single-Cell transcriptomics reveals that differentiation and spatial signatures shape epidermal and hair follicle heterogeneity.</article-title>
<source><italic>Cell Syst.</italic></source>
<volume>3</volume>
<fpage>221</fpage>&#x2013;<lpage>237.e229</lpage>. <pub-id pub-id-type="doi">10.1016/j.cels.2016.08.010</pub-id>
<pub-id pub-id-type="pmid">27641957</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaiskos</surname><given-names>N.</given-names></name><name><surname>Wahle</surname><given-names>P.</given-names></name><name><surname>Alles</surname><given-names>J.</given-names></name><name><surname>Boltengagen</surname><given-names>A.</given-names></name><name><surname>Ayoub</surname><given-names>S.</given-names></name><name><surname>Kipar</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>The <italic>Drosophila</italic> embryo at single-cell transcriptome resolution.</article-title>
<source><italic>Science</italic></source>
<volume>358</volume>
<fpage>194</fpage>&#x2013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1126/science.aan3235</pub-id>
<pub-id pub-id-type="pmid">28860209</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaya</surname><given-names>M.</given-names></name><name><surname>Bilge</surname><given-names>H.</given-names></name></person-group> (<year>2019</year>). <article-title>Deep metric learning: a survey.</article-title>
<source><italic>Symmetry</italic></source>
<volume>11</volume>:<issue>1066</issue>. <pub-id pub-id-type="doi">10.3390/sym11091066</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kingma</surname><given-names>D. P.</given-names></name><name><surname>Ba</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Adam: a method for stochastic optimization.</article-title>
<source><italic>arXiv</italic></source>
<comment>[preprint]</comment>:<volume>1412.6980</volume>. <issue>arXiv</issue>
<comment>e-prints</comment></mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiselev</surname><given-names>V. Y.</given-names></name><name><surname>Andrews</surname><given-names>T. S.</given-names></name><name><surname>Hemberg</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Challenges in unsupervised clustering of single-cell RNA-seq data.</article-title>
<source><italic>Nat. Rev. Genet.</italic></source>
<volume>20</volume>
<fpage>273</fpage>&#x2013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1038/s41576-018-0088-9</pub-id>
<pub-id pub-id-type="pmid">30617341</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiselev</surname><given-names>V. Y.</given-names></name><name><surname>Yiu</surname><given-names>A.</given-names></name><name><surname>Hemberg</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>scmap: projection of single-cell RNA-seq data across data sets.</article-title>
<source><italic>Nat. Methods</italic></source>
<volume>15</volume>
<fpage>359</fpage>&#x2013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.4644</pub-id>
<pub-id pub-id-type="pmid">29608555</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korsunsky</surname><given-names>I.</given-names></name><name><surname>Millard</surname><given-names>N.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Slowikowski</surname><given-names>K.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Wei</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Fast, sensitive and accurate integration of single-cell data with Harmony.</article-title>
<source><italic>Nat. Methods</italic></source>
<volume>16</volume>
<fpage>1289</fpage>&#x2013;<lpage>1296</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-019-0619-0</pub-id>
<pub-id pub-id-type="pmid">31740819</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulis</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>Metric learning: a survey.</article-title>
<source><italic>Found. Trends<sup>&#xAE;</sup> Mach. Learn.</italic></source>
<volume>5</volume>
<fpage>287</fpage>&#x2013;<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1561/2200000019</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>Y.</given-names></name><name><surname>Rokach</surname><given-names>L.</given-names></name><name><surname>Shay</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>CaSTLe &#x2013; Classification of single cells by transfer learning: harnessing the power of publicly available single cell RNA sequencing experiments to annotate new experiments.</article-title>
<source><italic>PLoS One</italic></source>
<volume>13</volume>:<issue>e0205499</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0205499</pub-id>
<pub-id pub-id-type="pmid">30304022</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>R.</given-names></name><name><surname>Nazaret</surname><given-names>A.</given-names></name><name><surname>Langevin</surname><given-names>M.</given-names></name><name><surname>Samaran</surname><given-names>J.</given-names></name><name><surname>Regier</surname><given-names>J.</given-names></name><name><surname>Jordan</surname><given-names>M. I.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>A joint model of unpaired data from scRNA-seq and spatial transcriptomics for imputing missing gene expression measurements.</article-title>
<source><italic>arXiv</italic></source>
<comment>[preprint]</comment>
<volume>arXiv</volume>:<issue>1905.02269</issue>.</mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>R.</given-names></name><name><surname>Regier</surname><given-names>J.</given-names></name><name><surname>Cole</surname><given-names>M. B.</given-names></name><name><surname>Jordan</surname><given-names>M. I.</given-names></name><name><surname>Yosef</surname><given-names>N.</given-names></name></person-group> (<year>2018</year>). <article-title>Deep generative modeling for single-cell transcriptomics.</article-title>
<source><italic>Nat. Methods</italic></source>
<volume>15</volume>
<fpage>1053</fpage>&#x2013;<lpage>1058</lpage>. <pub-id pub-id-type="doi">10.1038/s41592-018-0229-2</pub-id>
<pub-id pub-id-type="pmid">30504886</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luecken</surname><given-names>M. D.</given-names></name><name><surname>Theis</surname><given-names>F. J.</given-names></name></person-group> (<year>2019</year>). <article-title>Current best practices in single-cell RNA-seq analysis: a tutorial.</article-title>
<source><italic>Mol. Syst. Biol.</italic></source>
<volume>15</volume>:<issue>e8746</issue>. <pub-id pub-id-type="doi">10.15252/msb.20188746</pub-id>
<pub-id pub-id-type="pmid">31217225</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>F.</given-names></name><name><surname>Pellegrini</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>ACTINN: automated identification of cell types in single cell RNA sequencing.</article-title>
<source><italic>Bioinformatics</italic></source>
<volume>36</volume>
<fpage>533</fpage>&#x2013;<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btz592</pub-id>
<pub-id pub-id-type="pmid">31359028</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McInnes</surname><given-names>L.</given-names></name><name><surname>Healy</surname><given-names>J.</given-names></name><name><surname>Melville</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <source><italic>UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction.</italic></source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://ui.adsabs.harvard.edu/abs/2018arXiv180203426M">https://ui.adsabs.harvard.edu/abs/2018arXiv180203426M</ext-link>
<comment>(accessed February 01, 2018)</comment>.</mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meehan</surname><given-names>C.</given-names></name><name><surname>Ebrahimian</surname><given-names>J.</given-names></name><name><surname>Moore</surname><given-names>W.</given-names></name><name><surname>Meehan</surname><given-names>S.</given-names></name></person-group> (<year>2021</year>). <source><italic>Uniform Manifold Approximation and Projection (UMAP). MATLAB Central File Exchange</italic>.</source> Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.mathworks.com/matlabcentral/fileexchange/71902">https://www.mathworks.com/matlabcentral/fileexchange/71902</ext-link></mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffitt</surname><given-names>J. R.</given-names></name><name><surname>Bambah-Mukku</surname><given-names>D.</given-names></name><name><surname>Eichhorn</surname><given-names>S. W.</given-names></name><name><surname>Vaughn</surname><given-names>E.</given-names></name><name><surname>Shekhar</surname><given-names>K.</given-names></name><name><surname>Perez</surname><given-names>J. D.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region.</article-title>
<source><italic>Science</italic></source>
<volume>362</volume>:<issue>eaau5324</issue>. <pub-id pub-id-type="doi">10.1126/science.aau5324</pub-id>
<pub-id pub-id-type="pmid">30385464</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nitzan</surname><given-names>M.</given-names></name><name><surname>Karaiskos</surname><given-names>N.</given-names></name><name><surname>Friedman</surname><given-names>N.</given-names></name><name><surname>Rajewsky</surname><given-names>N.</given-names></name></person-group> (<year>2019</year>). <article-title>Gene expression cartography.</article-title>
<source><italic>Nature</italic></source>
<volume>576</volume>
<fpage>132</fpage>&#x2013;<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1773-3</pub-id>
<pub-id pub-id-type="pmid">31748748</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>S.</given-names></name><name><surname>Shekhar</surname><given-names>K.</given-names></name><name><surname>Regev</surname><given-names>A.</given-names></name><name><surname>Schier</surname><given-names>A. F.</given-names></name></person-group> (<year>2018</year>). <article-title>Comprehensive identification and spatial mapping of habenular neuronal types using single-Cell RNA-Seq.</article-title>
<source><italic>Curr. Biol.</italic></source>
<volume>28</volume>
<fpage>1052</fpage>&#x2013;<lpage>1065.e1057</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2018.02.040</pub-id>
<pub-id pub-id-type="pmid">29576475</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>G.</given-names></name><name><surname>Suo</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>F.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Spatial transcriptome for the molecular annotation of lineage fates and cell identity in mid-gastrula mouse embryo.</article-title>
<source><italic>Dev. Cell</italic></source>
<volume>36</volume>
<fpage>681</fpage>&#x2013;<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2016.02.020</pub-id>
<pub-id pub-id-type="pmid">27003939</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puram</surname><given-names>S. V.</given-names></name><name><surname>Tirosh</surname><given-names>I.</given-names></name><name><surname>Parikh</surname><given-names>A. S.</given-names></name><name><surname>Patel</surname><given-names>A. P.</given-names></name><name><surname>Yizhak</surname><given-names>K.</given-names></name><name><surname>Gillespie</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Single-Cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer.</article-title>
<source><italic>Cell</italic></source>
<volume>171</volume>
<fpage>1611</fpage>&#x2013;<lpage>1624.e1624</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.10.044</pub-id>
<pub-id pub-id-type="pmid">29198524</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriques</surname><given-names>S. G.</given-names></name><name><surname>Stickels</surname><given-names>R. R.</given-names></name><name><surname>Goeva</surname><given-names>A.</given-names></name><name><surname>Martin</surname><given-names>C. A.</given-names></name><name><surname>Murray</surname><given-names>E.</given-names></name><name><surname>Vanderburg</surname><given-names>C. R.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution.</article-title>
<source><italic>Science</italic></source>
<volume>363</volume>
<fpage>1463</fpage>&#x2013;<lpage>1467</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaw1219</pub-id>
<pub-id pub-id-type="pmid">30923225</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>A. B.</given-names></name><name><surname>Roco</surname><given-names>C. M.</given-names></name><name><surname>Muscat</surname><given-names>R. A.</given-names></name><name><surname>Kuchina</surname><given-names>A.</given-names></name><name><surname>Sample</surname><given-names>P.</given-names></name><name><surname>Yao</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding.</article-title>
<source><italic>Science</italic></source>
<volume>360</volume>
<fpage>176</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1126/science.aam8999</pub-id>
<pub-id pub-id-type="pmid">29545511</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satija</surname><given-names>R.</given-names></name><name><surname>Farrell</surname><given-names>J. A.</given-names></name><name><surname>Gennert</surname><given-names>D.</given-names></name><name><surname>Schier</surname><given-names>A. F.</given-names></name><name><surname>Regev</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Spatial reconstruction of single-cell gene expression data.</article-title>
<source><italic>Nat. Biotechnol.</italic></source>
<volume>33</volume>
<fpage>495</fpage>&#x2013;<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3192</pub-id><pub-id pub-id-type="pmid">25867923</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Lubeck</surname><given-names>E.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>In situ transcription profiling of single cells reveals spatial organization of cells in the mouse hippocampus.</article-title>
<source><italic>Neuron</italic></source>
<volume>92</volume>
<fpage>342</fpage>&#x2013;<lpage>357</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2016.10.001</pub-id>
<pub-id pub-id-type="pmid">27764670</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprague</surname><given-names>J.</given-names></name><name><surname>Bayraktaroglu</surname><given-names>L.</given-names></name><name><surname>Clements</surname><given-names>D.</given-names></name><name><surname>Conlin</surname><given-names>T.</given-names></name><name><surname>Fashena</surname><given-names>D.</given-names></name><name><surname>Frazer</surname><given-names>K.</given-names></name><etal/></person-group> (<year>2006</year>). <article-title>The zebrafish information network: the zebrafish model organism database.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>34</volume>
<fpage>D581</fpage>&#x2013;<lpage>D585</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkj086</pub-id>
<pub-id pub-id-type="pmid">16381936</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>St&#xE5;hl</surname><given-names>P. L.</given-names></name><name><surname>Salm&#xE9;n</surname><given-names>F.</given-names></name><name><surname>Vickovic</surname><given-names>S.</given-names></name><name><surname>Lundmark</surname><given-names>A.</given-names></name><name><surname>Navarro</surname><given-names>J. F.</given-names></name><name><surname>Magnusson</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics.</article-title>
<source><italic>Science</italic></source>
<volume>353</volume>
<fpage>78</fpage>&#x2013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf2403</pub-id>
<pub-id pub-id-type="pmid">27365449</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname><given-names>T.</given-names></name><name><surname>Butler</surname><given-names>A.</given-names></name><name><surname>Hoffman</surname><given-names>P.</given-names></name><name><surname>Hafemeister</surname><given-names>C.</given-names></name><name><surname>Papalexi</surname><given-names>E.</given-names></name><name><surname>Mauck</surname><given-names>W. M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Comprehensive integration of single-cell data.</article-title>
<source><italic>Cell</italic></source>
<volume>177</volume>
<fpage>1888</fpage>&#x2013;<lpage>1902.e1821</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
<pub-id pub-id-type="pmid">31178118</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svensson</surname><given-names>V.</given-names></name><name><surname>Vento-Tormo</surname><given-names>R.</given-names></name><name><surname>Teichmann</surname><given-names>S. A.</given-names></name></person-group> (<year>2018</year>). <article-title>Exponential scaling of single-cell RNA-seq in the past decade.</article-title>
<source><italic>Nat. Protoc.</italic></source>
<volume>13</volume>
<fpage>599</fpage>&#x2013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">29494575</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>Y.</given-names></name><name><surname>Cahan</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>SingleCellNet: a computational tool to classify single cell RNA-Seq data across platforms and across species.</article-title>
<source><italic>Cell Syst.</italic></source>
<volume>9</volume>
<fpage>207</fpage>&#x2013;<lpage>213.e202</lpage>.<pub-id pub-id-type="pmid">31377170</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tasic</surname><given-names>B.</given-names></name><name><surname>Menon</surname><given-names>V.</given-names></name><name><surname>Nguyen</surname><given-names>T. N.</given-names></name><name><surname>Kim</surname><given-names>T. K.</given-names></name><name><surname>Jarsky</surname><given-names>T.</given-names></name><name><surname>Yao</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Adult mouse cortical cell taxonomy revealed by single cell transcriptomics.</article-title>
<source><italic>Nat. Neurosci.</italic></source>
<volume>19</volume>
<fpage>335</fpage>&#x2013;<lpage>346</lpage>.<pub-id pub-id-type="pmid">26727548</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="book"><collab>The Mathworks, Inc</collab> (<year>2019a</year>). <source><italic>MATLAB Deep Learning Toolbox Release 2019b.</italic></source>
<publisher-loc>Natick</publisher-loc>: <publisher-name>The Mathworks, Inc</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="book"><collab>The Mathworks, Inc</collab> (<year>2019b</year>). <source><italic>MATLAB Parallel Toolbox Release 2019b.</italic></source>
<publisher-loc>Natick</publisher-loc>: <publisher-name>The Mathworks, Inc</publisher-name>.</mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>F.</given-names></name><name><surname>Yanai</surname><given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Moana: a robust and scalable cell type classification framework for single-cell RNA-Seq data.</article-title>
<source><italic>bioRxiv</italic></source>
<comment>[preprint]</comment>. <pub-id pub-id-type="doi">10.1101/456129</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Karikomi</surname><given-names>M.</given-names></name><name><surname>Maclean</surname><given-names>A. L.</given-names></name><name><surname>Nie</surname><given-names>Q.</given-names></name></person-group> (<year>2019</year>). <article-title>Cell lineage and communication network inference via optimization for single-cell transcriptomics.</article-title>
<source><italic>Nucleic Acids Res.</italic></source>
<volume>47</volume>:<issue>e66</issue>.</mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Allen</surname><given-names>W. E.</given-names></name><name><surname>Wright</surname><given-names>M. A.</given-names></name><name><surname>Sylwestrak</surname><given-names>E. L.</given-names></name><name><surname>Samusik</surname><given-names>N.</given-names></name><name><surname>Vesuna</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Three-dimensional intact-tissue sequencing of single-cell transcriptional states.</article-title>
<source><italic>Science</italic></source>
<volume>361</volume>:<issue>eaat5691</issue>.</mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>K. Q.</given-names></name><name><surname>Saul</surname><given-names>L. K.</given-names></name></person-group> (<year>2009</year>). <article-title>Distance metric learning for large margin nearest neighbor classification.</article-title>
<source><italic>J. Mach. Learn. Res.</italic></source>
<volume>10</volume>
<fpage>207</fpage>&#x2013;<lpage>244</lpage>.</mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welch</surname><given-names>J. D.</given-names></name><name><surname>Kozareva</surname><given-names>V.</given-names></name><name><surname>Ferreira</surname><given-names>A.</given-names></name><name><surname>Vanderburg</surname><given-names>C.</given-names></name><name><surname>Martin</surname><given-names>C.</given-names></name><name><surname>Macosko</surname><given-names>E. Z.</given-names></name></person-group> (<year>2019</year>). <article-title>Single-Cell multi-omic integration compares and contrasts features of brain cell identity.</article-title>
<source><italic>Cell</italic></source>
<volume>177</volume>
<fpage>1873</fpage>&#x2013;<lpage>1887.e1817</lpage>.<pub-id pub-id-type="pmid">31178122</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Xavier</surname><given-names>G.</given-names></name><name><surname>Yoshua</surname><given-names>B.</given-names></name></person-group> (<year>2010</year>). <article-title>&#x201C;Understanding the difficulty of training deep feedforward neural networks: PMLR,&#x201D; in</article-title>
<source><italic>Proceedings of the 13th International Conference on Artificial Intelligence and Statistics, JMLR Workshop and Conference Proceedings</italic></source>, <volume>Vol. 9</volume> (<publisher-loc>Sardinia</publisher-loc>: <publisher-name>Chia Laguna Resort</publisher-name>), <fpage>249</fpage>&#x2013;<lpage>256</lpage>.</mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>G.-C.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Elowitz</surname><given-names>M.</given-names></name><name><surname>Enver</surname><given-names>T.</given-names></name><name><surname>Fan</surname><given-names>G.</given-names></name><name><surname>Guo</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Challenges and emerging directions in single-cell analysis.</article-title>
<source><italic>Genome Biol.</italic></source>
<volume>18</volume>:<issue>84</issue>.</mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>Q.</given-names></name><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Dries</surname><given-names>R.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Yuan</surname><given-names>G.-C.</given-names></name></person-group> (<year>2018</year>). <article-title>Identification of spatially associated subpopulations by combining scRNAseq and sequential fluorescence in situ hybridization data.</article-title>
<source><italic>Nat. Biotechnol.</italic></source>
<volume>36</volume>
<fpage>1183</fpage>&#x2013;<lpage>1190</lpage>.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Commun</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id>
      <journal-title-group>
        <journal-title>Nature Communications</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2041-1723</issn>
      <publisher>
        <publisher-name>Nature Publishing Group UK</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34489413</article-id>
      <article-id pub-id-type="pmc">8421386</article-id>
      <article-id pub-id-type="publisher-id">25653</article-id>
      <article-id pub-id-type="doi">10.1038/s41467-021-25653-w</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Miao</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Atmanli</surname>
            <given-names>Ayhan</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morales</surname>
            <given-names>Maria Gabriela</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tan</surname>
            <given-names>Wei</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4083-841X</contrib-id>
          <name>
            <surname>Chen</surname>
            <given-names>Kenian</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xiao</surname>
            <given-names>Xue</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5815-4457</contrib-id>
          <name>
            <surname>Xu</surname>
            <given-names>Lin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0257-1889</contrib-id>
          <name>
            <surname>Liu</surname>
            <given-names>Ning</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7568-410X</contrib-id>
          <name>
            <surname>Bassel-Duby</surname>
            <given-names>Rhonda</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1151-8262</contrib-id>
          <name>
            <surname>Olson</surname>
            <given-names>Eric N.</given-names>
          </name>
          <address>
            <email>eric.olson@utsouthwestern.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>Department of Molecular Biology, the Hamon Center for Regenerative Science and Medicine, </institution><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX USA </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, </institution><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX USA </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.267313.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9482 7121</institution-id><institution>Quantitative Biomedical Research Center, Department of Population &amp; Data Sciences and Department of Pediatrics, </institution><institution>University of Texas Southwestern Medical Center, </institution></institution-wrap>Dallas, TX USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>6</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>6</day>
        <month>9</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>5270</elocation-id>
      <history>
        <date date-type="received">
          <day>18</day>
          <month>1</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>8</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2021</copyright-statement>
        <license>
          <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x2019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x2019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p id="Par1">Following injury, cells in regenerative tissues have the ability to regrow. The mechanisms whereby regenerating cells adapt to injury-induced stress conditions and activate the regenerative program remain to be defined. Here, using the mammalian neonatal heart regeneration model, we show that Nrf1, a stress-responsive transcription factor encoded by the Nuclear Factor Erythroid 2 Like 1 <italic>(Nfe2l1</italic>) gene, is activated in regenerating cardiomyocytes. Genetic deletion of <italic>Nrf1</italic> prevented regenerating cardiomyocytes from activating a transcriptional program required for heart regeneration. Conversely, Nrf1 overexpression protected the adult mouse heart from ischemia/reperfusion (I/R) injury. Nrf1 also protected human induced pluripotent stem cell-derived cardiomyocytes from doxorubicin-induced cardiotoxicity and other cardiotoxins. The protective function of Nrf1 is mediated by a dual stress response mechanism involving activation of the proteasome and redox balance. Our findings reveal that the adaptive stress response mechanism mediated by Nrf1 is required for neonatal heart regeneration and confers cardioprotection in the adult heart.</p>
      </abstract>
      <abstract id="Abs2" abstract-type="web-summary">
        <p id="Par2">Following injury, cells in regenerative tissues can regrow, but how they adapt to injury conditions to regenerate the tissue is unclear. Here the authors identify a stress-responsive and cardioprotective factor Nrf1 that is critical for neonatal heart regeneration.</p>
      </abstract>
      <kwd-group kwd-group-type="npg-subject">
        <title>Subject terms</title>
        <kwd>Transcriptomics</kwd>
        <kwd>Cardiac regeneration</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000050</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>HL-130253</award-id>
          <award-id>HL-138426</award-id>
          <award-id>HD-087351</award-id>
          <award-id>HL-130253</award-id>
          <award-id>HD-087351</award-id>
          <principal-award-recipient>
            <name>
              <surname>Bassel-Duby</surname>
              <given-names>Rhonda</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>Eric N.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000928</institution-id>
              <institution>Welch Foundation</institution>
            </institution-wrap>
          </funding-source>
          <award-id>1-0025</award-id>
          <principal-award-recipient>
            <name>
              <surname>Olson</surname>
              <given-names>Eric N.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)</institution>
          </funding-source>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000069</institution-id>
              <institution>U.S. Department of Health &amp; Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</institution>
            </institution-wrap>
          </funding-source>
          <award-id>AR-067294</award-id>
          <principal-award-recipient>
            <name>
              <surname>Olson</surname>
              <given-names>Eric N.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution-wrap>
              <institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001674</institution-id>
              <institution>Fondation Leducq</institution>
            </institution-wrap>
          </funding-source>
          <award-id>Transatlantic Networks of Excellence</award-id>
          <principal-award-recipient>
            <name>
              <surname>Olson</surname>
              <given-names>Eric N.</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2021</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p id="Par3">Heart disease represents a leading cause of morbidity and mortality in the developed world. Common types of heart disease include coronary artery disease, hypertension, and chemotherapy, all of which lead to loss or dysfunction of cardiac muscle. Preventing cardiomyocytes from death (cardioprotection) and replenishing the lost myocardium (regeneration) are the central goals for heart repair.</p>
      <p id="Par4">The adult mammalian heart lacks the ability to regenerate and, instead, responds to injury by replacing lost tissue with a non-contractile fibrotic scar, resulting in pathological remodeling that can eventually lead to heart failure<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>. In contrast, the heart of neonatal mice, within the first week after birth, possesses the ability to regenerate lost myocardium, mediated by the proliferation of cardiomyocytes<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. The molecular mechanisms underpinning the neonatal regenerative response and its absence in later life remain to be defined. Using single-nucleus RNA sequencing (snRNA-seq), we previously showed that neonatal regenerating cardiomyocytes activate a unique transcriptional response upon injury<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Interestingly, besides cell-cycle activation, this regenerative cell population also upregulates cell survival pathways, suggesting a coregulation between cardioprotection and heart regeneration. Although cardioprotection and heart regeneration have been traditionally thought to involve separate mechanisms, protection of cardiomyocytes from injury or disease stimuli is a prerequisite to any meaningful regenerative response.</p>
      <p id="Par5">Here, we sought to study how neonatal cardiomyocytes cope with injury-induced stress to regenerate damaged myocardium and whether the underlying mechanisms could be leveraged to promote heart regeneration and repair in adulthood. By spatial transcriptomic profiling, we visualized regenerative cardiomyocytes reconstituting damaged myocardium after ischemic injury and found that they are marked by the expression of Nrf1, an ER-bound stress-responsive transcription factor. SnRNA-seq revealed that genetic deletion of <italic>Nrf1</italic> prevented neonatal cardiomyocytes from activating a transcriptional program required for heart regeneration. Conversely, overexpression of Nrf1 using AAV9 gene therapy protects the adult mouse heart from ischemia/reperfusion (I/R) injury. The protective function of Nrf1 is mediated by the proteasomal activity and antioxidant response, including activation of the detoxifying enzyme Hmox1. Nrf1 also protects human-induced pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) from cardiotoxicity induced by the chemotherapeutic drug doxorubicin (Dox) and other toxic agents. Taken together, our study uncovers a unique adaptive mechanism activated in response to injury that maintains the tissue homeostatic balance required for heart regeneration. Reactivating this mechanism in the adult heart represents a potential therapeutic approach for cardiac repair.</p>
    </sec>
    <sec id="Sec2" sec-type="results">
      <title>Results</title>
      <sec id="Sec3">
        <title>The spatial transcriptome of the regenerating mouse heart</title>
        <p id="Par6">Regenerating cardiomyocytes in neonatal hearts are derived from preexisting cardiomyocytes instead of cardiac stem cells<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. Using snRNA-seq, we previously identified a population of cardiomyocytes (termed CM4) in the neonatal regenerative heart that enters the cell cycle after injury<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. CM4 cells exhibited an embryonic gene signature marked by the expression of <italic>Acta2</italic> (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a</xref>)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, a smooth muscle actin isoform that is transiently expressed in the embryonic heart<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Using an ultrasensitive and semi-quantitative RNA detection method (RNA-scope)<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>, we found that ~30% of cardiomyocytes in the regenerative heart at postnatal day (P) 1 showed enriched <italic>Acta2</italic> expression (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1b, c</xref>). This group of high <italic>Acta2</italic>-expressing cardiomyocytes was not detected in nonregenerative hearts at P8 (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c, d</xref>), validating our previous observation that CM4 cells disappear as the heart loses its ability to regenerate<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.<fig id="Fig1"><label>Fig. 1</label><caption><title>Nrf1 is expressed in regenerative CM4 cardiomyocytes.</title><p><bold>a</bold> Violin plot showing the expression of <italic>Acta2</italic> in CM1&#x2013;CM5 cardiomyocyte populations. Expression levels are shown as reads per 10k counts. <bold>b</bold>
<italic>Acta2</italic> and <italic>Tnnt2</italic> RNA transcripts detected by RNA-scope probes in the left ventricular myocardium on a transverse section of P1 hearts. Scale bar, 20&#x2009;&#x3BC;m. <bold>c</bold> Quantification of <italic>Acta2</italic> transcript levels in cardiomyocytes from P1 and P8 heart; <italic>n</italic>&#x2009;=&#x2009;29&#x2013;34 cardiomyocytes were quantified. <bold>d</bold>
<italic>Acta2</italic> and <italic>Tnnt2</italic> RNA transcripts detected by RNA-scope probes in the left ventricular myocardium on a transverse section of P8 hearts. Scale bar, 20&#x2009;&#x3BC;m. <bold>e</bold> Schematic diagram showing the spatial transcriptome analysis of heart sections to identify anatomic locations of cardiac cell type populations. <bold>f</bold> Hematoxylin and eosin (H&amp;E) image of a heart transverse section collected at 7-day post P1 MI. Left and right ventricles are indicated. Black arrowheads depict fibrotic tissue; Scale bar, 500&#x2009;&#x3BC;m. <bold>g</bold> Left: cell type composition shown in pie-charts for individual spatial spots mapped onto the heart section with H&amp;E staining shown in (<bold>f</bold>). Right: the boxed region is shown in high magnification overlayed with the H&amp;E image to highlight the fibrotic region; Scale bar, 200&#x2009;&#x3BC;m. <bold>h</bold>&#x2013;<bold>m</bold> Anatomic localization of endocardial cells (<bold>h</bold>), immune cells (<bold>i</bold>), fibroblasts (<bold>j</bold>), CM1 (<bold>k</bold>), CM5 (<bold>l</bold>), and CM4 (<bold>m</bold>) on the same heart section in (<bold>f</bold>). Color scale indicates cell type ratio from 0 to 1. Endocardium is outlined by black dash lines, and infarct region, which is identified by the location of suture, is outlined in white; Scale bar, 500&#x2009;&#x3BC;m. <bold>n</bold> Expression correlation plots between <italic>Nrf1</italic>, <italic>Acta2</italic>, and <italic>Mki67</italic> in individual cardiomyocytes from our previous snRNA-seq data (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130699">GSE130699</ext-link>). <italic>Nrf1</italic> positively correlates with <italic>Acta2</italic> (Spearman&#x2019;s coefficient&#x2009;=&#x2009;0.91). Color scale represents the expression level of <italic>Mki67</italic>. Expression levels are shown as reads per 10k counts. <bold>o</bold>, <bold>p</bold>
<italic>Nrf1</italic> and <italic>Tnnt2</italic> RNA transcripts detected by RNA-scope probes in the left ventricular myocardium on transverse sections of P1 hearts (<bold>o</bold>) and P8 hearts (<bold>p</bold>). Scale bar, 20&#x2009;&#x3BC;m. <bold>q</bold> Quantification of <italic>Nrf1</italic> expression levels in cardiomyocytes from P1 and P8 hearts; <italic>n</italic>&#x2009;=&#x2009;30 cardiomyocytes were quantified for each group. <bold>f</bold>&#x2013;<bold>m</bold> experiments were repeated independently twice with similar results. ***<italic>p</italic>&#x2009;&lt;&#x2009;0.0001, Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>c</bold> and <bold>q</bold> arb. units. arbitrary units. <bold>e</bold> and <bold>g</bold> EC endothelial cells, EndoEC endocardial cells, FB fibroblasts, EPI epicardial cells.</p></caption><graphic xlink:href="41467_2021_25653_Fig1_HTML" id="d32e595"/></fig></p>
        <p id="Par7">To visualize CM4 cells during heart regeneration, we analyzed the spatial transcriptome of heart sections collected at 3 and 7 days after myocardial infarction (MI) or Sham surgery performed at P1. Heart sections at 200&#x2009;&#x3BC;m below the ligation of the left anterior descending artery (LAD) in MI hearts or the equivalent position in sham hearts were used for the analysis. Using the Visium platform offered by 10&#xD7; Genomics, we captured on average 672 spatial spots for each section and 5549 detected genes per spot (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1a</xref>). Because each spot captures multiple cells, to deconvolute the underlying composition of cell types we integrated the spatial transcriptome data with our previous snRNA-seq datasets using a computational approach that identifies shared cell states (see the &#x201C;Methods&#x201D; section)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. The resulting data calculated the fraction of each cell type per given spot and mapped the anatomic distribution of cardiac cell types onto heart sections, which was further corroborated by the spatial expression of marker genes (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e&#x2013;g</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1b and c</xref>)<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Our analysis correctly identified the known anatomic localization of endocardial cells (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1h</xref>) and revealed a transient immune cell infiltration and accumulation of fibroblasts in the infarct region at day-3 and day-7 post-MI, respectively (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1i, j</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>), consistent with our previous studies<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. CM1 cells, the most abundant cardiomyocyte population, were detected across the entire myocardium (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1k</xref>), whereas CM5 cells, a group of injury-induced cardiomyocytes, were localized in the border zone adjacent to the injured tissue (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1l</xref>), consistent with previous immunohistochemistry results<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Importantly, we found that, while CM4 cells were sporadically localized in the Sham heart (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>), they became enriched in the infarct region and were proximal to the fibrotic tissue in MI hearts (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1m</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">2</xref>). The localization of CM4 cells in the infarct myocardium that is undergoing regrowth, along with their immature and proliferative transcriptional signatures<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, provide strong evidence that they represent regenerating cardiomyocytes that reconstitute the damaged myocardium.</p>
      </sec>
      <sec id="Sec4">
        <title>Regenerative cardiomyocytes express high levels of <italic>Nrf1</italic></title>
        <p id="Par8">Our previous analysis showed that, besides cell-cycle activation, CM4 cells also upregulate cell survival pathways following ischemic injury<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Indeed, protein poly-ubiquitination and proteasomal activity are maintained in the P1 regenerative heart after MI (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3</xref>), indicating preserved proteostasis during heart regeneration. This contrasts with the P8 non-regenerative heart, which showed increased ubiquitinated proteins and decreased proteasomal activity after MI, reflecting proteolytic stress (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">3</xref>).</p>
        <p id="Par9">Recent studies showed that Nrf1 (encoded by the <italic>Nfe2l1</italic> gene) functions as a guardian of tissue homeostasis by regulating proteostasis and redox balance in response to cellular stress<sup><xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref></sup>. Nrf1 belongs to the Cap&#x2019;N&#x2019;Collar (CNC) family of leucine zipper transcription factors, which include Nrf1, Nrf2, Nrf3, and Nfe2<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>, and is the most highly expressed member in the heart with enriched expression in cardiomyocytes (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4a, b</xref>). However, despite the high abundance, its cardiac functions are entirely unknown. From our previous snRNA-seq data, we found that <italic>Nrf1</italic> expression is enriched in CM4 cardiomyocytes (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4c</xref>) and is upregulated after MI<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Further analysis showed that the expression profile of <italic>Nrf1</italic> correlates with the expression of the CM4 marker <italic>Acta2</italic>, as well as with the cell-cycle genes <italic>Mki67</italic> and <italic>Ccnb2</italic>, in individual cardiomyocytes (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1n</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4d</xref>). Using RNA-scope, we verified that <italic>Nrf1</italic> transcripts are co-expressed with <italic>Acta2</italic> in CM4 cells (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">4e, f</xref>) and are expressed at higher levels in P1 compared to P8 cardiomyocytes (Fig.<xref rid="Fig1" ref-type="fig">1o&#x2013;q</xref>), suggesting a potential role of Nrf1 in neonatal heart regeneration.</p>
      </sec>
      <sec id="Sec5">
        <title>Nrf1 is required for neonatal heart regeneration</title>
        <p id="Par10">Mice with a cardiomyocyte-specific knockout of <italic>Nrf1</italic> (Nrf1 cKO), generated by crossing Nrf1<sup>fl/fl</sup> mice with &#x3B1;MHC-Cre transgenic mice, exhibited no aberrations in cardiac morphology or function at 2-month of age (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5a, b</xref>). To determine whether Nrf1 was required for neonatal heart regeneration, we performed MI on Nrf1 cKO and Nrf1<sup>fl/fl</sup> (control) mice at P3, followed by echocardiography and histological analyses at P28 (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>). While control hearts regenerated as expected, Nrf1 cKO hearts showed decreased cardiac function, measured as fractional shortening (FS), ejection fraction (EF), and myocardial wall motion (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b, c,</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5c</xref>), as well as increased fibrotic scarring (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2d</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">5d</xref>). Cardiomyocyte proliferation at 3-day post-MI was also significantly decreased in Nrf1 cKO hearts (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2e, f</xref>), underlying their impaired heart regeneration. Additionally, proteasomal activity was notably reduced in Nrf1 cKO hearts (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2g</xref>), consistent with the role of Nrf1 in regulating the proteasome<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>.<fig id="Fig2"><label>Fig. 2</label><caption><title>Nrf1 deletion impairs neonatal heart regeneration.</title><p><bold>a</bold> Illustration showing timeline of MI and Sham surgeries performed at P3 and subsequent days of sample collection. <bold>b</bold>, <bold>c</bold> Fractional shortening (<bold>b</bold>) and ejection fraction (<bold>c</bold>) of Nrf1<sup>fl/fl</sup> and Nrf1 cKO mouse hearts at 25 days after MI or Sham surgery; <italic>n</italic>&#x2009;=&#x2009;4 animals for Sham groups and <italic>n</italic>&#x2009;=&#x2009;7&#x2013;8 animals for MI groups; **<italic>p</italic>&#x2009;=&#x2009;0.0022 (<bold>b</bold>), **<italic>p</italic>&#x2009;=&#x2009;0.0009 (<bold>c</bold>) by Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>d</bold> Masson&#x2019;s trichrome staining showing fibrotic scarring in Nrf1<sup>fl/fl</sup> and Nrf1 cKO mouse hearts at 25-day after MI; similar results were observed in six animals; Scale bar, 200&#x2009;&#x3BC;m. <bold>e</bold> Immunohistochemistry showing pH3<sup>+</sup> cardiomyocytes (cTnT<sup>+</sup>), marked by arrows, in heart sections collected from Nrf1 cKO and Nrf1<sup>fl/fl</sup> mice 3-day post-MI; Scale bar, 50&#x2009;&#x3BC;m. <bold>f</bold> Quantification of pH3<sup>+</sup> cardiomyocytes (cTnT<sup>+</sup>) in heart sections from (<bold>e</bold>); <italic>n</italic>&#x2009;=&#x2009;12 animals for WT and <italic>n</italic>&#x2009;=&#x2009;11 animals for Nrf1 cKO, **<italic>p</italic>&#x2009;=&#x2009;0.0034 by Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>g</bold> Chymotrypsin-like activity of the proteasome in hearts from Nrf1 cKO and Nrf1<sup>fl/fl</sup> mice at P4. arb. units, arbitrary units; <italic>n</italic>&#x2009;=&#x2009;6 animals for each group; *<italic>p</italic>&#x2009;=&#x2009;0.0373 by Student&#x2019;s <italic>t</italic>-test one-tailed. <bold>h</bold> UMAP visualization of cardiomyocyte clusters colored by identity. CM1 and CM3 were merged as a single cluster due to their transcriptome similarity. <bold>i</bold> Fraction of cardiomyocyte populations in Nrf1<sup>fl/fl</sup> and Nrf1 cKO hearts in MI or Sham conditions; <italic>n</italic>&#x2009;=&#x2009;4&#x2013;6 animals for each group examined over 1 independent experiment; **<italic>p</italic>&#x2009;=&#x2009;4.49E<sup>&#x2212;16</sup> compared to WT-Sham, ##<italic>p</italic>&#x2009;=&#x2009;5.05E<sup>&#x2212;31</sup> compared to KO-Sham; Chi-squared test. <bold>j</bold> Representative images showing TUNEL staining on heart sections from Nrf1 cKO and Nrf1<sup>fl/fl</sup> mice at 1-day post-MI; Scale bar, 500&#x2009;&#x3BC;m. <bold>k</bold> Quantification of TUNEL positive area in heart sections collected at 200, 400, and 600&#x2009;&#x3BC;m below the ligation from Nrf1 cKO and Nrf1<sup>fl/fl</sup> mice at 1-day post-MI; <italic>n</italic>&#x2009;=&#x2009;3 animals for each group; *<italic>p</italic>&#x2009;=&#x2009;0.039 (200&#x2009;&#x3BC;m); <italic>p</italic>&#x2009;=&#x2009;0.025 (400&#x2009;&#x3BC;m), <italic>p</italic>&#x2009;=&#x2009;0.047 (600&#x2009;&#x3BC;m), Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>l</bold> Volcano plot showing fold-change and <italic>p</italic>-value of genes up-regulated (red) and down-regulated (blue) in CM4 cells of Nrf1 KO hearts compared to CM4 cells in control hearts at 1-day post-MI; <italic>p</italic>-adjust&#x2009;&lt;&#x2009;0.1 and fold-change&#x2009;&gt;&#x2009;1.5 were used for cutoffs; <italic>p</italic>-adjust values are calculated by Wilcoxon rank-sum test two-tailed. Top enriched GO terms are shown (right). <bold>m</bold> Quantification of ROS levels in Nrf1 cKO and Nrf1<sup>fl/fl</sup> mice at 3-day post-MI or Sham; <italic>n</italic>&#x2009;=&#x2009;3 animals for each group. WT-MI vs Nrf1 cKO-MI, *<italic>p</italic>&#x2009;=&#x2009;0.015; Nrf1 cKO-Sham vs. Nrf1 cKO-MI, *<italic>p</italic>&#x2009;=&#x2009;0.022, by Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>b</bold>, <bold>c</bold>, <bold>f</bold>, <bold>g</bold>, <bold>k</bold>, <bold>m</bold> results are shown as mean&#x2009;&#xB1;&#x2009;s.e.m.; n.s. not significant.</p></caption><graphic xlink:href="41467_2021_25653_Fig2_HTML" id="d32e995"/></fig></p>
        <p id="Par11">Neonatal cardiomyocytes are heterogeneous and comprised of five subpopulations (CM1&#x2013;CM5)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. To understand which cardiomyocyte population(s) account for the impaired heart regeneration in Nrf1 cKO mice, we performed snRNA-seq on cardiomyocytes from Nrf1 cKO and control hearts at 1-day post-MI or Sham surgery performed at P3. We sequenced 8585 cardiomyocytes and annotated the subpopulations based on the expression of their marker genes (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2h</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6</xref>)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. While the Nrf1 cKO and control hearts had comparable cardiomyocyte composition in the Sham samples, after MI, the Nrf1 cKO hearts showed a significant increase of CM5 cells&#x2014;the cardiomyocytes that respond to injury by apoptosis and hypertrophy<sup><xref ref-type="bibr" rid="CR5">5</xref></sup> (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2i</xref>). The enhanced induction of CM5 cells in the Nrf1 cKO hearts suggested increased cell death after MI. Indeed, TUNEL staining on heart samples collected at 1-day post-MI revealed a greater myocardial loss in the Nrf1 cKO hearts compared to controls (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2j, k</xref>).</p>
        <p id="Par12">To understand how <italic>Nrf1</italic> deletion affects the ability of CM4 cells to regenerate, we performed differentially expressed gene (DEG) analysis on CM4 cells in the MI samples from Nrf1 cKO and control hearts (Supplementary Data&#xA0;<xref rid="MOESM4" ref-type="media">1</xref>). We found that the oxidative phosphorylation (OXPHOS) pathway, which is downregulated in wild-type (WT) CM4 cells during heart regeneration<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, was instead upregulated in Nrf1 cKO hearts (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2l</xref>). Direct measurement of reactive oxygen species (ROS) by 2&#x2032;,7&#x2032;-dichlorodihydrofluorescein diacetate (DCFDA) oxidation assay showed a significant increase of ROS in Nrf1 cKO MI hearts compared to control MI hearts (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2m</xref>). In addition, <italic>Nppa</italic> and <italic>Nppb</italic>, markers of cardiac stress, were both upregulated by <italic>Nrf1</italic> deletion. Down-regulated genes in Nrf1 cKO hearts encode proteins that are associated with actin filament-based processes, the PI3K&#x2013;AKT signaling pathway, and the Wnt signaling pathway, and included known Nrf1 target genes, such as <italic>Hmox1</italic> and <italic>Psmd1</italic>, which encode a detoxifying enzyme and a proteasome subunit, respectively (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2l</xref>)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>. Notably, both the actin filament-based processes and the PI3K&#x2013;AKT signaling pathway were activated in CM4 cells of WT hearts during heart regeneration<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. Therefore, <italic>Nrf1</italic> deletion increased OXPHOS metabolism, which is known to inhibit cardiomyocyte proliferation<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>, and prevented CM4 cells from initiating the transcriptional response required for heart regeneration.</p>
      </sec>
      <sec id="Sec6">
        <title>Nrf1 overexpression protects adult hearts from I/R injury</title>
        <p id="Par13">To study whether Nrf1 overexpression might protect adult hearts against ischemia/reperfusion (I/R) injury, we generated cardio-trophic adeno-associated viral (AAV) vectors that expressed Nrf1 (AAV9-Nrf1) or TdTomato (control) (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">7a</xref>)<sup><xref ref-type="bibr" rid="CR20">20</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>. We ligated the LAD artery for 45&#x2009;min followed by 24&#x2009;h of reperfusion on 8-week-old mice pre-injected with AAV9 at P4 (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3b</xref>). We analyzed infarct size at the end of reperfusion by 2,3,5-Triphenyltetrazolium chloride (TTC) staining and cardiac function on three consecutive weeks after the surgery. At the baseline level, AAV-Nrf1 hearts had similar cardiac function and proportions of cardiac fibroblasts as well as tissue-resident immune cells compared to AAV9-TdTomato hearts (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">7b&#x2013;e</xref>). However, after injury, AAV9-Nrf1 significantly reduced the infarct area from 52% to 40% (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3c, d</xref>) and improved FS and EF after I/R (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3e, f</xref>). Additionally, the increase of diastolic and systolic volume of the left ventricle after MI, as seen in the control hearts, was profoundly attenuated in AAV9-Nrf1 treated mice (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3g</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8a</xref>), which showed reduced cardiac dilation and remodeling. Masson&#x2019;s trichrome staining at 3 weeks post-IR further revealed reduced fibrotic scarring in AAV9-Nrf1 mice (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3h, i</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">8b</xref>). Together, these data indicate that overexpression of Nrf1 in vivo confers a protective effect in adult hearts following ischemic injury.<fig id="Fig3"><label>Fig. 3</label><caption><title>Nrf1 overexpression protects cardiomyocytes against I/R and cardiotoxin injury.</title><p><bold>a</bold> Western blot analysis showing Nrf1 expression in hearts from mice at 4-week after AAV9-TdTomato and AAV9-Nrf1 injection at P4; experiments were repeated independently twice with similar results. <bold>b</bold> Illustration of a timeline showing the experimental design for AAV9 injection and time points of sample collections. <bold>c</bold> TTC staining showing infarct size on transverse heart sections collected at the end of reperfusion; Scale bar, 500&#x2009;&#x3BC;m. <bold>d</bold> Quantification of infarct area in sections from (<bold>c</bold>); AAV9-TdTomato, <italic>n</italic>&#x2009;=&#x2009;6; AAV9-Nrf1, <italic>n</italic>&#x2009;=&#x2009;5; *<italic>p</italic>&#x2009;=&#x2009;0.0183, by Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>e</bold>&#x2013;<bold>g</bold> Fractional shortening (<bold>e</bold>), ejection fraction (<bold>f</bold>), and systolic volume (<bold>g</bold>) of left ventricles from AAV9-TdTomato and AAV9-Nrf1 hearts at baseline (before I/R), and 1&#x2013;3 weeks (wk) after I/R; <italic>n</italic>&#x2009;=&#x2009;5 animals for each group. <bold>e</bold> 2wk, *<italic>p</italic>&#x2009;=&#x2009;0.0388; 3wk, *<italic>p</italic>&#x2009;=&#x2009;0.034. <bold>f</bold> 2wk, *<italic>p</italic>&#x2009;=&#x2009;0.0422; 3wk, *<italic>p</italic>&#x2009;=&#x2009;0.0336. <bold>g</bold> 1wk, *<italic>p</italic>&#x2009;=&#x2009;0.0207, 2wk, *<italic>p</italic>&#x2009;=&#x2009;0.0188; 3wk, *<italic>p</italic>&#x2009;=&#x2009;0.0155. <bold>h</bold> Masson&#x2019;s trichrome staining showing fibrotic scarring on transverse sections of hearts collected at 600&#x2009;&#x3BC;m below the ligation suture; Scale bar, 500&#x2009;&#x3BC;m. <bold>i</bold> Quantification of fibrotic regions of heart sections collected at multiple planes below the ligation suture from AAV-TdTomato and AAV-Nrf1 mice; AAV9-TdTomato, <italic>n</italic>&#x2009;=&#x2009;5; AAV9-Nrf1, <italic>n</italic>&#x2009;=&#x2009;4; 200&#x2009;&#x3BC;m, *<italic>p</italic>&#x2009;=&#x2009;0.012, 400&#x2009;&#x3BC;m, *<italic>p</italic>&#x2009;=&#x2009;0.0455, 600&#x2009;&#x3BC;m, *<italic>p</italic>&#x2009;=&#x2009;0.0007, 800&#x2009;&#x3BC;m, *<italic>p</italic>&#x2009;=&#x2009;0.0012. <bold>j</bold> Viable NRVMs with adenoviral (Ad) overexpression of LacZ or Nrf1 following H<sub>2</sub>O<sub>2</sub>, peroxynitrite, doxorubicin, and erastin treatments, indicated by Calcein AM (green); Scale bar, 100&#x2009;&#x3BC;m. <bold>k</bold> Cell death measured by lactate dehydrogenase (LDH) release in NRVMs-overexpressing LacZ, Nrf1, or Nrf2 following toxin treatments; <italic>n</italic>&#x2009;=&#x2009;4 biologically independent experiments for each group. H<sub>2</sub>O<sub>2</sub>, ***<italic>p</italic>&#x2009;&lt;&#x2009;0.000001, **<italic>p</italic>&#x2009;=&#x2009;0.0043. Peroxynitrite, ***<italic>p</italic>&#x2009;&lt;&#x2009;0.000001, **<italic>p</italic>&#x2009;=&#x2009;0.0022. Doxorubicin, ***<italic>p</italic>&#x2009;=&#x2009;0.000006, **<italic>p</italic>&#x2009;=&#x2009;0.0003. Erastin, **<italic>p</italic>&#x2009;=&#x2009;0.0039, *<italic>p</italic>&#x2009;=&#x2009;0.0215. <bold>d</bold>&#x2013;<bold>g</bold>, <bold>i</bold>, <bold>k</bold> Results are shown as mean&#x2009;&#xB1;&#x2009;s.e.m.; Student&#x2019;s <italic>t</italic>-test two-tailed; n.s. not significant.</p></caption><graphic xlink:href="41467_2021_25653_Fig3_HTML" id="d32e1296"/></fig></p>
        <p id="Par14">Next, to determine whether Nrf1 overexpression confers a broad protective benefit against general cardiac insults, we treated neonatal rat ventricular myocytes (NRVMs) overexpressing Nrf1 or LacZ (control) with H<sub>2</sub>O<sub>2</sub> (an oxidative stress inducer), peroxynitrite (a reactive nitrogen species released during I/R)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, Dox (a cardiotoxic chemotherapeutic drug)<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, or erastin (a ferroptosis inducer)<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, followed by analyses of cell survival. We observed a consistent protective effect of Nrf1 overexpression in the presence of all of these cardiotoxins, as revealed by Calcein AM staining that labels live cells (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3j</xref>). Nrf2, which is a family member of Nrf1, is a stress regulator that also confers cardio-protection<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Despite similar overexpression levels (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">9a</xref>), the protective effect of Nrf1 was greater than that of Nrf2 in response to all these cardiotoxin treatments (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3k</xref>), highlighting the importance of Nrf1 as a key regulator of cellular stress in the heart.</p>
      </sec>
      <sec id="Sec7">
        <title>The transcriptional activity of Nrf1 is required for cardioprotection</title>
        <p id="Par15">Nrf1 is an ER-bound transcription factor that is translocated to the nucleus upon the cleavage near the N-terminus. We observed increased nuclear translocation of Nrf1 in NRVMs after H<sub>2</sub>O<sub>2</sub> treatment (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">10a</xref>), suggesting that its nuclear function is involved in cytoprotection. To uncouple the transcriptional function of Nrf1 from its potential function in the ER, we generated truncation mutants of Nrf1 lacking the ER-binding domain within amino acids 1&#x2013;103 (Nrf1-&#x394;N) or the DNA-binding domain within amino acids 608&#x2013;741 (Nrf1-&#x394;C). Nrf1-&#x394;N corresponds to the naturally cleaved nuclear form of Nrf1, whereas Nrf1-&#x394;C displayed similar localization to Nrf1 (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">10b</xref>). Despite similar levels of overexpression (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">10c</xref>), Nrf1-&#x394;N conferred marked protection against H<sub>2</sub>O<sub>2</sub>, whereas Nrf1-&#x394;C was not protective (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">10d, e</xref>), showing that the transcriptional activity of Nrf1 is required for its cytoprotective function.</p>
      </sec>
      <sec id="Sec8">
        <title>Nrf1 regulates proteostasis and redox balance</title>
        <p id="Par16">To study the transcriptional program underlying the protective function of Nrf1, we performed RNA sequencing on NRVMs overexpressing LacZ, Nrf1, or Nrf2. DEG analysis between Nrf1 and LacZ samples identified 1241 genes that were upregulated by Nrf1 (Supplementary Data&#xA0;<xref rid="MOESM5" ref-type="media">2</xref>). Gene Ontology (GO) analysis revealed that up-regulated genes were associated with proteasome-mediated proteolysis, such as the proteasome protein catabolism and ER-associated degradation (ERAD) pathways, as well as the antioxidant response, such as glutathione and nicotinamide adenine dinucleotide phosphate (NADPH) metabolism (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a</xref>). Consistent with upregulation of the antioxidant response, oxidative DNA damage, marked by 8-Oxo-2&#x2032;-deoxyguanosine (8-OHdG), and activation of cellular, as well as mitochondrial ROS following H<sub>2</sub>O<sub>2</sub> treatment, were significantly attenuated in Nrf1-expressing cells compared to control cells (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">11</xref>). While pathways related to the antioxidant response were activated by both Nrf1 and Nrf2, the activation of proteasome-mediated proteolysis pathways was unique to Nrf1 overexpression (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4b, c</xref>). Consistent with this result, all three major cleavage activities of the proteasome (trypsin-like, chemotrypsin-like, and caspase-like) were significantly increased in NRVMs overexpressing Nrf1, which was not observed in response to Nrf2 overexpression (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4d</xref>). In addition, genes related to the innate immune response and cytokine production were down-regulated in both Nrf1 and Nrf2 samples, suggesting a shared anti-inflammatory function, whereas genes involved in extracellular matrix organization were specifically down-regulated by Nrf1 (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">9b</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><title>Nrf1 confers protection by regulating the proteasome and antioxidant response.</title><p><bold>a</bold> Gene ontology analysis of genes upregulated in Nrf1 samples compared to LacZ control samples. Upregulated genes are displayed in semantic space as clusters; the color and proportional size of circles indicate log10 (<italic>P</italic> value). <italic>P</italic> values were obtained using Metascape (see the &#x201C;Methods&#x201D; section). <bold>b</bold> Left: Venn diagram showing a number of genes upregulated by Nrf1, Nrf2, or both; Right: top enriched GO terms for each gene group. <bold>c</bold> Log2 fold-change (FC) of selected proteasome subunit genes (blue) and antioxidant genes (pink) in NRVMs overexpressing Nrf1 (<italic>x</italic>-axis) or Nrf2 (<italic>y</italic>-axis). <bold>d</bold> Proteasomal activity in arbitrary units (arb. units) of NRVMs overexpressing LacZ, Nrf1 or Nrf2; <italic>n</italic>&#x2009;=&#x2009;6 biologically independent experiments for groups LacZ and Nrf1; <italic>n</italic>&#x2009;=&#x2009;3 biologically independent experiments for group Nrf2; Trypsin-like, **<italic>p</italic>&#x2009;=&#x2009;0.0030; Chemotrypsin-like, ***<italic>p</italic>&#x2009;=&#x2009;0.000009; Caspase-like, **<italic>p</italic>&#x2009;=&#x2009;0.000031. <bold>e</bold> qPCR measurement of proteasome subunit genes and antioxidant genes in Nrf1 cKO and control hearts at P14; <italic>n</italic>&#x2009;=&#x2009;3 for each group. <italic>Psma1</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0266; <italic>Psma5</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0261; <italic>Psmd1</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0120; <italic>Cat</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0364; <italic>Sod1</italic>,*<italic>p</italic>&#x2009;=&#x2009;0.0462, <italic>Hmox1</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0510. <bold>f</bold> qPCR measurement of proteasome subunit genes and antioxidant genes in AAV-Nrf1 and AAV-TdTomato hearts from 2-month-old mice; <italic>n</italic>&#x2009;=&#x2009;3 for each group. <italic>Psma1</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0459; <italic>Psmb3</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0426; <italic>Psmd1</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0507; <italic>Sod1</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0128; <italic>Sod2</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0268, <italic>Hmox1</italic>, ***<italic>p</italic>&#x2009;=&#x2009;0.0001. <bold>g</bold> Expression of proteasome subunit genes and antioxidant genes in CM1&#x2013;CM5 cells from our previous snRNA-seq data (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130699">GSE130699</ext-link>). Expression levels in <italic>z</italic>-scores from 1-day post-Sham (Sham), 1-day post-MI (MI-day1), and 3-day post-MI (MI-day3) samples were plotted. <bold>h</bold> Western blot showing Hmox1 expression in NRVMs overexpressing LacZ, Nrf1, Nrf2, Nrf1-&#x394;N, or Nrf1-&#x394;C. <bold>i</bold>, <bold>j</bold> Viable cells (<bold>i</bold>, green) and percent of cell death (<bold>j</bold>) in NRVMs overexpressing Nrf1 plus <italic>Hmox1</italic> shRNA, or MG132 treatment, or both, following H<sub>2</sub>O<sub>2</sub> treatment; <italic>n</italic>&#x2009;=&#x2009;3 biologically independent experiments. ***<italic>p</italic>&#x2009;&lt;&#x2009;0.0001, **<italic>p</italic>&#x2009;=&#x2009;0.002 (column 3 vs. 4 and column 3 vs. 7), **<italic>p</italic>&#x2009;=&#x2009;0.0018 (column 3 vs. 6). Scale bar, 100&#x2009;&#x3BC;m; <bold>d</bold>, <bold>e</bold>, <bold>f</bold>, <bold>j</bold> results are shown as mean&#x2009;&#xB1;&#x2009;s.e.m.; Student&#x2019;s <italic>t</italic>-test two-tailed; n.s. not significant.</p></caption><graphic xlink:href="41467_2021_25653_Fig4_HTML" id="d32e1595"/></fig></p>
        <p id="Par17">Proteasome subunit genes, <italic>Psma1</italic>, <italic>Psmd1</italic>, and <italic>Psmb3</italic>, as well as antioxidant genes, <italic>Hmox1</italic>, <italic>Sod1</italic>, and <italic>Cat</italic>, were downregulated in Nrf1 cKO hearts and upregulated in AAV9-Nrf1 hearts, suggesting that they are direct targets of Nrf1 and underlie its cardioprotective function (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4e, f</xref>). To study potential redundant functions between Nrf1 and Nrf2, we generated mice with cardiomyocyte-specific knockout of <italic>Nrf2</italic> (Nrf2 cKO) or both genes (dKO) and compared them with Nrf1 cKO mice. The expression of proteasome and antioxidant target genes was reduced to greater degrees in Nrf1 cKO compared to Nrf2 cKO hearts, and, importantly, was not further reduced in dKO hearts, suggesting that Nrf1 plays a dominant role in regulating the expression of these genes in the heart (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">12</xref>). We further checked their expression in the five cardiomyocyte populations (CM1&#x2013;CM5). Like <italic>Nrf1</italic>, these target genes were highly expressed in CM4 cells (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4g</xref>), suggesting that the proteasome and antioxidant response pathways are more active in CM4 cells than in other cardiomyocytes. Moreover, consistent with the transcriptional upregulation of these genes, proteomics analysis on NRVMs overexpressing Nrf1 revealed increased levels of proteins involved in the proteasome complex pathway and the antioxidant response (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">13</xref> and Supplementary Data&#xA0;<xref rid="MOESM6" ref-type="media">3</xref>).</p>
        <p id="Par18">Hmox1, a detoxifying enzyme that catabolizes heme to Fe<sup>2+</sup>, CO, and biliverdin<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, was the most upregulated protein by Nrf1. Western blot analysis showed that Hmox1 expression positively correlated with the survival of cells overexpressing Nrf1 variants (Nrf1-&#x394;C and Nrf1-&#x394;N) or Nrf2 after H<sub>2</sub>O<sub>2</sub> treatment (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4h</xref>). To study whether the expression of Hmox1 is required for cardioprotection by Nrf1, we co-expressed Nrf1 with an shRNA targeting <italic>Hmox1</italic> or a scrambled shRNA control in NRVMs followed by H<sub>2</sub>O<sub>2</sub> treatment. The <italic>Hmox1</italic> shRNA reduced <italic>Hmox1</italic> transcripts by &gt;80% (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">14a</xref>) and significantly attenuated the protective effective of Nrf1 (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4i, j</xref>).</p>
        <p id="Par19">To determine whether increased proteasomal activity also contributes to Nrf1 function, we incubated Nrf1-overexpressing NRVMs with a proteasome inhibitor, MG132<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, during H<sub>2</sub>O<sub>2</sub> treatment. We observed a significant reduction of cell survival in MG132-treated cells (Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4i, j,</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">14b, c</xref>). Cell survival was further reduced with combined <italic>Hmox1</italic> shRNA and MG132 treatments, showing that both Hmox1 and proteasome activation mediate the protective function of Nrf1.</p>
      </sec>
      <sec id="Sec9">
        <title>Nrf1 protects hPSC-CMs from the cardiotoxin Dox</title>
        <p id="Par20">Analysis of human heart ventricles from 431 donors (age 20&#x2013;79) in the Genotype Tissue Expression (GTEx) database revealed varying levels (differing by over 70-fold) of <italic>NRF1</italic> expression among individuals (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>), with a significant decline in the elderly demographic (age 60&#x2013;79) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5b</xref>). Gene co-expression analysis on these samples identified 1167 genes, whose expression highly correlated with <italic>NRF1</italic> (Spearman correlation coefficient&#x2009;&gt;&#x2009;0.8, adjusted <italic>p</italic>-val&#x2009;&lt;&#x2009;0.00001) (Supplementary Data&#xA0;<xref rid="MOESM7" ref-type="media">4</xref>). The correlated genes include <italic>PSMC1</italic>, <italic>PSMD7</italic>, <italic>SOD1</italic>, and <italic>CAT</italic>, which are known NRF1 targets (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5c&#x2013;f</xref>). GO analysis revealed that these <italic>NRF1</italic> co-expressed genes are associated with key metabolic and energy production processes in the heart, such as fatty acid degradation, electron transport chain, and mitochondrial organization, as well as muscle contraction and known NRF1 downstream pathways&#x2014;ubiquitination, proteasome degradation, and autophagy (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5g</xref>). These data suggest that the degree of <italic>NRF1</italic> expression correlates with the metabolic and contractile properties of the heart, and thus likely affects cardiac function. Indeed, analysis of published datasets revealed a significant reduction of <italic>NRF1</italic> transcript levels in heart ventricles from three independent patient cohorts with heart failure (<italic>n</italic>&#x2009;=&#x2009;28) (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5h&#x2013;j</xref>).<fig id="Fig5"><label>Fig. 5</label><caption><title>NRF1 is an essential stress regulator in human iPSC-derived cardiomyocytes.</title><p><bold>a</bold> Expression (TPM, transcript per million reads) of <italic>NRF1</italic> in 431 human heart left ventricle samples from the GTEx database. Samples were collected from 293 males and 138 females. <bold>b</bold> Expression of <italic>NRF1</italic> grouped by age. Age 20&#x2013;29, <italic>n</italic>&#x2009;=&#x2009;22; Age 30&#x2013;39, <italic>n</italic>&#x2009;=&#x2009;26; Age 40&#x2013;49, <italic>n</italic>&#x2009;=&#x2009;66; Age 50&#x2013;59, <italic>n</italic>&#x2009;=&#x2009;154; Age 60&#x2013;69, <italic>n</italic>&#x2009;=&#x2009;149; Age 70&#x2013;79, <italic>n</italic>&#x2009;=&#x2009;14; *<italic>p</italic>&#x2009;=&#x2009;0.0106, **<italic>p</italic>&#x2009;=&#x2009;0.0027, one-way ANOVA test. <bold>c</bold>&#x2013;<bold>f</bold> Expression correlation plots showing that <italic>PSMD7</italic> (<bold>c</bold>), <italic>PSMC1</italic> (<bold>d</bold>), <italic>SOD1</italic> (<bold>e</bold>), and <italic>CAT</italic> (<bold>f</bold>) are highly co-expressed with <italic>NRF1</italic> in the 431 human heart left ventricle samples from the GTEx database. Spearman&#x2019;s correlation coefficient (<italic>&#x3C1;</italic>) and <italic>p</italic>-values are depicted; one-tailed <italic>t</italic>-test. <bold>g</bold> Top enriched GO terms for the 1167 <italic>NRF1</italic> co-expressed genes. <bold>h</bold>&#x2013;<bold>j</bold>
<italic>NRF1</italic> expression is significantly reduced in heart ventricular tissue from patients with heart failure compared to healthy hearts. Box-and-whisker plots are provided in which the central line denotes the median value, the edges of the boxes represent the upper and lower quartiles, and whiskers indicate the minimum and maximum values; *<italic>p</italic>&#x2009;&lt;&#x2009;0.05 with exact <italic>p</italic>-value depicted. <bold>h</bold> RNAseq data from <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147236">GSE147236</ext-link>; <italic>n</italic>&#x2009;=&#x2009;4 for heart failure, <italic>n</italic>&#x2009;=&#x2009;3 for healthy control; two-tailed Wald test. <bold>i</bold> Affymetrix microarray data from <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1145">GSE1145</ext-link>; <italic>n</italic>&#x2009;=&#x2009;12 for heart failure, <italic>n</italic>&#x2009;=&#x2009;4 for healthy control; Wilcoxon rank sum test two-tailed. <bold>j</bold> Agilent microarray data from <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE9800">GSE9800</ext-link>; <italic>n</italic>&#x2009;=&#x2009;12 for heart failure, <italic>n</italic>&#x2009;=&#x2009;11 for healthy control; Wilcoxon rank-sum test two-tailed. <bold>k</bold> Immunostaining of cleaved caspase-3 and &#x3B1;-actinin in hPSC-CMs overexpressing NRF1 or LacZ after Dox treatment. Scale bar, 100&#x2009;&#x3BC;m. <bold>l</bold>, <bold>m</bold> Quantification of the percentage of cleaved caspase-3<sup>+</sup> cardiomyocytes (<bold>l</bold>) and tota<bold>l</bold> cell number (<bold>m</bold>) in hPSC-CMs overexpressing NRF1 or LacZ after Dox treatment. ***<italic>p</italic>&#x2009;&lt;&#x2009;0.0001, Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>n</bold> Calcium transient in hPSC-CMs overexpressing NRF1 or LacZ with and without Dox treatment; <italic>n</italic>&#x2009;=&#x2009;29&#x2013;33 cells from two independent experiments were measured for each group. <bold>o</bold>, <bold>p</bold> Quantification of time-to-peak (<bold>o</bold>) and average decay time (Tau) (<bold>p</bold>) of calcium transient in hPSC-CMs overexpressing NRF1 or LacZ with and without Dox treatment; <italic>n</italic>&#x2009;=&#x2009;29&#x2013;33 cells from two independent experiments were measured for each group. <bold>o</bold> *<italic>p</italic>&#x2009;=&#x2009;0.0163, ***<italic>p</italic>&#x2009;=&#x2009;0.0004; <bold>p</bold> LacZ (&#x2212;Dox) vs. LacZ (+Dox), *<italic>p</italic>&#x2009;=&#x2009;0.0479; LacZ (+Dox) vs. Nrf1 (+Dox), *<italic>p</italic>&#x2009;=&#x2009;0.0416; one-way ANOVA. <bold>q</bold> Immunostaining with &#x3B1;-actinin antibody showing sarcomere disarray in LacZ control cells and preserved sarcomere organization in NRF1-expressing cells after Dox treatment. Scale bar, 20&#x2009;&#x3BC;m; <bold>r</bold> Quantification of the percentage of sarcomere disarray in hPSC-CMs overexpressing NRF1 or lacZ treated with Dox; <italic>n</italic>&#x2009;=&#x2009;481 cells from six independent experiments were measured for the &#x2018;&#x2212;Dox&#x2019; group; <italic>n</italic>&#x2009;=&#x2009;83 cells from six independent experiments were measured for the &#x2018;LacZ&#x2009;+&#x2009;Dox&#x2019; group; <italic>n</italic>&#x2009;=&#x2009;233 cells from six independent experiments were measured for the &#x2018;NRF1&#x2009;+&#x2009;Dox&#x2019; group. **<italic>p</italic>&#x2009;&lt;&#x2009;0.0001 compared to untreated &#x2018;&#x2212;Dox&#x2019; sample; ##<italic>p</italic>&#x2009;=&#x2009;0.001 compared to &#x2018;LacZ&#x2009;+&#x2009;Dox&#x2019; sample; Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>s</bold> Peak systolic force of single hPSC-CMs overexpressing NRF1 or LacZ with (+Dox) and without (&#x2212;Dox) Dox treatment; <italic>n</italic>&#x2009;=&#x2009;34 for LacZ (&#x2212;Dox), <italic>n</italic>&#x2009;=&#x2009;32 for LacZ (+Dox), <italic>n</italic>&#x2009;=&#x2009;36 for NRF1 (&#x2212;Dox), and <italic>n</italic>&#x2009;=&#x2009;35 for NRF1 (+Dox) from two independent experiments; ***<italic>p</italic>&#x2009;&lt;&#x2009;0.0001, one-way ANOVA. <bold>t</bold> qPCR measurement of proteasome subunit genes, <italic>PSMA1</italic> and <italic>PSMD1</italic>, and antioxidant genes, <italic>SOD1</italic> and <italic>HMOX1</italic>, in hPSC-CMs overexpressing NRF1 or LacZ; <italic>n</italic>&#x2009;=&#x2009;3 for each group; <italic>PSMA1</italic>, **<italic>p</italic>&#x2009;=&#x2009;0.0019; <italic>PSMD1</italic>, **<italic>p</italic>&#x2009;=&#x2009;0.0013; <italic>SOD1</italic>, *<italic>p</italic>&#x2009;=&#x2009;0.0486; <italic>HMOX1</italic>, ***<italic>p</italic>&#x2009;&lt;&#x2009;0.0001; Student&#x2019;s <italic>t</italic>-test two-tailed. <bold>b</bold>, <bold>l</bold>, <bold>t</bold> results are shown as mean&#x2009;&#xB1;&#x2009;s.d.; <bold>m</bold>, <bold>r</bold> results are shown as mean&#x2009;&#xB1;&#x2009;s.e.m.; <bold>o</bold>, <bold>p</bold>, <bold>s</bold> Box-and-whisker plots are provided in which the central line denotes the median value, the edges of the boxes represent the upper and lower quartiles, and whiskers indicate the 10&#x2013;90 percentile values with points below or above the whiskers shown as individual dots. n.s. not significant.</p></caption><graphic xlink:href="41467_2021_25653_Fig5_HTML" id="d32e2105"/></fig></p>
        <p id="Par21">Given that Dox-induced cardiomyopathy in cancer patients carries poor prognosis and is frequently fatal, we next studied whether NRF1 overexpression confers cardioprotection against Dox in hPSC-CMs. After treatment of hPSC-CMs with Dox, we observed significant cell apoptosis marked by cleaved caspase-3 and reduced cell numbers in control cells overexpressing LacZ (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5k&#x2013;m</xref>). In contrast, NRF1 overexpression in hPSC-CMs significantly attenuated Dox-induced cell death, as seen by reduced activation of cleaved caspase-3 and improved cell viability (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5k&#x2013;m</xref> and Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">15</xref>). Consistent with the improved cardiomyocyte survival, calcium transients were markedly improved in NRF1-overexpressing cells, as both the rise-time-to-peak and average decay time measurements were significantly reduced compared to control cells treated with Dox, and were comparable to untreated cells (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5n&#x2013;p</xref>). Additionally, NRF1-expressing cells exhibited less sarcomere disarray after Dox treatment (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5q, r</xref>), indicating preserved contractility. Indeed, the contractile force after Dox-treatment was significantly improved in hPSC-CMs overexpressing NRF1 compared to control cells (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5s</xref>). NRF1 overexpression increased the expression of <italic>PSMA1</italic>, <italic>PSMD1</italic>, <italic>SOD1</italic>, and <italic>HMOX1</italic> in hPSC-CMs (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5t</xref>), indicating a similar stress response mechanism that mediates the protective function of NRF1 in human cardiomyocytes.</p>
      </sec>
    </sec>
    <sec id="Sec10" sec-type="discussion">
      <title>Discussion</title>
      <p id="Par22">A universal characteristic of dysfunctional hearts is elevated ROS and perturbed ER homeostasis<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. Here, we demonstrate that Nrf1 gain-of-function is sufficient to protect adult mouse hearts from I/R injury by activating ROS scavengers and increasing proteasomal activity to maintain oxidative and proteolytic stress balance. Due to its ability to activate a dual functional stress response, Nrf1 confers a greater degree of protection than Nrf2, a &#x201C;master regulator&#x201D; of redox balance, and thus is a core component of stress adaptation in the heart.</p>
      <p id="Par23">Although antioxidant response and proteasome activation are the two major pathways upregulated by Nrf1, the protection mediated by Nrf1 likely involves additional mechanisms. For example, our RNA-sequencing analysis also identified genes involved in autophagy, such as <italic>Atg2a</italic>, <italic>Atg4d</italic>, and <italic>Atg13</italic> that were upregulated by Nrf1 overexpression. Activation of autophagy has been shown to be cardioprotective<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>, thus likely also contributing to the Nrf1-mediated protection. Recent studies suggested that Nrf1 also plays a role in maintaining metabolic homeostasis. In hepatocytes, Nrf1 was shown to directly regulate the expression of <italic>Lipin1</italic> and <italic>PGC-1</italic>, thus regulating lipid metabolism<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Additionally, NRF1 transgenic overexpression induced insulin resistance<sup><xref ref-type="bibr" rid="CR33">33</xref></sup>. Whether similar functions of Nrf1 in regulating metabolism exist in the heart and contribute to its protective role warrants additional investigation. Furthermore, Nrf1 could also confer protection through anti-inflammation and anti-fibrosis pathways, as genes involved in innate immune responses and extracellular matrix organization were significantly downregulated by Nrf1.</p>
      <p id="Par24">We identified Nrf1 based on its enriched expression in CM4 cells. We have previously shown that CM4 cardiomyocytes are immature, enriched in the regenerative mouse heart, and enter the cell cycle in response to injury. In this study, we used spatial transcriptomic profiling, for the first time, to map the anatomic localization of cardiac cell types in mouse hearts undergoing regeneration. We showed that CM4 cells, compared to other cardiomyocyte populations, are proximal to the infarct site, suggesting their role in reconstituting the damaged myocardium. Together, these results provide strong evidence that CM4 cells are the regenerative cardiomyocytes in neonatal mouse hearts, and the loss of CM4 cells in later life contributes to the loss of regenerative potential.</p>
      <p id="Par25">It is worth noting that several studies including ones from our lab have shown that BrdU<sup>+</sup> cardiomyocytes in regenerating hearts are localized throughout the ventricles<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>. However, to our knowledge, none of these studies provided direct evidence, such as lineage tracing, showing that BrdU<sup>+</sup> cardiomyocytes are in fact regenerating cardiomyocytes that ultimately reconstitute the damaged myocardium. The ubiquitous distribution of BrdU<sup>+</sup> cardiomyocytes could be attributed to the global binucleation and DNA synthesis events in cardiomyocytes during the neonatal stage, which cannot be easily distinguished from true proliferating cardiomyocytes that are induced by injury. In fact, when more faithful markers of cell proliferation, such as pH3, Aurora B, and clonal expansion were analyzed<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR34">34</xref></sup>, we and others showed that proliferating cells are more frequently observed in the apex and border zones compared to remote zones, consistent with our results from the spatial transcriptome analysis. Additionally, in our previous paper<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, besides CM4, we also identified another cardiomyocyte population, CM2, that expresses high levels of cell-cycle genes. Although CM2 cells are detected at a low frequency (~3%), it is possible that they are localized more broadly, accounting for the observed BrdU<sup>+</sup> cardiomyocytes in remote zones. Additionally, one limitation of snRNA-seq is its inability to distinguish mono-nucleated versus bi-nucleated cardiomyocytes. This inherent technical limitation potentially affects our estimation of percentages of different cardiomyocyte populations especially in later postnatal stages such as P8, when the majority of cardiomyocytes become binucleated. Future experiments using large particle fluorescence-activated cell sorting will reveal any potential differences in the degree of their nucleation<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. Nevertheless, the majority of cardiomyocyte binucleation arises from incomplete cell division instead of cell fusion, thus the two nuclei from the same cardiomyocyte should in principle share the same gene expression profile, which makes it unlikely to affect the transcriptomic analyses performed in this study.</p>
      <p id="Par26">In contrast to MI hearts, CM4 cells in Sham hearts were not anatomically confined and, instead, distributed sporadically in the ventricles. We cannot fully exclude the possibility that CM4 cells represent a transient transcriptome state that was activated in cardiomyocytes proximal to the infarct. However, given that CM4 cells are also present in Sham hearts, it is plausible that they migrate to the infarct site in response to injury. Indeed, several studies have shown that cardiomyocyte migration is required for heart regeneration<sup><xref ref-type="bibr" rid="CR36">36</xref>&#x2013;<xref ref-type="bibr" rid="CR38">38</xref></sup>. Future studies to fate map CM4 cells during heart regeneration may provide insight into how regenerating cardiomyocytes might be recruited to repair the infarct tissue and what chemo-attractants might mediate this recruitment.</p>
      <p id="Par27">The necessity of Nrf1 for neonatal heart regeneration indicates an intricate interplay between cytoprotection and cardiac regeneration programs. Indeed, several signaling pathways, including Yap and PI3K&#x2013;AKT pathways, were shown to promote both proliferation and survival of cardiomyocytes<sup><xref ref-type="bibr" rid="CR39">39</xref>&#x2013;<xref ref-type="bibr" rid="CR42">42</xref></sup>. Yet, different from Yap and PI3K&#x2013;AKT pathways, Nrf1 is not sufficient to promote cardiomyocyte proliferation by itself but rather provides a permissive state for cardiomyocytes to proliferate during regeneration. This is supported by two observations from our study: first, Nrf1 overexpression did not increase proliferation in cardiomyocytes, and second, Nrf1 cKO reduced the number of proliferating cardiomyocytes and impaired regeneration in neonatal hearts. Future rescue experiments by overexpressing Nrf1 and its target genes in Nrf1 cKO hearts will establish the role of Nrf1 in maintaining this regeneration permissive condition and further delineate the functional downstream pathways.</p>
      <p id="Par28">Together, our study uncovers a unique adaptive mechanism activated in response to injury that maintains the tissue homeostatic balance required for heart regeneration. Reactivating these mechanisms in the adult heart represents a potential therapeutic approach for cardiac repair.</p>
    </sec>
    <sec id="Sec11">
      <title>Methods</title>
      <sec id="Sec12">
        <title>Mice</title>
        <p id="Par29">All mouse experiments complied with all relevant ethical regulations and were performed according to protocols approved by the Institutional Animal Care and Use Committees at the University of Texas Southwestern Medical Center (protocol 2016-101833 and 2017-102269). UT Southwestern uses the &#x201C;Guide for the Care and Use of Laboratory Animals&#x201D; when establishing animal research standards. All mice used in this study were housed at the pathogen-free Animal Resource Center at the University of Texas Southwestern Medical Center. All animals were bred inside an SPF facility with 12&#x2009;h light/dark cycles with a temperature of 18&#x2013;24&#x2009;&#xB0;C and humidity of 35&#x2013;60% and monitored daily with no health problems. All animals were housed in groups of a maximum five per cage with ad libitum access to food and water. Nrf2<sup>fl/fl</sup> mice were obtained from the Jackson Laboratory (# 025433).</p>
      </sec>
      <sec id="Sec13">
        <title>Ethics statement</title>
        <p id="Par30">The GTEx (<ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/datasets">https://gtexportal.org/home/datasets</ext-link>) v7 data were downloaded from the database of Genotypes and Phenotypes (dbGaP) of the NIH (project id phs000424.v7.p2). The access to the data followed the guidelines in the Data Use Certification Agreement.</p>
      </sec>
      <sec id="Sec14">
        <title>Neonatal MI</title>
        <p id="Par31">All animal work described in this manuscript has been approved and conducted under the oversight of the UT Southwestern Institutional Animal Care and Use Committee. Timed-pregnant Nrf1<sup>fl/fl</sup>:aMHC-Cre and Nrf1<sup>fl/fl</sup> mice in the C57BL/6 background were used to deliver pups for neonatal MI surgery at P3. Neonatal mice were anesthetized by hypothermia, and neonatal MI was performed as described previously<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref>,<xref ref-type="bibr" rid="CR43">43</xref></sup>. Briefly, neonatal mice were anesthetized by hypothermia on an ice bed. Lateral thoracotomy at the fourth intercostal space was performed by blunt dissection of the intercostal muscles after skin incision. A tapered needle attached to a non-absorbable 8-0 suture (PROLENE, Ethicon) was passed through the mid-ventricle below the origin of the LAD coronary artery and tied to induce infarction. The pericardial membrane remained intact after LAD ligation. Myocardial ischemia is indicated by the light pallor of the myocardium below the ligature after suturing. After LAD ligation, neonates were removed from the ice, thoracic wall incisions were sutured with a 7-0 non-absorbable suture, and the skin wound closed by using skin adhesive. Sham-operated mice underwent the same procedure involving thoracotomy without LAD ligation.</p>
      </sec>
      <sec id="Sec15">
        <title>Adult I/R</title>
        <p id="Par32">Timed-pregnant wildtype C57BL/6 mice were used to deliver pups for systemic AAV9 injection on P4 and I/R surgery at 8 weeks of age. AAV9 vectors expressing TdTomato or Nrf1 driven by the muscle-specific CK8 promoter were cloned by replacing the Cas9 coding sequence of the AAV9-CK8-Cas9 vector<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> with the corresponding coding sequences of TdTomato, or mouse Nrf1, and were packaged by the Harvard Medical School/Boston Children&#x2019;s Hospital Viral Core, as previously described<sup><xref ref-type="bibr" rid="CR44">44</xref>,<xref ref-type="bibr" rid="CR45">45</xref></sup>. C57BL/6 mice were injected with AAV9 at P4 at a titer of 5E13&#x2009;vg/kg by intraperitoneal injection.</p>
        <p id="Par33">Heart ventricles from mice injected with AAV9-TdTomato or AAV9-Nrf1 were collected 4 weeks after injection to examine the overexpression levels of Nrf1. I/R surgery was performed on 8-week-old mice pre-injected with AAV9-TdTomato or AAV9-Nrf1. Mice were anesthetized with Ketamine/Xylazine complex, intubated, and ventilated with a MiniVent mouse ventilator (Hugo Sachs Elektronik; stroke volume, 250&#x2009;&#x3BC;L; respiratory rate, 105 breaths per minute). Body temperature was carefully monitored with a rectal probe and maintained as close as possible to 37.0&#x2009;&#xB0;C. With the aid of a dissecting microscope, following left thoracotomy between the fourth and fifth ribs, a 7-0 nylon suture was passed under the left anterior descending coronary artery, and a nontraumatic occluder was applied on the artery. After 45&#x2009;min of ischemia, the ligature was then released, the chest was closed in layers and the mice were allowed to recover.</p>
      </sec>
      <sec id="Sec16">
        <title>Transthoracic echocardiography</title>
        <p id="Par34">Cardiac function was evaluated by two-dimensional transthoracic echocardiography on conscious mice using a VisualSonics Vevo2100 imaging system as described previously. FS and EF were used as indices of cardiac contractile function. M-mode tracings were used to measure LV internal diameter at end-diastole (LVIDd) and end-systole (LVIDs). FS was calculated according to the following formula: FS&#x2009;=&#x2009;[(LVIDd&#x2212;LVIDs)/LVIDd]&#xD7;100%. EF was calculated as EF&#x2009;=&#x2009;[(LVEDV&#x2212;LVESV)/LVEDV]&#xD7;100%. (LVESV, left ventricular end-systolic volume; LVEDV, left ventricular end-diastolic volume.) All measurements were performed by an experienced operator blinded to the study.</p>
      </sec>
      <sec id="Sec17">
        <title>TTC staining</title>
        <p id="Par35">At the conclusion of reperfusion, the heart was excised and perfused with Krebs&#x2013;Henseleit solution through an aortic cannula. To delineate infarcted from viable myocardium, the heart was then perfused with 1% TTC in phosphate buffer. To delineate the occluded/reperfused bed, the coronary artery was tied at the site of the previous occlusion and the aortic root was perfused with 10% Phthalo blue dye. As a result of this procedure, the region at risk was identified by the absence of blue dye, whereas the rest of the left ventricle (LV) was stained dark blue. The LV was cut into five to six transverse slices, which were fixed in 10% neutral buffered formaldehyde, weighed, and photographed under a microscope. The corresponding areas were measured and from these measurements, infarct size was calculated as a percentage of the region at risk.</p>
      </sec>
      <sec id="Sec18">
        <title>Analysis of fibrotic tissue</title>
        <p id="Par36">Hearts were fixed in 4% paraformaldehyde in PBS, cryopreserved in 30% sucrose/PBS, and embedded in O.C.T. Compound. Hearts were cross-sectioned at 10&#x2009;&#xB5;m intervals starting from the ligation suture. Sections were collected at 0, 200, 400, 600, and 800&#x2009;&#x3BC;m below the suture were collected. Masson&#x2019;s Trichrome staining was performed on heart sections as described previously<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Afterimage acquisition of whole heart sections, the fibrotic region indicated in blue was quantified in Image J. Especially, the freehand selection tool was used to trace the fibrotic region, and the area was measured (Analysis&#x2009;&#x2192;&#x2009;Measure). The total heart cross-sectional area was also traced using the freehand selection tool and then measured. The fibrotic area was calculated as the fibrotic region normalized by the heart section area.</p>
      </sec>
      <sec id="Sec19">
        <title>Immunohistochemistry</title>
        <p id="Par37">Heart samples were fixed and sectioned as described above. Heart sections were air-dried for 30&#x2009;min at room temperature, fixed with 4% PFA for 20&#x2009;min, washed twice with PBS, and permeabilized with 0.3% Triton X-100 in PBS for 10&#x2009;min. Sections were then blocked in 5% goat serum/3% BSA/0.025% Triton X-100/PBS blocking solution for 1&#x2009;h and stained with the indicated primary antibodies prepared in blocking solution at 4&#x2009;&#xB0;C overnight using the following dilutions: cTnT (13-11) (Invitrogen, MA5-12960, 1:200), pH3 (Ser10) (Cell Signaling Technology, 9701S, 1:200), Nrf1 (Abcam, ab238154, 1:250), CD45 (30-F11) (Tonbo Biosciences, 70-0451, 1:250), Vimentin (280618) (R&amp;D Systems, MAB2105, 1:250), cTnI (Abcam, ab47003, 1:200). Sections were subsequently washed with 0.025% Triton X-100/PBS three times and incubated with corresponding secondary antibodies: Goat anti-mouse IgG Alexa 647 (ThermoFisher Scientific A32728, 1:500), Goat anti-mouse IgG Alexa 488 (ThermoFisher Scientific A32723, 1:500), Goat anti-rabbit IgG Alexa 647 (ThermoFisher Scientific A32731, 1:500), Goat anti-rat IgG Alexa 488 (ThermoFisher Scientific A-11006, 1:500) and Goat anti-mouse IgG Alexa 647 (ThermoFisher Scientific A32733, 1:500), prepared in blocking solution at room temperature for 1.5&#x2009;h. After secondary antibody incubation, sections were washed with PBS, incubated with DAPI at room temperature for 10&#x2009;min, and washed twice with PBS before mounting. Images were obtained using a Zeiss LSM 800 confocal microscope. TUNEL assay was performed using Click-iT Plus TUNEL Assay for In Situ Apoptosis Detection kit (Thermo Fisher Scientific, C10619) following manufacturer&#x2019;s protocol.</p>
      </sec>
      <sec id="Sec20">
        <title>Generation of adenoviruses</title>
        <p id="Par38">Adenovirus was generated using the Adeno-X Adenoviral System 3 (Clontech, 632267). Coding regions of &#x3B2;-galactosidase (lacZ), mouse Nrf1, human NRF1, and mouse Nrf2 were cloned into the pAdx-CMV vector containing a red fluorescent protein. Adenoviruses were generated by transfecting linearized recombinant adenoviral plasmids into a mammalian packaging cell line Adeno-X 293. Primary lysates were used to re-infect Adeno-X 293 cells to generate higher-titer viruses. The viral titer was determined in 292T cells using Adeno-X RapidTiter Kit (Clontech, 632250). Adenoviruses were stored in 20&#x2009;&#x3BC;L aliquots at &#x2212;80&#x2009;&#xB0;C.</p>
      </sec>
      <sec id="Sec21">
        <title>Cardiomyocyte in vitro survival assay</title>
        <p id="Par39">NRVMs were isolated from 1- or 2-day-old Sprague-Dawley rats with the Isolation System for Neonatal Rat/Mouse Cardiomyocytes (Cellutron, nc-6031) according to the manufacturer&#x2019;s instructions. NRVMs were plated at a density of 3&#x2009;&#xD7;&#x2009;10<sup>5</sup> cells/well to gelatin-coated 12-well plates and were maintained in DMEM/199 medium (3:1, 3% FBS) for 48&#x2009;h before adenoviral infection. Adenoviruses were diluted in DMEM/199 medium containing 3% FBS and were added to NRVMs at an MOI of 50. Forty-eight hours after the infection, NRVMs were treated with 50&#x2009;&#x3BC;M H<sub>2</sub>O<sub>2</sub>, 1&#x2009;mM peroxynitrite (Cayman Chemical), 5&#x2009;&#x3BC;M Dox (Sigma-Aldrich), or 10&#x2009;&#xB5;M erastin (Sigma-Aldrich) for 2, 2, and 24&#x2009;h, respectively. At the end of the treatments, the culture medium from treated cells was transferred and the level of lactate dehydrogenase (LDH) released from damaged cells was quantified using the LDH Assay Kit (Abcam, ab65393). NRVMs were next washed with PBS and incubated with Calcein AM dye (Thermo Fisher, L3224) for 20&#x2009;min following the manufacturer&#x2019;s protocol. Cell viability was then visualized on a Keyence BZ-X700 microscope.</p>
        <p id="Par40">To achieve Hmox1 knockdown in NRVMs, adenoviruses were generated to express shRNAs against rat Hmox1 under a U6 promoter. Three shRNAs were tested. shRNA #2 (target sequence 5-GATATCAGTGTGCAGAGATTT-3) showed the highest knockdown efficiency with ~80% reduction of Hmox1 expression and was chosen for the experiments shown in this study. NRVMs were co-infected with the Hmox1 shRNA adenoviruses and Nrf1 adenoviruses followed by H<sub>2</sub>O<sub>2</sub> treatment and analysis of cell survival as described above.</p>
        <p id="Par41">To inhibit the proteasome, 10&#x2009;&#xB5;M MG132 was added to NRVM cultures. Prolonged inhibition of the proteasome can perturb proteostasis, which may sensitize cells to H<sub>2</sub>O<sub>2</sub>-induced toxicity or cause spontaneous cell death. Therefore, we only applied MG132 20&#x2009;min before and during the 2&#x2009;h H<sub>2</sub>O<sub>2</sub> treatment, a condition that efficiently suppressed the proteolytic activity of the proteasome without compromising the viability of the cells without H<sub>2</sub>O<sub>2</sub> treatment.</p>
      </sec>
      <sec id="Sec22">
        <title>Protein isolation and immunoblot analysis</title>
        <p id="Par42">Dissected heart ventricles or cultured cells were homogenized on ice for 15&#x2009;min in RIPA buffer followed by 20&#x2009;min centrifugation at 12,000&#xD7;<italic>g</italic> to pellet cell debris. Protein concentration in cell lysates was measured by BCA protein assay. 5&#x2013;10&#x2009;&#xB5;g of protein was used for SDS&#x2013;PAGE gel electrophoresis. After gel to membrane transfer, membranes were blocked in 5% milk for 30&#x2009;min followed by primary antibody incubation at 4&#x2009;&#xB0;C overnight using the following dilutions: ubiquitin (P4D1) (Cell Signaling Technology, #3936, 1:5000), Hmox1 (Proteintech, 10701-1-AP, 1:500), Nrf1 (D5B10) (Cell Signaling Technology, #8052, 1:1000), and Nrf2 (Abcam, ab137550, 1:1000). After the primary antibody incubation, the protein-membrane was washed with 1&#xD7; TBST buffer and incubated with the corresponding secondary antibody conjugated with horseradish peroxidase (HRP): Goat anti-mouse IgG HRP (abcam, ab6789, 1:1000) and Goat anti-rabbit IgG HRP (abcam, ab6721, 1:1000). Chemiluminescent signal was developed using SuperSignal&#x2122; West Femto Maximum Sensitivity Substrate.</p>
      </sec>
      <sec id="Sec23">
        <title>Analysis of oxidative stress</title>
        <p id="Par43">To measure DNA damage, NRVMs were fixed with 4% PFA at room temperature for 15&#x2009;min, permeabilized with 0.3% Triton X-100 in PBS for 20&#x2009;min, followed by co-staining with antibody against 8-OHdG (Novus Biologicals, NB600-1508, 1:250) and antibody against cTnT (13-11) (Invitrogen, MA5-12960, 1:200) at 4&#x2009;&#xB0;C overnight. Donkey anti-mouse secondary antibody conjugated with Alexa 647 (Thermo Fisher Scientific, A32787, 1:500) and Donkey anti-goat secondary antibody conjugated with Alexa 488 (Thermo Fisher Scientific, A-11055, 1:500) were used. Images were acquired using a Zeiss LSM 800 confocal microscope.</p>
        <p id="Par44">To measure ROS levels in cells, live cells were incubated with DCFDA (Cellular ROS Assay kit, Abcam, ab113851) for 30&#x2009;min and washed twice with the wash buffer. Fluorescent signals at excitation/emission 485/535 were recorded. To measure ROS levels in heart tissue lysate, the method using CM-H2DCFDA (Invitrogen) was used. Briefly, the homogenized lysate was prepared in 1&#xD7; RIPA lysis buffer (DyneBio), supplemented with a protease inhibitor (cOmplete, mini, EDTA-free; Roche), and quantified for protein using a BCA protein assay kit (Pierce). Then, the lysate containing 100&#x2009;&#x3BC;g of protein was incubated with 2&#x2009;&#xB5;M CM-H2DCFDA for 30&#x2009;min at 37&#x2009;&#xB0;C in the dark. Fluorescence signals at excitation/emission 495/527 were recorded by a microplate reader. To measure mitochondrial ROS, live cells were incubated with 0.25&#x2009;&#x3BC;M of mitochondrial ROS detection reagent from the Mitochondrial ROS Detection Assay Kit (Cayman Chemical) for 20&#x2009;min at 37&#x2009;&#xB0;C. Cells were then treated with 50&#x2009;&#xB5;M H<sub>2</sub>O<sub>2</sub> for 30&#x2009;min at 37&#x2009;&#xB0;C in the dark. Fluorescence signals at excitation/emission 480/560 were recorded by a microplate reader.</p>
      </sec>
      <sec id="Sec24">
        <title>Analysis of proteasomal activity</title>
        <p id="Par45">The Cell-Base Proteasome-Glo Assays (Promega) was used to measure proteasome activity in NRVMs according to the manufacturer&#x2019;s instructions. Chemotrypsin-like, trypsin-like, and caspase-like activity of the proteasome was measured independently using the corresponding cleavage substrates. The proteasome activity in tissue lysate was measured using the Proteasome Activity Assay kit (abcam) according to the manufacturer&#x2019;s instructions. Briefly, heart tissue was lysed in 0.5% NP-40 (without supplement of additional ATP). The tissue lysate was incubated with proteasome substrate (Succ-LLVY-AMC) at 37&#x2009;&#xB0;C for 30&#x2009;min with or without MG132. The fluorescent signal was recorded to calculate the ATP-non-stimulable proteasomal activity, which is the MG132 inhibitable fraction of the signal.</p>
      </sec>
      <sec id="Sec25">
        <title>Tandem mass tag proteomics analysis</title>
        <p id="Par46">Ten million NRVMs infected with Nrf1 or LacZ adenoviruses were collected for proteomic analysis. Samples were reduced in volume by half using a SpeedVac, then an equal volume of 10% SDS with 100&#x2009;mM of triethylammonium bicarbonate (TEAB) buffer was added to each sample. Tris (2-carboxyethyl) phosphine (TCEP) was added to a final concentration of 10&#x2009;mM and incubated at 56&#x2009;&#xB0;C for 30&#x2009;min, followed by the addition of iodoacetamide to a final concentration of 20&#x2009;mM, which was incubated at room temperature for 30&#x2009;min in the dark. Solutions were then acidified with 12% phosphoric acid, followed by the addition of six times the volume of S-Trap binding buffer (90% methanol, 10% 1&#x2009;M TEAB), were then loaded onto the S-Trap column (Protifi). The column was washed 3 times with 150&#x2009;&#xB5;l of binding buffer followed by the addition of trypsin (1:10) in 50&#x2009;mM TEAB and overnight incubation at 37&#x2009;&#xB0;C. Peptides were recovered by eluting the s-Trap with 35&#x2009;&#xB5;l of 50&#x2009;mM TEAB, 0.2% formic acid (FA), and 50% ACN in 0.2% FA, sequentially. The eluate containing the peptides was fractionated into 8 fractions using the Pierce High pH Reversed-Phase Peptide Fractionation Kit.</p>
        <p id="Par47">The resulting fractions were dried and then reconstituted in 2% (v/v) ACN and 0.1% trifluoroacetic acid in water. These were injected onto an Orbitrap Fusion Lumos mass spectrometer coupled to an Ultimate 3000 RSLC-Nano liquid chromatography system. Samples were injected onto a 75&#x2009;&#xB5;m i.d., 75-cm long EasySpray column (Thermo) and eluted with a gradient from 0% to 28% buffer B over 180&#x2009;min. Buffer A contained 2% (v/v) ACN and 0.1% formic acid in water, and buffer B contained 80% (v/v) ACN, 10% (v/v) trifluoroethanol, and 0.1% formic acid in water. The mass spectrometer operated in positive ion mode with a source voltage of 1.8&#x2009;kV and an ion transfer tube temperature of 275&#x2009;&#xB0;C. MS scans were acquired at 120,000 resolution in the Orbitrap and the top 10 peaks with charge&#x2009;=&#x2009;2&#x2013;6 were selected for MS2 using collisionally induced dissociation with a collision energy of 35%. The top 10 fragments were selected for MS3 fragmentation using HCD (SPS-MS3), with a collision energy of 55%. Dynamic exclusion was set for 25&#x2009;s after an ion was selected for fragmentation.</p>
        <p id="Par48">Raw MS data files were analyzed using Proteome Discoverer v2.4 (Thermo), with peptide identification performed using Sequest HT searching against the rat protein database from UniProt. Fragment and precursor tolerances of 10&#x2009;ppm and 0.6&#x2009;Da were specified, and three missed cleavages were allowed. Oxidation of Met was set as a variable modification and TMT6plex addition to K and peptide N-termini were set as static modifications. The reporter ion intensities for peptides identified for each protein were further analyzed using msms.edgeR to identified DEG with cutoffs fold-change &gt;1.5 and FDR&#x2009;&lt;&#x2009;0.05.</p>
      </sec>
      <sec id="Sec26">
        <title>Human iPSC (hPSC) differentiation and Dox treatment</title>
        <p id="Par49">hPSC derived from a healthy male donor was directly obtained from the UT Southwestern Wellstone Myoediting Core. hPSCs culture and differentiation were performed as previously described<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. Briefly, hPSCs were cultured on Matrigel-coated tissue culture polystyrene plates and maintained in Essential 8 media (Thermo Fisher). hPSCs were passaged at 70&#x2013;80% confluency using Versene (Thermo Fisher). Cardiac differentiation of hPSCs was induced when hPSCs achieved confluency by treating cells with CHIR99021 (Selleckchem) in RPMI (Thermo Fisher) supplemented with B27 without insulin (Thermo Fisher) for 24&#x2009;h (from day 0 to day 1). The medium was replaced with RPMI/B27-insulin on day 1. The cells were then treated with IWP4 (Stemgent) in RPMI/B27-insulin at day 3 and the medium was refreshed on day 5 with RPMI/B27-insulin. Cardiac myocytes were maintained in RPMI supplemented with B27 (Thermo Fisher) starting from day 7, with the medium changed every 2&#x2013;3 days. Ascorbic acid at 50&#x2009;&#x3BC;g/mL was added to both media. Metabolic selection of cardiac myocytes was performed for 6 days starting at day 10 of differentiation by culturing cells in RPMI without glucose (Thermo Fisher) supplemented with 5&#x2009;mM sodium <sc>dl</sc>-lactate and CDM3 supplement<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>.</p>
        <p id="Par50">hPSC-CMs were harvested on day 30 of differentiation by treating the cells with TrypLe Express (Thermo Fisher). Cells were plated onto 12-well plates at 300k cells per well or 35&#x2009;mm glass-bottom dishes at single-cell density before infection with adenoviruses expressing human NRF1 and lacZ (control) on day 35 with MOI 25&#x2013;50. Adenoviral infection efficiency was assessed 30&#x2009;h after the infection and over 70% of cells were infected as indicated by a red fluorescent reporter. Forty-eight hours after the infection, hPSC-CMs were treated with 10&#x2009;&#xB5;M Dox.</p>
      </sec>
      <sec id="Sec27">
        <title>Calcium imaging and cell survival assessment in hPSC-CMs</title>
        <p id="Par51">After Dox treatment for 1&#x2009;h, cells were loaded with the fluorescent calcium indicator Fluo-4 AM (Thermo Fisher) at 2&#x2009;&#x3BC;M. Spontaneous Ca<sup>2+</sup> transients of beating hPSC&#x2013;CMs were imaged at 37&#x2009;&#xB0;C using a Nikon A1R&#x2009;+&#x2009;confocal system. Ca<sup>2+</sup> transients were processed using Fiji software and analyzed using Microsoft Excel and Clampfit 10.7 software (Axon Instrument). The calcium release phase was represented with time to peak, which was calculated as the time from baseline to maximal point of the transient. The calcium reuptake phase was represented with the time constant tau by fitting the decay phase of calcium transients with a first-order exponential function.</p>
        <p id="Par52">For analysis of cell survival, hPSC-CMs were treated with 10&#x2009;&#xB5;M Dox for 30&#x2009;h. Calcein AM staining was done as described above. Additionally, cells were fixed in 4% PFA and immunocytochemistry staining was performed using antibodies against cleaved caspase-3 (Cell Signaling Technology, 9661, 1:250) and &#x3B1;-actinin (Sigma, A7811, 1:250).</p>
      </sec>
      <sec id="Sec28">
        <title>Contractile force measurements</title>
        <p id="Par53">For single-cell peak systolic force measurements, hPSC-CMs were plated at single-cell density on flexible polydimethylsiloxane (PDMS) 527 substrates (Young&#x2019;s modulus&#x2009;=&#x2009;5&#x2009;kPa) prepared according to a previously established protocol<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Videos of contracting hPSC-CMs were captured at 37&#x2009;&#xB0;C using a Nikon A1R+ confocal system at 59 frames per second in resonance scanning mode.</p>
        <p id="Par54">Contractile force generation of single hPSC-CMs was quantified using a previously established method<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. In brief, movies of single contracting hPSC-CMs were analyzed using Fiji. Maximum and minimum cell lengths during contractions as well as cell widths were measured, and peak systolic forces generated were calculated using a previously published customized Matlab code<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>.</p>
      </sec>
      <sec id="Sec29">
        <title>Spatial transcriptome library preparation</title>
        <p id="Par55">The spatial transcriptome analysis on heart sections was performed using the Visium Spatial Gene Expression Reagents Kits (10&#xD7;Genomics) according to the manufacturer&#x2019;s protocol. Briefly, mouse hearts were dissected and immediately embedded in a tissue embedding mold filled with OCT and placed in a bath of isopentane and liquid nitrogen. OCT-embedded heart tissue blocks were cryosectioned in a cryostat to generate appropriately sized sections for Visium Spatial slides. 10&#x2009;&#xB5;m sections at 200&#x2009;&#xB5;m below the ligation suture in MI heart or corresponding positions in Sham hearts were collected and placed on the Visum Spatial slides capture areas. Additional 5&#x2013;10 sections from the same heart were collected in a 1.5&#x2009;mL Eppendorf tube for evaluation of RNA quality. After confirming the RNA quality using an Agilent 2100 TapeStation, tissue sections on the Gene Expression Spatial slides were fixed in methanol and stained with Hematoxylin and Eosin. The stained tissue sections were imaged using Keyence BZ-X710. Heart sections were next permeabilized for 18&#x2009;min followed by RNA reverse transcription. The optimized permeabilization time was determined using the Visum Spatial Tissue Optimization Kit (10xGenomics) according to the manufacturer&#x2019;s protocol. Second strand cDNA was subsequently synthesized on tissue sections and was transferred to an Eppendorf tube after denaturation. The cDNA from the tissue slide that was spatially barcoded was next amplified via PCR and enzymatically fragmented. P5, P7, i7, and i5 sample indexes are added via End Repair, A-tailing, Adaptor ligation, and PCR to make the final sequencing library. Sequencing was performed on an Illumina Nextseq 500 system operated by the Next Generation Sequencing Core of Children&#x2019;s Research Institute at UT Southwestern using the 150&#x2009;bp high output sequencing kit (Illumina), with the following pair-end sequencing settings: Read1&#x2014;28 cycles, i5 index&#x2014;10 cycles, i7 index&#x2014;10 cycles, Read2&#x2014;90 cycles.</p>
      </sec>
      <sec id="Sec30">
        <title>Spatial transcriptome data analysis</title>
        <p id="Par56">The Space Ranger Single-Cell Software Suit (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/spatial-gene-expression/software/pipelines/latest/what-is-space-ranger">https://support.10xgenomics.com/spatial-gene-expression/software/pipelines/latest/what-is-space-ranger</ext-link>) was used to perform sample demultiplexing, reads alignment, and to generate feature-spot matrices. The cDNA reads were aligned to the mm10/GRCm38 mRNA reference genome. H&amp;E staining images were supplemented to Spatial Ranger for tissue detection, fiducial detection, and alignment of the spatial position of sequenced data points. Further analyses were performed using the Seurat R package v3.2, following the instruction (<ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/v3.2/spatial_vignette.html">https://satijalab.org/seurat/v3.2/spatial_vignette.html</ext-link>). Specifically, data normalization was performed using sctransform, which builds regularized negative binomial models of gene expression to account for variance in sequencing depth across data points while preserving the biological spatial variance on tissue sections. Mapping statistics of each sample are shown in Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">1a</xref>. To map the spatial location of a cell type that we previously identified in neonatal regenerating hearts (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130699">GSE130699</ext-link>)<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>, we deconvoluted the spatial transcriptome by integrating it with the snRNA-seq gene expression matrix using the TransferData function in Seurat. This function implements an &#x2018;anchor&#x2019;-based integration workflow that enables a probabilistic transfer of annotations from a reference (snRNA-seq data) to a query (spatial transcriptome) data set. This analysis generated probability scores for each cell type at each capture spot, which correlate with cellular fraction and were used to generate pie-charts to show cellular composition. The spatial locations of each cell type were visualized using SpatialFeaturePlot in Seurat.</p>
      </sec>
      <sec id="Sec31">
        <title>In situ hybridization using RNA-scope</title>
        <p id="Par57">In situ hybridization was performed on frozen cryosections from mouse hearts at 3-day post P1 or P8 MI using the RNAscope Fluorescent Multiplex Kit (Advanced Cell Diagnostics). Briefly, fresh frozen tissue preparation and cryosectioning were performed as described above. Sections were fixed in 4% PFA for 15&#x2009;min at 4&#x2009;&#xB0;C and subsequently dehydrated in 50%, 70%, and 100% ethanol. Sections were then pretreated with Protease IV for 30&#x2009;min at RT and washed in PBS. Sections were next hybridized with a probe mixture containing Acta2-C1 and Tnnt2-C3 probes or containing Nrf1-C1 and Tnnt2-C3 probes for 2&#x2009;h at 40&#x2009;&#xB0;C in a HybEZ Oven. Slides were rinsed in 1&#xD7; Wash Buffer and sequentially incubated with AMP 1-FL, AMP 2-FL, AMP 3-FL, AMP 4-FL Alt A, and DAPI, according to the manufacturer&#x2019;s protocol. Samples were imaged using a ZEISS LSM800 microscope. Transcript levels of <italic>Acta2</italic> and <italic>Nrf1</italic> from 29&#x2013;34 cardiomyocytes from three individual sections were quantified using Image J. Specifically, the ROI manager function was used to trace cells between fluorescent channels. The transcript levels were calculated as the mean intergraded density (signal normalized by the area) using the &#x201C;measure&#x201D; function in Fiji.</p>
        <p id="Par58">A 10 ZZ probe was generated to target the mouse <italic>Nrf1</italic> transcript at the region below:</p>
        <p id="Par59">CATACAATATGGCACCCAGTGCCCTTGACTCTGCTGATCTACCACCACCCAGCACCCTCAAGAAAGGTAGCAAGGAAAAGCAGGCTGACTTCCTGGACAAGCAGATGAGCCGAGATGAGCACAGAGCCCGAGCCATGAAGATCCCATTCACCAATGACAAGATCATCAACCTGCCTGTAGAAGAATTCAATGAGCTGCTGTCCAAATACCAGCTGAGCGAGGCCCAGCTCAGCCTCATCCGGGATATCCGGCGCCGGGGCAAAAACAAGATGGCTGCACAGAACTGCCGCAAGCGCAAGTTGGACACCATCCTAAACCTAGAACGTGATGTGGAGGACTTGCAGCGAGATAAGGCCCGATTGCTTCGAGAAAAGGTAGAGTTCCTTCGGTCTCTGCGACAGATGAAGCAGAAGGTCCAAAGCTTATACCAGGAGGTGTTTGGGCGGCTGCGGGATGAGCATGGGAGGCCCTACTCACCCAGTC. RNA-scope Probe-Mm-Tnnt2-C3 (418681-C3) and RNA-scope Probe-Mm-Acta2 (319531) were purchased from Advanced Cell Diagnostics.</p>
      </sec>
      <sec id="Sec32">
        <title>Cardiac nuclei isolation and single nucleus RNA-seq sequencing</title>
        <p id="Par60">Tail genotyping was performed on the day of collection (P4, one day post-P3 surgery) to distinguish Nrf1<sup>fl/fl</sup> and Nrf1<sup>fl/fl</sup>:&#x3B1;MHC-Cre mice. Mice were then euthanized, and hearts were extracted. Each heart was dissected in ice-cold PBS and a transverse cut on the ligation plane (for MI hearts) or similar level (for sham hearts) was made. Heart tissue below the ligation plane was collected and pooled from 4 to 6 hearts of the same genotype for nuclei isolation. Cardiac nuclei isolation was performed as previously described<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Total cardiac nuclei were used to generate single nucleus RNA-seq libraries using Single Cell 3&#x2032; Reagent Kits v3 (10&#xD7;Genomics) according to the manufacturer&#x2019;s protocol.</p>
      </sec>
      <sec id="Sec33">
        <title>snRNA-seq data analysis</title>
        <p id="Par61">The Cell Ranger Single-Cell Software Suit (<ext-link ext-link-type="uri" xlink:href="https://support.10xgenomics.com/single-cell-geneexpression/software/pipelines/latest/what-is-cell-ranger">https://support.10xgenomics.com/single-cell-geneexpression/software/pipelines/latest/what-is-cell-ranger</ext-link>) was used to perform sample demultiplexing, barcode processing, and single-cell 3&#x2032; gene counting. The cDNA reads were aligned to the mm10/GRCm38 pre-mRNA reference genome. We sequenced an average of 14,610 reads with over 90% mapped to the genome and a median of 1321 genes per nucleus (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6a</xref>). Only confidently mapped reads with valid barcodes and unique molecular identifiers were used to generate the gene-barcode matrix. Further analyses for quality filtering were performed using the Seurat R package<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Doublets were identified using Scrublet and removed from downstream analysis<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>. The distribution of detected genes per cell in each sample is summarized in Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6b</xref>. For quantity filtering, we removed cells that had more than 2500 or fewer than 200 detected genes. We then normalized the data by the total expression, multiplied by a scale factor of 10,000, and log-transformed the result. To account for variation in the number of genes and UMI detected in each cell, we normalized the scaled expression matrix using the ScaleData function and set the vars.to.regress to nUMI and need. IntegrateData function implemented in Seurat V3 was used to correct batch effects between samples and to merge samples into one Seurat object. Briefly, we performed standard preprocessing (log-normalization) and identified the top 2000 variable features for each individual dataset. We then identified integration anchors using the FindIntegrationAnchors function. We used default parameters and dimension 30 to find anchors. We then passed these anchors to the IntegrateData function to generate an integrated Seurat object. To visualize the data, we used Uniform Manifold Approximation and Projection (UMAP) to project cells in 2D space on the basis of the aligned canonical correlation analysis<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>. Aligned canonical correlation vectors (1:30) were used to identify clusters using a shared nearest-neighborhood modularity optimization algorithm<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. Cell clusters were identified using the FindCluster function in Seurat with resolution 0.3. Four cardiomyocyte clusters were identified based on the expression of Tnnt2 (Supplementary Fig.&#xA0;<xref rid="MOESM1" ref-type="media">6d</xref>) and were used for further analyses. In total, we analyzed 5176 cardiomyocyte nuclei from Nrf1 cKO hearts (MI&#x2009;+&#x2009;Sham) and 3409 cardiomyocyte nuclei from control hearts (MI&#x2009;+&#x2009;Sham).</p>
        <p id="Par62">To classify cardiomyocytes based on the CM1&#x2013;CM5 populations that we previously identified in our snRNA-seq study, we followed the data transfer method developed in the Seurat package. The detailed procedure can be found at (<ext-link ext-link-type="uri" xlink:href="https://satijalab.org/seurat/v3.2/integration.html">https://satijalab.org/seurat/v3.2/integration.html</ext-link>). In brief, the FindTransferAnchors function was used to identify anchors between the query dataset (generated in this study) and the reference dataset (generated previously in ref. <sup><xref ref-type="bibr" rid="CR5">5</xref></sup>). The identified anchors were used to transfer cell type labels learned from the reference data to the query data with the function TransferData. After label transfer, CM1 and CM3 cells were merged into one cluster (CM1/3) due to the lack of clear separation on the UMAP. The remaining clusters, CM2, CM4, and CM5, formed distinct clusters as visualized in the UMAP plot. The percentage of label transferred CM1/3, CM2, CM4 and CM5 cells in each sample were calculated and shown in Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2i</xref>. Differential gene analysis was performed by comparing CM4 cells in Nrf1KO MI hearts to CM4 cells in the control MI heart (<italic>p</italic>-adjust&#x2009;&lt;&#x2009;0.1 and FC&#x2009;=&#x2009;1.5) to identify genes that showed up-regulated and down-regulated expression in CM4 cells by Nrf1 deletion at 1-day post-MI (Supplementary Data&#xA0;<xref rid="MOESM4" ref-type="media">1</xref>). To calculate the correlation between Nrf1, Acta2, Mki67, and Ccnb2, sparse single nucleus expression data were imputed using Markov Affinity-based Graph Imputation of Cells (MAGIC <ext-link ext-link-type="uri" xlink:href="https://github.com/KrishnaswamyLab/MAGIC">https://github.com/KrishnaswamyLab/MAGIC</ext-link>) and robust spearman correlation method was used.</p>
      </sec>
      <sec id="Sec34">
        <title>Bulk RNA Sequencing in NRVMs and data analysis</title>
        <p id="Par63">NRVMs were collected at 48&#x2009;h after infection with adenoviruses for lacZ, Nrf1, and Nrf2. RNA was extracted using the RNeasy Mini Kit (QIAGEN, 74104) according to the manufacturer&#x2019;s protocol. An Agilent 2100 TapeStation was used for RNA quality analysis. Stranded mRNA-seq libraries were generated using the KAPA mRNA HyperPrep Kit (Roche, KK8581) following the manufacturer&#x2019;s protocol. Sequencing was performed on an Illumina NextSeq 500 system using a 75-bp, high-output sequencing kit for single-end sequencing.</p>
        <p id="Par64">For data analysis, quality control of RNA-seq data was performed using the FastQC Tool (Version 0.11.4). Sequencing reads were aligned to rat Rnor 6.0 reference genome using HiSAT2 (Version 2.0.4) with default settings and -rna-strandness F<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>. After removal of duplicate reads using Samtools v0.1.18<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>, aligned reads were counted using featurecount (Version 1.6.0) per gene ID<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. Differential gene expression analysis was performed with the R package edgeR (Version 3.20.5) using the GLM approach<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>. For each comparison, genes with more than 1 count per million (CPM) in at least three samples were considered as expressed and were used for calculating the normalization factor. Cutoff values of absolute fold-change &gt;1.5 and false discovery rate &lt;0.05 were used to select DEGs between sample group comparisons.</p>
      </sec>
      <sec id="Sec35">
        <title>Pathway and gene set enrichment analysis</title>
        <p id="Par65">Enrichment analysis of gene sets was performed using the Metascape (<ext-link ext-link-type="uri" xlink:href="https://metascape.org/">https://metascape.org/</ext-link>) with the supply of upregulated or downregulated DEG. GO analysis results (<italic>P</italic>&#x2009;&lt;&#x2009;0.05) were visualized by using REVIGO (<ext-link ext-link-type="uri" xlink:href="http://revigo.irb.hr/">http://revigo.irb.hr/</ext-link>) in semantic space as cluster representatives, which stands for remaining terms after reduction of the redundancy. The interactive graph was also analyzed where highly similar GO terms were linked as representing the degree of similarity with width.</p>
      </sec>
      <sec id="Sec36">
        <title>Quantitative real-time PCR analysis</title>
        <p id="Par66">Total RNA was extracted from NRVMs using Trizol and reverse transcribed using iScript Reverse Transcription Supermix (Bio-Rad) with random primers. The quantitative polymerase chain reactions (qPCR) were assembled using KAPA SYBR Fast qPCR Master Mix (KAPA, KK4605). Assays were performed using a 7900HT Fast Real-Time PCR machine (Applied Biosystems). Expression values were normalized to 18S mRNA and were represented as fold change. Oligonucleotide sequences of qPCR primers are listed in Supplementary Table&#xA0;<xref rid="MOESM1" ref-type="media">1</xref>.</p>
      </sec>
      <sec id="Sec37">
        <title>Reporting summary</title>
        <p id="Par67">Further information on research design is available in the&#xA0;<xref rid="MOESM8" ref-type="media">Nature Research Reporting Summary</xref> linked to this article.</p>
      </sec>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary information</title>
      <sec id="Sec38">
        <p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41467_2021_25653_MOESM1_ESM.pdf"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41467_2021_25653_MOESM2_ESM.pdf"><caption><p>Peer Review File</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41467_2021_25653_MOESM3_ESM.docx"><caption><p>Description of Additional Supplementary Files</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41467_2021_25653_MOESM4_ESM.xlsx"><caption><p>Supplementary Data 1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41467_2021_25653_MOESM5_ESM.xlsx"><caption><p>Supplementary Data 2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41467_2021_25653_MOESM6_ESM.xlsx"><caption><p>Supplementary Data 3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41467_2021_25653_MOESM7_ESM.xlsx"><caption><p>Supplementary Data 4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41467_2021_25653_MOESM8_ESM.pdf"><caption><p>Reporting Summary</p></caption></media></supplementary-material>
</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec39">
          <title>Source data</title>
          <p id="Par70">
<media position="anchor" xlink:href="41467_2021_25653_MOESM9_ESM.xlsx" id="MOESM9"><caption><p>Source Data</p></caption></media>
</p>
        </sec>
      </app>
    </app-group>
    <fn-group>
      <fn>
        <p><bold>Peer review information</bold><italic>Nature Communications</italic> thanks Mauro Giacca, Manuel Mayr, Christer Sylven, and the other, anonymous, reviewer for their contribution to the peer review of this work. Peer reviewer reports are available.</p>
      </fn>
      <fn>
        <p><bold>Publisher&#x2019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <sec>
      <title>Supplementary information</title>
      <p>The online version contains supplementary material available at 10.1038/s41467-021-25653-w.</p>
    </sec>
    <ack>
      <title>Acknowledgements</title>
      <p>We thank Zhaoning Wang for contributing to the published snRNA-seq data generation; Dr. Gokhan S. Hotamisligil (Harvard University) for providing the Nrf1<sup>fl/fl</sup> mice; Jose Cabrera for graphics; Drs. Jian Xu and Yoon Jung Kim from the Children&#x2019;s Research Institute at the University of Texas Southwestern Medical Center for performing the Illumina sequencing; Dr. Feng Wang for assistance analyzing the human patient datasets; Dr. Xiang Luo and Erica Niewold for help with isolating NRVMs; John Shelton from the Molecular Histopathology Core for help with histology; Dr. Andrew Lemoff from the Proteomics Core for help with the TMT proteomics analysis. The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for the analyses described in this manuscript were obtained from dbGaP accession number phs000424.vN.pN. M.C. is supported by a K99/R00 pathway way to independence grant (NHLBI, K99HL153683). This work was supported by grants from the NIH (AR-067294, HL-130253, HL-138426, and HD-087351), the Foundation Leducq Transatlantic Networks of Excellence in Cardiovascular Research, and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.).</p>
    </ack>
    <notes notes-type="author-contribution">
      <title>Author contributions</title>
      <p>M.C., N.L., R.B.-D. and E.N.O. designed the experiments and overall study. M.C., N.L., R.B.-D. and E.N.O. wrote the manuscript. M.C., A.A., M.G.M. and W.T. performed the experiments. M.C. and K.C. performed the transcriptome and proteomics data analyses. M.C. performed the spatial transcriptome analysis. L.X. and X.X. analyzed the human patient sequencing data. All authors discussed the results and participated in the manuscript preparation and editing. Correspondence and requests for materials should be addressed to E.N.O. (eric.olson@utsouthwestern.edu).</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Data availability</title>
      <p>All data presented in this study are available in the main text or the&#xA0;<xref rid="MOESM1" ref-type="media">supplementary materials</xref>. Raw and analyzed RNA-sequencing data generated during this study are available in the Gene Expression Omnibus (GEO) repository (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link>) and are accessible through GEO series accession number <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163631">GSE163631</ext-link>. Raw proteomics data are available in MassIVE with accession number <ext-link ext-link-type="uri" xlink:href="https://massive.ucsd.edu/ProteoSAFe/dataset.jsp?task=4170f66badb7404390b9a713900e733a">MSV000087183</ext-link>. Source data are provided with this paper. Previously published datasets used in this study include: <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE130699">GSE130699</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE147236">GSE147236</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE1145">GSE1145</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE9800">GSE9800</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE95755">GSE95755</ext-link>, and GTEx [<ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/home/">https://gtexportal.org/home/</ext-link>].&#xA0;<xref rid="Sec39" ref-type="sec">Source data</xref> are provided with this paper.</p>
    </notes>
    <notes notes-type="data-availability">
      <title>Code availability</title>
      <p>The MATLAB code used to perform contractile force measurements of hPSC-CMs has been deposited to GitHub: <ext-link ext-link-type="uri" xlink:href="https://github.com/DarisaLLC/Cardio">https://github.com/DarisaLLC/Cardio</ext-link>.</p>
    </notes>
    <notes id="FPar1" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par68">The authors declare no competing interests as defined by Nature Research.</p>
    </notes>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohn</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Ferrari</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Sharpe</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <year>2000</year>
          <volume>35</volume>
          <fpage>569</fpage>
          <lpage>582</lpage>
          <pub-id pub-id-type="doi">10.1016/S0735-1097(99)00630-0</pub-id>
          <pub-id pub-id-type="pmid">10716457</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gaballa</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Ventricular remodeling in heart failure</article-title>
          <source>J. Card. Fail.</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>S476</fpage>
          <lpage>S485</lpage>
          <pub-id pub-id-type="doi">10.1054/jcaf.2002.129270</pub-id>
          <pub-id pub-id-type="pmid">12555161</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porrello</surname>
              <given-names>ER</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transient regenerative potential of the neonatal mouse heart</article-title>
          <source>Science (N. Y., N. Y.)</source>
          <year>2011</year>
          <volume>331</volume>
          <fpage>1078</fpage>
          <lpage>1080</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1200708</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porrello</surname>
              <given-names>ER</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2013</year>
          <volume>110</volume>
          <fpage>187</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1208863110</pub-id>
          <pub-id pub-id-type="pmid">23248315</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cui</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dynamic transcriptional responses to injury of regenerative and non-regenerative cardiomyocytes revealed by single-nucleus RNA sequencing</article-title>
          <source>Dev. Cell</source>
          <year>2020</year>
          <volume>53</volume>
          <fpage>102</fpage>
          <lpage>116.e108</lpage>
          <pub-id pub-id-type="doi">10.1016/j.devcel.2020.02.019</pub-id>
          <pub-id pub-id-type="pmid">32220304</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genetic lineage tracing of nonmyocyte population by dual recombinases</article-title>
          <source>Circulation</source>
          <year>2018</year>
          <volume>138</volume>
          <fpage>793</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.034250</pub-id>
          <pub-id pub-id-type="pmid">29700121</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potta</surname>
              <given-names>SP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Isolation and functional characterization of alpha-smooth muscle actin expressing cardiomyocytes from embryonic stem cells</article-title>
          <source>Cell Physiol. Biochem</source>
          <year>2010</year>
          <volume>25</volume>
          <fpage>595</fpage>
          <lpage>604</lpage>
          <pub-id pub-id-type="doi">10.1159/000315078</pub-id>
          <pub-id pub-id-type="pmid">20511704</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues</article-title>
          <source>J. Mol. Diagn.</source>
          <year>2012</year>
          <volume>14</volume>
          <fpage>22</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmoldx.2011.08.002</pub-id>
          <pub-id pub-id-type="pmid">22166544</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stuart</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive integration of single-cell data</article-title>
          <source>Cell</source>
          <year>2019</year>
          <volume>177</volume>
          <fpage>1888</fpage>
          <lpage>1902.e1821</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id>
          <pub-id pub-id-type="pmid">31178118</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>St&#xE5;hl</surname>
              <given-names>PL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Visualization and analysis of gene expression in tissue sections by spatial transcriptomics</article-title>
          <source>Science (N.Y., NY)</source>
          <year>2016</year>
          <volume>353</volume>
          <fpage>78</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aaf2403</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mechanistic basis of neonatal heart regeneration revealed by transcriptome and histone modification profiling</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2019</year>
          <volume>116</volume>
          <fpage>18455</fpage>
          <lpage>18465</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1905824116</pub-id>
          <pub-id pub-id-type="pmid">31451669</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bartelt</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Brown adipose tissue thermogenic adaptation requires Nrf1-mediated proteasomal activity</article-title>
          <source>Nat. Med.</source>
          <year>2018</year>
          <volume>24</volume>
          <fpage>292</fpage>
          <lpage>303</lpage>
          <pub-id pub-id-type="doi">10.1038/nm.4481</pub-id>
          <pub-id pub-id-type="pmid">29400713</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kobayashi</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction</article-title>
          <source>Genes Cells</source>
          <year>2011</year>
          <volume>16</volume>
          <fpage>692</fpage>
          <lpage>703</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2443.2011.01522.x</pub-id>
          <pub-id pub-id-type="pmid">21554501</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>4120</fpage>
          <lpage>4125</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0500660102</pub-id>
          <pub-id pub-id-type="pmid">15738389</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sykiotis</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Bohmann</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Stress-activated cap&#x2019;n&#x2019;collar transcription factors in aging and human disease</article-title>
          <source>Sci. Signal.</source>
          <year>2010</year>
          <volume>3</volume>
          <fpage>re3</fpage>
          <pub-id pub-id-type="doi">10.1126/scisignal.3112re3</pub-id>
          <pub-id pub-id-type="pmid">20215646</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>XL</given-names>
            </name>
            <name>
              <surname>Kan</surname>
              <given-names>YW</given-names>
            </name>
          </person-group>
          <article-title>Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>1993</year>
          <volume>90</volume>
          <fpage>11371</fpage>
          <lpage>11375</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.90.23.11371</pub-id>
          <pub-id pub-id-type="pmid">8248256</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Radhakrishnan</surname>
              <given-names>SK</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells</article-title>
          <source>Mol. Cell</source>
          <year>2010</year>
          <volume>38</volume>
          <fpage>17</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1016/j.molcel.2010.02.029</pub-id>
          <pub-id pub-id-type="pmid">20385086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biswas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>JY</given-names>
            </name>
          </person-group>
          <article-title>Role of Nrf1 in antioxidant response element-mediated gene expression and beyond</article-title>
          <source>Toxicol. Appl. Pharmacol.</source>
          <year>2010</year>
          <volume>244</volume>
          <fpage>16</fpage>
          <lpage>20</lpage>
          <pub-id pub-id-type="doi">10.1016/j.taap.2009.07.034</pub-id>
          <pub-id pub-id-type="pmid">19665035</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puente</surname>
              <given-names>BN</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The oxygen-rich postnatal environment induces cardiomyocyte cell-cycle arrest through DNA damage response</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>157</volume>
          <fpage>565</fpage>
          <lpage>579</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2014.03.032</pub-id>
          <pub-id pub-id-type="pmid">24766806</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Long</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy</article-title>
          <source>Science (N. Y., N. Y.)</source>
          <year>2016</year>
          <volume>351</volume>
          <fpage>400</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="doi">10.1126/science.aad5725</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Bassel-Duby</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>EN</given-names>
            </name>
          </person-group>
          <article-title>Genetic and epigenetic regulation of cardiomyocytes in development, regeneration and disease</article-title>
          <source>Development</source>
          <year>2018</year>
          <volume>145</volume>
          <fpage>dev171983</fpage>
          <pub-id pub-id-type="doi">10.1242/dev.171983</pub-id>
          <pub-id pub-id-type="pmid">30573475</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yasmin</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Strynadka</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts</article-title>
          <source>Cardiovasc. Res.</source>
          <year>1997</year>
          <volume>33</volume>
          <fpage>422</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="doi">10.1016/S0008-6363(96)00254-4</pub-id>
          <pub-id pub-id-type="pmid">9074708</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chatterjee</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Honbo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Karliner</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Doxorubicin cardiomyopathy</article-title>
          <source>Cardiology</source>
          <year>2010</year>
          <volume>115</volume>
          <fpage>155</fpage>
          <lpage>162</lpage>
          <pub-id pub-id-type="doi">10.1159/000265166</pub-id>
          <pub-id pub-id-type="pmid">20016174</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fang</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ferroptosis as a target for protection against cardiomyopathy</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2019</year>
          <volume>116</volume>
          <fpage>2672</fpage>
          <lpage>2680</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1821022116</pub-id>
          <pub-id pub-id-type="pmid">30692261</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tao</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury</article-title>
          <source>Nature</source>
          <year>2016</year>
          <volume>534</volume>
          <fpage>119</fpage>
          <lpage>123</lpage>
          <pub-id pub-id-type="doi">10.1038/nature17959</pub-id>
          <pub-id pub-id-type="pmid">27251288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Otterbein</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Soares</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Bach</surname>
              <given-names>FH</given-names>
            </name>
          </person-group>
          <article-title>Heme oxygenase-1: unleashing the protective properties of heme</article-title>
          <source>Trends Immunol.</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>449</fpage>
          <lpage>455</lpage>
          <pub-id pub-id-type="doi">10.1016/S1471-4906(03)00181-9</pub-id>
          <pub-id pub-id-type="pmid">12909459</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Moon</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>You</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>WH</given-names>
            </name>
          </person-group>
          <article-title>The effect of MG132, a proteasome inhibitor on HeLa cells in relation to cell growth, reactive oxygen species and GSH</article-title>
          <source>Oncol. Rep.</source>
          <year>2009</year>
          <volume>22</volume>
          <fpage>215</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">19513526</pub-id>
        </element-citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minamino</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kitakaze</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>ER stress in cardiovascular disease</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <year>2010</year>
          <volume>48</volume>
          <fpage>1105</fpage>
          <lpage>1110</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yjmcc.2009.10.026</pub-id>
          <pub-id pub-id-type="pmid">19913545</pub-id>
        </element-citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsutsui</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kinugawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Matsushima</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Oxidative stress and heart failure</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <year>2011</year>
          <volume>301</volume>
          <fpage>H2181</fpage>
          <lpage>H2190</lpage>
          <pub-id pub-id-type="doi">10.1152/ajpheart.00554.2011</pub-id>
          <pub-id pub-id-type="pmid">21949114</pub-id>
        </element-citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gustafsson</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Gottlieb</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Recycle or die: the role of autophagy in cardioprotection</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <year>2008</year>
          <volume>44</volume>
          <fpage>654</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="doi">10.1016/j.yjmcc.2008.01.010</pub-id>
          <pub-id pub-id-type="pmid">18353358</pub-id>
        </element-citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sciarretta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Shenoy</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Nagarajan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sadoshima</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The importance of autophagy in cardioprotection</article-title>
          <source>High Blood Press. Cardiovasc. Prev.</source>
          <year>2014</year>
          <volume>21</volume>
          <fpage>21</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1007/s40292-013-0029-9</pub-id>
          <pub-id pub-id-type="pmid">24235024</pub-id>
        </element-citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirotsu</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hataya</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Katsuoka</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1&#x3B2; genes</article-title>
          <source>Mol. Cell. Biol.</source>
          <year>2012</year>
          <volume>32</volume>
          <fpage>2760</fpage>
          <lpage>2770</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.06706-11</pub-id>
          <pub-id pub-id-type="pmid">22586274</pub-id>
        </element-citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirotsu</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Transcription factor NF-E2-related factor 1 impairs glucose metabolism in mice</article-title>
          <source>Genes Cells</source>
          <year>2014</year>
          <volume>19</volume>
          <fpage>650</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1111/gtc.12165</pub-id>
          <pub-id pub-id-type="pmid">25041126</pub-id>
        </element-citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sereti</surname>
              <given-names>KI</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of cardiomyocyte clonal expansion during mouse heart development and injury</article-title>
          <source>Nat. Commun.</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>754</fpage>
          <pub-id pub-id-type="doi">10.1038/s41467-018-02891-z</pub-id>
          <pub-id pub-id-type="pmid">29467410</pub-id>
        </element-citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kannan</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Large particle fluorescence-activated cell sorting enables high-quality single-cell RNA sequencing and functional analysis of adult cardiomyocytes</article-title>
          <source>Circ. Res.</source>
          <year>2019</year>
          <volume>125</volume>
          <fpage>567</fpage>
          <lpage>569</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.119.315493</pub-id>
          <pub-id pub-id-type="pmid">31415233</pub-id>
        </element-citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bergeron</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Filamentous nestin and nonmuscle myosin IIB are associated with a migratory phenotype in neonatal rat cardiomyocytes</article-title>
          <source>J. Cell. Physiol.</source>
          <year>2021</year>
          <volume>236</volume>
          <fpage>1281</fpage>
          <lpage>1294</lpage>
          <pub-id pub-id-type="doi">10.1002/jcp.29934</pub-id>
          <pub-id pub-id-type="pmid">32654195</pub-id>
        </element-citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ingason</surname>
              <given-names>AB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Angiogenesis precedes cardiomyocyte migration in regenerating mammalian hearts</article-title>
          <source>J. Thorac. Cardiovasc. Surg.</source>
          <year>2018</year>
          <volume>155</volume>
          <fpage>1118</fpage>
          <lpage>1127.e1111</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtcvs.2017.08.127</pub-id>
          <pub-id pub-id-type="pmid">29452461</pub-id>
        </element-citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Itou</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Migration of cardiomyocytes is essential for heart regeneration in zebrafish</article-title>
          <source>Development</source>
          <year>2012</year>
          <volume>139</volume>
          <fpage>4133</fpage>
          <lpage>4142</lpage>
          <pub-id pub-id-type="doi">10.1242/dev.079756</pub-id>
          <pub-id pub-id-type="pmid">23034636</pub-id>
        </element-citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model</article-title>
          <source>Circ. Res.</source>
          <year>2014</year>
          <volume>115</volume>
          <fpage>354</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.303632</pub-id>
          <pub-id pub-id-type="pmid">24833660</pub-id>
        </element-citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xin</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hippo pathway effector Yap promotes cardiac regeneration</article-title>
          <source>Proc. Natl Acad. Sci. USA</source>
          <year>2013</year>
          <volume>110</volume>
          <fpage>13839</fpage>
          <lpage>13844</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1313192110</pub-id>
          <pub-id pub-id-type="pmid">23918388</pub-id>
        </element-citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Song</surname>
              <given-names>HP</given-names>
            </name>
            <name>
              <surname>Chu</surname>
              <given-names>ZG</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>DX</given-names>
            </name>
            <name>
              <surname>Dang</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title>PI3K-AKT pathway protects cardiomyocytes against hypoxia-induced apoptosis by mitoKATP-mediated mitochondrial translocation of pAKT</article-title>
          <source>Cell. Physiol. Biochem.</source>
          <year>2018</year>
          <volume>49</volume>
          <fpage>717</fpage>
          <lpage>727</lpage>
          <pub-id pub-id-type="doi">10.1159/000493037</pub-id>
          <pub-id pub-id-type="pmid">30165359</pub-id>
        </element-citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lin</surname>
              <given-names>Z</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival</article-title>
          <source>Circ. Res.</source>
          <year>2015</year>
          <volume>116</volume>
          <fpage>35</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.304457</pub-id>
          <pub-id pub-id-type="pmid">25249570</pub-id>
        </element-citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahmoud</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Porrello</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Sadek</surname>
              <given-names>HA</given-names>
            </name>
          </person-group>
          <article-title>Surgical models for cardiac regeneration in neonatal mice</article-title>
          <source>Nat. Protoc.</source>
          <year>2014</year>
          <volume>9</volume>
          <fpage>305</fpage>
          <lpage>311</lpage>
          <pub-id pub-id-type="doi">10.1038/nprot.2014.021</pub-id>
          <pub-id pub-id-type="pmid">24434799</pub-id>
        </element-citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amoasii</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy</article-title>
          <source>Sci. Transl. Med.</source>
          <year>2017</year>
          <volume>9</volume>
          <fpage>pii: eaan8081</fpage>
          <pub-id pub-id-type="doi">10.1126/scitranslmed.aan8081</pub-id>
        </element-citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martari</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette</article-title>
          <source>Hum. Gene Ther.</source>
          <year>2009</year>
          <volume>20</volume>
          <fpage>759</fpage>
          <lpage>766</lpage>
          <pub-id pub-id-type="doi">10.1089/hum.2008.197</pub-id>
          <pub-id pub-id-type="pmid">19298131</pub-id>
        </element-citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atmanli</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiplex live single-cell transcriptional analysis demarcates cellular functional heterogeneity</article-title>
          <source>eLife</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>49599</fpage>
          <pub-id pub-id-type="doi">10.7554/eLife.49599</pub-id>
        </element-citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burridge</surname>
              <given-names>PW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Chemically defined generation of human cardiomyocytes</article-title>
          <source>Nat. Methods</source>
          <year>2014</year>
          <volume>11</volume>
          <fpage>855</fpage>
          <lpage>860</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.2999</pub-id>
          <pub-id pub-id-type="pmid">24930130</pub-id>
        </element-citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atmanli</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Domian</surname>
              <given-names>IJ</given-names>
            </name>
          </person-group>
          <article-title>Molecular etching: a novel methodology for the generation of complex micropatterned growth surfaces for human cellular assays</article-title>
          <source>Adv. Healthc Mater.</source>
          <year>2014</year>
          <volume>3</volume>
          <fpage>1759</fpage>
          <lpage>1764</lpage>
          <pub-id pub-id-type="doi">10.1002/adhm.201400010</pub-id>
          <pub-id pub-id-type="pmid">24805162</pub-id>
        </element-citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Metabolic maturation of human pluripotent stem cell-derived cardiomyocytes by inhibition of HIF1&#x3B1; and LDHA</article-title>
          <source>Circ. Res.</source>
          <year>2018</year>
          <volume>123</volume>
          <fpage>1066</fpage>
          <lpage>1079</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.313249</pub-id>
          <pub-id pub-id-type="pmid">30355156</pub-id>
        </element-citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kijlstra</surname>
              <given-names>JD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Integrated analysis of contractile kinetics, force generation, and electrical activity in single human stem cell-derived cardiomyocytes</article-title>
          <source>Stem Cell Rep.</source>
          <year>2015</year>
          <volume>5</volume>
          <fpage>1226</fpage>
          <lpage>1238</lpage>
          <pub-id pub-id-type="doi">10.1016/j.stemcr.2015.10.017</pub-id>
        </element-citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cui</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Olson</surname>
              <given-names>EN</given-names>
            </name>
          </person-group>
          <article-title>Protocol for single-nucleus transcriptomics of diploid and tetraploid cardiomyocytes in murine hearts</article-title>
          <source>STAR Protoc.</source>
          <year>2020</year>
          <volume>1</volume>
          <fpage>100049</fpage>
          <pub-id pub-id-type="doi">10.1016/j.xpro.2020.100049</pub-id>
          <pub-id pub-id-type="pmid">33111095</pub-id>
        </element-citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Butler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Smibert</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Papalexi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Satija</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>36</volume>
          <fpage>411</fpage>
          <lpage>420</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id>
          <pub-id pub-id-type="pmid">29608179</pub-id>
        </element-citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolock</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Scrublet: computational identification of cell doublets in single-cell transcriptomic data</article-title>
          <source>Cell Syst.</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>281</fpage>
          <lpage>291.e289</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cels.2018.11.005</pub-id>
          <pub-id pub-id-type="pmid">30954476</pub-id>
        </element-citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Becht</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dimensionality reduction for visualizing single-cell data using UMAP</article-title>
          <source>Nat. Biotechnol.</source>
          <year>2018</year>
          <volume>37</volume>
          <fpage>38</fpage>
          <lpage>44</lpage>
          <pub-id pub-id-type="doi">10.1038/nbt.4314</pub-id>
        </element-citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Langmead</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Salzberg</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>HISAT: a fast spliced aligner with low memory requirements</article-title>
          <source>Nat. Methods</source>
          <year>2015</year>
          <volume>12</volume>
          <fpage>357</fpage>
          <lpage>360</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id>
          <pub-id pub-id-type="pmid">25751142</pub-id>
        </element-citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The sequence alignment/map format and SAMtools</article-title>
          <source>Bioinformatics</source>
          <year>2009</year>
          <volume>25</volume>
          <fpage>2078</fpage>
          <lpage>2079</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id>
          <pub-id pub-id-type="pmid">19505943</pub-id>
        </element-citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title>
          <source>Bioinformatics</source>
          <year>2014</year>
          <volume>0</volume>
          <fpage>923</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id>
        </element-citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Smyth</surname>
              <given-names>GK</given-names>
            </name>
          </person-group>
          <article-title>edgeR: a Bioconductor package for differential expression analysis of digital gene expression data</article-title>
          <source>Bioinformatics</source>
          <year>2010</year>
          <volume>26</volume>
          <fpage>139</fpage>
          <lpage>140</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btp616</pub-id>
          <pub-id pub-id-type="pmid">19910308</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Immunol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Immunology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1664-3224</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33708206</article-id>
      <article-id pub-id-type="pmc">7940545</article-id>
      <article-id pub-id-type="doi">10.3389/fimmu.2021.611910</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Immunology</subject>
          <subj-group>
            <subject>Review</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Untangling Local Pro-Inflammatory, Reparative, and Regulatory Damage-Associated Molecular-Patterns (DAMPs) Pathways to Improve Transplant Outcomes</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dwyer</surname>
            <given-names>Gaelen K.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/1162348"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Turnquist</surname>
            <given-names>H&#x113;th R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
          <xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
          <uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/215435"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<sup>1</sup>
<institution>Departments of Surgery and Immunology, University of Pittsburgh School of Medicine</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country>United States</country>
</aff>
      <aff id="aff2">
<sup>2</sup>
<institution>Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country>United States</country>
</aff>
      <aff id="aff3">
<sup>3</sup>
<institution>McGowan Institute for Regenerative Medicine, University of Pittsburgh</institution>, <addr-line>Pittsburgh, PA</addr-line>, <country>United States</country>
</aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Xue-Zhong Yu, Medical University of South Carolina, United States</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Tomomi Toubai, Yamagata University, Japan; Carl Atkinson, Medical University of South Carolina, United States</p>
        </fn>
        <corresp id="fn001">*Correspondence: H&#x113;th R. Turnquist, <email xlink:href="mailto:het5@pitt.edu" xlink:type="simple">het5@pitt.edu</email>
</corresp>
        <fn fn-type="other" id="fn002">
          <p>This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>23</day>
        <month>2</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>611910</elocation-id>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>9</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>1</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2021 Dwyer and Turnquist</copyright-statement>
        <copyright-year>2021</copyright-year>
        <copyright-holder>Dwyer and Turnquist</copyright-holder>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Detrimental inflammatory responses after solid organ transplantation are initiated when immune cells sense pathogen-associated molecular patterns (PAMPs) and certain damage-associated molecular patterns (DAMPs) released or exposed during transplant-associated processes, such as ischemia/reperfusion injury (IRI), surgical trauma, and recipient conditioning. These inflammatory responses initiate and propagate anti-alloantigen (AlloAg) responses and targeting DAMPs and PAMPs, or the signaling cascades they activate, reduce alloimmunity, and contribute to improved outcomes after allogeneic solid organ transplantation in experimental studies. However, DAMPs have also been implicated in initiating essential anti-inflammatory and reparative functions of specific immune cells, particularly Treg and macrophages. Interestingly, DAMP signaling is also involved in local and systemic homeostasis. Herein, we describe the emerging literature defining how poor outcomes after transplantation may result, not from just an over-abundance of DAMP-driven inflammation, but instead an inadequate presence of a subset of DAMPs or related molecules needed to repair tissue successfully or re-establish tissue homeostasis. Adverse outcomes may also arise when these homeostatic or reparative signals become dysregulated or hijacked by alloreactive immune cells in transplant niches. A complete understanding of the critical pathways controlling tissue repair and homeostasis, and how alloimmune responses or transplant-related processes disrupt these will lead to new immunotherapeutics that can prevent or reverse the tissue pathology leading to lost grafts due to chronic rejection.</p>
      </abstract>
      <kwd-group>
        <kwd>transplantation</kwd>
        <kwd>ischemia&#x2013;reperfusion injury</kwd>
        <kwd>damage-associated molecular patterns</kwd>
        <kwd>tissue repair and fibrosis</kwd>
        <kwd>regulatory T cell</kwd>
        <kwd>macrophage</kwd>
        <kwd>alarmins</kwd>
        <kwd>immunometabolism</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
          <award-id rid="cn001">R01AR073527, R01HL22489, R56AI139327, F30AI147437</award-id>
        </award-group>
      </funding-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="189"/>
        <page-count count="20"/>
        <word-count count="11697"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Tissue injury negatively impacts outcomes after the transplantation (Tx) of cells, tissues, or organs. In solid organ transplantation (SOTx) and vascularized composite allograft (VCA) transplantation ischemia reperfusion injury (IRI), surgical manipulations, donor trauma, and brain death initiate the release of self-derived molecules containing damage-associated molecular patterns (DAMPs) that alert immune cells to the damage (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Released DAMPs will act on resident donor and graft-infiltrating immune cells to shape local and systemic immune functions that determine SOTx short and long-term outcomes. Some DAMPs are not released from necrotic cells, but instead are exposed on stressed or dying cell membranes (<xref rid="B3" ref-type="bibr">3</xref>). This review briefly discusses recent advances in understanding how DAMPs contribute to inflammation that stimulates alloimmunity, but highly detailed information can be found in numerous excellent reviews (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>&#x2013;<xref rid="B6" ref-type="bibr">6</xref>). In this review, we also elaborate on emerging concepts in Tx that are developing from an evolving understanding of the potential beneficial function of DAMPs in tissue repair and systemic homeostasis. We will also discuss examples of how these reparative or homeostatic DAMP pathways may become dysregulated or re-appropriated throughout the graft by anti-donor immune responses to also contribute to chronic rejection (CR).</p>
    </sec>
    <sec id="s2">
      <title>Current Understanding of DAMPs as Drivers of Alloimmune Responses and Poor Outcomes After SOTx</title>
      <p>Numerous DAMPs released during cellular stress, tissue injury, or <italic>via</italic> inflammatory cell death pathways such as ferroptosis, necroptosis, pyroptosis, have been identified (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). How these DAMPs initiate sterile inflammation and contribute to anti-AlloAg immune responses has been reviewed recently (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Well-characterized pro-inflammatory DAMPs active in Tx include nuclear materials, such as high-mobility group box 1 (HMGB1), interleukin (IL)-1&#x3B1;, cytoplasmic components, including ATP, heat shock proteins (HSPs), and s100 proteins, mitochondrial (mt) contents like mtDNA or mt transcriptional factor A, as well as extracellular matrix (ECM) components, including hyaluronan, fibronectin, and heparan sulfate have been assessed in Tx models (<xref rid="T1" ref-type="table">
<bold>Table 1</bold>
</xref>). Oxidative injury-induced neo-antigens and typically sequestered cytoplasmic proteins such as HSPs and the ER chaperone calreticulin can be exposed on or incorporated in the cell membrane.</p>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Inflammatory DAMPs and their impact on SOTx outcomes.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">Family</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Molecule</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Receptors</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Role in Tx- related inflammation/immunity/outcomes</th>
              <th valign="top" align="center" rowspan="1" colspan="1">References</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Inflammatory DAMPs</td>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Histones</td>
              <td valign="top" align="left" rowspan="1" colspan="1">TLR2, TLR4, and TLR9</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Causes TLR- and inflammasome-dependent generation of inflammatory response by innate cells</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">HMGB1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">TLR2, TLR4, RAGE, and TIM3</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Promotes the production of pro-inflammatory cytokines and chemokines by innate immune cells<break/>Induces metabolic reprogramming supporting the pro-inflammatory functions of myeloid APC<break/>Promotion of AR and CR in experimental models<break/>Implicated in poor outcomes after clinical transplantation</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B10" ref-type="bibr">10</xref>&#x2013;<xref rid="B15" ref-type="bibr">15</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">IL1&#x3B1;</td>
              <td valign="top" align="left" rowspan="1" colspan="1">IL-1R</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Promotes the production of pro-inflammatory cytokines and chemokines by innate immune cells</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B16" ref-type="bibr">16</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">ATP</td>
              <td valign="top" align="left" rowspan="1" colspan="1">P2Y2 and P2X7</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Attraction and activation of innate cells<break/>Promotes inflammasome activity<break/>Causes the release pro-inflammatory cytokines supporting rejection<break/>Promotes IL-1&#x3B2; and IL18 secretion and initiates inflammatory cell death<break/>Stimulates alloimmunity</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B17" ref-type="bibr">17</xref>&#x2013;<xref rid="B20" ref-type="bibr">20</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Vimentin</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Dectin-1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Induces metabolic reprogramming supporting the pro-inflammatory functions of myeloid APC<break/>Induces macrophage TNF &#x3B1; and IL-6 production</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B10" ref-type="bibr">10</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Hyaluronan (HA)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">TLR2 and TLR4</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Low molecular weight breakdown products stimulate macrophages pro-inflammatory cytokine production<break/>Supports of alloimmunity</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B21" ref-type="bibr">21</xref>&#x2013;<xref rid="B23" ref-type="bibr">23</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">S100s</td>
              <td valign="top" align="left" rowspan="1" colspan="1">TLR2, TLR4, RAGE</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Potent immunostimulatory activity, monocytes and neutrophils recruitment</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B24" ref-type="bibr">24</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Mitochondrial DNA (mDNA)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">TLR9</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Macrophages and neutrophils activation<break/>Promotes inflammasome activity<break/>Causes the release pro-inflammatory cytokines supporting rejection<break/>Promotes IL-1&#x3B2; and IL18 secretion and initiates inflammatory cell death</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>Many defined DAMPs are recognized by conserved pattern recognition receptors (PRRs) that also recognize non-self materials containing pathogen-associated molecular patterns (PAMPs) to generate protective immune responses (<xref rid="T1" ref-type="table">
<bold>Table 1</bold>
</xref>). This overlap has made it difficult to clearly define the role of specific DAMPs versus bacterial product contamination in early studies (<xref rid="B6" ref-type="bibr">6</xref>). Nevertheless, studies with antibodies targeting specific DAMPs, as well as the generation and use of DAMP KO mice, have established that self-derived materials influence SOTx outcomes in experimental transplant models (<xref rid="B5" ref-type="bibr">5</xref>). Other PRR-type receptors able to detect DAMPs include NOD-like receptors (NLRs), retinoic acid-inducible gene I (RIG-I)-like receptor (RLRs), C-type lectin receptors, and intracellular DNA sensors, such as cyclic GMP-AMP synthase (cGAS), and absent in melanoma 2 (AIM2) (<xref rid="B6" ref-type="bibr">6</xref>). Non-PRR receptors such as the receptor for advanced glycation end products (RAGE) as well as G-protein-coupled receptors like formyl peptide receptors (FPRs) and P2Y receptors, detecting extracellular nucleotides like ATP have been revealed to be important in sterile inflammation and supporting alloimmune responses leading to acute rejection (AR) and CR (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Exposed HSPs and calreticulin displayed on the cell surface can be recognized by CD91 and aid engulfment and presentation of alloAg by antigen presenting cells APC (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B28" ref-type="bibr">28</xref>). Natural antibody responses to displayed oxidative-induced neo-antigens can also trigger APC activation <italic>via</italic> the complement cascade (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>). DAMPs stimulation of pro-inflammatory immune response leading to increased alloimmunity is well appreciated to contribute significantly to both AR and CR in experimental models (<xref rid="B10" ref-type="bibr">10</xref>&#x2013;<xref rid="B12" ref-type="bibr">12</xref>) and this important subject has been the focus of several recent and thorough reviews (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). Clinically, DAMPs are implicated in AR of liver grafts (<xref rid="B13" ref-type="bibr">13</xref>) as well as CR of cardiac transplants (<xref rid="B14" ref-type="bibr">14</xref>). HMGB1 is induced by IRI in cadaveric kidney transplants, but absent from living donor grafts that have better outcomes (<xref rid="B15" ref-type="bibr">15</xref>). Similarly, recipients with a mutation in TLR4 that decreases the affinity for HMGB1 exhibit better early graft function (<xref rid="B15" ref-type="bibr">15</xref>).</p>
      <p>The concept that the presence of DAMPs leads to poor early and late Tx outcomes is supported by the clinical observation that shorter IRI times result in reduced risk of AR and CR after SOTx. The finding that HLA mismatch, recipients of living, unrelated donor kidneys have significantly better long-term outcomes relative to those receiving HLA-matched cadaveric kidney grafts subjected to longer periods of ischemia support this premise (<xref rid="B29" ref-type="bibr">29</xref>). Furthermore, each hour of cold ischemia increases the odds of AR (<xref rid="B30" ref-type="bibr">30</xref>), early graft failure, and mortality after kidney Tx (<xref rid="B31" ref-type="bibr">31</xref>). Similar negative associations with outcomes with increased ischemia times have been made for cardiac (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>) and liver Tx (<xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B35" ref-type="bibr">35</xref>).</p>
    </sec>
    <sec id="s3">
      <title>Directly Targeting DAMP Signaling to Improve Outcomes</title>
      <p>Clinical observations supporting DAMPs as a dominant initiator of IRI and contributor to alloimmunity and rejection have compelled efforts to antagonize them after SOTx. As outlined in <xref rid="T1" ref-type="table">
<bold>Table 1</bold>
</xref>, many DAMPs initiate function by activating TLRs and the downstream adapter MyD88. Pre-clinical studies using MyD88 or TLR deficient mice have identified both as effective targets to limit IRI, inflammation, and improve transplant outcomes (<xref rid="B36" ref-type="bibr">36</xref>). These early rodent studies utilizing TLR and MyD88 deficient mice have led to the development of numerous biologics targeting TLRs and MyD88, which have shown promise in promoting tolerance or limiting rejection (<xref rid="B37" ref-type="bibr">37</xref>&#x2013;<xref rid="B42" ref-type="bibr">42</xref>). For example, newer agents like Eritoran, which is a synthetic analog of the lipid A portion of lipopolysaccharide (LPS) that can antagonize LPS binding (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>), or the 2-aminothiazole-derived MyD88 inhibitor TJ-M2010-5, are potent inhibitors of DC activation and promoted long-term heart and skin graft survival in rodents (<xref rid="B37" ref-type="bibr">37</xref>).</p>
      <p>Nevertheless, successful translation of agents targeting these pathways remains to be realized. NI-0101 is a humanized, anti-TLR4 antibody that interferes with TLR4 dimerization and provides sustained blocking of LPS&#x2010;induced cytokine production in healthy volunteers (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). It, however, failed recently to alter disease in a Phase II, randomized, placebo-controlled, double-blind, international, multicenter study of individuals with moderate to severe rheumatoid arthritis (<xref rid="B47" ref-type="bibr">47</xref>). OPN-305 (Tomaralimab, Opsona Therapeutics) is a humanized, IgG4 monoclonal antibody against TLR2 under recent phase II investigation to prevent delayed graft function after kidney Tx (<xref rid="B48" ref-type="bibr">48</xref>). Both OPN-305 and OPN-201, its murine monoclonal parent antibody, have shown a potent ability to antagonize TLR2 signaling that is activated by HMGB1 and several HSPs, and limit IRI in rodents and swine (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>). An earlier Phase I study established that OPN-305 infusions were well tolerated and consistently inhibited heat-killed <italic>listeria monocytogenes</italic>-mediated IL-6 secretion by patients&#x2019; peripheral blood cells for periods up to 90 days (<xref rid="B51" ref-type="bibr">51</xref>). While these studies would suggest promise, the future of OPN-305 is unclear. There have not been any published reports from the Phase II trial, and as of 2019, Opsona was liquidated after the search for a development partner or buyer for its leading drug therapy was fruitless (<xref rid="B52" ref-type="bibr">52</xref>). Given the importance of TLRs and MyD88 to the initiation of detrimental pro-inflammatory response to after IRI and demonstrated in pre-clinical Tx studies, it can be expected that efforts to identify clinical candidates that effectively target this pathway and limit early inflammation after Tx will persist. As trials of these agents move forward, it will be very interesting to observe if the benefits that potent TLR signaling pathway inhibitors have against DAMP-driven IRI and tissue damage and the generation of alloimmune responses can outweigh the expected blunting of effective anti-pathogen immunity (<xref rid="B53" ref-type="bibr">53</xref>). If this class of drugs only produces the generalized immunosuppression similar to that observed with non-specific TCR signaling inhibition with drugs like Tacrolimus, their impact will be limited. However, if potent drugs blocking TLR signaling can be delivered for only for a short window in or around Tx surgery for highly effective prevention of the general innate inflammation initiating AlloAg-specific T cell responses DAMP-activated antigen presenting cells (APC), this class of drugs blocking tissue damage-mediated inflammation could be transformative.</p>
    </sec>
    <sec id="s4">
      <title>Targeting Immunometabolism to Limit the Pro-Inflammatory Activity of DAMPs</title>
      <p>Ischemia resulting from organ procurement not only causes cellular stress and cell death that releases DAMPs, but it will also cause graft hypoxia that will program graft-resident, donor immune cells and infiltrating recipient immune cells for an inflammatory response to these DAMPs. Myeloid cells in a hypoxic environment upregulate hypoxia-induced factor-1 alpha (HIF-1&#x3B1;), which is critical to coordinate a local pro-inflammatory response (<xref rid="B54" ref-type="bibr">54</xref>). HIF-1&#x3B1; dimerizes with HIF-1&#x3B2; and translocates to the nucleus to modulate transcription of genes with promoters containing HIF response elements (HREs), with many of the induced gene products supporting the recruitment, retention, and function of pro-inflammatory macrophages. The expression of HIF-1&#x3B1; is essential to myeloid cell transition to glycolysis during pro-inflammatory immune responses. Early studies by Cramer et&#xA0;al. demonstrated that HIF-1&#x3B1; deletion using a lysozyme 2 (<italic>Lys2</italic>, or L<italic>ysM</italic>)-driven Cre recombinase resulted in monocytes and macrophages that were defective in glycolysis and, as a result, impaired their capacity for motility, invasiveness, and phagocytic ability (<xref rid="B55" ref-type="bibr">55</xref>).</p>
      <p>The binding of TLR agonists by myeloid APC also shifts the cellular metabolism of myeloid cells towards glycolysis, which will supply ATP to support their inflammatory functions in oxygen sparse environments, but also generate nucleotides, lipids, and reactive oxygen species (ROS) used for anti-pathogen effector functions (<xref rid="B56" ref-type="bibr">56</xref>&#x2013;<xref rid="B59" ref-type="bibr">59</xref>). Such metabolic changes originate from TLR ligation-mediated inhibition of mitochondrial oxidative phosphorylation (OXPHOS) and associated remodeling of the tricarboxylic acid (TCA) cycle. A pivotal determinant of myeloid cells&#x2019; metabolic reprogramming during the generation of a pro-inflammatory subset is the <italic>de novo</italic> expression of inducible nitric oxide synthase (iNOS). Expression of iNOS generates large quantities of nitric oxide (NO) that inhibits mitochondrial respiration through the stable nitrosation of Complex I of the electron transport chain (ETC), as well as reversible inhibition Complex IV and isocitrate dehydrogenase (<xref rid="B60" ref-type="bibr">60</xref>). Induced changes in the TCA cycle result in the generation of metabolic intermediates that are determinants of the macrophage inflammatory phenotype due to their enforced reliance on glycolytic metabolism and preventing macrophages&#x2019; repolarization away from a pro-inflammatory macrophage subset (<xref rid="B61" ref-type="bibr">61</xref>). The O&#x2019;Neill group established that TLR4 ligation limits glutamine-dependent anaplerosis, or the replenishment of TCA cycle intermediates, to cause elevated levels of succinate to reach levels causing HIF-1&#x3B1; stabilization resulting in augment production of IL-1&#x3B2; (<xref rid="B62" ref-type="bibr">62</xref>). Interestingly, hypoxia alone was a weak inducer of <italic>Nos2</italic> mRNA in myeloid APC but synergized with TLR3, TLR4, and TLR9 agonists to prevent HIF-1&#x3B1;-dependent upregulation of <italic>Nos2</italic> mRNA and iNOS protein (<xref rid="B63" ref-type="bibr">63</xref>). The stimulation of TLRs by DAMPs like HMGB1, S100 proteins, mRNA, and mtDNA released during or after IRI in the hypoxic graft is a dominant driver of the pro-inflammatory responses that lead to early graft injury and failure, as well as stimulation of alloimmune responses that cause acute and chronic SOTx rejection.</p>
      <p>To date, TLRs and their pathways have proven challenging to antagonize early post-SOTx to limit early inflammation, but HIF-1&#x3B1; would seem like an attractive downstream target that could suppress myeloid cell pro-inflammatory activity by limiting glycolytic metabolism. However, limited pre-clinical studies indicated that non-specific targeting of HIF-1&#x3B1; might be detrimental due to important graft tissue protections provided by HIF-1&#x3B1; in stromal and parenchymal tissues. In an orthotopic tracheal Tx model, adenovirus-mediated HIF-1&#x3B1; gene transfer to the graft promoted repair of mouse airway allograft microvasculature and attenuated CR (<xref rid="B64" ref-type="bibr">64</xref>). This effect was due to the HIF-1&#x3B1;-dependent recruitment of recipient pro-angiogenic cells that contributed to repairing damaged airway microvasculature. HIF-1&#x3B1; delivery before Tx increased graft perfusion to decreased fibrosis and improve graft survival (<xref rid="B64" ref-type="bibr">64</xref>). Other studies have demonstrated the importance of protective signaling of HIF-1&#x3B1; in the stroma and parenchyma after heart and kidney IRI before transplant (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). The deletion of HIF-1&#x3B1; in macrophages causes the decreased production of vascular endothelial growth factor (VEGF), which is an important stimulus for initiating repair and vascularization of tissues damaged by IRI. While the early activity of the HIF-1&#x3B1;-VEGF is vital for the initiation of tissue repair, the sustained activation of the HIF-1&#x3B1;-VEGF pathway may later contribute to CR (<xref rid="B67" ref-type="bibr">67</xref>). HIF-1&#x3B1; is a critical factor that shapes the immune response after IRI and Tx; effectively targeting it will require both myeloid cell-specific delivery and understanding whether the graft&#x2019;s current conditions will require a HIF-1&#x3B1; antagonist or agonist.</p>
      <p>Recently, Ochando and colleagues completed exciting studies where they used myeloid cell-targeting nanoparticles to deliver an inhibitor of mammalian target of rapamycin (mTOR), which blocked HMGB1-induced glycolytic reprogramming (<xref rid="B10" ref-type="bibr">10</xref>). When mTOR-targeting nanoparticles were combined with antagonism of the CD40-TRAF6 axis, the result was long-term, fully MHC-mismatch cardiac allograft acceptance (<xref rid="B10" ref-type="bibr">10</xref>). The power of mTOR in stimulating macrophage pro-inflammatory functions was also demonstrated when the Medzhitov group established that IL-10 regulates macrophage pro-inflammatory responses by limiting glycolysis through the induction of a potent mTOR inhibitor, DDIT4 (<xref rid="B68" ref-type="bibr">68</xref>). IL-10 has long been understood to generate reparative and regulatory myeloid cells that support transplant tolerance, yet the mechanism(s) by which IL-10 mediates such potent impacts on myeloid cells has remained poorly understood. These studies established that myeloid cells stimulated with IL-10 resists the typical metabolic reprogramming induced by TLR4 ligation and, instead, maintained mitochondrial integrity and function to support OXPHOS. IL-10 also limits activation of the inflammasome by ATP in TLR4-stimulated macrophages. These recent investigations provide compelling evidence that myeloid cell-specific inhibition of mTOR and glycolysis will be an effective way to antagonist multiple DAMP pro-inflammatory pathways early after Tx.</p>
      <p>ATP, while the energy currency of immunometabolism, has also emerged as a highly influential TLR-independent DAMP released by damaged, dying, and activated cells (<xref rid="B6" ref-type="bibr">6</xref>), particularly after Tx. Recent basic discovery and clinical studies have elucidated how immune cells release ATP as an inflammatory signal in response to allogeneic Tx and signal in a feedback mechanism <italic>via</italic> P2X7 to promote the release pro-inflammatory cytokines supporting rejection (<xref rid="B17" ref-type="bibr">17</xref>). The pro-inflammatory cytokine IL-1&#x3B2; plays a crucial role in early immune responses to tissue injury and pathogens, but even when induced by pro-inflammatory stimuli it is generated in an inactive pro-form that requires processing by caspase-1 to an active form. Activation of caspase-1 relies on the inflammasome, a multi-protein complex containing members of the nucleotide-binding domain- and leucine-rich repeat-containing receptor (NLR) family. The best-characterized inflammasome is NLRP3, whose activity is induced by a wide range of diverse stimuli, including PAMPs, numerous DAMPs, such as ATP and mtDNA, ROS, and even particulate matter (<xref rid="B69" ref-type="bibr">69</xref>). Activating the NLRP3 inflammasome and subsequent secretion of IL-1&#x3B2; requires two signals (<xref rid="B69" ref-type="bibr">69</xref>). First, a NF&#x3BA;&#x3B2; activating signal, often a TLR-agonist, that induces and increases the expression of pro-IL-1&#x3B2; and NLRP3. A second signal, like the activation of the P2X7 receptor by extracellular ATP, or TLR detection of released mtROS or mtDNA, will cause inflammasome formation. The inflammasome activates associated caspase-1 that mediates the processing of pro-IL-1&#x3B2; or the closely related IL-1 family member, IL-18, into their mature and active cytokine form. Targeting P2X7 with an irreversible antagonist for 14 days after fully mismatched murine heart transplant promoted long-term cardiac transplant survival (<xref rid="B18" ref-type="bibr">18</xref>). Additional recent studies convincingly revealed that extracellular ATP is an early DAMP released by the transplant. ATP acts in a feed-forward loop to sustain high extracellular ATP levels in the graft by causing infiltrating recipient myeloid cells to release ATP locally. These high levels of ATP are crucial for augmented <italic>Nlrp2, Casp1</italic>, and <italic>Il1b</italic> expression in the graft, as well as, the secretion of IL-18 that contributes to type 1 alloimmune responses (<xref rid="B17" ref-type="bibr">17</xref>). While the survival benefits provided by inhibiting P2X7 in a rigorous skin transplant model was modest (<xref rid="B17" ref-type="bibr">17</xref>), the emerging importance of ATP and P2X7 after Tx suggest that targeting this pathway may be highly effective when combined with low doses of immunosuppression, or act synergistically with TLR antagonists to limit the activating signals feeding inflammasome/caspase-1 activation.</p>
    </sec>
    <sec id="s5">
      <title>Natural Pro-Inflammatory DAMP Regulators</title>
      <p>As discussed above, the bulk of past Tx-related studies have sought to identify how to blunt DAMP pathways that initiate early inflammation after IRI responses with the prediction that this would lead to reduced alloimmune response or even aid tolerance induction. This approach has shown promise, particularly in experimental animal studies, where DAMP targeting with antibodies to DAMPs or their receptors reduces alloimmunity and limits AR. DAMP targeting also limited later development of CR-associated graft vasculopathy and fibrosis. Recently, another promising approach has been the identification of natural/endogenous pro-inflammatory DAMP regulators (<xref rid="T2" ref-type="table">
<bold>Table 2</bold>
</xref>) that the body utilizes to regulate pro-inflammatory DAMPs and harness them to limit alloimmunity or improve transplant outcomes. Past studies by Liu and colleagues demonstrated that the sialic-acid&#x2013;binding immunoglobulin-like lectins (Siglecs)-CD24 signaling pathway suppresses inflammation triggered by DAMPs to protect against pathological inflammatory responses arising from cell death and necrosis (<xref rid="B70" ref-type="bibr">70</xref>). Importantly, they revealed that the Siglec-CD24 pathway only regulated DAMP signaling, while leaving the protective immune response to pathogen-derived PAMPs unabated (<xref rid="B70" ref-type="bibr">70</xref>). CD24 associates with DAMPs, particularly HMGB1, to negatively regulate their stimulatory activity by binding and presenting them to Siglecs that then downregulate immune responses <italic>via</italic> intracellular immunoreceptor tyrosine-based inhibitory motifs (ITIMs) domains (<xref rid="B71" ref-type="bibr">71</xref>). Active CD24-DAMPs-Siglec axis limits the inflammatory signaling in myeloid antigen, especially DC, to blunt their pro-inflammatory functions, particularly the secretion of TNF-&#x3B1;, IL-1&#x3B2;, and IL-6 (<xref rid="B71" ref-type="bibr">71</xref>). Harnessing this pathway has been particularly promising as a means to limit alloimmunity (<xref rid="B72" ref-type="bibr">72</xref>, <xref rid="B110" ref-type="bibr">110</xref>) and assessment of the CD24-DAMPs-Siglec axis as a way to limit AR and CR after SOTx may also be worthy of further focused investigation.</p>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p>Regulatory or reparative DAMPs and related molecules in Tx.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th valign="top" align="left" rowspan="1" colspan="1">Family</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Molecule</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Receptors</th>
              <th valign="top" align="center" rowspan="1" colspan="1">Role in Tx- related inflammation/immunity/outcomes</th>
              <th valign="top" align="center" rowspan="1" colspan="1">References</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Regulatory or reparative DAMPs</td>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">CD24</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Siglec</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Associates with DAMPS to negatively regulate their stimulatory activity<break/>Protect against pathological inflammatory responses arising from cell death and necrosis<break/>Limits T cell alloimmunity</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B70" ref-type="bibr">70</xref>&#x2013;<xref rid="B73" ref-type="bibr">73</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">IL-33</td>
              <td valign="top" align="left" rowspan="1" colspan="1">ST2</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Promotes the systemic expansion of ST2<sup>+</sup> Treg able to limit alloimmunity<break/>Promotes the secretion of Areg and other growth factors act on tissues and stem cells to support repair<break/>Induces TCR-independent Treg secretion of IL-13 and Areg that to control local inflammation and the generation of reparative type macrophages<break/>Directly promotes the generation of reparative macrophage phenotype through a metabolic reprogramming that augments OXHPOS and FA uptake</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B74" ref-type="bibr">74</xref>&#x2013;<xref rid="B82" ref-type="bibr">82</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Heat Shock Proteins (HSPs)</td>
              <td valign="top" align="left" rowspan="1" colspan="1">CD91, TLR2, TLR4, SREC1, and FEEL1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Supports debris clearance and wound repair<break/>Protect organs from IRI<break/>Extend graft survival<break/>Induce IL-10 secretion by T cells<break/>Support polarization of macrophages towards regulatory and reparative subsets</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B83" ref-type="bibr">83</xref>&#x2013;<xref rid="B89" ref-type="bibr">89</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Hyaluronan</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Lyve1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">High weight forms support the survival and localization of macrophage subsets that productively remodel ECM to support vasculature function after injury<break/>Contribute to tissue integrity and functional immunological niches</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B90" ref-type="bibr">90</xref>&#x2013;<xref rid="B94" ref-type="bibr">94</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1">Specialized pro-resolving mediators (SPMs) and related molecules</td>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="center" rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Annexin A1</td>
              <td valign="top" align="left" rowspan="1" colspan="1">FPR2/ALX</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Polarization of macrophage towards a pro-reparative subset<break/>Prolong allografts survival with sub-therapeutic immunosuppression<break/>Protect organs after IRI</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B95" ref-type="bibr">95</xref>&#x2013;<xref rid="B99" ref-type="bibr">99</xref>)</td>
            </tr>
            <tr>
              <td valign="top" align="left" rowspan="1" colspan="1"/>
              <td valign="top" align="left" rowspan="1" colspan="1">Maresins, Lipoxins, and Resolvins</td>
              <td valign="top" align="left" rowspan="1" colspan="1">GPR32 and ALX/FPR2 receptors</td>
              <td valign="top" align="left" rowspan="1" colspan="1">Limiting neutrophil infiltration and induction of neutrophil apoptosis<break/>Directly limiting adaptive immune responses<break/>Organ-protective and regenerative actions after IRI<break/>Stimulate macrophage transition toward reparative subsets<break/>Enhance Treg functions<break/>Prolongation of allograft survival</td>
              <td valign="top" align="center" rowspan="1" colspan="1"> (<xref rid="B100" ref-type="bibr">100</xref>&#x2013;<xref rid="B109" ref-type="bibr">109</xref>)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec id="s6">
      <title>Immune Cells Involved in a Regulated, Immune-Mediated Tissue Repair Process</title>
      <sec id="s6_1">
        <title>Tissue-Resident and Type 2 Cytokine-Activated Monocyte-Derived Macrophages</title>
        <p>Tissues and organs of the body have resident populations of macrophages seeded during the embryonic or early postnatal period from early hematopoietic progenitors from the yolk sac and fetal liver, as well as a small subset originating later from circulating monocytes (<xref rid="B111" ref-type="bibr">111</xref>). In homeostatic mouse and human hearts, myeloid cells can be fractionated by their expression of the C-C chemokine receptor 2 (CCR2). At homeostasis, both rodent and human heart contain predominantly fetal-derived CCR2<sup>-</sup> MHCII<sup>lo</sup> macrophages, and small subsets of monocyte-derived CCR2<sup>+</sup> MHCII<sup>hi</sup> macrophages, as well as CCR2<sup>+</sup> MHCII<sup>lo</sup> monocytes (<xref rid="B112" ref-type="bibr">112</xref>). However, after the ischemic injury of organs and tissues, infiltrating monocytes and monocyte-derived CCR2<sup>+</sup> macrophages rapidly dominate damaged tissues where they initiate the pro-inflammatory response discussed above. Studies of the CCR2<sup>-</sup> population have demonstrated the importance of this subset to limit adverse remodeling, but the propensity to be lost at sites of IRI (<xref rid="B90" ref-type="bibr">90</xref>). Studies of IRI in commonly transplanted organs, such as the heart, lung, liver, and kidney, have provided evidence for the existence of certain DAMPs that not only initiate inflammation but also, or instead, initiate and sustain tissue injury resolution responses and repair by infiltrating immune cells. The study of mucosal injury and repair suggests a similar evolution where homeostatic resident myeloid cells are rapidly outnumbered by infiltrating monocytes and monocyte-derived macrophages (<xref rid="B113" ref-type="bibr">113</xref>). Through these models (<xref rid="B114" ref-type="bibr">114</xref>, <xref rid="B115" ref-type="bibr">115</xref>), we now have a framework paradigm of an effective inflammation resolution and repair processes after tissue insult due to ischemic stimuli, and we are beginning to understand the DAMP-influenced processes and pathways directing immune cell-mediated response after injury (<xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>). Findings in these injury models will not be confounded by the unique immunological situation found in SOTx where adaptive and innate immune cells will respond to non-self, allogeneic graft components. In injury models, a highly regulated, immune-mediated tissue repair process that is shaped by DAMPs after injury has emerged. This process consists of a pro-inflammatory phase, a resolution phase, and a repair phase (<xref ref-type="fig" rid="f1">
<bold>Figure 1B</bold>
</xref>). How anti-AlloAg responses impact the typical signaling induced by DAMPs during the cellular responses leading to the early inflammatory phase and resolution and reparative phase after ischemic injury remains poorly understood. These questions are beginning to be addressed in recent rodent Tx studies described below, as well as speculated on in the later sections of our review.</p>
        <fig id="f1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Impact of pro-inflammatory versus reparative and regulatory DAMPs on immune cells during inflammation, resolution, and repair phases after tissue injury. <bold>(A)</bold> Recruited CCR2<sup>+</sup> monocytes and the macrophages derived from them participate in a highly regulated, immune-mediated tissue repair process shaped by <italic>1.</italic> Pro-inflammatory and <italic>2.</italic> Reparative and Regulatory DAMPs. These also act on Treg and potentially resident macrophages to support the survival and function of these immune cells. <bold>(B)</bold> This process can be divided into three overlapping phases, including a: <italic>1.</italic> pro-inflammatory phase (red), <italic>2.</italic> resolution phase (blue), and <italic>3.</italic> repair phase (green). In the first phase, pro-inflammatory DAMPs act on monocytes and macrophages to generate or support the function of highly phagocytic, inflammatory macrophages that use robust production of NO and pro-inflammatory cytokines to mediate the removal of any pathogens and damaged necrotic tissue. The transition to the resolution phase involves efferocytosis, or the phagocytosis of apoptotic cells, by macrophages receiving input from reparative and regulatory DAMPs and type 2 cytokines. These can both block the impact of pro-inflammatory stimuli on macrophages and contribute to the generation of Treg that support local immune suppression. The final phase involves little pro-inflammatory DAMP activity. It is dominated by reparative and regulatory DAMPs macrophage metabolism enabling the function of reparative and regulatory macrophages, such as secretion of cytokines, effector molecules, and growth factors that mediate responses in stromal, parenchymal cells, and stem cells to facilitate tissue repair. Regulatory and reparative DAMPs also act on Treg, which support the generation of reparative and regulatory macrophages and contribute growth factors to the repair environment. Reparative and Regulatory DAMP most likely also act on resident macrophages that are important for injury resolution and re-establishment and maintenance of tissue homeostasis. Abbreviations used: Areg, Amphiregulin; ATP, Adenosine Triphosphate; CCR2, CC Motif Receptor 2; DAMP, damage-associated molecular pattern; gDNA, Genomic DNA; HSP, Heat Shock Protein; HMGB1, High-mobility group box 1; IL, Interleukin; Ly6C, Lymphocyte antigen 6 complex, locus C1; mDNA, Mitochondrial DNA; NO, Nitric Oxide; SPM, Specialized pro-resolving mediators;TGF, Transforming growth factor; Treg, Regulatory T cell.</p>
          </caption>
          <graphic xlink:href="fimmu-12-611910-g001"/>
        </fig>
        <p>As discussed above, myeloid cells are primary sensors of early damage. Yet, how infiltrating monocytes and tissue-resident macrophages respond to early hypoxia and DAMPs released due to ischemia is quite distinct. Infiltrating monocytes will differentiate into macrophages activated by pro-inflammatory cytokines (TNF&#x3B1;, IL-1&#x3B2;, IFN&#x3B3;, IL-6) and DAMPs (HMGBI, ATP, Genomic DNA/Histones, IL-1&#x3B1;) into highly pro-inflammatory cells that, with neutrophils, dominate the pro-inflammatory phase after IRI. After ischemic injury due to myocardial infarction (MI), however, the resident CCR2<sup>-</sup> macrophage subset, while able to proliferate in non-damaged tissues, is lost due to anoxia and nutrient depletion (<xref rid="B90" ref-type="bibr">90</xref>). Thus, the ischemic areas are rapidly dominated by responding neutrophils and infiltrating Ly6C<sup>hi</sup> CCR2<sup>+</sup> monocytes, and F4-80<sup>+</sup> Ly6C<sup>hi</sup> CCR2<sup>+</sup> MHCII pro-inflammatory macrophages. The pro-inflammatory state of differentiation and functional activity of these macrophages will be enhanced by DAMPs like HMGB1 and Vimentin and local type-1 cytokines, particularly IL-1&#x3B2;, IFN&#x3B3;, and TNF&#x3B1;. As described by Braza et&#xA0;al., HMGB1 and Vimentin promoted a pro-inflammatory training of cardiac graft-infiltrating macrophages that secreted increased TNF&#x3B1; and IL-6 (<xref rid="B10" ref-type="bibr">10</xref>). These type-1 cytokine-activated macrophages approximate the well-characterized &#x201C;M1&#x201D; macrophages generated <italic>in vitro</italic> by exposing macrophages to LPS and IFN&#x3B3;. They use their high phagocytic capacity, robust production of NO, and pro-inflammatory cytokines to mediate the removal of any pathogens and any damaged necrotic tissue. These macrophages will also have high levels of HIF-1&#x3B1;, facilitating their glycolytic metabolism and the release of pro-inflammatory cytokines and chemokines that attract and activate additional infiltrating neutrophils and monocytes. The result is the collateral damage of healthy tissue from the induction of this response; thus, the benefit of limiting the pro-inflammatory response after Tx is apparent.</p>
        <p>Nevertheless, this pro-inflammatory process involving macrophages is essential to address pathogens and dead cells and crucial to the initiation of the resolution phase and subsequent repair phase (<xref ref-type="fig" rid="f1">
<bold>Figure 1B</bold>
</xref>) of the wound healing responses (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B59" ref-type="bibr">59</xref>, <xref rid="B116" ref-type="bibr">116</xref>). Indeed, if macrophages are depleted early after IRI injury, the overall inflammatory response is greatly diminished, yet this results in ineffective clearing of necrotic cells from the damaged site and leads to inefficient repair and regeneration (<xref rid="B117" ref-type="bibr">117</xref>). Thus, one lesson from these studies for the transplant community is not to seek the total absence of an inflammatory macrophage response after Tx, but instead encourage a restrained early response that is brief and limited in scope to not cause overwhelming tissue damage that leads to early graft failure or persisting tissue injury. The success of reagents like co-stimulatory blockade in tolerance induction may be due, in part, from their ability to limit the antigen-presentation function of myeloid, but not ablate myeloid cell injury resolution functions. A vital transition in local macrophages next occurs in ischemic areas where they assume a phenotype associated with immune regulation and wound-healing. This transition is orchestrated by macrophage efferocytosis, or the phagocytosis of apoptotic cells, especially neutrophils, in the absence of pro-inflammatory stimuli and the presence of the type-2 cytokines, IL-4 or IL-13 (<xref rid="B118" ref-type="bibr">118</xref>).</p>
        <p>A wealth of knowledge regarding type-2 cytokine activated macrophages has been generated through the <italic>ex vivo</italic> study of macrophages treatment with IL-4. IL-4 augments fatty acid (FA) uptake and oxidative phosphorylation (OXPHOS) to supports macrophage regulatory and reparative functions (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B61" ref-type="bibr">61</xref>). The importance of FA uptake and &#x3B2;-oxidation in regulatory and reparative macrophage polarization has been controversial (<xref rid="B119" ref-type="bibr">119</xref>). Yet, the disruption of FA uptake through inhibitors or loss of the FA translocase CD36 in mice and humans limits the generation and function of immunosuppressive and regulatory myeloid cells (<xref rid="B120" ref-type="bibr">120</xref>, <xref rid="B121" ref-type="bibr">121</xref>). Inhibition of this pathway blocks the IL-4-induced expression of crucial genes, including CD206, CD301, and RELM&#x3B1; that are functional phenotypic markers of reparative and regulatory macrophage (<xref rid="B61" ref-type="bibr">61</xref>). Macrophages programmed towards repair through efferocytosis and IL-4 secrete the anti-inflammatory cytokine IL-10. IL-10 will act in the local environment to support macrophage OXPHOS and preserve their respiratory capacity by facilitating the removal of dysfunctional mitochondria <italic>via</italic> mitophagy (<xref rid="B68" ref-type="bibr">68</xref>). Upregulation of peroxisome proliferator activated receptor &#x3B3; (PPAR&#x3B3;) and PPAR&#x3B3; coactivator 1B is important for FA oxidation and mitochondrial biogenesis in IL-4-exposed macrophages (<xref rid="B122" ref-type="bibr">122</xref>, <xref rid="B123" ref-type="bibr">123</xref>). In addition to IL-10, type 2 activated macrophages secrete TGF-&#x3B2; and express programmed cell death ligands to suppress local immune responses (<xref rid="B116" ref-type="bibr">116</xref>). Arginase 1 (Arg1) is also induced to generate ornithine from L-arginine to support tissue repair (<xref rid="B124" ref-type="bibr">124</xref>), but also generates metabolites that dampen T cell responses, including those of alloreactive T cells (<xref rid="B125" ref-type="bibr">125</xref>, <xref rid="B126" ref-type="bibr">126</xref>). IL-4-activated macrophages aid injury resolution through the production of several growth factors, including platelet-derived growth factor, transforming growth factor&#x3B2;1 (TGF-&#x3B2;1), insulin-like growth factor 1 (IGF-1), and VEGF&#x3B1; to promote cellular proliferation, blood vessel development, and attract and differentiate tissue fibroblasts into myofibroblasts (<xref rid="B116" ref-type="bibr">116</xref>). The capacity of reparative macrophages to control myofibroblasts that modulate the local ECM to initiate wound contraction and closure and direct re-vascularization makes them critical to the restoration of injured tissues and organs as close to a homeostatic state as possible (<xref rid="B121" ref-type="bibr">121</xref>).</p>
        <p>The ability of type 2-activated macrophages to both repair tissue and suppress local T cell responses has made them an attractive target population in SOTx to support tolerance induction, as well as limit or potentially even reverse CR (<xref rid="B127" ref-type="bibr">127</xref>). Further research is necessary to understand what endogenous local molecules initiate or support monocytes&#x2019; transition to reparative and regulatory macrophages at the end of the injury&#x2019;s pro-inflammatory phase. The signals that direct their reparative response to resolve damage and restore homeostasis or functionality to damaged tissues and organs will be important targets to define for the generation of new biologics for use in SOTx. With a clear picture of the stimuli that control both the initiation, magnitude, and length of the inflammatory and repair and resolution phases after injury comes the capacity to control the process through regulated delivery of agents directing the appropriate pathways at the correct time. The elucidation of these macrophage-mediated pathways in innovative transplant models will be vital. These studies should also explain how the typical process and pathways leading to effective repair in tissues and organs are impeded, augmented, or dysregulated by a persistent local immune response to AlloAg.</p>
      </sec>
      <sec id="s6_2">
        <title>Lyve1<sup>hi</sup> Macrophages</title>
        <p>While infiltrating monocyte-derived macrophages are the prevailing effectors during the immune response to ischemic injury, other immune cells have been identified that also contribute significantly to effective healing and remodeling after tissue damage. A recent paper has described a Lyve1<sup>hi</sup> MHCII<sup>lo</sup> CX3CR1<sup>+</sup> CCR2<sup>-</sup> interstitial macrophage subset in the vasculature adventitia of the lung, heart, fat, and dermis (<xref rid="B128" ref-type="bibr">128</xref>). Depletion of this subset before bleomycin-induced lung injury or isoproterenol-induced cardiac hypertrophy augmented fibrotic disease in both models (<xref rid="B128" ref-type="bibr">128</xref>). Comparison of the arterial Lyve1<sup>+</sup> vs. Lyve1<sup>-</sup> macrophages revealed that the Lyve1<sup>+</sup> subset was enriched for genes involved in homeostasis and ECM remodeling, and their deletion result in ECM abnormalities causing lost vascular wall integrity and impeded blood flow (<xref rid="B91" ref-type="bibr">91</xref>). Further mechanistic investigations revealed that Lyve1<sup>+</sup> macrophages bind to smooth muscle cells (SMC) <italic>via</italic> ECM interactions and shape artery tone and function by regulating ECM collagen deposition (<xref rid="B91" ref-type="bibr">91</xref>). As mentioned briefly above, studies by Dick et&#xA0;al. have shown that a similar population of fetal-derived, TIMD4<sup>+</sup> Lyve1<sup>+</sup> MHC<sup>lo</sup> CCR2<sup>-</sup> cardiac resident cells are lost at sites of IRI. These cells are rapidly replaced by CCR2<sup>+</sup> monocyte-derived cells, some of which can take on a CCR2<sup>-</sup> resident phenotype, but lack expression of <italic>Lyve1</italic> or <italic>Timd4</italic> (<xref rid="B90" ref-type="bibr">90</xref>). The TIMD4<sup>+</sup> Lyve1<sup>+</sup> resident macrophage subset also repopulates after loss through proliferation in the peri-infarct area and their depletion post-MI resulted in poor cardiac function (<xref rid="B90" ref-type="bibr">90</xref>). Data generated using the depletion of resident CCR2<sup>-</sup> macrophages before syngeneic cardiac Tx established that the therapeutic benefit they provide after IRI is due, in at least part, to their capacity to inhibit CCR2<sup>+</sup> monocyte recruitment (<xref rid="B92" ref-type="bibr">92</xref>). It is not entirely clear if monocyte-derived Lyve1<sup>+</sup> CCR2<sup>-</sup> subsets are as effective as the fetal-derived subset they replace over time. There is, however, accumulating evidence that Lyve1<sup>+</sup> CCR2<sup>-</sup> macrophages are essential for the healing after cardiac IRI and contribute to local homeostasis by directing the infiltration of other immune cells through modulation of local ECM.</p>
      </sec>
      <sec id="s6_3">
        <title>Tregs in Tissue Repair</title>
        <p>CD25<sup>hi</sup> forkhead box P3 (Foxp3)<sup>+</sup> regulatory T cells (Tregs) are an essential endogenous population of CD4<sup>+</sup> T cells that act as potent immunosuppressive cells to control autoreactive immune responses and limit tumor immunity. Tregs use multiple mechanisms for their immunosuppressive functions that limit the size and quality of other T cell responses. These mechanisms include the production of anti-inflammatory cytokines, such as IL-10, IL-35, and TGF&#x3B2;, that act directly on T cells to suppress their expansion and effector functions, as well as promote their exhaustion and deletion. Tregs ample expression of CD25 allows them to sequester IL-2 from immunological microenvironments. The importance of their suppressive capacity was first made evident in the study of mice and humans with Foxp3<sup>+</sup> mutations that caused aggressive and lethal systemic autoimmunity (<xref rid="B129" ref-type="bibr">129</xref>, <xref rid="B130" ref-type="bibr">130</xref>). Ongoing clinical trials are attempting to harness the potent immunosuppressive capacity of Tregs as cell therapy and reduce autoimmune pathology, or ideally, restore lost tolerance in patients with Crohn&#x2019;s Disease, Type 1 diabetes, and lupus (<xref rid="B131" ref-type="bibr">131</xref>). Based on rodent pre-clinical Tx studies&#x2019; successes where administered polyclonal or AlloAg-specific Tregs support Tx tolerance induction, more than 15 clinical studies have been recently completed or underway in SOTx.</p>
        <p>In addition to preventing tissue injury by limiting collateral damage mediated by an unrestrained immune response, Tregs also secrete factors that support the proliferation and survival of stem cells. Tregs secrete amphiregulin (Areg), a bi-functional growth factor that supports stem cell proliferation and differentiation through actions on the epidermal growth factor receptor (EGFR) (<xref rid="B132" ref-type="bibr">132</xref>). Related studies have identified Tregs secretion of keratinocyte growth factor as an import signal for alveolar epithelial proliferation and regenerative alveologenesis (<xref rid="B133" ref-type="bibr">133</xref>). In addition to the ability of Tregs to shape the function of monocytes and myeloid APC through secreted molecules like IL-10 and TGF&#x3B2;, they also express indoleamine 2,3-dioxygenase that catalyzes the degradation of tryptophan to limit the function of CD8<sup>+</sup> T effector cells (<xref rid="B134" ref-type="bibr">134</xref>). Tregs also have the capacity, at least <italic>in vitro</italic>, to direct the polarization of monocytes towards macrophage populations exhibiting features of those exhibiting reparative and regulatory functions <italic>in vivo</italic>. When both mouse or human monocytes are cultured with Treg, they upregulate their expression of CD206 and Arginase 1, both functional phenotypic markers of reparative and regulatory macrophages, due to Tregs secretion of IL-10 and IL-13 (<xref rid="B135" ref-type="bibr">135</xref>). Tregs are also essential to limit the damage and support function after ischemic injuries to the heart and brain (<xref rid="B136" ref-type="bibr">136</xref>, <xref rid="B137" ref-type="bibr">137</xref>). Thus, in addition to their canonical role in suppressing detrimental immune responses and maintaining immune homeostasis, Tregs participate in the repair of tissue damage.</p>
      </sec>
    </sec>
    <sec id="s7">
      <title>Regulatory and Reparative DAMPs and Specialized Pro-Resolving Mediators (SPMs) in Tissue Injury Resolution</title>
      <p>In the above sections, we outline the importance of several macrophage subsets, with input from Treg, needed to complete a highly regulated resolution and repair process that is relatively universal across organs and tissues. While not the focus of this review, it should be mentioned that other immune cells, particularly dendritic cells, various T helper subsets, and innate lymphocytes, also play essential roles in the repair process initiated by DAMPs (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B138" ref-type="bibr">138</xref>). It is also hopefully more clear how pro-inflammatory DAMPs, like HMGB1, ATP, and mDNA, are important initiators of, or at a minimum - crucial contributor to the early pro-inflammatory phase of tissue injury. Nevertheless, other endogenous signals, like CD24, that quell local inflammation or initiate the resolution and repair phases after IRI or other Tx-relevant injuries remain poorly understood. Previously suggested pro-inflammatory DAMPs, particularly IL-33, HSPs, and HA, however, support the expansion of reparative cells. These DAMPs also drive the function of immune cells during the resolution and reparative programs induced in various injury models (<xref rid="T2" ref-type="table">
<bold>Table 2</bold>
</xref>). Other biomolecules, such as Annexin A1 (AnxA1) and specialized pro-resolving mediators (SPMs), including resolvins and maresins, also act as powerful endogenous signals that support immune-mediated inflammation resolution and the return to local homeostasis (<xref rid="T2" ref-type="table">
<bold>Table 2</bold>
</xref>).</p>
      <p>When considered from a more general perspective, there are several common characteristics of regulatory DAMPs and SPMs that standout. First, these molecules are typically sequestered or shielded from recognition by the immune system until they are released after injury. Second, both groups limit local infiltration by inflammatory leukocytes and instead orchestrate the differentiation and function of immune cells that restore local homeostasis through inflammation resolution and repair. Third, most contribute to the differentiation of reparative- or regulatory-type macrophages <italic>via</italic> induced signaling and metabolic programming towards OXPHOS and FA uptake. Fourth, the capacity of regulatory DAMPs and SPMs to directly stimulate Treg expansion and function, or support Treg expansion indirectly through actions on myeloid APC and macrophages is common. Finally, many of these molecules may be released at very low concentrations during normal cell turnover to sustain the immune cells maintaining homeostasis. The molecules and immune cells, like Treg and macrophages, restoring local and systemic homeostasis, may overlap considerably with cells and systems that typically maintain it. We discuss below the limited, but growing, literature describing a potential role for regulatory DAMPs and SPMs and their target cells in influencing alloimmunity and Tx outcomes.</p>
      <sec id="s7_1">
        <title>Specialized Pro-Resolving Mediators (SPMs)</title>
        <p>SPMs are a superfamily of lipid molecules that are generated locally after injury and target G coupled receptors (GPRs) in order to stop excessive neutrophil infiltration, counter pro-inflammatory signals, enhance efferocytosis, and the clearance of dead cells by macrophages (<xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B140" ref-type="bibr">140</xref>). SPMs are generated from essential polyunsaturated FA in enzymatic reactions completed by both leukocytes, platelets, and parenchymal and stromal cells into several related groups of immunoresolvins, including lipoxins, E, and D series resolvins, protectins, and maresins (<xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B139" ref-type="bibr">139</xref>, <xref rid="B140" ref-type="bibr">140</xref>). Lipoxin is secreted by neutrophils and macrophages after being synthesized from arachidonic acid. It acts on cells expressing the G protein-coupled lipoxin A4 (ALX)/formyl peptide receptor (FPR2) or GPR 32, the aryl hydrocarbon receptor, estrogen receptor, as well as the cysteinyl leukotriene receptor (<xref rid="B141" ref-type="bibr">141</xref>). Important actions of lipoxin on innate immune cells after injury include limiting neutrophil infiltration and the induction of neutrophil apoptosis. Lipoxin also supports injury and inflammation resolution by delaying the apoptosis of macrophages completing efferocytosis and local debridement (<xref rid="B142" ref-type="bibr">142</xref>). Limited studies suggest that lipoxin may have the ability to directly regulate B-cell antibody production and proliferation, as well as limit T cell effector functions (<xref rid="B101" ref-type="bibr">101</xref>, <xref rid="B102" ref-type="bibr">102</xref>). While lipoxin impacts on innate and adaptive immune cells would be expected to improve Tx outcomes, to date, however, the influence of lipoxin on alloimmunity and Tx outcomes has been poorly explored. A limited assessment in clinical lung Tx samples revealed the presence of lipoxin in these samples, and the delivery of a stable lipoxin analog provided subtle improvements in mouse heart and kidney Tx models (<xref rid="B103" ref-type="bibr">103</xref>). This initial testing was completed in MHC-fully mismatched models; thus, experimentation in less aggressive combinations is warranted to understand better if lipoxin can improve CR by limiting IRI, reducing alloimmunity, or initiating repair responses.</p>
        <p>E-series resolvins are generated primarily by neutrophils from the exudate omega-3 FA eicosapentaenoic acid (EPA), where D-series resolvins are made by neutrophils from docosahexaenoic acid (DHA), which also serves for the starting blocks of maresins, which is synthesized from DHA by macrophages (<xref rid="B100" ref-type="bibr">100</xref>). Like lipoxin, both resolvins limit neutrophil infiltration and promote their apoptosis. Some resolvins have potent organ-protective and regenerative actions that would be highly relevant in surgery-induced IRI. SPM-stimulated macrophage transition toward those reflective of IL-4-activated macrophages, which, as discussed, are characterized by high levels of FA uptake and are the primary source of maresins (<xref rid="B104" ref-type="bibr">104</xref>). These lipid mediators have also been shown to induce macrophage production of IL-10 while reducing dendritic cell production of IL-12 (<xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B105" ref-type="bibr">105</xref>). SPMs also have potent anti-IRI activities demonstrated for kidney, liver, and lung mediated by limiting TLR4/MAPK/NF-&#x3BA;B pathway activity and activating the Nrf2 pathway to limit oxidative stress (<xref rid="B106" ref-type="bibr">106</xref>&#x2013;<xref rid="B108" ref-type="bibr">108</xref>). Other intriguing studies have suggested that D-series resolvins and maresin can act on T cell GPR32 and ALX/FPR2 receptors to limit human and mouse pro-inflammatory cytokine production, while simultaneously enhancing Treg function. It has also been described how a decrease in resolvins and maresins are observed in obese subjects or individuals suffering from autoimmunity or systemic inflammatory diseases. These findings suggest the importance of these molecules in systemic homeostasis (<xref rid="B143" ref-type="bibr">143</xref>). Based on these effects, the role of SPMs in the early and late immunobiology of Tx deserves investigation.</p>
      </sec>
      <sec id="s7_2">
        <title>Annexin A1 (AnxA1)</title>
        <p>AnxA1 is a phospholipid-binding protein sequestered in the cytoplasm of neutrophils, monocytes, and macrophages and released upon their activation (<xref rid="B144" ref-type="bibr">144</xref>). The production of AnxA1 is highly responsive to glucocorticoids, with endogenous and delivered glucocorticoids increasing both AnxA1 expression and secretion (<xref rid="B144" ref-type="bibr">144</xref>). The anti-inflammatory and pro-resolving effects of AnxA1 are mediated through binding to FPR2/ALX, which limits neutrophil transmigration tissue infiltration and induces neutrophil apoptosis. AnxA1 acts on macrophage FPR2/ALX receptors to activate AMPK, which is a potent regulator of mTOR (<xref rid="B95" ref-type="bibr">95</xref>). This results in the polarization of macrophage towards a pro-reparative subset. These data indicate that AnxA1 acts as a natural factor that can regulate the pro-inflammatory DAMP metabolic reprogramming described by Braza et&#xA0;al. Thus, AnxA1 may act like the pro-tolerogenic signals generated when nanoparticles containing the mTOR inhibitor rapamycin were used targeted to graft macrophages after heart transplant (<xref rid="B10" ref-type="bibr">10</xref>). Delivery of an AnxA1 mimetic could prolong BALB/c skin grafts on B6 recipients, but only when given with sub-therapeutic cyclosporine A (<xref rid="B96" ref-type="bibr">96</xref>). Targeting FPR2/ALX with AnxA1, like lipoxin above, provides a protective, but not robustly immunosuppressant or protective effect after Tx. Given the importance of limiting early graft injury and rapidly transitioning from a local pro-inflammatory state to one of injury resolution and tissue repair, it is easy to envision how reagents targeting this pathway could be combined into immunosuppressive protocols to improve outcomes by limiting the pro-inflammatory phase and accelerating pro-inflammation resolution after IRI. Tx researchers have spent most of our energy looking for reagents that are potent immunosuppressants or able to induce tolerance. AnxA1 may be able to contribute here through actions on Dectin-1 (<xref rid="B145" ref-type="bibr">145</xref>). However, it is advisable that we also harness the wealth of past evidence that AnxA1 or its derivatives are useful when used to target FPR2/ALX to limit MI-mediated pathology and acute kidney injury (<xref rid="B97" ref-type="bibr">97</xref>&#x2013;<xref rid="B99" ref-type="bibr">99</xref>). These data would support an investigation into using these reagents to limit early graft failure or IRI under cover of immunosuppression.</p>
      </sec>
      <sec id="s7_3">
        <title>Heat Shock Proteins (HSPs)</title>
        <p>Heat shock proteins (HSPs) are highly conserved proteins grouped according to their molecular weights (e.g., Hsp 27, Hsp40). They are upregulated in response to stress conditions that result in damaged proteins, such as extreme heat, hypoxia, oxidative stress, inflammation, injury, or infections. They are essential for intracellular functions involving the initiation of protein folding, repair, refolding of misfolded peptides, and aiding in the degradation of irreparable proteins.&#xA0;However, upon necrotic cell death or cellular stress, HSPs are released and were initially characterized as pro-inflammatory DAMPs that acted on TLR4. However, several pre-clinical studies have demonstrated various extracellular HSPs that, when overexpressed or delivered, can protect organs from IRI (<xref rid="B83" ref-type="bibr">83</xref>, <xref rid="B84" ref-type="bibr">84</xref>) and extend graft survival (<xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>). When delivered, various HSPs are potent inducers of T cell IL-10 production and support the polarization of macrophages towards regulatory and reparative subsets (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>). These findings and their implications in Tx have been recently expertly-reviewed (<xref rid="B89" ref-type="bibr">89</xref>) and thoroughly describes the literature supporting consideration of HSPs as a regulatory DAMP in Tx.</p>
      </sec>
      <sec id="s7_4">
        <title>Hyaluronan (HA)</title>
        <p>HA, also known as hyaluronic acid, is an important ECM component synthesized by HA synthase at the plasma membrane of predominantly mesenchymal cells. Here it associates with different HA-binding proteins to form pericellular and extracellular matrices that are important for creating space and a matrix allowing cellular migration and localization. HA is also generated as part of the tissue injury and repair response, where it directs and regulates the infiltration and function of fibroblasts, blood vessels, and immune cells (<xref rid="B93" ref-type="bibr">93</xref>). HA is connected to the early inflammatory responses after injury, as degraded HA induces signaling <italic>via</italic> TLR4 and TLR2 on macrophages to drive pro-inflammatory cytokine production (<xref rid="B21" ref-type="bibr">21</xref>). HA has a long history in Tx, as Goldstein and colleagues showed convincingly that HA fragments could induce DC maturation and initiate alloimmunity (<xref rid="B22" ref-type="bibr">22</xref>). That HA can induce alloimmunity is of clinical relevance as the bronchial lavage fluid of lung transplant patients undergoing AR displays significantly higher HA levels than those with no rejection (<xref rid="B146" ref-type="bibr">146</xref>). Additional studies established that HA was prominent in areas of intraluminal small airway fibrosis in lung transplants bronchiolitis obliterans, as was the message for HA synthase (<xref rid="B147" ref-type="bibr">147</xref>). Increased local and circulating levels of HA have also been noted in rodent skin and cardiac transplant models (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B148" ref-type="bibr">148</xref>). Yet, the impact of HA on alloimmunity is not clear and potentially double-edged, as different molecular weight HA products seem to produce pro-inflammatory or regulatory impacts depending on the transplanted organ. The accumulation of lower molecular weight HA stimulated lung inflammation after lung injury and was shown to contribute to lung transplant rejection, while high-molecular-weight HA attenuated allograft inflammation and contributed to lung epithelium integrity (<xref rid="B21" ref-type="bibr">21</xref>&#x2013;<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B147" ref-type="bibr">147</xref>). In contrast, low molecular weight HA delivery prolonged renal and cardiac allograft survival (<xref rid="B149" ref-type="bibr">149</xref>, <xref rid="B150" ref-type="bibr">150</xref>). These contrasting findings may reflect different biological functions of HA between different organs and or distinct roles of HA in the different physiological processes happening, i.e., AR, CR, or tissue repair.</p>
        <p>One aspect that should be discussed further that may account for these varied responses in transplanted organs is the emerging importance of intact, high molecular weight HA to the generation of functional immunological and repair niches. HA interactions are critical to hematopoietic and tissue-forming stem cell migration, function, and survival (<xref rid="B93" ref-type="bibr">93</xref>). HA stem-supporting characteristics also aid the function and survival of cancer cells, and HA in the ECM of the tumor environment supports tumor-associated macrophages&#x2019; polarization and survival (<xref rid="B151" ref-type="bibr">151</xref>, <xref rid="B152" ref-type="bibr">152</xref>). Thus, while the DAMP activity of HA is an important consideration, an equally important function of HA in the transplant microenvironment may be its role in providing the localizing, supporting structure to the hematopoietic and structural cells that are being tuned by DAMPs and other signals in the environment to shape any alloimmune response or resolve a local injury. HA contributions to &#x201C;rejection&#x201D; niches are implied by the observation that delivery of low molecular weight fragments antagonize cardiac graft infiltration by effector cells using the HA binding receptor CD44. This interaction can also be targeted effectively with anti-CD44 antibodies (<xref rid="B153" ref-type="bibr">153</xref>).</p>
        <p>Nevertheless, several recent studies have revealed the importance of HA niches and protective HA-binding myeloid cells in them after IRI. As introduced above, Dick et&#xA0;al. described the importance of fetal-derived, self-renewing Lyve1<sup>+</sup> MHCII<sup>lo</sup> CCR2<sup>-</sup> macrophage subset in productive repair after myocardial infarction (MI) (<xref rid="B90" ref-type="bibr">90</xref>). Lyve1 is the receptor for HA, and the expression of this receptor by CCR2<sup>-</sup> macrophages appears to target them to HA dense areas, particularly the adventitial layer of arteries. Deletion of these macrophages post-IRI resulted in the dysregulated repair after myocardial infarction (<xref rid="B90" ref-type="bibr">90</xref>). Related studies also used a different system to completed targeted deletion of Lyve1<sup>+</sup> macrophages and established that an important function this subset was to modulate the ECM in these arterial niches and prevent arterial stiffness at homeostasis (<xref rid="B91" ref-type="bibr">91</xref>). This function required Lyve1-HA-interaction-induced production of matrix metalloproteinase 9 (<xref rid="B91" ref-type="bibr">91</xref>). Further mechanistic investigations revealed that Lyve1<sup>+</sup> macrophages bind to smooth muscle cells (SMC) <italic>via</italic> interactions with HA and shape artery tone and function by regulating ECM collagen deposition (<xref rid="B91" ref-type="bibr">91</xref>). HA&#x2019;s importance for healing after IRI was also demonstrated in mice with inducible deletion of HA synthase 2 (HAS2). HAS2 deletion before IRI resulted in a severely impaired hemodynamic function associated with a loss of cardiac macrophages, but not monocytes (<xref rid="B94" ref-type="bibr">94</xref>). The authors accounted poor function to increased apoptosis of macrophages in the absence of HA stimulation (<xref rid="B94" ref-type="bibr">94</xref>). The loss of HA also resulted in decreased myofibroblast in the infarct site, and <italic>in vitro</italic> studies outlined an intricate network were HA-positive fibroblasts and Lyve1<sup>+</sup> macrophages communicate to generate functional ECM after IR. These observations mesh with syngeneic cardiac Tx studies completed by Kreisel and Lavine, where they demonstrated that CCR2<sup>-</sup> macrophages inhibit monocyte recruitment, where the CCR2<sup>+</sup> macrophage subset promoted monocyte recruitment <italic>via</italic> MyD88-dependent mechanism and the release of monocyte chemoattractant proteins (<xref rid="B92" ref-type="bibr">92</xref>). These recent studies shed light on how critical local niches shaped by ECM components, including HA, will be important to outcomes after Tx.</p>
      </sec>
      <sec id="s7_5">
        <title>Interleukin-33 (IL-33)</title>
        <p>IL-33 is a member of the IL-1 superfamily sequestered in the nucleus due to a nuclear localization domain and chromatin binding motif (<xref rid="B154" ref-type="bibr">154</xref>, <xref rid="B155" ref-type="bibr">155</xref>). IL-33 released during necrotic cell death and cellular stress is functional, but its activity is negatively regulated by caspases, oxidation, and chromatin occupancy. Several proteases can increase the activity of full-length IL-33 by cleaving off the nuclear localization domain and chromatin binding motif (<xref rid="B154" ref-type="bibr">154</xref>, <xref rid="B156" ref-type="bibr">156</xref>). We have also recently demonstrated that bio-active IL-33 is present in vesicles bound to the ECM of stromal cells where it is protected from proteolytic modification (<xref rid="B157" ref-type="bibr">157</xref>).</p>
        <p>IL-33 was originally identified and described as inflammatory DAMP that drives type 2-cytokine-mediated inflammation when it is released after tissue damage and stimulates immune cells <italic>via</italic> the IL-33 receptor IL-1R-like-1(IL1RL1), more commonly referred to as Stimulation-2 (ST2) (<xref rid="B158" ref-type="bibr">158</xref>). Numerous immune cells express varying levels of ST2. These include basophils, mast cells, eosinophils, group 2 innate lymphoid cells (ILC2s) (<xref rid="B154" ref-type="bibr">154</xref>), CD8<sup>+</sup> (<xref rid="B159" ref-type="bibr">159</xref>, <xref rid="B160" ref-type="bibr">160</xref>), and CD4<sup>+</sup> T cells (<xref rid="B161" ref-type="bibr">161</xref>), particularly Th2 cells and Treg (<xref rid="B74" ref-type="bibr">74</xref>&#x2013;<xref rid="B77" ref-type="bibr">77</xref>, <xref rid="B158" ref-type="bibr">158</xref>, <xref rid="B162" ref-type="bibr">162</xref>), B cells (<xref rid="B163" ref-type="bibr">163</xref>), macrophages (<xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B157" ref-type="bibr">157</xref>, <xref rid="B163" ref-type="bibr">163</xref>), and DC subsets (<xref rid="B162" ref-type="bibr">162</xref>, <xref rid="B164" ref-type="bibr">164</xref>, <xref rid="B165" ref-type="bibr">165</xref>). IL-33 acts on these cells to support type 2 responses dominated by the cytokines IL-5 and IL-13. IL-33 induction of type 2 cytokines aides parasite clearance and drives allergic responses, lung inflammation, and fibrotic skin diseases. There is a close link between type 2 cytokines and tissue repair, and IL-33 has emerged as a crucial mediator of the repair process. Much of the known repair activity of IL-33 involves its capacity to target ST2<sup>+</sup> Tregs, a predominantly peripheral tissue-resident subset, and induce their expansion and production of IL-10, IL-13, and Areg (<xref rid="B166" ref-type="bibr">166</xref>). Seminal studies by the Rudensky group established an essential role for Tregs in the resolution of epithelial injury after virally-induced lung injury due to their secretion of Areg. Interestingly, it was Tregs recognition of IL-18 or IL-33, not TCR signaling, that led to this reparative action (<xref rid="B74" ref-type="bibr">74</xref>). IL-33 also induces TCR-independent Treg secretion of IL-13 that is critical to control local inflammation and after chemical or viral lung injury (<xref rid="B77" ref-type="bibr">77</xref>). Treg secreted IL-13 generates Arginase 1<sup>+</sup> macrophages implicated in tissue repair and homeostasis (<xref rid="B77" ref-type="bibr">77</xref>). ILC2 secrete IL-13 in response to IL-33 to promote lung regeneration by stimulating macrophage support of type 2 alveolar epithelial stem cell proliferation (<xref rid="B167" ref-type="bibr">167</xref>). There is a prominent role for IL-33 in regulating metabolic homeostasis, and disruption of the Treg-ILC2-Macrophage axis contributes to increased inflammation and obesity (<xref rid="B168" ref-type="bibr">168</xref>&#x2013;<xref rid="B170" ref-type="bibr">170</xref>). Fibro/adipogenic progenitor cells in the skeletal muscle express IL-33 and sustains skeletal muscle Tregs that are important for muscle regeneration after injury through secretion of Areg that supports muscle satellite cells (<xref rid="B75" ref-type="bibr">75</xref>, <xref rid="B76" ref-type="bibr">76</xref>) and potentially limits the local generation of inflammatory Ly6C<sup>hi</sup> macrophages (<xref rid="B75" ref-type="bibr">75</xref>).</p>
        <p>Numerous studies have suggested the potential to harness the emerging regulatory and reparative properties of IL-33 in Tx. Administration of IL&#x2010;33 post-heart Tx expands ST2<sup>+</sup> Treg to prolong allograft survival across MHC barriers in rodent heart transplant models (<xref rid="B79" ref-type="bibr">79</xref>, <xref rid="B158" ref-type="bibr">158</xref>). Skin graft acceptance could also be aided through IL-33-induced expansion of regulatory myeloid cells and Treg (<xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B81" ref-type="bibr">81</xref>). It was not until recently that we also revealed an essential regulatory function for graft-derived IL-33 that involved the direct targeting of infiltrating recipient monocytes and macrophages (<xref rid="B78" ref-type="bibr">78</xref>). We used heart transplants lacking IL-33 or recipients with ST2-deficient macrophages to clarify that a critical function of endogenous IL-33 was to promote the generation of reparative macrophage phenotype through a metabolic reprogramming augmenting OXHPOS and FA uptake. Thus, IL-33 is unique relative to DAMPs like HMGB1 that drives glycolysis and epigenetic modifications enabling inflammatory cytokine production (<xref rid="B10" ref-type="bibr">10</xref>). IL-33 instead blocks iNOS expression and, like IL-4, IL-10, and IL-13, increases mitochondrial function and FA uptake (<xref rid="B61" ref-type="bibr">61</xref>, <xref rid="B78" ref-type="bibr">78</xref>). In total, it is safe to describe IL-33 as a regulatory DAMP in Tx, and it will be necessary to use tissue-specific disruption of IL-33 and immune cell-specific deletion of ST2 to help us further understand how IL-33 coordinates responses to IRI and alloinjury after SOTx.</p>
      </sec>
    </sec>
    <sec id="s8">
      <title>Understanding Where Pro-Inflammatory and Regulatory and Reparative Damp Signals Get Tangled and Lead to Poor Outcomes After Tx</title>
      <p>As outline above, the process of injury recognition, inflammation initiation and resolution, and then tissue repair after IRI is complex in both signals and cells involved. It is also subject to pathology when not perfectly orchestrated, or a phase in the process is amplified or incomplete. It is easy to appreciate how an augmented inflammatory response due to an extended ischemia period releasing prodigious amounts of pro-inflammatory DAMPs across an entire organ can lead to early graft dysfunction and failure. It is clear how this would also lead to AR due to widespread activation of resident DC and other APC presenting AlloAg, which then travel to the secondary lymphoid organs to stimulate an alloimmune response. The inflamed tissues would also be an ideal environment for the generation of inflammatory APC as infiltrating recipient monocyte differentiate into pro-inflammatory macrophages and DC that support local alloresponses that drive rejection (<xref rid="B171" ref-type="bibr">171</xref>). The ongoing efforts discussed above to block the early inflammation mediated by pro-inflammatory DAMPs, if found therapeutic, should have an impact here. However, despite the availability of potent immunosuppressants available to target adaptive immune responses and the shortening ischemia times common in current clinical transplant medicine, CR remains a persistent problem. The development of CR in immunosuppressed individuals suggests that other factors beyond pro-inflammatory DAMPs may need to be considered. In this remaining section, we briefly postulate how unique aspects of SOTx may interfere with appropriate resolution or re-establish tissue homeostasis after Tx to lead to CR.</p>
      <sec id="s8_1">
        <title>Alloimmunity Prevents Effective Resolution and Repair</title>
        <p>Transplanted organs represent a unique immunological situation where non-self, allogeneic signals will impact the typical immune responses working toward resolving early ischemic injury and any damage caused by allorecognition. The reaction to AlloAg by the adaptive immune systems, as well as NK cells, has been long recognized, yet how innate alloimmune responses influence acute and chronic tissue injury resolution and repair responses remains unclear. Precise mouse studies have now established that graft infiltrating monocytes, in addition to detecting DAMPs, will recognize allogenic molecules, such as the polymorphic signal regulatory protein &#x3B1; (SIRP&#x3B1;). The binding of allogeneic SIRP&#x3B1; to the nonpolymorphic CD47 causes monocytes to mature into monoDCs expressing IL-12 and stimulating T cell proliferation and IFN&#x3B3; production in the graft (<xref rid="B172" ref-type="bibr">172</xref>, <xref rid="B173" ref-type="bibr">173</xref>). Murine monocytes and macrophages can also recognize and acquire memory specific to MHC-I antigens <italic>via</italic> paired immunoglobulin-like receptors-A (PIR-A) (<xref rid="B174" ref-type="bibr">174</xref>). As outlined in <xref ref-type="fig" rid="f1">
<bold>Figure 1</bold>
</xref>, these infiltrating monocytes are the main coordinators of local DAMP and cytokine signals needed to initiate and then resolve tissue injury. It is easy to speculate how alloreactive macrophage will increase local IL-12 and IFN&#x3B3; to prolong the pro-inflammatory phase or prevent transition to resolution and repair (<xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref>). Nevertheless, these changes may augment counter-responses to increase damage and regulatory and reparative DAMPs (<xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref>). Thus, CR may instead result from an overzealous or persistent resolution response mediated by reparative Treg and macrophages that sustain a response to an unresolved allogeneic injury.</p>
        <fig id="f2" position="float">
          <label>Figure 2</label>
          <caption>
            <p>DAMP may contribute to CR after Tx in several scenarios. <bold>(A)</bold> The alloreactive response of innate and adaptive cells may sustain the pro-inflammatory phase and lead to a failure to fully transition through the resolution phase and complete the repair phase. In this scenario, CR represents a failure to resolve and repair, leading to residual graft damage and failure to restore tissue homeostasis. Alternatively, these changes may cause an overzealous counter-responses initiated by reparative Treg and reparative macrophages in responses to regulatory and reparative DAMPs released by an unresolved allogeneic wound. <bold>(B)</bold> Alternatively, lost or depleted reparative and regulatory cells due to ischemia or alloimmune responses may lead to a failed resolution phase leading to residual graft damage.&#xA0;This scenario may also arise from a depletion of local reparative and regulatory DAMPs over time. In this case, CR would represent a failure to restore tissue homeostasis due to persisting graft damage.</p>
          </caption>
          <graphic xlink:href="fimmu-12-611910-g002"/>
        </fig>
      </sec>
      <sec id="s8_2">
        <title>Replacement of Donor CCR2<sup>-</sup> Macrophages by a Recipient CCR2<sup>+</sup> Pro-Inflammatory Subsets</title>
        <p>The importance of fetal-derived, Lyve1<sup>+</sup> CCR2<sup>-</sup> resident macrophages cells to control pro-inflammatory CCR2<sup>+</sup> monocytes&#x2019; infiltration and mediate ECM remodeling to allow inflammation resolution and productive tissue repair after cardiac IRI was laid out above. Comparable populations of self-replicating, fetal-derived macrophages are noted around the vasculature of the lung, fat, dermis (<xref rid="B128" ref-type="bibr">128</xref>), as well as in the kidney (<xref rid="B175" ref-type="bibr">175</xref>). The CCR2<sup>-</sup> macrophage subset appears critical for local control of inflammation and remodeling after injury, but susceptible to loss due to conditions typical of IRI and CR, including hypoxia and the loss of an HA-rich ECM. Once lost, this subset is rapidly replaced by a circulating CCR2<sup>+</sup> monocyte-derived subset, which lacks the capacity of the CCR2<sup>-</sup> subset for limiting fibrosis (<xref rid="B90" ref-type="bibr">90</xref>&#x2013;<xref rid="B92" ref-type="bibr">92</xref>). Similar findings in human transplant samples were observed when endomyocardial biopsies from sex-mismatched heart transplant recipients were assessed for the presence of donor tissue-resident CCR2<sup>-</sup> macrophages (<xref rid="B112" ref-type="bibr">112</xref>). These studies confirmed that the CCR2<sup>-</sup> subset was almost exclusively donor-derived. Parallel transcriptomic profiling of CCR2<sup>-</sup> and CCR2<sup>+</sup> macrophages isolated from failing human hearts were consistent with the conclusion that these two populations were distinct cell types. The CCR2<sup>+</sup> subset appeared monocyte-derived and expressed inflammatory mediators, including IL-1&#x3B2;, components of the inflammasome, and genes involved in adverse cardiac remodeling. The CCR2<sup>-</sup> subset instead expressed increased Lyve1, growth factors, and ECM genes implicated in tissue remodeling. The CCR2<sup>+</sup> macrophage subset was more abundant than the CCR2<sup>-</sup> subset in heart failure samples from those with worse left ventricular systolic dysfunction and adverse remodeling (<xref rid="B112" ref-type="bibr">112</xref>). This seminal study provides the initial confirmation of a potentially beneficial donor CCR2<sup>-</sup> macrophage population in transplanted organs.</p>
        <p>Further studies can build on this work to define if shorter ischemia times, <italic>ex vivo</italic> normothermic perfusion, or specific immunosuppression protocols can prevent or slow the loss of donor CCR2<sup>-</sup> macrophages and the subsequent replacement by CCR2<sup>+</sup> recipient macrophages after SOTx. These examinations or related pre-clinical studies will provide an understanding if AR, CR, IRI, or recipient alloimmunity causes the CCR2<sup>-</sup> subset to drop below a significant reparative threshold after Tx. It would be expected that this would lead to increased inflammation and a sustained loss of homeostasis (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>). Such a scenario would account for increased alloimmunity and fibrosis, that culminates CR pathology after SOTx (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>). An important additional question to answer if local reparative DAMPs support the survival or local proliferation of the CCR2<sup>-</sup> subset during homeostasis or after IRI.</p>
      </sec>
      <sec id="s8_3">
        <title>Dysregulated Local Niches in the Tx Microenvironment</title>
        <p>Immunological niches typically provide a hospitable place that concentrates the signals needed to nurture the immune and stromal cells need to maintain an effective local immune response or local homeostasis. An organized immunological microenvironment, or niche, controls local immune responses during tumor development, is necessary for regulating immune cell functions in the secondary lymphoid organs, and fundamental to the production of blood cells in the bone marrow (<xref rid="B176" ref-type="bibr">176</xref>&#x2013;<xref rid="B178" ref-type="bibr">178</xref>). We briefly discussed how HA-rich niches in the adventitia are critical for the homeostatic maintenance of vessel function and how these can be disrupted through the loss of specific cells like CCR2<sup>-</sup> macrophages or local environmental signals like HA. The role of immunological niches in transplant outcomes is currently entirely speculative but is an exciting concept. However, based on what is known about both IRI and the alloimmune response after Tx, we would expect that &#x201C;homeostatic,&#x201D; &#x201C;acute rejecting,&#x201D; and &#x201C;injured/reparative,&#x201D; &#x201C;dysregulated/fibrotic/CR&#x201D; areas all would be observed, and often co-exist, throughout the lifespan of a transplant. Work in this space by the Halloran group revealed using unsupervised principal component analysis and archetypal analysis on microarray assessment of HTx endomyocardial biopsies (EMB) identified that samples that abnormal EMB did not associate cleanly with rejection and instead expressed transcripts indicating a tissue injury response (<xref rid="B179" ref-type="bibr">179</xref>, <xref rid="B180" ref-type="bibr">180</xref>). These samples were enriched for transcripts for DAMPs, as well as macrophages. The injury-related scores were also high at early times post-transplant and routinely diminished over time. The decreasing rejection scores suggest that repair and resolutions of global IRI injury to the graft is indeed typical unless interrupted by a local alloimmune response that is not effectively inhibited by immunosuppression.</p>
        <p>IL-33 has been implicated in adventitial vascular niches, where the IL-33 deletion causes an inadequate local immune response to pathogens (<xref rid="B164" ref-type="bibr">164</xref>). Ablation of IL-33 from white adipose niche caused immune dysregulation in these niches resulting in immune dysfunction and obesity associated with increased pro-inflammatory myeloid cells (<xref rid="B181" ref-type="bibr">181</xref>). A high-fat diet also reduces IL-33 expression in the white adipose niches to produce similar outcomes. As discussed above, we found that the upregulation of IL-33 during clinical and experimental HTx rejection decreased CR due to this regulatory DAMP&#x2019;s potent capacity to limit the generation of pro-inflammatory macrophages from monocytes infiltrating the grafts (<xref rid="B78" ref-type="bibr">78</xref>). Nevertheless, it is yet to be determined how IL-33 or other regulatory DAMPs are maintained in SOTx regions of the graft with acute or sustained alloimmunity. Limited evidence from EMB suggests that grafts maintaining IL-33 display less CR (<xref rid="B78" ref-type="bibr">78</xref>). It is known that IL-33 decreases with age in the muscle leading to inadequate regenerative responses associated with decreased Treg and increased inflammatory macrophages. How the expression of these DAMPs are modulated in fibrotic areas to instruct local CCR2<sup>-</sup> and CCR2<sup>+</sup> macrophages will be an essential question to answer. A lost local repair response may become further augmented when niches become depleted of reparative, or regulatory DAMPs or the niche ECM becomes unsupportive of cells needed for repair and instead overtook by alloreactive T cells that are stimulated by pro-inflammatorymacrophages. As vessels become occluded due to damage or CR, the niche will become hypoxic and may further drive macrophages towards pro-inflammatory subsets supporting rejection. Conversely, sustained hypoxic environments in areas of the graft could instead favor the generation of regulatory macrophages due to the induction and modulation of local DAMPs. Both HMGB1 and IL-33 functionality is impacted by their redox state. While oxidation of IL-33 into a disulfide-bonded form negatively regulates its function (<xref rid="B182" ref-type="bibr">182</xref>), oxidized HMGB1 induces the expression of proinflammatory cytokines and chemokines by macrophages through its binding to MD-2 and TLR4 (<xref rid="B183" ref-type="bibr">183</xref>). Conversely, reduced HMGB1 associates with the chemokine CXCL12 and binds the CXCR4 receptor to recruit circulating leukocytes and stem cells to the site of damage and promote tissue regeneration (<xref rid="B184" ref-type="bibr">184</xref>, <xref rid="B185" ref-type="bibr">185</xref>). Reduced HMGB1 in hypoxic tumor sites is suggested to generate regulatory and reparative macrophages that shape an immunosuppressive tumor microenvironment (<xref rid="B186" ref-type="bibr">186</xref>). HSPs would also be induced in hypoxic areas or by cell stress associated with ischemia, rejection, and fibrosis. Important future studies will be needed to establish how reduced, oxidized, or induced DAMPs function in hypoxic versus normoxic regions of solid organ transplants to dictate short and long-term outcomes.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="s9">
      <title>Conclusions</title>
      <p>The original concept that DAMPs function after Tx as endogenous PAMPs in one-way paths that can be blocked to prevent early inflammation while regulatory and repair signals proceed unabated is dated. Our current understanding, generated from limited Tx data and studies of organ IRI models, is that the transcription factors and metabolic processes activated by pro-inflammatory DAMPs triggering inflammation after IRI and tissue injury are an essential part of a dynamic process that needs to function to trigger resolution and allow damaged tissues to return to homeostasis. It is also clear that regulatory and reparative DAMPs, closely related SPMs, are also significant players in shaping the ideal size and duration of the inflammatory phase after tissue injury. Regulatory and reparative DAMPs are also active mediators of subsequent resolution and repair phases.</p>
      <p>As tools such as scRNAseq and spatial transcriptomics become more widely applied in Tx, it will become more apparent how these different subsets of DAMPs contribute to immune cell networks during effective responses to IRI and how these are altered by local alloimmune responses by innate and adaptive cells. Value-added histology approaches utilizing mapped total RNA analysis (i.e., 10x Genomics Visium technology) or multiplexing immunofluorescent tags detecting RNA messages or specific proteins (i.e., Nanostring GeoMx technology) will be incredibly helpful to add to our understanding of the DAMP-driven immunology and physiology existing throughout the graft. Chronological graft assessment will define how sustained generation or depletion of regulatory or reparative signals triggering inflammation, resolution, and repair are modulated in graft AR and CR in crucial spaces, such as the vasculature. Applying advanced bioinformatics techniques such as artificial intelligence and machine learning can be used to investigate immune cell/DAMP interactions to help establish how these interactions shape the active signaling networks at each step after injury, inflammation, resolution, and repair of the graft (<xref rid="B187" ref-type="bibr">187</xref>). Using these types of analyses with precise mouse models allows for temporal control of the local DAMPs or AlloAg, which will allow us to untangle AlloAg input into pro-inflammatory, resolution, and repair pathways after SOTx.</p>
      <p>This knowledge will provide the transplant community with a framework for developing precision-medicine approaches where biologicals direct immune processes in the graft effectively. This family of drugs will be delivered to modulate dominant networks active in the graft instead of typical efforts to target individual immune populations or cytokines. Given the emerging evidence that DAMPs are important mediators of both early inflammation, injury resolution and repair there is significant therapeutic potential in manipulating the expression or delivery of DAMPs during the course SOTx. We have shown that the delivery of regulatory biomolecules, such as IL-33, using a hydrogel immediately post transplantation could improve outcomes by reducing the generation of inflammatory macrophages in HTx early after transplantation (<xref rid="B78" ref-type="bibr">78</xref>). Exploration into the <italic>ex vivo</italic> manipulation of organs prior to transplantation as a means to minimize inflammation and induce the expression of regulatory DAMPs is warranted. With the more recent development of normothermic <italic>ex vivo</italic> organ perfusion storage to mitigate IRI, there is a window of opportunity to biologically modify the donor organ either through the delivery of biomolecules, including regulatory DAMPs, encased in biovesicles or synthetic nanoparticles or potentially through gene therapy (<xref rid="B188" ref-type="bibr">188</xref>, <xref rid="B189" ref-type="bibr">189</xref>). Another potential therapy to investigate is hypoxic pre-conditioning before transplantation in order to induce the expression of HSPs and other DAMPs that are regulatory in their reduced form. Future studies will be needed to establish the best timing and mechanism of therapeutic delivery of regulatory DAMPs following solid organ transplantation to limit AR and CR.</p>
    </sec>
    <sec id="s10">
      <title>Author Contributions</title>
      <p>HT and GD together generated the text and figures. All authors contributed to the article and approved the submitted version.</p>
    </sec>
    <sec sec-type="funding-information" id="s11">
      <title>Funding</title>
      <p>The authors are supported by NIH grants: R01AR073527(HRT), R01HL122489(HRT), R56AI139327(HRT), T32CA082084(GKD), and F30AI147437(GKD).</p>
    </sec>
    <sec sec-type="COI-statement" id="s12">
      <title>Conflict of Interest</title>
      <p>HT is a listed inventor on patent application PCT/US2019/030547 (&#x201C;MATRIX BOUND VESICLES (MBVS) CONTAINING IL-33 AND THEIR USE&#x201D;).</p>
      <p>The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>We thank Carla Forsythe for excellent administrative support in the generation of this review.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braza</surname><given-names>F</given-names></name><name><surname>Brouard</surname><given-names>S</given-names></name><name><surname>Chadban</surname><given-names>S</given-names></name><name><surname>Goldstein</surname><given-names>DR</given-names></name></person-group>. <article-title>Role of TLRs and DAMPs in allograft inflammation and transplant outcomes</article-title>. <source>Nat Rev Nephrol</source> (<year>2016</year>) <volume>12</volume>(<issue>5</issue>):<page-range>281&#x2013;90</page-range>. <pub-id pub-id-type="doi">10.1038/nrneph.2016.41</pub-id>
</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Todd</surname><given-names>JL</given-names></name><name><surname>Palmer</surname><given-names>SM</given-names></name></person-group>. <article-title>Danger signals in regulating the immune response to solid organ transplantation</article-title>. <source>J Clin Invest</source> (<year>2017</year>) <volume>127</volume>(<issue>7</issue>):<page-range>2464&#x2013;72</page-range>. <pub-id pub-id-type="doi">10.1172/JCI90594</pub-id>
</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Land</surname><given-names>WG</given-names></name></person-group>. <article-title>Endogenous DAMPs, Category I: Constitutively Expressed, Native Molecules (Cat. I DAMPs). Damage-Associated Molecular Patterns in Human Diseases</article-title>. In: <source>Injury-Induced Innate Immune Responses</source>, vol. <volume>1</volume>. <publisher-loc>Cham</publisher-loc>: <publisher-name>Springer International Publishing</publisher-name> (<year>2018</year>). p. <page-range>219&#x2013;68</page-range>.</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Land</surname><given-names>WG</given-names></name><name><surname>Agostinis</surname><given-names>P</given-names></name><name><surname>Gasser</surname><given-names>S</given-names></name><name><surname>Garg</surname><given-names>AD</given-names></name><name><surname>Linkermann</surname><given-names>A</given-names></name></person-group>. <article-title>Transplantation and Damage-Associated Molecular Patterns (DAMPs)</article-title>. <source>Am J Transplant</source> (<year>2016</year>) <volume>16</volume>(<issue>12</issue>):<page-range>3338&#x2013;61</page-range>. <pub-id pub-id-type="doi">10.1111/ajt.13963</pub-id>
</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matta</surname><given-names>BM</given-names></name><name><surname>Reichenbach</surname><given-names>DK</given-names></name><name><surname>Blazar</surname><given-names>BR</given-names></name><name><surname>Turnquist</surname><given-names>HR</given-names></name></person-group>. <article-title>Alarmins and Their Receptors as Modulators and Indicators of Alloimmune Responses</article-title>. <source>Am J Transplant</source> (<year>2017</year>) <volume>17</volume>(<issue>2</issue>):<page-range>320&#x2013;7</page-range>. <pub-id pub-id-type="doi">10.1111/ajt.13887</pub-id>
</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gong</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name></person-group>. <article-title>DAMP-sensing receptors in sterile inflammation and inflammatory diseases</article-title>. <source>Nat Rev Immunol</source> (<year>2020</year>) <volume>20</volume>(<issue>2</issue>):<fpage>95</fpage>&#x2013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-019-0215-7</pub-id>
<pub-id pub-id-type="pmid">31558839</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Galluzzi</surname><given-names>L</given-names></name><name><surname>Vitale</surname><given-names>I</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name><name><surname>Abrams</surname><given-names>JM</given-names></name><name><surname>Adam</surname><given-names>D</given-names></name><name><surname>Agostinis</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018</article-title>. <source>Cell Death Differ</source> (<year>2018</year>) <volume>25</volume>(<issue>3</issue>):<fpage>486</fpage>&#x2013;<lpage>541</lpage>. <pub-id pub-id-type="doi">10.1038/s41418-018-0102-y</pub-id>
<pub-id pub-id-type="pmid">29362479</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>HW</given-names></name><name><surname>Evankovich</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Rosborough</surname><given-names>BR</given-names></name><name><surname>Nace</surname><given-names>GW</given-names></name><etal/></person-group>. <article-title>Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>(<issue>5</issue>):<page-range>2665&#x2013;79</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.1202733</pub-id>
</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Monestier</surname><given-names>M</given-names></name><name><surname>Esmon</surname><given-names>NL</given-names></name><name><surname>Esmon</surname><given-names>CT</given-names></name></person-group>. <article-title>Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>(<issue>5</issue>):<page-range>2626&#x2013;31</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.1003930</pub-id>
</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Braza</surname><given-names>MS</given-names></name><name><surname>van Leent</surname><given-names>MMT</given-names></name><name><surname>Lameijer</surname><given-names>M</given-names></name><name><surname>Sanchez-Gaytan</surname><given-names>BL</given-names></name><name><surname>Arts</surname><given-names>RJW</given-names></name><name><surname>Perez-Medina</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance</article-title>. <source>Immunity</source> (<year>2018</year>) <volume>49</volume>(<issue>5</issue>):<fpage>819</fpage>&#x2013;<lpage>28.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.09.008</pub-id>
<pub-id pub-id-type="pmid">30413362</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Hreggvidsdottir</surname><given-names>HS</given-names></name><name><surname>Palmblad</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ochani</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>(<issue>26</issue>):<page-range>11942&#x2013;7</page-range>. <pub-id pub-id-type="doi">10.1073/pnas.1003893107</pub-id>
</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zou</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Ming</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>HMGB1 is involved in chronic rejection of cardiac allograft via promoting inflammatory-like mDCs</article-title>. <source>Am J Transplant</source> (<year>2014</year>) <volume>14</volume>(<issue>8</issue>):<page-range>1765&#x2013;77</page-range>. <pub-id pub-id-type="doi">10.1111/ajt.12781</pub-id>
</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Testro</surname><given-names>AG</given-names></name><name><surname>Visvanathan</surname><given-names>K</given-names></name><name><surname>Skinner</surname><given-names>N</given-names></name><name><surname>Markovska</surname><given-names>V</given-names></name><name><surname>Crowley</surname><given-names>P</given-names></name><name><surname>Angus</surname><given-names>PW</given-names></name><etal/></person-group>. <article-title>Acute allograft rejection in human liver transplant recipients is associated with signaling through toll-like receptor 4</article-title>. <source>J Gastroenterol Hepatol</source> (<year>2011</year>) <volume>26</volume>(<issue>1</issue>):<page-range>155&#x2013;63</page-range>. <pub-id pub-id-type="doi">10.1111/j.1440-1746.2010.06324.x</pub-id>
</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Methe</surname><given-names>H</given-names></name><name><surname>Zimmer</surname><given-names>E</given-names></name><name><surname>Grimm</surname><given-names>C</given-names></name><name><surname>Nabauer</surname><given-names>M</given-names></name><name><surname>Koglin</surname><given-names>J</given-names></name></person-group>. <article-title>Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation</article-title>. <source>Transplantation</source> (<year>2004</year>) <volume>78</volume>(<issue>9</issue>):<page-range>1324&#x2013;31</page-range>. <pub-id pub-id-type="doi">10.1097/01.TP.0000137930.40597.03</pub-id>
</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kruger</surname><given-names>B</given-names></name><name><surname>Krick</surname><given-names>S</given-names></name><name><surname>Dhillon</surname><given-names>N</given-names></name><name><surname>Lerner</surname><given-names>SM</given-names></name><name><surname>Ames</surname><given-names>S</given-names></name><name><surname>Bromberg</surname><given-names>JS</given-names></name><etal/></person-group>. <article-title>Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2009</year>) <volume>106</volume>(<issue>9</issue>):<page-range>3390&#x2013;5</page-range>. <pub-id pub-id-type="doi">10.1073/pnas.0810169106</pub-id>
</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dinarello</surname><given-names>CA</given-names></name></person-group>. <article-title>Introduction to the interleukin-1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity</article-title>. <source>Immunol Rev</source> (<year>2018</year>) <volume>281</volume>(<issue>1</issue>):<fpage>5</fpage>&#x2013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/imr.12624</pub-id>
<pub-id pub-id-type="pmid">29248001</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amores-Iniesta</surname><given-names>J</given-names></name><name><surname>Barbera-Cremades</surname><given-names>M</given-names></name><name><surname>Martinez</surname><given-names>CM</given-names></name><name><surname>Pons</surname><given-names>JA</given-names></name><name><surname>Revilla-Nuin</surname><given-names>B</given-names></name><name><surname>Martinez-Alarcon</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Extracellular ATP Activates the NLRP3 Inflammasome and Is an EarlyDanger Signal of Skin Allograft Rejection</article-title>. <source>Cell Rep</source> (<year>2017</year>) <volume>21</volume>(<issue>12</issue>):<page-range>3414&#x2013;26</page-range>. <pub-id pub-id-type="doi">10.1016/j.celrep.2017.11.079</pub-id>
</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vergani</surname><given-names>A</given-names></name><name><surname>Tezza</surname><given-names>S</given-names></name><name><surname>D&#x2019;Addio</surname><given-names>F</given-names></name><name><surname>Fotino</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Niewczas</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Long-term heart transplant survival by targeting the ionotropicpurinergic receptor P2X7</article-title>. <source>Circulation</source> (<year>2013</year>) <volume>127</volume>(<issue>4</issue>):<page-range>463&#x2013;75</page-range>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.112.123653</pub-id>
</mixed-citation>
      </ref>
      <ref id="B19">
        <label>19</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Apostolova</surname><given-names>P</given-names></name><name><surname>Zeiser</surname><given-names>R</given-names></name></person-group>. <article-title>The role of danger signals and ectonucleotidases in acutegraft-versus-host disease</article-title>. <source>Hum Immunol</source> (<year>2016</year>) <volume>77</volume>(<issue>11</issue>):<page-range>1037&#x2013;47</page-range>. <pub-id pub-id-type="doi">10.1016/j.humimm.2016.02.005</pub-id>
</mixed-citation>
      </ref>
      <ref id="B20">
        <label>20</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Idzko</surname><given-names>M</given-names></name><name><surname>Ferrari</surname><given-names>D</given-names></name><name><surname>Eltzschig</surname><given-names>HK</given-names></name></person-group>. <article-title>Nucleotide signalling during inflammation</article-title>.<source>Nature</source> (<year>2014</year>) <volume>509</volume>(<issue>7500</issue>):<page-range>310&#x2013;7</page-range>. <pub-id pub-id-type="doi">10.1038/nature13085</pub-id>
</mixed-citation>
      </ref>
      <ref id="B21">
        <label>21</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Regulation of lung injury and repair by Toll-like receptors andhyaluronan</article-title>. <source>Nat Med</source> (<year>2005</year>) <volume>11</volume>(<issue>11</issue>):<page-range>1173&#x2013;9</page-range>. <pub-id pub-id-type="doi">10.1038/nm1315</pub-id>
</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tesar</surname><given-names>BM</given-names></name><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Palmer</surname><given-names>SM</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name><name><surname>Goldstein</surname><given-names>DR</given-names></name></person-group>. <article-title>The role of hyaluronan degradation products as innate alloimmune agonists</article-title>. <source>Am J Transplant</source> (<year>2006</year>) <volume>6</volume>(<issue>11</issue>):<page-range>2622&#x2013;35</page-range>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2006.01537.x</pub-id>
</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cui</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Monzon-Medina</surname><given-names>ME</given-names></name><name><surname>Padera</surname><given-names>RF</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>George</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Therapeutic lymphangiogenesis ameliorates established acute lung allograft rejection</article-title>. <source>J Clin Invest</source> (<year>2015</year>) <volume>125</volume>(<issue>11</issue>):<page-range>4255&#x2013;68</page-range>. <pub-id pub-id-type="doi">10.1172/JCI79693</pub-id>
</mixed-citation>
      </ref>
      <ref id="B24">
        <label>24</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bianchi</surname><given-names>ME</given-names></name></person-group>. <article-title>DAMPs, PAMPs and alarmins: all we need to know about danger</article-title>. <source>J Leukoc Biol</source> (<year>2007</year>) <volume>81</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1189/jlb.0306164</pub-id>
</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krysko</surname><given-names>DV</given-names></name><name><surname>Agostinis</surname><given-names>P</given-names></name><name><surname>Krysko</surname><given-names>O</given-names></name><name><surname>Garg</surname><given-names>AD</given-names></name><name><surname>Bachert</surname><given-names>C</given-names></name><name><surname>Lambrecht</surname><given-names>BN</given-names></name><etal/></person-group>. <article-title>Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation</article-title>. <source>Trends Immunol</source> (<year>2011</year>) <volume>32</volume>(<issue>4</issue>):<page-range>157&#x2013;64</page-range>. <pub-id pub-id-type="doi">10.1016/j.it.2011.01.005</pub-id>
</mixed-citation>
      </ref>
      <ref id="B26">
        <label>26</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Raoof</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Sumi</surname><given-names>Y</given-names></name><name><surname>Sursal</surname><given-names>T</given-names></name><name><surname>Junger</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Circulating mitochondrial DAMPs cause inflammatory responses to injury</article-title>. <source>Nature</source> (<year>2010</year>) <volume>464</volume>(<issue>7285</issue>):<page-range>104&#x2013;7</page-range>. <pub-id pub-id-type="doi">10.1038/nature08780</pub-id>
</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bzowska</surname><given-names>M</given-names></name><name><surname>Nogiec</surname><given-names>A</given-names></name><name><surname>Bania</surname><given-names>K</given-names></name><name><surname>Zygmunt</surname><given-names>M</given-names></name><name><surname>Zarebski</surname><given-names>M</given-names></name><name><surname>Dobrucki</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Involvement of cell surface 90 kDa heat shock protein (HSP90) in pattern recognition by human monocyte-derived macrophages</article-title>. <source>J Leukoc Biol</source> (<year>2017</year>) <volume>102</volume>(<issue>3</issue>):<page-range>763&#x2013;74</page-range>. <pub-id pub-id-type="doi">10.1189/jlb.2MA0117-019R</pub-id>
</mixed-citation>
      </ref>
      <ref id="B28">
        <label>28</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gardai</surname><given-names>SJ</given-names></name><name><surname>McPhillips</surname><given-names>KA</given-names></name><name><surname>Frasch</surname><given-names>SC</given-names></name><name><surname>Janssen</surname><given-names>WJ</given-names></name><name><surname>Starefeldt</surname><given-names>A</given-names></name><name><surname>Murphy-Ullrich</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte</article-title>. <source>Cell</source> (<year>2005</year>) <volume>123</volume>(<issue>2</issue>):<page-range>321&#x2013;34</page-range>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.032</pub-id>
</mixed-citation>
      </ref>
      <ref id="B29">
        <label>29</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terasaki</surname><given-names>PI</given-names></name><name><surname>Cecka</surname><given-names>JM</given-names></name><name><surname>Gjertson</surname><given-names>DW</given-names></name><name><surname>Takemoto</surname><given-names>S</given-names></name></person-group>. <article-title>High survival rates of kidney transplants from spousal and living unrelated donors</article-title>. <source>N Engl J Med</source> (<year>1995</year>) <volume>333</volume>(<issue>6</issue>):<page-range>333&#x2013;6</page-range>. <pub-id pub-id-type="doi">10.1056/NEJM199508103330601</pub-id>
</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mikhalski</surname><given-names>D</given-names></name><name><surname>Wissing</surname><given-names>KM</given-names></name><name><surname>Ghisdal</surname><given-names>L</given-names></name><name><surname>Broeders</surname><given-names>N</given-names></name><name><surname>Touly</surname><given-names>M</given-names></name><name><surname>Hoang</surname><given-names>AD</given-names></name><etal/></person-group>. <article-title>Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression</article-title>. <source>Transplantation</source> (<year>2008</year>) <volume>85</volume>(<issue>7 Suppl</issue>):<page-range>S3&#x2013;9</page-range>. <pub-id pub-id-type="doi">10.1097/TP.0b013e318169c29e</pub-id>
</mixed-citation>
      </ref>
      <ref id="B31">
        <label>31</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Debout</surname><given-names>A</given-names></name><name><surname>Foucher</surname><given-names>Y</given-names></name><name><surname>Trebern-Launay</surname><given-names>K</given-names></name><name><surname>Legendre</surname><given-names>C</given-names></name><name><surname>Kreis</surname><given-names>H</given-names></name><name><surname>Mourad</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation</article-title>. <source>Kidney Int</source> (<year>2015</year>) <volume>87</volume>(<issue>2</issue>):<page-range>343&#x2013;9</page-range>. <pub-id pub-id-type="doi">10.1038/ki.2014.304</pub-id>
</mixed-citation>
      </ref>
      <ref id="B32">
        <label>32</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Banner</surname><given-names>NR</given-names></name><name><surname>Thomas</surname><given-names>HL</given-names></name><name><surname>Curnow</surname><given-names>E</given-names></name><name><surname>Hussey</surname><given-names>JC</given-names></name><name><surname>Rogers</surname><given-names>CA</given-names></name><name><surname>Bonser</surname><given-names>RS</given-names></name><etal/></person-group>. <article-title>The importance of cold and warm cardiac ischemia for survival afterheart transplantation</article-title>. <source>Transplantation</source> (<year>2008</year>) <volume>86</volume>(<issue>4</issue>):<page-range>542&#x2013;7</page-range>. <pub-id pub-id-type="doi">10.1097/TP.0b013e31818149b9</pub-id>
</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stehlik</surname><given-names>J</given-names></name><name><surname>Edwards</surname><given-names>LB</given-names></name><name><surname>Kucheryavaya</surname><given-names>AY</given-names></name><name><surname>Benden</surname><given-names>C</given-names></name><name><surname>Christie</surname><given-names>JD</given-names></name><name><surname>Dobbels</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>The Registry of the International Society for Heart and LungTransplantation: Twenty-eighth Adult Heart Transplant Report&#x2013;2011</article-title>. <source>J Heart Lung Transplant</source> (<year>2011</year>) <volume>30</volume>(<issue>10</issue>):<page-range>1078&#x2013;94</page-range>. <pub-id pub-id-type="doi">10.1016/j.healun.2011.08.003</pub-id>
</mixed-citation>
      </ref>
      <ref id="B34">
        <label>34</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ali</surname><given-names>JM</given-names></name><name><surname>Davies</surname><given-names>SE</given-names></name><name><surname>Brais</surname><given-names>RJ</given-names></name><name><surname>Randle</surname><given-names>LV</given-names></name><name><surname>Klinck</surname><given-names>JR</given-names></name><name><surname>Allison</surname><given-names>ME</given-names></name><etal/></person-group>. <article-title>Analysis of ischemia/reperfusion injury in time-zero biopsiespredicts liver allograft outcomes</article-title>. <source>Liver Transpl</source> (<year>2015</year>) <volume>21</volume>(<issue>4</issue>):<page-range>487&#x2013;99</page-range>. <pub-id pub-id-type="doi">10.1002/lt.24072</pub-id>
</mixed-citation>
      </ref>
      <ref id="B35">
        <label>35</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duffy</surname><given-names>JP</given-names></name><name><surname>Kao</surname><given-names>K</given-names></name><name><surname>Ko</surname><given-names>CY</given-names></name><name><surname>Farmer</surname><given-names>DG</given-names></name><name><surname>McDiarmid</surname><given-names>SV</given-names></name><name><surname>Hong</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>Long-term patient outcome and quality of life after livertransplantation: analysis of 20-year survivors</article-title>. <source>Ann Surg</source> (<year>2010</year>) <volume>252</volume>(<issue>4</issue>):<page-range>652&#x2013;61</page-range>. <pub-id pub-id-type="doi">10.1097/SLA.0b013e3181f5f23a</pub-id>
</mixed-citation>
      </ref>
      <ref id="B36">
        <label>36</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ochando</surname><given-names>J</given-names></name><name><surname>Ordikhani</surname><given-names>F</given-names></name><name><surname>Boros</surname><given-names>P</given-names></name><name><surname>Jordan</surname><given-names>S</given-names></name></person-group>. <article-title>The innate immune response to allotransplants: mechanisms andtherapeutic potentials</article-title>. <source>Cell Mol Immunol</source> (<year>2019</year>) <volume>16</volume>(<issue>4</issue>):<page-range>350&#x2013;6</page-range>. <pub-id pub-id-type="doi">10.1038/s41423-019-0216-2</pub-id>
</mixed-citation>
      </ref>
      <ref id="B37">
        <label>37</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>LM</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>MQ</given-names></name><etal/></person-group>. <article-title>Short-term Pharmacological Inhibition of MyD88 Homodimerization by aNovel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation</article-title>. <source>Transplantation</source> (<year>2017</year>) <volume>101</volume>(<issue>2</issue>):<page-range>284&#x2013;93</page-range>. <pub-id pub-id-type="doi">10.1097/TP.0000000000001471</pub-id>
</mixed-citation>
      </ref>
      <ref id="B38">
        <label>38</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>DR</given-names></name><name><surname>Tesar</surname><given-names>BM</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Lakkis</surname><given-names>FG</given-names></name></person-group>. <article-title>Critical role of the Toll-like receptor signal adaptor protein MyD88in acute allograft rejection</article-title>. <source>J Clin Invest</source> (<year>2003</year>) <volume>111</volume>(<issue>10</issue>):<page-range>1571&#x2013;8</page-range>. <pub-id pub-id-type="doi">10.1172/JCI17573</pub-id>
</mixed-citation>
      </ref>
      <ref id="B39">
        <label>39</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Noordmans</surname><given-names>GA</given-names></name><name><surname>O&#x2019;Brien</surname><given-names>MR</given-names></name><name><surname>Ma</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>CY</given-names></name><name><surname>Zhang</surname><given-names>GY</given-names></name><etal/></person-group>. <article-title>Absence of MyD88 signaling induces donor-specific kidney allografttolerance</article-title>. <source>J Am Soc Nephrol</source> (<year>2012</year>) <volume>23</volume>(<issue>10</issue>):<page-range>1701&#x2013;16</page-range>. <pub-id pub-id-type="doi">10.1681/ASN.2012010052</pub-id>
</mixed-citation>
      </ref>
      <ref id="B40">
        <label>40</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lerret</surname><given-names>NM</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Kang</surname><given-names>HK</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Recipient Myd88 Deficiency Promotes Spontaneous Resolution of KidneyAllograft Rejection</article-title>. <source>J Am Soc Nephrol</source> (<year>2015</year>) <volume>26</volume>(<issue>11</issue>):<page-range>2753&#x2013;64</page-range>. <pub-id pub-id-type="doi">10.1681/ASN.2014080813</pub-id>
</mixed-citation>
      </ref>
      <ref id="B41">
        <label>41</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Beduhn</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Lian</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Induction of alloimmune tolerance in heart transplantation throughgene silencing of TLR adaptors</article-title>. <source>Am J Transplant</source> (<year>2012</year>) <volume>12</volume>(<issue>10</issue>):<page-range>2675&#x2013;88</page-range>. <pub-id pub-id-type="doi">10.1111/j.1600-6143.2012.04196.x</pub-id>
</mixed-citation>
      </ref>
      <ref id="B42">
        <label>42</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>WT</given-names></name><name><surname>Zhang</surname><given-names>LM</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>SY</given-names></name><name><surname>Ding</surname><given-names>ZC</given-names></name><name><surname>Fang</surname><given-names>ZM</given-names></name><etal/></person-group>. <article-title>Short-term MyD88 inhibition ameliorates cardiac graft rejection andpromotes donor-specific hyporesponsiveness of skin grafts in mice</article-title>. <source>Transpl Int</source> (<year>2016</year>) <volume>29</volume>(<issue>8</issue>):<page-range>941&#x2013;52</page-range>. <pub-id pub-id-type="doi">10.1111/tri.12789</pub-id>
</mixed-citation>
      </ref>
      <ref id="B43">
        <label>43</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barochia</surname><given-names>A</given-names></name><name><surname>Solomon</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Natanson</surname><given-names>C</given-names></name><name><surname>Eichacker</surname><given-names>PQ</given-names></name></person-group>. <article-title>Eritoran tetrasodium (E5564) treatment for sepsis: review ofpreclinical and clinical studies</article-title>. <source>Expert Opin Drug Metab Toxicol</source> (<year>2011</year>) <volume>7</volume>(<issue>4</issue>):<page-range>479&#x2013;94</page-range>. <pub-id pub-id-type="doi">10.1517/17425255.2011.558190</pub-id>
</mixed-citation>
      </ref>
      <ref id="B44">
        <label>44</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>Laterre</surname><given-names>PF</given-names></name><name><surname>Francois</surname><given-names>B</given-names></name><name><surname>LaRosa</surname><given-names>SP</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Mira</surname><given-names>JP</given-names></name><etal/></person-group>. <article-title>Effect of eritoran, an antagonist of MD2-TLR4, on mortality inpatients with severe sepsis: the ACCESS randomized trial</article-title>. <source>JAMA</source> (<year>2013</year>) <volume>309</volume>(<issue>11</issue>):<page-range>1154&#x2013;62</page-range>. <pub-id pub-id-type="doi">10.1001/jama.2013.2194</pub-id>
</mixed-citation>
      </ref>
      <ref id="B45">
        <label>45</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dunn-Siegrist</surname><given-names>I</given-names></name><name><surname>Leger</surname><given-names>O</given-names></name><name><surname>Daubeuf</surname><given-names>B</given-names></name><name><surname>Poitevin</surname><given-names>Y</given-names></name><name><surname>Depis</surname><given-names>F</given-names></name><name><surname>Herren</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Pivotal involvement of Fcgamma receptor IIA in the neutralization oflipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1</article-title>. <source>J Biol Chem</source> (<year>2007</year>) <volume>282</volume>(<issue>48</issue>):<page-range>34817&#x2013;27</page-range>. <pub-id pub-id-type="doi">10.1074/jbc.M706440200</pub-id>
</mixed-citation>
      </ref>
      <ref id="B46">
        <label>46</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monnet</surname><given-names>E</given-names></name><name><surname>Lapeyre</surname><given-names>G</given-names></name><name><surname>Poelgeest</surname><given-names>EV</given-names></name><name><surname>Jacqmin</surname><given-names>P</given-names></name><name><surname>Graaf</surname><given-names>K</given-names></name><name><surname>Reijers</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody,in a randomized phase I dose escalation study in healthy volunteers receiving LPS</article-title>. <source>Clin Pharmacol Ther</source> (<year>2017</year>) <volume>101</volume>(<issue>2</issue>):<page-range>200&#x2013;8</page-range>. <pub-id pub-id-type="doi">10.1002/cpt.522</pub-id>
</mixed-citation>
      </ref>
      <ref id="B47">
        <label>47</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Monnet</surname><given-names>E</given-names></name><name><surname>Choy</surname><given-names>EH</given-names></name><name><surname>McInnes</surname><given-names>I</given-names></name><name><surname>Kobakhidze</surname><given-names>T</given-names></name><name><surname>de Graaf</surname><given-names>K</given-names></name><name><surname>Jacqmin</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Efficacy and safety of NI-0101, an anti-toll-like receptor 4monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study</article-title>. <source>Ann Rheum Dis</source> (<year>2020</year>) <volume>79</volume>(<issue>3</issue>):<page-range>316&#x2013;23</page-range>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2019-216487</pub-id>
</mixed-citation>
      </ref>
      <ref id="B48">
        <label>48</label>
        <mixed-citation publication-type="webpage">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>RM</given-names></name></person-group>. (Oct. 2012-June 30, 2016). <article-title>Placebo-controlled study to evaluate the safety and efficacy of OPN-305 in preventing delayed renal graft function</article-title>. Identifier NCT01794663. <uri xlink:type="simple" xlink:href="https://www.clinicaltrials.gov/ct2/show/NCT01794663?term1/4opsona&amp;rank1/41">https://www.clinicaltrials.gov/ct2/show/NCT01794663?term1/4opsona&amp;rank1/41</uri>.</mixed-citation>
      </ref>
      <ref id="B49">
        <label>49</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Farrar</surname><given-names>CA</given-names></name><name><surname>Keogh</surname><given-names>B</given-names></name><name><surname>McCormack</surname><given-names>W</given-names></name><name><surname>O&#x2019;Shaughnessy</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>A</given-names></name><name><surname>Reilly</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Inhibition of TLR2 promotes graft function in a murine model ofrenal transplant ischemia-reperfusion injury</article-title>. <source>FASEB J</source> (<year>2012</year>) <volume>26</volume>(<issue>2</issue>):<fpage>799</fpage>&#x2013;<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1096/fj.11-195396</pub-id>
<pub-id pub-id-type="pmid">22042224</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arslan</surname><given-names>F</given-names></name><name><surname>Houtgraaf</surname><given-names>JH</given-names></name><name><surname>Keogh</surname><given-names>B</given-names></name><name><surname>Kazemi</surname><given-names>K</given-names></name><name><surname>de Jong</surname><given-names>R</given-names></name><name><surname>McCormack</surname><given-names>WJ</given-names></name><etal/></person-group>. <article-title>Treatment with OPN-305, a humanized anti-Toll-Like receptor-2antibody, reduces myocardial ischemia/reperfusion injury in pigs</article-title>. <source>Circ Cardiovasc Interv</source> (<year>2012</year>) <volume>5</volume>(<issue>2</issue>):<page-range>279&#x2013;87</page-range>. <pub-id pub-id-type="doi">10.1161/CIRCINTERVENTIONS.111.967596</pub-id>
</mixed-citation>
      </ref>
      <ref id="B51">
        <label>51</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reilly</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>RM</given-names></name><name><surname>Thomson</surname><given-names>MH</given-names></name><name><surname>Patris</surname><given-names>V</given-names></name><name><surname>Ryle</surname><given-names>P</given-names></name><name><surname>McLoughlin</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Randomized, double-blind, placebo-controlled, dose-escalating phaseI, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody</article-title>. <source>Clin Pharmacol Ther</source> (<year>2013</year>) <volume>94</volume>(<issue>5</issue>):<fpage>593</fpage>&#x2013;<lpage>600</lpage>. <pub-id pub-id-type="doi">10.1038/clpt.2013.150</pub-id>
<pub-id pub-id-type="pmid">23880971</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52</label>
        <mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Carey</surname><given-names>B</given-names></name></person-group>. <source>Irish biotech firm Opsona Therapeutics pops its final pill. The Sunday Times</source>. <publisher-name>Times Newspapers Limited, England</publisher-name>. <publisher-loc>England</publisher-loc>: <publisher-name>Times Newspapers Limited</publisher-name> (<year>2019</year>). Available at: <uri xlink:type="simple" xlink:href="https://www.thetimes.co.uk/article/irish-biotech-firm-opsona-therapeutics-pops-its-final-pill-jx5nrgj99">https://www.thetimes.co.uk/article/irish-biotech-firm-opsona-therapeutics-pops-its-final-pill-jx5nrgj99</uri>.</mixed-citation>
      </ref>
      <ref id="B53">
        <label>53</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thomson</surname><given-names>AW</given-names></name></person-group>. <article-title>MyD88 Inhibitors and the Continuing Challenge of TLRAntagonism</article-title>. <source>Transplantation</source> (<year>2017</year>) <volume>101</volume>(<issue>2</issue>):<page-range>230&#x2013;1</page-range>. <pub-id pub-id-type="doi">10.1097/TP.0000000000001565</pub-id>
</mixed-citation>
      </ref>
      <ref id="B54">
        <label>54</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>N</given-names></name><name><surname>Simon</surname><given-names>MC</given-names></name></person-group>. <article-title>Hypoxia-inducible factors: key regulators of myeloid cells during inflammation</article-title>. <source>J Clin Invest</source> (<year>2016</year>) <volume>126</volume>(<issue>10</issue>):<page-range>3661&#x2013;71</page-range>. <pub-id pub-id-type="doi">10.1172/JCI84426</pub-id>
</mixed-citation>
      </ref>
      <ref id="B55">
        <label>55</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cramer</surname><given-names>T</given-names></name><name><surname>Yamanishi</surname><given-names>Y</given-names></name><name><surname>Clausen</surname><given-names>BE</given-names></name><name><surname>Forster</surname><given-names>I</given-names></name><name><surname>Pawlinski</surname><given-names>R</given-names></name><name><surname>Mackman</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>HIF-1alpha is essential for myeloid cell-mediated inflammation</article-title>. <source>Cell</source> (<year>2003</year>) <volume>112</volume>(<issue>5</issue>):<page-range>645&#x2013;57</page-range>. <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00154-5</pub-id>
</mixed-citation>
      </ref>
      <ref id="B56">
        <label>56</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O&#x2019;Neill</surname><given-names>LA</given-names></name><name><surname>Pearce</surname><given-names>EJ</given-names></name></person-group>. <article-title>Immunometabolism governs dendritic cell and macrophage function</article-title>. <source>J Exp Med</source> (<year>2016</year>) <volume>213</volume>(<issue>1</issue>):<fpage>15</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20151570</pub-id>
<pub-id pub-id-type="pmid">26694970</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eming</surname><given-names>SA</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Martin</surname><given-names>P</given-names></name></person-group>. <article-title>Inflammation and metabolism in tissue repair and regeneration</article-title>. <source>Science</source> (<year>2017</year>) <volume>356</volume>(<issue>6342</issue>):<page-range>1026&#x2013;30</page-range>. <pub-id pub-id-type="doi">10.1126/science.aam7928</pub-id>
</mixed-citation>
      </ref>
      <ref id="B58">
        <label>58</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>VanderVen</surname><given-names>BC</given-names></name></person-group>. <article-title>Immunometabolism at the interface between macrophages and pathogens</article-title>. <source>Nat Rev Immunol</source> (<year>2019</year>) <volume>19</volume>(<issue>5</issue>):<fpage>291</fpage>&#x2013;<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1038/s41577-019-0124-9</pub-id>
<pub-id pub-id-type="pmid">30679807</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Singer</surname><given-names>BD</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group>. <article-title>Immunometabolism of pro-repair cells</article-title>. <source>J Clin Invest</source> (<year>2019</year>) <volume>129</volume>(<issue>7</issue>):<page-range>2597&#x2013;607</page-range>. <pub-id pub-id-type="doi">10.1172/JCI124613</pub-id>
</mixed-citation>
      </ref>
      <ref id="B60">
        <label>60</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bailey</surname><given-names>JD</given-names></name><name><surname>Diotallevi</surname><given-names>M</given-names></name><name><surname>Nicol</surname><given-names>T</given-names></name><name><surname>McNeill</surname><given-names>E</given-names></name><name><surname>Shaw</surname><given-names>A</given-names></name><name><surname>Chuaiphichai</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Nitric Oxide Modulates Metabolic Remodeling in Inflammatory Macrophages through TCA Cycle Regulation and Itaconate Accumulation</article-title>. <source>Cell Rep</source> (<year>2019</year>) <volume>28</volume>(<issue>1</issue>):<fpage>218</fpage>&#x2013;<lpage>30.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.06.018</pub-id>
<pub-id pub-id-type="pmid">31269442</pub-id></mixed-citation>
      </ref>
      <ref id="B61">
        <label>61</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>SC</given-names></name><name><surname>Everts</surname><given-names>B</given-names></name><name><surname>Ivanova</surname><given-names>Y</given-names></name><name><surname>O&#x2019;Sullivan</surname><given-names>D</given-names></name><name><surname>Nascimento</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>(<issue>9</issue>):<page-range>846&#x2013;55</page-range>. <pub-id pub-id-type="doi">10.1038/ni.2956</pub-id>
</mixed-citation>
      </ref>
      <ref id="B62">
        <label>62</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tannahill</surname><given-names>GM</given-names></name><name><surname>Curtis</surname><given-names>AM</given-names></name><name><surname>Adamik</surname><given-names>J</given-names></name><name><surname>Palsson-McDermott</surname><given-names>EM</given-names></name><name><surname>McGettrick</surname><given-names>AF</given-names></name><name><surname>Goel</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha</article-title>. <source>Nature</source> (<year>2013</year>) <volume>496</volume>(<issue>7444</issue>):<page-range>238&#x2013;42</page-range>. <pub-id pub-id-type="doi">10.1038/nature11986</pub-id>
</mixed-citation>
      </ref>
      <ref id="B63">
        <label>63</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jantsch</surname><given-names>J</given-names></name><name><surname>Wiese</surname><given-names>M</given-names></name><name><surname>Schodel</surname><given-names>J</given-names></name><name><surname>Castiglione</surname><given-names>K</given-names></name><name><surname>Glasner</surname><given-names>J</given-names></name><name><surname>Kolbe</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Toll-like receptor activation and hypoxia use distinct signaling pathways to stabilize hypoxia-inducible factor 1alpha (HIF1A) and result in differential HIF1A-dependent gene expression</article-title>. <source>J Leukoc Biol</source> (<year>2011</year>) <volume>90</volume>(<issue>3</issue>):<page-range>551&#x2013;62</page-range>. <pub-id pub-id-type="doi">10.1189/jlb.1210683</pub-id>
</mixed-citation>
      </ref>
      <ref id="B64">
        <label>64</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Khan</surname><given-names>MA</given-names></name><name><surname>Tian</surname><given-names>W</given-names></name><name><surname>Beilke</surname><given-names>J</given-names></name><name><surname>Natarajan</surname><given-names>R</given-names></name><name><surname>Kosek</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Adenovirus-mediated HIF-1alpha gene transfer promotes repair of mouse airway allograft microvasculature and attenuates chronic rejection</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>(<issue>6</issue>):<page-range>2336&#x2013;49</page-range>. <pub-id pub-id-type="doi">10.1172/JCI46192</pub-id>
</mixed-citation>
      </ref>
      <ref id="B65">
        <label>65</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Loor</surname><given-names>G</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group>. <article-title>Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion</article-title>. <source>Cell Death Differ</source> (<year>2008</year>) <volume>15</volume>(<issue>4</issue>):<page-range>686&#x2013;90</page-range>. <pub-id pub-id-type="doi">10.1038/cdd.2008.13</pub-id>
</mixed-citation>
      </ref>
      <ref id="B66">
        <label>66</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amaral</surname><given-names>N</given-names></name><name><surname>Okonko</surname><given-names>DO</given-names></name></person-group>. <article-title>Mitigation of myocardial ischemia-reperfusion injury via HIF-1alpha-frataxin signaling</article-title>. <source>Am J Physiol Heart Circ Physiol</source> (<year>2015</year>) <volume>309</volume>(<issue>5</issue>):<page-range>H728&#x2013;30</page-range>. <pub-id pub-id-type="doi">10.1152/ajpheart.00553.2015</pub-id>
</mixed-citation>
      </ref>
      <ref id="B67">
        <label>67</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Abuduwufuer</surname><given-names>A</given-names></name><name><surname>Lv</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>The role of HIF-1alpha-VEGF pathway in bronchiolitis obliterans after lung transplantation</article-title>. <source>J Cardiothorac Surg</source> (<year>2019</year>) <volume>14</volume>(<issue>1</issue>):<fpage>27</fpage>. <pub-id pub-id-type="doi">10.1186/s13019-019-0832-z</pub-id>
<pub-id pub-id-type="pmid">30696477</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <label>68</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ip</surname><given-names>WKE</given-names></name><name><surname>Hoshi</surname><given-names>N</given-names></name><name><surname>Shouval</surname><given-names>DS</given-names></name><name><surname>Snapper</surname><given-names>S</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>. <article-title>Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages</article-title>. <source>Science</source> (<year>2017</year>) <volume>356</volume>(<issue>6337</issue>):<page-range>513&#x2013;9</page-range>. <pub-id pub-id-type="doi">10.1126/science.aal3535</pub-id>
</mixed-citation>
      </ref>
      <ref id="B69">
        <label>69</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Hara</surname><given-names>H</given-names></name><name><surname>Nunez</surname><given-names>G</given-names></name></person-group>. <article-title>Mechanism and Regulation of NLRP3 Inflammasome Activation</article-title>. <source>Trends Biochem Sci</source> (<year>2016</year>) <volume>41</volume>(<issue>12</issue>):<page-range>1012&#x2013;21</page-range>. <pub-id pub-id-type="doi">10.1016/j.tibs.2016.09.002</pub-id>
</mixed-citation>
      </ref>
      <ref id="B70">
        <label>70</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chen</surname><given-names>GY</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group>. <article-title>CD24 and Siglec-10 selectively repress tissue damage-induced immune responses</article-title>. <source>Science</source> (<year>2009</year>) <volume>323</volume>(<issue>5922</issue>):<page-range>1722&#x2013;5</page-range>. <pub-id pub-id-type="doi">10.1126/science.1168988</pub-id>
</mixed-citation>
      </ref>
      <ref id="B71">
        <label>71</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Macauley</surname><given-names>MS</given-names></name><name><surname>Crocker</surname><given-names>PR</given-names></name><name><surname>Paulson</surname><given-names>JC</given-names></name></person-group>. <article-title>Siglec-mediated regulation of immune cell function in disease</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>(<issue>10</issue>):<page-range>653&#x2013;66</page-range>. <pub-id pub-id-type="doi">10.1038/nri3737</pub-id>
</mixed-citation>
      </ref>
      <ref id="B72">
        <label>72</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toubai</surname><given-names>T</given-names></name><name><surname>Hou</surname><given-names>G</given-names></name><name><surname>Mathewson</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Oravecz-Wilson</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Siglec-G-CD24 axis controls the severity of graft-versus-host disease in mice</article-title>. <source>Blood</source> (<year>2014</year>) <volume>123</volume>(<issue>22</issue>):<page-range>3512&#x2013;23</page-range>. <pub-id pub-id-type="doi">10.1182/blood-2013-12-545335</pub-id>
</mixed-citation>
      </ref>
      <ref id="B73">
        <label>73</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Devenport</surname><given-names>M</given-names></name><name><surname>Reddy</surname><given-names>P</given-names></name><name><surname>Farag</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Targeting Danger Associated Molecular Pattern (DAMP) with CD24Fc to Reduce Acute Gvhd: Study Design on a Randomized Double Blind Placebo Controlled Phase III Clinical Trial (CATHY Study)</article-title>. <source>Biol Blood Marrow Transplant</source> (<year>2020</year>) <volume>26</volume>(<issue>3</issue>):<page-range>S180&#x2013;S1</page-range>. <pub-id pub-id-type="doi">10.1016/j.bbmt.2019.12.741</pub-id>
</mixed-citation>
      </ref>
      <ref id="B74">
        <label>74</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arpaia</surname><given-names>N</given-names></name><name><surname>Green</surname><given-names>JA</given-names></name><name><surname>Moltedo</surname><given-names>B</given-names></name><name><surname>Arvey</surname><given-names>A</given-names></name><name><surname>Hemmers</surname><given-names>S</given-names></name><name><surname>Yuan</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>A Distinct Function of Regulatory T Cells in Tissue Protection</article-title>. <source>Cell</source> (<year>2015</year>) <volume>162</volume>(<issue>5</issue>):<page-range>1078&#x2013;89</page-range>. <pub-id pub-id-type="doi">10.1016/j.cell.2015.08.021</pub-id>
</mixed-citation>
      </ref>
      <ref id="B75">
        <label>75</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burzyn</surname><given-names>D</given-names></name><name><surname>Kuswanto</surname><given-names>W</given-names></name><name><surname>Kolodin</surname><given-names>D</given-names></name><name><surname>Shadrach</surname><given-names>JL</given-names></name><name><surname>Cerletti</surname><given-names>M</given-names></name><name><surname>Jang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>A special population of regulatory T cells potentiates muscle repair</article-title>. <source>Cell</source> (<year>2013</year>) <volume>155</volume>(<issue>6</issue>):<page-range>1282&#x2013;95</page-range>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.10.054</pub-id>
</mixed-citation>
      </ref>
      <ref id="B76">
        <label>76</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kuswanto</surname><given-names>W</given-names></name><name><surname>Burzyn</surname><given-names>D</given-names></name><name><surname>Panduro</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>KK</given-names></name><name><surname>Jang</surname><given-names>YC</given-names></name><name><surname>Wagers</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>44</volume>(<issue>2</issue>):<page-range>355&#x2013;67</page-range>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.01.009</pub-id>
</mixed-citation>
      </ref>
      <ref id="B77">
        <label>77</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Dwyer</surname><given-names>GK</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Mathews</surname><given-names>LR</given-names></name><name><surname>Chakka</surname><given-names>AB</given-names></name><etal/></person-group>. <article-title>IL-33-mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury</article-title>. <source>JCI Insight</source> (<year>2019</year>) <volume>4</volume>(<issue>6</issue>). <pub-id pub-id-type="doi">10.1172/jci.insight.123919</pub-id>
</mixed-citation>
      </ref>
      <ref id="B78">
        <label>78</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Bartolacci</surname><given-names>JG</given-names></name><name><surname>Dwyer</surname><given-names>GK</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Mathews</surname><given-names>LR</given-names></name><etal/></person-group>. <article-title>Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection</article-title>. <source>J Clin Invest</source> (<year>2020</year>). <pub-id pub-id-type="doi">10.1172/JCI133008</pub-id>
</mixed-citation>
      </ref>
      <ref id="B79">
        <label>79</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brunner</surname><given-names>SM</given-names></name><name><surname>Schiechl</surname><given-names>G</given-names></name><name><surname>Falk</surname><given-names>W</given-names></name><name><surname>Schlitt</surname><given-names>HJ</given-names></name><name><surname>Geissler</surname><given-names>EK</given-names></name><name><surname>Fichtner-Feigl</surname><given-names>S</given-names></name></person-group>. <article-title>Interleukin-33 prolongs allograft survival during chronic cardiac rejection</article-title>. <source>Transpl Int</source> (<year>2011</year>) <volume>24</volume>(<issue>10</issue>):<page-range>1027&#x2013;39</page-range>. <pub-id pub-id-type="doi">10.1111/j.1432-2277.2011.01306.x</pub-id>
</mixed-citation>
      </ref>
      <ref id="B80">
        <label>80</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gajardo</surname><given-names>T</given-names></name><name><surname>Morales</surname><given-names>RA</given-names></name><name><surname>Campos-Mora</surname><given-names>M</given-names></name><name><surname>Campos-Acuna</surname><given-names>J</given-names></name><name><surname>Pino-Lagos</surname><given-names>K</given-names></name></person-group>. <article-title>Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3(+) regulatory T cells in skin-transplanted mice</article-title>. <source>Immunology</source> (<year>2015</year>) <volume>146</volume>(<issue>1</issue>):<page-range>81&#x2013;8</page-range>. <pub-id pub-id-type="doi">10.1111/imm.12483</pub-id>
</mixed-citation>
      </ref>
      <ref id="B81">
        <label>81</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawai</surname><given-names>K</given-names></name><name><surname>Uchiyama</surname><given-names>M</given-names></name><name><surname>Hester</surname><given-names>J</given-names></name><name><surname>Issa</surname><given-names>F</given-names></name></person-group>. <article-title>IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation</article-title>. <source>Am J Transplant</source> (<year>2020</year>). <pub-id pub-id-type="doi">10.1111/ajt.16266</pub-id>
</mixed-citation>
      </ref>
      <ref id="B82">
        <label>82</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matta</surname><given-names>BM</given-names></name><name><surname>Reichenbach</surname><given-names>DK</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Mathews</surname><given-names>L</given-names></name><name><surname>Koehn</surname><given-names>BH</given-names></name><name><surname>Dwyer</surname><given-names>GK</given-names></name><etal/></person-group>. <article-title>Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD</article-title>. <source>Blood</source> (<year>2016</year>) <volume>128</volume>(<issue>3</issue>):<page-range>427&#x2013;39</page-range>. <pub-id pub-id-type="doi">10.1182/blood-2015-12-684142</pub-id>
</mixed-citation>
      </ref>
      <ref id="B83">
        <label>83</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jones</surname><given-names>Q</given-names></name><name><surname>Voegeli</surname><given-names>TS</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Currie</surname><given-names>RW</given-names></name></person-group>. <article-title>Heat shock proteins protect against ischemia and inflammation through multiple mechanisms</article-title>. <source>Inflammation Allergy Drug Targets</source> (<year>2011</year>) <volume>10</volume>(<issue>4</issue>):<page-range>247&#x2013;59</page-range>. <pub-id pub-id-type="doi">10.2174/187152811796117726</pub-id>
</mixed-citation>
      </ref>
      <ref id="B84">
        <label>84</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seemampillai</surname><given-names>B</given-names></name><name><surname>Germack</surname><given-names>R</given-names></name><name><surname>Felkin</surname><given-names>LE</given-names></name><name><surname>McCormack</surname><given-names>A</given-names></name><name><surname>Rose</surname><given-names>ML</given-names></name></person-group>. <article-title>Heat shock protein-27 delays acute rejection after cardiac transplantation: an experimental model</article-title>. <source>Transplantation</source> (<year>2014</year>) <volume>98</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1097/TP.0000000000000170</pub-id>
<pub-id pub-id-type="pmid">24879379</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <label>85</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Elias</surname><given-names>D</given-names></name><name><surname>Meilin</surname><given-names>A</given-names></name><name><surname>Ablamunits</surname><given-names>V</given-names></name><name><surname>Birk</surname><given-names>OS</given-names></name><name><surname>Carmi</surname><given-names>P</given-names></name><name><surname>Konen-Waisman</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens</article-title>. <source>Diabetes</source> (<year>1997</year>) <volume>46</volume>(<issue>5</issue>):<page-range>758&#x2013;64</page-range>. <pub-id pub-id-type="doi">10.2337/diabetes.46.5.758</pub-id>
</mixed-citation>
      </ref>
      <ref id="B86">
        <label>86</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Luna</surname><given-names>E</given-names></name><name><surname>Postol</surname><given-names>E</given-names></name><name><surname>Caldas</surname><given-names>C</given-names></name><name><surname>Benvenuti</surname><given-names>LA</given-names></name><name><surname>Rodrigues</surname><given-names>JMJ</given-names></name><name><surname>Lima</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Treatment with encapsulated Hsp60 peptide (p277) prolongs skin graft survival in a murine model of minor antigen disparity</article-title>. <source>Scand J Immunol</source> (<year>2007</year>) <volume>66</volume>(<issue>1</issue>):<fpage>62</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3083.2007.01951.x</pub-id>
<pub-id pub-id-type="pmid">17587347</pub-id></mixed-citation>
      </ref>
      <ref id="B87">
        <label>87</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borges</surname><given-names>TJ</given-names></name><name><surname>Porto</surname><given-names>BN</given-names></name><name><surname>Teixeira</surname><given-names>CA</given-names></name><name><surname>Rodrigues</surname><given-names>M</given-names></name><name><surname>Machado</surname><given-names>FD</given-names></name><name><surname>Ornaghi</surname><given-names>AP</given-names></name><etal/></person-group>. <article-title>Prolonged survival of allografts induced by mycobacterial Hsp70 is dependent on CD4+CD25+ regulatory T cells</article-title>. <source>PloS One</source> (<year>2010</year>) <volume>5</volume>(<issue>12</issue>):<fpage>e14264</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0014264</pub-id>
<pub-id pub-id-type="pmid">21170379</pub-id></mixed-citation>
      </ref>
      <ref id="B88">
        <label>88</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopes</surname><given-names>RL</given-names></name><name><surname>Borges</surname><given-names>TJ</given-names></name><name><surname>Araujo</surname><given-names>JF</given-names></name><name><surname>Pinho</surname><given-names>NG</given-names></name><name><surname>Bergamin</surname><given-names>LS</given-names></name><name><surname>Battastini</surname><given-names>AM</given-names></name><etal/></person-group>. <article-title>Extracellular mycobacterial DnaK polarizes macrophages to the M2-like phenotype</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>(<issue>11</issue>):<fpage>e113441</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0113441</pub-id>
<pub-id pub-id-type="pmid">25419575</pub-id></mixed-citation>
      </ref>
      <ref id="B89">
        <label>89</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borges</surname><given-names>TJ</given-names></name><name><surname>Lang</surname><given-names>BJ</given-names></name><name><surname>Lopes</surname><given-names>RL</given-names></name><name><surname>Bonorino</surname><given-names>C</given-names></name></person-group>. <article-title>Modulation of Alloimmunity by Heat Shock Proteins</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<elocation-id>303</elocation-id>. <pub-id pub-id-type="doi">10.3389/fimmu.2016.00303</pub-id>
<pub-id pub-id-type="pmid">27555846</pub-id></mixed-citation>
      </ref>
      <ref id="B90">
        <label>90</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dick</surname><given-names>SA</given-names></name><name><surname>Macklin</surname><given-names>JA</given-names></name><name><surname>Nejat</surname><given-names>S</given-names></name><name><surname>Momen</surname><given-names>A</given-names></name><name><surname>Clemente-Casares</surname><given-names>X</given-names></name><name><surname>Althagafi</surname><given-names>MG</given-names></name><etal/></person-group>. <article-title>Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction</article-title>. <source>Nat Immunol</source> (<year>2019</year>) <volume>20</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1038/s41590-018-0272-2</pub-id>
<pub-id pub-id-type="pmid">30538339</pub-id></mixed-citation>
      </ref>
      <ref id="B91">
        <label>91</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lim</surname><given-names>HY</given-names></name><name><surname>Lim</surname><given-names>SY</given-names></name><name><surname>Tan</surname><given-names>CK</given-names></name><name><surname>Thiam</surname><given-names>CH</given-names></name><name><surname>Goh</surname><given-names>CC</given-names></name><name><surname>Carbajo</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Hyaluronan Receptor LYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen</article-title>. <source>Immunity</source> (<year>2018</year>) <volume>49</volume>(<issue>2</issue>):<fpage>326</fpage>&#x2013;<lpage>41.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2018.12.009</pub-id>
<pub-id pub-id-type="pmid">30054204</pub-id></mixed-citation>
      </ref>
      <ref id="B92">
        <label>92</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bajpai</surname><given-names>G</given-names></name><name><surname>Bredemeyer</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Zaitsev</surname><given-names>K</given-names></name><name><surname>Koenig</surname><given-names>AL</given-names></name><name><surname>Lokshina</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury</article-title>. <source>Circ Res</source> (<year>2019</year>) <volume>124</volume>(<issue>2</issue>):<page-range>263&#x2013;78</page-range>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.314028</pub-id>
</mixed-citation>
      </ref>
      <ref id="B93">
        <label>93</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name></person-group>. <article-title>Hyaluronan as an immune regulator in human diseases</article-title>. <source>Physiol Rev</source> (<year>2011</year>) <volume>91</volume>(<issue>1</issue>):<page-range>221&#x2013;64</page-range>. <pub-id pub-id-type="doi">10.1152/physrev.00052.2009</pub-id>
</mixed-citation>
      </ref>
      <ref id="B94">
        <label>94</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petz</surname><given-names>A</given-names></name><name><surname>Grandoch</surname><given-names>M</given-names></name><name><surname>Gorski</surname><given-names>DJ</given-names></name><name><surname>Abrams</surname><given-names>M</given-names></name><name><surname>Piroth</surname><given-names>M</given-names></name><name><surname>Schneckmann</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Cardiac Hyaluronan Synthesis Is Critically Involved in the Cardiac Macrophage Response and Promotes Healing After Ischemia Reperfusion Injury</article-title>. <source>Circ Res</source> (<year>2019</year>) <volume>124</volume>(<issue>10</issue>):<page-range>1433&#x2013;47</page-range>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.118.313285</pub-id>
</mixed-citation>
      </ref>
      <ref id="B95">
        <label>95</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McArthur</surname><given-names>S</given-names></name><name><surname>Juban</surname><given-names>G</given-names></name><name><surname>Gobbetti</surname><given-names>T</given-names></name><name><surname>Desgeorges</surname><given-names>T</given-names></name><name><surname>Theret</surname><given-names>M</given-names></name><name><surname>Gondin</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation</article-title>. <source>J Clin Invest</source> (<year>2020</year>) <volume>130</volume>(<issue>3</issue>):<page-range>1156&#x2013;67</page-range>. <pub-id pub-id-type="doi">10.1172/JCI124635</pub-id>
</mixed-citation>
      </ref>
      <ref id="B96">
        <label>96</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Teixeira</surname><given-names>RA</given-names></name><name><surname>Mimura</surname><given-names>KK</given-names></name><name><surname>Araujo</surname><given-names>LP</given-names></name><name><surname>Greco</surname><given-names>KV</given-names></name><name><surname>Oliani</surname><given-names>SM</given-names></name></person-group>. <article-title>The essential role of annexin A1 mimetic peptide in the skin allograft survival</article-title>. <source>J Tissue Eng Regener Med</source> (<year>2016</year>) <volume>10</volume>(<issue>2</issue>):<page-range>E44&#x2013;53</page-range>. <pub-id pub-id-type="doi">10.1002/term.1773</pub-id>
</mixed-citation>
      </ref>
      <ref id="B97">
        <label>97</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>La</surname><given-names>M</given-names></name><name><surname>D&#x2019;Amico</surname><given-names>M</given-names></name><name><surname>Bandiera</surname><given-names>S</given-names></name><name><surname>Di Filippo</surname><given-names>C</given-names></name><name><surname>Oliani</surname><given-names>SM</given-names></name><name><surname>Gavins</surname><given-names>FN</given-names></name><etal/></person-group>. <article-title>Annexin 1 peptides protect against experimental myocardial ischemia-reperfusion: analysis of their mechanism of action</article-title>. <source>FASEB J</source> (<year>2001</year>) <volume>15</volume>(<issue>12</issue>):<page-range>2247&#x2013;56</page-range>. <pub-id pub-id-type="doi">10.1096/fj.01-0196com</pub-id>
</mixed-citation>
      </ref>
      <ref id="B98">
        <label>98</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Buxton</surname><given-names>KD</given-names></name><name><surname>Pepe</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>AH</given-names></name><name><surname>Venardos</surname><given-names>K</given-names></name><name><surname>Love</surname><given-names>JE</given-names></name><etal/></person-group>. <article-title>Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26)</article-title>. <source>Br J Pharmacol</source> (<year>2013</year>) <volume>168</volume>(<issue>1</issue>):<page-range>238&#x2013;52</page-range>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.2012.02176.x</pub-id>
</mixed-citation>
      </ref>
      <ref id="B99">
        <label>99</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qin</surname><given-names>CX</given-names></name><name><surname>Finlayson</surname><given-names>SB</given-names></name><name><surname>Al-Sharea</surname><given-names>A</given-names></name><name><surname>Tate</surname><given-names>M</given-names></name><name><surname>De Blasio</surname><given-names>MJ</given-names></name><name><surname>Deo</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo</article-title>. <source>Sci Rep</source> (<year>2017</year>) <volume>7</volume>(<issue>1</issue>):<fpage>16615</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-16317-1</pub-id>
<pub-id pub-id-type="pmid">29192208</pub-id></mixed-citation>
      </ref>
      <ref id="B100">
        <label>100</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Pro-resolving lipid mediators are leads for resolution physiology</article-title>. <source>Nature</source> (<year>2014</year>) <volume>510</volume>(<issue>7503</issue>):<fpage>92</fpage>&#x2013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1038/nature13479</pub-id>
<pub-id pub-id-type="pmid">24899309</pub-id></mixed-citation>
      </ref>
      <ref id="B101">
        <label>101</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Buckley</surname><given-names>CD</given-names></name><name><surname>Gilroy</surname><given-names>DW</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name></person-group>. <article-title>Proresolving lipid mediators and mechanisms in the resolution of acute inflammation</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>(<issue>3</issue>):<page-range>315&#x2013;27</page-range>. <pub-id pub-id-type="doi">10.1016/j.immuni.2014.02.009</pub-id>
</mixed-citation>
      </ref>
      <ref id="B102">
        <label>102</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ramon</surname><given-names>S</given-names></name><name><surname>Bancos</surname><given-names>S</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name><name><surname>Phipps</surname><given-names>RP</given-names></name></person-group>. <article-title>Lipoxin A(4) modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>2</issue>):<page-range>357&#x2013;69</page-range>. <pub-id pub-id-type="doi">10.1002/eji.201343316</pub-id>
</mixed-citation>
      </ref>
      <ref id="B103">
        <label>103</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levy</surname><given-names>BD</given-names></name><name><surname>Zhang</surname><given-names>QY</given-names></name><name><surname>Bonnans</surname><given-names>C</given-names></name><name><surname>Primo</surname><given-names>V</given-names></name><name><surname>Reilly</surname><given-names>JJ</given-names></name><name><surname>Perkins</surname><given-names>DL</given-names></name><etal/></person-group>. <article-title>The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection</article-title>. <source>Prostaglandins Leukot Essent Fatty Acids</source> (<year>2011</year>) <volume>84</volume>(<issue>1-2</issue>):<fpage>43</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/j.plefa.2010.09.002</pub-id>
<pub-id pub-id-type="pmid">20869861</pub-id></mixed-citation>
      </ref>
      <ref id="B104">
        <label>104</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dalli</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>M</given-names></name><name><surname>Vlasenko</surname><given-names>NA</given-names></name><name><surname>Deng</surname><given-names>B</given-names></name><name><surname>Haeggstrom</surname><given-names>JZ</given-names></name><name><surname>Petasis</surname><given-names>NA</given-names></name><etal/></person-group>. <article-title>The novel 13S,14S-epoxy-maresin is converted by human macrophages to maresin 1 (MaR1), inhibits leukotriene A4 hydrolase (LTA4H), and shifts macrophage phenotype</article-title>. <source>FASEB J</source> (<year>2013</year>) <volume>27</volume>(<issue>7</issue>):<page-range>2573&#x2013;83</page-range>. <pub-id pub-id-type="doi">10.1096/fj.13-227728</pub-id>
</mixed-citation>
      </ref>
      <ref id="B105">
        <label>105</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Navarro-Xavier</surname><given-names>RA</given-names></name><name><surname>Newson</surname><given-names>J</given-names></name><name><surname>Silveira</surname><given-names>VL</given-names></name><name><surname>Farrow</surname><given-names>SN</given-names></name><name><surname>Gilroy</surname><given-names>DW</given-names></name><name><surname>Bystrom</surname><given-names>J</given-names></name></person-group>. <article-title>A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>(<issue>3</issue>):<page-range>1516&#x2013;25</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.0902866</pub-id>
</mixed-citation>
      </ref>
      <ref id="B106">
        <label>106</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name></person-group>. <article-title>Maresin 1 mitigates renal ischemia/reperfusion injury in mice via inhibition of the TLR4/MAPK/NF-kappaB pathways and activation of the Nrf2 pathway</article-title>. <source>Drug Des Devel Ther</source> (<year>2019</year>) <volume>13</volume>:<page-range>739&#x2013;45</page-range>. <pub-id pub-id-type="doi">10.2147/DDDT.S188654</pub-id>
</mixed-citation>
      </ref>
      <ref id="B107">
        <label>107</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soto</surname><given-names>G</given-names></name><name><surname>Rodriguez</surname><given-names>MJ</given-names></name><name><surname>Fuentealba</surname><given-names>R</given-names></name><name><surname>Treuer</surname><given-names>AV</given-names></name><name><surname>Castillo</surname><given-names>I</given-names></name><name><surname>Gonzalez</surname><given-names>DR</given-names></name><etal/></person-group>. <article-title>Maresin 1, a Proresolving Lipid Mediator, Ameliorates Liver Ischemia-Reperfusion Injury and Stimulates Hepatocyte Proliferation in Sprague-Dawley Rats</article-title>. <source>Int J Mol Sci</source> (<year>2020</year>) <volume>21</volume>(<issue>2</issue>). <pub-id pub-id-type="doi">10.3390/ijms21020540</pub-id>
</mixed-citation>
      </ref>
      <ref id="B108">
        <label>108</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group>. <article-title>Maresin 1 Ameliorates Lung Ischemia/Reperfusion Injury by Suppressing Oxidative Stress via Activation of the Nrf-2-Mediated HO-1 Signaling Pathway</article-title>. <source>Oxid Med Cell Longev</source> (<year>2017</year>) <volume>2017</volume>:<fpage>9634803</fpage>. <pub-id pub-id-type="doi">10.1155/2017/9634803</pub-id>
<pub-id pub-id-type="pmid">28751936</pub-id></mixed-citation>
      </ref>
      <ref id="B109">
        <label>109</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chiurchiu</surname><given-names>V</given-names></name><name><surname>Leuti</surname><given-names>A</given-names></name><name><surname>Dalli</surname><given-names>J</given-names></name><name><surname>Jacobsson</surname><given-names>A</given-names></name><name><surname>Battistini</surname><given-names>L</given-names></name><name><surname>Maccarrone</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1are critical in modulating T cell responses</article-title>. <source>Sci Transl Med</source> (<year>2016</year>) <volume>8</volume>(<issue>353</issue>):<fpage>353ra111</fpage>. <pub-id pub-id-type="doi">10.1126/scitranslmed.aaf7483</pub-id>
</mixed-citation>
      </ref>
      <ref id="B110">
        <label>110</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toubai</surname><given-names>T</given-names></name><name><surname>Rossi</surname><given-names>C</given-names></name><name><surname>Oravecz-Wilson</surname><given-names>K</given-names></name><name><surname>Zajac</surname><given-names>C</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Braun</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Siglec-G represses DAMP-mediated effects on T cells</article-title>.<source>JCI Insight</source> (<year>2017</year>) <volume>2</volume>(<issue>14</issue>). <pub-id pub-id-type="doi">10.1172/jci.insight.92293</pub-id>
</mixed-citation>
      </ref>
      <ref id="B111">
        <label>111</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gautier</surname><given-names>EL</given-names></name><name><surname>Shay</surname><given-names>T</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name><name><surname>Jakubzick</surname><given-names>C</given-names></name><name><surname>Ivanov</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Gene-expression profiles and transcriptional regulatory pathwaysthat underlie the identity and diversity of mouse tissue macrophages</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>(<issue>11</issue>):<page-range>1118&#x2013;28</page-range>. <pub-id pub-id-type="doi">10.1038/ni.2419</pub-id>
</mixed-citation>
      </ref>
      <ref id="B112">
        <label>112</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bajpai</surname><given-names>G</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Bredemeyer</surname><given-names>A</given-names></name><name><surname>Hulsmans</surname><given-names>M</given-names></name><name><surname>Nahrendorf</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The human heart contains distinct macrophage subsets with divergentorigins and functions</article-title>. <source>Nat Med</source> (<year>2018</year>) <volume>24</volume>(<issue>8</issue>):<page-range>1234&#x2013;45</page-range>. <pub-id pub-id-type="doi">10.1038/s41591-018-0059-x</pub-id>
</mixed-citation>
      </ref>
      <ref id="B113">
        <label>113</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meziani</surname><given-names>L</given-names></name><name><surname>Deutsch</surname><given-names>E</given-names></name><name><surname>Mondini</surname><given-names>M</given-names></name></person-group>. <article-title>Macrophages in radiation injury: a new therapeutictarget</article-title>. <source>Oncoimmunology</source> (<year>2018</year>) <volume>7</volume>(<issue>10</issue>):<fpage>e1494488</fpage>. <pub-id pub-id-type="doi">10.1080/2162402X.2018.1494488</pub-id>
<pub-id pub-id-type="pmid">30288363</pub-id></mixed-citation>
      </ref>
      <ref id="B114">
        <label>114</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Huen</surname><given-names>S</given-names></name><name><surname>Nishio</surname><given-names>H</given-names></name><name><surname>Nishio</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>HK</given-names></name><name><surname>Choi</surname><given-names>BS</given-names></name><etal/></person-group>. <article-title>Distinct macrophage phenotypes contribute to kidney injury and repair</article-title>. <source>J Am Soc Nephrol</source> (<year>2011</year>) <volume>22</volume>(<issue>2</issue>):<page-range>317&#x2013;26</page-range>. <pub-id pub-id-type="doi">10.1681/ASN.2009060615</pub-id>
</mixed-citation>
      </ref>
      <ref id="B115">
        <label>115</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heidt</surname><given-names>T</given-names></name><name><surname>Courties</surname><given-names>G</given-names></name><name><surname>Dutta</surname><given-names>P</given-names></name><name><surname>Sager</surname><given-names>HB</given-names></name><name><surname>Sebas</surname><given-names>M</given-names></name><name><surname>Iwamoto</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction</article-title>. <source>Circ Res</source> (<year>2014</year>) <volume>115</volume>(<issue>2</issue>):<page-range>284&#x2013;95</page-range>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.303567</pub-id>
</mixed-citation>
      </ref>
      <ref id="B116">
        <label>116</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Vannella</surname><given-names>KM</given-names></name></person-group>. <article-title>Macrophages in Tissue Repair, Regeneration, and Fibrosis</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>44</volume>(<issue>3</issue>):<page-range>450&#x2013;62</page-range>. <pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.015</pub-id>
</mixed-citation>
      </ref>
      <ref id="B117">
        <label>117</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aurora</surname><given-names>AB</given-names></name><name><surname>Porrello</surname><given-names>ER</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Mahmoud</surname><given-names>AI</given-names></name><name><surname>Hill</surname><given-names>JA</given-names></name><name><surname>Bassel-Duby</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Macrophages are required for neonatal heart regeneration</article-title>. <source>J Clin Invest</source> (<year>2014</year>) <volume>124</volume>(<issue>3</issue>):<page-range>1382&#x2013;92</page-range>. <pub-id pub-id-type="doi">10.1172/JCI72181</pub-id>
</mixed-citation>
      </ref>
      <ref id="B118">
        <label>118</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bosurgi</surname><given-names>L</given-names></name><name><surname>Cao</surname><given-names>YG</given-names></name><name><surname>Cabeza-Cabrerizo</surname><given-names>M</given-names></name><name><surname>Tucci</surname><given-names>A</given-names></name><name><surname>Hughes</surname><given-names>LD</given-names></name><name><surname>Kong</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells</article-title>. <source>Science</source> (<year>2017</year>) <volume>356</volume>(<issue>6342</issue>):<page-range>1072&#x2013;6</page-range>. <pub-id pub-id-type="doi">10.1126/science.aai8132</pub-id>
</mixed-citation>
      </ref>
      <ref id="B119">
        <label>119</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herber</surname><given-names>DL</given-names></name><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Nefedova</surname><given-names>Y</given-names></name><name><surname>Novitskiy</surname><given-names>SV</given-names></name><name><surname>Nagaraj</surname><given-names>S</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><etal/></person-group>. <article-title>Lipid accumulation and dendritic cell dysfunction in cancer</article-title>. <source>Nat Med</source> (<year>2010</year>) <volume>16</volume>(<issue>8</issue>):<page-range>880&#x2013;6</page-range>. <pub-id pub-id-type="doi">10.1038/nm.2172</pub-id>
</mixed-citation>
      </ref>
      <ref id="B120">
        <label>120</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mills</surname><given-names>EL</given-names></name><name><surname>O&#x2019;Neill</surname><given-names>LA</given-names></name></person-group>. <article-title>Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal</article-title>. <source>Eur J Immunol</source> (<year>2016</year>) <volume>46</volume>(<issue>1</issue>):<fpage>13</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/eji.201445427</pub-id>
<pub-id pub-id-type="pmid">26643360</pub-id></mixed-citation>
      </ref>
      <ref id="B121">
        <label>121</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shiraishi</surname><given-names>M</given-names></name><name><surname>Shintani</surname><given-names>Y</given-names></name><name><surname>Shintani</surname><given-names>Y</given-names></name><name><surname>Ishida</surname><given-names>H</given-names></name><name><surname>Saba</surname><given-names>R</given-names></name><name><surname>Yamaguchi</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Alternatively activated macrophages determine repair of the infarcted adult murine heart</article-title>. <source>J Clin Invest</source> (<year>2016</year>) <volume>126</volume>(<issue>6</issue>):<page-range>2151&#x2013;66</page-range>. <pub-id pub-id-type="doi">10.1172/JCI85782</pub-id>
</mixed-citation>
      </ref>
      <ref id="B122">
        <label>122</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kang</surname><given-names>K</given-names></name><name><surname>Reilly</surname><given-names>SM</given-names></name><name><surname>Karabacak</surname><given-names>V</given-names></name><name><surname>Gangl</surname><given-names>MR</given-names></name><name><surname>Fitzgerald</surname><given-names>K</given-names></name><name><surname>Hatano</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity</article-title>. <source>Cell Metab</source> (<year>2008</year>) <volume>7</volume>(<issue>6</issue>):<page-range>485&#x2013;95</page-range>. <pub-id pub-id-type="doi">10.1016/j.cmet.2008.04.002</pub-id>
</mixed-citation>
      </ref>
      <ref id="B123">
        <label>123</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vats</surname><given-names>D</given-names></name><name><surname>Mukundan</surname><given-names>L</given-names></name><name><surname>Odegaard</surname><given-names>JI</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Smith</surname><given-names>KL</given-names></name><name><surname>Morel</surname><given-names>CR</given-names></name><etal/></person-group>. <article-title>Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation</article-title>. <source>Cell Metab</source> (<year>2006</year>) <volume>4</volume>(<issue>1</issue>):<fpage>13</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2006.05.011</pub-id>
<pub-id pub-id-type="pmid">16814729</pub-id></mixed-citation>
      </ref>
      <ref id="B124">
        <label>124</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rath</surname><given-names>M</given-names></name><name><surname>M&#xFC;ller</surname><given-names>I</given-names></name><name><surname>Kropf</surname><given-names>P</given-names></name><name><surname>Closs</surname><given-names>EI</given-names></name><name><surname>Munder</surname><given-names>M</given-names></name></person-group>. <article-title>Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages</article-title>. <source>Front Immunol</source> (<year>2014</year>) <volume>5</volume>(<issue>532</issue>). <pub-id pub-id-type="doi">10.3389/fimmu.2014.00532</pub-id>
</mixed-citation>
      </ref>
      <ref id="B125">
        <label>125</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bronte</surname><given-names>V</given-names></name><name><surname>Serafini</surname><given-names>P</given-names></name><name><surname>De Santo</surname><given-names>C</given-names></name><name><surname>Marigo</surname><given-names>I</given-names></name><name><surname>Tosello</surname><given-names>V</given-names></name><name><surname>Mazzoni</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>170</volume>(<issue>1</issue>):<page-range>270&#x2013;8</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.170.1.270</pub-id>
</mixed-citation>
      </ref>
      <ref id="B126">
        <label>126</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Highfill</surname><given-names>SL</given-names></name><name><surname>Rodriguez</surname><given-names>PC</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Goetz</surname><given-names>CA</given-names></name><name><surname>Koehn</surname><given-names>BH</given-names></name><name><surname>Veenstra</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13</article-title>. <source>Blood</source> (<year>2010</year>) <volume>116</volume>(<issue>25</issue>):<page-range>5738&#x2013;47</page-range>. <pub-id pub-id-type="doi">10.1182/blood-2010-06-287839</pub-id>
</mixed-citation>
      </ref>
      <ref id="B127">
        <label>127</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Broichhausen</surname><given-names>C</given-names></name><name><surname>Riquelme</surname><given-names>P</given-names></name><name><surname>Geissler</surname><given-names>EK</given-names></name><name><surname>Hutchinson</surname><given-names>JA</given-names></name></person-group>. <article-title>Regulatory macrophages as therapeutic targets and therapeutic agents in solid organ transplantation</article-title>. <source>Curr Opin Organ Transplant</source> (<year>2012</year>) <volume>17</volume>(<issue>4</issue>):<page-range>332&#x2013;42</page-range>. <pub-id pub-id-type="doi">10.1097/MOT.0b013e328355a979</pub-id>
</mixed-citation>
      </ref>
      <ref id="B128">
        <label>128</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chakarov</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>HY</given-names></name><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Lim</surname><given-names>SY</given-names></name><name><surname>See</surname><given-names>P</given-names></name><name><surname>Lum</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches</article-title>. <source>Science</source> (<year>2019</year>) <volume>363</volume>(<issue>6432</issue>). <pub-id pub-id-type="doi">10.1126/science.aau0964</pub-id>
</mixed-citation>
      </ref>
      <ref id="B129">
        <label>129</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wildin</surname><given-names>RS</given-names></name><name><surname>Ramsdell</surname><given-names>F</given-names></name><name><surname>Peake</surname><given-names>J</given-names></name><name><surname>Faravelli</surname><given-names>F</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Buist</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy</article-title>. <source>Nat Genet</source> (<year>2001</year>) <volume>27</volume>(<issue>1</issue>):<fpage>18</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1038/83707</pub-id>
<pub-id pub-id-type="pmid">11137992</pub-id></mixed-citation>
      </ref>
      <ref id="B130">
        <label>130</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakaguchi</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Nomura</surname><given-names>T</given-names></name><name><surname>Ono</surname><given-names>M</given-names></name></person-group>. <article-title>Regulatory T cells and immune tolerance</article-title>. <source>Cell</source> (<year>2008</year>) <volume>133</volume>(<issue>5</issue>):<page-range>775&#x2013;87</page-range>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.05.009</pub-id>
</mixed-citation>
      </ref>
      <ref id="B131">
        <label>131</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Romano</surname><given-names>M</given-names></name><name><surname>Fanelli</surname><given-names>G</given-names></name><name><surname>Albany</surname><given-names>CJ</given-names></name><name><surname>Giganti</surname><given-names>G</given-names></name><name><surname>Lombardi</surname><given-names>G</given-names></name></person-group>. <article-title>Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>43</elocation-id>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.00043</pub-id>
<pub-id pub-id-type="pmid">30804926</pub-id></mixed-citation>
      </ref>
      <ref id="B132">
        <label>132</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zaiss</surname><given-names>DMW</given-names></name><name><surname>Gause</surname><given-names>WC</given-names></name><name><surname>Osborne</surname><given-names>LC</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>(<issue>2</issue>):<page-range>216&#x2013;26</page-range>. <pub-id pub-id-type="doi">10.1016/j.immuni.2015.01.020</pub-id>
</mixed-citation>
      </ref>
      <ref id="B133">
        <label>133</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dial</surname><given-names>CF</given-names></name><name><surname>Tune</surname><given-names>MK</given-names></name><name><surname>Doerschuk</surname><given-names>CM</given-names></name><name><surname>Mock</surname><given-names>JR</given-names></name></person-group>. <article-title>Foxp3(+) Regulatory T Cell Expression of Keratinocyte Growth Factor Enhances Lung Epithelial Proliferation</article-title>. <source>Am J Respir Cell Mol Biol</source> (<year>2017</year>) <volume>57</volume>(<issue>2</issue>):<page-range>162&#x2013;73</page-range>. <pub-id pub-id-type="doi">10.1165/rcmb.2017-0019OC</pub-id>
</mixed-citation>
      </ref>
      <ref id="B134">
        <label>134</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Bizargity</surname><given-names>P</given-names></name><name><surname>Hancock</surname><given-names>WW</given-names></name><name><surname>Visner</surname><given-names>GA</given-names></name></person-group>. <article-title>Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>(<issue>2</issue>):<page-range>1022&#x2013;31</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.0900408</pub-id>
</mixed-citation>
      </ref>
      <ref id="B135">
        <label>135</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tiemessen</surname><given-names>MM</given-names></name><name><surname>Jagger</surname><given-names>AL</given-names></name><name><surname>Evans</surname><given-names>HG</given-names></name><name><surname>van Herwijnen</surname><given-names>MJ</given-names></name><name><surname>John</surname><given-names>S</given-names></name><name><surname>Taams</surname><given-names>LS</given-names></name></person-group>. <article-title>CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2007</year>) <volume>104</volume>(<issue>49</issue>):<page-range>19446&#x2013;51</page-range>. <pub-id pub-id-type="doi">10.1073/pnas.0706832104</pub-id>
</mixed-citation>
      </ref>
      <ref id="B136">
        <label>136</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liesz</surname><given-names>A</given-names></name><name><surname>Kleinschnitz</surname><given-names>C</given-names></name></person-group>. <article-title>Regulatory T Cells in Post-stroke Immune Homeostasis</article-title>. <source>Transl Stroke Res</source> (<year>2016</year>) <volume>7</volume>(<issue>4</issue>):<page-range>313&#x2013;21</page-range>. <pub-id pub-id-type="doi">10.1007/s12975-016-0465-7</pub-id>
</mixed-citation>
      </ref>
      <ref id="B137">
        <label>137</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weirather</surname><given-names>J</given-names></name><name><surname>Hofmann</surname><given-names>UD</given-names></name><name><surname>Beyersdorf</surname><given-names>N</given-names></name><name><surname>Ramos</surname><given-names>GC</given-names></name><name><surname>Vogel</surname><given-names>B</given-names></name><name><surname>Frey</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation</article-title>. <source>Circ Res</source> (<year>2014</year>) <volume>115</volume>(<issue>1</issue>):<fpage>55</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.115.303895</pub-id>
<pub-id pub-id-type="pmid">24786398</pub-id></mixed-citation>
      </ref>
      <ref id="B138">
        <label>138</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Julier</surname><given-names>Z</given-names></name><name><surname>Park</surname><given-names>AJ</given-names></name><name><surname>Briquez</surname><given-names>PS</given-names></name><name><surname>Martino</surname><given-names>MM</given-names></name></person-group>. <article-title>Promoting tissue regeneration by modulating the immune system</article-title>. <source>Acta Biomater</source> (<year>2017</year>) <volume>53</volume>:<fpage>13</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.actbio.2017.01.056</pub-id>
<pub-id pub-id-type="pmid">28119112</pub-id></mixed-citation>
      </ref>
      <ref id="B139">
        <label>139</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Serhan</surname><given-names>CN</given-names></name><name><surname>Levy</surname><given-names>BD</given-names></name></person-group>. <article-title>Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators</article-title>. <source>J Clin Invest</source> (<year>2018</year>) <volume>128</volume>(<issue>7</issue>):<page-range>2657&#x2013;69</page-range>. <pub-id pub-id-type="doi">10.1172/JCI97943</pub-id>
</mixed-citation>
      </ref>
      <ref id="B140">
        <label>140</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basil</surname><given-names>MC</given-names></name><name><surname>Levy</surname><given-names>BD</given-names></name></person-group>. <article-title>Specialized pro-resolving mediators: endogenous regulators of infection and inflammation</article-title>. <source>Nat Rev Immunol</source> (<year>2016</year>) <volume>16</volume>(<issue>1</issue>):<fpage>51</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2015.4</pub-id>
<pub-id pub-id-type="pmid">26688348</pub-id></mixed-citation>
      </ref>
      <ref id="B141">
        <label>141</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chandrasekharan</surname><given-names>JA</given-names></name><name><surname>Sharma-Walia</surname><given-names>N</given-names></name></person-group>. <article-title>Lipoxins: nature&#x2019;s way to resolve inflammation</article-title>. <source>J Inflammation Res</source> (<year>2015</year>) <volume>8</volume>:<page-range>181&#x2013;92</page-range>. <pub-id pub-id-type="doi">10.2147/JIR.S90380</pub-id>
</mixed-citation>
      </ref>
      <ref id="B142">
        <label>142</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El Kebir</surname><given-names>D</given-names></name><name><surname>Jozsef</surname><given-names>L</given-names></name><name><surname>Pan</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Petasis</surname><given-names>NA</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name><etal/></person-group>. <article-title>15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2009</year>) <volume>180</volume>(<issue>4</issue>):<page-range>311&#x2013;9</page-range>. <pub-id pub-id-type="doi">10.1164/rccm.200810-1601OC</pub-id>
</mixed-citation>
      </ref>
      <ref id="B143">
        <label>143</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Titos</surname><given-names>E</given-names></name><name><surname>Rius</surname><given-names>B</given-names></name><name><surname>Lopez-Vicario</surname><given-names>C</given-names></name><name><surname>Alcaraz-Quiles</surname><given-names>J</given-names></name><name><surname>Garcia-Alonso</surname><given-names>V</given-names></name><name><surname>Lopategi</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue</article-title>. <source>J Immunol</source> (<year>2016</year>) <volume>197</volume>(<issue>8</issue>):<page-range>3360&#x2013;70</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.1502522</pub-id>
</mixed-citation>
      </ref>
      <ref id="B144">
        <label>144</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gavins</surname><given-names>FN</given-names></name><name><surname>Hickey</surname><given-names>MJ</given-names></name></person-group>. <article-title>Annexin A1 and the regulation of innate and adaptive immunity</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<elocation-id>354</elocation-id>. <pub-id pub-id-type="doi">10.3389/fimmu.2012.00354</pub-id>
<pub-id pub-id-type="pmid">23230437</pub-id></mixed-citation>
      </ref>
      <ref id="B145">
        <label>145</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bode</surname><given-names>K</given-names></name><name><surname>Bujupi</surname><given-names>F</given-names></name><name><surname>Link</surname><given-names>C</given-names></name><name><surname>Hein</surname><given-names>T</given-names></name><name><surname>Zimmermann</surname><given-names>S</given-names></name><name><surname>Peiris</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2</article-title>. <source>Cell Rep</source> (<year>2019</year>) <volume>29</volume>(<issue>13</issue>):<fpage>4435</fpage>&#x2013;<lpage>46.e9</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.11.086</pub-id>
<pub-id pub-id-type="pmid">31875551</pub-id></mixed-citation>
      </ref>
      <ref id="B146">
        <label>146</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Riise</surname><given-names>GC</given-names></name><name><surname>Schersten</surname><given-names>H</given-names></name><name><surname>Nilsson</surname><given-names>F</given-names></name><name><surname>Ryd</surname><given-names>W</given-names></name><name><surname>Andersson</surname><given-names>BA</given-names></name></person-group>. <article-title>Activation of eosinophils and fibroblasts assessed by eosinophil cationic protein and hyaluronan in BAL. Association with acute rejection in lung transplant recipients</article-title>. <source>Chest</source> (<year>1996</year>) <volume>110</volume>(<issue>1</issue>):<fpage>89</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1378/chest.110.1.89</pub-id>
<pub-id pub-id-type="pmid">8681673</pub-id></mixed-citation>
      </ref>
      <ref id="B147">
        <label>147</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Todd</surname><given-names>JL</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sugimoto</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>VE</given-names></name><name><surname>Zhang</surname><given-names>HL</given-names></name><name><surname>Pavlisko</surname><given-names>EN</given-names></name><etal/></person-group>. <article-title>Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2014</year>) <volume>189</volume>(<issue>5</issue>):<page-range>556&#x2013;66</page-range>. <pub-id pub-id-type="doi">10.1164/rccm.201308-1481OC</pub-id>
</mixed-citation>
      </ref>
      <ref id="B148">
        <label>148</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnsson</surname><given-names>C</given-names></name><name><surname>Tufveson</surname><given-names>G</given-names></name></person-group>. <article-title>Serum hyaluronan&#x2013;a potential marker of cardiac allograft rejection</article-title>? <source>J Heart Lung Transplant</source> (<year>2006</year>) <volume>25</volume>(<issue>5</issue>):<page-range>544&#x2013;9</page-range>. <pub-id pub-id-type="doi">10.1016/j.healun.2005.06.029</pub-id>
</mixed-citation>
      </ref>
      <ref id="B149">
        <label>149</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knoflach</surname><given-names>A</given-names></name><name><surname>Magee</surname><given-names>C</given-names></name><name><surname>Denton</surname><given-names>MD</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Buelow</surname><given-names>R</given-names></name><name><surname>Hancock</surname><given-names>WW</given-names></name><etal/></person-group>. <article-title>Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection</article-title>. <source>Transplantation</source> (<year>1999</year>) <volume>67</volume>(<issue>6</issue>):<page-range>909&#x2013;14</page-range>. <pub-id pub-id-type="doi">10.1097/00007890-199903270-00020</pub-id>
</mixed-citation>
      </ref>
      <ref id="B150">
        <label>150</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>L</given-names></name><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>D</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Blocking of CD44-hyaluronic acid interaction prolongs rat allograft survival</article-title>. <source>Transplantation</source> (<year>2000</year>) <volume>69</volume>(<issue>4</issue>):<page-range>665&#x2013;7</page-range>. <pub-id pub-id-type="doi">10.1097/00007890-200002270-00032</pub-id>
</mixed-citation>
      </ref>
      <ref id="B151">
        <label>151</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chanmee</surname><given-names>T</given-names></name><name><surname>Ontong</surname><given-names>P</given-names></name><name><surname>Itano</surname><given-names>N</given-names></name></person-group>. <article-title>Hyaluronan: A modulator of the tumor microenvironment</article-title>. <source>Cancer Lett</source> (<year>2016</year>) <volume>375</volume>(<issue>1</issue>):<fpage>20</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2016.02.031</pub-id>
<pub-id pub-id-type="pmid">26921785</pub-id></mixed-citation>
      </ref>
      <ref id="B152">
        <label>152</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skandalis</surname><given-names>SS</given-names></name><name><surname>Karalis</surname><given-names>TT</given-names></name><name><surname>Chatzopoulos</surname><given-names>A</given-names></name><name><surname>Karamanos</surname><given-names>NK</given-names></name></person-group>. <article-title>Hyaluronan-CD44 axis orchestrates cancer stem cell functions</article-title>. <source>Cell Signal</source> (<year>2019</year>) <volume>63</volume>:<fpage>109377</fpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2019.109377</pub-id>
<pub-id pub-id-type="pmid">31362044</pub-id></mixed-citation>
      </ref>
      <ref id="B153">
        <label>153</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Shao</surname><given-names>W</given-names></name><name><surname>Xie</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lan</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Anti-CD44 monoclonal antibody inhibits heart transplant rejection mediated by alloantigen-primed CD4(+) memory T cells in nude mice</article-title>. <source>Immunol Invest</source> (<year>2010</year>) <volume>39</volume>(<issue>8</issue>):<page-range>807&#x2013;19</page-range>. <pub-id pub-id-type="doi">10.3109/08820139.2010.497833</pub-id>
</mixed-citation>
      </ref>
      <ref id="B154">
        <label>154</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liew</surname><given-names>FY</given-names></name><name><surname>Girard</surname><given-names>JP</given-names></name><name><surname>Turnquist</surname><given-names>HR</given-names></name></person-group>. <article-title>Interleukin-33 in health and disease</article-title>. <source>NatRev Immunol</source> (<year>2016</year>) <volume>16</volume>(<issue>11</issue>):<page-range>676&#x2013;89</page-range>. <pub-id pub-id-type="doi">10.1038/nri.2016.95</pub-id>
</mixed-citation>
      </ref>
      <ref id="B155">
        <label>155</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roussel</surname><given-names>L</given-names></name><name><surname>Erard</surname><given-names>M</given-names></name><name><surname>Cayrol</surname><given-names>C</given-names></name><name><surname>Girard</surname><given-names>JP</given-names></name></person-group>. <article-title>Molecular mimicry between IL-33 and KSHV for attachment to chromatinthrough the H2A-H2B acidic pocket</article-title>. <source>EMBO Rep</source> (<year>2008</year>) <volume>9</volume>(<issue>10</issue>):<page-range>1006&#x2013;12</page-range>. <pub-id pub-id-type="doi">10.1038/embor.2008.145</pub-id>
</mixed-citation>
      </ref>
      <ref id="B156">
        <label>156</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Travers</surname><given-names>J</given-names></name><name><surname>Rochman</surname><given-names>M</given-names></name><name><surname>Miracle</surname><given-names>CE</given-names></name><name><surname>Habel</surname><given-names>JE</given-names></name><name><surname>Brusilovsky</surname><given-names>M</given-names></name><name><surname>Caldwell</surname><given-names>JM</given-names></name><etal/></person-group>. <article-title>Chromatin regulates IL-33 release and extracellular cytokineactivity</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>(<issue>1</issue>):<fpage>3244</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-018-05485-x</pub-id>
<pub-id pub-id-type="pmid">30108214</pub-id></mixed-citation>
      </ref>
      <ref id="B157">
        <label>157</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hussey</surname><given-names>GS</given-names></name><name><surname>Dziki</surname><given-names>JL</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><name><surname>Bartolacci</surname><given-names>JG</given-names></name><name><surname>Behun</surname><given-names>M</given-names></name><name><surname>Turnquist</surname><given-names>HR</given-names></name><etal/></person-group>. <article-title>Matrix bound nanovesicle-associated IL-33 activates a pro-remodelingmacrophage phenotype via a non-canonical, ST2-independent pathway</article-title>. <source>J Immunol Regener Med</source> (<year>2019</year>) <volume>3</volume>:<fpage>26</fpage>&#x2013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/j.regen.2019.01.001</pub-id>
</mixed-citation>
      </ref>
      <ref id="B158">
        <label>158</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turnquist</surname><given-names>HR</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Rosborough</surname><given-names>BR</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Castellaneta</surname><given-names>A</given-names></name><name><surname>Isse</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells,including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>(<issue>9</issue>):<page-range>4598&#x2013;610</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.1100519</pub-id>
</mixed-citation>
      </ref>
      <ref id="B159">
        <label>159</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bonilla</surname><given-names>WV</given-names></name><name><surname>Frohlich</surname><given-names>A</given-names></name><name><surname>Senn</surname><given-names>K</given-names></name><name><surname>Kallert</surname><given-names>S</given-names></name><name><surname>Fernandez</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses</article-title>. <source>Science</source> (<year>2012</year>) <volume>335</volume>(<issue>6071</issue>):<page-range>984&#x2013;9</page-range>. <pub-id pub-id-type="doi">10.1126/science.1215418</pub-id>
</mixed-citation>
      </ref>
      <ref id="B160">
        <label>160</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reichenbach</surname><given-names>DK</given-names></name><name><surname>Schwarze</surname><given-names>V</given-names></name><name><surname>Matta</surname><given-names>BM</given-names></name><name><surname>Tkachev</surname><given-names>V</given-names></name><name><surname>Lieberknecht</surname><given-names>E</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>The IL-33/ST2 axis augments effector T-cell responses during acute GVHD</article-title>. <source>Blood</source> (<year>2015</year>) <volume>125</volume>(<issue>20</issue>):<page-range>3183&#x2013;92</page-range>. <pub-id pub-id-type="doi">10.1182/blood-2014-10-606830</pub-id>
</mixed-citation>
      </ref>
      <ref id="B161">
        <label>161</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baumann</surname><given-names>C</given-names></name><name><surname>Bonilla</surname><given-names>WV</given-names></name><name><surname>Frohlich</surname><given-names>A</given-names></name><name><surname>Helmstetter</surname><given-names>C</given-names></name><name><surname>Peine</surname><given-names>M</given-names></name><name><surname>Hegazy</surname><given-names>AN</given-names></name><etal/></person-group>. <article-title>T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2015</year>) <volume>112</volume>(<issue>13</issue>):<page-range>4056&#x2013;61</page-range>. <pub-id pub-id-type="doi">10.1073/pnas.1418549112</pub-id>
</mixed-citation>
      </ref>
      <ref id="B162">
        <label>162</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matta</surname><given-names>BM</given-names></name><name><surname>Lott</surname><given-names>JM</given-names></name><name><surname>Mathews</surname><given-names>LR</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Rosborough</surname><given-names>BR</given-names></name><name><surname>Blazar</surname><given-names>BR</given-names></name><etal/></person-group>. <article-title>IL-33 is an unconventional Alarmin that stimulates IL-2 secretion by dendritic cells to selectively expand IL-33R/ST2+ regulatory T cells</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>193</volume>(<issue>8</issue>):<page-range>4010&#x2013;20</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.1400481</pub-id>
</mixed-citation>
      </ref>
      <ref id="B163">
        <label>163</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stier</surname><given-names>MT</given-names></name><name><surname>Mitra</surname><given-names>R</given-names></name><name><surname>Nyhoff</surname><given-names>LE</given-names></name><name><surname>Goleniewska</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Puccetti</surname><given-names>MV</given-names></name><etal/></person-group>. <article-title>IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development</article-title>. <source>J Immunol</source> (<year>2019</year>) <volume>203</volume>(<issue>6</issue>):<page-range>1457&#x2013;67</page-range>. <pub-id pub-id-type="doi">10.4049/jimmunol.1900408</pub-id>
</mixed-citation>
      </ref>
      <ref id="B164">
        <label>164</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dahlgren</surname><given-names>MW</given-names></name><name><surname>Jones</surname><given-names>SW</given-names></name><name><surname>Cautivo</surname><given-names>KM</given-names></name><name><surname>Dubinin</surname><given-names>A</given-names></name><name><surname>Ortiz-Carpena</surname><given-names>JF</given-names></name><name><surname>Farhat</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Adventitial Stromal Cells Define Group 2 Innate Lymphoid Cell Tissue Niches</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>50</volume>(<issue>3</issue>):<fpage>707</fpage>&#x2013;<lpage>22.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2019.02.002</pub-id>
<pub-id pub-id-type="pmid">30824323</pub-id></mixed-citation>
      </ref>
      <ref id="B165">
        <label>165</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Turnquist</surname><given-names>HR</given-names></name><name><surname>Cardinal</surname><given-names>J</given-names></name><name><surname>Macedo</surname><given-names>C</given-names></name><name><surname>Rosborough</surname><given-names>BR</given-names></name><name><surname>Sumpter</surname><given-names>TL</given-names></name><name><surname>Geller</surname><given-names>DA</given-names></name><etal/></person-group>. <article-title>mTOR and GSK-3 shape the CD4+ T-cell stimulatory and differentiation capacity of myeloid DCs after exposure to LPS</article-title>. <source>Blood</source> (<year>2010</year>) <volume>115</volume>(<issue>23</issue>):<page-range>4758&#x2013;69</page-range>. <pub-id pub-id-type="doi">10.1182/blood-2009-10-251488</pub-id>
</mixed-citation>
      </ref>
      <ref id="B166">
        <label>166</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Panduro</surname><given-names>M</given-names></name><name><surname>Benoist</surname><given-names>C</given-names></name><name><surname>Mathis</surname><given-names>D</given-names></name></person-group>. <article-title>Tissue Tregs</article-title>. <source>Annu Rev Immunol</source> (<year>2016</year>) <volume>34</volume>:<page-range>609&#x2013;33</page-range>. <pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-095948</pub-id>
</mixed-citation>
      </ref>
      <ref id="B167">
        <label>167</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lechner</surname><given-names>AJ</given-names></name><name><surname>Driver</surname><given-names>IH</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Conroy</surname><given-names>CM</given-names></name><name><surname>Nagle</surname><given-names>A</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name><etal/></person-group>. <article-title>Recruited Monocytes and Type 2 Immunity Promote Lung Regeneration following Pneumonectomy</article-title>. <source>Cell Stem Cell</source> (<year>2017</year>) <volume>21</volume>(<issue>1</issue>):<fpage>120</fpage>&#x2013;<lpage>34.e7</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2017.03.024</pub-id>
<pub-id pub-id-type="pmid">28506464</pub-id></mixed-citation>
      </ref>
      <ref id="B168">
        <label>168</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kolodin</surname><given-names>D</given-names></name><name><surname>van Panhuys</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Magnuson</surname><given-names>AM</given-names></name><name><surname>Cipolletta</surname><given-names>D</given-names></name><name><surname>Miller</surname><given-names>CM</given-names></name><etal/></person-group>. <article-title>Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice</article-title>. <source>Cell Metab</source> (<year>2015</year>) <volume>21</volume>(<issue>4</issue>):<page-range>543&#x2013;57</page-range>. <pub-id pub-id-type="doi">10.1016/j.cmet.2015.03.005</pub-id>
</mixed-citation>
      </ref>
      <ref id="B169">
        <label>169</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Miller</surname><given-names>AM</given-names></name><name><surname>Asquith</surname><given-names>DL</given-names></name><name><surname>Hueber</surname><given-names>AJ</given-names></name><name><surname>Anderson</surname><given-names>LA</given-names></name><name><surname>Holmes</surname><given-names>WM</given-names></name><name><surname>McKenzie</surname><given-names>AN</given-names></name><etal/></person-group>. <article-title>Interleukin-33 induces protective effects in adipose tissueinflammation during obesity in mice</article-title>. <source>Circ Res</source> (<year>2010</year>) <volume>107</volume>(<issue>5</issue>):<page-range>650&#x2013;8</page-range>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.218867</pub-id>
</mixed-citation>
      </ref>
      <ref id="B170">
        <label>170</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Molofsky</surname><given-names>AB</given-names></name><name><surname>Nussbaum</surname><given-names>JC</given-names></name><name><surname>Liang</surname><given-names>HE</given-names></name><name><surname>Van Dyken</surname><given-names>SJ</given-names></name><name><surname>Cheng</surname><given-names>LE</given-names></name><name><surname>Mohapatra</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Innate lymphoid type 2 cells sustain visceral adipose tissueeosinophils and alternatively activated macrophages</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>(<issue>3</issue>):<page-range>535&#x2013;49</page-range>. <pub-id pub-id-type="doi">10.1084/jem.20121964</pub-id>
</mixed-citation>
      </ref>
      <ref id="B171">
        <label>171</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Divito</surname><given-names>SJ</given-names></name><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Yatim</surname><given-names>KM</given-names></name><name><surname>Hughes</surname><given-names>AD</given-names></name><etal/></person-group>. <article-title>Graft-infiltrating host dendritic cells play a key role in organtransplant rejection</article-title>. <source>Nat Commun</source> (<year>2016</year>) <volume>7</volume>:<fpage>12623</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms12623</pub-id>
<pub-id pub-id-type="pmid">27554168</pub-id></mixed-citation>
      </ref>
      <ref id="B172">
        <label>172</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Friday</surname><given-names>AJ</given-names></name><name><surname>Abou-Daya</surname><given-names>KI</given-names></name><name><surname>Williams</surname><given-names>AL</given-names></name><name><surname>Mortin-Toth</surname><given-names>S</given-names></name><name><surname>Nicotra</surname><given-names>ML</given-names></name><etal/></person-group>. <article-title>Donor SIRPalpha polymorphism modulates the innate immune response toallogeneic grafts</article-title>. <source>Sci Immunol</source> (<year>2017</year>) <volume>2</volume>(<issue>12</issue>). <pub-id pub-id-type="doi">10.1126/sciimmunol.aam6202</pub-id>
</mixed-citation>
      </ref>
      <ref id="B173">
        <label>173</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oberbarnscheidt</surname><given-names>MH</given-names></name><name><surname>Zeng</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Williams</surname><given-names>AL</given-names></name><name><surname>Shlomchik</surname><given-names>WD</given-names></name><etal/></person-group>. <article-title>Non-self recognition by monocytes initiates allograftrejection</article-title>. <source>J Clin Invest</source> (<year>2014</year>) <volume>124</volume>(<issue>8</issue>):<page-range>3579&#x2013;89</page-range>. <pub-id pub-id-type="doi">10.1172/JCI74370</pub-id>
</mixed-citation>
      </ref>
      <ref id="B174">
        <label>174</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Lan</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Abou-Daya</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>PIRs mediate innate myeloid cell memory to nonself MHC molecules</article-title>. <source>Science</source> (<year>2020</year>) <volume>368</volume>(<issue>6495</issue>):<page-range>1122&#x2013;7</page-range>. <pub-id pub-id-type="doi">10.1126/science.aax4040</pub-id>
</mixed-citation>
      </ref>
      <ref id="B175">
        <label>175</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lever</surname><given-names>JM</given-names></name><name><surname>Hull</surname><given-names>TD</given-names></name><name><surname>Boddu</surname><given-names>R</given-names></name><name><surname>Pepin</surname><given-names>ME</given-names></name><name><surname>Black</surname><given-names>LM</given-names></name><name><surname>Adedoyin</surname><given-names>OO</given-names></name><etal/></person-group>. <article-title>Resident macrophages reprogram toward a developmental state after acute kidney injury</article-title>. <source>JCI Insight</source> (<year>2019</year>) <volume>4</volume>(<issue>2</issue>). <pub-id pub-id-type="doi">10.1172/jci.insight.125503</pub-id>
</mixed-citation>
      </ref>
      <ref id="B176">
        <label>176</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>AL</given-names></name><name><surname>Baker</surname><given-names>AT</given-names></name><name><surname>Lukacs-Kornek</surname><given-names>V</given-names></name><name><surname>Knoblich</surname><given-names>K</given-names></name></person-group>. <article-title>The fibroblastic T cell niche in lymphoid tissues</article-title>. <source>Curr Opin Immunol</source> (<year>2020</year>) <volume>64</volume>:<page-range>110&#x2013;6</page-range>. <pub-id pub-id-type="doi">10.1016/j.coi.2020.04.007</pub-id>
</mixed-citation>
      </ref>
      <ref id="B177">
        <label>177</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gajewski</surname><given-names>TF</given-names></name><name><surname>Schreiber</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>YX</given-names></name></person-group>. <article-title>Innate and adaptive immune cells in the tumor microenvironment</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>(<issue>10</issue>):<page-range>1014&#x2013;22</page-range>. <pub-id pub-id-type="doi">10.1038/ni.2703</pub-id>
</mixed-citation>
      </ref>
      <ref id="B178">
        <label>178</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mendez-Ferrer</surname><given-names>S</given-names></name><name><surname>Bonnet</surname><given-names>D</given-names></name><name><surname>Steensma</surname><given-names>DP</given-names></name><name><surname>Hasserjian</surname><given-names>RP</given-names></name><name><surname>Ghobrial</surname><given-names>IM</given-names></name><name><surname>Gribben</surname><given-names>JG</given-names></name><etal/></person-group>. <article-title>Bone marrow niches in haematological malignancies</article-title>. <source>Nat Rev Cancer</source> (<year>2020</year>) <volume>20</volume>(<issue>5</issue>):<page-range>285&#x2013;98</page-range>. <pub-id pub-id-type="doi">10.1038/s41568-020-0245-2</pub-id>
</mixed-citation>
      </ref>
      <ref id="B179">
        <label>179</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jardine</surname><given-names>L</given-names></name><name><surname>Cytlak</surname><given-names>U</given-names></name><name><surname>Gunawan</surname><given-names>M</given-names></name><name><surname>Reynolds</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>XN</given-names></name><etal/></person-group>. <article-title>Donor monocyte-derived macrophages promote human acute graft-versus-host disease</article-title>. <source>J Clin Invest</source> (<year>2020</year>) <volume>130</volume>(<issue>9</issue>):<page-range>4574&#x2013;86</page-range>. <pub-id pub-id-type="doi">10.1172/JCI133909</pub-id>
</mixed-citation>
      </ref>
      <ref id="B180">
        <label>180</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Halloran</surname><given-names>PF</given-names></name><name><surname>Reeve</surname><given-names>J</given-names></name><name><surname>Aliabadi</surname><given-names>AZ</given-names></name><name><surname>Cadeiras</surname><given-names>M</given-names></name><name><surname>Crespo-Leiro</surname><given-names>MG</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Exploring the cardiac response to injury in heart transplant biopsies</article-title>. <source>JCI Insight</source> (<year>2018</year>) <volume>3</volume>(<issue>20</issue>). <pub-id pub-id-type="doi">10.1172/jci.insight.123674</pub-id>
</mixed-citation>
      </ref>
      <ref id="B181">
        <label>181</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mahlakoiv</surname><given-names>T</given-names></name><name><surname>Flamar</surname><given-names>AL</given-names></name><name><surname>Johnston</surname><given-names>LK</given-names></name><name><surname>Moriyama</surname><given-names>S</given-names></name><name><surname>Putzel</surname><given-names>GG</given-names></name><name><surname>Bryce</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Stromal cells maintain immune cell homeostasis in adipose tissue via production of interleukin-33</article-title>. <source>Sci Immunol</source> (<year>2019</year>) <volume>4</volume>(<issue>35</issue>). <pub-id pub-id-type="doi">10.1126/sciimmunol.aax0416</pub-id>
</mixed-citation>
      </ref>
      <ref id="B182">
        <label>182</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cohen</surname><given-names>ES</given-names></name><name><surname>Scott</surname><given-names>IC</given-names></name><name><surname>Majithiya</surname><given-names>JB</given-names></name><name><surname>Rapley</surname><given-names>L</given-names></name><name><surname>Kemp</surname><given-names>BP</given-names></name><name><surname>England</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation</article-title>. <source>Nat Commun</source> (<year>2015</year>) <volume>6</volume>:<fpage>8327</fpage>. <pub-id pub-id-type="doi">10.1183/13993003.congress-2015.OA292</pub-id>
<pub-id pub-id-type="pmid">26365875</pub-id></mixed-citation>
      </ref>
      <ref id="B183">
        <label>183</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Ju</surname><given-names>Z</given-names></name><name><surname>Ragab</surname><given-names>AA</given-names></name><name><surname>Lundback</surname><given-names>P</given-names></name><name><surname>Long</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>MD-2 is required for disulfide HMGB1-dependent TLR4 signaling</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>1</issue>):<fpage>5</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20141318</pub-id>
<pub-id pub-id-type="pmid">25559892</pub-id></mixed-citation>
      </ref>
      <ref id="B184">
        <label>184</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tirone</surname><given-names>M</given-names></name><name><surname>Tran</surname><given-names>NL</given-names></name><name><surname>Ceriotti</surname><given-names>C</given-names></name><name><surname>Gorzanelli</surname><given-names>A</given-names></name><name><surname>Canepari</surname><given-names>M</given-names></name><name><surname>Bottinelli</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>High mobility group box 1 orchestrates tissue regeneration via CXCR4</article-title>. <source>J Exp Med</source> (<year>2018</year>) <volume>215</volume>(<issue>1</issue>):<page-range>303&#x2013;18</page-range>. <pub-id pub-id-type="doi">10.1084/jem.20160217</pub-id>
</mixed-citation>
      </ref>
      <ref id="B185">
        <label>185</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Venereau</surname><given-names>E</given-names></name><name><surname>Casalgrandi</surname><given-names>M</given-names></name><name><surname>Schiraldi</surname><given-names>M</given-names></name><name><surname>Antoine</surname><given-names>DJ</given-names></name><name><surname>Cattaneo</surname><given-names>A</given-names></name><name><surname>De Marchis</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>(<issue>9</issue>):<page-range>1519&#x2013;28</page-range>. <pub-id pub-id-type="doi">10.1084/jem.20120189</pub-id>
</mixed-citation>
      </ref>
      <ref id="B186">
        <label>186</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huber</surname><given-names>R</given-names></name><name><surname>Meier</surname><given-names>B</given-names></name><name><surname>Otsuka</surname><given-names>A</given-names></name><name><surname>Fenini</surname><given-names>G</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Gehrke</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages</article-title>. <source>Sci Rep</source> (<year>2016</year>) <volume>6</volume>:<fpage>29914</fpage>. <pub-id pub-id-type="doi">10.1038/srep29914</pub-id>
<pub-id pub-id-type="pmid">27426915</pub-id></mixed-citation>
      </ref>
      <ref id="B187">
        <label>187</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Guardado</surname><given-names>J</given-names></name><name><surname>Hoffman</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Namas</surname><given-names>R</given-names></name><name><surname>Vodovotz</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>IL33-mediated ILC2 activation and neutrophil IL5 production in the lung response after severe trauma: A reverse translation study from a human cohort to a mouse trauma model</article-title>. <source>PloS Med</source> (<year>2017</year>) <volume>14</volume>(<issue>7</issue>):<fpage>e1002365</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pmed.1002365</pub-id>
<pub-id pub-id-type="pmid">28742815</pub-id></mixed-citation>
      </ref>
      <ref id="B188">
        <label>188</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ardehali</surname><given-names>A</given-names></name><name><surname>Esmailian</surname><given-names>F</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><name><surname>Soltesz</surname><given-names>E</given-names></name><name><surname>Hsich</surname><given-names>E</given-names></name><name><surname>Naka</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial</article-title>. <source>Lancet</source> (<year>2015</year>) <volume>385</volume>(<issue>9987</issue>):<page-range>2577&#x2013;84</page-range>. <pub-id pub-id-type="doi">10.1016/S0140-6736(15)60261-6</pub-id>
</mixed-citation>
      </ref>
      <ref id="B189">
        <label>189</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bishawi</surname><given-names>M</given-names></name><name><surname>Roan</surname><given-names>JN</given-names></name><name><surname>Milano</surname><given-names>CA</given-names></name><name><surname>Daneshmand</surname><given-names>MA</given-names></name><name><surname>Schroder</surname><given-names>JN</given-names></name><name><surname>Chiang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy</article-title>. <source>Sci Rep</source> (<year>2019</year>) <volume>9</volume>(<issue>1</issue>):<fpage>8029</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-43737-y</pub-id>
<pub-id pub-id-type="pmid">31142753</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cancers (Basel)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cancers (Basel)</journal-id>
      <journal-id journal-id-type="publisher-id">cancers</journal-id>
      <journal-title-group>
        <journal-title>Cancers</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2072-6694</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33669271</article-id>
      <article-id pub-id-type="pmc">7920025</article-id>
      <article-id pub-id-type="doi">10.3390/cancers13040821</article-id>
      <article-id pub-id-type="publisher-id">cancers-13-00821</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9776-598X</contrib-id>
          <name>
            <surname>Ramesh</surname>
            <given-names>Prathyaya</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cancers-13-00821">1</xref>
          <xref ref-type="aff" rid="af2-cancers-13-00821">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5777-0116</contrib-id>
          <name>
            <surname>Shivde</surname>
            <given-names>Rohan</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cancers-13-00821">1</xref>
          <xref ref-type="aff" rid="af2-cancers-13-00821">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7906-176X</contrib-id>
          <name>
            <surname>Jaishankar</surname>
            <given-names>Dinesh</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cancers-13-00821">1</xref>
          <xref ref-type="aff" rid="af2-cancers-13-00821">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6756-3620</contrib-id>
          <name>
            <surname>Saleiro</surname>
            <given-names>Diana</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cancers-13-00821">1</xref>
          <xref ref-type="aff" rid="af3-cancers-13-00821">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6853-4007</contrib-id>
          <name>
            <surname>Le Poole</surname>
            <given-names>I. Caroline</given-names>
          </name>
          <xref ref-type="aff" rid="af1-cancers-13-00821">1</xref>
          <xref ref-type="aff" rid="af2-cancers-13-00821">2</xref>
          <xref ref-type="aff" rid="af4-cancers-13-00821">4</xref>
          <xref rid="c1-cancers-13-00821" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Gee</surname>
            <given-names>Katrina</given-names>
          </name>
          <role>Academic Editor</role>
        </contrib>
      </contrib-group>
      <aff id="af1-cancers-13-00821"><label>1</label>Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL 60611, USA; <email>prathyaya.ramesh@northwestern.edu</email> (P.R.); <email>rohan.shivde@northwestern.edu</email> (R.S.); <email>dinesh.jaishankar@northwestern.edu</email> (D.J.); <email>diana.saleiro@northwestern.edu</email> (D.S.)</aff>
      <aff id="af2-cancers-13-00821"><label>2</label>Department of Dermatology, Northwestern University, Chicago, IL 60611, USA</aff>
      <aff id="af3-cancers-13-00821"><label>3</label>Division of Hematology-Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA</aff>
      <aff id="af4-cancers-13-00821"><label>4</label>Department of Microbiology and Immunology, Northwestern University at Chicago, Chicago, IL 60611, USA</aff>
      <author-notes>
        <corresp id="c1-cancers-13-00821"><label>*</label>Correspondence: <email>caroline.lepoole@northwestern.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>16</day>
        <month>2</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>2</month>
        <year>2021</year>
      </pub-date>
      <volume>13</volume>
      <issue>4</issue>
      <elocation-id>821</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>12</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>2</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2021 by the authors.</copyright-statement>
        <copyright-year>2021</copyright-year>
        <license license-type="open-access">
          <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Simple Summary</title>
          <p>Cytokines are molecules that help cells communicate at short range. Often, a single cytokine is measured in patient tissues to understand whether immune cells are actively clearing a tumor. We can learn whether a therapy works, even before changes in tumor burden are found. However, measuring multiple different cytokines better reflects ongoing anti-tumor activity. That is especially true for T cell-based therapies, as these cells secrete different cytokines when they eliminate tumors or not. We also need to consider that a single cytokine can perform activities that can either suppress, or support tumor growth. Taken together, we can best describe the function of T cells in a (pre) clinical setting by a palette of cytokines working together to paint a picture of ongoing immune responses to tumor cells.</p>
        </sec>
        <sec>
          <title>Abstract</title>
          <p>Cytokines are key molecules within the tumor microenvironment (TME) that can be used as biomarkers to predict the magnitude of anti-tumor immune responses. During immune monitoring, it has been customary to predict outcomes based on the abundance of a single cytokine, in particular IFN-&#x3B3; or TGF-&#x3B2;, as a readout of ongoing anti-cancer immunity. However, individual cytokines within the TME can exhibit dual opposing roles. For example, both IFN-&#x3B3; and TGF-&#x3B2; have been associated with pro- and anti-tumor functions. Moreover, cytokines originating from different cellular sources influence the crosstalk between CD4<sup>+</sup> and CD8<sup>+</sup> T cells, while the array of cytokines expressed by T cells is also instrumental in defining the mechanisms of action and efficacy of treatments. Thus, it becomes increasingly clear that a reliable readout of ongoing immunity within the TME will have to include more than the measurement of a single cytokine. This review focuses on defining a panel of cytokines that could help to reliably predict and analyze the outcomes of T cell-based anti-tumor therapies.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>T cell</kwd>
        <kwd>cytokines</kwd>
        <kwd>tumor</kwd>
        <kwd>effector function</kwd>
        <kwd>immunotherapy</kwd>
        <kwd>polyfunctionality</kwd>
        <kwd>immune monitoring</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec1-cancers-13-00821">
      <title>1. Introduction</title>
      <p>Cytokines are intercellular signaling molecules that control critical biological functions such as cell proliferation, differentiation, survival, cell cycle progression, and immune-cell activity [<xref rid="B1-cancers-13-00821" ref-type="bibr">1</xref>]. Based on their function, cytokines can be divided into subgroups: lymphokines, monokines, chemokines, interleukins (IL), and interferons (IFNs) [<xref rid="B2-cancers-13-00821" ref-type="bibr">2</xref>]. These secreted proteins act at short range as humoral regulators, attuning the functional processes of individual cells to maintain cellular homeostasis [<xref rid="B1-cancers-13-00821" ref-type="bibr">1</xref>]. Importantly, cytokines are key mediators of anti-tumor immune responses by controlling activation of immune cells [<xref rid="B2-cancers-13-00821" ref-type="bibr">2</xref>,<xref rid="B3-cancers-13-00821" ref-type="bibr">3</xref>]. As such, the abundance and type of cytokines within the tumor microenvironment (TME) is an important biomarker to predict tumor progression [<xref rid="B1-cancers-13-00821" ref-type="bibr">1</xref>]. However, further studies are required to fully elucidate the different biological functions induced by the presence of a single versus multiple cytokines, and by the &#x201C;cross-talk&#x201D; between cytokine-mediated signaling pathways [<xref rid="B1-cancers-13-00821" ref-type="bibr">1</xref>].</p>
      <p>Typically, the TME is characterized by presenting high levels of the anti-inflammatory, immunosuppressive cytokine IL-10, which facilitates tumor expansion [<xref rid="B3-cancers-13-00821" ref-type="bibr">3</xref>]. Meanwhile, IFNs hold anti-tumor, anti-viral, and immunomodulatory properties [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>], with IFN-gamma (IFN-&#x3B3;) playing a critical role in defining a pro- versus anti-TME. IFN-&#x3B3; has long been studied as the ultimate pro-inflammatory cytokine, with the responsibility to regulate anti-inflammatory responses. It also inhibits differentiation of immunosuppressive regulatory T cells (Tregs), and balances tissue destruction in chronic inflammation conditions [<xref rid="B5-cancers-13-00821" ref-type="bibr">5</xref>,<xref rid="B6-cancers-13-00821" ref-type="bibr">6</xref>]. Interestingly, depending on the biological context, IFN-&#x3B3; can enhance or diminish the expression of tumor antigens, thereby determining the extent of anti-tumor immune responses [<xref rid="B7-cancers-13-00821" ref-type="bibr">7</xref>]. Thus, some pro-tumor consequences of IFN-&#x3B3; exposure exist, and its role may depend on the length of exposure and absolute abundance of the cytokine within the TME [<xref rid="B5-cancers-13-00821" ref-type="bibr">5</xref>]. Additionally, while necessary, this cytokine does not seem to be sufficient on its own to halt the development of tumors [<xref rid="B6-cancers-13-00821" ref-type="bibr">6</xref>].</p>
      <p>Transforming growth factor-beta (TGF-&#x3B2;) operates in different capacities throughout disease progression. TGF-&#x3B2; can function as a tumor suppressor, inducing apoptosis and suppressing proliferation of pre-malignant and cancer cells [<xref rid="B8-cancers-13-00821" ref-type="bibr">8</xref>]. However, as the name suggests, TGF-&#x3B2; can also mediate pro-metastatic and tumorigenic responses and support an immunosuppressive TME. TGF-&#x3B2; can help control inflammation and mediate immune tolerance [<xref rid="B8-cancers-13-00821" ref-type="bibr">8</xref>]. The interchange of TGF-&#x3B2; with IFN-&#x3B3; can be indicative of the effectiveness of cancer therapies and of an immune-active TME. However, the dual face of these cytokines is emblematic as to why a single cytokine is not satisfactory to adequately determine the ongoing immunity of the TME. Besides IL-10, TGF-&#x3B2;, and IFN-&#x3B3;, it is the concerted action of multiple cytokines within the TME that mainly determines the extent and success of anti-tumor immune responses. Cytokines allow immune cells to transmit signals to each other and, under ideal conditions, promote a vigorous and harmonized response against target cells in both a paracrine and autocrine manner over short distances [<xref rid="B9-cancers-13-00821" ref-type="bibr">9</xref>,<xref rid="B10-cancers-13-00821" ref-type="bibr">10</xref>]. The anti-tumor activities of several cytokines have been established in animal models, serving as a premise for several cytokine-based immunotherapies [<xref rid="B10-cancers-13-00821" ref-type="bibr">10</xref>]. Moreover, T cell engineering can be used for the expression of an antigen specific CAR or TCR to drive responses selectively towards tumor cells [<xref rid="B11-cancers-13-00821" ref-type="bibr">11</xref>]. The pattern of cytokines expressed in response to immune cell therapy can then be used as a readout for anti-tumor control.</p>
      <p>As important as cytokines are in predicting tumor progression and the success of cancer therapies, they can provide the identity and abundance of immune cells infiltrating the TME. Tumor infiltrating lymphocyte (TIL) populations include CD3<sup>+</sup>CD4<sup>+</sup> and CD3<sup>+</sup> CD8<sup>+</sup> T cells, which can each be engaged in suppressing tumor growth [<xref rid="B12-cancers-13-00821" ref-type="bibr">12</xref>,<xref rid="B13-cancers-13-00821" ref-type="bibr">13</xref>]. B cells can also be present in the TME, and among them, regulatory B cells are known for the release of immunoregulatory cytokines that hinder anti-tumor responses by inhibiting natural killer (NK) cells and CD8<sup>+</sup> cytotoxic T cells [<xref rid="B14-cancers-13-00821" ref-type="bibr">14</xref>]. Inflammatory cells within the TME can either actively hinder tumor development or contribute to tumor progression [<xref rid="B12-cancers-13-00821" ref-type="bibr">12</xref>]. More ambiguous roles have been assigned to T helper 2 (Th2) CD4<sup>+</sup> T cell populations, which produce IL-4, IL-5, and IL-3 in support of B and T helper 17 (Th17) cell responses [<xref rid="B15-cancers-13-00821" ref-type="bibr">15</xref>]. Thus, it will be imperative to expand our understanding of cytokine function to understand the true breadth and role that these biomarkers play in the activation of these immune cells and establishing anti-tumor immunity.</p>
      <p>Identifying a defined palette of cytokines that can predict immune activation versus immunosuppression enables a better characterization of the TME. Here, we provide a magnified perspective of the cytokine patterns that represent the inner workings of immune cells, and specifically T cells responding within the TME. The observation of different secreted cytokine patterns can be associated with respective outcomes, and then used to accurately evaluate the effectiveness of immune-based therapies.</p>
    </sec>
    <sec id="sec2-cancers-13-00821">
      <title>2. T Cell-Derived Cytokines as Biomarkers of Anti-Tumor Activity</title>
      <p>T cells are a notable indicator for characterizing ongoing immunity within the tumor microenvironment. However, T cell abundance is not an adequate marker of whether tumors will regress. <xref ref-type="fig" rid="cancers-13-00821-f001">Figure 1</xref> showcases a human melanoma tumor with an abundance of T cells. This exemplifies the need to example T cell function over T cell abundance to understand the nature of tumor progression.</p>
      <p>A combination of cytokine markers can provide reliable information on the capacity of T cells to act within the tumor. T cells are the primary source of each cytokine and these profiles are used to define T cell subsets [<xref rid="B16-cancers-13-00821" ref-type="bibr">16</xref>]. Specific combinations of cytokines are associated with Th1, Th9, and Th17 T cells. As an additional parameter, most studies will include CD107A as a surrogate marker of cytotoxic activity.</p>
      <p>In reference to the Th1 subset, the ratio of Th1 to Th2-associated cytokines provides information on the outcome of ongoing antitumor immune responses [<xref rid="B17-cancers-13-00821" ref-type="bibr">17</xref>]. Representative cytokines for the Th1 subset, with classic anti-tumor activity include IFN-&#x3B3; and IL-2 [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>] and the Th1/Th2 ratio is critical for numerous immune responses [<xref rid="B19-cancers-13-00821" ref-type="bibr">19</xref>]. Showing the ability of antigen specific Th1 cells through the use of adhesion molecules places the Th1 subset at the forefront of tumor rejection activity [<xref rid="B17-cancers-13-00821" ref-type="bibr">17</xref>]. Th1 cells primarily stimulate CTL activation and differentiation and the secretion of cytokines such as IL-2, IL-12, IFN-&#x3B3;, and TNF-&#x3B1; support CTL effector phenotype [<xref rid="B20-cancers-13-00821" ref-type="bibr">20</xref>]. Additionally, Th1 therapy can induce lasting immunological memory to revive CTL generation upon tumor recurrence [<xref rid="B17-cancers-13-00821" ref-type="bibr">17</xref>]. Critical to this work is the discovery that Th1 cells expressed adhesion molecules LFA-1/ICAM-1 [<xref rid="B19-cancers-13-00821" ref-type="bibr">19</xref>], that allow transmigration into tumor tissues across tumor vessels, supporting tumor metastasis [<xref rid="B17-cancers-13-00821" ref-type="bibr">17</xref>,<xref rid="B19-cancers-13-00821" ref-type="bibr">19</xref>]. The cytokines secreted by Th1 T cells are commonly associated with a good prognosis for anti-tumor therapies [<xref rid="B20-cancers-13-00821" ref-type="bibr">20</xref>]. Moreover, Th1 cytokines produced upon antigen stimulation directly induce the recruitment of effector cells such as CD8<sup>+</sup> T cells, NKT cells, and NK cells to the tumor [<xref rid="B17-cancers-13-00821" ref-type="bibr">17</xref>].</p>
      <p>Th9 cytokines were designated as a separate T cell subset preferentially producing IL9 [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>]. However, IL9 secretion per se is not restricted to Th9 cells, and can also be produced by Treg, Th17, or Th2 cells [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>]. IRF4 expression combined with TGF-&#x3B2; and IL-4 exposure are critical for Th9 differentiation [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>]. IL-9 is implicated in the anticancer effects of Th9 cells [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>], whereas IL-2 supports the production of IL-9 [<xref rid="B21-cancers-13-00821" ref-type="bibr">21</xref>]. The cytokine enhances dendritic cell survival and strengthens their capacity to induce and foster protective immunity [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>]. Typically, Th9 cells produce low levels of IL-21, and also generate IL-25 and IL-1, but the anticancer effects of Th9 cells predominantly depend on IL-9 [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>]. Originally assigned a function in combating parasitic infections, Th9 cells have been designated as anti-tumor T cells and their IL-9 expression can potentially induce bystander cell recruitment (such as NK cells and CD8 cells) [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>]. Transcription factors, including STAT6, GATA3, PU.1, and IRF4, are central to Th9 polarization [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>]. Of these, GATA3 and STAT6 have also been detected in Th2 cells. In other reports, IL-9 has been identified for targeted proliferation and activation of mast cells and enhancement of dendritic cell survival [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>], highlighting IL-9 as a nominal marker for antitumor activity.</p>
      <p>The Th17 cell subset does not exhibit stable differentiation and rather adorns a plasticity which allows it to adapt to its surroundings [<xref rid="B22-cancers-13-00821" ref-type="bibr">22</xref>]. Th17 cells were identified as an individual subset based on their production of IL-17 [<xref rid="B22-cancers-13-00821" ref-type="bibr">22</xref>]. Additionally, this subset produces IL-17F, IL-21, GM-CSF, and IL-22, whereas IL-23 is required for Th17 cell survival and pathogenesis [<xref rid="B22-cancers-13-00821" ref-type="bibr">22</xref>]. Th17 cells have predominantly been associated with autoimmune and inflammatory diseases [<xref rid="B22-cancers-13-00821" ref-type="bibr">22</xref>]. The plasticity of this subset places its role in cancer under debate, as Th17 can transdifferentiate into other subsets. Th1 conversion supports anti-tumor value, but Th17 can also morph into TR1, Th2, or TFH cells. Thus, Th17 are equipped to mediate several contradicting functions [<xref rid="B22-cancers-13-00821" ref-type="bibr">22</xref>]. Within melanoma however, Th17 cells tend to spur protective immunity and establish tumor regression [<xref rid="B22-cancers-13-00821" ref-type="bibr">22</xref>]. Within the TME, Th17 cells did not exhibit killing activity, but instead promoted dendritic cell and CD4<sup>+</sup> and CD8<sup>+</sup> T cell recruitment [<xref rid="B22-cancers-13-00821" ref-type="bibr">22</xref>]. Th17 T cell function is thus difficult to classify due to its plasticity.</p>
      <p>CD107a (also known as LAMP-1) is not a cytokine, but serves as a substitute marker of cytotoxic activity expressed by natural killer (NK), &#x3B3;&#x3B4; T cells, and cytotoxic T cells, briefly found on the cell surface upon degranulation [<xref rid="B23-cancers-13-00821" ref-type="bibr">23</xref>,<xref rid="B24-cancers-13-00821" ref-type="bibr">24</xref>]. NK cells help mediate tumor cell clearance and viral infections [<xref rid="B25-cancers-13-00821" ref-type="bibr">25</xref>]. Expression of CD107a is aligned with IFN-&#x3B3; and TNF-&#x3B1; expression and cytotoxicity by T cells, and is likewise upregulated on activated NK cells, thus functioning as a general NK functional activity marker [<xref rid="B25-cancers-13-00821" ref-type="bibr">25</xref>].</p>
      <p>Besides T cell derived cytokines themselves, the cytokines that induce T cell activity can also be informative of the tumor microenvironment and can be used as treatments as well. Therapeutic cytokines for tumor patients can be subclassified into the IL-1, IL-2, and IL-12 families [<xref rid="B26-cancers-13-00821" ref-type="bibr">26</xref>]. IL-1 is categorized as a pro-inflammatory cytokine and works as a T cell co-stimulator along with its role in inducing effector cell proliferation [<xref rid="B26-cancers-13-00821" ref-type="bibr">26</xref>]. IL-2 was originally discovered as T cell growth factor and is key in promoting CD8<sup>+</sup> mediated antitumor immunity [<xref rid="B26-cancers-13-00821" ref-type="bibr">26</xref>], stimulating T cell growth, differentiation of effector T cells and Th1 cells, and activation of NK cells. In fact, it is the most used cytokine in cancer therapy [<xref rid="B26-cancers-13-00821" ref-type="bibr">26</xref>]. Finally, IL-12 is capable of inducing Th1 and IFN-&#x3B3; responses (activates JAK-STAT pathway after binding to its receptor) within T cells [<xref rid="B26-cancers-13-00821" ref-type="bibr">26</xref>]. IL-12 is produced by dendritic cells and macrophages and like the other Th1 cytokines, plays a role in NK cell activation and Th1 differentiation [<xref rid="B26-cancers-13-00821" ref-type="bibr">26</xref>]. IL-12 tends to display limited therapeutic potential, though IL-12-producing chimeric antigen receptor (CAR)-modified T cells potently destroy existing tumors [<xref rid="B26-cancers-13-00821" ref-type="bibr">26</xref>].</p>
      <p>Among T cell-derived biomarkers, Th1 cytokines IFN-&#x3B3;, IL-2, and TNF-&#x3B1; present themselves as the most notable markers of responses to therapy [<xref rid="B18-cancers-13-00821" ref-type="bibr">18</xref>,<xref rid="B25-cancers-13-00821" ref-type="bibr">25</xref>]. The synergy of these and other cytokines (in a polyfunctional manner) as outlined in <xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref>, can produce positive, potent, and efficient responses to cytokine therapies. <xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref> serves to highlight the most commonly measured cytokine responses across different tumor types with T cell-based therapeutics. By relating these secondary outcome measures to treatment outcomes, we create a foundation for a palette of cytokines that can better serve to relate therapeutic outcomes. From this table, we conclude that detecting a combination of IFN-&#x3B3;, TNF-&#x3B1; and IL-2 is more informative than measuring a single cytokine such as IFN-&#x3B3; alone. Moreover, the function of a cytokine within the tumor environment can be ambivalent and several factors can affect their in vivo functionality.</p>
    </sec>
    <sec id="sec3-cancers-13-00821">
      <title>3. The Dual Face of IFN-&#x3B3; and TGF-&#x3B2;</title>
      <p>Of the many cytokines available, the balance between IFN-&#x3B3; and TGF-&#x3B2; plays a pivotal role in determining the pro- versus anti-tumor characteristics and outcomes within the TME. However, simply measuring IFN-&#x3B3; or TGF-&#x3B2; secretion in the TME is not enough to accurately characterize the anti-tumor potential of the TME. IFN-&#x3B3; is a hallmark cytokine produced by Th1 cells, but also by CD8<sup>+</sup> T cells, &#x3B3;&#x3B4; T cells, NKT cells, NK cells, dendritic cells, and macrophages [<xref rid="B6-cancers-13-00821" ref-type="bibr">6</xref>,<xref rid="B33-cancers-13-00821" ref-type="bibr">33</xref>,<xref rid="B34-cancers-13-00821" ref-type="bibr">34</xref>]. The biological functions exhibited by IFN-&#x3B3; are derived from its interaction with the IFN-&#x3B3; receptors IFNGR1 and IFNGR2 [<xref rid="B33-cancers-13-00821" ref-type="bibr">33</xref>]. TGF-&#x3B2; is the hallmark cytokine involved in lymphoid organs and the immune system with a pivotal role in the maintenance of T-cell homeostasis [<xref rid="B33-cancers-13-00821" ref-type="bibr">33</xref>]. TGF-&#x3B2; signaling is dependent on environmental cues within the TME and exhibits its dual role in response to these cues.</p>
      <p>IFN-&#x3B3; has long been prominently hailed as an anti-tumor environment-promoting cytokine [<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>]. IFN-&#x3B3; affects both antitumor effector cells and tumor cells themselves [<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>]. This cytokine has a pleiotropic effect on several responsive cell types [<xref rid="B6-cancers-13-00821" ref-type="bibr">6</xref>,<xref rid="B33-cancers-13-00821" ref-type="bibr">33</xref>]. IFN-&#x3B3; has direct anti-tumor effects by inhibiting tumor cell proliferation through induction of cyclin-dependent kinase inhibitor 1 (p21) expression and consequent cell cycle arrest [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>,<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>]. Moreover, IFN-&#x3B3; can upregulate expression of caspase-1, -3, and -8, promoting tumor cell apoptosis [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>]. IFN-&#x3B3; also stimulates an anti-tumor environment by increasing expression of classical MHC class I genes, cytotoxicity, effector functions, CD4<sup>+</sup> and CD8<sup>+</sup> T cell proliferation, and survival, while also decreasing Treg suppressive activity and endothelial cell proliferation [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>,<xref rid="B36-cancers-13-00821" ref-type="bibr">36</xref>,<xref rid="B37-cancers-13-00821" ref-type="bibr">37</xref>]. The inhibition of tumor angiogenesis is another prominent function of IFN-&#x3B3; in establishing an anti-tumor environment [<xref rid="B36-cancers-13-00821" ref-type="bibr">36</xref>]. IFN-&#x3B3; can inhibit angiogenesis directly in combination with TNF-&#x3B1;, or indirectly through the production of secondary anti-angiogenic molecules such as MIG and IP-10 [<xref rid="B36-cancers-13-00821" ref-type="bibr">36</xref>]. However, IFN-&#x3B3; can also promote angiogenesis by downregulating TNFSF15 [<xref rid="B38-cancers-13-00821" ref-type="bibr">38</xref>].</p>
      <p>Individual facets of IFN-&#x3B3; activity are dependent upon factors such as signal intensity, signal duration, and other microenvironmental cues [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>]. On one hand, tumor cells are a direct target of IFN-&#x3B3; activity [<xref rid="B39-cancers-13-00821" ref-type="bibr">39</xref>] and are also very vulnerable to destruction by IFN-&#x3B3; activated immune effector cells [<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>]. Indeed, exposure to IFN-&#x3B3; causes increased expression of IL-12, IL-18, and IL-17 by antigen presenting cell (APC), which encourages Th1 differentiation and supports CTL functions [<xref rid="B37-cancers-13-00821" ref-type="bibr">37</xref>]. Further supporting its anti-tumor activity, a loss of responsiveness to IFN-&#x3B3; signaling in tumor cells is associated with anti-apoptotic and proliferative activity [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>,<xref rid="B37-cancers-13-00821" ref-type="bibr">37</xref>]. On the other hand, chronic exposure to IFN-&#x3B3; can mediate tumor immunoevasion [<xref rid="B39-cancers-13-00821" ref-type="bibr">39</xref>] by the development and recruitment of myeloid-derived suppressor cells (MDSCs). Moreover, IFN-&#x3B3; induces the expression of PD-L1 inhibiting T cell effector functions [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>] promoting tumor progression and expression of MUC16 to promote tumor progression [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>,<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>,<xref rid="B39-cancers-13-00821" ref-type="bibr">39</xref>,<xref rid="B40-cancers-13-00821" ref-type="bibr">40</xref>]. Furthermore, genomic instability induced by IFN-&#x3B3; can cause phenotypic changes in tumor cells that lead to therapeutic resistance or support metastasis [<xref rid="B39-cancers-13-00821" ref-type="bibr">39</xref>].</p>
      <p>TGF-&#x3B2; is popularly categorized as a pro-tumor cytokine and plays an integral role in immunoregulation and cancer. It is instrumental in the promotion of differentiation and homeostasis of certain T cell populations [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>,<xref rid="B42-cancers-13-00821" ref-type="bibr">42</xref>]. This particular pleiotropic cytokine promotes an antitumor environment by increasing tumor cell apoptosis, reducing expression of growth factors and inhibiting cell cycle progression [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>,<xref rid="B43-cancers-13-00821" ref-type="bibr">43</xref>]. Conversely, unlike IFN-&#x3B3;, high levels of TGF-&#x3B2; are typically considered a &#x201C;negative prognostic indicator&#x201D; [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>]. Initially, TGF-&#x3B2; was simply defined as an immunosuppressant, but this cytokine has more than just immunosuppressive capabilities [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>,<xref rid="B42-cancers-13-00821" ref-type="bibr">42</xref>].</p>
      <p>TGF-&#x3B2; inhibits differentiation of Th1 and Th2 cells but is required for Th17 cell differentiation [<xref rid="B42-cancers-13-00821" ref-type="bibr">42</xref>]. TGF-&#x3B2; can also directly suppress CD8<sup>+</sup> T cell responses in the TME by inhibiting expression of cytotoxic genes [<xref rid="B42-cancers-13-00821" ref-type="bibr">42</xref>]. CD8<sup>+</sup> T cells with impaired TGF-&#x3B2; signaling have been found to inhibit tumor development and evoke strong antitumor immune responses [<xref rid="B42-cancers-13-00821" ref-type="bibr">42</xref>]. As a tumor suppressor, TGF-&#x3B2; inhibits tumor cell proliferation and induces pre-malignant cell apoptosis typically triggered within cells that suffer oncogenic stress [<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>].</p>
      <p>The dual role of TGF-&#x3B2; is context-dependent as its downstream signaling effects vary depending on the progression of the disease [<xref rid="B44-cancers-13-00821" ref-type="bibr">44</xref>]. During pre-malignant disease progression, TGF-&#x3B2; signaling promotes a pro-tumorigenic microenvironment [<xref rid="B43-cancers-13-00821" ref-type="bibr">43</xref>]. As a tumor suppressor, TGF-&#x3B2; inhibits tumor cell proliferation and induces pre-malignant cell apoptosis typically triggered within cells that suffer oncogenic stress [<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>]. Furthermore, TGF-&#x3B2; can drive invasion, metastasis, and epithelial-to-mesenchymal transition (EMT) by influencing both the stroma and cancer cells [<xref rid="B35-cancers-13-00821" ref-type="bibr">35</xref>]. When the disease progresses to late-stage cancer, the tumor is resistant to suppressive signaling effects due to TGF-&#x3B2; loss-of-function mutations [<xref rid="B43-cancers-13-00821" ref-type="bibr">43</xref>].</p>
      <p>As the disease advances, TGF-&#x3B2; functions as a crucial mechanism for immune evasion [<xref rid="B8-cancers-13-00821" ref-type="bibr">8</xref>]. The protumor capacity of TGF-&#x3B2; relies largely on the tumor cells themselves. The ability of TGF-&#x3B2; to convert CD4<sup>+</sup>CD25<sup>&#x2212;</sup> T cells into iTreg cells is one of many methods to evade antitumor immunity [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>]. Indeed, an increased presence of Tregs within the TME is driven by tumor-derived TGF-&#x3B2; [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>]. Additionally, the conversion of dendritic cells into MDSCs occurs via tumor-cell produced TGF-&#x3B2;, which in turn stimulates Treg cell proliferation [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>]. A TGF-&#x3B2;-abundant microenvironment thus facilitates the evasion of host immune surveillance [<xref rid="B41-cancers-13-00821" ref-type="bibr">41</xref>].</p>
      <p>High levels of IFN-&#x3B3; are a known indicator of &#x201C;good T-cells&#x201D; but as indicated above, the role of IFN-&#x3B3; in the TME is highly context-dependent [<xref rid="B4-cancers-13-00821" ref-type="bibr">4</xref>]. In part, this context is provided by the temporal abundance of TGF-&#x3B2;. The ratio between these two cytokines is a more telling parameter to measure within the TME and these measurements can be further enhanced using cytokine analysis. However, the interplay of these dominant cytokines is not enough to accurately identify the status of tumor immunity within the microenvironment, mark T cell activity and response or determine tumor outcomes.</p>
    </sec>
    <sec id="sec4-cancers-13-00821">
      <title>4. The Interplay of CD4<sup>+</sup> and CD8<sup>+</sup> T Cells Define Immune Responses in the TME</title>
      <p>Therapeutic T cells within the TME can display varying levels of efficacy based on the cytokines they release, which ultimately defines the scope of functionality for that T cell. There is a mutually supportive relationship between CD4<sup>+</sup> and CD8<sup>+</sup> T cells; both cell types are components of the adaptive arm of the immune system and rely on antigen expression to initiate anti-tumor immunity [<xref rid="B45-cancers-13-00821" ref-type="bibr">45</xref>]. CD4<sup>+</sup> T cells are defined as either helper (Th) or suppressor T cells, which express unique transcription factors that direct the transcription of specific cytokine genes associated with each subset. CD4<sup>+</sup> T cells most commonly associated with anti-tumor responses include Th1, Th9, and Th17 cells, which drive cell-mediated responses [<xref rid="B46-cancers-13-00821" ref-type="bibr">46</xref>], while Th2 cells support the humoral arm of the adaptive immune response considered less effective at containing tumors [<xref rid="B47-cancers-13-00821" ref-type="bibr">47</xref>]. In contrast, immunosuppressive CD4<sup>+</sup> Tregs have an integral role in immune tolerance, thus actively interfering with anti-tumor responses [<xref rid="B15-cancers-13-00821" ref-type="bibr">15</xref>,<xref rid="B45-cancers-13-00821" ref-type="bibr">45</xref>]. Th22 T cells are associated with a poor prognosis [<xref rid="B48-cancers-13-00821" ref-type="bibr">48</xref>] and are likewise known for interfering with ongoing anti-tumor immunity [<xref rid="B49-cancers-13-00821" ref-type="bibr">49</xref>]. However, the precise role of IL-22 producing Th22 cells is poorly defined [<xref rid="B50-cancers-13-00821" ref-type="bibr">50</xref>].</p>
      <p>CD8<sup>+</sup> T cells, on the other hand, are the cytotoxic subset of T cells that have traditionally been pursued as the most critical for tumor control. And yet, as depicted in <xref ref-type="fig" rid="cancers-13-00821-f002">Figure 2</xref>, ongoing crosstalk between CD4<sup>+</sup> Th1 and CD8<sup>+</sup> T cells is an often-overlooked requirement for immune activation and is necessary for suppressing tumor growth [<xref rid="B45-cancers-13-00821" ref-type="bibr">45</xref>]. Th1 cells promote the ability of CD8<sup>+</sup> T cells to produce IFN-&#x3B3; and IL-2, and conduct clonal expansion [<xref rid="B15-cancers-13-00821" ref-type="bibr">15</xref>,<xref rid="B51-cancers-13-00821" ref-type="bibr">51</xref>]. Moreover, some CD4<sup>+</sup> T cells display cytotoxic functions of their own [<xref rid="B47-cancers-13-00821" ref-type="bibr">47</xref>]. Tumor-reactive CD4<sup>+</sup> cells are adept at communicating with diverse innate and adaptive immune cell types within the TME [<xref rid="B45-cancers-13-00821" ref-type="bibr">45</xref>]. CD4<sup>+</sup> cells are effective educators and inducers of other cell types. For example, CD4<sup>+</sup> T cells can license dendritic cells to activate CD8<sup>+</sup> cytotoxic T cells, or induce B cells (Th2) to activate a switch between different classes of antibodies [<xref rid="B52-cancers-13-00821" ref-type="bibr">52</xref>]. Th9 T cells can support mast cell activation and cytotoxic activity [<xref rid="B53-cancers-13-00821" ref-type="bibr">53</xref>]. Th17 cells can affect endothelial cell function and vascular integrity, while presenting a plastic population that can emerge as Th1 cells [<xref rid="B54-cancers-13-00821" ref-type="bibr">54</xref>]. As such, CD4<sup>+</sup> T cells are oftentimes responsible for the cytokine composition found in regressing tumors. Al- though CD4<sup>+</sup> T cells generally display minimal in vivo or in vitro lytic activity against tumors, one could say that their activation in the TME determines tumor rejection to a greater extent than activation of CD8<sup>+</sup> T cells [<xref rid="B52-cancers-13-00821" ref-type="bibr">52</xref>,<xref rid="B55-cancers-13-00821" ref-type="bibr">55</xref>].</p>
      <p>CD8<sup>+</sup> T effector cells are categorized into two main classes: CD8<sup>+</sup> type 1 (Tc1) cells, which primarily produce IFN-&#x3B3; and TNF-&#x3B1;, and type 2 (Tc2) cells, which produce IL-4, IL-5, IL-10, and IL-13 [<xref rid="B36-cancers-13-00821" ref-type="bibr">36</xref>]. Tc1 cells have the potency to kill target antigen bearing cells, via the release of perforin and granzyme B [<xref rid="B56-cancers-13-00821" ref-type="bibr">56</xref>]. These cytotoxic mediators are released into the immunological synapse, whereupon T cells secrete cytokines such as IFN-&#x3B3; and TNF-&#x3B1; to further induce the immune response [<xref rid="B57-cancers-13-00821" ref-type="bibr">57</xref>]. On the other hand, Tc2 cells often aggravate diseases and can only mediate low levels of cytotoxicity [<xref rid="B57-cancers-13-00821" ref-type="bibr">57</xref>]. Thus, type 1 cytokines are associated with potent cytotoxicity and establish lasting anti-tumor immunity.</p>
      <p>Tumor immunotherapy is evolving to include antigen specific, transgenic T cells [<xref rid="B58-cancers-13-00821" ref-type="bibr">58</xref>]. In areas of cancer immunotherapy where traditional therapies have proved unsuccessful, a different approach is required; namely, adoptive T cell transfer [<xref rid="B58-cancers-13-00821" ref-type="bibr">58</xref>]. CD8<sup>+</sup> T cells have become the front runner in several cancer immunotherapies, given their cytolytic activity [<xref rid="B56-cancers-13-00821" ref-type="bibr">56</xref>]. Besides adoptive transfer of TCR transgenic CD8<sup>+</sup> cytotoxic T cells responding to a tumor-associated antigen, the concept of chimeric antigen receptor-transduced T cells has taken flight [<xref rid="B56-cancers-13-00821" ref-type="bibr">56</xref>]. One difference among these 2 approaches is their dependence (or independence) on a CD4<sup>+</sup> or CD8<sup>+</sup> co-receptor to function [<xref rid="B59-cancers-13-00821" ref-type="bibr">59</xref>]. Indeed, chimeric antigen receptor (CAR) transduced CD4<sup>+</sup> (CAR4) and CD8<sup>+</sup> (CAR8) T cell subsets each respond to antigen, with individually defined roles in the anti-tumor response [<xref rid="B60-cancers-13-00821" ref-type="bibr">60</xref>].</p>
      <p>The relative efficacy of CD4<sup>+</sup> and CD8<sup>+</sup> T cells can be observed in several models. For example, in an attempt to define the consequences of TCR activation of CAR T cell potency, researchers designed a comparative murine study which resulted in notably different responses amongst CAR4 and CAR8 cells [<xref rid="B61-cancers-13-00821" ref-type="bibr">61</xref>]. T cells exhibited increased signs of exhaustion in the presence of the TCR marker with an increase in PD-1 and LAG3 expression, in contrast to CAR4 cells, inhibiting their ability for leukemia clearance [<xref rid="B61-cancers-13-00821" ref-type="bibr">61</xref>]. In this study, parallel activation of the existing TCR and the newly introduced CAR obliterated CAR8 efficacy within the TME [<xref rid="B61-cancers-13-00821" ref-type="bibr">61</xref>]. The CAR8 T cells were more vulnerable to apoptosis and expressed T cell markers which signal a diminished ability to clear the targeted B cells [<xref rid="B61-cancers-13-00821" ref-type="bibr">61</xref>]. On the other hand, CAR4 T cells displayed resistance to immunosuppression following TCR stimulation, specifically to early activity and expansion. This may be due to copious recognition of tumor antigen presented in the context to MHC class I (HY and OVA peptide specific mice) and subsequent TCR-mediated activation of CD8<sup>+</sup> cells, while CD4<sup>+</sup> T cells are TCR-activated only by antigen presenting cells that carry MHC class II molecules [<xref rid="B13-cancers-13-00821" ref-type="bibr">13</xref>,<xref rid="B61-cancers-13-00821" ref-type="bibr">61</xref>]. Moreover, CD8<sup>+</sup> T cells are more restricted in their choice of antigenic peptides to respond to, with very little allowance for changes to the cognate peptide [<xref rid="B62-cancers-13-00821" ref-type="bibr">62</xref>].</p>
      <p>In summary, when comparing the contribution between CD4<sup>+</sup> and CD8<sup>+</sup> T cells against tumors, CD4<sup>+</sup> T cells can be assigned a mentoring and directive role [<xref rid="B45-cancers-13-00821" ref-type="bibr">45</xref>]. The effectiveness of T cells and their responses is significantly enhanced when multiple cytokines are secreted into the TME. In correlation with <xref ref-type="fig" rid="cancers-13-00821-f002">Figure 2</xref>, the cytokines most telling of favorable responses are IFN-&#x3B3; (Th1, TC1, TC17), TNF-&#x3B1; (Th1, TC1, and TC17), and IL-2 (Th1), as shown in <xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref> studies 1,2,5, and 6. Current therapeutics can be associated with adverse events that are also marked by cytokines [<xref rid="B63-cancers-13-00821" ref-type="bibr">63</xref>]. This combination of secreted cytokines can be highly instrumental in understanding anti-tumor functionality.</p>
    </sec>
    <sec id="sec5-cancers-13-00821">
      <title>5. T Cell Polyfunctionality</title>
      <p>T cell subset-associated transcription factors are considered the primary indicators for T cell classification [<xref rid="B64-cancers-13-00821" ref-type="bibr">64</xref>]. However, T cell classification usually relies on the expression of a combination of cell surface glycoproteins by flow cytometry analyses [<xref rid="B27-cancers-13-00821" ref-type="bibr">27</xref>]. This array of surface molecules aligns with specific functional features, which allow classification of T cells according to their activation status, including the identification of the cytokines that they produce. The ability to produce multiple cytokines is dependent on the TCR binding affinity and antigen-sensitivity of a T cell [<xref rid="B29-cancers-13-00821" ref-type="bibr">29</xref>]. Polyfunctionality, the ability of T cells to produce multiple cytokines, enhances immune responses to infectious diseases and following vaccinations [<xref rid="B27-cancers-13-00821" ref-type="bibr">27</xref>,<xref rid="B29-cancers-13-00821" ref-type="bibr">29</xref>]. However, the process by which polyfunctional T cells arise to enhance immune response is not yet fully understood [<xref rid="B27-cancers-13-00821" ref-type="bibr">27</xref>].</p>
      <p>A first step towards answering this question includes single-cell analysis of cytokines secreted by polyclonally activated peripheral blood human CD8<sup>+</sup> T cells [<xref rid="B27-cancers-13-00821" ref-type="bibr">27</xref>]. Here, dynamic single-cell analysis of cytokine release by individual T cells was determined over time by enzyme-linked immunosorbent assay (ELISA) (<xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref>, study #1). This study revealed the presence of dynamically evolving T cell polyfunctional responses, suggesting that T cells present functional plasticity over time. The initial cytokine pattern in response to antigen stimulation is essentially monofunctional, whereas polyfunctionality develops later and represents a transient functional state [<xref rid="B27-cancers-13-00821" ref-type="bibr">27</xref>]. Among the cytokines analyzed, secretion of IFN-&#x3B3; or IL-2 showed remarkable consistency and dominance among individually defined polyfunctional states and secretion was markedly increased over time, while cells secreting TNF-&#x3B1; diminished [<xref rid="B27-cancers-13-00821" ref-type="bibr">27</xref>].</p>
      <p>In another study [<xref rid="B28-cancers-13-00821" ref-type="bibr">28</xref>] (<xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref>, study #2), different peripheral blood T lymphocyte subsets and renal parenchymal tissue were analyzed to better understand the relationship between immune cells and cancer cells. A notable observation was the increased production of IL-10 amongst the CD4<sup>+</sup> and CD8<sup>+</sup> tumor infiltrating T lymphocytes, but this response was not observed among autologous PBMC&#x2019;s from patients responding to therapy [<xref rid="B28-cancers-13-00821" ref-type="bibr">28</xref>]. Through immunohistochemistry, both CD8<sup>+</sup> effector memory cells and polyfunctional CD4<sup>+</sup> T cells were observed in abundance among tumor infiltrating lymphocytes (TILs) [<xref rid="B28-cancers-13-00821" ref-type="bibr">28</xref>]. While intra-tumoral CD8<sup>+</sup> T cells were observed, CD4<sup>+</sup> T cells were the predominant cell type in TILs of the renal tumor and constitute the more functional and experienced effector memory cells [<xref rid="B28-cancers-13-00821" ref-type="bibr">28</xref>].</p>
      <p>Further, in a study to evaluate the effects of anti-PD-1 therapy in melanoma patients, polyfunctional and persistent, older CD8<sup>+</sup>T cells were found to drive polyfunctionality of newer monofunctional CD8<sup>+</sup> T cells over time (<xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref>, study #3) [<xref rid="B29-cancers-13-00821" ref-type="bibr">29</xref>]. CD107a expression among tumor reactive CD8<sup>+</sup> T cells indicates that an accumulation of polyfunctional T cells occurs in their peripheral pool [<xref rid="B29-cancers-13-00821" ref-type="bibr">29</xref>]. This accumulation serves as a predictor of lasting immune responses. Polyfunctional T cells were consistently present for up to one year post-infusion and changes in non-tumor reactive CD8<sup>+</sup> T cells are likely indicative of a replacement by the infused de novo population [<xref rid="B29-cancers-13-00821" ref-type="bibr">29</xref>]. Indeed, expression of exhaustion marker PD-1 in T cells expressing both IFN-&#x3B3; and TNF was associated with long-term memory responses.</p>
      <p>The presence of polyfunctional T cells has also been used as a biomarker of success for immunotherapeutic strategies used in glioblastoma (GBM) patients (<xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref>, study #4) [<xref rid="B30-cancers-13-00821" ref-type="bibr">30</xref>]. Injection of cytomegalovirus (CMV) antigens in conjunction with dendritic cells was used to enhance polyfunctionality among CMV-reactive T cells in GBM patients, and consequently enhance immune anti-tumor responses. Blood sample analyses established that circulating patient T cells are not actively polyfunctional until ex vivo exposure to the CMV antigen. Vaccinated patients displayed improved survival, correlating with increased polyfunctional T cell abundance [<xref rid="B30-cancers-13-00821" ref-type="bibr">30</xref>].</p>
      <p>In another study, cytokine treatments were used to induce T cell polyfunctionality profiles (<xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref>, study #5) [<xref rid="B31-cancers-13-00821" ref-type="bibr">31</xref>]. IL-2 treatment combined with anti-CD3 therapy was found to restrict tumor cell proliferation and enhance secretion of TNF-&#x3B1;. Where additions of single cytokines did not induce significant changes in profile, a combination of exogenous cytokines (IL-2+, IL-12+ IL-21 or IL-2+, IL-12, IL-18) was needed for polyfunctionality induction and treatment efficacy resulting in a marked increase of IFN-&#x3B3;, TNF-&#x3B1;, and CCL4 expression [<xref rid="B31-cancers-13-00821" ref-type="bibr">31</xref>]. Researchers used a Boolean gate analysis to monitor changes in T cell polyfunctional permutations. The overall observations apply to both CD8<sup>+</sup> and CD4<sup>+</sup> T cell subsets, though relative to proliferation, cytokine combinations were required primarily for CD8<sup>+</sup> T cells.</p>
      <p>In study #6 (<xref rid="cancers-13-00821-t001" ref-type="table">Table 1</xref>) the need for polyfunctionality to support successful TIL therapy is definitively demonstrated [<xref rid="B32-cancers-13-00821" ref-type="bibr">32</xref>]. Polyfunctionality was observed in TILs, which secreted IL-2 and at least one of the other main cytokines, IFN-&#x3B3; or TNF-&#x3B1;. Overall, the results show that the presence of polyfunctional, tumor reactive CD4<sup>+</sup> T cells can be a desirable prognostic biomarker for survival [<xref rid="B32-cancers-13-00821" ref-type="bibr">32</xref>].</p>
      <p>The role of cytokines for T cell differentiation, migration, survival, transformation, and replication has also been evaluated in vivo [<xref rid="B1-cancers-13-00821" ref-type="bibr">1</xref>]. Polyfunctional CD4<sup>+</sup> T effector cells were found to mediate dendritic cell licensing and enhance CD8<sup>+</sup> T cell activation within the TME [<xref rid="B65-cancers-13-00821" ref-type="bibr">65</xref>], contributing to robust antitumor immune responses and preventing B-cell lymphoma recurrence in vivo. CD4+ cells can act upon the dual secretion effects of IFN-&#x3B3; and TNF-&#x3B1; by inhibiting tumor angiogenesis [<xref rid="B65-cancers-13-00821" ref-type="bibr">65</xref>].</p>
      <p>When CD8<sup>+</sup> T cells from the same host were transduced to express three different TCRs (SILv44, R6C12, and T4H2) responding to the same HLA-A2-restricted peptide, we found that the resulting cytokine responses varied, suggesting that subtle changes in TCR structure can affect the resulting cytokine secretion patterns of host T cells and impact anti-tumor responses in ways that do not correlate with IFN-&#x3B3; secretion, but rather with IL-17 expression levels [<xref rid="B66-cancers-13-00821" ref-type="bibr">66</xref>].</p>
      <p>Together these studies add to our understanding of polyfunctionality enhancing T cell function. The release of multiple cytokines and their synergistic capabilities significantly increases treatment efficacy and can also exogenously enhance T cell function in an autocrine fashion while supporting anti-tumor immunity within the TME. In order to accurately gain an understanding of how and when these cytokines are released, the use of reliable and informative analysis techniques is necessary.</p>
    </sec>
    <sec id="sec6-cancers-13-00821">
      <title>6. Monitoring Cytokine Abundance</title>
      <p>Recent technological advances have improved our ability to detect multiple cytokines and assign cytokine production to respective immune cells. Techniques such as FACS, ELISA, and ELISpot, are fundamental assessment tools that provide basic information about cytokine production [<xref rid="B67-cancers-13-00821" ref-type="bibr">67</xref>,<xref rid="B68-cancers-13-00821" ref-type="bibr">68</xref>]. More recently developed technologies offer greater signal separation to evaluate for a greater number of analytes and can provide additional single cell readouts of cytokine production, location, or function over time [<xref rid="B69-cancers-13-00821" ref-type="bibr">69</xref>,<xref rid="B70-cancers-13-00821" ref-type="bibr">70</xref>,<xref rid="B71-cancers-13-00821" ref-type="bibr">71</xref>].</p>
      <p>Flow cytometry or fluorescence activated cell scanning (FACS) is a commonly used technique that can provide quantitative information by intracellular cytokine staining (ICS) on a per cell basis [<xref rid="B72-cancers-13-00821" ref-type="bibr">72</xref>,<xref rid="B73-cancers-13-00821" ref-type="bibr">73</xref>]. ICS is a hallmark method for visualization of cellular responses and in particular, T cell responses [<xref rid="B73-cancers-13-00821" ref-type="bibr">73</xref>]. However, this technique lacks the sensitivity to detect cytokines at low levels [<xref rid="B68-cancers-13-00821" ref-type="bibr">68</xref>]. Flow cytometry does not determine where the cytokine is being released, nor whether the artificial backup created by chemically preventing secretion influences downstream production of the cytokine [<xref rid="B73-cancers-13-00821" ref-type="bibr">73</xref>]. CyTOF (mass cytometry) is a recently developed technique, which adopts the format of flow cytometry (FC) using the precision of mass spectrometry [<xref rid="B74-cancers-13-00821" ref-type="bibr">74</xref>], and holds the ability to survey millions of cells per sample for over 40 cellular parameters in parallel at the single cell level [<xref rid="B74-cancers-13-00821" ref-type="bibr">74</xref>,<xref rid="B75-cancers-13-00821" ref-type="bibr">75</xref>]. CyTEK offers a more accessible alternative to this technique, using spectral analysis to separate fluorochromes that are close in maximum emission wavelengths [<xref rid="B76-cancers-13-00821" ref-type="bibr">76</xref>].</p>
      <p>Another sensitive technique for cytokine detection is quantitative polymerase chain reaction (qPCR), which allows detection of cytokines being actively transcribed. This is a targeted approach requiring specific probes to detect cytokines transcripts from bulk RNA. With the advent of next generation sequencing (NGS) technologies like ribonucleic acid (RNA) sequencing (RNA-seq), unbiased, multi-target analysis can be performed and rare cytokine transcripts can be detected. [<xref rid="B77-cancers-13-00821" ref-type="bibr">77</xref>,<xref rid="B78-cancers-13-00821" ref-type="bibr">78</xref>]. Bulk RNA analysis holds shortcomings such as an inability to identify the source of the gene, and to reveal whether actual protein is made and secreted, and lacks delivery of a holistic analysis to the TME or cytokine secretion [<xref rid="B79-cancers-13-00821" ref-type="bibr">79</xref>].</p>
      <p>Enzyme-linked immunosorbent assay (ELISA) is yet one more analytical method to determine the total concentration of a secreted cytokine present in biological fluids or tissue culture supernatants [<xref rid="B72-cancers-13-00821" ref-type="bibr">72</xref>,<xref rid="B79-cancers-13-00821" ref-type="bibr">79</xref>]. However, this bulk cytokine estimation method does not provide information at a single-cell level [<xref rid="B80-cancers-13-00821" ref-type="bibr">80</xref>,<xref rid="B81-cancers-13-00821" ref-type="bibr">81</xref>]. Enzyme-linked immunospot assays (ELISPOTs) do report primarily qualitative data about cytokine-producing cells, enabling data regarding the number of activated cells and multiple secreted cytokines at the single cell level [<xref rid="B68-cancers-13-00821" ref-type="bibr">68</xref>].</p>
      <p>Analytical platforms for multiplexed cytokine detection such as Luminex and Meso Scale Discovery (MSD) are highly sensitive and use significantly less sample compared to a traditional ELISA [<xref rid="B82-cancers-13-00821" ref-type="bibr">82</xref>]. Luminex is a bead-based immunoassay wherein fluorescent beads are coated with capture antibodies to specific analytes and are incubated with the samples [<xref rid="B83-cancers-13-00821" ref-type="bibr">83</xref>]. MSD immunoassays are an advanced sandwich-based ELISA wherein analytes are detected using sulfo-tag conjugated detection antibodies instead of fluorescent-conjugated antibodies [<xref rid="B84-cancers-13-00821" ref-type="bibr">84</xref>]. Both these assays, however, do not enable the phenotyping of cytokine secreting cells and are intended for fluids analysis.</p>
      <p>More recent analytical tools seek to bridge the gap between the breadth of information captured, and the precision of that information. For example, IsoLight can be used to determine functional single cell secretion of multiple cytokines [<xref rid="B85-cancers-13-00821" ref-type="bibr">85</xref>]. The IsoCode chip allows for the combined technology of a sandwich ELISA, fluorescence signal detection, and a quantitative measurement protein secreted per cell [<xref rid="B85-cancers-13-00821" ref-type="bibr">85</xref>]. The Berkeley Light Switch operates similarly, however, the cells are moved to individual wells by light, so that all cells are analyzable [<xref rid="B71-cancers-13-00821" ref-type="bibr">71</xref>]. Visium technology from 10&#xD7; Genomics combines transcriptome probe field with tissue histology to provide the benefits of localized transcriptome analysis, allowing for combined information about tissue location at the protein level, and transcript quantification at the RNA level [<xref rid="B86-cancers-13-00821" ref-type="bibr">86</xref>].</p>
      <p>In summary, a variety of technologies and platforms are available to detect cytokines secreted within the TME. The choice of technology depends mostly on the type of analyses to be done and the cost. <xref rid="cancers-13-00821-t002" ref-type="table">Table 2</xref> places the emphasis on a single, popular therapeutic, (CD19 CAR) to highlight that a colorful palette of cytokines provides granularity and functional insight into therapeutic outcomes. This table outlines clinical trial studies in which different cytokine monitoring techniques were used and illustrates how cytokine detection is useful to evaluate anti-tumor responses.</p>
    </sec>
    <sec sec-type="conclusions" id="sec7-cancers-13-00821">
      <title>7. Conclusions</title>
      <p>The detection of cytokines and cytokine based anti-tumor immunotherapies, particularly polyfunctional T cell-based therapies, has shown promise in regenerating immune responses within the TME. Cytokine detection can prove a powerful tool to tailor immunotherapies in the fight against cancer. By identifying the unique combination of cytokines that are secreted as a positive response to respective cancer therapies, researchers can advance the methods by which they target and attack tumors. Further studies to explore and identify the ideal palette of cytokines, using of single cell cytokine monitoring techniques can increase the precision with which we characterize the ongoing immunity within the TME and can re-design the manner in which we establish anti-tumor immunity.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><bold>Publisher&#x2019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </fn>
    </fn-group>
    <notes>
      <title>Author Contributions</title>
      <p>P.R. drafted the manuscript, D.S. and I.C.L.P. conceived the manuscript material and revised the text, R.S. and D.J. prepared the figure and reviewed the text. All authors have read and agreed to the published version of the manuscript.</p>
    </notes>
    <notes>
      <title>Funding</title>
      <p>This research is supported by DoD grant W81XWH-17-TSCRP-CTRA and NCI grant 1RO1CA191317 to I.C.L.P, as well as NCI grant 1R21 CA245447 to D.S. are gratefully recognized. Also, the TEST IT core (I.C.L.P, co-director) under NIAMS P30 AR075049 (A. Paller, PI) has provided support.</p>
    </notes>
    <notes notes-type="COI-statement">
      <title>Conflicts of Interest</title>
      <p>The authors have no conflicts of interest to declare.</p>
    </notes>
    <ref-list>
      <title>References</title>
      <ref id="B1-cancers-13-00821">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Foster</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>The functions of cytokines and their uses in toxicology</article-title>
          <source>Int. J. Exp. Pathol.</source>
          <year>2001</year>
          <volume>82</volume>
          <fpage>171</fpage>
          <lpage>192</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1365-2613.2001.iep192.x</pub-id>
          <pub-id pub-id-type="pmid">11488991</pub-id>
        </element-citation>
      </ref>
      <ref id="B2-cancers-13-00821">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bonini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Mondino</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Adoptive T-cell therapy for cancer: The era of engineered T cells</article-title>
          <source>Eur. J. Immunol.</source>
          <year>2015</year>
          <volume>45</volume>
          <fpage>2457</fpage>
          <lpage>2469</lpage>
          <pub-id pub-id-type="doi">10.1002/eji.201545552</pub-id>
          <pub-id pub-id-type="pmid">26202766</pub-id>
        </element-citation>
      </ref>
      <ref id="B3-cancers-13-00821">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Germano</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Allavena</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Mantovani</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Cytokines as a key component of cancer-related inflammation</article-title>
          <source>Cytokine</source>
          <year>2008</year>
          <volume>43</volume>
          <fpage>374</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cyto.2008.07.014</pub-id>
          <pub-id pub-id-type="pmid">18701317</pub-id>
        </element-citation>
      </ref>
      <ref id="B4-cancers-13-00821">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castro</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Goncalves</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Serre</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>M.J.</given-names>
            </name>
          </person-group>
          <article-title>Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion</article-title>
          <source>Front. Immunol.</source>
          <year>2018</year>
          <volume>9</volume>
          <fpage>847</fpage>
          <pub-id pub-id-type="doi">10.3389/fimmu.2018.00847</pub-id>
          <pub-id pub-id-type="pmid">29780381</pub-id>
        </element-citation>
      </ref>
      <ref id="B5-cancers-13-00821">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jorgovanovic</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Roles of IFN-&#x3B3; in tumor progression and regression: A review</article-title>
          <source>Biomark. Res.</source>
          <year>2020</year>
          <volume>8</volume>
          <fpage>49</fpage>
          <pub-id pub-id-type="doi">10.1186/s40364-020-00228-x</pub-id>
          <pub-id pub-id-type="pmid">33005420</pub-id>
        </element-citation>
      </ref>
      <ref id="B6-cancers-13-00821">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jennifer Gillary Segal</surname>
              <given-names>N.C.L.</given-names>
            </name>
            <name>
              <surname>Tsung</surname>
              <given-names>Y.L.</given-names>
            </name>
            <name>
              <surname>Jeffrey</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Norton</surname>
              <given-names>K.T.</given-names>
            </name>
          </person-group>
          <article-title>The Role of IFN-y in Rejection of Established Tumors by IL-12: Source of Productiona and Target</article-title>
          <source>Cancer Res.</source>
          <year>2002</year>
          <volume>62</volume>
          <fpage>4696</fpage>
          <lpage>4703</lpage>
          <pub-id pub-id-type="pmid">12183428</pub-id>
        </element-citation>
      </ref>
      <ref id="B7-cancers-13-00821">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Le Poole</surname>
              <given-names>I.C.</given-names>
            </name>
            <name>
              <surname>Riker</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Quevedo</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Stennett</surname>
              <given-names>L.S.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Marincola</surname>
              <given-names>F.M.</given-names>
            </name>
            <name>
              <surname>Kast</surname>
              <given-names>W.M.</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>J.K.</given-names>
            </name>
            <name>
              <surname>Nickoloff</surname>
              <given-names>B.J.</given-names>
            </name>
          </person-group>
          <article-title>Interferon-gamma reduces melanosomal antigen expression and recognition of melanoma cells by cytotoxic T cells</article-title>
          <source>Am. J. Pathol.</source>
          <year>2002</year>
          <volume>160</volume>
          <fpage>521</fpage>
          <lpage>528</lpage>
          <pub-id pub-id-type="doi">10.1016/S0002-9440(10)64871-7</pub-id>
          <pub-id pub-id-type="pmid">11839572</pub-id>
        </element-citation>
      </ref>
      <ref id="B8-cancers-13-00821">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Batlle</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Massague</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Transforming Growth Factor-beta Signaling in Immunity and Cancer</article-title>
          <source>Immunity</source>
          <year>2019</year>
          <volume>50</volume>
          <fpage>924</fpage>
          <lpage>940</lpage>
          <pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.024</pub-id>
          <pub-id pub-id-type="pmid">30995507</pub-id>
        </element-citation>
      </ref>
      <ref id="B9-cancers-13-00821">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Conlon</surname>
              <given-names>K.C.</given-names>
            </name>
            <name>
              <surname>Miljkovic</surname>
              <given-names>M.D.</given-names>
            </name>
            <name>
              <surname>Waldmann</surname>
              <given-names>T.A.</given-names>
            </name>
          </person-group>
          <article-title>Cytokines in the Treatment of Cancer</article-title>
          <source>J. Interferon Cytokine Res.</source>
          <year>2019</year>
          <volume>39</volume>
          <fpage>6</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1089/jir.2018.0019</pub-id>
          <pub-id pub-id-type="pmid">29889594</pub-id>
        </element-citation>
      </ref>
      <ref id="B10-cancers-13-00821">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Margolin</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Cytokines in cancer immunotherapy</article-title>
          <source>Cancers</source>
          <year>2011</year>
          <volume>3</volume>
          <fpage>3856</fpage>
          <lpage>3893</lpage>
          <pub-id pub-id-type="doi">10.3390/cancers3043856</pub-id>
          <pub-id pub-id-type="pmid">24213115</pub-id>
        </element-citation>
      </ref>
      <ref id="B11-cancers-13-00821">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>K.G.</given-names>
            </name>
            <name>
              <surname>Stromnes</surname>
              <given-names>I.M.</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>P.D.</given-names>
            </name>
          </person-group>
          <article-title>Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies</article-title>
          <source>Cancer Cell</source>
          <year>2017</year>
          <volume>31</volume>
          <fpage>311</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ccell.2017.02.008</pub-id>
          <pub-id pub-id-type="pmid">28292435</pub-id>
        </element-citation>
      </ref>
      <ref id="B12-cancers-13-00821">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Whiteside</surname>
              <given-names>T.L.</given-names>
            </name>
          </person-group>
          <article-title>The tumor microenvironment and its role in promoting tumor growth</article-title>
          <source>Oncogene</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>5904</fpage>
          <lpage>5912</lpage>
          <pub-id pub-id-type="doi">10.1038/onc.2008.271</pub-id>
          <pub-id pub-id-type="pmid">18836471</pub-id>
        </element-citation>
      </ref>
      <ref id="B13-cancers-13-00821">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pennock</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Cross</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Cheney</surname>
              <given-names>E.E.</given-names>
            </name>
            <name>
              <surname>Tamburini</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Kedl</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>T cell responses: Naive to memory and everything in between</article-title>
          <source>Adv. Physiol. Educ.</source>
          <year>2013</year>
          <volume>37</volume>
          <fpage>273</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1152/advan.00066.2013</pub-id>
          <pub-id pub-id-type="pmid">24292902</pub-id>
        </element-citation>
      </ref>
      <ref id="B14-cancers-13-00821">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yuen</surname>
              <given-names>G.J.</given-names>
            </name>
            <name>
              <surname>Demissie</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Pillai</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>B lymphocytes and cancer: A love-hate relationship</article-title>
          <source>Trends Cancer</source>
          <year>2016</year>
          <volume>2</volume>
          <fpage>747</fpage>
          <lpage>757</lpage>
          <pub-id pub-id-type="doi">10.1016/j.trecan.2016.10.010</pub-id>
          <pub-id pub-id-type="pmid">28626801</pub-id>
        </element-citation>
      </ref>
      <ref id="B15-cancers-13-00821">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balkwill</surname>
              <given-names>F.R.</given-names>
            </name>
            <name>
              <surname>Capasso</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hagemann</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>The tumor microenvironment at a glance</article-title>
          <source>J. Cell Sci.</source>
          <year>2012</year>
          <volume>125</volume>
          <fpage>5591</fpage>
          <lpage>5596</lpage>
          <pub-id pub-id-type="doi">10.1242/jcs.116392</pub-id>
          <pub-id pub-id-type="pmid">23420197</pub-id>
        </element-citation>
      </ref>
      <ref id="B16-cancers-13-00821">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raphael</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Nalawade</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Eagar</surname>
              <given-names>T.N.</given-names>
            </name>
            <name>
              <surname>Forsthuber</surname>
              <given-names>T.G.</given-names>
            </name>
          </person-group>
          <article-title>T cell subsets and their signature cytokines in autoimmune and inflammatory diseases</article-title>
          <source>Cytokine</source>
          <year>2015</year>
          <volume>74</volume>
          <fpage>5</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cyto.2014.09.011</pub-id>
          <pub-id pub-id-type="pmid">25458968</pub-id>
        </element-citation>
      </ref>
      <ref id="B17-cancers-13-00821">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knutson</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Disis</surname>
              <given-names>M.L.</given-names>
            </name>
          </person-group>
          <article-title>Tumor antigen-specific T helper cells in cancer immunity and immunotherapy</article-title>
          <source>Cancer Immunol. Immunother.</source>
          <year>2005</year>
          <volume>54</volume>
          <fpage>721</fpage>
          <lpage>728</lpage>
          <pub-id pub-id-type="doi">10.1007/s00262-004-0653-2</pub-id>
          <pub-id pub-id-type="pmid">16010587</pub-id>
        </element-citation>
      </ref>
      <ref id="B18-cancers-13-00821">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vegran</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Apetoh</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Ghiringhelli</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>Th9 cells: A novel CD4 T-cell subset in the immune war against cancer</article-title>
          <source>Cancer Res.</source>
          <year>2015</year>
          <volume>75</volume>
          <fpage>475</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-14-2748</pub-id>
          <pub-id pub-id-type="pmid">25589348</pub-id>
        </element-citation>
      </ref>
      <ref id="B19-cancers-13-00821">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishimura</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Iwakabe</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Sekimoto</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ohmi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yahata</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Nakui</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Habu</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tashiro</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distinct Role of Antigen-specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo</article-title>
          <source>Rockefeller Univ. Press</source>
          <year>1999</year>
          <volume>190</volume>
          <fpage>617</fpage>
          <lpage>627</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.190.5.617</pub-id>
        </element-citation>
      </ref>
      <ref id="B20-cancers-13-00821">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>van Belzen</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Kesmir</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Immune biomarkers for predicting response to adoptive cell transfer as cancer treatment</article-title>
          <source>Immunogenetics</source>
          <year>2019</year>
          <volume>71</volume>
          <fpage>71</fpage>
          <lpage>86</lpage>
          <pub-id pub-id-type="doi">10.1007/s00251-018-1083-1</pub-id>
          <pub-id pub-id-type="pmid">30232514</pub-id>
        </element-citation>
      </ref>
      <ref id="B21-cancers-13-00821">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goswami</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kaplan</surname>
              <given-names>M.H.</given-names>
            </name>
          </person-group>
          <article-title>A brief history of IL-9</article-title>
          <source>J. Immunol.</source>
          <year>2011</year>
          <volume>186</volume>
          <fpage>3283</fpage>
          <lpage>3288</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.1003049</pub-id>
          <pub-id pub-id-type="pmid">21368237</pub-id>
        </element-citation>
      </ref>
      <ref id="B22-cancers-13-00821">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guery</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hugues</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Th17 Cell Plasticity and Functions in Cancer Immunity</article-title>
          <source>Biomed. Res. Int</source>
          <year>2015</year>
          <volume>2015</volume>
          <fpage>314620</fpage>
          <pub-id pub-id-type="doi">10.1155/2015/314620</pub-id>
          <pub-id pub-id-type="pmid">26583099</pub-id>
        </element-citation>
      </ref>
      <ref id="B23-cancers-13-00821">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Badri</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hyjek</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Schuger</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schuger</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Chekaluk</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kwiatkowski</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Zhe</surname>
              <given-names>X.</given-names>
            </name>
          </person-group>
          <article-title>Exonic mutations of TSC2/TSC1 are common but not seen in all sporadic pulmonary lymphangioleiomyomatosis</article-title>
          <source>Am. J. Respir. Crit. Care Med.</source>
          <year>2013</year>
          <volume>187</volume>
          <fpage>663</fpage>
          <lpage>665</lpage>
          <pub-id pub-id-type="doi">10.1164/ajrccm.187.6.663</pub-id>
          <pub-id pub-id-type="pmid">23504366</pub-id>
        </element-citation>
      </ref>
      <ref id="B24-cancers-13-00821">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Silva-Santos</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Serre</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Norell</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>&#x3B3;&#x3B4; T cells in cancer</article-title>
          <source>Nat. Rev. Immunol.</source>
          <year>2015</year>
          <volume>15</volume>
          <fpage>683</fpage>
          <lpage>691</lpage>
          <pub-id pub-id-type="doi">10.1038/nri3904</pub-id>
          <pub-id pub-id-type="pmid">26449179</pub-id>
        </element-citation>
      </ref>
      <ref id="B25-cancers-13-00821">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alter</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Malenfant</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Altfeld</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>CD107a as a functional marker for the identification of natural killer cell activity</article-title>
          <source>J. Immunol. Methods</source>
          <year>2004</year>
          <volume>294</volume>
          <fpage>15</fpage>
          <lpage>22</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jim.2004.08.008</pub-id>
          <pub-id pub-id-type="pmid">15604012</pub-id>
        </element-citation>
      </ref>
      <ref id="B26-cancers-13-00821">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>H.-M.</given-names>
            </name>
          </person-group>
          <article-title>Th1 cytokine-based immunotherapy for cancer</article-title>
          <source>Hepatobiliary Pancreat. Dis. Int.</source>
          <year>2014</year>
          <volume>13</volume>
          <fpage>482</fpage>
          <lpage>494</lpage>
          <pub-id pub-id-type="doi">10.1016/S1499-3872(14)60305-2</pub-id>
          <pub-id pub-id-type="pmid">25308358</pub-id>
        </element-citation>
      </ref>
      <ref id="B27-cancers-13-00821">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Bagheri</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Bradshaw</surname>
              <given-names>E.M.</given-names>
            </name>
            <name>
              <surname>Hafler</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Lauffenburger</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Love</surname>
              <given-names>J.C.</given-names>
            </name>
          </person-group>
          <article-title>Polyfunctional responses by human T cells result from sequential release of cytokines</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>2012</year>
          <volume>109</volume>
          <fpage>1607</fpage>
          <lpage>1612</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1117194109</pub-id>
          <pub-id pub-id-type="pmid">22160692</pub-id>
        </element-citation>
      </ref>
      <ref id="B28-cancers-13-00821">
        <label>28.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Attig</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hennenlotter</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Pawelec</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Klein</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Pircher</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Feyerabend</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wernet</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Stenzl</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Rammensee</surname>
              <given-names>H.G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas</article-title>
          <source>Cancer Res.</source>
          <year>2009</year>
          <volume>69</volume>
          <fpage>8412</fpage>
          <lpage>8419</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-0852</pub-id>
          <pub-id pub-id-type="pmid">19843860</pub-id>
        </element-citation>
      </ref>
      <ref id="B29-cancers-13-00821">
        <label>29.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donia</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kjeldsen</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Westergaard</surname>
              <given-names>M.C.W.</given-names>
            </name>
            <name>
              <surname>Bianchi</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Legut</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Attaf</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Szomolay</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ott</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dolton</surname>
              <given-names>G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>PD-1(+) Polyfunctional T Cells Dominate the Periphery after Tumor-Infiltrating Lymphocyte Therapy for Cancer</article-title>
          <source>Clin. Cancer Res.</source>
          <year>2017</year>
          <volume>23</volume>
          <fpage>5779</fpage>
          <lpage>5788</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-16-1692</pub-id>
          <pub-id pub-id-type="pmid">28679768</pub-id>
        </element-citation>
      </ref>
      <ref id="B30-cancers-13-00821">
        <label>30.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reap</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Suryadevara</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Batich</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Sanchez-Perez</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Archer</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Schmittling</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Norberg</surname>
              <given-names>P.K.</given-names>
            </name>
            <name>
              <surname>Herndon</surname>
              <given-names>J.E.</given-names>
              <suffix>2nd</suffix>
            </name>
            <name>
              <surname>Healy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Congdon</surname>
              <given-names>K.L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma</article-title>
          <source>Cancer Res.</source>
          <year>2018</year>
          <volume>78</volume>
          <fpage>256</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-17-0469</pub-id>
          <pub-id pub-id-type="pmid">29093005</pub-id>
        </element-citation>
      </ref>
      <ref id="B31-cancers-13-00821">
        <label>31.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tran</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Wick</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>L.D.</given-names>
            </name>
            <name>
              <surname>Nesslinger</surname>
              <given-names>N.J.</given-names>
            </name>
            <name>
              <surname>McMurtrie</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Webb</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Nelson</surname>
              <given-names>B.H.</given-names>
            </name>
          </person-group>
          <article-title>Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines</article-title>
          <source>PLoS ONE</source>
          <year>2010</year>
          <volume>5</volume>
          <elocation-id>e15625</elocation-id>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0015625</pub-id>
          <pub-id pub-id-type="pmid">21203522</pub-id>
        </element-citation>
      </ref>
      <ref id="B32-cancers-13-00821">
        <label>32.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Groot</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Van Loenen</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Guislain</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Nicolet</surname>
              <given-names>B.P.</given-names>
            </name>
            <name>
              <surname>Freen-Van Heeren</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Verhagen</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Van Den Heuvel</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>De Jong</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Burger</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Van Der Schoot</surname>
              <given-names>C.E.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Polyfunctional tumor-reactive T cells are effectively expanded from non-small cell lung cancers, and correlate with an immune-engaged T cell profile</article-title>
          <source>Oncoimmunology</source>
          <year>2019</year>
          <volume>8</volume>
          <fpage>e1648170</fpage>
          <pub-id pub-id-type="doi">10.1080/2162402X.2019.1648170</pub-id>
          <pub-id pub-id-type="pmid">31646094</pub-id>
        </element-citation>
      </ref>
      <ref id="B33-cancers-13-00821">
        <label>33.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alshaker</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Matalka</surname>
              <given-names>K.Z.</given-names>
            </name>
          </person-group>
          <article-title>IFN-gamma, IL-17 and TGF-beta involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors</article-title>
          <source>Cancer Cell Int.</source>
          <year>2011</year>
          <volume>11</volume>
          <fpage>33</fpage>
          <pub-id pub-id-type="doi">10.1186/1475-2867-11-33</pub-id>
          <pub-id pub-id-type="pmid">21943203</pub-id>
        </element-citation>
      </ref>
      <ref id="B34-cancers-13-00821">
        <label>34.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gao</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Pan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Scully</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Girardi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Augenlicht</surname>
              <given-names>L.H.</given-names>
            </name>
            <name>
              <surname>Craft</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>Z.</given-names>
            </name>
          </person-group>
          <article-title>Gamma delta T cells provide an early source of interferon gamma in tumor immunity</article-title>
          <source>J. Exp. Med.</source>
          <year>2003</year>
          <volume>198</volume>
          <fpage>433</fpage>
          <lpage>442</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.20030584</pub-id>
          <pub-id pub-id-type="pmid">12900519</pub-id>
        </element-citation>
      </ref>
      <ref id="B35-cancers-13-00821">
        <label>35.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaidi</surname>
              <given-names>M.R.</given-names>
            </name>
          </person-group>
          <article-title>The Interferon-Gamma Paradox in Cancer</article-title>
          <source>J. Interferon Cytokine Res.</source>
          <year>2019</year>
          <volume>39</volume>
          <fpage>30</fpage>
          <lpage>38</lpage>
          <pub-id pub-id-type="doi">10.1089/jir.2018.0087</pub-id>
          <pub-id pub-id-type="pmid">30388040</pub-id>
        </element-citation>
      </ref>
      <ref id="B36-cancers-13-00821">
        <label>36.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beatty</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Paterson</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of Tumor Growth by IFN-y in Cancer Immunotherapy</article-title>
          <source>Immunol. Res.</source>
          <year>2001</year>
          <volume>24</volume>
          <fpage>201</fpage>
          <lpage>210</lpage>
          <pub-id pub-id-type="doi">10.1385/IR:24:2:201</pub-id>
          <pub-id pub-id-type="pmid">11594457</pub-id>
        </element-citation>
      </ref>
      <ref id="B37-cancers-13-00821">
        <label>37.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kursunel</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Esendagli</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The untold story of IFN-gamma in cancer biology</article-title>
          <source>Cytokine Growth Factor Rev.</source>
          <year>2016</year>
          <volume>31</volume>
          <fpage>73</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cytogfr.2016.07.005</pub-id>
          <pub-id pub-id-type="pmid">27502919</pub-id>
        </element-citation>
      </ref>
      <ref id="B38-cancers-13-00821">
        <label>38.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Gu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Xiang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Qin</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Interferon-&#x3B3; produced by tumor-infiltrating NK cells and CD4+ T cells downregulates TNFSF15 expression in vascular endothelial cells</article-title>
          <source>Angiogenesis</source>
          <year>2014</year>
          <volume>17</volume>
          <fpage>529</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="doi">10.1007/s10456-013-9397-y</pub-id>
          <pub-id pub-id-type="pmid">24141405</pub-id>
        </element-citation>
      </ref>
      <ref id="B39-cancers-13-00821">
        <label>39.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mojic</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Hayakawa</surname>
              <given-names>Y.</given-names>
            </name>
          </person-group>
          <article-title>The Dark Side of IFN-gamma: Its Role in Promoting Cancer Immunoevasion</article-title>
          <source>Int. J. Mol. Sci.</source>
          <year>2017</year>
          <volume>19</volume>
          <elocation-id>89</elocation-id>
          <pub-id pub-id-type="doi">10.3390/ijms19010089</pub-id>
        </element-citation>
      </ref>
      <ref id="B40-cancers-13-00821">
        <label>40.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ni</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Interferon gamma in cancer immunotherapy</article-title>
          <source>Cancer Med.</source>
          <year>2018</year>
          <volume>7</volume>
          <fpage>4509</fpage>
          <lpage>4516</lpage>
          <pub-id pub-id-type="doi">10.1002/cam4.1700</pub-id>
          <pub-id pub-id-type="pmid">30039553</pub-id>
        </element-citation>
      </ref>
      <ref id="B41-cancers-13-00821">
        <label>41.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.R.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>G.F.</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mao</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Jia</surname>
              <given-names>Z.H.</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>Z.Y.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>L.Q.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>Z.N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tumor-derived transforming growth factor-beta is critical for tumor progression and evasion from immune surveillance</article-title>
          <source>Asian Pac. J. Cancer Prev.</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>5181</fpage>
          <lpage>5186</lpage>
          <pub-id pub-id-type="doi">10.7314/APJCP.2014.15.13.5181</pub-id>
          <pub-id pub-id-type="pmid">25040972</pub-id>
        </element-citation>
      </ref>
      <ref id="B42-cancers-13-00821">
        <label>42.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tu</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Chia</surname>
              <given-names>P.Z.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>TGFbeta in T cell biology and tumor immunity: Angel or devil?</article-title>
          <source>Cytokine Growth Factor Rev.</source>
          <year>2014</year>
          <volume>25</volume>
          <fpage>423</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cytogfr.2014.07.014</pub-id>
          <pub-id pub-id-type="pmid">25156420</pub-id>
        </element-citation>
      </ref>
      <ref id="B43-cancers-13-00821">
        <label>43.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huynh</surname>
              <given-names>L.K.</given-names>
            </name>
            <name>
              <surname>Hipolito</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Ten Dijke</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>A Perspective on the Development of TGF-beta Inhibitors for Cancer Treatment</article-title>
          <source>Biomolecules</source>
          <year>2019</year>
          <volume>9</volume>
          <elocation-id>743</elocation-id>
          <pub-id pub-id-type="doi">10.3390/biom9110743</pub-id>
        </element-citation>
      </ref>
      <ref id="B44-cancers-13-00821">
        <label>44.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dahmani</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Delisle</surname>
              <given-names>J.S.</given-names>
            </name>
          </person-group>
          <article-title>TGF-beta in T Cell Biology: Implications for Cancer Immunotherapy</article-title>
          <source>Cancers</source>
          <year>2018</year>
          <volume>10</volume>
          <elocation-id>194</elocation-id>
          <pub-id pub-id-type="doi">10.3390/cancers10060194</pub-id>
        </element-citation>
      </ref>
      <ref id="B45-cancers-13-00821">
        <label>45.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ostroumov</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Fekete-Drimusz</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Saborowski</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kuhnel</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Woller</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>CD4 and CD8 T lymphocyte interplay in controlling tumor growth</article-title>
          <source>Cell Mol. Life Sci.</source>
          <year>2018</year>
          <volume>75</volume>
          <fpage>689</fpage>
          <lpage>713</lpage>
          <pub-id pub-id-type="doi">10.1007/s00018-017-2686-7</pub-id>
          <pub-id pub-id-type="pmid">29032503</pub-id>
        </element-citation>
      </ref>
      <ref id="B46-cancers-13-00821">
        <label>46.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luckheeram</surname>
              <given-names>R.V.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Verma</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>CD4(+)T cells: Differentiation and functions</article-title>
          <source>Clin. Dev. Immunol.</source>
          <year>2012</year>
          <volume>2012</volume>
          <fpage>925135</fpage>
          <pub-id pub-id-type="doi">10.1155/2012/925135</pub-id>
          <pub-id pub-id-type="pmid">22474485</pub-id>
        </element-citation>
      </ref>
      <ref id="B47-cancers-13-00821">
        <label>47.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeuchi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>CD4 CTL, a Cytotoxic Subset of CD4(+) T Cells, Their Differentiation and Function</article-title>
          <source>Front. Immunol.</source>
          <year>2017</year>
          <volume>8</volume>
          <fpage>194</fpage>
          <pub-id pub-id-type="doi">10.3389/fimmu.2017.00194</pub-id>
          <pub-id pub-id-type="pmid">28280496</pub-id>
        </element-citation>
      </ref>
      <ref id="B48-cancers-13-00821">
        <label>48.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Di Lullo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Marcatti</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Heltai</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Brunetto</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Tresoldi</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bondanza</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bonini</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ponzoni</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tonon</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Ciceri</surname>
              <given-names>F.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival</article-title>
          <source>Oncoimmunology</source>
          <year>2015</year>
          <volume>4</volume>
          <fpage>e1005460</fpage>
          <pub-id pub-id-type="doi">10.1080/2162402X.2015.1005460</pub-id>
          <pub-id pub-id-type="pmid">26155400</pub-id>
        </element-citation>
      </ref>
      <ref id="B49-cancers-13-00821">
        <label>49.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petrausch</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Poehlein</surname>
              <given-names>C.H.</given-names>
            </name>
            <name>
              <surname>Jensen</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Twitty</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Assmann</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Puri</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>LaCelle</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>Moudgil</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maston</surname>
              <given-names>L.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cancer immunotherapy: The role regulatory T cells play and what can be done to overcome their inhibitory effects</article-title>
          <source>Curr. Mol. Med.</source>
          <year>2009</year>
          <volume>9</volume>
          <fpage>673</fpage>
          <lpage>682</lpage>
          <pub-id pub-id-type="doi">10.2174/156652409788970670</pub-id>
          <pub-id pub-id-type="pmid">19689294</pub-id>
        </element-citation>
      </ref>
      <ref id="B50-cancers-13-00821">
        <label>50.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perusina Lanfranca</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Fang</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Biological and pathological activities of interleukin-22</article-title>
          <source>J. Mol. Med.</source>
          <year>2016</year>
          <volume>94</volume>
          <fpage>523</fpage>
          <lpage>534</lpage>
          <pub-id pub-id-type="doi">10.1007/s00109-016-1391-6</pub-id>
          <pub-id pub-id-type="pmid">26923718</pub-id>
        </element-citation>
      </ref>
      <ref id="B51-cancers-13-00821">
        <label>51.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Borst</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ahrends</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Babala</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Melief</surname>
              <given-names>C.J.M.</given-names>
            </name>
            <name>
              <surname>Kastenmuller</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <article-title>CD4(+) T cell help in cancer immunology and immunotherapy</article-title>
          <source>Nat. Rev. Immunol.</source>
          <year>2018</year>
          <volume>18</volume>
          <fpage>635</fpage>
          <lpage>647</lpage>
          <pub-id pub-id-type="doi">10.1038/s41577-018-0044-0</pub-id>
          <pub-id pub-id-type="pmid">30057419</pub-id>
        </element-citation>
      </ref>
      <ref id="B52-cancers-13-00821">
        <label>52.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Perez-Diez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Joncker</surname>
              <given-names>N.T.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>W.F.</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Lantz</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Matzinger</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>CD4 cells can be more efficient at tumor rejection than CD8 cells</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>109</volume>
          <fpage>5346</fpage>
          <lpage>5354</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2006-10-051318</pub-id>
          <pub-id pub-id-type="pmid">17327412</pub-id>
        </element-citation>
      </ref>
      <ref id="B53-cancers-13-00821">
        <label>53.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rivera Vargas</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Humblin</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Vegran</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ghiringhelli</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Apetoh</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>TH9 cells in anti-tumor immunity</article-title>
          <source>Semin. Immunopathol.</source>
          <year>2017</year>
          <volume>39</volume>
          <fpage>39</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="doi">10.1007/s00281-016-0599-4</pub-id>
          <pub-id pub-id-type="pmid">27832300</pub-id>
        </element-citation>
      </ref>
      <ref id="B54-cancers-13-00821">
        <label>54.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruiz de Morales</surname>
              <given-names>J.M.G.</given-names>
            </name>
            <name>
              <surname>Puig</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Dauden</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Canete</surname>
              <given-names>J.D.</given-names>
            </name>
            <name>
              <surname>Pablos</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>A.O.</given-names>
            </name>
            <name>
              <surname>Juanatey</surname>
              <given-names>C.G.</given-names>
            </name>
            <name>
              <surname>Adan</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Montalban</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Borruel</surname>
              <given-names>N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies</article-title>
          <source>Autoimmun. Rev.</source>
          <year>2020</year>
          <volume>19</volume>
          <fpage>102429</fpage>
          <pub-id pub-id-type="doi">10.1016/j.autrev.2019.102429</pub-id>
          <pub-id pub-id-type="pmid">31734402</pub-id>
        </element-citation>
      </ref>
      <ref id="B55-cancers-13-00821">
        <label>55.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zanetti</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Tapping CD4 T cells for cancer immunotherapy: The choice of personalized genomics</article-title>
          <source>J. Immunol.</source>
          <year>2015</year>
          <volume>194</volume>
          <fpage>2049</fpage>
          <lpage>2056</lpage>
          <pub-id pub-id-type="doi">10.4049/jimmunol.1402669</pub-id>
          <pub-id pub-id-type="pmid">25710958</pub-id>
        </element-citation>
      </ref>
      <ref id="B56-cancers-13-00821">
        <label>56.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jackson</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Yuan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Teague</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Targeting CD8+ T-cell tolerance for cancer immunotherapy</article-title>
          <source>Immunotherapy</source>
          <year>2014</year>
          <volume>6</volume>
          <fpage>833</fpage>
          <lpage>852</lpage>
          <pub-id pub-id-type="doi">10.2217/imt.14.51</pub-id>
          <pub-id pub-id-type="pmid">25290416</pub-id>
        </element-citation>
      </ref>
      <ref id="B57-cancers-13-00821">
        <label>57.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mittrucker</surname>
              <given-names>H.W.</given-names>
            </name>
            <name>
              <surname>Visekruna</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Huber</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Heterogeneity in the differentiation and function of CD8(+) T cells</article-title>
          <source>Arch. Immunol. Ther. Exp.</source>
          <year>2014</year>
          <volume>62</volume>
          <fpage>449</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="doi">10.1007/s00005-014-0293-y</pub-id>
        </element-citation>
      </ref>
      <ref id="B58-cancers-13-00821">
        <label>58.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fousek</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ahmed</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>The Evolution of T-cell Therapies for Solid Malignancies</article-title>
          <source>Clin. Cancer Res.</source>
          <year>2015</year>
          <volume>21</volume>
          <fpage>3384</fpage>
          <lpage>3392</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-14-2675</pub-id>
          <pub-id pub-id-type="pmid">26240290</pub-id>
        </element-citation>
      </ref>
      <ref id="B59-cancers-13-00821">
        <label>59.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harris</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Kranz</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors</article-title>
          <source>Trends Pharmacol. Sci.</source>
          <year>2016</year>
          <volume>37</volume>
          <fpage>220</fpage>
          <lpage>230</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tips.2015.11.004</pub-id>
          <pub-id pub-id-type="pmid">26705086</pub-id>
        </element-citation>
      </ref>
      <ref id="B60-cancers-13-00821">
        <label>60.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sommermeyer</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hudecek</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kosasih</surname>
              <given-names>P.L.</given-names>
            </name>
            <name>
              <surname>Gogishvili</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Maloney</surname>
              <given-names>D.G.</given-names>
            </name>
            <name>
              <surname>Turtle</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Riddell</surname>
              <given-names>S.R.</given-names>
            </name>
          </person-group>
          <article-title>Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo</article-title>
          <source>Leukemia</source>
          <year>2016</year>
          <volume>30</volume>
          <fpage>492</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="doi">10.1038/leu.2015.247</pub-id>
          <pub-id pub-id-type="pmid">26369987</pub-id>
        </element-citation>
      </ref>
      <ref id="B61-cancers-13-00821">
        <label>61.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Kohler</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Chien</surname>
              <given-names>C.D.</given-names>
            </name>
            <name>
              <surname>Sauter</surname>
              <given-names>C.T.</given-names>
            </name>
            <name>
              <surname>Jacoby</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wanhainen</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Fry</surname>
              <given-names>T.J.</given-names>
            </name>
          </person-group>
          <article-title>TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance</article-title>
          <source>Sci. Transl. Med.</source>
          <year>2017</year>
          <volume>9</volume>
          <pub-id pub-id-type="doi">10.1126/scitranslmed.aag1209</pub-id>
        </element-citation>
      </ref>
      <ref id="B62-cancers-13-00821">
        <label>62.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takada</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Jameson</surname>
              <given-names>S.C.</given-names>
            </name>
          </person-group>
          <article-title>Self-class I MHC molecules support survival of naive CD8 T cells, but depress their functional sensitivity through regulation of CD8 expression levels</article-title>
          <source>J. Exp. Med.</source>
          <year>2009</year>
          <volume>206</volume>
          <fpage>2253</fpage>
          <lpage>2269</lpage>
          <pub-id pub-id-type="doi">10.1084/jem.20082553</pub-id>
          <pub-id pub-id-type="pmid">19752186</pub-id>
        </element-citation>
      </ref>
      <ref id="B63-cancers-13-00821">
        <label>63.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donnelly</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>H.A.</given-names>
            </name>
            <name>
              <surname>Rosenberg</surname>
              <given-names>A.S.</given-names>
            </name>
          </person-group>
          <article-title>An overview of cytokines and cytokine antagonists as therapeutic agents</article-title>
          <source>Ann. N. Y. Acad. Sci.</source>
          <year>2009</year>
          <volume>1182</volume>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05382.x</pub-id>
          <pub-id pub-id-type="pmid">20074270</pub-id>
        </element-citation>
      </ref>
      <ref id="B64-cancers-13-00821">
        <label>64.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koizumi</surname>
              <given-names>S.I.</given-names>
            </name>
            <name>
              <surname>Ishikawa</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional Regulation of Differentiation and Functions of Effector T Regulatory Cells</article-title>
          <source>Cells</source>
          <year>2019</year>
          <volume>8</volume>
          <elocation-id>939</elocation-id>
          <pub-id pub-id-type="doi">10.3390/cells8080939</pub-id>
          <pub-id pub-id-type="pmid">31434282</pub-id>
        </element-citation>
      </ref>
      <ref id="B65-cancers-13-00821">
        <label>65.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ding</surname>
              <given-names>Z.C.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Blazar</surname>
              <given-names>B.R.</given-names>
            </name>
            <name>
              <surname>Yagita</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Mellor</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Munn</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Polyfunctional CD4(+) T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>120</volume>
          <fpage>2229</fpage>
          <lpage>2239</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2011-12-398321</pub-id>
          <pub-id pub-id-type="pmid">22859605</pub-id>
        </element-citation>
      </ref>
      <ref id="B66-cancers-13-00821">
        <label>66.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eby</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Riley</surname>
              <given-names>T.P.</given-names>
            </name>
            <name>
              <surname>Cosgrove</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ankney</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Henning</surname>
              <given-names>S.W.</given-names>
            </name>
            <name>
              <surname>Paulos</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Garrett-Mayer</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Luiten</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Nishimura</surname>
              <given-names>M.I.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Molecular properties of gp100-reactive T-cell receptors drive the cytokine profile and antitumor efficacy of transgenic host T cells</article-title>
          <source>Pigment. Cell Melanoma Res.</source>
          <year>2019</year>
          <volume>32</volume>
          <fpage>68</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="doi">10.1111/pcmr.12724</pub-id>
          <pub-id pub-id-type="pmid">30009548</pub-id>
        </element-citation>
      </ref>
      <ref id="B67-cancers-13-00821">
        <label>67.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Greenplate</surname>
              <given-names>A.R.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>D.B.</given-names>
            </name>
            <name>
              <surname>Ferrell</surname>
              <given-names>P.B.</given-names>
              <suffix>Jr.</suffix>
            </name>
            <name>
              <surname>Irish</surname>
              <given-names>J.M.</given-names>
            </name>
          </person-group>
          <article-title>Systems immune monitoring in cancer therapy</article-title>
          <source>Eur. J. Cancer</source>
          <year>2016</year>
          <volume>61</volume>
          <fpage>77</fpage>
          <lpage>84</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ejca.2016.03.085</pub-id>
          <pub-id pub-id-type="pmid">27155446</pub-id>
        </element-citation>
      </ref>
      <ref id="B68-cancers-13-00821">
        <label>68.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Clay</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Hobeika</surname>
              <given-names>A.C.</given-names>
            </name>
            <name>
              <surname>Mosca</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Lyerly</surname>
              <given-names>H.K.</given-names>
            </name>
            <name>
              <surname>Morse</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Assays for Monitoring Cellular Immune Responses to Active Immunotherapy of Cancer</article-title>
          <source>Clin. Cancer Res.</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>1127</fpage>
          <lpage>1135</lpage>
          <pub-id pub-id-type="pmid">11350875</pub-id>
        </element-citation>
      </ref>
      <ref id="B69-cancers-13-00821">
        <label>69.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diefenbach</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Raphael</surname>
              <given-names>B.G.</given-names>
            </name>
            <name>
              <surname>Hymes</surname>
              <given-names>K.B.</given-names>
            </name>
            <name>
              <surname>Grossbard</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Moskovits</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Ruan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Leonard</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Chattopadhyay</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of the Functional Landscape of Systemic Immunity in Classical Hodgkin Using a Novel Single Cell Platform (Isolight)</article-title>
          <source>Blood</source>
          <year>2019</year>
          <volume>134</volume>
          <fpage>3980</fpage>
          <pub-id pub-id-type="doi">10.1182/blood-2019-128366</pub-id>
        </element-citation>
      </ref>
      <ref id="B70-cancers-13-00821">
        <label>70.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ji</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Rubin</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Thrane</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Reynolds</surname>
              <given-names>D.L.</given-names>
            </name>
            <name>
              <surname>Meyers</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>M.G.</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Mollbrink</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bergenstrahle</surname>
              <given-names>J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma</article-title>
          <source>Cell</source>
          <year>2020</year>
          <volume>182</volume>
          <fpage>497</fpage>
          <lpage>514</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2020.05.039</pub-id>
          <pub-id pub-id-type="pmid">32579974</pub-id>
        </element-citation>
      </ref>
      <ref id="B71-cancers-13-00821">
        <label>71.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mocciaro</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Roth</surname>
              <given-names>T.L.</given-names>
            </name>
            <name>
              <surname>Bennett</surname>
              <given-names>H.M.</given-names>
            </name>
            <name>
              <surname>Soumillon</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hiatt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Chapman</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Marson</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Lavieu</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Light-activated cell identification and sorting (LACIS) for selection of edited clones on a nanofluidic device</article-title>
          <source>Commun. Biol.</source>
          <year>2018</year>
          <volume>1</volume>
          <fpage>41</fpage>
          <pub-id pub-id-type="doi">10.1038/s42003-018-0034-6</pub-id>
          <pub-id pub-id-type="pmid">30271925</pub-id>
        </element-citation>
      </ref>
      <ref id="B72-cancers-13-00821">
        <label>72.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siebert</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>E.B.</given-names>
            </name>
          </person-group>
          <article-title>Monitoring cytokine profiles during immunotherapy</article-title>
          <source>Immunotherapy</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>799</fpage>
          <lpage>816</lpage>
          <pub-id pub-id-type="doi">10.2217/imt.10.76</pub-id>
          <pub-id pub-id-type="pmid">21091113</pub-id>
        </element-citation>
      </ref>
      <ref id="B73-cancers-13-00821">
        <label>73.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lovelace</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Maecker</surname>
              <given-names>H.T.</given-names>
            </name>
          </person-group>
          <article-title>Multiparameter intracellular cytokine staining</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2011</year>
          <volume>699</volume>
          <fpage>165</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-61737-950-5_8</pub-id>
          <pub-id pub-id-type="pmid">21116983</pub-id>
        </element-citation>
      </ref>
      <ref id="B74-cancers-13-00821">
        <label>74.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spitzer</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Nolan</surname>
              <given-names>G.P.</given-names>
            </name>
          </person-group>
          <article-title>Mass Cytometry: Single Cells, Many Features</article-title>
          <source>Cell</source>
          <year>2016</year>
          <volume>165</volume>
          <fpage>780</fpage>
          <lpage>791</lpage>
          <pub-id pub-id-type="doi">10.1016/j.cell.2016.04.019</pub-id>
          <pub-id pub-id-type="pmid">27153492</pub-id>
        </element-citation>
      </ref>
      <ref id="B75-cancers-13-00821">
        <label>75.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gadalla</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Noamani</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>MacLeod</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Dickson</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Lukhele</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Elsaesser</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Razak</surname>
              <given-names>A.R.A.</given-names>
            </name>
            <name>
              <surname>Hirano</surname>
              <given-names>N.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Validation of CyTOF Against Flow Cytometry for Immunological Studies and Monitoring of Human Cancer Clinical Trials</article-title>
          <source>Front. Oncol.</source>
          <year>2019</year>
          <volume>9</volume>
          <fpage>415</fpage>
          <pub-id pub-id-type="doi">10.3389/fonc.2019.00415</pub-id>
          <pub-id pub-id-type="pmid">31165047</pub-id>
        </element-citation>
      </ref>
      <ref id="B76-cancers-13-00821">
        <label>76.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>L.M.</given-names>
            </name>
            <name>
              <surname>Lannigan</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Jaimes</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>OMIP-069: Forty-Color Full Spectrum Flow Cytometry Panel for Deep Immunophenotyping of Major Cell Subsets in Human Peripheral Blood</article-title>
          <source>Cytom. A</source>
          <year>2020</year>
          <volume>97</volume>
          <fpage>1044</fpage>
          <lpage>1051</lpage>
          <pub-id pub-id-type="doi">10.1002/cyto.a.24213</pub-id>
          <pub-id pub-id-type="pmid">32830910</pub-id>
        </element-citation>
      </ref>
      <ref id="B77-cancers-13-00821">
        <label>77.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kukurba</surname>
              <given-names>K.R.</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>S.B.</given-names>
            </name>
          </person-group>
          <article-title>RNA Sequencing and Analysis</article-title>
          <source>Cold Spring Harb. Protoc.</source>
          <year>2015</year>
          <volume>2015</volume>
          <fpage>951</fpage>
          <lpage>969</lpage>
          <pub-id pub-id-type="doi">10.1101/pdb.top084970</pub-id>
          <pub-id pub-id-type="pmid">25870306</pub-id>
        </element-citation>
      </ref>
      <ref id="B78-cancers-13-00821">
        <label>78.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Choi</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Yong</surname>
              <given-names>K.W.</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Cowie</surname>
              <given-names>A.C.</given-names>
            </name>
          </person-group>
          <article-title>Single-Cell RNA Sequencing and Its Combination with Protein and DNA Analyses</article-title>
          <source>Cells</source>
          <year>2020</year>
          <volume>9</volume>
          <elocation-id>1130</elocation-id>
          <pub-id pub-id-type="doi">10.3390/cells9051130</pub-id>
        </element-citation>
      </ref>
      <ref id="B79-cancers-13-00821">
        <label>79.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mocellin</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Provenzano</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>C.R.</given-names>
            </name>
            <name>
              <surname>Pilati</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Nitti</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lise</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment</article-title>
          <source>J. Immunol. Methods</source>
          <year>2003</year>
          <volume>280</volume>
          <fpage>1</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-1759(03)00274-6</pub-id>
          <pub-id pub-id-type="pmid">12972183</pub-id>
        </element-citation>
      </ref>
      <ref id="B80-cancers-13-00821">
        <label>80.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Rissin</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Fournier</surname>
              <given-names>D.R.</given-names>
            </name>
            <name>
              <surname>Piech</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>P.P.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>D.H.</given-names>
            </name>
            <name>
              <surname>Duffy</surname>
              <given-names>D.C.</given-names>
            </name>
          </person-group>
          <article-title>Single molecule enzyme-linked immunosorbent assays: Theoretical considerations</article-title>
          <source>J. Immunol. Methods</source>
          <year>2012</year>
          <volume>378</volume>
          <fpage>102</fpage>
          <lpage>115</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jim.2012.02.011</pub-id>
          <pub-id pub-id-type="pmid">22370429</pub-id>
        </element-citation>
      </ref>
      <ref id="B81-cancers-13-00821">
        <label>81.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chiswick</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Duffy</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Japp</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Remick</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Detection and quantification of cytokines and other biomarkers</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2012</year>
          <volume>844</volume>
          <fpage>15</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-61779-527-5_2</pub-id>
          <pub-id pub-id-type="pmid">22262432</pub-id>
        </element-citation>
      </ref>
      <ref id="B82-cancers-13-00821">
        <label>82.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Blank</surname>
              <given-names>C.U.</given-names>
            </name>
          </person-group>
          <article-title>A user&#x2019;s perspective on GeoMxTM digital spatial profiling</article-title>
          <source>Immuno-Oncol. Technol.</source>
          <year>2019</year>
          <volume>1</volume>
          <fpage>11</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1016/j.iotech.2019.05.001</pub-id>
        </element-citation>
      </ref>
      <ref id="B83-cancers-13-00821">
        <label>83.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Young</surname>
              <given-names>H.A.</given-names>
            </name>
          </person-group>
          <article-title>Cytokine multiplex analysis</article-title>
          <source>Methods Mol. Biol.</source>
          <year>2009</year>
          <volume>511</volume>
          <fpage>85</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="doi">10.1007/978-1-59745-447-6_4</pub-id>
          <pub-id pub-id-type="pmid">19347294</pub-id>
        </element-citation>
      </ref>
      <ref id="B84-cancers-13-00821">
        <label>84.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chowdhury</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Williams</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling</article-title>
          <source>J. Immunol. Methods</source>
          <year>2009</year>
          <volume>340</volume>
          <fpage>55</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jim.2008.10.002</pub-id>
          <pub-id pub-id-type="pmid">18983846</pub-id>
        </element-citation>
      </ref>
      <ref id="B85-cancers-13-00821">
        <label>85.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Thurin</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cesano</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Marincola</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <source>Biomarkers for Immunotherapy of Cancer: Methods and Protocols</source>
          <publisher-name>Humana Press</publisher-name>
          <publisher-loc>Totowa, NJ, USA</publisher-loc>
          <year>2020</year>
          <fpage>731</fpage>
        </element-citation>
      </ref>
      <ref id="B86-cancers-13-00821">
        <label>86.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Teves</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Won</surname>
              <given-names>K.J.</given-names>
            </name>
          </person-group>
          <article-title>Mapping Cellular Coordinates through Advances in Spatial Transcriptomics Technology</article-title>
          <source>Mol. Cells</source>
          <year>2020</year>
          <volume>43</volume>
          <fpage>591</fpage>
          <lpage>599</lpage>
          <pub-id pub-id-type="doi">10.14348/molcells.2020.0020</pub-id>
          <pub-id pub-id-type="pmid">32507771</pub-id>
        </element-citation>
      </ref>
      <ref id="B87-cancers-13-00821">
        <label>87.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ho</surname>
              <given-names>J.Y.</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Xuan</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ba</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evidence of long-lasting anti-CD19 activity of engrafted CD19 chimeric antigen receptor&#x2013;modified T cells in a phase I study targeting pediatrics with acute lymphoblastic leukemia</article-title>
          <source>Hematol. Oncol.</source>
          <year>2019</year>
          <volume>37</volume>
          <fpage>601</fpage>
          <lpage>608</lpage>
          <pub-id pub-id-type="doi">10.1002/hon.2672</pub-id>
          <pub-id pub-id-type="pmid">31465532</pub-id>
        </element-citation>
      </ref>
      <ref id="B88-cancers-13-00821">
        <label>88.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>J.H.</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>F.A.</given-names>
            </name>
            <name>
              <surname>Taur</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sadelain</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brentjens</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Hohl</surname>
              <given-names>T.M.</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <article-title>Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells</article-title>
          <source>Clin. Infect. Dis.</source>
          <year>2018</year>
          <volume>67</volume>
          <fpage>533</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="doi">10.1093/cid/ciy152</pub-id>
          <pub-id pub-id-type="pmid">29481659</pub-id>
        </element-citation>
      </ref>
      <ref id="B89-cancers-13-00821">
        <label>89.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gofshteyn</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Teachey</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Grupp</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Maude</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Banwell</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lacey</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Melenhorst</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Edmonson</surname>
              <given-names>M.J.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neurotoxicity after CTL019 in a pediatric and young adult cohort</article-title>
          <source>Ann. Neurol.</source>
          <year>2018</year>
          <volume>84</volume>
          <fpage>537</fpage>
          <lpage>546</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.25315</pub-id>
          <pub-id pub-id-type="pmid">30178481</pub-id>
        </element-citation>
      </ref>
      <ref id="B90-cancers-13-00821">
        <label>90.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirayama</surname>
              <given-names>A.V.</given-names>
            </name>
            <name>
              <surname>Gauthier</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hay</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Voutsinas</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Gooley</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Cherian</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Pender</surname>
              <given-names>B.S.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells</article-title>
          <source>Blood</source>
          <year>2019</year>
          <volume>133</volume>
          <fpage>1876</fpage>
          <lpage>1887</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2018-11-887067</pub-id>
          <pub-id pub-id-type="pmid">30782611</pub-id>
        </element-citation>
      </ref>
      <ref id="B91-cancers-13-00821">
        <label>91.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Paczkowski</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Shen</surname>
              <given-names>Y.-W.</given-names>
            </name>
            <name>
              <surname>Morse</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Flynn</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kaiser</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Gallatin</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Cain</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL</article-title>
          <source>Blood</source>
          <year>2018</year>
          <volume>132</volume>
          <fpage>804</fpage>
          <lpage>814</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2018-01-828343</pub-id>
          <pub-id pub-id-type="pmid">29895668</pub-id>
        </element-citation>
      </ref>
      <ref id="B92-cancers-13-00821">
        <label>92.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kochenderfer</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Dudley</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Feldman</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>W.H.</given-names>
            </name>
            <name>
              <surname>Spaner</surname>
              <given-names>D.E.</given-names>
            </name>
            <name>
              <surname>Maric</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Stetler-Stevenson</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Phan</surname>
              <given-names>G.Q.</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Sherry</surname>
              <given-names>R.M.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells</article-title>
          <source>Blood</source>
          <year>2012</year>
          <volume>119</volume>
          <fpage>2709</fpage>
          <lpage>2720</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2011-10-384388</pub-id>
          <pub-id pub-id-type="pmid">22160384</pub-id>
        </element-citation>
      </ref>
      <ref id="B93-cancers-13-00821">
        <label>93.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Turtle</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Hanafi</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Hudecek</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Pender</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Hawkins</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Chaney</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cherian</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Immunotherapy of non-Hodgkin&#x2019;s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells</article-title>
          <source>Sci. Transl. Med.</source>
          <year>2016</year>
          <volume>8</volume>
          <fpage>355ra116</fpage>
          <pub-id pub-id-type="doi">10.1126/scitranslmed.aaf8621</pub-id>
          <pub-id pub-id-type="pmid">27605551</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="cancers-13-00821-f001" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>T cell Infiltration per se does not define tumor regression. P607 tumor tissue was surgically resected from a metastatic melanoma patient, revealing abundant T cell infiltration by immunoperoxidase labeled anti-CD8 (red) and alkaline phosphatase labeled anti-CD3 staining (blue). Cytokine analysis of tumor homogenates can reveal the prevailing immune response to better understand tumor expansion despite heavy T cell presence.</p>
      </caption>
      <graphic xlink:href="cancers-13-00821-g001"/>
    </fig>
    <fig id="cancers-13-00821-f002" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>CD4<sup>+</sup> and CD8<sup>+</sup> T cell identity and functions are regulated by a palette of cytokines. CD4<sup>+</sup> and CD8<sup>+</sup> T cells interact within the tumor microenvironment and secrete different sets of cytokines, which control several and distinct immune responses, represented by different colors in the diagram. Cytokines secreted by each T cell type are as follows: IFN-&#x3B3;, IL-2, TNF-&#x3B1;, and TNF-&#x3B2; by TH1, IL-4 and IL-10 by Th2, IL-9 by TH9, IL-17, IL-17F, IL-21, and IL-22 by Th17, IFN-&#x3B3; and TNF-&#x3B1; by TC1, IL-4 and IL-12 byTC2, IL-9 by TC9, and IL-17A, IFN-&#x3B3;, TNF-&#x3B1;, IL-21, and IL-22 by TC17. Arrow thickness and size represent the magnitude of influence that a specific subset of cytokines have on the tumor microenvironment immune responses. CD8<sup>+</sup> T cell functions are regulated by CD4<sup>+</sup> T cells and the cross talk between the two cell types is critical for establishing an effective anti-tumor immunity and microenvironment. Figure created with BioRender.com.</p>
      </caption>
      <graphic xlink:href="cancers-13-00821-g002"/>
    </fig>
    <table-wrap id="cancers-13-00821-t001" orientation="portrait" position="float">
      <object-id pub-id-type="pii">cancers-13-00821-t001_Table 1</object-id>
      <label>Table 1</label>
      <caption>
        <p>Correlating cytokine profiles and T cell responses.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cytokines Probed and Monitoring Methods</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Patients/Source of T Cells</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cancer Type and Treatment</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">T cell Treatment Outcome Response and Correlated Cytokine</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#1 [<xref rid="B27-cancers-13-00821" ref-type="bibr">27</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-&#x3B3;, IL-2, TNF-&#x3B1;<break/>FACS analysis, ICS, ELISpot</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Healthy donors</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CD3<sup>+</sup> T cells isolated from peripheral blood</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-2 (mostly among CD8<sup>&#x2212;</sup> T cells) and IFN-&#x3B3; secreting cells increased, TNF-&#x3B1; secreting cells decreased.<break/><italic>IFN-</italic><italic>&#x3B3; and IL-2 secreting cytokines showed functional state persistence.</italic></td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#2 [<xref rid="B28-cancers-13-00821" ref-type="bibr">28</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF-&#x3B1; IFN-&#x3B3;, IL-10, IL-17, IL-2<break/>Intracellular cytokine staining of CD4<sup>+</sup> and CD8<sup>+</sup> T cells, in renal parenchyma tissues</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peripheral blood, fresh tumor, and autologous renal parenchyma</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal cell carcinoma <break/>PBMC and TIL thawed and analyzed for cytokine release.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-10 increased among CD4<sup>+</sup> and CD8<sup>+</sup> subsets; TNF-&#x3B1; (CD4<sup>+</sup> and CD8<sup>+</sup>), IFN-&#x3B3; (CD8<sup>+</sup>) increased after activation. Some patients had increased IL-17 in CD4<sup>+</sup> TIL. CD107a surface expression found in CD8<sup>+</sup> and some CD4<sup>+</sup> cells post- activation.<break/><italic>Cytokine secretion pattern of responders: TNF-</italic><italic>&#x3B1;, IFN-</italic><italic>&#x3B3;, IL-2 with little IL-5.</italic></td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#3 [<xref rid="B29-cancers-13-00821" ref-type="bibr">29</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNF, IFN-&#x3B3;, CD107a (cytotoxicity marker).<break/>FACS analysis, cytotoxicity assays, phenotype analysis, flow cytometry</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serial blood sample obtained from TIL treated patients</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Melanoma <break/>IL-2 based TIL therapy</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CD8<sup>+</sup> T cells expressing CD107a were fewer than cytokine producing cells.<break/><italic>Most CD107a + cells also produced one cytokine.</italic></td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#4 [<xref rid="B30-cancers-13-00821" ref-type="bibr">30</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-&#x3B3;, TNF-&#x3B1;, CCL3 <break/>IFN&#x3B3; ELISPOT assay, FlowJo</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 CMV seropositive patients</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glioblastoma <break/>In vitro generation of (CMV) pp65 T cells and CMV pp65- DCs from PBMCs</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patients receiving CMV pp65 T cells had more IFN&#x3B3;<sup>+</sup>, TNF&#x3B1;<sup>+</sup> CCL3<sup>+</sup> pp65 specific CD8<sup>+</sup> T cells.<break/><italic>Survival in treated patients correlated with expression of IFN</italic><italic>&#x3B3;, TNF</italic><italic>&#x3B1; and CCL3.</italic></td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#5 [<xref rid="B31-cancers-13-00821" ref-type="bibr">31</xref>].</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-&#x3B3;<sup>2</sup>,TNF-&#x3B1;<sup>1,2</sup>, IL-2, IL-12, IL-18, IL-21 CCL4<sup>1,2</sup>, CD107a<sup>2</sup>(cytotoxicity marker)<break/>Flow cytometry, ELISA, Bio-Plex</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bulk ascites cell preparations from high-grade serous EOC patients</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Epithelial ovarian cancer (EOC)<break/>Exogenous cytokine therapy and introduction of EOC ascites environment on T&#x2014;cell polyfunctionality</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-1<sup>+</sup>, IL-12<sup>+</sup> IL-18 enhanced IFN&#x3B3; (by CD8<sup>+</sup> cells), TNF-&#x3B1;, and CCL4 expression<break/><italic>Cytokine combination synergistically induced polyfunctional responses and decreased cytokine negative or monofunctional T cells.</italic></td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#6 [<xref rid="B32-cancers-13-00821" ref-type="bibr">32</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-&#x3B3;<sup>3</sup>, TNF-&#x3B1;<sup>3</sup> IL-2<sup>3</sup><break/>Flow cytometry, immunohistochemistry</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 treatment- na&#xEF;ve NSCLC patients with clinical stage I-Iva tumors.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-small cell lung cancers (NSCLC)<break/>TIL therapy</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CD4<sup>+</sup>/CD8<sup>+</sup> cells producing either 2 or 3 of the cytokines were most informative.<break/><italic>TNF</italic><italic>&#x3B1; and IL-2 were crucial to T cell mediated immunity.</italic></td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
    <table-wrap id="cancers-13-00821-t002" orientation="portrait" position="float">
      <object-id pub-id-type="pii">cancers-13-00821-t002_Table 2</object-id>
      <label>Table 2</label>
      <caption>
        <p>Correlation between cytokine detection and treatment outcomes in clinical trials using CD19- targeted CAR-modified T cells.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Patient/Sample Measured</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cytokines Probed</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Monitoring Techniques</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Patient Outcomes</th>
            <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Correlation between Cytokines Detected and CAR T Cell Function</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study 1: NCT02963038 [<xref rid="B87-cancers-13-00821" ref-type="bibr">87</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 patients<break/>Serum concentration</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Il-1&#x3B2;, IFN-&#x3B1;2, IFN-&#x3B3;, TNF-&#x3B1;, MCP-1, IL-6, IL-8, IL-10, IL-12p70, IL-17A, Il-18A, IL-18, IL-23, IL-33</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flow cytometry, qPCR</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">80% achieved MRD 30% have remained in remission state. 10% achieved complete remission. Long-term engrafted CAR-T cell clone CD19 activity observed in one patient for &gt;2 years.<break/>40% experienced grade 2 or higher CRS.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High concentrations of IFN-&#x3B3;, IL-6, IL-8, IL-18, and MCP-1 correlate with CAR-T cell expansion.</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study 2: NCT01044069 [<xref rid="B88-cancers-13-00821" ref-type="bibr">88</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53 patients<break/>Serial serum samples</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-&#x3B3;, IL-6, IL-10, IL-15, TNF-&#x3B1;</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Luminex FlexMAP 3D system, 38-plex cytokine detection assays</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83% achieved complete remission<break/>42% experienced infections.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cytokine Release Syndrome (CRS) secretion of:<break/>IFN-&#x3B3;: expressed by a greater # of patients w/o infection.<break/>IL-6: Patients with CRS grade 2 and 3 had more infections than without. <break/>IL-10: expressed by a greater # of patients without infection.<break/>Il-15: Patients with CRS grade 3 had slightly more infections than without.<break/>TNF-&#x3B1;: Patients with grades 4-5 CRS had more infections than without.</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study 3: NCT01626495 [<xref rid="B89-cancers-13-00821" ref-type="bibr">89</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 patients <break/>Serum concentration levels</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43 cytokines tested (not individually listed)</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Luminex bead array, FlexMap 3D system</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98% saw B-cell ALL with CD19 expression <break/>Neurotoxicity observed in 46% patients.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serum IL-2, IL-15, IL-4, and HGF concentrations were notably higher in patients with neurotoxicity.<break/>TNFR-1 significantly higher in patients with encephalopathy.<break/>22 cytokines accurately predict neurotoxicity.<break/>Predicting regression: IL-12, sgp130, sRAGE, sTNFR-1, sVEGFR, and sVEGFR2.</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study 4: NCT01865617 [<xref rid="B90-cancers-13-00821" ref-type="bibr">90</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47 patients <break/>Serum concentrations</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL-7, IL-15</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">qPCR, Luminex Assay</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Objective response observed in 51% of patients. 40% achieved complete remission<break/>CRS grade 1&#x2013;3 observed in a subset of patients</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High levels of IL-7 correlate with favorable outcomes.<break/>IL-7 concentration increases along with serum IL-15 levels.</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study 5: NCT00924326. [<xref rid="B91-cancers-13-00821" ref-type="bibr">91</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 patients<break/>Coculture and Serum concentrations</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 total cytokines: Granzyme B, IFN-&#x3B3;, MIP-1&#x3B1;, perforin, TNF-&#x3B1;, TNF-&#x3B2;,IL-2, IL-5, IL-7, IL-8, IL-9, IL-12, IL-15, IL-21 IL-2, IL-10, IL-13, IL-22, TGF-&#x3B2;1, IL-1B, IL-6, IL-17A, IL-17F, MCP-1, MCP-4, CCL-11, IP-10, MIP-1&#x3B2;, sCD137, sCD40L, RANTES</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PCR, MULTI-SPOT, EMD Millipore Luminex xMAP multiplex assays.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">70% objective response to CAR-T cell therapy.<break/>65% observable CRS of grade 3 or higher.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Both polyfunctional CD4<sup>+</sup> and CD8<sup>+</sup> T cells secrete: IFN-&#x3B3;, IL-8, IL-5, granzyme B, and/or MIP-1&#x3B1;.<break/>CD4+ population contained IL-17A<sup>+</sup> polyfunctional T cells.<break/>Responders had higher levels of inflammatory, regulatory, chemoattractive, stimulatory, and effector cytokines).</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study 6: NCT00924326. [<xref rid="B92-cancers-13-00821" ref-type="bibr">92</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 patients <break/>Serum concentration</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-&#x3B3;, TNF, IL-2, CD107a (cytotoxicity marker)</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ELISA, ICS followed by flow cytometry detection, CD107a degranulation assay. PCR</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75% attained remission. 50% had prominently elevated serum levels of IFN-&#x3B3; and TNF</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CAR T cells were the source of inflammatory cytokines IFN-&#x3B3; and TNF found in some patient sera.</td>
          </tr>
          <tr>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Study 7: NCT01865617 [<xref rid="B93-cancers-13-00821" ref-type="bibr">93</xref>]</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37 patients: relapsed or refractory CD19<sup>+</sup> NHL<break/>Serum concentrations</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IFN-&#x3B3; IL-6, IL-8, IL-10, IL-15, TGF-&#x3B2;</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Luminex Assay</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">89% receiving CAR T cell infusion saw objective response.<break/>Severe CRS observed in 4/32 patients post Cy/Flu conditioning. Severe neurotoxicity observed in 9/32 patients.</td>
            <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cy/Flu conditioning induced higher response rates.<break/>Peak serum concentrations for IL-6, and IFN-&#x3B3; observed in correlation with sCRS and Cy/Flu conditioning. <break/>Patients with grade &#x2265; 3 CRS saw increased serum concentrations of IL-6, IFN-&#x3B3;, IL-15, IL-2, IL-18, and reduced TGF-&#x3B2;.<break/>High levels of IL-6, IFN-&#x3B3;, IL-15, IL- 8, and IL-10 and low levels of TGF-&#x3B2; correlated with severe neurotoxicity.</td>
          </tr>
        </tbody>
      </table>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
